data_1yjv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yjv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.897 0 N-CA-C 111.236 -0.746 . . . . 1.98 111.236 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 p -75.54 123.47 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.784 -0.821 . . . . 3.03 108.784 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 tp -146.26 77.37 1.48 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.024 0.44 . . . . 4.02 110.412 -168.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -78.55 76.0 5.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.602 0.715 . . . . 4.23 110.101 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -78.91 156.9 28.38 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.922 0.889 . . . . 3.58 110.908 176.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.24 139.07 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.365 -1.717 . . . . 1.8 106.365 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.9 t -130.83 122.84 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 C-N-CA 126.844 2.058 . . . . 2.96 105.841 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.1 mtp-105 -117.75 164.25 15.28 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.828 1.251 . . . . 6.21 109.815 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.55 -6.88 77.79 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.206 0.908 . . . . 1.19 111.625 -171.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 30.3 mtm -72.81 69.64 0.94 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.189 0.996 . . . . 2.2 110.269 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -69.01 -16.77 63.8 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.165 1.172 . . . . 2.32 114.165 -166.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.0 p -160.53 173.77 15.05 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 120.205 1.366 . . . . 0.77 110.699 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.13 -40.18 45.41 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.991 0.916 . . . . 1.8 111.341 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 m -61.87 -27.41 68.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.625 0.77 . . . . 2.22 112.291 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.4 m -71.15 -61.72 1.66 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.913 -0.773 . . . . 0.67 108.913 164.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.6 t -45.42 -59.23 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.769 0.828 . . . . 2.06 111.572 -170.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -28.32 68.44 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.58 -0.7 . . . . 0.83 112.01 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -70.55 -47.64 59.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.737 -0.838 . . . . 4.85 108.737 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.9 mt -54.09 -55.58 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 108.273 -1.01 . . . . 2.01 108.273 174.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -48.74 -66.98 0.31 Allowed 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 124.357 1.035 . . . . 3.99 110.174 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.4 t -54.83 -39.4 68.52 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.801 0.84 . . . . 1.86 110.88 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.7 t -66.59 -51.12 59.94 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.72 -0.844 . . . . 1.98 108.72 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -60.06 -43.5 95.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.383 -0.823 . . . . 3.41 111.301 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.5 m -59.44 -11.43 4.45 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.87 0.868 . . . . 2.76 112.813 176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -61.79 -35.38 78.0 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.905 -1.122 . . . . 6.45 111.426 167.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -59.57 135.03 57.54 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.308 -0.997 . . . . 4.03 108.308 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -26.54 61.65 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.143 0.883 . . . . 11.01 108.777 162.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.48 41.41 2.08 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 121.604 -0.685 . . . . 1.96 112.643 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 pp -146.17 150.74 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 105.643 -1.984 . . . . 3.39 105.643 172.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.3 mt -104.28 -25.7 12.78 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 123.306 0.379 . . . . 2.76 111.381 167.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -156.34 152.92 28.22 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 118.668 0.667 . . . . 3.56 109.378 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.7 t -143.95 128.24 17.79 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.248 1.019 . . . . 2.49 109.25 164.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.1 t -135.5 92.92 2.89 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.191 1.396 . . . . 2.01 108.708 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.35 152.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 126.009 1.724 . . . . 2.96 111.563 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.23 129.31 8.81 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.705 0.402 . . . . 1.85 110.973 171.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 pp -76.07 -10.25 59.27 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.688 0.795 . . . . 2.2 112.787 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.99 -54.9 17.27 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.025 -0.731 . . . . 2.03 109.025 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -27.38 40.58 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.615 0.766 . . . . 2.42 110.812 174.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.9 m120 71.13 57.81 0.2 Allowed 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 125.352 1.461 . . . . 1.81 107.964 -169.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.44 170.42 15.74 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 112.484 0.549 . . . . 3.08 112.484 -169.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.72 100.17 3.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.631 1.972 . . . . 1.69 109.317 174.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -77.34 82.49 3.8 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 105.307 -2.109 . . . . 1.43 105.307 169.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 pt -85.3 147.63 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-N 114.486 -1.234 . . . . 4.19 108.322 166.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -113.33 104.7 12.58 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 103.54 -2.763 . . . . 4.28 103.54 157.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -98.46 135.47 39.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 124.168 0.917 . . . . 4.05 109.282 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.92 120.38 81.34 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 123.716 0.806 . . . . 3.22 109.221 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.07 2.68 7.8 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.1 1.867 . . . . 1.87 114.524 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -86.55 -43.01 13.04 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 121.414 1.916 . . . . 5.59 109.073 167.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.2 mm -88.15 -46.31 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 112.074 0.398 . . . . 4.19 112.074 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mm -120.71 146.32 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.921 -1.14 . . . . 2.92 107.921 -162.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.0 160.92 12.86 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 108.999 -1.641 . . . . 1.52 108.999 165.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -53.15 -38.38 80.97 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.828 2.352 . . . . 1.91 111.221 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -41.04 20.71 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.565 0.746 . . . . 9.12 111.658 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -66.43 -50.61 62.82 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.105 0.866 . . . . 2.14 109.481 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.1 mp -54.05 -47.05 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 109.709 -0.478 . . . . 2.1 109.709 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mt -55.87 -51.89 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 119.206 -0.426 . . . . 2.59 109.955 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -52.6 -42.75 64.83 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.612 0.642 . . . . 4.44 110.672 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 35.0 m -63.67 -54.84 29.3 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.348 -0.612 . . . . 1.97 109.348 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.3 mt -48.05 -49.59 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.528 1.531 . . . . 2.57 111.042 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -59.55 -49.77 76.5 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.182 0.993 . . . . 2.05 110.483 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.2 t -62.57 -22.82 66.64 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 118.201 -0.904 . . . . 2.26 112.542 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.26 -102.43 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.195 -1.039 . . . . 3.68 108.195 160.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.46 39.22 0.48 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.313 -0.715 . . . . 1.23 111.386 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -128.25 171.37 12.03 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.937 0.869 . . . . 2.81 110.393 -167.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.12 166.15 21.73 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.523 1.129 . . . . 3.21 108.55 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.43 161.8 40.91 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.549 0.613 . . . . 2.28 111.998 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.9 m -156.59 131.54 9.04 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.091 1.356 . . . . 2.06 109.787 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 CA--C 1.53 0.198 0 N-CA-C 108.229 -1.026 . . . . 4.22 108.229 173.499 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.647 0 CA-C-O 119.818 -0.435 . . . . 3.08 113.14 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.3 p -145.77 137.91 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 117.582 0.691 . . . . 3.42 110.178 170.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.5 tp -148.37 119.3 7.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.543 -0.91 . . . . 3.11 108.543 167.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -108.4 121.51 45.09 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.947 -1.501 . . . . 2.94 106.947 167.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -131.02 146.13 52.28 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.629 -0.878 . . . . 3.53 108.629 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -76.22 135.5 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 104.595 -2.372 . . . . 1.75 104.595 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.4 t -125.21 115.92 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 105.088 -2.19 . . . . 3.03 105.088 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -108.44 153.3 23.51 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.779 0.431 . . . . 7.25 110.115 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.24 -5.51 55.62 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.651 1.12 . . . . 1.05 111.985 -171.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 38.1 mtm -74.17 66.94 1.3 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.512 1.156 . . . . 2.32 110.677 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -68.88 -15.3 63.46 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.267 1.21 . . . . 1.9 114.267 -164.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.9 p -160.1 173.05 16.39 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 120.289 1.404 . . . . 0.84 110.508 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.54 -37.21 38.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.864 0.866 . . . . 2.01 111.326 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 t -61.08 -29.27 69.64 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 118.867 -0.587 . . . . 2.89 111.523 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.4 m -71.67 -57.08 4.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.89 0.768 . . . . 0.85 109.551 168.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.9 t -49.6 -60.46 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.472 0.709 . . . . 2.0 111.451 -172.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.86 -29.2 69.05 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.621 -0.674 . . . . 0.97 111.568 -175.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -65.28 -48.35 73.49 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.386 -0.968 . . . . 3.87 108.386 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 79.4 mt -55.4 -55.64 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 108.668 -0.864 . . . . 1.7 108.668 174.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -54.99 -49.95 70.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.425 0.631 . . . . 3.49 110.87 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -56.55 -48.96 76.18 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.885 0.874 . . . . 1.29 110.682 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.3 m -61.65 -42.13 98.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.7 -0.625 . . . . 3.15 110.539 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.64 -54.19 39.69 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.844 1.258 . . . . 3.66 110.671 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.0 p -59.17 -18.59 37.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.151 0.426 . . . . 2.65 112.151 -173.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -50.24 -41.88 50.85 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.271 -0.871 . . . . 5.65 113.008 166.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -67.44 163.73 20.28 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.34 0.973 . . . . 2.26 111.661 -170.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.01 -29.13 11.11 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.391 0.677 . . . . 7.62 112.021 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.57 -14.76 77.57 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 119.918 -0.379 . . . . 1.39 112.491 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -77.86 149.93 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 117.782 0.791 . . . . 3.77 109.113 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 36.6 tp -109.08 -42.89 4.3 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.521 1.928 . . . . 4.56 108.708 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -155.79 163.88 39.27 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.22 0.464 . . . . 3.34 110.949 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.7 t -144.19 118.81 9.77 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 127.084 2.154 . . . . 3.02 106.846 174.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.97 96.74 5.14 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.204 -1.406 . . . . 2.24 107.204 175.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -107.64 141.32 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.23 0.612 . . . . 3.48 111.294 -174.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.47 125.72 9.34 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 123.729 0.811 . . . . 1.91 111.377 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.61 -15.04 60.39 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.522 1.129 . . . . 2.47 112.236 172.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.2 -51.7 68.64 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.012 -0.736 . . . . 2.44 109.012 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.87 -45.28 18.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.625 -0.88 . . . . 2.84 108.625 171.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 83.92 52.9 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 127.696 2.398 . . . . 2.98 107.39 -163.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.61 160.24 40.56 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 122.501 0.32 . . . . 3.33 110.705 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.12 120.06 30.35 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.61 -1.255 . . . . 1.73 107.61 168.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -93.86 94.44 8.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.863 -1.903 . . . . 1.45 105.863 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.45 152.22 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 107.58 -1.267 . . . . 2.91 107.58 174.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -131.95 134.14 45.3 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.416 -2.439 . . . . 3.08 104.416 159.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -161.65 153.69 19.47 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.066 1.346 . . . . 3.66 107.39 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -80.91 124.2 81.65 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 119.044 0.838 . . . . 3.41 109.732 170.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -63.59 -21.17 70.39 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.995 2.463 . . . . 1.8 115.467 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -79.33 -45.59 19.34 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.991 1.269 . . . . 3.67 108.758 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.2 mt -71.71 -38.83 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 120.724 -0.39 . . . . 4.2 111.482 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.48 122.9 45.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 N-CA-C 106.029 -1.841 . . . . 2.66 106.029 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.02 168.29 44.82 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.187 -1.165 . . . . 1.07 110.187 172.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -59.58 -43.08 41.72 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.116 1.878 . . . . 1.22 109.564 170.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -46.0 35.86 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.039 1.335 . . . . 6.85 112.455 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.06 -55.59 31.05 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.864 0.756 . . . . 2.46 110.148 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.6 mt -63.21 -54.37 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.12 -0.491 . . . . 2.03 109.745 -174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.8 mt -49.52 -50.03 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.219 -0.66 . . . . 2.45 109.219 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -70.04 -29.21 66.19 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.622 -0.674 . . . . 5.79 111.813 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.2 m -61.88 -47.27 85.73 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.309 -0.997 . . . . 2.0 108.309 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 78.7 mt -57.37 -43.0 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.234 1.014 . . . . 2.32 111.006 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -57.21 -57.13 13.97 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 109.181 -0.674 . . . . 2.61 109.181 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -55.38 -42.44 73.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.168 1.387 . . . . 2.15 111.144 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.9 mt -61.75 -82.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.565 0.346 . . . . 3.27 111.241 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.66 17.85 0.17 Allowed Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.356 -1.247 . . . . 0.93 114.621 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -137.4 175.13 9.88 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 119.352 1.576 . . . . 3.68 110.916 -153.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -126.44 161.28 28.28 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 107.65 -1.241 . . . . 3.34 107.65 172.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.02 160.03 40.94 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 112.325 0.491 . . . . 2.11 112.325 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 m -155.79 146.59 22.16 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.845 1.658 . . . . 2.36 107.613 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 CA--C 1.534 0.35 0 CA-C-N 118.775 0.716 . . . . 3.36 111.187 -177.669 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.735 0 N-CA-C 109.08 -1.608 . . . . 2.28 109.08 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.96 148.82 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 O-C-N 122.162 -0.61 . . . . 3.1 110.152 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.2 tp -151.43 159.63 44.12 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.077 -1.083 . . . . 4.13 108.077 162.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -141.65 117.29 10.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.43 -1.693 . . . . 4.15 106.43 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.6 mt -118.58 142.43 47.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.33 1.452 . . . . 4.07 107.184 -177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.48 129.69 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.098 -1.816 . . . . 2.15 106.098 163.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.2 t -117.79 102.85 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 126.099 1.76 . . . . 3.14 106.964 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -96.08 134.57 38.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.653 1.581 . . . . 8.11 108.134 -172.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.43 -9.41 38.47 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.307 0.956 . . . . 1.24 112.455 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.4 ttp -70.08 69.76 0.35 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.252 1.821 . . . . 2.64 109.831 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 t -79.42 -2.59 42.58 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.281 1.585 . . . . 1.97 115.281 -159.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -159.62 164.48 34.09 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.052 1.296 . . . . 1.36 110.892 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.61 -39.81 51.08 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.326 1.05 . . . . 1.82 110.306 173.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -46.59 -43.97 17.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.16 1.384 . . . . 1.94 111.676 171.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . 0.258 73.5 m -72.61 -48.19 41.61 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 118.408 -0.806 . . . . 1.08 113.159 173.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.9 t -41.83 -66.31 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.514 0.726 . . . . 1.85 110.65 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -31.07 67.59 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 119.906 -0.717 . . . . 0.87 112.436 -172.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -58.03 -54.4 47.36 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.703 0.683 . . . . 4.37 109.436 173.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.5 mt -50.61 -61.57 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 108.445 -0.946 . . . . 1.94 108.445 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -55.37 -55.88 26.52 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.066 0.46 . . . . 3.24 111.766 -173.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -54.03 -43.77 70.42 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.023 0.929 . . . . 1.48 110.443 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -68.07 -55.25 13.21 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.177 -1.046 . . . . 2.13 108.177 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -57.87 -43.35 85.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.052 -0.405 . . . . 3.88 111.884 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.9 m -57.24 -16.91 9.45 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.238 0.459 . . . . 3.19 112.238 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.35 -41.66 63.24 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.134 -0.979 . . . . 6.77 111.187 168.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -86.87 109.04 19.04 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.82 -0.807 . . . . 3.12 108.82 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.3 mtm105 -52.76 -21.8 4.54 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.584 0.957 . . . . 8.1 113.584 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -52.19 -37.07 46.02 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.385 -0.675 . . . . 1.34 112.081 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.5 129.28 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.959 -1.126 . . . . 3.73 107.959 170.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.38 -44.85 8.48 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.607 -0.886 . . . . 5.03 108.607 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -142.09 144.18 33.42 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.562 -0.533 . . . . 3.24 109.562 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.5 p -131.08 144.43 51.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.333 1.853 . . . . 3.06 106.767 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -152.11 83.35 1.26 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.772 -1.195 . . . . 2.17 107.772 -166.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 m -101.85 153.38 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 123.868 0.867 . . . . 2.69 111.077 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.36 136.16 13.58 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.478 -0.564 . . . . 1.98 109.478 173.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -81.42 -11.42 59.26 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.459 1.104 . . . . 2.24 112.697 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.07 -49.51 77.07 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.158 -0.682 . . . . 1.99 109.158 173.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -86.01 -40.33 15.92 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.154 0.582 . . . . 3.48 109.597 171.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 80.89 61.79 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 127.25 2.22 . . . . 3.09 107.415 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.32 166.31 25.11 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 123.065 0.546 . . . . 3.03 110.187 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.24 110.6 11.23 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 127.288 2.235 . . . . 1.78 106.862 163.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -86.3 134.9 33.71 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.301 -2.111 . . . . 1.0 105.301 162.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.8 pt -139.18 151.63 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 124.682 1.193 . . . . 4.42 107.82 -172.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -139.28 99.84 3.85 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 102.591 -3.115 . . . . 3.69 102.591 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -145.11 142.24 29.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.221 1.409 . . . . 3.06 108.801 -162.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -80.3 119.69 77.19 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 108.848 -0.797 . . . . 2.82 108.848 175.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.63 -32.8 47.25 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.47 1.447 . . . . 2.03 111.909 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.2 44.67 0.42 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.914 0.779 . . . . 3.72 112.42 -175.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -172.49 -38.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.886 1.674 . . . . 4.49 110.25 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 tt -138.05 118.63 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.318 -1.364 . . . . 2.75 107.318 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.29 156.28 53.31 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.196 -1.562 . . . . 1.22 109.196 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -53.88 -45.39 41.37 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.527 1.484 . . . . 1.52 109.197 171.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -50.96 -37.73 46.38 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 112.268 0.47 . . . . 7.9 112.268 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.15 -40.37 74.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.099 0.863 . . . . 2.73 109.522 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.8 mt -57.98 -46.77 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 118.841 -0.599 . . . . 1.71 109.933 170.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.7 mm -51.73 -57.73 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.825 0.739 . . . . 2.98 110.081 173.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -50.14 -43.34 51.95 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.285 1.034 . . . . 5.08 110.541 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.9 m -64.48 -49.6 70.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.756 -0.461 . . . . 2.08 109.756 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.1 mt -53.69 -47.32 61.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.261 0.624 . . . . 2.5 111.324 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -58.27 -51.91 67.81 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.169 0.588 . . . . 2.23 109.7 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.8 t -52.16 -48.25 65.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.768 0.827 . . . . 2.08 110.905 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.4 -60.01 4.17 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.939 -0.476 . . . . 3.24 111.032 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.66 -42.02 0.02 OUTLIER Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.091 1.196 . . . . 1.9 116.091 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -118.01 164.85 14.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 117.642 0.721 . . . . 2.82 112.769 -136.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.81 98.92 10.25 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.983 -1.488 . . . . 4.47 106.983 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.32 139.95 32.74 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.811 -0.44 . . . . 2.19 109.811 169.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.0 t -144.21 128.94 18.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.596 -1.631 . . . . 3.18 106.596 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 CA--C 1.534 0.334 0 C-N-CA 119.675 -0.81 . . . . 4.57 109.148 159.793 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.874 0 N-CA-C 108.269 -1.932 . . . . 2.29 108.269 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 p -78.66 120.75 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.432 -1.321 . . . . 3.21 107.432 168.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.16 112.85 12.08 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.019 -1.104 . . . . 4.12 108.019 -172.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -88.01 113.21 23.43 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.76 -1.2 . . . . 3.5 107.76 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -101.24 150.46 22.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.686 -0.857 . . . . 3.62 108.686 166.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 t -81.82 139.82 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 105.107 -2.183 . . . . 1.97 105.107 151.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.65 133.04 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.377 -1.712 . . . . 3.44 106.377 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 mtp85 -129.09 158.68 38.26 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.697 0.799 . . . . 7.36 109.411 -176.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.92 -18.91 55.72 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.727 0.68 . . . . 1.13 112.055 -174.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -74.57 69.48 1.72 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.198 0.999 . . . . 2.66 111.229 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.1 t -62.05 -17.23 56.75 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 116.028 1.862 . . . . 2.06 116.028 -162.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.5 p -160.74 -179.92 8.0 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 121.306 1.866 . . . . 0.78 112.502 -172.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.5 -44.19 35.74 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.714 1.206 . . . . 1.71 111.413 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.6 m -63.99 -22.71 67.04 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.814 0.845 . . . . 1.92 112.322 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.3 m -73.64 -64.18 1.05 Allowed 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.524 -0.735 . . . . 0.69 110.733 161.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.7 t -38.08 -64.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.945 1.298 . . . . 1.88 112.12 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.11 -29.39 70.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.621 -0.431 . . . . 1.14 111.194 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -70.67 -46.55 62.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.682 -0.859 . . . . 3.93 108.682 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.3 mt -54.85 -58.32 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.702 -0.851 . . . . 1.83 108.702 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -59.29 -53.71 55.15 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.642 0.258 . . . . 3.51 111.477 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.5 t -53.86 -45.6 71.04 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.975 -0.453 . . . . 1.48 110.629 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 t -66.07 -50.85 62.69 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.955 -1.128 . . . . 1.84 107.955 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.0 mt -48.57 -51.68 26.59 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.915 0.486 . . . . 4.02 111.376 176.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.4 p -57.81 -14.43 5.92 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.609 0.966 . . . . 2.73 113.609 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -28.37 68.3 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.415 1.007 . . . . 5.0 112.39 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -90.37 104.97 17.49 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 107.755 -1.202 . . . . 2.45 107.755 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -26.25 9.43 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.28 -0.888 . . . . 10.14 111.669 172.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -48.89 -40.64 27.24 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.103 -0.832 . . . . 1.37 112.811 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.83 123.3 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.513 -1.662 . . . . 3.13 106.513 171.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.3 tp -79.93 -38.05 33.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.574 1.15 . . . . 4.3 109.163 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -151.32 154.29 36.45 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.651 -0.5 . . . . 2.97 109.651 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.4 p -133.96 147.7 51.07 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 125.184 1.394 . . . . 3.4 108.827 169.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.4 t -155.02 99.64 2.12 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.695 1.598 . . . . 1.97 107.097 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 m -91.82 167.87 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 122.627 0.371 . . . . 2.82 110.405 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.5 131.68 10.17 Favored 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 121.879 -0.513 . . . . 1.83 110.866 165.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.8 mt -49.8 -50.8 43.58 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 124.488 1.115 . . . . 3.24 108.684 159.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.64 -53.6 17.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.802 0.841 . . . . 2.24 112.113 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.52 -2.42 54.37 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.037 0.935 . . . . 2.58 111.996 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m120 50.02 39.69 19.54 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 125.047 1.339 . . . . 2.21 110.33 -166.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.61 170.38 8.36 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 120.983 0.42 . . . . 3.16 111.257 -167.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -151.31 97.07 2.37 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 126.64 1.976 . . . . 2.0 108.113 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -79.48 106.09 11.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.708 -2.33 . . . . 1.66 104.708 165.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.77 145.52 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 105.256 -2.127 . . . . 2.69 105.256 163.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.2 mtmt -114.52 129.41 56.66 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.937 -1.875 . . . . 3.93 105.937 158.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -138.03 144.6 41.1 Favored 'General case' 0 C--N 1.338 0.089 0 CA-C-N 118.745 0.702 . . . . 4.02 111.607 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -75.44 117.82 66.17 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 107.36 -1.348 . . . . 3.83 107.36 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -80.67 56.36 6.05 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.202 3.268 . . . . 2.07 112.014 -165.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -145.61 -53.74 0.28 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.536 1.934 . . . . 3.69 107.55 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.8 mt -74.43 -33.26 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.411 1.084 . . . . 3.64 110.738 -172.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.6 tt -147.39 138.37 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.432 -1.322 . . . . 2.82 107.432 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.45 168.23 27.97 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.359 0.981 . . . . 1.19 111.66 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.08 -43.45 15.24 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.788 2.325 . . . . 1.17 109.534 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -54.29 -44.19 71.72 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 122.479 0.312 . . . . 7.3 110.405 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -63.98 -47.21 81.29 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.343 -0.614 . . . . 2.65 109.343 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.9 mt -52.79 -52.48 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 O-C-N 122.015 -0.428 . . . . 1.72 110.153 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.4 mt -54.25 -53.31 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 122.053 -0.404 . . . . 2.19 110.177 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.4 -32.76 67.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.219 0.608 . . . . 5.43 111.265 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.5 m -65.2 -49.47 69.61 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.067 -1.021 . . . . 1.97 108.45 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.0 mt -54.62 -41.41 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.703 0.801 . . . . 2.51 110.692 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -57.62 -54.98 40.76 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.207 0.458 . . . . 2.3 110.364 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.5 m -57.53 -29.16 64.13 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.231 1.012 . . . . 3.31 112.465 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.7 -89.42 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.882 -0.785 . . . . 3.47 108.882 166.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.47 25.0 0.24 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-O 118.517 -1.157 . . . . 1.04 113.955 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.75 175.57 9.07 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.011 1.406 . . . . 3.71 112.596 -153.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -112.58 149.7 32.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.299 -1.741 . . . . 3.78 106.299 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.18 161.49 41.19 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.989 0.813 . . . . 2.25 111.68 166.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.0 t -151.75 149.32 28.92 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.543 -1.651 . . . . 4.05 106.543 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 108.95 -0.759 . . . . 3.63 108.95 162.781 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 N-CA-C 109.567 -1.413 . . . . 2.24 109.567 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.08 141.8 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 107.97 -1.122 . . . . 3.33 107.97 173.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -150.8 148.54 28.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.277 -0.638 . . . . 3.78 109.277 164.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -93.48 127.3 39.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.077 -1.823 . . . . 3.16 106.077 152.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 pp -107.32 151.18 25.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.384 -1.339 . . . . 3.58 107.384 164.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.61 143.93 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 104.831 -2.285 . . . . 2.57 104.831 161.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 p -141.78 133.51 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 124.007 0.923 . . . . 3.38 108.545 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -134.87 165.53 25.1 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.22 1.408 . . . . 8.22 109.065 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.09 -39.38 2.78 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.12 0.867 . . . . 1.48 111.378 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.0 ptt? -67.34 65.27 0.07 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.4 1.48 . . . . 3.01 112.88 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -71.62 19.1 0.07 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.117 1.525 . . . . 2.36 115.117 -165.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -166.57 158.57 13.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.589 1.086 . . . . 1.14 110.187 177.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.24 -37.41 35.5 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.152 0.981 . . . . 2.08 111.12 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.7 p -58.16 -33.21 68.96 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.727 0.411 . . . . 2.97 111.425 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . 0.259 72.6 m -75.77 -44.71 40.21 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 120.819 -1.176 . . . . 1.61 113.676 168.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.7 t -50.01 -60.03 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.168 0.44 . . . . 1.9 110.738 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -25.44 63.05 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.445 -0.784 . . . . 1.26 112.159 -176.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.16 -51.86 67.26 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 108.562 -0.903 . . . . 4.56 108.562 173.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -52.58 -60.8 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 108.447 -0.946 . . . . 1.96 108.447 172.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -53.09 -56.45 16.16 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.336 0.589 . . . . 3.27 110.605 -170.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.1 t -56.09 -48.37 76.25 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.916 1.286 . . . . 1.46 111.103 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.8 t -64.64 -57.82 8.01 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.04 -0.726 . . . . 2.42 109.04 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.3 tp -54.21 -49.12 70.13 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.336 1.454 . . . . 3.43 111.111 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.5 p -59.47 -12.76 6.75 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.601 0.963 . . . . 3.26 113.601 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -24.88 66.77 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.889 1.222 . . . . 5.56 112.322 175.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -80.67 130.77 35.29 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.44 0.564 . . . . 3.14 109.653 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -58.31 151.85 18.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.461 -0.94 . . . . 7.48 108.461 169.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.24 -27.82 15.44 Favored Glycine 0 C--O 1.224 -0.495 0 N-CA-C 111.035 -0.826 . . . . 2.46 111.035 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.1 mm -79.22 121.19 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 119.138 1.469 . . . . 5.38 107.217 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.3 mt -94.99 -44.59 7.63 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.125 -0.695 . . . . 2.95 109.125 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -153.49 153.63 32.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.199 -0.667 . . . . 3.98 109.199 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.5 m -138.75 132.97 31.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 105.481 -2.044 . . . . 2.29 105.481 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -134.87 89.67 2.56 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 105.88 -1.896 . . . . 3.22 105.88 166.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 p -97.94 137.61 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.309 1.043 . . . . 3.56 111.156 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 134.07 21.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.811 0.845 . . . . 1.91 111.091 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 pp -72.05 -34.38 68.71 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 124.661 1.185 . . . . 3.37 110.672 170.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.64 -32.47 42.11 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.648 0.779 . . . . 2.49 111.674 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -120.55 11.79 11.4 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.801 1.24 . . . . 3.96 111.496 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.0 m120 35.32 52.08 0.65 Allowed 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.887 1.675 . . . . 2.73 112.778 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.23 151.97 40.18 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.117 -0.698 . . . . 4.49 109.117 -171.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.97 118.26 17.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.758 -0.83 . . . . 1.8 108.758 170.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -84.76 106.16 16.09 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.135 -1.802 . . . . 1.22 106.135 170.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.2 mp -106.95 136.3 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.792 -1.558 . . . . 2.54 106.792 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -116.09 140.2 49.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.458 -1.682 . . . . 4.06 106.458 163.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -158.69 161.04 37.06 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.724 0.81 . . . . 2.71 110.013 -167.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -87.78 110.94 38.86 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 107.122 -1.436 . . . . 4.04 107.122 173.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.23 59.23 7.3 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.088 3.192 . . . . 2.04 110.799 -168.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -167.26 -46.72 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.53 1.532 . . . . 3.2 108.857 -173.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.2 mm -65.96 -39.18 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.517 -0.549 . . . . 3.43 109.517 170.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.07 154.73 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 105.835 -1.913 . . . . 2.42 105.835 -175.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -116.77 174.22 15.11 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.875 1.226 . . . . 1.28 112.145 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.15 -39.38 31.31 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.231 2.621 . . . . 1.2 110.413 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -47.57 -56.65 6.69 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.804 0.842 . . . . 8.59 110.368 170.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.0 -54.85 29.11 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.716 -0.475 . . . . 2.28 109.716 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.3 mt -52.69 -60.16 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.059 0.544 . . . . 1.94 111.149 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.8 mt -52.11 -51.79 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 C-N-CA 123.715 0.806 . . . . 2.23 110.133 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -68.08 -33.33 74.34 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.215 -0.448 . . . . 5.62 111.07 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.9 m -60.88 -46.62 89.9 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 108.091 -1.077 . . . . 1.81 108.091 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.2 mt -56.25 -58.15 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.263 -0.643 . . . . 2.39 109.263 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -53.99 -43.77 70.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.913 0.387 . . . . 3.19 110.356 -168.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.5 m -62.74 -15.62 53.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.356 1.462 . . . . 3.57 114.125 -172.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.97 -83.27 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.885 -1.154 . . . . 4.22 107.885 170.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.03 42.62 0.48 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.476 -1.449 . . . . 1.71 109.476 166.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -126.88 176.65 7.14 Favored 'General case' 0 CA--C 1.524 -0.04 0 CA-C-N 117.311 0.555 . . . . 3.65 111.328 -159.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.36 145.52 47.81 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 104.923 -2.251 . . . . 4.82 104.923 170.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.44 146.0 27.21 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 123.688 0.617 . . . . 2.64 111.036 165.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t -155.57 131.0 9.63 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.831 -0.433 . . . . 3.1 109.831 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 CA--C 1.535 0.367 0 C-N-CA 124.165 0.986 . . . . 3.3 111.627 177.284 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 109.932 -1.267 . . . . 2.1 109.932 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.31 130.6 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.028 -1.471 . . . . 3.45 107.028 170.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.3 tp -124.65 139.62 53.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.025 -1.472 . . . . 3.54 107.025 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.41 143.24 48.77 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.64 -1.244 . . . . 4.39 107.64 176.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.78 150.09 24.22 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.122 0.969 . . . . 3.88 108.931 176.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.35 112.35 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 104.186 -2.524 . . . . 1.91 104.186 169.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.82 142.73 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.158 -1.423 . . . . 3.86 107.158 162.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -131.84 166.05 22.47 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.254 -0.647 . . . . 7.23 109.254 167.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.63 -38.72 3.18 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 121.757 -0.59 . . . . 1.13 112.252 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.04 77.36 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.418 1.487 . . . . 3.47 111.93 176.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.4 t -74.52 -16.95 60.82 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 115.069 1.507 . . . . 2.1 115.069 -161.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 p -158.36 176.44 12.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 120.605 1.548 . . . . 0.79 111.747 -172.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.62 -46.15 9.96 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.288 1.435 . . . . 1.7 111.464 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 m -61.98 -30.67 71.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.679 0.792 . . . . 1.99 112.271 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.3 m -72.88 -56.69 4.83 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.862 0.756 . . . . 0.64 110.333 166.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.4 t -42.8 -61.71 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.593 1.157 . . . . 1.77 111.39 -176.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.99 -28.26 67.28 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 120.046 -0.662 . . . . 0.88 111.692 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -64.86 -48.53 73.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.301 -0.999 . . . . 3.57 108.301 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.7 mt -53.98 -63.48 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.64 -0.874 . . . . 1.79 108.64 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -52.95 -50.43 64.06 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.174 0.443 . . . . 3.83 111.729 -173.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.0 t -55.97 -46.79 78.51 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.4 1.08 . . . . 1.43 111.317 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.2 p -69.02 -37.43 78.65 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.695 -0.628 . . . . 3.32 110.098 -173.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.7 mp -72.2 -48.25 44.48 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.748 1.219 . . . . 3.53 111.631 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 t -71.88 65.36 0.53 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 123.325 1.536 . . . . 3.41 112.027 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.61 -23.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.635 2.774 . . . . 5.55 111.935 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -60.51 -14.38 19.36 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.169 1.174 . . . . 2.95 114.169 176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? 70.83 -54.35 0.66 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.402 1.881 . . . . 7.5 110.843 -171.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.94 -32.14 55.84 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 117.953 0.342 . . . . 1.3 112.32 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 38.5 mt -79.37 104.88 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.23 -1.396 . . . . 5.53 107.23 167.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.2 mt -78.98 -28.12 43.49 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.152 0.581 . . . . 2.76 109.648 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -156.71 157.2 34.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.414 -0.958 . . . . 3.23 108.414 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.6 p -138.59 140.28 38.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.024 1.73 . . . . 2.6 107.136 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.9 t -146.99 101.3 3.41 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.836 -1.542 . . . . 2.02 106.836 169.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.72 152.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 124.294 1.038 . . . . 3.88 109.848 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.05 127.51 7.89 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 121.66 -0.65 . . . . 1.73 111.328 170.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.48 -28.69 68.07 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.419 0.687 . . . . 2.76 110.714 162.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.44 -49.77 69.23 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 120.97 0.414 . . . . 1.91 110.001 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.36 -35.11 25.38 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.17 0.588 . . . . 2.55 111.096 173.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.26 76.04 0.36 Allowed 'General case' 0 C--N 1.344 0.339 0 N-CA-C 106.926 -1.509 . . . . 2.14 106.926 -151.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.62 163.13 39.26 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.02 0.528 . . . . 3.54 109.89 177.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.15 94.12 2.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.889 1.276 . . . . 1.81 109.916 169.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -77.99 104.19 8.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 105.967 -1.864 . . . . 1.2 105.967 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.69 115.61 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 105.923 -1.88 . . . . 2.59 105.923 174.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -82.03 75.46 8.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.793 -1.188 . . . . 4.58 107.793 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.67 161.44 23.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.055 -0.521 . . . . 4.35 110.794 170.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -104.85 133.49 20.13 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 107.227 -1.397 . . . . 3.22 107.227 142.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.57 -31.79 59.65 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.138 2.558 . . . . 2.14 114.472 -171.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -81.19 -43.37 19.4 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 120.473 1.488 . . . . 2.97 110.251 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 tp -73.42 -26.19 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 118.85 -0.595 . . . . 3.69 111.459 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.1 tt -148.09 124.27 2.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-N 120.171 1.351 . . . . 2.89 109.96 167.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.08 159.56 49.24 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 109.67 -1.372 . . . . 1.08 109.67 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -58.85 -39.89 77.21 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.087 1.858 . . . . 1.22 109.247 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -41.65 -48.55 4.12 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.214 1.406 . . . . 10.15 111.007 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -72.31 -45.11 61.4 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.0 0.92 . . . . 2.31 109.539 -169.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.2 mt -54.04 -50.55 53.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.037 -0.727 . . . . 1.72 109.037 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.4 mt -55.48 -52.42 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 119.582 -0.247 . . . . 2.11 110.467 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -52.25 -39.67 60.65 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.476 0.71 . . . . 4.47 110.861 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 31.1 m -64.83 -50.46 66.57 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.238 -0.652 . . . . 1.65 109.238 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.4 mt -55.06 -48.26 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.21 1.004 . . . . 2.29 110.579 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -56.32 -57.12 13.6 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.59 0.756 . . . . 2.14 110.492 173.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.8 t -51.02 -43.6 60.88 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.813 1.245 . . . . 2.39 110.895 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.63 -73.7 0.08 Allowed 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.359 -0.213 . . . . 3.21 110.44 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.41 -5.52 0.05 OUTLIER Glycine 0 CA--C 1.529 0.948 0 N-CA-C 117.41 1.724 . . . . 1.18 117.41 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -131.33 172.21 12.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.758 1.779 . . . . 2.86 112.999 -137.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.48 150.27 20.49 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.834 -1.543 . . . . 4.8 106.834 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.7 124.88 10.09 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.898 0.38 . . . . 2.11 111.457 162.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 p -129.14 122.45 29.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.964 1.305 . . . . 2.77 109.18 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 113.631 0.974 . . . . 3.91 113.631 -172.04 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.817 0 N-CA-C 110.733 -0.947 . . . . 1.96 110.733 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -78.26 97.16 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.845 0.858 . . . . 3.1 108.973 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.03 155.67 19.57 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.937 0.875 . . . . 5.26 109.071 171.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -146.23 136.75 24.02 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 105.846 -1.909 . . . . 4.32 105.846 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 pp -152.61 148.66 27.59 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.601 1.161 . . . . 3.09 109.217 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.89 125.62 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 105.569 -2.012 . . . . 1.93 105.569 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.9 t -104.71 138.03 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 106.356 -1.72 . . . . 2.78 106.356 168.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.16 175.3 9.98 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.777 1.631 . . . . 6.0 108.55 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.43 -50.17 4.3 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.186 -1.166 . . . . 1.64 110.186 -172.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -50.33 126.66 15.48 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.034 0.534 . . . . 3.0 111.556 175.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 p -88.68 -41.37 12.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.971 0.73 . . . . 3.38 112.971 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.4 p -152.41 177.06 11.0 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.843 0.747 . . . . 0.84 112.543 -161.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.0 -42.09 17.44 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.876 1.27 . . . . 1.9 111.585 175.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.0 t -60.56 -34.39 74.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.507 0.723 . . . . 2.37 110.912 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.2 m -71.53 -54.97 8.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.375 0.534 . . . . 0.67 109.85 169.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.1 t -45.8 -62.35 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.592 0.757 . . . . 1.92 111.45 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.7 -27.0 66.45 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 120.046 -0.661 . . . . 1.13 111.632 -174.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -68.06 -48.89 64.36 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.744 0.818 . . . . 3.64 109.224 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.7 mt -53.8 -58.72 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 N-CA-C 107.899 -1.148 . . . . 2.11 107.899 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.46 -53.82 33.19 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.369 0.604 . . . . 3.58 110.412 -176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 t -57.76 -37.72 74.13 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.641 1.176 . . . . 1.31 111.754 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.9 t -71.46 -40.78 70.11 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.788 0.835 . . . . 2.27 110.67 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.5 mp -66.86 -51.78 51.42 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.457 1.103 . . . . 3.39 109.26 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.1 t -71.71 60.95 0.37 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.258 1.028 . . . . 3.51 110.734 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.05 -48.1 0.32 Allowed 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 128.895 2.878 . . . . 7.79 108.045 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -69.99 26.2 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.281 1.586 . . . . 3.19 115.281 -165.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 66.02 -60.75 0.29 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.651 2.38 . . . . 6.91 114.177 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.47 -15.92 62.21 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.715 -0.492 . . . . 1.43 113.23 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.2 mm -79.43 105.42 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.901 1.28 . . . . 5.56 107.734 176.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.73 -38.97 37.57 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.308 -0.627 . . . . 4.39 109.308 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -152.41 152.08 31.58 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.996 -0.742 . . . . 3.56 108.996 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.0 t -136.26 132.34 35.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.804 1.642 . . . . 3.16 106.586 174.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.1 t -134.85 103.73 5.72 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.927 -1.509 . . . . 1.95 106.927 165.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p -104.23 147.84 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.824 1.25 . . . . 3.89 109.82 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.35 142.32 19.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 O-C-N 121.401 -0.812 . . . . 1.99 110.868 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -83.82 -38.09 21.68 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 123.952 0.901 . . . . 3.28 109.753 170.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.24 -35.86 60.43 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.458 0.703 . . . . 2.36 110.755 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -117.54 16.47 14.61 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.62 1.168 . . . . 3.48 110.35 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.4 m120 23.23 70.83 0.03 OUTLIER 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.646 1.978 . . . . 2.14 112.737 -173.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 166.59 26.67 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.576 0.35 . . . . 3.8 110.342 -172.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.99 92.91 1.68 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.365 1.466 . . . . 1.97 109.343 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -78.33 108.27 11.55 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.738 -2.319 . . . . 1.88 104.738 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.0 mp -110.92 127.14 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 106.662 -1.607 . . . . 2.55 106.662 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -92.44 104.66 16.96 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 104.869 -2.271 . . . . 3.12 104.869 160.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -122.05 134.6 54.78 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 118.592 0.633 . . . . 3.04 109.344 175.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -72.63 117.68 61.32 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 120.167 -0.613 . . . . 3.01 109.37 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -81.76 64.56 8.55 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.05 2.5 . . . . 2.37 112.471 -163.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -158.38 -52.66 0.07 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.526 1.13 . . . . 2.97 109.035 168.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -57.99 -35.16 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.788 1.235 . . . . 3.94 111.659 172.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mm -139.17 139.32 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.748 -1.945 . . . . 2.63 105.748 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.57 167.9 15.01 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.3 1.428 . . . . 1.03 110.374 169.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -61.87 -41.95 34.28 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.534 2.156 . . . . 1.19 110.17 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.9 -35.95 25.54 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 118.119 -0.943 . . . . 6.74 112.127 174.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -68.64 -49.81 56.23 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 119.711 1.141 . . . . 2.08 110.147 -176.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 mt -53.74 -53.23 27.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.922 -0.77 . . . . 1.94 108.922 172.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.4 mt -53.52 -44.14 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 118.512 -0.756 . . . . 2.14 110.642 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -53.12 -38.42 62.64 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 119.275 0.943 . . . . 4.22 110.776 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.1 m -67.01 -53.44 31.32 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.004 0.82 . . . . 2.28 108.875 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mp -50.81 -51.81 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.339 0.656 . . . . 2.54 110.28 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.51 -51.58 64.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.839 1.256 . . . . 2.35 110.612 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.0 t -65.71 -20.05 66.13 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 118.009 -0.996 . . . . 2.33 112.866 -171.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.8 -101.55 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 119.551 1.069 . . . . 4.11 108.388 163.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.46 36.68 0.48 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.411 -1.076 . . . . 1.62 110.411 173.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -126.74 154.62 43.94 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.819 -0.808 . . . . 3.87 108.819 -162.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -109.49 152.77 24.99 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.553 -0.906 . . . . 3.6 108.553 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.09 148.45 50.57 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 125.563 1.545 . . . . 2.35 110.246 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.1 m -154.15 99.7 2.26 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.787 0.835 . . . . 2.17 110.402 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mt . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 108.075 -1.083 . . . . 4.14 108.075 164.374 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.438 0 N-CA-C 106.984 -2.446 . . . . 1.83 106.984 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.9 t -136.76 134.37 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.998 -1.482 . . . . 3.65 106.998 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.5 mt -135.19 117.13 15.24 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.324 -1.362 . . . . 3.61 107.324 171.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -79.42 89.38 5.01 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.918 -1.882 . . . . 3.52 105.918 155.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.2 mt -78.67 134.88 37.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.709 -1.589 . . . . 3.28 106.709 172.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.83 119.2 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 104.977 -2.231 . . . . 2.31 104.977 162.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -124.86 110.41 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 105.708 -1.96 . . . . 3.32 105.708 -175.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.6 mtp-105 -117.63 160.02 21.97 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.381 1.073 . . . . 6.93 109.768 -165.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.36 0.59 88.35 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.876 -0.889 . . . . 1.27 110.876 -163.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.6 ttm -69.44 68.2 0.22 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.534 1.534 . . . . 3.0 109.805 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -67.36 -31.55 71.89 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.465 0.542 . . . . 2.42 112.465 -166.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.6 p -155.04 174.94 14.47 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.993 0.815 . . . . 0.75 112.117 -170.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.02 -41.97 17.42 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.119 1.368 . . . . 2.09 111.786 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 m -54.2 -43.62 70.9 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 122.953 0.501 . . . . 1.88 110.894 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.3 m -66.12 -50.68 63.18 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.291 0.496 . . . . 0.73 109.96 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.2 t -46.19 -64.12 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.377 0.671 . . . . 2.27 110.378 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -31.0 67.13 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.233 -0.587 . . . . 1.08 112.218 -174.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -51.85 67.72 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.701 0.682 . . . . 6.52 109.467 174.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.3 mt -56.01 -62.67 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 108.099 -1.074 . . . . 2.26 108.099 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -49.33 -56.34 9.83 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 123.744 0.652 . . . . 3.89 110.167 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.6 t -57.66 -48.64 78.93 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.959 0.504 . . . . 1.59 111.209 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.5 t -71.81 -22.9 61.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.759 -0.588 . . . . 2.12 110.78 -171.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mp -73.65 -63.79 1.13 Allowed 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 121.349 -0.844 . . . . 3.54 110.569 163.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 84.8 m -54.63 -23.55 17.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.38 1.072 . . . . 2.51 113.1 -170.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -53.0 -34.95 58.68 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.072 1.138 . . . . 6.3 114.072 170.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -70.25 120.45 15.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.572 -0.899 . . . . 2.85 108.572 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -74.43 56.61 0.67 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.506 0.593 . . . . 8.17 110.66 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.08 42.33 0.44 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.115 -1.594 . . . . 1.97 109.115 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.6 pp -147.51 163.47 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 127.057 2.143 . . . . 3.79 105.243 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -111.36 -43.01 3.77 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.785 0.834 . . . . 3.5 109.833 171.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -156.26 158.05 36.84 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.272 0.942 . . . . 3.05 110.9 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.0 m -143.23 124.87 14.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.318 1.847 . . . . 2.58 106.368 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.54 106.3 6.94 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.975 0.91 . . . . 2.1 108.705 173.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.6 m -100.85 147.86 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 125.274 1.43 . . . . 3.52 110.727 -173.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.28 125.5 18.71 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.814 -0.81 . . . . 1.8 108.814 166.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.4 pp -64.93 -37.34 87.33 Favored 'General case' 0 C--N 1.338 0.098 0 O-C-N 123.395 0.435 . . . . 2.68 110.436 168.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.55 -49.77 55.2 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.458 1.103 . . . . 1.83 111.123 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.5 8.5 33.44 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.256 0.622 . . . . 3.1 110.983 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.264 0.0 OUTLIER 47.12 61.22 2.98 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 126.355 1.862 . . . . 2.86 109.907 173.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.24 166.29 31.36 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.303 -0.862 . . . . 3.31 111.944 -173.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.05 110.24 6.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.014 2.526 . . . . 2.19 107.823 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -78.74 97.08 5.76 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 105.467 -2.049 . . . . 1.22 105.467 167.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.9 mt -104.22 138.91 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 107.001 -1.481 . . . . 2.74 107.001 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -127.44 135.99 51.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.904 -1.888 . . . . 4.43 105.904 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -161.53 158.99 27.28 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.4 1.08 . . . . 3.91 108.149 -167.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -79.63 126.92 79.64 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.397 -1.334 . . . . 3.55 107.397 169.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -80.97 46.28 2.23 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.01 2.473 . . . . 2.04 109.801 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -137.45 -62.03 0.62 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.931 1.292 . . . . 4.08 108.181 -165.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 tt -74.13 -26.95 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 121.946 -0.471 . . . . 3.59 111.4 176.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.25 129.96 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.269 -1.752 . . . . 2.37 106.269 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.28 -179.53 53.06 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 110.498 -1.041 . . . . 1.24 110.498 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.66 -54.52 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.211 1.941 . . . . 1.53 111.347 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -67.09 -25.69 66.34 Favored 'General case' 0 C--O 1.221 -0.411 0 O-C-N 121.7 -0.625 . . . . 7.36 111.773 -172.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.77 -50.55 5.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.384 1.874 . . . . 2.97 110.744 172.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.9 mt -66.4 -52.16 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.082 -0.71 . . . . 1.84 109.082 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mt -53.68 -45.97 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 122.801 0.44 . . . . 2.26 110.656 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -50.67 -41.3 55.44 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.636 1.174 . . . . 4.78 110.674 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.8 m -65.45 -48.51 72.44 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.169 -0.678 . . . . 2.03 109.169 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.07 -55.82 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.045 0.538 . . . . 2.5 110.121 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -53.3 -53.52 49.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.149 0.98 . . . . 2.27 110.081 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.9 t -55.01 -40.36 70.07 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.014 1.326 . . . . 1.93 111.452 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.6 mt -60.02 -86.22 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 117.946 0.339 . . . . 3.38 111.593 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.03 32.82 0.38 Allowed Glycine 0 CA--C 1.524 0.623 0 CA-C-O 118.653 -1.082 . . . . 0.96 113.118 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -133.06 163.34 29.47 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 118.715 1.257 . . . . 3.59 113.064 -158.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -97.21 144.86 26.61 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.219 2.208 . . . . 3.7 105.157 171.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.95 140.12 40.09 Favored 'General case' 0 CA--C 1.526 0.024 0 CA-C-N 118.772 0.715 . . . . 3.05 111.416 -168.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.6 p -155.76 175.44 13.93 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.235 1.014 . . . . 2.93 108.43 165.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 N-CA-C 105.314 -2.106 . . . . 3.46 105.314 158.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.594 0 N-CA-C 110.107 -1.197 . . . . 1.89 110.107 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.53 66.91 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 124.912 1.285 . . . . 3.91 108.696 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.33 79.63 4.76 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.037 -1.468 . . . . 3.91 107.037 -176.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -99.12 99.74 10.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.343 -1.299 . . . . 2.98 107.942 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.98 153.32 36.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.487 1.115 . . . . 3.55 109.164 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.9 123.75 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 106.824 -1.547 . . . . 1.87 106.824 174.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.9 t -100.91 109.32 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.898 -1.89 . . . . 3.07 105.898 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -88.25 137.4 32.36 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.323 -0.991 . . . . 7.7 108.323 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.06 1.68 41.88 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.73 -1.039 . . . . 1.09 113.455 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 48.3 mtm -71.45 71.02 0.65 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.44 1.62 . . . . 2.5 110.406 175.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -71.72 -19.17 62.09 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.678 -1.154 . . . . 2.09 113.768 -168.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -162.7 173.41 13.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 120.152 1.342 . . . . 0.88 111.022 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.59 -39.41 35.24 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.223 1.009 . . . . 1.74 111.54 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 m -59.61 -30.49 68.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.406 0.682 . . . . 1.98 112.146 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.1 m -71.07 -55.38 8.35 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.834 0.743 . . . . 1.0 109.898 168.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.28 -59.95 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.918 0.887 . . . . 1.7 110.886 -173.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.66 -31.72 71.04 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.236 -0.586 . . . . 1.09 111.707 -174.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -60.41 -51.69 68.4 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.75 -0.833 . . . . 4.12 108.75 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.0 mt -53.1 -64.47 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 108.63 -0.878 . . . . 2.06 108.63 174.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -49.46 -60.37 2.91 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 123.951 0.782 . . . . 3.8 110.031 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 t -52.96 -48.4 67.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.87 0.868 . . . . 1.4 110.442 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.1 m -59.9 -54.69 43.21 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.125 -0.694 . . . . 3.2 109.125 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.64 -37.19 65.37 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.739 0.815 . . . . 3.46 111.858 -173.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.3 p -54.97 -26.52 37.22 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.592 0.96 . . . . 2.92 113.592 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -4.18 37.55 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.941 1.246 . . . . 5.74 113.457 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -88.14 69.01 9.22 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 106.843 -1.54 . . . . 2.69 106.843 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -47.59 -16.14 0.06 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 118.017 2.599 . . . . 7.93 118.017 -161.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.07 -7.0 86.63 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 119.837 1.199 . . . . 1.29 113.114 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.16 137.32 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.442 -1.318 . . . . 3.25 107.442 168.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.5 mt -85.43 -39.76 17.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.267 1.027 . . . . 3.19 109.683 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -157.05 153.32 27.72 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.627 -0.879 . . . . 3.76 108.627 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.5 t -127.98 146.72 50.57 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.622 -0.881 . . . . 2.51 108.622 166.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 m -148.26 107.89 3.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.873 0.869 . . . . 2.83 109.933 164.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.74 145.3 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 125.951 1.7 . . . . 2.93 110.394 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.14 120.75 10.44 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 124.02 0.928 . . . . 2.08 109.462 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 pp -81.65 -12.34 58.73 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.271 1.029 . . . . 2.43 113.392 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.36 -49.4 34.34 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.134 -1.061 . . . . 2.51 108.134 172.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -79.47 -25.56 41.86 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.664 1.186 . . . . 2.58 111.221 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.8 m120 63.82 42.22 6.26 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 126.02 1.728 . . . . 1.9 109.666 -172.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.26 148.88 45.44 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 124.253 1.021 . . . . 3.9 108.319 -170.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.17 109.46 12.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.837 -1.171 . . . . 1.73 107.837 165.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -82.84 105.35 13.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.574 -1.639 . . . . 1.6 106.574 167.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.29 123.58 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.545 -1.65 . . . . 2.68 106.545 168.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -93.95 145.92 24.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.712 -1.218 . . . . 3.48 107.712 162.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -163.73 158.45 20.29 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.024 0.529 . . . . 2.77 110.304 -168.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -100.03 121.0 55.43 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 124.441 1.088 . . . . 3.4 108.098 170.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.57 -38.13 19.98 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.845 2.363 . . . . 2.04 112.898 -168.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -58.4 -40.54 82.68 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.978 0.511 . . . . 3.33 111.652 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -81.67 -50.75 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 123.104 0.562 . . . . 3.82 110.245 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.54 100.71 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.63 -0.878 . . . . 2.94 108.63 -173.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -63.9 140.6 44.14 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 108.763 -1.735 . . . . 1.61 108.763 168.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -56.93 -32.43 92.55 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.812 2.341 . . . . 1.41 112.005 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.475 HH11 ' CD2' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -58.36 -28.33 65.01 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 117.954 -1.022 . . . . 7.15 112.714 176.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.14 -55.69 23.08 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.431 1.469 . . . . 4.94 109.756 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.8 mt -51.74 -52.08 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.455 0.702 . . . . 1.75 109.168 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.7 mt -57.65 -49.27 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 118.707 -0.663 . . . . 2.89 110.323 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.475 ' CD2' HH11 ' A' ' 56' ' ' ARG . 27.7 m80 -54.09 -41.1 67.85 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.225 0.92 . . . . 3.96 111.294 174.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.7 m -58.62 -54.85 42.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.449 -0.945 . . . . 2.01 108.449 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.85 -55.46 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.598 0.759 . . . . 3.09 110.505 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -51.32 -59.4 4.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.57 0.748 . . . . 2.0 109.718 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.4 t -55.56 -48.4 74.83 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.572 1.149 . . . . 2.32 111.233 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.7 mt -59.04 -51.41 70.15 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.835 0.68 . . . . 3.15 112.835 -172.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.69 1.61 0.06 OUTLIER Glycine 0 CA--C 1.529 0.948 0 N-CA-C 117.156 1.623 . . . . 1.67 117.156 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -139.21 177.07 8.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.637 1.718 . . . . 2.91 111.712 -139.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.94 152.3 32.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.022 -1.473 . . . . 3.15 107.022 165.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.87 146.65 37.33 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.853 0.861 . . . . 2.59 109.251 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.6 m -147.92 107.93 4.04 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.766 0.826 . . . . 2.47 108.835 173.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.279 0 C-N-CA 124.755 1.222 . . . . 3.94 111.936 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.819 0 N-CA-C 106.663 -2.575 . . . . 1.72 106.663 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.26 109.41 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 123.54 0.736 . . . . 3.12 109.347 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -104.23 87.3 2.72 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.226 -1.398 . . . . 4.22 107.226 166.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -82.06 91.93 6.73 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.586 -1.635 . . . . 4.35 106.586 160.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 pp -105.34 157.71 17.13 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.446 -0.797 . . . . 3.08 109.037 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 t -79.05 140.98 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 106.537 -1.653 . . . . 2.43 106.537 171.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.2 t -125.52 123.87 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 105.951 -1.87 . . . . 3.06 105.951 173.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.6 mtt-85 -112.56 152.72 28.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.396 -0.964 . . . . 8.33 108.396 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.49 -6.93 61.34 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.271 -0.738 . . . . 1.2 112.886 -171.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 57.0 mtm -69.94 74.46 0.45 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.892 1.346 . . . . 2.51 110.288 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -67.36 -34.48 77.38 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 119.255 -0.403 . . . . 2.34 111.757 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.1 p -152.95 172.86 16.17 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.09 0.859 . . . . 0.93 112.678 -173.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.34 -44.02 7.91 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.587 1.555 . . . . 2.18 111.854 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.2 m -58.9 -33.41 70.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.779 0.831 . . . . 1.84 112.387 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.2 m -71.05 -57.16 4.81 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 122.308 1.051 . . . . 0.93 109.252 170.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.5 t -49.26 -60.73 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.75 1.62 . . . . 2.2 110.297 -170.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.68 -28.54 67.77 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.784 -0.573 . . . . 1.14 111.389 -175.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -68.58 -39.26 81.04 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.503 -0.555 . . . . 6.78 109.503 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.2 mt -57.01 -61.29 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.125 -0.694 . . . . 2.14 109.125 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -45.97 -59.76 2.66 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.152 0.581 . . . . 3.36 111.343 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.8 t -56.56 -39.12 72.92 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.825 0.85 . . . . 1.22 111.917 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.8 t -70.46 -55.34 9.23 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.417 -1.327 . . . . 1.9 107.417 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.0 -35.47 80.33 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 121.96 -0.462 . . . . 3.63 110.589 -170.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.4 m -69.77 67.49 0.25 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.228 1.013 . . . . 3.14 110.238 171.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -158.39 -42.59 0.06 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 128.885 2.874 . . . . 6.05 109.249 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -66.69 110.89 3.41 Favored 'General case' 0 C--N 1.345 0.373 0 N-CA-C 108.786 -0.82 . . . . 2.2 108.786 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.76 -18.83 57.19 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.292 -0.88 . . . . 7.67 111.449 173.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -51.86 -39.64 48.23 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.717 0.675 . . . . 2.1 112.485 167.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -93.83 157.17 3.02 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 CA-C-N 117.588 0.694 . . . . 3.18 110.794 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.9 mt -105.98 -40.32 5.72 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.933 1.293 . . . . 2.85 109.685 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -153.6 156.95 38.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.044 0.384 . . . . 3.94 110.775 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.8 t -139.64 135.25 33.08 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.029 -1.841 . . . . 2.62 106.029 167.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 t -147.96 144.64 28.14 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.027 0.83 . . . . 3.25 110.277 154.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.4 m -113.22 166.57 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 123.939 0.895 . . . . 3.15 111.553 -168.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.93 139.76 29.32 Favored 'General case' 0 CA--C 1.52 -0.198 0 O-C-N 122.061 -0.399 . . . . 1.91 110.985 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 mp -72.0 -63.04 1.22 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.571 1.548 . . . . 4.66 109.845 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.76 -45.83 81.82 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 123.808 0.843 . . . . 3.47 111.141 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.25 -16.8 57.46 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.841 0.856 . . . . 2.34 110.857 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 55.12 62.57 2.44 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.125 1.37 . . . . 2.88 107.689 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.3 pttp -134.68 160.78 37.06 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.011 0.374 . . . . 2.9 112.011 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.12 112.9 9.54 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.388 1.475 . . . . 1.77 108.491 169.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -79.68 93.72 5.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.707 2.003 . . . . 1.74 107.006 169.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.0 mm -92.25 134.59 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.323 -1.362 . . . . 3.01 107.323 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -118.69 119.97 36.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 105.319 -2.104 . . . . 3.18 105.319 163.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -142.65 156.39 45.05 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 107.918 -1.141 . . . . 2.91 107.918 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -89.33 116.3 65.97 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.36 -0.829 . . . . 3.34 109.143 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.06 70.12 3.03 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.238 3.292 . . . . 2.89 110.976 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -161.66 -55.65 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 127.183 2.193 . . . . 3.28 106.675 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.4 pt -88.88 -11.19 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.906 0.883 . . . . 4.34 112.654 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 tt -158.35 156.31 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.078 -2.193 . . . . 2.88 105.078 171.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.9 -178.71 27.95 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 109.402 -1.479 . . . . 1.14 109.402 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.5 -40.75 9.89 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.866 1.71 . . . . 1.13 109.591 171.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -38.43 69.41 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 117.991 -1.004 . . . . 6.73 111.1 -171.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.57 -50.5 69.24 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.772 0.714 . . . . 2.46 110.284 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.6 mp -60.33 -47.54 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.204 -1.035 . . . . 3.07 108.204 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.4 mt -55.08 -43.44 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 116.325 -0.398 . . . . 2.37 110.954 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -32.04 73.29 Favored 'General case' 0 C--O 1.224 -0.273 0 O-C-N 120.858 -1.151 . . . . 5.82 111.034 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.2 m -63.8 -48.29 77.45 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.356 -0.979 . . . . 1.73 108.356 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 65.2 mt -54.37 -46.18 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.411 1.084 . . . . 2.58 110.458 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -55.57 -54.48 43.57 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.181 0.515 . . . . 2.06 110.362 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 t -56.76 -38.04 71.9 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 126.068 1.747 . . . . 2.15 111.722 -171.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.77 -92.6 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.605 -0.517 . . . . 3.57 109.605 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.87 30.13 0.33 Allowed Glycine 0 C--N 1.337 0.602 0 CA-C-O 118.712 -1.049 . . . . 1.16 112.802 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -129.81 160.74 32.53 Favored 'General case' 0 N--CA 1.458 -0.047 0 CA-C-N 118.797 1.299 . . . . 2.81 111.415 -159.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -104.6 154.38 20.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.571 1.549 . . . . 3.27 107.159 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.55 151.68 49.17 Favored 'General case' 0 C--O 1.23 0.054 0 C-N-CA 123.315 0.646 . . . . 2.23 110.176 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.1 m -152.17 104.85 3.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.275 -1.009 . . . . 2.41 108.275 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 CA--C 1.53 0.2 0 O-C-N 121.279 -0.888 . . . . 3.68 109.964 174.157 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.674 0 N-CA-C 108.288 -1.925 . . . . 2.48 108.288 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.8 t -78.57 126.02 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 107.943 -1.132 . . . . 4.01 107.943 170.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.1 tp -155.59 100.63 2.11 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.747 0.419 . . . . 4.22 111.387 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.76 89.39 4.01 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 122.766 1.269 . . . . 3.89 109.276 153.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pp -81.73 154.04 26.22 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 113.967 -1.469 . . . . 3.01 108.52 162.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.79 141.53 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.487 -2.042 . . . . 2.06 105.487 168.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.5 127.81 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 104.942 -2.244 . . . . 2.9 104.942 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.6 mtp-105 -120.34 160.82 22.26 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.205 0.911 . . . . 6.44 110.498 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.13 6.17 65.16 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.376 0.989 . . . . 1.16 111.691 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 73.4 mtp -74.39 62.79 1.0 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.569 1.148 . . . . 2.89 110.298 -177.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -69.66 -16.4 63.36 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.256 1.206 . . . . 1.83 114.256 -162.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.2 p -161.53 175.2 12.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 120.202 1.364 . . . . 0.65 110.678 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.96 -39.51 19.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.449 1.1 . . . . 1.78 111.718 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -59.67 -33.28 71.37 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.112 0.565 . . . . 3.26 111.3 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.8 m -71.65 -54.12 11.41 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.643 0.656 . . . . 0.69 109.674 170.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.7 t -47.09 -60.7 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.008 0.923 . . . . 1.82 110.821 -174.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.89 -31.12 68.76 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.321 -0.551 . . . . 0.8 111.624 -174.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -60.52 -51.98 67.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.902 -0.777 . . . . 3.94 108.902 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.6 mt -51.88 -58.94 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.202 0 C-N-CA 123.302 0.641 . . . . 2.03 109.453 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -53.93 -57.01 12.57 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 123.559 0.537 . . . . 3.73 109.845 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.8 t -53.29 -42.7 66.87 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.574 1.15 . . . . 1.4 111.427 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.4 m -70.78 -44.83 65.85 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.999 -0.741 . . . . 3.03 108.999 -175.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.0 mt -64.57 -55.66 18.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.459 -0.337 . . . . 3.67 110.818 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 t -56.68 -19.86 18.63 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.674 -0.641 . . . . 3.26 111.657 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -34.78 75.62 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.122 -0.986 . . . . 5.55 112.757 174.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -80.72 119.56 23.48 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.681 -1.229 . . . . 2.4 107.681 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -49.46 -28.92 5.83 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.883 1.068 . . . . 6.22 113.883 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.16 -22.37 70.73 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.017 -0.879 . . . . 1.25 113.227 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.3 mm -84.27 110.3 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.731 -1.211 . . . . 5.46 107.731 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.09 -33.28 29.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.07 0.548 . . . . 3.88 109.882 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -155.64 158.52 38.47 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.277 -0.638 . . . . 3.49 109.277 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.6 t -145.74 135.52 23.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.741 0.817 . . . . 2.95 108.897 168.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 t -126.13 94.67 4.16 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.858 -1.534 . . . . 2.64 106.858 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 m -78.7 148.43 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.61 1.564 . . . . 3.47 110.441 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.04 123.58 5.51 Favored 'General case' 0 C--N 1.339 0.13 0 O-C-N 122.088 -0.383 . . . . 2.09 111.097 164.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.02 -8.59 56.95 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.206 1.003 . . . . 2.36 113.001 174.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.56 -64.04 1.16 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.312 -0.996 . . . . 2.89 108.312 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 p -77.0 -5.92 50.6 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.849 -0.532 . . . . 2.86 110.455 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 57.57 57.49 4.29 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.889 1.276 . . . . 2.74 107.742 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 168.93 18.6 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.441 0.638 . . . . 2.77 111.68 -170.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -142.3 106.12 4.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.38 -1.736 . . . . 1.86 106.518 167.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -77.0 93.29 3.8 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 103.679 -2.711 . . . . 1.17 103.679 168.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.1 mt -89.33 143.88 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 106.577 -1.638 . . . . 2.89 106.577 174.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -124.16 119.79 30.44 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 105.181 -2.155 . . . . 4.14 105.181 163.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -139.89 162.37 35.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.324 0.649 . . . . 2.98 110.243 -174.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -93.28 109.87 42.86 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 107.803 -1.184 . . . . 3.47 107.803 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.43 60.51 7.56 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 124.331 3.354 . . . . 1.55 111.677 -167.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -171.5 -45.02 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.501 1.92 . . . . 3.01 108.21 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.0 mt -67.13 -38.2 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 108.889 -0.782 . . . . 4.16 108.889 170.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 tt -147.34 136.97 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.655 -1.609 . . . . 2.51 106.655 174.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.22 165.58 30.3 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.009 -0.837 . . . . 1.24 111.009 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -55.24 -47.34 26.67 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.24 1.96 . . . . 1.29 109.737 171.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -51.37 -37.83 50.08 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.314 0.646 . . . . 8.76 112.038 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -70.52 -47.75 58.93 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.284 -0.636 . . . . 2.38 109.284 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.4 mt -53.54 -52.09 36.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 122.846 0.458 . . . . 2.07 110.301 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.9 mm -51.81 -51.6 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.313 0.645 . . . . 3.05 109.655 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -56.22 -40.2 73.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.074 -0.391 . . . . 6.38 111.587 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.3 m -60.37 -56.71 18.2 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.084 -0.709 . . . . 2.06 109.084 175.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.2 mt -47.6 -53.18 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.607 1.163 . . . . 2.71 111.346 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -59.27 -56.23 24.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.466 1.106 . . . . 2.22 110.362 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.3 t -59.12 -30.08 67.86 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.433 0.693 . . . . 2.28 111.841 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.9 mt -71.87 -74.86 0.14 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.349 0.522 . . . . 3.36 110.618 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.51 6.83 0.08 OUTLIER Glycine 0 CA--C 1.529 0.965 0 CA-C-O 117.862 -1.521 . . . . 1.15 116.231 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -130.85 158.31 40.52 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 120.2 2.0 . . . . 2.81 112.165 -146.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -92.55 167.53 11.87 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 107.509 -1.293 . . . . 3.08 107.509 170.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.25 169.16 24.83 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.901 0.381 . . . . 1.97 111.192 164.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.4 m -154.6 125.61 7.2 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.831 1.252 . . . . 2.18 108.059 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 C-N-CA 123.516 0.727 . . . . 3.62 111.874 -175.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 108.155 -1.978 . . . . 1.81 108.155 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.96 132.81 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.236 -1.394 . . . . 3.58 107.236 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.6 tp -148.48 143.31 26.62 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.293 -1.373 . . . . 4.04 107.293 172.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -133.72 113.82 12.75 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.322 -1.362 . . . . 3.98 107.322 172.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.79 153.68 39.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.379 0.672 . . . . 3.34 109.493 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.48 140.65 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.075 -1.454 . . . . 1.81 107.075 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.6 t -131.97 93.0 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 C-N-CA 127.062 2.145 . . . . 3.2 106.052 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.4 mtm105 -79.79 157.74 27.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.485 -0.561 . . . . 6.76 109.485 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.79 -6.08 56.92 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.403 1.002 . . . . 1.19 112.082 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 71.8 mtp -71.88 74.07 0.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.166 0.983 . . . . 3.3 110.958 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 t -70.76 -17.15 62.8 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 117.277 -1.344 . . . . 2.1 114.257 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.2 p -163.78 176.15 9.81 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 120.727 1.603 . . . . 0.71 111.381 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.65 -38.41 21.01 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.805 1.242 . . . . 1.7 111.892 175.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 t -49.07 -48.57 44.05 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 109.425 -0.583 . . . . 2.8 109.425 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.6 m -62.32 -46.03 90.58 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 122.258 0.223 . . . . 0.89 110.773 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 80.2 t -52.49 -65.1 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 109.921 -0.4 . . . . 2.4 109.921 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -30.58 67.67 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 118.986 -1.085 . . . . 1.11 111.842 -172.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -53.19 -53.43 50.76 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.37 -0.604 . . . . 4.29 109.37 169.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.9 mt -60.65 -58.37 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 118.461 -0.781 . . . . 1.86 110.024 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -49.51 -55.46 13.25 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.994 0.816 . . . . 3.88 110.548 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.1 t -56.58 -38.98 72.73 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.326 1.05 . . . . 1.64 111.388 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.3 t -71.13 -36.35 72.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.476 -0.765 . . . . 2.65 109.845 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.1 mt -66.99 -62.19 1.56 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 118.488 -0.768 . . . . 4.26 110.488 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.1 p -70.62 65.66 0.32 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.249 1.419 . . . . 2.79 111.697 -172.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.8 tptp -176.48 -48.2 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.55 1.14 . . . . 4.8 108.167 -151.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -73.29 90.59 1.64 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.897 -1.149 . . . . 2.55 107.897 166.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -51.76 105.1 0.1 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.526 -0.546 . . . . 7.6 109.526 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.79 -43.9 0.7 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 108.727 -1.749 . . . . 2.22 108.727 -164.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.45 131.57 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 105.436 -2.061 . . . . 3.78 105.436 161.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.7 mt -94.24 -42.72 8.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.909 1.284 . . . . 2.59 108.351 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -149.04 154.24 39.01 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.441 -0.578 . . . . 3.84 109.441 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.3 p -143.93 152.71 41.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.381 1.472 . . . . 3.05 108.306 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.9 m -155.25 82.78 1.06 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.673 1.189 . . . . 2.71 108.396 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.56 154.24 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 125.086 1.354 . . . . 3.74 108.871 174.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.04 130.06 11.82 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 120.736 -1.228 . . . . 1.8 110.786 172.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.59 -32.99 72.08 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.316 0.507 . . . . 2.98 110.159 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -47.59 -43.48 25.6 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.621 1.168 . . . . 2.31 112.449 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 t -121.76 1.97 10.0 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.706 0.403 . . . . 3.57 111.975 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 52.17 66.29 1.25 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.481 1.513 . . . . 2.81 108.46 174.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.48 166.02 27.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.427 1.091 . . . . 3.1 108.323 -175.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.48 108.85 12.04 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.832 2.053 . . . . 1.98 106.255 166.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -80.54 132.9 35.73 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 103.746 -2.687 . . . . 1.52 103.746 159.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.8 pt -138.84 151.27 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 106.796 -1.557 . . . . 4.71 106.796 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -139.28 101.01 4.15 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 102.802 -3.036 . . . . 3.49 102.802 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -129.91 149.01 51.83 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.523 0.729 . . . . 2.76 109.205 -169.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -82.96 117.79 69.69 Favored Pre-proline 0 N--CA 1.451 -0.423 0 N-CA-C 107.809 -1.182 . . . . 2.87 107.809 173.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.11 -26.99 78.5 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.443 1.428 . . . . 1.93 111.625 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -80.8 42.04 0.6 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.145 0.884 . . . . 4.27 111.363 -174.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -175.5 -43.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.682 1.593 . . . . 3.86 110.277 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 tt -132.67 124.03 50.32 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 108.108 -1.071 . . . . 2.5 108.108 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.4 173.59 51.11 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 110.679 -0.968 . . . . 1.2 110.679 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.63 -54.73 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.45 2.1 . . . . 1.06 110.263 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -50.46 -42.94 54.97 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.297 0.639 . . . . 6.99 110.944 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.51 -49.32 18.68 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.816 2.046 . . . . 2.68 110.154 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 54.7 mt -70.32 -47.59 65.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.234 0.614 . . . . 2.54 110.312 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.3 mm -50.03 -47.24 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 118.132 0.424 . . . . 3.46 110.858 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -45.17 -44.99 11.25 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.316 1.446 . . . . 3.79 111.445 173.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.0 m -58.89 -55.09 39.61 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.565 -0.902 . . . . 2.18 108.565 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.5 -53.67 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.197 0.599 . . . . 3.16 109.966 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -61.78 -48.34 81.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.618 -0.433 . . . . 3.03 110.22 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.6 t -55.65 -48.41 75.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.174 0.59 . . . . 1.79 111.549 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.1 mt -54.97 -59.51 4.65 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.903 -0.498 . . . . 3.36 112.316 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.68 -0.01 0.06 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 116.961 1.544 . . . . 1.57 116.961 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -131.94 175.18 9.44 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 119.897 1.849 . . . . 2.95 113.371 -139.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -125.68 103.44 7.83 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.685 1.194 . . . . 4.12 107.977 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.79 157.27 21.03 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.96 0.356 . . . . 2.42 111.96 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.9 t -154.45 133.09 12.12 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.424 1.09 . . . . 2.97 108.315 165.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.6 mt . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 109.026 -0.731 . . . . 3.38 109.026 163.401 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.437 0 N-CA-C 109.037 -1.625 . . . . 4.32 109.037 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 p -158.04 166.54 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.754 -1.572 . . . . 3.58 106.754 169.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 tp -133.27 128.45 35.85 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.468 -1.308 . . . . 3.14 107.468 151.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -121.89 133.28 54.86 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.385 1.474 . . . . 3.72 108.133 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.98 157.12 41.29 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.378 -0.601 . . . . 3.7 109.378 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.61 145.21 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.263 -1.754 . . . . 1.87 106.263 169.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.8 137.24 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 125.672 1.589 . . . . 2.92 108.467 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -130.36 163.19 27.41 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.093 0.957 . . . . 7.06 108.779 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.67 -15.4 63.22 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.455 0.55 . . . . 1.41 112.275 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.2 mtm -69.14 78.98 0.34 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.208 1.004 . . . . 2.42 110.097 175.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 t -71.46 -16.75 62.38 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.753 -1.117 . . . . 2.34 113.097 -174.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.5 p -161.72 172.68 15.81 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.94 1.245 . . . . 1.04 110.792 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.16 -41.12 25.98 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.782 1.233 . . . . 1.74 111.536 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.5 m -61.01 -29.29 69.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.523 0.729 . . . . 2.19 112.205 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.7 m -72.03 -56.62 5.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.161 0.892 . . . . 0.81 110.03 166.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.3 t -43.71 -62.35 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.588 1.155 . . . . 2.19 110.781 -173.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -25.31 63.53 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 120.586 -0.446 . . . . 0.93 111.898 -175.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -67.88 -41.17 83.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.205 -0.665 . . . . 3.78 109.205 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 mt -54.94 -59.03 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.494 -0.558 . . . . 2.21 109.494 173.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -52.97 -51.2 62.31 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.548 0.613 . . . . 3.72 111.388 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.2 t -54.93 -37.38 66.33 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.143 0.977 . . . . 1.71 111.205 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.3 t -71.29 -57.87 4.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.736 -1.209 . . . . 2.06 107.736 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.0 mt -51.17 -49.66 60.47 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.014 0.925 . . . . 3.68 112.085 -174.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.3 t -56.77 -17.92 10.85 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.456 -0.777 . . . . 3.74 112.61 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -30.45 71.3 Favored 'General case' 0 C--N 1.343 0.287 0 O-C-N 121.139 -0.976 . . . . 6.62 112.34 175.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -81.18 113.22 19.18 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 106.543 -1.651 . . . . 2.18 106.543 170.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -55.84 -26.33 46.18 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.524 0.565 . . . . 7.48 112.524 -173.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.82 -22.26 59.62 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.818 0.723 . . . . 1.37 113.437 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.2 mm -79.59 97.88 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.282 -1.377 . . . . 5.4 107.282 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.3 mt -77.68 -34.78 52.84 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.024 -0.732 . . . . 2.67 109.024 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -148.75 158.55 44.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.591 -0.892 . . . . 3.71 108.591 165.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.6 p -145.26 138.02 26.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.963 1.705 . . . . 3.22 107.717 173.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 t -142.16 106.93 4.87 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.496 -1.668 . . . . 2.27 106.496 170.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.9 m -84.87 171.78 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.159 0.436 . . . . 2.67 109.936 170.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -157.12 141.3 16.36 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.063 -0.717 . . . . 2.08 109.063 152.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.98 -38.07 53.92 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 108.521 -0.918 . . . . 3.43 108.521 166.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.36 -38.96 69.49 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.582 0.753 . . . . 2.78 110.609 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 m -112.1 14.52 20.71 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.389 1.076 . . . . 2.89 110.284 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.3 m120 32.29 53.08 0.29 Allowed 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 126.392 1.877 . . . . 2.33 113.512 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.68 168.47 17.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 122.864 0.465 . . . . 3.48 111.29 -171.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.26 135.59 32.46 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.29 -1.323 . . . . 1.65 109.22 150.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -110.4 107.34 17.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 104.288 -2.486 . . . . 1.42 104.288 168.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.74 146.56 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 105.889 -1.893 . . . . 3.05 105.889 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -113.16 93.21 4.3 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 105.307 -2.108 . . . . 3.65 105.307 170.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.78 150.89 20.87 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.318 1.047 . . . . 4.44 112.755 -174.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -87.22 126.5 62.41 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 107.066 -1.457 . . . . 3.09 107.066 150.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.02 -19.62 20.22 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.877 3.052 . . . . 1.82 113.447 -171.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -93.05 -45.1 8.07 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.874 -0.788 . . . . 3.44 108.874 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.1 mt -68.12 -35.76 72.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 109.553 -0.536 . . . . 3.96 109.553 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 mm -130.71 116.18 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.041 -1.466 . . . . 2.76 107.041 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.43 152.64 49.62 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 108.234 -1.946 . . . . 1.03 108.234 169.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -55.66 -38.55 94.12 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.028 1.819 . . . . 1.8 111.013 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -67.22 -23.83 65.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 118.841 -0.599 . . . . 7.8 112.408 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -65.59 -35.64 81.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 120.702 1.592 . . . . 2.44 112.285 -170.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.4 mt -53.47 -48.05 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 109.176 -0.676 . . . . 2.39 109.176 171.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.0 mt -62.69 -49.02 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.705 0.802 . . . . 2.54 109.733 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -48.89 -44.6 40.18 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.132 0.878 . . . . 4.98 110.66 175.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.6 m -65.0 -56.63 11.99 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.302 -0.629 . . . . 1.96 109.302 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.7 mt -46.89 -49.87 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.454 1.102 . . . . 2.62 110.88 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -58.1 -53.76 54.63 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.797 1.239 . . . . 2.15 111.0 174.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.2 p -60.06 -29.99 68.91 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.316 0.488 . . . . 3.24 112.316 -172.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.38 -97.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.59 -0.522 . . . . 3.9 109.59 167.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.29 35.94 0.44 Allowed Glycine 0 C--N 1.337 0.607 0 O-C-N 121.167 -0.958 . . . . 1.25 112.403 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -131.57 159.37 38.42 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.465 1.132 . . . . 3.68 110.283 -165.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -99.5 155.86 17.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.597 -0.89 . . . . 3.66 108.597 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.72 162.47 35.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.349 0.26 . . . . 2.3 110.953 162.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.0 m -155.44 116.93 4.0 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.79 0.836 . . . . 2.34 109.847 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.374 0 C-N-CA 124.029 0.932 . . . . 3.22 110.743 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 106.626 -2.59 . . . . 2.1 106.626 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.5 p -129.57 134.89 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.458 -1.312 . . . . 3.13 107.458 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.4 tp -145.29 113.3 6.47 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.919 -1.141 . . . . 2.94 107.919 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -94.0 133.23 37.67 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.681 -0.488 . . . . 3.32 109.681 165.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -131.94 148.73 52.54 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.558 -1.275 . . . . 3.18 107.558 172.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 t -79.71 142.72 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 106.174 -1.788 . . . . 1.92 106.174 162.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 p -122.73 96.12 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 125.682 1.593 . . . . 3.55 107.678 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -80.87 59.76 3.85 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.388 -0.82 . . . . 8.26 109.768 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.57 0.42 0.21 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.988 -0.896 . . . . 2.39 114.419 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.5 mtm -77.13 76.88 3.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.411 1.605 . . . . 2.55 109.735 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -75.67 -11.63 60.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.886 -1.055 . . . . 2.68 112.963 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.8 p -160.75 172.51 16.92 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 120.008 1.276 . . . . 1.32 109.2 172.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.23 -44.98 11.52 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.459 1.104 . . . . 2.35 111.466 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -50.38 -40.94 51.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.745 0.418 . . . . 2.75 110.846 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.0 m -58.97 -34.6 71.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.41 0.522 . . . . 1.14 112.41 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.66 -67.94 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.738 0.78 . . . . 2.21 109.19 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.76 -32.25 73.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 118.399 -0.81 . . . . 1.58 111.279 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -53.85 -52.84 59.11 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.767 1.167 . . . . 3.84 109.975 172.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.5 mt -54.93 -64.3 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 109.032 -0.729 . . . . 1.91 109.032 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -56.42 -54.73 42.23 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.907 -0.717 . . . . 4.22 110.164 -171.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -51.64 -43.83 62.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.464 1.106 . . . . 1.58 111.98 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.4 t -70.67 -33.28 70.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.208 -0.933 . . . . 1.94 109.852 -175.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.01 -48.15 38.84 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 111.745 0.276 . . . . 3.61 111.745 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.2 p -60.29 -18.38 48.91 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.737 -1.227 . . . . 2.83 113.671 -165.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -39.3 63.11 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.138 0.792 . . . . 6.16 113.138 168.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -60.92 167.98 2.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.382 0.992 . . . . 2.5 109.13 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.66 -18.53 12.75 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.773 -0.579 . . . . 7.86 111.869 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.27 -22.8 78.49 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 118.63 0.65 . . . . 1.29 112.015 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.7 157.92 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 117.94 0.87 . . . . 4.09 109.785 174.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.5 mt -119.17 -46.43 2.51 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.02 1.328 . . . . 2.78 109.428 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -155.44 153.7 30.76 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 117.728 -1.13 . . . . 3.31 108.641 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.6 t -131.69 77.06 1.75 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.362 1.065 . . . . 2.95 109.472 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.51 85.05 3.89 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 120.75 -1.219 . . . . 4.03 109.82 -168.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.89 138.45 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 128.039 2.536 . . . . 3.9 111.841 -171.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.39 124.3 10.63 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 118.635 0.652 . . . . 2.11 111.629 172.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.4 mt -47.85 -43.79 28.59 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.97 0.908 . . . . 3.63 109.655 158.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.7 -24.71 1.48 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.49 1.116 . . . . 2.71 113.723 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 t -139.5 25.06 2.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.965 0.802 . . . . 3.78 112.438 169.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.2 m120 40.6 45.91 2.08 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.821 2.048 . . . . 1.88 112.816 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.99 170.81 14.82 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 118.543 0.611 . . . . 2.92 111.391 -171.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.11 130.19 23.34 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 125.176 1.547 . . . . 2.08 109.614 164.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -97.98 97.7 9.14 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.043 1.737 . . . . 1.12 107.618 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.5 mp -86.94 112.78 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 106.285 -1.746 . . . . 2.45 106.285 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -88.21 135.17 33.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.073 -1.825 . . . . 3.36 106.073 157.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -162.74 175.05 11.71 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.416 1.086 . . . . 2.86 109.253 -171.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -106.34 125.15 33.63 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 107.064 -1.458 . . . . 3.09 107.064 162.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.67 -6.36 18.11 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.696 2.93 . . . . 1.77 113.567 -171.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -108.33 -34.97 6.65 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.643 1.177 . . . . 3.93 109.074 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.0 mt -70.32 -33.51 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 O-C-N 121.765 -0.584 . . . . 4.55 110.648 169.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 tt -140.2 129.36 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.97 -1.122 . . . . 2.43 107.97 168.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.53 176.16 42.53 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.622 0.63 . . . . 1.81 111.902 -173.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.91 -57.0 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.797 2.332 . . . . 3.11 111.27 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.436 HH21 ' CD ' ' A' ' 63' ' ' GLU . 71.8 ttt180 -65.42 -33.65 76.46 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 117.958 -1.02 . . . . 7.23 110.695 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -35.6 -57.5 0.63 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.766 1.626 . . . . 2.32 111.486 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.6 mt -52.09 -58.89 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.937 1.295 . . . . 1.9 110.868 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.2 mm -50.66 -62.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 124.859 1.263 . . . . 3.01 109.409 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -49.68 -34.82 19.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.297 1.839 . . . . 5.64 112.03 176.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.2 m -65.34 -48.4 73.12 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.703 1.138 . . . . 1.91 108.82 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 59.3 mt -57.37 -47.07 85.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.584 0.753 . . . . 2.22 111.109 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.436 ' CD ' HH21 ' A' ' 56' ' ' ARG . 49.7 mt-10 -51.46 -57.73 8.19 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.956 0.902 . . . . 2.28 109.261 172.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 t -65.77 -27.31 68.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.394 1.078 . . . . 2.04 112.291 -171.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.0 mt -65.83 -81.32 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.859 0.754 . . . . 3.48 110.04 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.25 25.94 0.26 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.599 -1.112 . . . . 0.93 113.235 171.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -134.29 176.44 8.6 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 118.825 1.313 . . . . 3.03 112.276 -153.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -127.41 136.34 51.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.357 -2.09 . . . . 3.35 105.357 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.19 153.67 35.92 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.27 1.028 . . . . 1.88 110.391 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.1 m -154.67 132.0 11.14 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.757 0.823 . . . . 2.18 109.6 170.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 CA--C 1.534 0.359 0 C-N-CA 125.251 1.42 . . . . 4.61 109.017 -175.532 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 109.651 -1.38 . . . . 1.88 109.651 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 p -145.09 90.42 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.389 -0.967 . . . . 3.46 108.389 172.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -78.51 80.01 4.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.779 -1.934 . . . . 4.26 105.779 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -84.7 123.73 30.71 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 114.071 -1.422 . . . . 3.54 108.802 168.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 157.78 39.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 123.648 0.592 . . . . 3.5 110.617 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -79.06 115.77 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 106.476 -1.676 . . . . 1.87 106.476 170.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.04 73.55 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 105.952 -1.87 . . . . 3.31 105.952 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.03 100.98 5.09 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.904 -1.887 . . . . 8.34 105.904 -166.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.92 -43.65 0.24 Allowed Glycine 0 C--N 1.334 0.441 0 O-C-N 120.343 -1.473 . . . . 2.14 113.548 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.31 75.74 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.105 1.15 . . . . 3.65 114.105 -173.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.2 t -69.35 -13.1 62.19 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.723 1.379 . . . . 2.24 114.723 -166.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.7 p -155.12 170.33 22.05 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.078 1.308 . . . . 0.87 109.931 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.35 -45.73 8.98 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.962 1.305 . . . . 1.78 111.542 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -54.1 -39.53 66.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.339 1.456 . . . . 3.04 112.029 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.1 m -71.98 -55.12 8.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.994 -0.373 . . . . 0.72 109.994 170.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.7 t -47.56 -60.62 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 123.655 0.782 . . . . 1.95 110.623 -173.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.72 -24.66 65.4 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.657 -0.652 . . . . 0.89 111.863 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -67.14 -48.26 68.58 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.773 -0.825 . . . . 4.45 108.773 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.8 mt -57.4 -57.12 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 118.507 0.594 . . . . 2.01 109.432 174.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -53.53 -50.92 64.46 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.44 0.638 . . . . 3.53 110.386 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.0 t -56.72 -51.64 68.05 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 118.326 -0.845 . . . . 1.33 109.87 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 t -57.33 -44.61 84.4 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 119.494 1.043 . . . . 2.43 108.514 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.1 mt -56.44 -53.13 61.06 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.337 -0.847 . . . . 4.06 111.795 175.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.7 p -57.78 -10.41 1.65 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.923 1.083 . . . . 2.68 113.923 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -33.47 69.2 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.427 1.012 . . . . 8.11 110.863 173.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -78.65 148.44 33.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.614 -0.884 . . . . 2.5 108.614 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -95.34 -24.41 16.75 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.172 0.589 . . . . 7.86 111.29 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.31 -19.97 76.38 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 122.165 -0.335 . . . . 1.23 112.388 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -84.05 127.71 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 105.932 -1.877 . . . . 3.22 105.932 164.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.91 -38.0 33.48 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.442 -0.577 . . . . 3.8 109.442 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -155.48 153.54 30.45 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.752 -1.203 . . . . 3.78 107.752 -175.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.8 p -139.12 146.76 41.06 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 123.744 0.652 . . . . 3.12 109.359 168.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 t -144.5 105.17 4.15 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.154 -1.424 . . . . 2.05 107.154 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 m -90.45 159.05 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.703 0.801 . . . . 2.71 110.132 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.68 130.31 9.09 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 121.745 -0.597 . . . . 1.71 110.757 163.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 pp -68.1 -23.61 64.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 123.552 0.532 . . . . 2.31 111.957 165.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.43 -47.63 72.62 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.377 0.535 . . . . 1.99 110.084 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.99 -17.3 20.15 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.176 0.99 . . . . 2.61 112.144 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.56 38.26 25.35 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.883 1.273 . . . . 2.59 109.29 -162.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.55 160.83 16.81 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.311 0.645 . . . . 3.43 110.027 -173.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.4 122.21 22.24 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.147 -1.427 . . . . 1.65 107.147 159.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -96.36 108.89 21.48 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 104.455 -2.424 . . . . 1.11 104.455 166.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.8 mt -120.33 104.49 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.36 -1.348 . . . . 2.78 107.36 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -79.97 138.68 37.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.367 -1.346 . . . . 3.59 107.367 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -159.58 147.78 17.44 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 119.196 -0.43 . . . . 3.11 110.828 -159.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -85.83 103.74 4.2 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 106.356 -1.72 . . . . 3.15 106.356 168.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.26 -54.64 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.573 2.182 . . . . 2.54 111.422 -165.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -53.83 -44.24 70.09 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.007 1.323 . . . . 3.38 111.819 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.2 -47.01 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 122.377 0.271 . . . . 4.04 110.624 -173.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -48.19 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 117.923 0.329 . . . . 3.98 110.87 -171.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.93 116.27 2.42 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 110.41 -1.076 . . . . 2.2 110.41 -170.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -59.95 -39.38 71.63 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 119.955 1.878 . . . . 1.34 109.653 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.4 HH21 ' CG ' ' A' ' 57' ' ' ASP . 22.5 ttp180 -37.89 -53.45 1.32 Allowed 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 125.378 1.471 . . . . 9.93 110.815 164.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.4 ' CG ' HH21 ' A' ' 56' ' ' ARG . 15.0 m-20 -73.74 -36.05 65.12 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.996 0.918 . . . . 3.01 113.159 -174.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.1 mt -53.48 -48.94 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.356 -0.84 . . . . 1.86 109.636 166.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.5 mt -58.71 -47.2 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 109.495 -0.558 . . . . 2.62 109.495 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -50.21 -42.49 51.58 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.692 0.678 . . . . 3.98 111.033 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.4 m -60.48 -54.48 45.06 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.279 0.945 . . . . 2.37 109.092 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.1 mt -52.13 -51.64 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.382 1.073 . . . . 2.66 111.758 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -60.06 -56.99 14.81 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.257 1.023 . . . . 2.24 110.463 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -52.93 -42.95 65.89 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.629 1.172 . . . . 2.36 110.632 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.5 mt -62.56 -70.91 0.18 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.437 -0.316 . . . . 3.36 110.573 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.64 -10.34 0.04 OUTLIER Glycine 0 CA--C 1.531 1.044 0 N-CA-C 117.614 1.805 . . . . 1.18 117.614 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -133.23 156.35 47.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.845 1.823 . . . . 2.97 111.533 -137.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -80.23 159.04 26.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.179 0.992 . . . . 3.63 108.551 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.15 141.96 50.63 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.577 1.151 . . . . 2.75 109.432 172.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.7 m -153.37 110.0 3.4 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.543 0.737 . . . . 2.15 109.72 170.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.533 0.299 0 CA-C-N 118.768 0.713 . . . . 4.29 109.804 176.537 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.721 0 N-CA-C 109.813 -1.315 . . . . 2.13 109.813 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 m -109.77 101.22 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.856 1.662 . . . . 3.15 108.975 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.33 106.19 18.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.672 -1.233 . . . . 4.26 107.672 175.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -107.46 103.4 12.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.268 -1.012 . . . . 3.61 108.268 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.3 mt -106.09 144.58 32.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.081 0.953 . . . . 3.42 108.458 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.49 128.22 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 104.721 -2.326 . . . . 2.14 104.721 151.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 p -101.23 85.31 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.014 1.326 . . . . 3.72 107.554 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -83.27 59.25 4.9 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.312 1.045 . . . . 6.97 109.633 -169.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.67 -44.01 0.03 OUTLIER Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.849 -0.691 . . . . 1.87 112.959 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.18 131.78 52.04 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.674 -0.861 . . . . 3.62 108.674 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.2 p -94.08 -57.32 2.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.053 0.541 . . . . 3.53 110.317 -175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 p -134.44 176.97 8.13 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.477 0.711 . . . . 0.76 112.2 -160.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.43 -42.99 10.95 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.674 1.189 . . . . 1.73 111.9 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -54.4 -48.45 71.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.967 0.507 . . . . 2.78 109.72 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.6 m -67.29 -41.43 85.42 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 122.091 -0.381 . . . . 0.82 111.053 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.1 t -53.5 -63.96 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 122.591 0.357 . . . . 1.7 110.408 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.261 0.1 OUTLIER -70.68 -25.89 63.18 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.991 -1.068 . . . . 0.96 112.356 -175.639 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -55.01 -52.46 63.09 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.629 0.65 . . . . 4.38 109.703 167.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.1 mt -52.48 -63.83 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.235 0 N-CA-C 108.876 -0.787 . . . . 1.89 108.876 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -56.54 -51.38 68.76 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 120.595 -0.442 . . . . 3.58 111.366 -171.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.6 t -58.19 -43.46 87.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.5 -0.762 . . . . 1.52 110.408 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 t -63.18 -56.19 18.8 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 120.022 1.283 . . . . 2.05 108.1 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.41 -45.08 89.08 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.303 -0.862 . . . . 3.51 112.242 -175.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.8 p -58.59 -17.19 19.86 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.943 0.72 . . . . 2.73 112.943 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -65.93 -28.37 68.87 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.246 0.93 . . . . 7.7 111.088 173.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -83.88 105.23 14.61 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 108.565 -0.902 . . . . 3.03 108.565 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -57.11 -17.94 12.76 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.526 0.936 . . . . 6.89 113.526 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.8 -27.77 70.63 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.185 -0.786 . . . . 1.2 112.122 172.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.38 145.31 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 119.186 1.493 . . . . 3.15 108.38 169.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.4 mt -109.57 -39.42 5.16 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.678 1.191 . . . . 3.1 109.695 -168.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -155.16 149.54 26.13 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.715 -1.217 . . . . 3.09 107.715 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.9 m -124.89 147.39 48.84 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.679 -1.23 . . . . 2.29 107.679 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 m -154.48 85.04 1.12 Allowed 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.982 1.313 . . . . 2.62 108.921 172.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.11 157.74 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 123.291 0.636 . . . . 2.92 110.678 172.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.33 144.94 22.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.063 0.545 . . . . 1.76 110.332 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -85.53 -41.33 15.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.956 1.302 . . . . 3.9 108.675 170.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.45 -16.42 3.69 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.071 1.348 . . . . 2.77 112.977 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.6 m -140.79 20.03 2.33 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.432 -0.793 . . . . 2.61 110.392 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.3 m120 36.77 47.27 0.54 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.712 2.005 . . . . 2.24 113.834 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.45 171.7 13.93 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 117.986 0.357 . . . . 2.96 111.386 -165.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.59 108.03 5.56 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.54 2.336 . . . . 1.79 106.211 173.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -87.42 114.48 24.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.722 -2.325 . . . . 1.1 104.722 162.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 67.5 mt -123.16 111.5 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.399 -2.074 . . . . 3.08 105.399 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.96 134.23 36.24 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.014 -1.476 . . . . 3.6 107.014 170.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -148.32 149.57 32.06 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 117.815 0.279 . . . . 4.21 111.365 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -80.73 115.09 53.17 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 107.42 -1.326 . . . . 3.03 107.42 167.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -73.43 -13.11 25.24 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.124 2.55 . . . . 1.61 113.175 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -88.92 -44.87 10.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.513 -0.921 . . . . 2.93 108.513 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.5 mt -72.2 -42.26 66.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 122.848 0.459 . . . . 3.81 110.556 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 mm -125.14 115.47 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.18 -1.785 . . . . 2.48 106.18 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.58 148.51 51.24 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 108.178 -1.969 . . . . 1.09 108.178 171.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -57.44 -40.92 77.41 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 CA-C-N 119.493 1.646 . . . . 1.41 110.37 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -56.35 -28.56 59.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.553 -0.737 . . . . 7.26 112.153 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -71.7 -39.24 70.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 120.123 1.329 . . . . 2.5 112.046 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.5 mt -56.48 -47.46 81.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.604 -0.887 . . . . 2.09 108.604 171.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.6 mt -61.26 -45.23 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 118.851 -0.595 . . . . 2.29 110.204 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -50.85 -43.55 59.31 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.371 0.987 . . . . 4.77 110.201 173.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.6 m -65.54 -54.54 26.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.35 -0.981 . . . . 1.88 108.35 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.8 mt -49.02 -53.41 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.026 0.93 . . . . 2.43 110.823 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -52.48 -53.58 43.78 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.854 0.861 . . . . 2.18 110.145 174.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.1 t -62.73 -26.53 68.73 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 117.788 -1.101 . . . . 1.81 113.091 -174.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.16 -91.37 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.854 1.206 . . . . 3.33 109.937 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.98 40.89 0.42 Allowed Glycine 0 CA--C 1.524 0.604 0 O-C-N 120.936 -1.103 . . . . 1.16 111.646 174.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -138.82 176.44 8.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 117.954 0.877 . . . . 4.28 110.124 -162.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -133.64 164.61 26.82 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.434 -1.321 . . . . 4.22 107.434 167.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.12 166.78 23.27 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.97 0.908 . . . . 2.27 112.118 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.9 m -150.76 155.54 39.47 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 106.708 -1.589 . . . . 2.05 106.708 160.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 CA--C 1.535 0.375 0 CA-C-N 119.557 1.072 . . . . 3.97 109.243 179.061 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.665 0 N-CA-C 110.455 -1.058 . . . . 3.33 110.455 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -119.81 136.12 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 126.052 1.741 . . . . 3.03 110.407 -176.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.28 112.71 5.3 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 123.958 0.903 . . . . 4.13 108.822 176.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.62 113.8 27.61 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 122.992 0.517 . . . . 2.95 109.989 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.2 mt -86.51 157.07 19.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 124.645 1.215 . . . . 3.47 108.076 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.62 142.07 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 105.632 -1.988 . . . . 2.03 105.632 148.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.8 t -135.06 114.25 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 126.314 1.846 . . . . 3.03 106.821 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -110.37 170.97 7.73 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.73 1.212 . . . . 7.88 110.466 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.15 -47.78 2.42 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.723 -0.951 . . . . 1.3 110.723 -173.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -51.4 -45.71 62.63 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 121.964 0.888 . . . . 3.11 112.071 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.317 9.3 t 58.71 -63.25 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.986 2.114 . . . . 3.34 115.32 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 p -110.6 162.13 15.03 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 120.271 1.396 . . . . 1.67 112.82 -163.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.7 -48.17 5.5 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 125.58 1.552 . . . . 2.49 111.516 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -51.51 -48.43 62.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.098 1.359 . . . . 3.51 111.438 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.6 m -72.71 -42.89 63.69 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 122.147 -0.346 . . . . 0.95 110.858 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.3 t -52.1 -64.1 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 117.928 0.331 . . . . 2.2 110.553 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -28.46 68.2 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.847 -1.158 . . . . 1.74 111.716 -173.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -57.44 -55.23 37.49 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.389 0.675 . . . . 3.42 109.581 169.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.88 -52.07 53.36 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 108.996 -0.742 . . . . 2.0 108.996 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -50.83 -60.23 3.28 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.768 0.827 . . . . 3.54 109.785 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.2 t -53.65 -45.95 70.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.517 0.727 . . . . 1.75 110.417 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.7 t -58.96 -53.37 59.18 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.45 -0.944 . . . . 2.09 108.45 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.84 -50.76 44.14 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.911 0.884 . . . . 4.05 110.793 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.0 m -57.49 -24.88 58.43 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.732 0.641 . . . . 2.99 112.732 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -63.5 -33.1 74.82 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.356 -0.84 . . . . 8.79 110.792 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -55.18 143.1 28.67 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 108.558 -0.904 . . . . 3.24 108.558 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.79 159.65 16.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.084 -1.821 . . . . 7.84 106.084 163.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.45 -16.39 45.03 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 122.215 -0.303 . . . . 3.07 113.065 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 pp -78.86 141.14 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 108.191 -1.04 . . . . 4.1 108.191 170.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.6 -47.09 9.5 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.409 1.484 . . . . 4.27 108.318 172.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -156.98 158.09 35.93 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.706 -1.22 . . . . 3.72 107.706 -175.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 p -135.08 151.17 50.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.717 -1.216 . . . . 2.68 107.717 161.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 t -154.35 146.52 23.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.061 -0.718 . . . . 2.96 109.061 152.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.26 152.22 33.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 124.971 1.309 . . . . 2.73 110.207 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.25 155.97 34.75 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-O 121.026 0.441 . . . . 1.73 111.185 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.98 -8.51 14.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.77 1.628 . . . . 2.92 113.046 -165.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.53 -57.62 6.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.034 -1.099 . . . . 2.86 108.034 169.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -79.9 -28.99 39.76 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.203 0.601 . . . . 3.35 111.301 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 m120 73.91 56.59 0.1 Allowed 'General case' 0 C--N 1.343 0.3 0 C-N-CA 125.542 1.537 . . . . 1.67 108.235 -173.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -124.86 159.22 31.58 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.749 1.22 . . . . 5.17 110.793 -166.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -142.35 96.98 3.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 125.31 1.631 . . . . 1.81 107.894 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -81.16 102.42 10.29 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.506 -1.664 . . . . 1.3 106.506 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.33 150.11 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.027 -1.842 . . . . 2.77 106.027 167.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -120.57 137.64 54.3 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.931 -1.878 . . . . 4.36 105.931 161.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -150.69 154.8 38.09 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 123.579 0.752 . . . . 3.29 111.892 -167.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -74.75 126.02 88.92 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.308 -0.997 . . . . 3.67 108.308 159.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.57 -19.2 16.91 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.413 2.742 . . . . 1.71 113.296 -171.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -83.31 -47.34 11.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.625 -0.88 . . . . 3.46 108.625 -176.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 tp -71.98 -40.92 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 119.68 -0.2 . . . . 4.68 111.133 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mm -127.22 110.64 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.421 -1.326 . . . . 2.58 107.421 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.48 158.57 39.7 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 108.91 -1.676 . . . . 1.02 108.91 168.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -55.66 -40.47 85.1 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.25 1.967 . . . . 1.49 109.269 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -29.29 -58.23 0.15 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.119 2.168 . . . . 11.02 112.261 163.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -70.58 -43.5 69.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.7 0.762 . . . . 2.41 109.662 -168.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 mt -58.68 -51.54 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.87 -0.605 . . . . 1.98 109.405 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.2 mt -52.45 -55.48 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.218 -0.66 . . . . 2.16 109.218 176.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 56.0 m170 -51.53 -42.17 61.56 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.957 0.503 . . . . 4.44 111.284 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 31.2 m -62.18 -51.21 68.73 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.718 -0.614 . . . . 2.28 109.79 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -59.96 -40.85 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.465 1.106 . . . . 3.89 111.363 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.04 -53.54 57.15 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.871 0.868 . . . . 2.02 109.955 168.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.6 t -60.96 -27.41 68.24 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.495 0.718 . . . . 2.13 112.174 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.04 -85.9 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.719 -0.845 . . . . 3.16 108.719 166.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.74 18.54 0.18 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.489 -1.173 . . . . 1.26 114.608 169.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -132.58 151.85 51.8 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 119.441 1.62 . . . . 3.11 111.495 -148.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -78.5 163.96 25.13 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.119 -1.067 . . . . 4.86 108.119 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.12 158.09 42.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 121.395 -0.122 . . . . 1.81 110.902 160.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.5 t -155.18 134.52 12.46 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.543 -0.91 . . . . 3.01 108.543 173.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.208 0 O-C-N 121.6 -0.687 . . . . 3.15 109.283 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.685 0 N-CA-C 109.34 -1.504 . . . . 1.89 109.34 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.93 133.9 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 107.555 -1.276 . . . . 3.5 107.555 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 tp -136.09 121.06 18.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.215 -1.402 . . . . 3.39 107.215 162.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -109.53 70.81 0.74 Allowed 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 125.17 1.388 . . . . 3.58 108.361 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.32 149.96 33.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.13 -0.628 . . . . 3.87 109.439 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.47 135.26 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 105.52 -2.03 . . . . 1.8 105.52 164.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.08 131.75 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 125.509 1.524 . . . . 3.5 108.003 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -123.67 163.35 21.25 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.886 0.874 . . . . 6.49 109.834 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.56 -15.42 62.79 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.997 0.808 . . . . 1.23 111.856 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.8 mtm -70.33 77.61 0.54 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 117.891 0.846 . . . . 2.26 110.31 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -70.52 -14.87 62.69 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.984 -1.008 . . . . 2.43 113.35 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 p -161.64 169.93 20.68 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.652 1.114 . . . . 1.06 109.682 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.11 -36.73 30.9 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.331 1.052 . . . . 2.09 111.6 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -47.57 -38.84 15.17 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.334 1.853 . . . . 2.72 112.196 173.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.5 m -71.5 -54.81 9.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 122.039 -0.413 . . . . 0.73 110.117 172.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.4 t -49.05 -60.6 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.189 0.995 . . . . 1.91 110.494 -173.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -27.21 67.06 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.163 -0.615 . . . . 0.9 111.643 -175.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -64.69 -50.95 64.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.952 -0.759 . . . . 3.92 108.952 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 mt -53.09 -58.35 3.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 N-CA-C 108.946 -0.761 . . . . 2.29 108.946 172.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -49.13 -57.71 6.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.417 0.627 . . . . 3.87 110.921 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -62.26 -41.18 98.22 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.268 1.027 . . . . 1.34 111.112 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.8 t -67.0 -45.23 78.2 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.534 -0.913 . . . . 1.95 108.534 -176.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.91 -49.31 47.14 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 118.796 -0.621 . . . . 3.92 112.203 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.4 p -54.87 -25.43 28.75 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.883 0.765 . . . . 3.06 112.632 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -45.34 -44.28 11.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.894 1.278 . . . . 7.17 112.646 168.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -64.94 117.53 7.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.422 1.089 . . . . 2.43 108.869 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -75.2 36.11 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.523 1.129 . . . . 7.6 113.354 -169.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -132.46 -5.81 3.19 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.397 1.475 . . . . 1.47 111.519 168.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.5 mm -83.84 109.46 17.37 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 N-CA-C 107.021 -1.474 . . . . 5.28 107.021 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.9 mt -79.72 -38.88 32.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.803 0.841 . . . . 2.77 109.489 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -154.38 158.21 39.7 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 108.809 -0.812 . . . . 3.07 108.809 174.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.9 t -139.36 134.84 33.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.244 1.018 . . . . 2.47 108.516 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.1 t -134.54 85.38 2.18 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.054 -1.091 . . . . 2.05 108.054 169.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.1 m -78.9 149.76 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 125.234 1.413 . . . . 3.16 110.081 170.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.15 132.17 10.84 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.014 0.526 . . . . 1.71 109.756 166.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.88 -35.36 74.59 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 109.406 -0.591 . . . . 2.9 109.406 167.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.92 -35.82 64.58 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.786 0.835 . . . . 2.52 111.826 -174.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 m -119.26 18.04 13.04 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.868 0.867 . . . . 2.72 110.325 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.1 m120 33.95 48.89 0.25 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 126.279 1.831 . . . . 2.57 113.489 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.96 162.84 26.66 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.797 -0.446 . . . . 3.28 109.797 -169.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.43 100.92 3.42 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.713 -0.847 . . . . 1.86 108.713 169.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -80.3 100.41 8.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.621 -1.992 . . . . 1.31 105.621 166.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -94.35 135.36 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 105.797 -1.927 . . . . 2.74 105.797 165.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -100.45 117.02 33.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 104.831 -2.285 . . . . 3.02 104.831 158.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -117.14 168.81 9.95 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.544 0.738 . . . . 3.15 110.006 172.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.02 133.99 26.71 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 107.238 -1.393 . . . . 3.61 107.238 153.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -72.8 -10.69 25.2 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.558 2.172 . . . . 1.72 113.475 -174.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -83.22 -47.54 11.44 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.39 -0.967 . . . . 3.34 108.39 -173.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.8 mm -81.89 -36.72 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.723 -0.656 . . . . 3.54 110.927 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 mm -133.72 118.02 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 119.293 0.951 . . . . 2.49 108.534 -174.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.75 176.71 47.9 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 110.16 -1.176 . . . . 1.08 110.16 169.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.52 -42.17 22.52 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.663 2.242 . . . . 1.16 109.985 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.85 -54.71 5.04 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.212 1.405 . . . . 8.85 111.214 173.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -53.13 -55.93 20.2 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.462 0.574 . . . . 2.46 110.516 -176.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.9 mt -59.85 -53.26 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 116.236 -0.438 . . . . 1.83 110.012 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.9 mt -53.59 -54.66 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 109.487 -0.56 . . . . 1.94 109.487 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -52.06 -41.27 62.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.267 1.027 . . . . 5.66 111.531 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 44.9 m -69.85 -48.51 58.58 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.721 -0.474 . . . . 2.12 109.721 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.8 mt -51.47 -50.64 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 109.527 -0.546 . . . . 2.51 109.527 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.05 -55.58 31.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.934 0.893 . . . . 2.46 111.171 176.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.7 p -62.68 -32.12 73.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.899 -0.572 . . . . 2.47 112.054 -173.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.92 -85.44 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.57 0.623 . . . . 3.78 111.17 171.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.59 25.86 0.25 Allowed Glycine 0 CA--C 1.526 0.752 0 O-C-N 121.151 -0.968 . . . . 1.01 113.833 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -137.2 177.35 7.93 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.617 1.209 . . . . 2.76 111.069 -155.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -120.43 157.57 29.04 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.856 -1.164 . . . . 3.48 107.856 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.41 152.98 40.68 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.75 0.42 . . . . 1.95 111.253 167.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.3 m -156.4 135.44 11.97 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.604 1.162 . . . . 2.65 109.38 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 N--CA 1.467 0.409 0 C-N-CA 124.271 1.028 . . . . 3.95 110.442 -179.695 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.542 0 N-CA-C 108.417 -1.873 . . . . 2.03 108.417 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.54 131.38 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 106.442 -1.688 . . . . 3.41 106.442 168.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.2 99.19 5.77 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.091 0.956 . . . . 3.91 108.63 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -87.46 106.75 18.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.194 -1.41 . . . . 3.03 107.194 161.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.91 150.16 30.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.51 -0.922 . . . . 3.6 108.51 168.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.55 142.7 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 104.787 -2.301 . . . . 1.79 104.787 159.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.9 p -139.66 135.54 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 106.796 -1.557 . . . . 3.42 106.796 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -134.51 168.78 18.34 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.294 1.438 . . . . 9.46 108.915 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.88 -14.59 61.41 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.903 0.764 . . . . 1.29 111.222 -163.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.1 mtp -68.51 77.6 0.28 Allowed 'General case' 0 C--N 1.341 0.225 0 CA-C-N 118.194 0.997 . . . . 3.14 110.799 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.5 p -61.09 -41.39 96.57 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.72 -0.657 . . . . 3.73 112.516 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.3 p -156.28 -179.37 8.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.171 0.896 . . . . 0.77 112.794 -166.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.09 -40.7 46.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.812 1.245 . . . . 2.01 111.577 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 m -60.81 -29.49 69.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.086 0.554 . . . . 1.99 111.898 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.7 m -71.85 -58.58 3.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.902 0.774 . . . . 0.67 109.927 167.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.0 t -38.7 -64.78 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.937 1.295 . . . . 2.2 111.481 -177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -28.45 65.98 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.181 -0.608 . . . . 1.08 111.69 -172.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -66.56 -52.49 45.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.88 -0.785 . . . . 4.33 108.88 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.6 -59.37 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 N-CA-C 108.341 -0.985 . . . . 1.95 108.341 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -50.15 -62.99 1.25 Allowed 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 124.057 0.848 . . . . 3.8 110.097 -175.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.6 t -56.32 -41.28 75.73 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.484 0.714 . . . . 1.27 111.163 -177.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 t -65.58 -54.13 32.19 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.417 -0.957 . . . . 2.04 108.417 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 mp -52.42 -46.58 66.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.794 0.438 . . . . 3.55 110.911 175.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.1 m -62.8 -9.83 10.87 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.964 0.728 . . . . 2.73 112.964 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -25.1 62.11 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.718 -1.239 . . . . 6.34 111.963 169.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -69.54 140.89 53.93 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 107.553 -1.277 . . . . 2.6 107.553 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.9 ttm-85 -81.81 -28.02 33.34 Favored 'General case' 0 C--O 1.226 -0.154 0 O-C-N 121.41 -0.807 . . . . 6.34 111.846 -177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.8 5.47 83.7 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.454 -0.636 . . . . 1.35 113.802 -173.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.39 159.06 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 118.513 1.157 . . . . 3.88 109.415 164.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.4 mt -113.88 -39.78 3.9 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.466 1.506 . . . . 3.18 109.316 176.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -156.15 156.61 34.53 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.449 -0.575 . . . . 3.52 109.449 174.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.1 m -138.16 135.21 35.46 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.495 -1.669 . . . . 2.79 106.495 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.5 t -147.97 143.77 27.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.684 -1.598 . . . . 2.35 106.684 163.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 m -137.5 144.03 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.399 1.079 . . . . 2.68 108.741 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.29 111.55 6.81 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.638 1.175 . . . . 1.79 110.002 -175.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.94 -22.89 61.4 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.309 1.444 . . . . 2.21 113.152 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.51 -50.28 53.37 Favored 'General case' 0 C--O 1.226 -0.159 0 N-CA-C 108.38 -0.97 . . . . 2.3 108.38 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.61 -19.96 51.5 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.192 0.997 . . . . 2.49 110.878 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.4 m120 57.84 46.48 16.84 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 126.118 1.767 . . . . 1.9 109.971 -172.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.47 157.86 45.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.97 -0.381 . . . . 4.11 109.97 -170.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.69 127.65 25.71 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.844 -1.169 . . . . 1.95 107.844 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -99.17 98.27 9.28 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 105.332 -2.099 . . . . 1.07 105.332 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.0 mm -94.58 147.65 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 106.135 -1.802 . . . . 2.87 106.135 170.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -124.62 135.75 53.37 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.428 -2.434 . . . . 4.84 104.428 159.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -156.34 160.66 39.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.255 0.622 . . . . 3.15 109.902 -162.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -93.44 125.79 52.72 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.752 -0.833 . . . . 3.15 108.752 171.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.0 -14.28 29.15 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.824 2.35 . . . . 1.77 113.875 -172.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -121.19 25.4 9.56 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.866 1.212 . . . . 3.15 112.402 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.7 tp -132.39 -63.56 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 118.988 -0.529 . . . . 4.66 110.283 159.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.95 -44.28 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 119.669 1.122 . . . . 3.03 108.321 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.22 168.51 18.77 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.109 -0.567 . . . . 3.4 111.805 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -71.52 -57.28 0.1 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.043 1.829 . . . . 1.37 111.731 -170.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 ttt-85 -70.64 -20.16 62.75 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.064 0.765 . . . . 7.18 113.064 -167.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.31 -35.1 71.14 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.438 1.017 . . . . 3.8 112.93 -175.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.3 mt -48.84 -50.22 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 121.432 -0.793 . . . . 2.38 109.236 164.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mt -63.15 -42.6 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 117.715 -1.136 . . . . 2.2 110.727 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -49.55 -44.05 46.32 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.39 1.45 . . . . 4.52 110.152 170.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.4 m -66.29 -50.49 63.49 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.32 -0.622 . . . . 1.9 109.32 -175.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 64.0 mt -52.97 -52.81 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.537 1.135 . . . . 2.65 110.959 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -53.96 -53.92 46.06 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.107 1.363 . . . . 1.9 110.293 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t -58.91 -41.77 88.05 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.111 0.964 . . . . 2.16 111.436 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.3 mt -64.13 -84.05 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.584 0.353 . . . . 3.1 110.897 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.24 22.51 0.22 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.638 -1.09 . . . . 0.98 113.818 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -134.92 162.62 31.9 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 118.945 1.372 . . . . 2.79 111.047 -156.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -115.78 152.1 33.93 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.335 1.454 . . . . 3.84 107.412 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.85 166.53 33.12 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.424 1.011 . . . . 2.51 113.276 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 p -155.33 123.21 5.73 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.193 1.397 . . . . 2.57 109.791 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.465 0.292 0 C-N-CA 123.342 0.657 . . . . 3.31 109.942 170.102 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.537 0 N-CA-C 106.955 -2.458 . . . . 2.12 106.955 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.33 129.2 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 109.416 -0.587 . . . . 3.13 109.416 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.36 136.8 39.95 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.259 1.024 . . . . 3.63 108.529 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.21 144.01 48.83 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.617 -1.994 . . . . 4.87 105.617 167.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.14 147.8 24.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.696 -0.853 . . . . 3.18 108.696 167.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.31 134.58 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 105.665 -1.976 . . . . 2.12 105.665 173.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.3 t -116.44 117.91 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 106.873 -1.528 . . . . 3.14 106.873 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.1 mtt180 -85.59 143.83 28.23 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.09 -1.078 . . . . 7.95 108.09 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.14 -1.0 58.98 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.088 -0.84 . . . . 1.2 113.684 173.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.3 mtp -71.4 72.38 0.69 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.138 1.469 . . . . 2.81 110.436 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -73.97 -17.0 61.06 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 117.683 -1.151 . . . . 2.35 113.819 -169.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.2 p -159.01 172.75 17.62 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 120.23 1.377 . . . . 0.89 110.724 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.58 -36.7 35.98 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.406 1.082 . . . . 2.04 111.794 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 t -56.53 -45.4 81.16 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.873 -0.417 . . . . 2.72 109.873 175.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.9 m -63.7 -47.81 79.63 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.684 -0.635 . . . . 0.7 110.527 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.2 t -49.66 -66.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.439 -0.578 . . . . 2.0 109.439 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.288 0.1 OUTLIER -71.19 -23.45 62.04 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 118.954 -1.098 . . . . 1.32 112.804 -173.523 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -52.99 -49.44 66.17 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.718 1.144 . . . . 4.34 109.15 169.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.7 mt -56.95 -59.05 3.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 109.529 -0.545 . . . . 1.97 109.529 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.3 -47.65 84.58 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.125 0.488 . . . . 4.65 111.064 -171.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -57.07 -33.91 67.74 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.818 1.247 . . . . 1.85 110.826 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.7 m -71.72 -60.64 2.13 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.705 -0.622 . . . . 2.72 109.409 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -54.6 -42.82 71.59 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.433 0.693 . . . . 3.73 112.179 -171.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.2 p -57.39 -18.77 19.33 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.462 0.542 . . . . 2.55 112.462 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -70.79 -27.81 64.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.041 0.937 . . . . 7.09 111.743 175.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -70.74 -12.05 61.32 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.039 1.125 . . . . 3.17 114.039 -165.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.6 mmp_? 72.17 -44.54 0.6 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 126.281 1.832 . . . . 8.18 113.567 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.15 53.21 1.79 Allowed Glycine 0 CA--C 1.525 0.689 0 CA-C-N 119.036 0.835 . . . . 1.65 111.223 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.44 133.55 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 106.722 -1.584 . . . . 4.38 106.722 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.0 mt -88.66 -45.55 9.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.833 -1.173 . . . . 3.33 107.833 167.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -157.15 154.32 29.14 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 122.198 -0.314 . . . . 4.07 111.017 -178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.3 t -130.2 110.63 11.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.777 1.231 . . . . 2.88 109.932 170.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.1 t -115.71 84.9 2.18 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.224 1.81 . . . . 2.07 107.86 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.76 152.15 3.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.343 1.057 . . . . 3.13 110.341 174.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.08 135.06 12.95 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 119.394 -0.336 . . . . 1.93 110.137 170.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.55 -32.3 71.02 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 123.409 0.443 . . . . 2.65 110.203 168.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.86 -48.17 60.2 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.386 0.674 . . . . 2.02 111.281 -176.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -105.52 10.06 33.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.327 1.451 . . . . 3.03 111.451 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.3 m120 41.17 47.66 2.88 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.185 1.794 . . . . 2.17 112.299 -175.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.71 171.2 11.38 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.149 0.58 . . . . 3.29 111.679 -165.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.99 87.41 1.41 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.954 1.302 . . . . 1.77 109.809 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -79.25 96.47 5.93 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.797 -1.557 . . . . 1.12 106.797 171.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.32 141.31 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.983 -1.488 . . . . 2.51 106.983 171.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -114.52 116.42 28.79 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 104.207 -2.516 . . . . 3.56 104.207 165.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -125.69 157.3 37.66 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.874 0.87 . . . . 3.0 111.65 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.92 114.9 59.51 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.905 1.682 . . . . 5.05 107.879 176.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.79 36.2 0.6 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.481 2.121 . . . . 2.38 113.762 -166.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -140.22 33.23 1.91 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.421 1.088 . . . . 3.3 110.18 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 tp -171.83 -49.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 124.891 1.276 . . . . 4.93 108.671 -170.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mm -122.91 132.73 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 105.384 -2.08 . . . . 2.44 105.384 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.72 -179.7 19.48 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.839 1.685 . . . . 1.38 109.311 167.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.65 -40.59 28.97 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.338 2.025 . . . . 1.16 110.306 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -42.19 69.8 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.187 0.595 . . . . 10.99 111.469 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -58.98 -54.14 50.49 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.305 -0.628 . . . . 2.2 109.305 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.5 mt -56.9 -50.41 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 123.616 0.766 . . . . 1.79 109.933 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.6 mt -53.09 -57.42 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.316 0.646 . . . . 2.27 109.957 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -52.34 -44.59 65.27 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.236 0.614 . . . . 4.26 110.44 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.6 m -64.11 -51.2 65.13 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.308 -0.627 . . . . 1.9 109.308 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.3 mt -51.9 -59.7 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.792 0.837 . . . . 2.42 109.157 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -63.14 -47.91 80.71 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 119.676 -0.81 . . . . 2.97 109.979 -169.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 t -54.23 -39.95 67.23 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.154 0.582 . . . . 2.24 111.863 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.4 mt -61.23 -59.63 5.0 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.825 0.739 . . . . 3.35 112.431 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.31 16.0 0.14 Allowed Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.409 -1.217 . . . . 1.57 115.432 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -143.07 -179.74 6.55 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.008 1.404 . . . . 3.66 111.44 -142.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -127.91 154.4 45.57 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 105.765 -1.939 . . . . 3.67 105.765 163.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.95 154.52 27.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.98 0.809 . . . . 2.36 110.532 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.3 m -155.26 103.45 2.35 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.102 1.361 . . . . 2.66 109.453 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.463 0.201 0 C-N-CA 123.215 0.606 . . . . 3.78 109.453 169.326 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.799 0 N-CA-C 108.19 -1.964 . . . . 2.14 108.19 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.4 t -98.11 144.79 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 124.753 1.221 . . . . 3.69 108.909 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.8 tp -127.81 123.24 34.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 106.418 -1.697 . . . . 3.69 106.418 165.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -120.8 126.52 50.31 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 108.274 -1.01 . . . . 4.09 108.274 179.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.17 155.65 48.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 123.571 0.545 . . . . 3.89 109.994 178.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.45 112.24 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 104.435 -2.432 . . . . 2.13 104.435 166.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 p -79.6 137.6 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 106.889 -1.523 . . . . 3.94 106.889 166.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -139.28 173.54 11.44 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.194 1.398 . . . . 7.22 108.377 -179.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.39 -46.82 2.28 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.478 -0.649 . . . . 1.6 111.478 -176.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.16 136.92 46.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.531 -0.914 . . . . 3.46 108.531 -177.128 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -141.56 8.46 1.97 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.726 1.75 . . . . 2.15 115.726 -156.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.6 p -159.39 173.19 16.62 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 121.173 1.806 . . . . 0.78 111.782 174.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.59 -42.64 56.01 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.207 1.003 . . . . 1.64 111.135 175.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 m -65.93 -20.95 66.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.761 0.824 . . . . 2.25 112.286 178.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.3 m -73.51 -62.1 1.6 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.036 0.835 . . . . 0.82 111.222 158.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.1 t -39.43 -63.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 124.588 1.155 . . . . 1.95 111.457 -173.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.87 -29.87 70.38 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.439 -0.505 . . . . 0.92 111.579 -173.603 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -70.45 -44.78 67.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.68 0.792 . . . . 4.24 108.976 -178.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.2 mt -55.2 -59.14 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.393 -0.966 . . . . 2.17 108.393 175.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -55.77 -53.92 50.78 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 117.979 0.354 . . . . 3.87 111.014 -178.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -55.37 -36.51 66.42 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.005 0.922 . . . . 1.43 111.973 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 t -70.1 -54.72 11.8 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.132 -1.062 . . . . 1.87 108.132 177.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 mp -57.46 -42.72 83.12 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.155 0.582 . . . . 3.44 112.179 -174.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.3 p -60.09 -12.46 8.4 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.265 -0.897 . . . . 2.6 113.029 178.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.4 -32.59 74.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.093 0.86 . . . . 4.71 110.561 172.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -78.29 106.91 10.53 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.218 -0.66 . . . . 2.14 109.218 178.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -57.66 -20.82 36.18 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.871 -1.143 . . . . 7.02 112.62 171.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.3 -32.47 72.29 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.902 -0.943 . . . . 1.21 112.323 172.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -88.92 137.36 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 118.671 1.236 . . . . 3.37 108.098 170.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 mt -95.86 -36.53 11.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.552 0.741 . . . . 2.75 109.471 177.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -150.11 153.69 36.82 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.774 0.261 . . . . 2.94 110.483 173.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -137.28 130.46 30.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.421 1.888 . . . . 2.73 106.728 171.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.4 t -128.18 110.45 12.45 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 106.526 -1.657 . . . . 2.1 106.526 168.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.59 150.91 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.255 1.022 . . . . 3.88 110.72 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.17 122.54 5.59 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.856 -0.528 . . . . 1.8 111.177 174.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.12 -26.36 67.41 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.371 0.668 . . . . 2.48 109.936 161.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.2 -49.19 77.91 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.259 0.481 . . . . 2.25 109.884 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.45 -37.51 36.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.793 0.437 . . . . 2.43 110.349 173.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 m120 68.89 71.75 0.27 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.774 -1.565 . . . . 1.88 106.774 -151.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.33 158.11 43.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.173 -0.329 . . . . 3.39 110.251 173.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.27 129.58 47.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.547 -2.02 . . . . 1.93 105.547 151.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -107.4 116.53 32.11 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 102.85 -3.019 . . . . 1.19 102.85 166.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mm -107.9 149.5 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 104.728 -2.323 . . . . 2.97 104.728 174.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.94 139.8 47.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.2 -1.037 . . . . 3.19 108.2 157.155 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -162.82 160.83 25.65 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 124.092 0.87 . . . . 3.68 109.718 -153.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -93.37 124.61 57.03 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 108.882 -0.785 . . . . 3.57 108.882 168.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.74 -19.08 24.47 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.935 2.424 . . . . 2.04 113.689 -173.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.32 -48.7 10.88 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.003 -1.11 . . . . 4.28 108.003 176.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.4 mt -63.9 -40.13 87.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-O 119.227 -0.416 . . . . 4.04 110.038 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.3 tt -137.34 109.32 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.346 0.594 . . . . 2.6 110.91 173.079 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.88 141.01 47.26 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.411 -1.476 . . . . 1.41 109.411 172.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -55.71 -40.16 86.91 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.741 2.294 . . . . 1.27 111.815 -172.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -56.9 -29.53 63.09 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 118.178 -0.915 . . . . 7.56 112.369 178.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.23 -44.18 92.68 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 120.015 1.279 . . . . 4.12 110.35 -179.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.2 mt -56.56 -52.97 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.308 -0.627 . . . . 1.83 109.308 175.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.1 mm -51.04 -56.87 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.089 0.556 . . . . 3.18 109.833 177.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.33 -34.98 69.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.788 0.835 . . . . 5.73 111.465 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.3 m -65.47 -52.99 48.98 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.881 -1.155 . . . . 1.8 107.881 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.1 mt -50.9 -50.74 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.12 0.568 . . . . 2.24 110.237 176.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -53.54 -50.28 65.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.047 0.451 . . . . 2.25 110.39 175.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.7 t -67.28 -14.66 63.12 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.512 1.125 . . . . 2.01 113.305 -173.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 mp -72.13 -91.01 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.911 1.232 . . . . 3.28 107.709 165.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.44 35.88 0.48 Allowed Glycine 0 CA--C 1.523 0.586 0 O-C-N 121.347 -0.845 . . . . 1.18 111.815 169.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -130.61 177.52 7.32 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.552 0.676 . . . . 2.78 110.927 -156.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -119.73 148.43 43.41 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.593 -1.632 . . . . 3.67 106.593 175.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.58 133.42 32.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.919 0.887 . . . . 2.03 108.736 170.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.3 t -133.77 103.39 5.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.34 1.056 . . . . 2.59 109.002 -177.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.374 0 C-N-CA 124.809 1.244 . . . . 3.81 110.879 178.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.74 0 N-CA-C 107.437 -2.265 . . . . 1.71 107.437 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.74 91.57 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.678 1.191 . . . . 3.38 109.65 -177.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.71 79.24 7.38 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.277 -1.379 . . . . 3.92 107.277 175.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -102.23 116.01 31.75 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.096 -0.956 . . . . 3.85 109.615 174.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.91 166.42 24.52 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.915 1.286 . . . . 2.86 110.421 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.33 143.55 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 106.54 -1.652 . . . . 2.03 106.54 173.187 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.0 t -136.53 130.49 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 126.025 1.73 . . . . 3.07 107.356 175.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -132.03 156.43 46.28 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.262 1.425 . . . . 6.95 108.618 -174.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.34 -24.56 28.51 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.641 -0.533 . . . . 1.26 112.253 177.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.75 76.25 0.85 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.396 1.093 . . . . 2.95 110.201 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -70.21 -12.34 61.52 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 115.399 1.629 . . . . 2.38 115.399 -157.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.6 p -157.14 174.02 16.11 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 120.523 1.511 . . . . 0.76 110.724 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.91 -44.54 14.73 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.814 1.245 . . . . 1.96 111.529 177.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 m -57.67 -37.32 73.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.525 0.73 . . . . 2.05 111.854 178.507 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.6 m -71.43 -50.35 32.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.438 0.563 . . . . 0.78 110.306 171.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.9 t -52.38 -56.6 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 122.737 0.415 . . . . 2.09 111.01 -175.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -27.96 64.22 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.613 -0.679 . . . . 0.99 112.065 -177.325 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -57.77 -48.04 80.79 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.776 -0.824 . . . . 4.45 108.776 170.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 81.9 mt -56.67 -66.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 108.743 -0.836 . . . . 1.85 108.743 171.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -46.11 -56.43 5.64 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.176 0.99 . . . . 3.79 110.765 -169.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.4 t -57.63 -51.4 69.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.562 0.745 . . . . 1.68 110.175 -176.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -59.78 -40.66 89.0 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.438 0.637 . . . . 2.06 109.724 -178.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -49.83 75.01 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.547 0.739 . . . . 3.81 110.759 178.069 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.1 p -56.01 -41.48 74.96 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.202 0.91 . . . . 2.53 110.759 175.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -57.53 -9.67 1.21 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.96 1.304 . . . . 5.43 113.154 175.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -56.43 -32.83 65.26 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 119.975 -1.703 . . . . 4.42 111.334 164.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 70.62 -51.05 0.67 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 126.606 1.962 . . . . 8.48 110.927 -168.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.37 53.39 1.89 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.672 0.653 . . . . 1.74 112.775 178.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -136.54 172.02 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.399 -1.334 . . . . 4.06 107.399 172.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.9 mt -117.57 -42.12 2.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.197 0.999 . . . . 3.05 109.346 -178.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -155.8 156.22 34.39 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 108.659 -0.867 . . . . 3.78 108.659 175.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.1 m -132.8 130.4 39.81 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 105.613 -1.995 . . . . 2.82 105.613 176.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.6 p -144.74 98.01 3.12 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.643 -0.873 . . . . 3.9 108.643 173.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 p -116.13 139.81 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.493 1.517 . . . . 3.53 109.342 -172.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.67 123.65 6.28 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.072 0.549 . . . . 1.91 110.294 -172.136 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.48 -32.77 74.56 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 109.56 -0.533 . . . . 2.98 109.56 167.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.9 -34.44 67.9 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.792 0.837 . . . . 2.3 111.825 -176.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.0 m -117.44 21.9 12.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.843 0.857 . . . . 2.84 109.787 175.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.3 m120 25.6 61.4 0.07 Allowed 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 126.834 2.054 . . . . 2.29 113.66 -172.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.57 166.54 26.17 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 120.619 0.247 . . . . 3.15 111.277 -173.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -139.02 125.9 20.98 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 124.663 1.227 . . . . 1.64 108.395 160.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -108.26 102.16 11.31 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.075 -2.194 . . . . 1.08 105.075 171.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.38 118.37 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 105.402 -2.073 . . . . 2.86 105.402 171.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -81.14 130.17 34.9 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.267 -1.753 . . . . 3.54 106.267 164.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -139.74 149.18 43.29 Favored 'General case' 0 N--CA 1.46 0.068 0 C-N-CA 124.265 1.026 . . . . 3.06 109.736 -168.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.76 131.48 70.52 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.465 -1.309 . . . . 2.97 107.465 161.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -82.75 0.13 9.82 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.807 2.338 . . . . 1.48 114.268 -172.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -93.09 -50.39 5.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 119.677 1.126 . . . . 4.02 108.148 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.8 tt -70.88 -29.89 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.734 0.642 . . . . 3.51 112.734 -174.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mm -142.69 144.47 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 105.6 -2.0 . . . . 2.47 105.6 -172.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.53 -178.14 15.72 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.187 1.375 . . . . 1.44 110.902 171.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.48 -48.13 22.08 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.208 2.605 . . . . 1.92 110.511 174.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.4 -61.29 1.07 Allowed 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 125.016 1.326 . . . . 8.18 110.895 176.31 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -53.74 -54.38 38.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.644 0.735 . . . . 2.62 110.387 -173.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.2 mt -58.86 -53.75 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.808 -0.633 . . . . 1.85 110.023 -177.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.1 mt -54.11 -53.23 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.416 -0.587 . . . . 2.24 109.416 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 52.3 m170 -55.1 -41.25 71.37 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.332 0.653 . . . . 4.36 110.651 179.03 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.5 m -62.08 -52.11 65.25 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.11 -0.7 . . . . 1.86 109.11 178.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.52 -51.06 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 123.495 0.718 . . . . 2.95 111.086 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -58.31 -58.12 9.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.602 1.161 . . . . 2.13 110.197 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -51.52 -46.94 63.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.317 1.047 . . . . 2.0 110.471 -178.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.32 -53.74 52.88 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.404 -0.331 . . . . 3.17 111.225 177.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.82 -41.48 0.02 OUTLIER Glycine 0 CA--C 1.529 0.919 0 N-CA-C 115.641 1.017 . . . . 1.51 115.641 174.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -122.39 160.83 24.63 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.7 0.63 . . . . 2.93 112.7 -127.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -82.45 150.55 26.99 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.09 -1.078 . . . . 3.68 108.09 -179.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.72 160.04 43.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.81 0.444 . . . . 2.12 111.661 172.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.4 m -155.92 128.0 7.54 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.473 0.709 . . . . 2.12 110.871 177.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 CA--C 1.535 0.375 0 C-N-CA 123.938 0.895 . . . . 3.93 109.546 169.702 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.946 0 CA-C-O 118.587 -1.118 . . . . 3.84 113.447 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.8 t -80.79 129.23 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 120.094 1.947 . . . . 4.72 109.127 174.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -150.94 123.05 8.25 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.845 0.748 . . . . 4.2 110.102 -175.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.39 121.7 45.9 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.945 1.298 . . . . 5.39 110.926 175.042 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 mt -104.06 160.81 14.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.996 -1.112 . . . . 3.94 107.996 164.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -85.08 143.61 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 106.246 -1.761 . . . . 2.05 106.246 147.316 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.2 144.64 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 106.139 -1.8 . . . . 3.68 106.139 175.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -146.07 164.77 31.1 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.313 0.645 . . . . 6.75 109.958 -178.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.83 -10.14 40.83 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.577 1.084 . . . . 1.16 111.048 -173.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -73.23 79.16 1.3 Allowed 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.045 0.923 . . . . 2.45 110.144 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -64.33 -15.84 61.08 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.479 -1.248 . . . . 2.04 113.358 -177.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.0 p -165.12 175.84 9.02 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 120.511 1.505 . . . . 0.75 110.753 177.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.99 -40.07 43.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.935 0.894 . . . . 1.81 111.499 175.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -57.62 -27.27 62.62 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.83 1.252 . . . . 2.72 111.905 178.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.1 m -73.85 -64.02 1.09 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.414 0.552 . . . . 0.72 110.941 162.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.7 t -44.75 -55.95 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 124.369 1.067 . . . . 2.01 111.646 -168.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -30.71 69.57 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.074 0.464 . . . . 1.79 111.559 -175.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -38.4 71.61 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.594 1.158 . . . . 5.05 109.447 -172.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.0 mt -55.93 -64.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.583 -0.895 . . . . 2.07 108.583 176.491 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -57.51 9.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.407 0.683 . . . . 4.43 109.813 178.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 t -54.75 -43.7 72.93 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.514 -0.741 . . . . 1.93 111.791 -175.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t -71.52 -49.1 44.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.886 -0.508 . . . . 2.23 110.222 -177.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.4 tp -73.35 -52.29 14.37 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 124.813 1.245 . . . . 4.05 112.852 -173.098 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.7 m -59.54 -21.76 60.71 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.288 0.848 . . . . 3.22 113.288 -171.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -22.18 66.92 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.166 -0.959 . . . . 5.25 113.451 172.218 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -66.2 106.03 1.55 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.042 -1.096 . . . . 2.56 108.042 175.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -52.69 100.43 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.274 1.029 . . . . 6.79 109.862 175.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 144.4 -32.06 1.77 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.04 -1.224 . . . . 2.14 110.04 -169.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.1 mm -79.63 151.1 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.26 -1.385 . . . . 5.54 107.26 161.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 50.7 mt -114.21 -47.68 2.93 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.906 1.283 . . . . 3.26 109.42 175.161 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -156.19 150.33 25.37 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 108.117 -1.068 . . . . 4.44 108.117 -175.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.9 m -125.86 80.72 1.93 Allowed 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.149 0.98 . . . . 3.37 110.301 174.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 t -78.26 77.97 4.74 Favored 'General case' 0 C--O 1.237 0.43 0 O-C-N 120.787 -1.196 . . . . 1.94 109.203 178.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -91.13 141.04 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 125.035 1.334 . . . . 3.96 110.456 171.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.77 118.44 6.58 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.218 0.463 . . . . 2.38 110.662 169.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -55.57 -19.61 10.65 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.5 1.12 . . . . 2.28 113.624 177.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.14 -34.63 78.04 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.318 0.647 . . . . 1.95 110.939 175.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.74 -8.22 10.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.904 0.882 . . . . 3.88 111.651 -178.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m120 60.97 26.29 16.24 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 125.023 1.329 . . . . 2.26 110.976 176.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.66 161.98 13.67 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.026 -1.472 . . . . 3.64 107.026 -176.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -139.6 90.49 2.41 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 105.533 -2.025 . . . . 2.14 105.533 165.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -78.88 83.81 4.97 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 103.25 -2.87 . . . . 1.96 103.25 167.125 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.0 pt -81.46 165.24 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 106.503 -1.666 . . . . 4.15 106.503 170.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -127.78 133.86 49.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 105.352 -2.092 . . . . 4.39 105.352 160.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.93 176.41 9.3 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 126.13 1.772 . . . . 3.35 108.181 -169.359 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -111.62 132.99 21.62 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 107.568 -1.271 . . . . 3.08 107.568 155.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.26 -17.68 18.8 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.414 2.743 . . . . 1.93 113.489 -172.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -89.6 -50.17 6.23 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 118.878 0.763 . . . . 3.09 109.217 -176.098 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.2 pt -85.96 1.64 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 113.33 0.863 . . . . 4.25 113.33 -176.294 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -152.13 123.55 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 106.624 -1.621 . . . . 2.5 106.624 171.063 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.63 148.6 42.12 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 109.804 -1.318 . . . . 1.42 109.804 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -56.58 -44.05 49.28 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 CA-C-N 119.402 1.601 . . . . 1.23 108.504 165.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.438 HH11 ' CD2' ' A' ' 60' ' ' HIS . 6.8 tpp180 -51.16 -32.91 24.8 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 117.952 -1.023 . . . . 6.97 112.015 170.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -72.47 -43.39 63.79 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 121.173 1.806 . . . . 2.39 113.112 176.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mt -48.91 -50.99 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.221 -0.592 . . . . 1.91 109.469 165.022 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.7 mm -58.66 -44.88 90.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 118.246 -0.883 . . . . 3.4 111.45 175.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.438 ' CD2' HH11 ' A' ' 56' ' ' ARG . 21.7 m170 -50.44 -45.73 56.07 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.31 1.414 . . . . 4.15 109.348 177.1 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.0 m -65.49 -53.47 42.07 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.291 -0.633 . . . . 1.86 109.291 -177.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.1 mt -50.98 -52.07 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.636 1.174 . . . . 2.51 110.854 178.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -54.12 -55.88 23.4 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.151 1.38 . . . . 2.34 110.182 173.015 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -63.78 -26.23 68.54 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 118.224 -0.893 . . . . 2.27 112.84 -171.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.9 mp -73.55 -95.41 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.251 -1.018 . . . . 3.32 108.251 168.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.97 34.11 0.44 Allowed Glycine 0 C--N 1.336 0.549 0 CA-C-O 119.012 -0.882 . . . . 0.99 112.635 173.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -130.42 163.59 26.59 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.483 1.141 . . . . 3.67 110.408 -163.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -117.03 157.52 25.69 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 108.051 -1.092 . . . . 3.01 108.051 174.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.54 165.53 36.31 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 118.446 0.566 . . . . 2.41 111.735 172.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 p -155.11 147.95 24.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.284 1.433 . . . . 2.88 108.652 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.154 0 N-CA-C 107.79 -1.189 . . . . 3.49 107.79 165.183 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.626 0 N-CA-C 106.372 -2.691 . . . . 1.77 106.372 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.55 96.18 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 125.368 1.467 . . . . 3.2 108.379 -177.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.9 tp -110.16 101.47 10.25 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.427 1.091 . . . . 3.4 108.21 -176.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -99.08 94.82 6.72 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.537 -0.912 . . . . 3.06 108.537 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -85.42 156.69 20.73 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.967 -0.753 . . . . 3.93 108.967 177.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.58 144.36 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.107 -1.442 . . . . 1.77 107.107 149.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.52 133.47 42.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.095 1.358 . . . . 3.5 109.237 177.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -137.37 166.12 24.58 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.04 0.536 . . . . 7.57 110.977 -177.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.55 -11.43 70.09 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.403 1.001 . . . . 1.33 110.726 -165.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 29.0 mtm -74.86 73.39 2.11 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.419 1.088 . . . . 2.1 110.192 -177.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.9 t -60.69 -37.09 80.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.459 1.104 . . . . 2.53 113.029 -170.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.4 p -145.04 167.27 23.09 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 118.81 0.732 . . . . 0.83 110.77 -173.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.5 -47.54 2.67 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.288 1.435 . . . . 1.97 111.965 -178.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 m -43.74 -42.43 5.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.445 1.098 . . . . 2.22 112.387 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.7 m -55.95 -36.0 67.29 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.393 0.677 . . . . 0.94 112.458 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.7 t -55.67 -60.29 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.2 0.524 . . . . 2.46 109.872 -177.139 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -71.25 -30.83 66.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.485 -0.769 . . . . 2.08 111.497 178.027 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -48.88 -45.52 41.2 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.137 0.881 . . . . 4.17 109.495 171.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.2 mt -69.59 -74.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 109.656 -0.498 . . . . 2.55 109.656 168.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -57.25 -48.4 78.96 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.435 0.561 . . . . 3.85 111.764 -161.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 t -63.39 -28.13 69.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.098 -0.477 . . . . 1.48 110.993 -178.137 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.2 t -71.99 -69.26 0.4 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.048 -0.723 . . . . 2.02 109.048 168.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.2 tp -54.62 -32.38 58.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.22 1.808 . . . . 4.24 113.165 -168.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.0 m -58.14 -19.74 35.08 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.151 -0.968 . . . . 3.28 112.656 176.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -57.04 -25.04 57.94 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.896 -1.127 . . . . 5.59 112.272 170.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -89.04 93.79 9.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.965 -1.124 . . . . 2.69 107.965 175.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.63 5.27 0.46 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.105 1.15 . . . . 7.51 114.105 -174.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.73 -26.86 73.95 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.243 -0.911 . . . . 1.25 111.423 164.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -79.75 146.28 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.438 -1.319 . . . . 3.22 107.438 170.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.9 mt -102.32 -42.51 5.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.368 1.467 . . . . 2.94 108.872 175.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -155.46 155.03 32.78 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 118.075 -0.964 . . . . 3.99 109.965 173.209 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -131.07 81.7 2.01 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.969 0.908 . . . . 2.83 109.519 178.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -77.69 78.89 4.19 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.019 -1.051 . . . . 1.81 108.945 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.0 t -79.86 140.01 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 126.311 1.844 . . . . 3.9 109.138 176.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.57 152.14 28.43 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.237 0.542 . . . . 1.87 110.789 169.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -95.84 -36.06 11.26 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.266 1.427 . . . . 2.67 109.938 -178.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.15 -36.99 32.41 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.114 0.966 . . . . 2.07 112.807 179.182 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.2 7.3 15.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.739 0.816 . . . . 2.74 111.445 174.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.3 m120 45.82 51.47 10.42 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.986 0.914 . . . . 2.71 111.744 -175.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -121.39 158.75 27.61 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.578 1.151 . . . . 5.54 110.253 -170.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.76 96.75 2.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.785 -1.098 . . . . 1.79 108.712 168.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -81.24 94.4 6.69 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.352 -1.351 . . . . 1.23 107.352 171.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.09 122.89 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 107.235 -1.394 . . . . 2.76 107.235 171.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -97.18 129.45 44.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.346 -2.094 . . . . 3.16 105.346 161.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -154.6 160.84 41.71 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.004 0.922 . . . . 3.84 109.757 -173.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.22 118.47 69.19 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 108.263 -1.014 . . . . 3.4 108.263 169.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -79.24 61.08 8.06 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.989 3.126 . . . . 2.19 111.877 -167.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -169.35 -45.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.08 1.352 . . . . 3.41 109.519 -174.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.2 mt -66.79 -33.12 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 122.77 0.428 . . . . 4.2 110.007 176.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.8 tt -146.78 134.9 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.241 -1.392 . . . . 2.77 107.241 178.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.17 161.69 37.88 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 111.304 -0.719 . . . . 1.11 111.304 178.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -60.21 -45.03 25.02 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.69 2.26 . . . . 1.04 110.382 177.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.443 HH11 ' CD2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -64.88 -30.59 71.6 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 118.739 -0.648 . . . . 7.89 110.988 177.057 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -66.66 -48.64 68.74 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.814 1.188 . . . . 2.62 109.547 177.378 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.8 mt -49.74 -57.77 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.996 -0.742 . . . . 1.87 108.996 170.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.5 mt -55.69 -47.16 79.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 118.72 -0.657 . . . . 2.09 111.53 -177.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.443 ' CD2' HH11 ' A' ' 56' ' ' ARG . 27.3 m80 -49.12 -45.52 43.62 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.611 0.764 . . . . 4.39 109.821 172.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.5 m -65.16 -48.94 71.75 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.435 -0.95 . . . . 2.08 108.435 -176.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.0 -61.65 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.2 0 N-CA-C 109.584 -0.524 . . . . 2.72 109.584 177.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -60.46 -37.84 82.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.464 -0.334 . . . . 3.05 110.344 -164.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.6 m -54.14 -33.9 59.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.84 0.856 . . . . 2.99 113.184 177.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.66 -60.17 3.43 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.368 0.986 . . . . 3.32 111.409 -176.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.95 22.61 0.19 Allowed Glycine 0 CA--C 1.526 0.742 0 O-C-N 120.645 -1.284 . . . . 1.36 112.925 166.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -134.28 176.58 8.47 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.537 1.168 . . . . 3.56 113.093 -143.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -128.89 160.02 33.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.891 -1.522 . . . . 3.83 106.891 167.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.71 163.53 31.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.02 0.528 . . . . 1.87 110.577 171.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -155.18 177.55 11.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.086 1.354 . . . . 2.49 107.773 173.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 C--N 1.332 -0.195 0 C-N-CA 124.213 1.005 . . . . 4.03 109.09 -179.988 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 107.737 -2.145 . . . . 2.34 107.737 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.7 85.57 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 122.662 1.22 . . . . 3.42 108.864 173.241 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 tp -77.76 72.95 4.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.165 -1.05 . . . . 4.19 108.165 167.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.54 125.53 29.48 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.216 -1.356 . . . . 3.22 108.402 153.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -148.39 160.89 42.57 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 125.384 1.678 . . . . 2.93 109.208 178.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.88 137.57 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.705 -1.961 . . . . 2.11 105.705 168.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.3 t -116.43 135.21 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 105.612 -1.996 . . . . 3.15 105.612 165.123 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -110.01 169.25 8.85 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.838 -1.171 . . . . 8.72 107.838 162.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.39 -119.9 6.34 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 106.373 -2.691 . . . . 2.48 106.373 -152.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 47.0 mtm 36.14 60.84 0.82 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.075 1.75 . . . . 2.77 113.095 178.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.7 t -85.59 -9.81 56.78 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 117.916 -1.04 . . . . 1.86 112.964 -176.306 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.7 p -163.69 171.7 15.26 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.843 1.201 . . . . 0.76 109.708 173.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.97 -43.2 29.27 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.538 1.135 . . . . 1.71 111.538 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.9 m -65.6 -25.91 67.6 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.623 -0.703 . . . . 2.24 112.619 -179.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.1 m -73.36 -57.49 3.97 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 119.093 0.86 . . . . 0.82 110.455 163.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.1 t -43.79 -63.17 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 124.04 0.936 . . . . 2.15 109.971 -175.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.01 -10.55 54.49 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 119.732 -0.787 . . . . 1.59 113.052 -173.372 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -70.23 -41.29 73.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.0 -1.111 . . . . 3.92 108.0 -178.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.6 mt -55.74 -62.97 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.243 -1.021 . . . . 2.33 108.243 177.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -53.21 -57.65 9.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.993 0.517 . . . . 3.3 110.457 -179.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.8 t -51.43 -48.75 62.6 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.058 0.543 . . . . 1.79 111.422 -179.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 t -70.34 -33.22 71.23 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.801 -0.814 . . . . 2.0 108.801 -172.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.2 mt -70.32 -45.71 65.69 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.624 -0.672 . . . . 3.41 111.16 174.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.4 p -57.76 -15.67 8.81 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.513 1.671 . . . . 2.99 115.513 -168.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.94 -36.43 74.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.603 1.092 . . . . 6.51 112.136 168.578 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -66.85 138.86 57.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.687 -0.857 . . . . 2.62 108.687 177.03 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -92.03 -5.88 52.12 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.274 0.23 . . . . 7.23 110.963 169.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.4 -30.58 58.28 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.585 -0.606 . . . . 1.22 111.585 174.358 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.79 146.19 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.6 -1.63 . . . . 3.29 106.6 168.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.0 mt -109.97 -37.79 5.51 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.989 1.716 . . . . 2.82 109.288 -175.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -153.27 150.29 28.8 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.412 -0.958 . . . . 3.51 108.412 176.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.0 m -130.79 142.45 50.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.168 -1.419 . . . . 2.58 107.168 172.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.9 t -152.26 157.23 41.11 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.271 -1.381 . . . . 2.33 107.271 159.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.43 138.83 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 124.573 1.149 . . . . 3.04 109.257 -178.025 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.84 95.95 4.49 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.017 0.927 . . . . 2.51 109.03 177.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -25.59 44.34 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.89 0.33 . . . . 4.47 111.89 167.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.55 -40.48 68.76 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.301 0.64 . . . . 1.93 111.552 178.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.5 t -110.27 -15.34 13.99 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.836 0.855 . . . . 3.77 111.301 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 65.88 74.31 0.37 Allowed 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 126.493 1.917 . . . . 2.38 110.339 -171.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.46 145.92 21.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.17 -0.678 . . . . 5.1 109.17 171.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.19 132.38 54.17 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 106.818 -1.549 . . . . 1.76 106.818 167.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -109.07 99.25 8.59 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 127.496 2.319 . . . . 1.17 104.953 176.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.2 mm -108.18 110.93 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 106.077 -1.823 . . . . 3.19 106.077 176.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.2 mmtt -82.45 128.83 34.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.3 -1.741 . . . . 4.26 106.3 165.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -141.88 157.2 45.27 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.84 0.856 . . . . 3.21 108.946 174.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.5 121.89 63.95 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 107.113 -1.44 . . . . 3.48 107.113 173.281 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.56 44.1 1.57 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.196 2.597 . . . . 1.99 112.588 -172.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -132.88 6.47 3.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.946 1.698 . . . . 3.57 110.838 -179.021 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -157.19 -30.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.866 0.866 . . . . 3.62 112.525 -162.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 tt -139.25 145.03 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.765 -1.939 . . . . 2.48 105.765 165.383 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.03 154.53 24.57 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.134 -1.186 . . . . 1.29 110.134 176.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -59.06 -38.5 86.94 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.056 1.838 . . . . 1.21 109.792 173.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -54.35 -39.52 67.19 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.678 0.791 . . . . 7.11 111.864 173.43 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -70.09 -44.83 68.24 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.797 0.726 . . . . 2.44 109.356 -177.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.7 mt -53.95 -52.27 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.394 -0.595 . . . . 2.06 109.394 173.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.4 mt -52.33 -53.93 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.164 0.585 . . . . 2.33 110.34 176.199 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -51.28 -44.24 61.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.858 0.754 . . . . 3.79 110.882 175.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.7 m -66.25 -40.75 90.43 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 110.075 -0.343 . . . . 2.0 110.075 -174.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.8 mt -56.55 -67.58 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.791 -0.818 . . . . 2.31 108.791 168.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -61.82 -43.51 98.71 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.548 -0.296 . . . . 3.8 111.372 -161.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.2 m -63.56 -13.1 38.26 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.249 0.833 . . . . 3.44 113.249 -174.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.7 mt -70.76 -80.16 0.06 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.322 -0.992 . . . . 2.99 108.322 171.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.94 42.41 0.45 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-O 118.759 -1.023 . . . . 1.13 110.828 165.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -131.25 177.16 7.68 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.823 0.812 . . . . 3.04 110.586 -161.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -134.51 145.95 49.26 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.915 -1.513 . . . . 5.0 106.915 176.367 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.44 150.94 48.99 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 120.57 1.532 . . . . 1.88 113.082 -178.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.8 t -155.31 129.18 8.66 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 109.064 -0.717 . . . . 3.32 109.064 166.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 C--O 1.234 0.254 0 N-CA-C 109.314 -0.625 . . . . 3.56 109.314 162.264 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.729 0 N-CA-C 106.872 -2.491 . . . . 1.7 106.872 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -121.87 74.89 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 118.672 1.236 . . . . 3.6 109.058 -176.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 tp -79.99 71.8 6.72 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.766 -0.827 . . . . 3.4 108.766 -177.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -78.03 69.43 4.25 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.645 0.736 . . . . 3.55 109.153 -178.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.81 156.33 26.21 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.437 0.695 . . . . 3.28 111.097 -176.705 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.94 123.51 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.246 -1.39 . . . . 1.92 107.246 172.033 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.2 t -112.06 125.08 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.073 -1.825 . . . . 2.99 106.073 176.287 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.22 176.83 5.4 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.391 1.476 . . . . 6.87 109.231 -173.478 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.46 -69.52 3.24 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 108.767 -1.733 . . . . 2.41 108.767 -177.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.6 mtp 2.31 66.42 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.864 2.866 . . . . 2.71 115.477 -178.468 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.5 t -87.69 -11.43 48.35 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 117.59 -1.195 . . . . 2.14 113.694 -161.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.6 p -164.78 178.9 6.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 120.418 1.463 . . . . 0.78 110.479 175.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.41 -39.64 47.72 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.538 1.135 . . . . 1.77 111.599 175.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -52.4 -43.05 64.53 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.552 -0.536 . . . . 2.86 109.552 175.684 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.7 m -65.33 -57.23 8.91 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 121.504 -0.748 . . . . 0.94 109.153 -178.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 83.7 t -40.47 -68.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.567 1.147 . . . . 2.02 111.33 177.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -31.43 68.99 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 119.474 -0.891 . . . . 0.86 111.876 -169.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -65.6 -48.12 73.37 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 121.617 -0.677 . . . . 4.48 109.319 178.169 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.4 mt -53.21 -61.23 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.048 -1.093 . . . . 2.14 108.048 173.33 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -51.3 -49.71 60.77 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.246 0.618 . . . . 3.71 111.793 -176.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 t -55.12 -53.42 56.09 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.999 0.519 . . . . 2.19 109.862 176.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.4 m -59.86 -40.1 87.44 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.223 0.535 . . . . 2.92 110.08 -176.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -51.52 63.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.922 0.889 . . . . 3.76 110.376 -179.608 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 26.5 m -58.01 -29.47 65.32 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.767 -0.651 . . . . 3.12 110.183 176.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -5.67 8.67 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.412 1.264 . . . . 5.83 114.412 174.446 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -74.02 -122.26 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 120.437 1.471 . . . . 4.48 111.378 -178.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.18 -62.45 0.09 Allowed 'General case' 0 C--N 1.342 0.259 0 O-C-N 120.928 -1.108 . . . . 14.09 110.466 177.707 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.72 47.28 3.62 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.575 -0.61 . . . . 1.94 111.575 -177.817 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -115.06 136.6 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.8 -1.185 . . . . 4.1 107.8 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.9 mt -97.73 -42.22 7.72 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.156 0.983 . . . . 2.92 108.671 175.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -156.11 154.04 30.3 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 110.017 -0.364 . . . . 3.37 110.017 -178.278 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 p -132.22 144.34 50.56 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.639 0.775 . . . . 3.54 109.453 162.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 m -154.07 122.58 6.2 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.881 1.272 . . . . 3.22 107.914 161.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -115.18 154.67 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.021 0.529 . . . . 2.75 109.886 -178.12 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.22 123.25 14.53 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.891 0.476 . . . . 1.9 109.918 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.96 -15.0 60.24 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.806 1.242 . . . . 2.45 112.546 177.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.58 -50.4 37.66 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.872 -0.788 . . . . 2.11 108.872 173.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.73 -24.53 41.57 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.586 0.754 . . . . 2.55 110.695 177.392 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.5 m120 62.75 47.9 4.44 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 125.69 1.596 . . . . 1.85 108.881 -170.542 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.48 153.28 51.76 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.796 -0.446 . . . . 3.1 109.796 -172.679 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.74 99.99 6.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 124.523 1.139 . . . . 1.74 108.83 173.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -78.45 89.26 4.42 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 105.751 -1.944 . . . . 1.29 105.751 172.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.2 pt -93.27 140.95 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 107.65 -1.241 . . . . 4.23 107.65 165.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -112.21 130.33 55.96 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 106.309 -1.737 . . . . 3.54 106.309 160.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -141.07 161.27 38.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.598 0.759 . . . . 2.88 111.361 -166.399 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -93.02 103.8 10.15 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 125.785 1.634 . . . . 4.34 108.105 178.656 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.25 59.6 7.46 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.909 3.073 . . . . 2.45 111.221 -168.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -173.39 -49.01 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.283 1.833 . . . . 3.29 108.04 -172.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.3 mt -74.65 -37.7 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 109.818 -0.438 . . . . 4.24 109.818 173.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 tt -128.87 126.42 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 106.593 -1.632 . . . . 2.47 106.593 177.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.14 174.86 52.99 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.437 -1.865 . . . . 1.1 108.437 168.145 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.11 -48.51 4.88 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.687 1.592 . . . . 1.33 110.137 175.48 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.25 31.4 ttt85 -70.1 -20.82 63.17 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.271 0.841 . . . . 7.13 113.271 -169.559 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -46.63 -57.18 5.03 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.638 0.654 . . . . 2.84 109.719 167.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.02 -48.21 84.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 109.425 -0.583 . . . . 2.6 109.425 -176.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.5 mt -56.59 -40.89 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.937 -0.574 . . . . 2.47 110.473 -176.34 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -52.52 -40.76 62.8 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 118.938 0.79 . . . . 4.07 111.644 172.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.2 m -66.47 -51.17 59.68 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.741 0.701 . . . . 2.21 109.314 178.296 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.87 -52.56 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.0 0.92 . . . . 3.36 110.735 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.2 -56.2 24.92 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.456 1.102 . . . . 1.88 110.322 174.178 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 t -65.57 -21.19 66.57 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 118.231 -0.89 . . . . 2.46 112.921 -171.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.2 mt -71.23 -96.27 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.008 -1.108 . . . . 3.07 108.008 166.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.71 36.93 0.47 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.575 -1.125 . . . . 1.14 112.053 171.053 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -131.86 127.65 37.0 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 118.569 1.184 . . . . 2.99 110.406 -166.106 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -78.73 159.63 27.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.555 -0.905 . . . . 4.16 108.555 178.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.34 142.4 50.08 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.883 0.873 . . . . 2.75 110.338 -173.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -155.23 124.24 6.2 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.654 -0.869 . . . . 2.97 108.654 167.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 CA--C 1.529 0.137 0 N-CA-C 109.256 -0.646 . . . . 3.91 109.256 172.589 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 106.997 -2.441 . . . . 1.74 106.997 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.69 78.4 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.091 1.356 . . . . 3.8 109.632 -173.076 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.1 82.33 5.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.305 -0.872 . . . . 4.08 109.257 -175.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -85.15 117.21 23.97 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.655 -0.869 . . . . 4.4 108.655 165.113 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.86 169.78 16.86 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.088 0.955 . . . . 2.99 109.995 170.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -90.08 142.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.396 -0.965 . . . . 1.79 108.396 170.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.18 130.46 74.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 125.713 1.605 . . . . 3.75 108.353 174.085 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -121.94 144.55 48.8 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.208 1.803 . . . . 6.74 107.72 -174.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.78 -125.34 7.36 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 106.288 -2.725 . . . . 2.78 106.288 -163.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.8 mtm 49.73 68.61 0.71 Allowed 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.791 1.236 . . . . 2.6 112.288 178.015 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 p -61.39 -28.86 69.54 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.674 0.62 . . . . 3.97 112.674 178.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.56 171.22 16.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.751 0.705 . . . . 1.49 110.259 -171.402 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.45 -37.36 17.04 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.344 1.058 . . . . 2.16 111.45 176.113 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -47.95 -33.84 8.3 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.294 2.238 . . . . 2.88 113.06 174.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.7 m -74.89 -60.99 2.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.305 1.042 . . . . 0.79 111.445 166.554 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.3 t -45.62 -58.4 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.799 1.24 . . . . 2.19 110.947 -171.245 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.47 -30.58 71.36 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.175 0.512 . . . . 1.82 111.363 -176.454 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -71.29 -49.24 44.88 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.192 -1.04 . . . . 4.56 108.192 -176.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 77.0 mt -54.03 -56.15 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 108.572 -0.899 . . . . 1.86 108.572 174.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -64.98 -44.75 88.28 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.59 0.233 . . . . 3.9 111.627 -171.326 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.5 t -63.59 -42.29 98.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.209 0.603 . . . . 1.8 110.617 177.044 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.9 t -62.96 -50.82 69.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.365 -1.346 . . . . 2.09 107.365 -178.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.1 mt -47.17 -53.6 12.66 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 122.983 0.513 . . . . 4.1 111.459 174.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.8 p -58.4 -12.22 3.62 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.082 1.142 . . . . 2.63 114.082 -178.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -32.48 73.99 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.709 1.141 . . . . 5.81 111.956 172.599 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -88.24 110.26 20.58 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 108.067 -1.086 . . . . 2.25 108.067 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.8 -17.12 33.29 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.309 -0.869 . . . . 7.08 112.005 172.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.47 -33.99 67.74 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.911 -0.938 . . . . 1.22 112.686 169.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.24 128.34 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.783 -1.562 . . . . 3.5 106.783 172.71 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.3 mt -86.58 -35.53 19.41 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.821 1.248 . . . . 2.98 109.35 -176.117 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -154.8 147.36 24.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.295 -1.002 . . . . 3.23 108.295 177.393 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.8 p -124.75 147.18 48.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.02 0.928 . . . . 2.74 109.046 169.221 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.9 t -152.39 101.28 2.66 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.979 -1.119 . . . . 2.0 107.979 169.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.6 m -90.26 161.74 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.048 1.339 . . . . 2.88 110.441 176.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.64 138.39 14.23 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.281 -0.637 . . . . 1.97 109.281 155.19 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 pp -76.13 -32.47 59.15 Favored 'General case' 0 C--O 1.227 -0.099 0 N-CA-C 108.841 -0.8 . . . . 2.6 108.841 159.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.08 -15.45 23.31 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.282 1.033 . . . . 2.53 111.938 179.156 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.9 m -139.3 20.35 2.58 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 121.535 -0.728 . . . . 2.89 110.575 172.557 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.7 m120 33.41 43.72 0.06 Allowed 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 125.757 1.623 . . . . 2.47 114.121 -176.273 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.3 158.49 30.88 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.233 0.613 . . . . 3.47 110.089 -170.69 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.37 115.32 9.18 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.633 -1.247 . . . . 1.62 107.633 163.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -99.16 105.32 17.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 106.07 -1.826 . . . . 1.18 106.07 170.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.58 110.29 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 105.921 -1.881 . . . . 2.95 105.921 175.371 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -82.91 136.29 34.63 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.717 -1.586 . . . . 4.76 106.717 164.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -158.65 155.55 28.38 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 118.956 0.798 . . . . 2.79 112.864 -168.076 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -87.19 120.28 71.3 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.184 0.993 . . . . 3.17 108.432 167.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.07 -14.55 23.49 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.066 2.511 . . . . 1.96 113.695 -174.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -84.67 -47.7 10.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.175 -1.046 . . . . 4.2 108.175 176.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.2 mt -66.47 -36.91 78.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 119.256 -0.402 . . . . 4.05 110.569 -178.388 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.0 tt -144.03 124.2 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.845 -0.798 . . . . 2.51 108.845 176.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.79 154.37 52.17 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.335 -1.106 . . . . 1.15 110.335 179.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -57.87 -41.28 70.85 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.923 1.749 . . . . 1.2 109.88 174.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -62.88 -30.09 71.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.922 -0.561 . . . . 6.81 111.911 176.127 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -70.38 -44.94 67.01 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.556 1.071 . . . . 2.26 109.19 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 mt -52.47 -55.94 8.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.15 -0.685 . . . . 1.94 109.15 171.133 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.4 mt -52.2 -53.41 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 119.401 -0.333 . . . . 2.04 110.632 179.411 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -50.65 -43.49 57.21 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.024 0.53 . . . . 4.03 110.938 175.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.8 m -62.44 -49.49 75.24 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.561 -0.533 . . . . 1.77 109.561 -177.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.82 -54.47 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.209 0.604 . . . . 2.9 109.96 176.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -58.19 -50.66 72.76 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.428 0.691 . . . . 2.59 110.582 -176.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -54.99 -33.39 62.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.443 1.497 . . . . 2.03 112.217 -172.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.8 mt -63.55 -82.89 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.047 0.385 . . . . 3.15 110.612 178.461 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.98 33.12 0.43 Allowed Glycine 0 CA--C 1.525 0.701 0 O-C-N 121.217 -0.927 . . . . 0.99 112.775 173.355 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -135.08 176.06 9.01 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.26 1.03 . . . . 2.78 110.316 -159.671 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -130.3 136.57 49.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.507 -1.294 . . . . 3.78 107.507 172.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.73 156.97 16.31 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.559 0.744 . . . . 2.14 109.774 177.029 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.2 m -151.33 114.25 4.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.455 -0.942 . . . . 2.51 108.455 170.012 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.365 0 C-N-CA 124.323 1.049 . . . . 4.45 110.849 179.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 CA-C-O 121.805 0.669 . . . . 2.2 114.2 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.98 133.44 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 125.974 1.71 . . . . 3.29 107.066 176.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 tt -139.13 103.56 4.8 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.425 -1.695 . . . . 3.95 106.425 173.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -112.29 117.28 32.06 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.524 0.602 . . . . 3.83 110.667 177.532 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.78 161.32 35.92 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.531 1.132 . . . . 3.9 111.08 -171.068 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.5 t -82.71 111.98 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 125.378 1.471 . . . . 2.29 107.411 176.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -86.85 73.75 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.679 1.192 . . . . 3.67 108.336 172.629 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.11 66.21 3.67 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.445 1.098 . . . . 7.84 109.71 -172.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.36 -44.4 0.02 OUTLIER Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.854 -0.899 . . . . 2.33 110.854 -175.416 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -61.4 120.05 9.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.562 0.681 . . . . 2.83 109.193 177.75 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 t -98.53 -45.65 6.02 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.988 0.515 . . . . 2.28 111.751 -172.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.0 p -130.59 172.75 11.59 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.758 0.708 . . . . 0.96 110.868 -175.125 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.46 -45.47 9.15 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.9 1.28 . . . . 2.07 111.922 179.422 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 m -54.41 -42.12 70.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.217 1.007 . . . . 2.59 111.584 177.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.6 m -71.41 -51.36 24.4 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.031 0.532 . . . . 0.96 110.643 174.736 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.3 t -44.75 -59.02 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.299 1.039 . . . . 2.16 109.988 -179.049 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.306 0.2 OUTLIER -69.14 -14.88 63.24 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 119.257 -0.977 . . . . 1.71 112.028 -175.238 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.1 tttt -71.34 -46.56 60.24 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 120.766 -1.209 . . . . 3.86 108.269 -175.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.4 mt -52.74 -67.67 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.221 -1.029 . . . . 2.44 108.221 177.378 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -66.09 0.46 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.177 0.806 . . . . 4.25 113.177 178.466 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.2 m -50.69 -39.33 50.92 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 118.433 0.561 . . . . 3.45 112.216 -177.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.3 t -70.57 -60.78 2.06 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.441 -0.948 . . . . 2.15 108.441 179.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -52.58 -34.8 52.22 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.447 1.099 . . . . 3.64 112.296 -174.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.3 m -55.28 -22.59 19.22 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.947 0.721 . . . . 3.18 112.947 179.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -66.06 -23.76 66.6 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 120.101 1.319 . . . . 5.92 112.507 174.099 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -81.62 103.7 11.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.09 -1.448 . . . . 2.64 107.09 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 25.3 mtp-105 -57.19 -21.86 36.41 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.498 1.045 . . . . 8.24 112.13 173.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.82 0.97 18.0 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.743 -1.032 . . . . 1.67 113.951 173.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 pp -120.06 128.57 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 119.315 1.558 . . . . 3.65 106.933 159.175 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.4 mt -83.71 -30.66 26.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 110.257 -0.275 . . . . 2.84 110.257 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -157.07 151.6 25.42 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.589 -1.263 . . . . 3.4 107.589 178.085 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.5 t -128.65 119.14 24.14 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.882 1.273 . . . . 2.9 108.723 169.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 t -120.91 93.89 4.17 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.019 1.328 . . . . 2.08 109.975 -173.405 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -92.98 149.74 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.973 1.709 . . . . 3.51 111.719 -169.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.9 139.65 18.02 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.237 0.615 . . . . 1.95 111.666 168.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.0 mt -78.89 -54.52 5.96 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 125.541 1.536 . . . . 3.77 108.694 170.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -45.81 -42.61 12.47 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.63 0.772 . . . . 2.57 111.866 -177.28 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -101.02 -5.05 26.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.051 0.94 . . . . 2.99 112.247 -178.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.02 69.23 0.63 Allowed 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.988 1.315 . . . . 2.41 111.041 -178.574 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.98 163.52 39.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.177 0.513 . . . . 3.52 111.56 -172.501 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -147.01 103.5 3.61 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.959 2.104 . . . . 2.01 107.427 171.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -80.37 106.41 12.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.37 -1.715 . . . . 1.28 106.37 172.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.0 mt -105.98 114.41 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 106.66 -1.607 . . . . 2.87 106.66 177.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -78.63 71.93 5.13 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.836 -1.172 . . . . 3.91 107.836 172.719 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.91 153.62 43.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.755 -0.657 . . . . 3.81 111.232 -179.122 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -106.17 117.53 57.19 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 108.869 -0.789 . . . . 3.13 108.869 162.041 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -67.27 -23.16 45.3 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.153 2.568 . . . . 1.63 113.009 -173.539 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -74.52 -43.46 55.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.302 0.955 . . . . 3.8 109.283 -174.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.6 tp -89.16 -34.96 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.339 0.496 . . . . 4.72 112.339 -179.129 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mm -133.47 112.68 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.487 -0.931 . . . . 2.68 108.487 -170.065 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.94 163.28 49.33 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 110.831 -0.908 . . . . 1.39 110.831 177.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -55.97 -43.26 58.5 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.721 2.281 . . . . 1.55 109.957 175.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -32.87 65.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.307 0.643 . . . . 7.68 112.66 176.201 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -70.12 -49.42 50.93 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.879 0.763 . . . . 2.6 109.012 179.139 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.6 mt -53.64 -57.25 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.034 -0.358 . . . . 2.29 110.034 174.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.9 mt -49.58 -54.95 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 123.646 0.778 . . . . 2.56 109.139 178.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -55.39 -41.4 72.61 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 111.51 0.189 . . . . 5.65 111.51 178.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 64.5 m -62.94 -49.6 74.11 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.794 -0.817 . . . . 2.16 108.794 -177.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.78 -53.85 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.487 -0.56 . . . . 2.56 109.487 174.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -56.02 -37.63 69.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.146 0.578 . . . . 2.21 111.522 -178.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.1 m -63.67 -15.88 59.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.461 -0.78 . . . . 3.21 113.094 -178.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.31 -96.6 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.593 1.088 . . . . 3.23 108.754 169.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.33 44.97 0.47 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.928 -1.269 . . . . 1.34 109.928 174.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -134.15 176.62 8.43 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.592 1.157 . . . . 3.02 109.169 -163.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -139.68 167.79 21.31 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.737 -1.208 . . . . 3.51 107.737 164.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -135.22 152.41 51.53 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.567 1.147 . . . . 1.88 110.384 -167.076 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.6 m -150.87 124.17 8.88 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.803 -0.56 . . . . 2.36 110.257 168.305 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 108.929 -0.767 . . . . 4.8 108.929 169.193 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.685 0 N-CA-C 108.23 -1.948 . . . . 2.26 108.23 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.47 158.47 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.517 0.727 . . . . 3.58 109.148 173.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.03 131.74 17.9 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.84 -1.541 . . . . 3.64 106.84 169.732 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -117.34 112.92 21.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.837 -0.801 . . . . 3.31 108.837 175.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.7 mt -109.93 136.16 49.66 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.244 1.417 . . . . 3.4 108.08 -179.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -78.54 96.45 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.255 -2.498 . . . . 2.23 104.255 156.678 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.5 t -82.69 131.21 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.004 -1.48 . . . . 2.77 107.004 172.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -144.2 136.85 26.93 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.771 0.828 . . . . 6.25 108.877 -169.717 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.4 -25.91 9.46 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.47 1.033 . . . . 1.31 110.775 -169.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -70.57 74.22 0.55 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 122.173 0.987 . . . . 2.79 110.972 179.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -50.68 -36.0 33.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.865 1.266 . . . . 2.5 114.303 -168.42 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 p -146.6 170.62 16.54 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.146 0.885 . . . . 0.92 111.978 -168.505 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.79 -41.8 24.36 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.583 1.153 . . . . 1.85 111.457 176.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 m -59.98 -33.2 71.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.158 0.583 . . . . 2.33 111.724 178.272 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.5 m -72.62 -46.26 54.95 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 119.007 0.821 . . . . 1.24 112.045 167.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.0 t -51.18 -60.98 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 118.262 0.483 . . . . 1.9 110.8 -178.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -27.65 65.0 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.383 -0.823 . . . . 1.03 111.931 -174.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -55.56 -54.68 41.05 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 108.698 -0.852 . . . . 4.25 108.698 169.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.8 mt -54.56 -59.39 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 118.451 -0.785 . . . . 1.88 109.012 176.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -50.83 -59.78 3.75 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 123.779 0.674 . . . . 4.24 110.288 -173.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.9 t -58.1 -45.78 86.64 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.653 0.781 . . . . 2.01 110.861 -176.122 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.5 t -64.78 -56.83 11.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.126 -0.694 . . . . 2.11 109.126 -178.038 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.5 tp -52.57 -51.4 59.94 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 125.012 1.325 . . . . 3.34 111.021 -177.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.6 m -62.87 -9.31 9.18 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.954 0.724 . . . . 3.08 112.954 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -31.28 72.44 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.557 -1.339 . . . . 5.45 111.523 168.481 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -79.75 71.87 6.43 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.948 -0.76 . . . . 2.59 108.948 -178.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -42.97 102.23 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.197 1.399 . . . . 7.7 110.137 177.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.24 -39.33 0.81 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.22 -1.552 . . . . 2.69 109.22 -164.167 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.31 140.86 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 104.346 -2.464 . . . . 4.18 104.346 148.579 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.5 mt -104.24 -42.56 5.47 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.576 1.15 . . . . 2.61 109.715 -175.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -146.71 153.06 39.82 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.856 -0.424 . . . . 3.11 109.856 176.162 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.3 t -136.93 136.37 38.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.484 1.914 . . . . 2.95 107.986 174.696 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -131.13 82.17 2.03 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.891 1.277 . . . . 3.32 107.876 172.108 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.58 141.71 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.102 0.961 . . . . 2.86 110.268 172.341 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.77 151.07 26.82 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.196 0.598 . . . . 1.99 110.107 169.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.2 -11.97 14.52 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.812 1.245 . . . . 2.21 113.346 -165.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.99 -51.01 52.11 Favored 'General case' 0 C--O 1.226 -0.174 0 N-CA-C 108.576 -0.898 . . . . 2.72 108.576 173.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 m -79.81 -29.17 40.17 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.983 -0.553 . . . . 3.16 111.416 174.252 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.7 m120 67.2 79.71 0.23 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.242 -1.392 . . . . 1.82 107.242 -165.574 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -147.91 158.9 44.28 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.534 -0.543 . . . . 6.06 109.534 -176.186 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.64 108.86 4.44 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.519 1.928 . . . . 1.89 106.612 163.503 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -86.26 117.16 24.89 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.781 -2.303 . . . . 1.44 104.781 164.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.29 148.36 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 105.293 -2.114 . . . . 2.93 105.293 171.358 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.48 141.25 51.05 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.692 -0.855 . . . . 3.29 108.692 156.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -154.46 153.93 32.34 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.315 1.046 . . . . 3.83 109.211 -163.03 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -84.93 114.25 54.62 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 107.665 -1.235 . . . . 3.52 107.665 173.163 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.23 52.51 4.31 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.07 3.18 . . . . 2.09 111.777 -170.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -144.82 -59.7 0.36 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.094 1.758 . . . . 2.93 106.874 -177.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.6 tt -72.63 -25.49 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.203 1.401 . . . . 3.49 111.972 179.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.8 tt -145.93 143.08 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.723 -1.584 . . . . 2.75 106.723 172.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -99.55 161.82 19.66 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.367 -1.093 . . . . 1.13 110.367 174.018 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -56.54 -41.12 79.38 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.501 2.134 . . . . 1.27 110.03 174.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.445 HH22 ' CD ' ' A' ' 63' ' ' GLU . 37.4 tpt85 -56.28 -36.03 68.14 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.09 -0.957 . . . . 7.1 111.726 179.175 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -71.26 -48.17 52.65 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.524 0.73 . . . . 2.19 110.026 -177.37 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 mt -49.63 -56.48 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 108.21 -1.033 . . . . 1.9 108.21 171.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.2 mt -56.05 -43.1 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.893 -0.594 . . . . 2.06 109.999 -179.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -56.7 -40.62 75.96 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.397 0.679 . . . . 5.73 111.414 176.308 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.16 -43.92 77.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 119.443 -0.903 . . . . 2.99 109.293 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.9 -52.0 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 124.52 1.128 . . . . 3.16 111.057 174.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.445 ' CD ' HH22 ' A' ' 56' ' ' ARG . 35.6 mt-10 -57.92 -55.52 33.8 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.595 1.158 . . . . 1.94 110.019 175.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.2 t -53.48 -43.42 68.18 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.262 1.025 . . . . 1.97 110.851 -175.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.2 mt -62.59 -66.14 0.58 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 110.312 -0.255 . . . . 3.05 110.312 173.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.99 -24.94 0.02 OUTLIER Glycine 0 CA--C 1.53 0.993 0 N-CA-C 117.504 1.762 . . . . 1.31 117.504 -178.223 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -126.6 152.16 47.01 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 119.055 1.427 . . . . 2.88 110.535 -137.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -84.41 152.42 24.04 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.521 -1.289 . . . . 4.06 107.521 172.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -122.12 129.51 52.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.78 0.832 . . . . 2.21 109.478 163.514 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -108.36 104.41 13.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.496 -1.298 . . . . 2.86 107.496 169.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 CA--C 1.533 0.312 0 CA-C-N 119.019 0.827 . . . . 4.87 110.633 175.081 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.906 0 N-CA-C 106.239 -2.744 . . . . 2.01 106.239 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.5 82.79 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 124.549 1.14 . . . . 4.12 110.635 -172.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 tp -81.55 81.67 7.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.201 -1.037 . . . . 4.27 108.201 175.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -95.0 102.77 14.6 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.155 -0.929 . . . . 2.89 109.029 171.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.6 151.0 40.88 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.755 1.222 . . . . 3.16 109.376 -177.55 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 t -77.6 129.87 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 105.717 -1.957 . . . . 2.1 105.717 166.046 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.4 t -111.35 97.7 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 105.452 -2.055 . . . . 3.44 105.452 174.068 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -81.68 146.43 30.02 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.267 -1.012 . . . . 8.54 108.267 178.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.13 -9.51 56.37 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.06 0.838 . . . . 1.06 112.1 -174.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.7 ttm -65.96 71.95 0.06 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.605 1.562 . . . . 3.12 110.935 176.676 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -71.98 -31.47 66.3 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.697 0.629 . . . . 2.13 112.697 -167.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.9 p -154.18 174.81 14.25 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.255 0.934 . . . . 0.89 112.397 -169.359 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.89 -41.26 45.27 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.503 1.121 . . . . 1.93 111.046 175.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.9 m -63.72 -24.79 67.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.174 0.589 . . . . 2.12 112.235 178.498 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.3 m -72.57 -62.6 1.39 Allowed 'General case' 0 C--N 1.337 0.05 0 CA-C-N 119.478 1.035 . . . . 0.95 110.086 163.207 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.7 t -36.24 -66.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 125.538 1.535 . . . . 1.9 111.072 -177.002 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.33 -27.6 66.41 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.705 -0.398 . . . . 0.95 111.604 -172.555 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -69.43 -55.63 9.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.912 -1.144 . . . . 4.47 107.912 -179.533 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.4 mt -50.02 -59.44 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.293 -1.003 . . . . 2.0 108.293 177.52 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.65 -56.01 25.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.186 -0.915 . . . . 3.88 110.338 -174.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.5 t -66.08 -29.59 69.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.168 -0.92 . . . . 1.9 112.271 -176.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.6 m -70.93 -50.66 32.23 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.957 -1.127 . . . . 3.42 107.957 179.38 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.2 mt -53.54 -46.57 70.24 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.468 -0.333 . . . . 3.42 110.831 175.163 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.2 m -56.4 -9.12 0.63 Allowed 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.964 1.098 . . . . 2.57 113.964 -179.252 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -75.92 -29.81 58.53 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.527 -1.358 . . . . 8.23 112.024 172.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -75.18 161.68 29.16 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.017 0.927 . . . . 2.26 109.509 -173.571 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.45 -42.76 7.57 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-O 119.131 -0.462 . . . . 9.5 111.479 -175.285 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.29 -12.75 69.67 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 119.112 0.869 . . . . 1.55 113.207 -176.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -77.54 159.31 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 107.785 -1.191 . . . . 3.48 107.785 168.18 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.3 mt -129.39 -41.1 1.4 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.223 1.009 . . . . 3.34 110.112 -172.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -149.84 148.22 28.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.646 -1.613 . . . . 3.21 106.646 174.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -128.87 126.25 39.36 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.232 -2.136 . . . . 2.75 105.232 178.473 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.1 t -144.54 104.93 4.11 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.831 -0.803 . . . . 1.88 108.831 178.233 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.95 148.64 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 123.63 0.772 . . . . 2.62 111.428 -175.766 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.74 109.43 3.45 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 122.08 -0.387 . . . . 1.8 111.759 -176.849 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.65 -15.42 19.08 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.919 1.081 . . . . 2.51 113.919 177.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.36 -35.27 76.99 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.874 0.47 . . . . 2.01 110.656 171.589 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -116.49 -6.21 11.7 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.748 1.219 . . . . 4.16 111.467 178.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.9 m120 56.64 29.32 15.48 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.838 1.655 . . . . 1.89 110.764 -179.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.66 144.64 37.73 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.495 -1.668 . . . . 4.29 106.495 -176.89 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.82 114.2 20.73 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.465 -1.68 . . . . 2.01 106.465 165.445 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -91.2 104.7 17.22 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 105.418 -2.067 . . . . 2.03 105.418 172.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.1 mp -103.99 115.86 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 105.987 -1.857 . . . . 2.57 105.987 170.302 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -78.51 133.9 37.35 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 105.645 -1.983 . . . . 3.9 105.645 162.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -151.53 163.57 38.73 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.548 0.739 . . . . 2.88 109.84 -173.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -100.18 124.92 41.53 Favored Pre-proline 0 N--CA 1.449 -0.513 0 N-CA-C 108.552 -0.907 . . . . 3.48 108.552 163.04 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.79 -17.02 33.2 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.663 2.909 . . . . 2.03 113.663 -174.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.56 -44.47 11.89 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.416 -0.957 . . . . 3.38 108.416 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.6 mt -71.25 -43.09 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 122.244 -0.285 . . . . 4.41 110.82 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.59 118.93 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 105.83 -1.915 . . . . 2.66 105.83 -178.574 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.95 150.38 51.92 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 108.718 -1.753 . . . . 1.32 108.718 171.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -57.64 -40.48 79.63 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 CA-C-N 119.248 1.524 . . . . 1.2 109.736 175.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -42.8 -42.23 3.52 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.182 1.393 . . . . 8.66 112.578 168.134 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -71.28 -43.05 67.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.996 0.816 . . . . 2.2 110.121 -172.034 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.5 mt -57.78 -48.3 83.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 109.133 -0.691 . . . . 1.67 109.133 173.503 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.2 mt -54.41 -53.22 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.842 -0.429 . . . . 2.45 109.842 176.09 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -50.63 -45.71 57.82 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.599 0.636 . . . . 4.16 110.422 176.016 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.2 m -60.14 -52.08 66.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.269 -0.641 . . . . 2.39 109.269 -176.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.29 -61.96 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.534 0.734 . . . . 2.4 110.035 175.337 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -66.19 -25.24 66.84 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.308 -0.406 . . . . 3.22 111.438 -167.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.8 t -63.47 -15.73 58.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 117.789 -1.1 . . . . 2.42 112.891 175.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.38 -96.56 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 120.065 1.302 . . . . 4.16 108.664 170.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.72 50.65 0.42 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.739 -1.344 . . . . 1.36 109.739 177.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -135.92 175.03 9.97 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.351 1.06 . . . . 3.67 108.971 -170.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -141.01 140.89 34.38 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.254 -1.387 . . . . 4.87 107.254 173.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.54 159.7 18.55 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.476 0.655 . . . . 2.19 112.611 -173.108 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.4 133.86 10.8 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 125.03 1.332 . . . . 2.74 108.21 172.376 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 CA--C 1.534 0.335 0 CA-C-N 119.646 1.112 . . . . 3.3 110.19 173.419 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 106.465 -1.68 . . . . 10.84 106.465 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.32 154.52 24.46 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.945 -1.662 . . . . 7.25 108.945 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -72.67 174.25 7.85 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.075 1.75 . . . . 6.21 111.569 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.72 81.18 0.06 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.917 1.246 . . . . 1.98 111.236 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 p -75.54 123.47 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.784 -0.821 . . . . 3.03 108.784 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 tp -146.26 77.37 1.48 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.024 0.44 . . . . 4.02 110.412 -168.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -78.55 76.0 5.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.602 0.715 . . . . 4.23 110.101 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -78.91 156.9 28.38 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.922 0.889 . . . . 3.58 110.908 176.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.24 139.07 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.365 -1.717 . . . . 1.8 106.365 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.9 t -130.83 122.84 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 C-N-CA 126.844 2.058 . . . . 2.96 105.841 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.1 mtp-105 -117.75 164.25 15.28 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.828 1.251 . . . . 6.21 109.815 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.55 -6.88 77.79 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.206 0.908 . . . . 1.19 111.625 -171.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 30.3 mtm -72.81 69.64 0.94 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.189 0.996 . . . . 2.2 110.269 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -69.01 -16.77 63.8 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.165 1.172 . . . . 2.32 114.165 -166.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.0 p -160.53 173.77 15.05 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 120.205 1.366 . . . . 0.77 110.699 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.13 -40.18 45.41 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.991 0.916 . . . . 1.8 111.341 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 m -61.87 -27.41 68.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.625 0.77 . . . . 2.22 112.291 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.4 m -71.15 -61.72 1.66 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.913 -0.773 . . . . 0.67 108.913 164.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.6 t -45.42 -59.23 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.769 0.828 . . . . 2.06 111.572 -170.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -28.32 68.44 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.58 -0.7 . . . . 0.83 112.01 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -70.55 -47.64 59.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.737 -0.838 . . . . 4.85 108.737 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.9 mt -54.09 -55.58 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 108.273 -1.01 . . . . 2.01 108.273 174.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -48.74 -66.98 0.31 Allowed 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 124.357 1.035 . . . . 3.99 110.174 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.4 t -54.83 -39.4 68.52 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.801 0.84 . . . . 1.86 110.88 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.7 t -66.59 -51.12 59.94 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.72 -0.844 . . . . 1.98 108.72 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -60.06 -43.5 95.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.383 -0.823 . . . . 3.41 111.301 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.5 m -59.44 -11.43 4.45 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.87 0.868 . . . . 2.76 112.813 176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -61.79 -35.38 78.0 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.905 -1.122 . . . . 6.45 111.426 167.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -59.57 135.03 57.54 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.308 -0.997 . . . . 4.03 108.308 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -26.54 61.65 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.143 0.883 . . . . 11.01 108.777 162.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.48 41.41 2.08 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 121.604 -0.685 . . . . 1.96 112.643 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 pp -146.17 150.74 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 105.643 -1.984 . . . . 3.39 105.643 172.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.3 mt -104.28 -25.7 12.78 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 123.306 0.379 . . . . 2.76 111.381 167.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -156.34 152.92 28.22 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 118.668 0.667 . . . . 3.56 109.378 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.7 t -143.95 128.24 17.79 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.248 1.019 . . . . 2.49 109.25 164.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.1 t -135.5 92.92 2.89 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.191 1.396 . . . . 2.01 108.708 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.35 152.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 126.009 1.724 . . . . 2.96 111.563 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.23 129.31 8.81 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.705 0.402 . . . . 1.85 110.973 171.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 pp -76.07 -10.25 59.27 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.688 0.795 . . . . 2.2 112.787 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.99 -54.9 17.27 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.025 -0.731 . . . . 2.03 109.025 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -27.38 40.58 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.615 0.766 . . . . 2.42 110.812 174.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.9 m120 71.13 57.81 0.2 Allowed 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 125.352 1.461 . . . . 1.81 107.964 -169.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.44 170.42 15.74 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 112.484 0.549 . . . . 3.08 112.484 -169.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.72 100.17 3.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.631 1.972 . . . . 1.69 109.317 174.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -77.34 82.49 3.8 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 105.307 -2.109 . . . . 1.43 105.307 169.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 pt -85.3 147.63 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-N 114.486 -1.234 . . . . 4.19 108.322 166.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -113.33 104.7 12.58 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 103.54 -2.763 . . . . 4.28 103.54 157.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -98.46 135.47 39.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 124.168 0.917 . . . . 4.05 109.282 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.92 120.38 81.34 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 123.716 0.806 . . . . 3.22 109.221 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.07 2.68 7.8 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.1 1.867 . . . . 1.87 114.524 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -86.55 -43.01 13.04 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 121.414 1.916 . . . . 5.59 109.073 167.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.2 mm -88.15 -46.31 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 112.074 0.398 . . . . 4.19 112.074 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mm -120.71 146.32 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.921 -1.14 . . . . 2.92 107.921 -162.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.0 160.92 12.86 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 108.999 -1.641 . . . . 1.52 108.999 165.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -53.15 -38.38 80.97 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.828 2.352 . . . . 1.91 111.221 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -41.04 20.71 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.565 0.746 . . . . 9.12 111.658 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -66.43 -50.61 62.82 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.105 0.866 . . . . 2.14 109.481 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.1 mp -54.05 -47.05 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 109.709 -0.478 . . . . 2.1 109.709 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mt -55.87 -51.89 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 119.206 -0.426 . . . . 2.59 109.955 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -52.6 -42.75 64.83 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.612 0.642 . . . . 4.44 110.672 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 35.0 m -63.67 -54.84 29.3 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.348 -0.612 . . . . 1.97 109.348 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.3 mt -48.05 -49.59 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.528 1.531 . . . . 2.57 111.042 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -59.55 -49.77 76.5 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.182 0.993 . . . . 2.05 110.483 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.2 t -62.57 -22.82 66.64 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 118.201 -0.904 . . . . 2.26 112.542 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.26 -102.43 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.195 -1.039 . . . . 3.68 108.195 160.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.46 39.22 0.48 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.313 -0.715 . . . . 1.23 111.386 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -128.25 171.37 12.03 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.937 0.869 . . . . 2.81 110.393 -167.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.12 166.15 21.73 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.523 1.129 . . . . 3.21 108.55 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.43 161.8 40.91 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.549 0.613 . . . . 2.28 111.998 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.9 m -156.59 131.54 9.04 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.091 1.356 . . . . 2.06 109.787 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.2 mp -69.35 106.34 2.89 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.229 -1.026 . . . . 4.22 108.229 173.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -62.78 -48.12 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.671 -0.863 . . . . 3.76 108.671 170.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.72 71.39 2.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.697 0.799 . . . . 5.46 109.192 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.3 mm -61.43 -79.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.193 -1.04 . . . . 9.52 108.193 171.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 117.479 -1.248 . . . . 10.77 109.031 179.245 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.8 mtt . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.075 0.464 . . . . 11.69 110.57 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.59 39.53 0.08 OUTLIER Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.055 -1.618 . . . . 4.07 109.055 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -148.81 26.52 0.91 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.489 1.916 . . . . 7.65 109.257 -152.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.31 86.68 1.53 Allowed Glycine 0 N--CA 1.446 -0.647 0 O-C-N 121.918 -0.489 . . . . 3.08 113.14 -162.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.3 p -145.77 137.91 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 117.582 0.691 . . . . 3.42 110.178 170.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.5 tp -148.37 119.3 7.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.543 -0.91 . . . . 3.11 108.543 167.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -108.4 121.51 45.09 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.947 -1.501 . . . . 2.94 106.947 167.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -131.02 146.13 52.28 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.629 -0.878 . . . . 3.53 108.629 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -76.22 135.5 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 104.595 -2.372 . . . . 1.75 104.595 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.4 t -125.21 115.92 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 105.088 -2.19 . . . . 3.03 105.088 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -108.44 153.3 23.51 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.779 0.431 . . . . 7.25 110.115 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.24 -5.51 55.62 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.651 1.12 . . . . 1.05 111.985 -171.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 38.1 mtm -74.17 66.94 1.3 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.512 1.156 . . . . 2.32 110.677 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -68.88 -15.3 63.46 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.267 1.21 . . . . 1.9 114.267 -164.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.9 p -160.1 173.05 16.39 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 120.289 1.404 . . . . 0.84 110.508 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.54 -37.21 38.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.864 0.866 . . . . 2.01 111.326 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 t -61.08 -29.27 69.64 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 118.867 -0.587 . . . . 2.89 111.523 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.4 m -71.67 -57.08 4.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.89 0.768 . . . . 0.85 109.551 168.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.9 t -49.6 -60.46 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.472 0.709 . . . . 2.0 111.451 -172.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.86 -29.2 69.05 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.621 -0.674 . . . . 0.97 111.568 -175.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -65.28 -48.35 73.49 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.386 -0.968 . . . . 3.87 108.386 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 79.4 mt -55.4 -55.64 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 108.668 -0.864 . . . . 1.7 108.668 174.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -54.99 -49.95 70.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.425 0.631 . . . . 3.49 110.87 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -56.55 -48.96 76.18 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.885 0.874 . . . . 1.29 110.682 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.3 m -61.65 -42.13 98.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.7 -0.625 . . . . 3.15 110.539 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -63.64 -54.19 39.69 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.844 1.258 . . . . 3.66 110.671 176.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.0 p -59.17 -18.59 37.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.151 0.426 . . . . 2.65 112.151 -173.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -50.24 -41.88 50.85 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.271 -0.871 . . . . 5.65 113.008 166.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -67.44 163.73 20.28 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.34 0.973 . . . . 2.26 111.661 -170.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.01 -29.13 11.11 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.391 0.677 . . . . 7.62 112.021 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.57 -14.76 77.57 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 119.918 -0.379 . . . . 1.39 112.491 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -77.86 149.93 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 117.782 0.791 . . . . 3.77 109.113 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 36.6 tp -109.08 -42.89 4.3 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.521 1.928 . . . . 4.56 108.708 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -155.79 163.88 39.27 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.22 0.464 . . . . 3.34 110.949 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.7 t -144.19 118.81 9.77 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 127.084 2.154 . . . . 3.02 106.846 174.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.97 96.74 5.14 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.204 -1.406 . . . . 2.24 107.204 175.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -107.64 141.32 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.23 0.612 . . . . 3.48 111.294 -174.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.47 125.72 9.34 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 123.729 0.811 . . . . 1.91 111.377 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.61 -15.04 60.39 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.522 1.129 . . . . 2.47 112.236 172.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.2 -51.7 68.64 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.012 -0.736 . . . . 2.44 109.012 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.87 -45.28 18.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.625 -0.88 . . . . 2.84 108.625 171.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 83.92 52.9 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 127.696 2.398 . . . . 2.98 107.39 -163.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.61 160.24 40.56 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 122.501 0.32 . . . . 3.33 110.705 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.12 120.06 30.35 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.61 -1.255 . . . . 1.73 107.61 168.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -93.86 94.44 8.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.863 -1.903 . . . . 1.45 105.863 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.45 152.22 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 107.58 -1.267 . . . . 2.91 107.58 174.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -131.95 134.14 45.3 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.416 -2.439 . . . . 3.08 104.416 159.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -161.65 153.69 19.47 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.066 1.346 . . . . 3.66 107.39 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -80.91 124.2 81.65 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 119.044 0.838 . . . . 3.41 109.732 170.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -63.59 -21.17 70.39 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.995 2.463 . . . . 1.8 115.467 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -79.33 -45.59 19.34 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.991 1.269 . . . . 3.67 108.758 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.2 mt -71.71 -38.83 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 120.724 -0.39 . . . . 4.2 111.482 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.48 122.9 45.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 N-CA-C 106.029 -1.841 . . . . 2.66 106.029 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.02 168.29 44.82 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.187 -1.165 . . . . 1.07 110.187 172.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -59.58 -43.08 41.72 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.116 1.878 . . . . 1.22 109.564 170.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -46.0 35.86 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.039 1.335 . . . . 6.85 112.455 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.06 -55.59 31.05 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.864 0.756 . . . . 2.46 110.148 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 37.6 mt -63.21 -54.37 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.12 -0.491 . . . . 2.03 109.745 -174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.8 mt -49.52 -50.03 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.219 -0.66 . . . . 2.45 109.219 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -70.04 -29.21 66.19 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.622 -0.674 . . . . 5.79 111.813 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.2 m -61.88 -47.27 85.73 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.309 -0.997 . . . . 2.0 108.309 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 78.7 mt -57.37 -43.0 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.234 1.014 . . . . 2.32 111.006 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -57.21 -57.13 13.97 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 109.181 -0.674 . . . . 2.61 109.181 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -55.38 -42.44 73.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.168 1.387 . . . . 2.15 111.144 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.9 mt -61.75 -82.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.565 0.346 . . . . 3.27 111.241 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.66 17.85 0.17 Allowed Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.356 -1.247 . . . . 0.93 114.621 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -137.4 175.13 9.88 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 119.352 1.576 . . . . 3.68 110.916 -153.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -126.44 161.28 28.28 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 107.65 -1.241 . . . . 3.34 107.65 172.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.02 160.03 40.94 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 112.325 0.491 . . . . 2.11 112.325 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 m -155.79 146.59 22.16 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.845 1.658 . . . . 2.36 107.613 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.3 mt -59.24 151.83 22.15 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.775 0.716 . . . . 3.36 111.187 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.1 120.59 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 108.272 -1.01 . . . . 4.43 108.272 174.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -167.6 -53.77 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.606 1.562 . . . . 6.17 109.966 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.1 mt -77.33 -71.9 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 106.2 -1.778 . . . . 6.54 106.2 174.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 . . . . . 0 C--O 1.256 1.411 0 CA-C-O 117.191 -1.385 . . . . 10.13 108.151 156.247 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 108.399 -0.963 . . . . 8.65 108.399 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -54.35 -54.82 29.91 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 108.789 -1.724 . . . . 6.22 108.789 165.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.25 -176.82 4.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.691 1.596 . . . . 5.6 107.247 156.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.38 141.62 12.7 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.08 -1.608 . . . . 2.28 109.08 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.96 148.82 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 O-C-N 122.162 -0.61 . . . . 3.1 110.152 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.2 tp -151.43 159.63 44.12 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.077 -1.083 . . . . 4.13 108.077 162.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -141.65 117.29 10.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.43 -1.693 . . . . 4.15 106.43 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.6 mt -118.58 142.43 47.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.33 1.452 . . . . 4.07 107.184 -177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.48 129.69 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.098 -1.816 . . . . 2.15 106.098 163.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.2 t -117.79 102.85 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 126.099 1.76 . . . . 3.14 106.964 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -96.08 134.57 38.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.653 1.581 . . . . 8.11 108.134 -172.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.43 -9.41 38.47 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.307 0.956 . . . . 1.24 112.455 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.4 ttp -70.08 69.76 0.35 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.252 1.821 . . . . 2.64 109.831 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 t -79.42 -2.59 42.58 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.281 1.585 . . . . 1.97 115.281 -159.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -159.62 164.48 34.09 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.052 1.296 . . . . 1.36 110.892 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.61 -39.81 51.08 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.326 1.05 . . . . 1.82 110.306 173.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -46.59 -43.97 17.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.16 1.384 . . . . 1.94 111.676 171.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . 0.258 73.5 m -72.61 -48.19 41.61 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 118.408 -0.806 . . . . 1.08 113.159 173.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.9 t -41.83 -66.31 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.514 0.726 . . . . 1.85 110.65 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -31.07 67.59 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 119.906 -0.717 . . . . 0.87 112.436 -172.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -58.03 -54.4 47.36 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.703 0.683 . . . . 4.37 109.436 173.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.5 mt -50.61 -61.57 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 108.445 -0.946 . . . . 1.94 108.445 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -55.37 -55.88 26.52 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.066 0.46 . . . . 3.24 111.766 -173.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -54.03 -43.77 70.42 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.023 0.929 . . . . 1.48 110.443 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -68.07 -55.25 13.21 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.177 -1.046 . . . . 2.13 108.177 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -57.87 -43.35 85.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.052 -0.405 . . . . 3.88 111.884 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.9 m -57.24 -16.91 9.45 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.238 0.459 . . . . 3.19 112.238 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.35 -41.66 63.24 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.134 -0.979 . . . . 6.77 111.187 168.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -86.87 109.04 19.04 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.82 -0.807 . . . . 3.12 108.82 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.3 mtm105 -52.76 -21.8 4.54 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.584 0.957 . . . . 8.1 113.584 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -52.19 -37.07 46.02 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.385 -0.675 . . . . 1.34 112.081 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.5 129.28 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.959 -1.126 . . . . 3.73 107.959 170.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.38 -44.85 8.48 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.607 -0.886 . . . . 5.03 108.607 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -142.09 144.18 33.42 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.562 -0.533 . . . . 3.24 109.562 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.5 p -131.08 144.43 51.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.333 1.853 . . . . 3.06 106.767 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -152.11 83.35 1.26 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.772 -1.195 . . . . 2.17 107.772 -166.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 m -101.85 153.38 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 123.868 0.867 . . . . 2.69 111.077 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.36 136.16 13.58 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.478 -0.564 . . . . 1.98 109.478 173.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -81.42 -11.42 59.26 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.459 1.104 . . . . 2.24 112.697 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.07 -49.51 77.07 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.158 -0.682 . . . . 1.99 109.158 173.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -86.01 -40.33 15.92 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.154 0.582 . . . . 3.48 109.597 171.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 80.89 61.79 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 127.25 2.22 . . . . 3.09 107.415 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.32 166.31 25.11 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 123.065 0.546 . . . . 3.03 110.187 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.24 110.6 11.23 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 127.288 2.235 . . . . 1.78 106.862 163.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -86.3 134.9 33.71 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.301 -2.111 . . . . 1.0 105.301 162.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.8 pt -139.18 151.63 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 124.682 1.193 . . . . 4.42 107.82 -172.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -139.28 99.84 3.85 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 102.591 -3.115 . . . . 3.69 102.591 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -145.11 142.24 29.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.221 1.409 . . . . 3.06 108.801 -162.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -80.3 119.69 77.19 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 108.848 -0.797 . . . . 2.82 108.848 175.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.63 -32.8 47.25 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.47 1.447 . . . . 2.03 111.909 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.2 44.67 0.42 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.914 0.779 . . . . 3.72 112.42 -175.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -172.49 -38.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.886 1.674 . . . . 4.49 110.25 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 tt -138.05 118.63 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.318 -1.364 . . . . 2.75 107.318 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.29 156.28 53.31 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.196 -1.562 . . . . 1.22 109.196 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -53.88 -45.39 41.37 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.527 1.484 . . . . 1.52 109.197 171.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -50.96 -37.73 46.38 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 112.268 0.47 . . . . 7.9 112.268 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.15 -40.37 74.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.099 0.863 . . . . 2.73 109.522 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.8 mt -57.98 -46.77 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 118.841 -0.599 . . . . 1.71 109.933 170.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.7 mm -51.73 -57.73 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.825 0.739 . . . . 2.98 110.081 173.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -50.14 -43.34 51.95 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.285 1.034 . . . . 5.08 110.541 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.9 m -64.48 -49.6 70.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.756 -0.461 . . . . 2.08 109.756 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.1 mt -53.69 -47.32 61.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.261 0.624 . . . . 2.5 111.324 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -58.27 -51.91 67.81 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.169 0.588 . . . . 2.23 109.7 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.8 t -52.16 -48.25 65.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.768 0.827 . . . . 2.08 110.905 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.4 -60.01 4.17 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.939 -0.476 . . . . 3.24 111.032 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.66 -42.02 0.02 OUTLIER Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.091 1.196 . . . . 1.9 116.091 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -118.01 164.85 14.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 117.642 0.721 . . . . 2.82 112.769 -136.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.81 98.92 10.25 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.983 -1.488 . . . . 4.47 106.983 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.32 139.95 32.74 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.811 -0.44 . . . . 2.19 109.811 169.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.0 t -144.21 128.94 18.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.596 -1.631 . . . . 3.18 106.596 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -60.97 161.91 7.7 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 119.675 -0.81 . . . . 4.57 109.148 159.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.5 p -159.89 95.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 106.454 -1.684 . . . . 3.53 106.454 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -147.26 -64.58 0.27 Allowed 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 105.397 -2.075 . . . . 5.77 105.397 173.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.6 tp -73.16 150.47 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.688 -1.597 . . . . 8.13 106.688 144.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 C--O 1.256 1.404 0 N-CA-C 103.989 -2.597 . . . . 11.94 103.989 159.18 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.0 mtp . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 107.836 -1.172 . . . . 11.77 107.836 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.12 32.82 77.21 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 109.323 -1.511 . . . . 4.27 109.323 -160.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.99 123.04 18.75 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.18 1.392 . . . . 4.94 109.535 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.64 107.94 2.24 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 108.269 -1.932 . . . . 2.29 108.269 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 p -78.66 120.75 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.432 -1.321 . . . . 3.21 107.432 168.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.16 112.85 12.08 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.019 -1.104 . . . . 4.12 108.019 -172.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -88.01 113.21 23.43 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.76 -1.2 . . . . 3.5 107.76 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -101.24 150.46 22.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.686 -0.857 . . . . 3.62 108.686 166.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 t -81.82 139.82 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 105.107 -2.183 . . . . 1.97 105.107 151.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.65 133.04 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.377 -1.712 . . . . 3.44 106.377 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 mtp85 -129.09 158.68 38.26 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.697 0.799 . . . . 7.36 109.411 -176.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.92 -18.91 55.72 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.727 0.68 . . . . 1.13 112.055 -174.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -74.57 69.48 1.72 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.198 0.999 . . . . 2.66 111.229 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.1 t -62.05 -17.23 56.75 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 116.028 1.862 . . . . 2.06 116.028 -162.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.5 p -160.74 -179.92 8.0 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 121.306 1.866 . . . . 0.78 112.502 -172.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.5 -44.19 35.74 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.714 1.206 . . . . 1.71 111.413 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.6 m -63.99 -22.71 67.04 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.814 0.845 . . . . 1.92 112.322 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.3 m -73.64 -64.18 1.05 Allowed 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.524 -0.735 . . . . 0.69 110.733 161.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.7 t -38.08 -64.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.945 1.298 . . . . 1.88 112.12 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.11 -29.39 70.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.621 -0.431 . . . . 1.14 111.194 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -70.67 -46.55 62.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.682 -0.859 . . . . 3.93 108.682 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.3 mt -54.85 -58.32 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.702 -0.851 . . . . 1.83 108.702 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -59.29 -53.71 55.15 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.642 0.258 . . . . 3.51 111.477 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.5 t -53.86 -45.6 71.04 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.975 -0.453 . . . . 1.48 110.629 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 t -66.07 -50.85 62.69 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.955 -1.128 . . . . 1.84 107.955 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.0 mt -48.57 -51.68 26.59 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.915 0.486 . . . . 4.02 111.376 176.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.4 p -57.81 -14.43 5.92 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.609 0.966 . . . . 2.73 113.609 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -28.37 68.3 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.415 1.007 . . . . 5.0 112.39 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -90.37 104.97 17.49 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 107.755 -1.202 . . . . 2.45 107.755 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -26.25 9.43 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.28 -0.888 . . . . 10.14 111.669 172.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -48.89 -40.64 27.24 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.103 -0.832 . . . . 1.37 112.811 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.83 123.3 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.513 -1.662 . . . . 3.13 106.513 171.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.3 tp -79.93 -38.05 33.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.574 1.15 . . . . 4.3 109.163 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -151.32 154.29 36.45 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.651 -0.5 . . . . 2.97 109.651 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.4 p -133.96 147.7 51.07 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 125.184 1.394 . . . . 3.4 108.827 169.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.4 t -155.02 99.64 2.12 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.695 1.598 . . . . 1.97 107.097 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 m -91.82 167.87 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 122.627 0.371 . . . . 2.82 110.405 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.5 131.68 10.17 Favored 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 121.879 -0.513 . . . . 1.83 110.866 165.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.8 mt -49.8 -50.8 43.58 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 124.488 1.115 . . . . 3.24 108.684 159.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.64 -53.6 17.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.802 0.841 . . . . 2.24 112.113 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.52 -2.42 54.37 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.037 0.935 . . . . 2.58 111.996 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m120 50.02 39.69 19.54 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 125.047 1.339 . . . . 2.21 110.33 -166.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.61 170.38 8.36 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 120.983 0.42 . . . . 3.16 111.257 -167.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -151.31 97.07 2.37 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 126.64 1.976 . . . . 2.0 108.113 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -79.48 106.09 11.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.708 -2.33 . . . . 1.66 104.708 165.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.77 145.52 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 105.256 -2.127 . . . . 2.69 105.256 163.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.2 mtmt -114.52 129.41 56.66 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.937 -1.875 . . . . 3.93 105.937 158.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -138.03 144.6 41.1 Favored 'General case' 0 C--N 1.338 0.089 0 CA-C-N 118.745 0.702 . . . . 4.02 111.607 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -75.44 117.82 66.17 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 107.36 -1.348 . . . . 3.83 107.36 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -80.67 56.36 6.05 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.202 3.268 . . . . 2.07 112.014 -165.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -145.61 -53.74 0.28 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.536 1.934 . . . . 3.69 107.55 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.8 mt -74.43 -33.26 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.411 1.084 . . . . 3.64 110.738 -172.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.6 tt -147.39 138.37 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.432 -1.322 . . . . 2.82 107.432 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.45 168.23 27.97 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.359 0.981 . . . . 1.19 111.66 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.08 -43.45 15.24 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.788 2.325 . . . . 1.17 109.534 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -54.29 -44.19 71.72 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 122.479 0.312 . . . . 7.3 110.405 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -63.98 -47.21 81.29 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.343 -0.614 . . . . 2.65 109.343 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.9 mt -52.79 -52.48 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 O-C-N 122.015 -0.428 . . . . 1.72 110.153 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.4 mt -54.25 -53.31 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 122.053 -0.404 . . . . 2.19 110.177 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.4 -32.76 67.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.219 0.608 . . . . 5.43 111.265 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.5 m -65.2 -49.47 69.61 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.067 -1.021 . . . . 1.97 108.45 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.0 mt -54.62 -41.41 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.703 0.801 . . . . 2.51 110.692 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -57.62 -54.98 40.76 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.207 0.458 . . . . 2.3 110.364 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.5 m -57.53 -29.16 64.13 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.231 1.012 . . . . 3.31 112.465 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.7 -89.42 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.882 -0.785 . . . . 3.47 108.882 166.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.47 25.0 0.24 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-O 118.517 -1.157 . . . . 1.04 113.955 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.75 175.57 9.07 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.011 1.406 . . . . 3.71 112.596 -153.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -112.58 149.7 32.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.299 -1.741 . . . . 3.78 106.299 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.18 161.49 41.19 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.989 0.813 . . . . 2.25 111.68 166.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.0 t -151.75 149.32 28.92 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.543 -1.651 . . . . 4.05 106.543 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -53.46 144.43 16.95 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.95 -0.759 . . . . 3.63 108.95 162.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.6 p -125.92 130.74 72.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 109.646 -0.501 . . . . 4.42 109.646 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.73 -50.32 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.235 1.014 . . . . 5.2 108.838 174.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.4 mt -81.88 104.87 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.063 -1.458 . . . . 7.29 107.063 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 C--O 1.255 1.356 0 N-CA-C 104.84 -2.281 . . . . 11.35 104.84 172.692 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' H3 ' ' CG ' ' A' ' 3' ' ' ASP . 56.6 mtt . . . . . 0 N--CA 1.473 0.675 0 N-CA-C 106.694 -1.595 . . . . 9.49 106.694 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.98 21.71 73.63 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 123.652 0.595 . . . . 4.52 111.76 -171.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.516 ' CG ' ' H3 ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -85.34 65.72 9.34 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.447 -1.031 . . . . 6.07 108.844 -170.012 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.98 113.21 5.66 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.567 -1.413 . . . . 2.24 109.567 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.08 141.8 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 107.97 -1.122 . . . . 3.33 107.97 173.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -150.8 148.54 28.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.277 -0.638 . . . . 3.78 109.277 164.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -93.48 127.3 39.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.077 -1.823 . . . . 3.16 106.077 152.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 pp -107.32 151.18 25.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.384 -1.339 . . . . 3.58 107.384 164.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.61 143.93 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 104.831 -2.285 . . . . 2.57 104.831 161.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 p -141.78 133.51 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 124.007 0.923 . . . . 3.38 108.545 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -134.87 165.53 25.1 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.22 1.408 . . . . 8.22 109.065 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.09 -39.38 2.78 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.12 0.867 . . . . 1.48 111.378 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.0 ptt? -67.34 65.27 0.07 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.4 1.48 . . . . 3.01 112.88 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -71.62 19.1 0.07 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.117 1.525 . . . . 2.36 115.117 -165.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -166.57 158.57 13.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.589 1.086 . . . . 1.14 110.187 177.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.24 -37.41 35.5 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.152 0.981 . . . . 2.08 111.12 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.7 p -58.16 -33.21 68.96 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.727 0.411 . . . . 2.97 111.425 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . 0.259 72.6 m -75.77 -44.71 40.21 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 120.819 -1.176 . . . . 1.61 113.676 168.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.7 t -50.01 -60.03 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.168 0.44 . . . . 1.9 110.738 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -25.44 63.05 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.445 -0.784 . . . . 1.26 112.159 -176.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.16 -51.86 67.26 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 108.562 -0.903 . . . . 4.56 108.562 173.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.3 mt -52.58 -60.8 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 108.447 -0.946 . . . . 1.96 108.447 172.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -53.09 -56.45 16.16 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.336 0.589 . . . . 3.27 110.605 -170.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.1 t -56.09 -48.37 76.25 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.916 1.286 . . . . 1.46 111.103 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.8 t -64.64 -57.82 8.01 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.04 -0.726 . . . . 2.42 109.04 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.3 tp -54.21 -49.12 70.13 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.336 1.454 . . . . 3.43 111.111 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.5 p -59.47 -12.76 6.75 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.601 0.963 . . . . 3.26 113.601 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -24.88 66.77 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.889 1.222 . . . . 5.56 112.322 175.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -80.67 130.77 35.29 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.44 0.564 . . . . 3.14 109.653 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -58.31 151.85 18.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.461 -0.94 . . . . 7.48 108.461 169.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.24 -27.82 15.44 Favored Glycine 0 C--O 1.224 -0.495 0 N-CA-C 111.035 -0.826 . . . . 2.46 111.035 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.1 mm -79.22 121.19 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 119.138 1.469 . . . . 5.38 107.217 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.3 mt -94.99 -44.59 7.63 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.125 -0.695 . . . . 2.95 109.125 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -153.49 153.63 32.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.199 -0.667 . . . . 3.98 109.199 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.5 m -138.75 132.97 31.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 105.481 -2.044 . . . . 2.29 105.481 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -134.87 89.67 2.56 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 105.88 -1.896 . . . . 3.22 105.88 166.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 p -97.94 137.61 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.309 1.043 . . . . 3.56 111.156 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 134.07 21.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.811 0.845 . . . . 1.91 111.091 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 pp -72.05 -34.38 68.71 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 124.661 1.185 . . . . 3.37 110.672 170.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.64 -32.47 42.11 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.648 0.779 . . . . 2.49 111.674 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -120.55 11.79 11.4 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.801 1.24 . . . . 3.96 111.496 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.0 m120 35.32 52.08 0.65 Allowed 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.887 1.675 . . . . 2.73 112.778 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.23 151.97 40.18 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.117 -0.698 . . . . 4.49 109.117 -171.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.97 118.26 17.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.758 -0.83 . . . . 1.8 108.758 170.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -84.76 106.16 16.09 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.135 -1.802 . . . . 1.22 106.135 170.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.2 mp -106.95 136.3 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.792 -1.558 . . . . 2.54 106.792 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -116.09 140.2 49.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.458 -1.682 . . . . 4.06 106.458 163.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -158.69 161.04 37.06 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.724 0.81 . . . . 2.71 110.013 -167.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -87.78 110.94 38.86 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 107.122 -1.436 . . . . 4.04 107.122 173.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.23 59.23 7.3 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.088 3.192 . . . . 2.04 110.799 -168.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -167.26 -46.72 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.53 1.532 . . . . 3.2 108.857 -173.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.2 mm -65.96 -39.18 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.517 -0.549 . . . . 3.43 109.517 170.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.07 154.73 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 105.835 -1.913 . . . . 2.42 105.835 -175.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -116.77 174.22 15.11 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.875 1.226 . . . . 1.28 112.145 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.15 -39.38 31.31 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.231 2.621 . . . . 1.2 110.413 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -47.57 -56.65 6.69 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.804 0.842 . . . . 8.59 110.368 170.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.0 -54.85 29.11 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.716 -0.475 . . . . 2.28 109.716 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.3 mt -52.69 -60.16 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.059 0.544 . . . . 1.94 111.149 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.8 mt -52.11 -51.79 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 C-N-CA 123.715 0.806 . . . . 2.23 110.133 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -68.08 -33.33 74.34 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.215 -0.448 . . . . 5.62 111.07 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.9 m -60.88 -46.62 89.9 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 108.091 -1.077 . . . . 1.81 108.091 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.2 mt -56.25 -58.15 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.263 -0.643 . . . . 2.39 109.263 173.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -53.99 -43.77 70.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.913 0.387 . . . . 3.19 110.356 -168.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.5 m -62.74 -15.62 53.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.356 1.462 . . . . 3.57 114.125 -172.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.97 -83.27 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.885 -1.154 . . . . 4.22 107.885 170.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.03 42.62 0.48 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.476 -1.449 . . . . 1.71 109.476 166.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -126.88 176.65 7.14 Favored 'General case' 0 CA--C 1.524 -0.04 0 CA-C-N 117.311 0.555 . . . . 3.65 111.328 -159.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.36 145.52 47.81 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 104.923 -2.251 . . . . 4.82 104.923 170.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.44 146.0 27.21 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 123.688 0.617 . . . . 2.64 111.036 165.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t -155.57 131.0 9.63 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.831 -0.433 . . . . 3.1 109.831 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -53.73 140.38 29.79 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.165 0.986 . . . . 3.3 111.627 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.84 154.36 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.363 0.665 . . . . 4.37 110.002 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -167.35 173.04 9.19 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.744 -1.947 . . . . 6.85 105.744 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.0 170.04 18.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.851 -1.537 . . . . 7.98 106.851 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 . . . . . 0 C--O 1.256 1.438 0 N-CA-C 104.445 -2.428 . . . . 9.31 104.445 170.703 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 107.388 -1.338 . . . . 9.44 107.388 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.4 112.6 1.99 Allowed Glycine 0 CA--C 1.526 0.727 1 N-CA-C 102.66 -4.176 . . . . 4.76 102.66 -135.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 148.07 177.67 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 128.552 2.741 . . . . 5.26 107.609 -145.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.81 175.02 35.18 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.932 -1.267 . . . . 2.1 109.932 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.31 130.6 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.028 -1.471 . . . . 3.45 107.028 170.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.3 tp -124.65 139.62 53.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.025 -1.472 . . . . 3.54 107.025 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.41 143.24 48.77 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.64 -1.244 . . . . 4.39 107.64 176.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.78 150.09 24.22 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.122 0.969 . . . . 3.88 108.931 176.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.35 112.35 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 104.186 -2.524 . . . . 1.91 104.186 169.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.82 142.73 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.158 -1.423 . . . . 3.86 107.158 162.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -131.84 166.05 22.47 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.254 -0.647 . . . . 7.23 109.254 167.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.63 -38.72 3.18 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 121.757 -0.59 . . . . 1.13 112.252 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.04 77.36 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.418 1.487 . . . . 3.47 111.93 176.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.4 t -74.52 -16.95 60.82 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 115.069 1.507 . . . . 2.1 115.069 -161.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 p -158.36 176.44 12.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 120.605 1.548 . . . . 0.79 111.747 -172.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.62 -46.15 9.96 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.288 1.435 . . . . 1.7 111.464 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 m -61.98 -30.67 71.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.679 0.792 . . . . 1.99 112.271 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.3 m -72.88 -56.69 4.83 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.862 0.756 . . . . 0.64 110.333 166.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.4 t -42.8 -61.71 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.593 1.157 . . . . 1.77 111.39 -176.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.99 -28.26 67.28 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 120.046 -0.662 . . . . 0.88 111.692 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -64.86 -48.53 73.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.301 -0.999 . . . . 3.57 108.301 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.7 mt -53.98 -63.48 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.64 -0.874 . . . . 1.79 108.64 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -52.95 -50.43 64.06 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.174 0.443 . . . . 3.83 111.729 -173.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.0 t -55.97 -46.79 78.51 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.4 1.08 . . . . 1.43 111.317 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.2 p -69.02 -37.43 78.65 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.695 -0.628 . . . . 3.32 110.098 -173.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.7 mp -72.2 -48.25 44.48 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.748 1.219 . . . . 3.53 111.631 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 t -71.88 65.36 0.53 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 123.325 1.536 . . . . 3.41 112.027 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.61 -23.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.635 2.774 . . . . 5.55 111.935 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -60.51 -14.38 19.36 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.169 1.174 . . . . 2.95 114.169 176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? 70.83 -54.35 0.66 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.402 1.881 . . . . 7.5 110.843 -171.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.94 -32.14 55.84 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 117.953 0.342 . . . . 1.3 112.32 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 38.5 mt -79.37 104.88 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.23 -1.396 . . . . 5.53 107.23 167.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.2 mt -78.98 -28.12 43.49 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.152 0.581 . . . . 2.76 109.648 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -156.71 157.2 34.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.414 -0.958 . . . . 3.23 108.414 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.6 p -138.59 140.28 38.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.024 1.73 . . . . 2.6 107.136 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.9 t -146.99 101.3 3.41 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.836 -1.542 . . . . 2.02 106.836 169.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 p -100.72 152.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 124.294 1.038 . . . . 3.88 109.848 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.05 127.51 7.89 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 121.66 -0.65 . . . . 1.73 111.328 170.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.48 -28.69 68.07 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.419 0.687 . . . . 2.76 110.714 162.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.44 -49.77 69.23 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 120.97 0.414 . . . . 1.91 110.001 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.36 -35.11 25.38 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.17 0.588 . . . . 2.55 111.096 173.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.26 76.04 0.36 Allowed 'General case' 0 C--N 1.344 0.339 0 N-CA-C 106.926 -1.509 . . . . 2.14 106.926 -151.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.62 163.13 39.26 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.02 0.528 . . . . 3.54 109.89 177.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.15 94.12 2.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.889 1.276 . . . . 1.81 109.916 169.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -77.99 104.19 8.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 105.967 -1.864 . . . . 1.2 105.967 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.69 115.61 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 105.923 -1.88 . . . . 2.59 105.923 174.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -82.03 75.46 8.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.793 -1.188 . . . . 4.58 107.793 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.67 161.44 23.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.055 -0.521 . . . . 4.35 110.794 170.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -104.85 133.49 20.13 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 107.227 -1.397 . . . . 3.22 107.227 142.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.57 -31.79 59.65 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.138 2.558 . . . . 2.14 114.472 -171.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -81.19 -43.37 19.4 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 120.473 1.488 . . . . 2.97 110.251 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 tp -73.42 -26.19 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 118.85 -0.595 . . . . 3.69 111.459 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.1 tt -148.09 124.27 2.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-N 120.171 1.351 . . . . 2.89 109.96 167.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.08 159.56 49.24 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 109.67 -1.372 . . . . 1.08 109.67 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -58.85 -39.89 77.21 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.087 1.858 . . . . 1.22 109.247 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -41.65 -48.55 4.12 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.214 1.406 . . . . 10.15 111.007 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -72.31 -45.11 61.4 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.0 0.92 . . . . 2.31 109.539 -169.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.2 mt -54.04 -50.55 53.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.037 -0.727 . . . . 1.72 109.037 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.4 mt -55.48 -52.42 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 119.582 -0.247 . . . . 2.11 110.467 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -52.25 -39.67 60.65 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.476 0.71 . . . . 4.47 110.861 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 31.1 m -64.83 -50.46 66.57 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.238 -0.652 . . . . 1.65 109.238 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.4 mt -55.06 -48.26 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.21 1.004 . . . . 2.29 110.579 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -56.32 -57.12 13.6 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.59 0.756 . . . . 2.14 110.492 173.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.8 t -51.02 -43.6 60.88 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.813 1.245 . . . . 2.39 110.895 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.63 -73.7 0.08 Allowed 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.359 -0.213 . . . . 3.21 110.44 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.41 -5.52 0.05 OUTLIER Glycine 0 CA--C 1.529 0.948 0 N-CA-C 117.41 1.724 . . . . 1.18 117.41 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -131.33 172.21 12.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.758 1.779 . . . . 2.86 112.999 -137.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.48 150.27 20.49 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.834 -1.543 . . . . 4.8 106.834 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.7 124.88 10.09 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.898 0.38 . . . . 2.11 111.457 162.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 p -129.14 122.45 29.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.964 1.305 . . . . 2.77 109.18 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -55.28 -41.86 72.83 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.631 0.974 . . . . 3.91 113.631 -172.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.9 t 64.38 -73.52 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.866 1.266 . . . . 3.95 111.177 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.1 tptm 45.11 53.25 7.96 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.338 1.855 . . . . 4.54 112.225 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.96 118.31 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.893 -1.892 . . . . 7.36 105.893 165.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 C--O 1.249 1.06 0 N-CA-C 104.289 -2.486 . . . . 8.99 104.289 -164.793 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptp . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 114.595 1.331 . . . . 10.92 114.595 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 124.29 173.78 13.93 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 120.451 1.478 . . . . 5.03 112.671 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -17.0 -66.38 0.01 OUTLIER 'General case' 0 C--N 1.339 0.147 0 C-N-CA 129.774 3.23 . . . . 4.97 117.187 -172.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 50.96 71.47 0.64 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.733 -0.947 . . . . 1.96 110.733 -167.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -78.26 97.16 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.845 0.858 . . . . 3.1 108.973 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.03 155.67 19.57 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.937 0.875 . . . . 5.26 109.071 171.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -146.23 136.75 24.02 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 105.846 -1.909 . . . . 4.32 105.846 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 pp -152.61 148.66 27.59 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.601 1.161 . . . . 3.09 109.217 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.89 125.62 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 105.569 -2.012 . . . . 1.93 105.569 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.9 t -104.71 138.03 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 106.356 -1.72 . . . . 2.78 106.356 168.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.16 175.3 9.98 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.777 1.631 . . . . 6.0 108.55 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.43 -50.17 4.3 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.186 -1.166 . . . . 1.64 110.186 -172.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -50.33 126.66 15.48 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.034 0.534 . . . . 3.0 111.556 175.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 p -88.68 -41.37 12.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.971 0.73 . . . . 3.38 112.971 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.4 p -152.41 177.06 11.0 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.843 0.747 . . . . 0.84 112.543 -161.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.0 -42.09 17.44 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.876 1.27 . . . . 1.9 111.585 175.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.0 t -60.56 -34.39 74.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.507 0.723 . . . . 2.37 110.912 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.2 m -71.53 -54.97 8.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.375 0.534 . . . . 0.67 109.85 169.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.1 t -45.8 -62.35 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.592 0.757 . . . . 1.92 111.45 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.7 -27.0 66.45 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 120.046 -0.661 . . . . 1.13 111.632 -174.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -68.06 -48.89 64.36 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.744 0.818 . . . . 3.64 109.224 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.7 mt -53.8 -58.72 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 N-CA-C 107.899 -1.148 . . . . 2.11 107.899 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.46 -53.82 33.19 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.369 0.604 . . . . 3.58 110.412 -176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 t -57.76 -37.72 74.13 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.641 1.176 . . . . 1.31 111.754 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.9 t -71.46 -40.78 70.11 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.788 0.835 . . . . 2.27 110.67 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.5 mp -66.86 -51.78 51.42 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.457 1.103 . . . . 3.39 109.26 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.1 t -71.71 60.95 0.37 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.258 1.028 . . . . 3.51 110.734 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.05 -48.1 0.32 Allowed 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 128.895 2.878 . . . . 7.79 108.045 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -69.99 26.2 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.281 1.586 . . . . 3.19 115.281 -165.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 66.02 -60.75 0.29 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.651 2.38 . . . . 6.91 114.177 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.47 -15.92 62.21 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.715 -0.492 . . . . 1.43 113.23 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.2 mm -79.43 105.42 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.901 1.28 . . . . 5.56 107.734 176.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.73 -38.97 37.57 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.308 -0.627 . . . . 4.39 109.308 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -152.41 152.08 31.58 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.996 -0.742 . . . . 3.56 108.996 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.0 t -136.26 132.34 35.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.804 1.642 . . . . 3.16 106.586 174.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.1 t -134.85 103.73 5.72 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.927 -1.509 . . . . 1.95 106.927 165.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p -104.23 147.84 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.824 1.25 . . . . 3.89 109.82 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.35 142.32 19.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 O-C-N 121.401 -0.812 . . . . 1.99 110.868 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -83.82 -38.09 21.68 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 123.952 0.901 . . . . 3.28 109.753 170.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.24 -35.86 60.43 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.458 0.703 . . . . 2.36 110.755 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -117.54 16.47 14.61 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.62 1.168 . . . . 3.48 110.35 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.4 m120 23.23 70.83 0.03 OUTLIER 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.646 1.978 . . . . 2.14 112.737 -173.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 166.59 26.67 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.576 0.35 . . . . 3.8 110.342 -172.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.99 92.91 1.68 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.365 1.466 . . . . 1.97 109.343 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -78.33 108.27 11.55 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.738 -2.319 . . . . 1.88 104.738 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.0 mp -110.92 127.14 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 106.662 -1.607 . . . . 2.55 106.662 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -92.44 104.66 16.96 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 104.869 -2.271 . . . . 3.12 104.869 160.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -122.05 134.6 54.78 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 118.592 0.633 . . . . 3.04 109.344 175.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -72.63 117.68 61.32 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 120.167 -0.613 . . . . 3.01 109.37 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -81.76 64.56 8.55 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.05 2.5 . . . . 2.37 112.471 -163.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -158.38 -52.66 0.07 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.526 1.13 . . . . 2.97 109.035 168.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -57.99 -35.16 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.788 1.235 . . . . 3.94 111.659 172.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mm -139.17 139.32 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.748 -1.945 . . . . 2.63 105.748 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.57 167.9 15.01 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.3 1.428 . . . . 1.03 110.374 169.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -61.87 -41.95 34.28 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.534 2.156 . . . . 1.19 110.17 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.9 -35.95 25.54 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 118.119 -0.943 . . . . 6.74 112.127 174.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -68.64 -49.81 56.23 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 119.711 1.141 . . . . 2.08 110.147 -176.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 mt -53.74 -53.23 27.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.922 -0.77 . . . . 1.94 108.922 172.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.4 mt -53.52 -44.14 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 118.512 -0.756 . . . . 2.14 110.642 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -53.12 -38.42 62.64 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 119.275 0.943 . . . . 4.22 110.776 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.1 m -67.01 -53.44 31.32 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.004 0.82 . . . . 2.28 108.875 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mp -50.81 -51.81 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.339 0.656 . . . . 2.54 110.28 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.51 -51.58 64.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.839 1.256 . . . . 2.35 110.612 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.0 t -65.71 -20.05 66.13 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 118.009 -0.996 . . . . 2.33 112.866 -171.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.8 -101.55 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 119.551 1.069 . . . . 4.11 108.388 163.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.46 36.68 0.48 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.411 -1.076 . . . . 1.62 110.411 173.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -126.74 154.62 43.94 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.819 -0.808 . . . . 3.87 108.819 -162.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -109.49 152.77 24.99 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.553 -0.906 . . . . 3.6 108.553 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.09 148.45 50.57 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 125.563 1.545 . . . . 2.35 110.246 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.1 m -154.15 99.7 2.26 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.787 0.835 . . . . 2.17 110.402 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mt -54.98 126.31 24.02 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.075 -1.083 . . . . 4.14 108.075 164.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.26 144.5 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 105.13 -2.174 . . . . 3.99 105.13 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -125.86 -48.56 1.63 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.429 1.092 . . . . 5.21 110.166 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.76 -54.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 105.574 -2.01 . . . . 7.11 105.574 170.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 . . . . . 0 C--O 1.248 0.997 0 N-CA-C 106.184 -1.784 . . . . 11.54 106.184 142.807 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttm . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 119.333 -0.365 . . . . 8.83 110.648 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -145.55 58.24 0.51 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 106.523 -2.631 . . . . 3.8 106.523 174.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -134.26 125.75 28.39 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.501 -1.296 . . . . 5.16 107.501 -159.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.45 136.67 8.53 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 106.984 -2.446 . . . . 1.83 106.984 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.9 t -136.76 134.37 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.998 -1.482 . . . . 3.65 106.998 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.5 mt -135.19 117.13 15.24 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.324 -1.362 . . . . 3.61 107.324 171.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -79.42 89.38 5.01 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.918 -1.882 . . . . 3.52 105.918 155.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.2 mt -78.67 134.88 37.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.709 -1.589 . . . . 3.28 106.709 172.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.83 119.2 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 104.977 -2.231 . . . . 2.31 104.977 162.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -124.86 110.41 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 105.708 -1.96 . . . . 3.32 105.708 -175.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.6 mtp-105 -117.63 160.02 21.97 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.381 1.073 . . . . 6.93 109.768 -165.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.36 0.59 88.35 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.876 -0.889 . . . . 1.27 110.876 -163.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.6 ttm -69.44 68.2 0.22 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.534 1.534 . . . . 3.0 109.805 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -67.36 -31.55 71.89 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.465 0.542 . . . . 2.42 112.465 -166.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.6 p -155.04 174.94 14.47 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.993 0.815 . . . . 0.75 112.117 -170.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.02 -41.97 17.42 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.119 1.368 . . . . 2.09 111.786 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 m -54.2 -43.62 70.9 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 122.953 0.501 . . . . 1.88 110.894 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.3 m -66.12 -50.68 63.18 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.291 0.496 . . . . 0.73 109.96 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.2 t -46.19 -64.12 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.377 0.671 . . . . 2.27 110.378 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -31.0 67.13 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.233 -0.587 . . . . 1.08 112.218 -174.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -51.85 67.72 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.701 0.682 . . . . 6.52 109.467 174.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.3 mt -56.01 -62.67 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 108.099 -1.074 . . . . 2.26 108.099 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -49.33 -56.34 9.83 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 123.744 0.652 . . . . 3.89 110.167 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.6 t -57.66 -48.64 78.93 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.959 0.504 . . . . 1.59 111.209 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.5 t -71.81 -22.9 61.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.759 -0.588 . . . . 2.12 110.78 -171.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mp -73.65 -63.79 1.13 Allowed 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 121.349 -0.844 . . . . 3.54 110.569 163.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 84.8 m -54.63 -23.55 17.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.38 1.072 . . . . 2.51 113.1 -170.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -53.0 -34.95 58.68 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.072 1.138 . . . . 6.3 114.072 170.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -70.25 120.45 15.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.572 -0.899 . . . . 2.85 108.572 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -74.43 56.61 0.67 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.506 0.593 . . . . 8.17 110.66 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.08 42.33 0.44 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.115 -1.594 . . . . 1.97 109.115 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.6 pp -147.51 163.47 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 127.057 2.143 . . . . 3.79 105.243 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -111.36 -43.01 3.77 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.785 0.834 . . . . 3.5 109.833 171.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -156.26 158.05 36.84 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.272 0.942 . . . . 3.05 110.9 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.0 m -143.23 124.87 14.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.318 1.847 . . . . 2.58 106.368 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.54 106.3 6.94 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.975 0.91 . . . . 2.1 108.705 173.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.6 m -100.85 147.86 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 125.274 1.43 . . . . 3.52 110.727 -173.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.28 125.5 18.71 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.814 -0.81 . . . . 1.8 108.814 166.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.4 pp -64.93 -37.34 87.33 Favored 'General case' 0 C--N 1.338 0.098 0 O-C-N 123.395 0.435 . . . . 2.68 110.436 168.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.55 -49.77 55.2 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.458 1.103 . . . . 1.83 111.123 -174.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.5 8.5 33.44 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.256 0.622 . . . . 3.1 110.983 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.264 0.0 OUTLIER 47.12 61.22 2.98 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 126.355 1.862 . . . . 2.86 109.907 173.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.24 166.29 31.36 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.303 -0.862 . . . . 3.31 111.944 -173.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.05 110.24 6.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.014 2.526 . . . . 2.19 107.823 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -78.74 97.08 5.76 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 105.467 -2.049 . . . . 1.22 105.467 167.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.9 mt -104.22 138.91 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 107.001 -1.481 . . . . 2.74 107.001 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -127.44 135.99 51.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.904 -1.888 . . . . 4.43 105.904 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -161.53 158.99 27.28 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.4 1.08 . . . . 3.91 108.149 -167.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -79.63 126.92 79.64 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.397 -1.334 . . . . 3.55 107.397 169.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -80.97 46.28 2.23 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.01 2.473 . . . . 2.04 109.801 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -137.45 -62.03 0.62 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.931 1.292 . . . . 4.08 108.181 -165.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 tt -74.13 -26.95 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 121.946 -0.471 . . . . 3.59 111.4 176.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.25 129.96 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.269 -1.752 . . . . 2.37 106.269 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.28 -179.53 53.06 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 110.498 -1.041 . . . . 1.24 110.498 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.66 -54.52 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.211 1.941 . . . . 1.53 111.347 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -67.09 -25.69 66.34 Favored 'General case' 0 C--O 1.221 -0.411 0 O-C-N 121.7 -0.625 . . . . 7.36 111.773 -172.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.77 -50.55 5.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.384 1.874 . . . . 2.97 110.744 172.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.9 mt -66.4 -52.16 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.082 -0.71 . . . . 1.84 109.082 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mt -53.68 -45.97 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 122.801 0.44 . . . . 2.26 110.656 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -50.67 -41.3 55.44 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.636 1.174 . . . . 4.78 110.674 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.8 m -65.45 -48.51 72.44 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.169 -0.678 . . . . 2.03 109.169 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.07 -55.82 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.045 0.538 . . . . 2.5 110.121 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -53.3 -53.52 49.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.149 0.98 . . . . 2.27 110.081 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.9 t -55.01 -40.36 70.07 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.014 1.326 . . . . 1.93 111.452 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.6 mt -60.02 -86.22 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 117.946 0.339 . . . . 3.38 111.593 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.03 32.82 0.38 Allowed Glycine 0 CA--C 1.524 0.623 0 CA-C-O 118.653 -1.082 . . . . 0.96 113.118 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -133.06 163.34 29.47 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 118.715 1.257 . . . . 3.59 113.064 -158.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -97.21 144.86 26.61 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.219 2.208 . . . . 3.7 105.157 171.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.95 140.12 40.09 Favored 'General case' 0 CA--C 1.526 0.024 0 CA-C-N 118.772 0.715 . . . . 3.05 111.416 -168.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.6 p -155.76 175.44 13.93 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.235 1.014 . . . . 2.93 108.43 165.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.02 151.68 29.03 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 105.314 -2.106 . . . . 3.46 105.314 158.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.0 t -129.8 136.03 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 107.979 -1.119 . . . . 3.4 107.979 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -170.55 -179.26 2.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.236 1.814 . . . . 5.68 106.18 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.0 tp -84.81 -66.04 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.259 0.624 . . . . 7.1 112.557 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.258 0 C-N-CA 127.907 2.483 . . . . 9.23 113.919 -167.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 107.636 -1.246 . . . . 9.16 107.636 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.18 176.52 28.78 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 107.079 -2.409 . . . . 5.13 107.079 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.467 ' CG ' ' HZ2' ' A' ' 47' ' ' LYS . 57.9 t0 -155.07 164.39 38.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.697 -1.594 . . . . 4.49 106.697 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.4 126.45 5.56 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.107 -1.197 . . . . 1.89 110.107 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.53 66.91 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 124.912 1.285 . . . . 3.91 108.696 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.33 79.63 4.76 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.037 -1.468 . . . . 3.91 107.037 -176.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -99.12 99.74 10.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.343 -1.299 . . . . 2.98 107.942 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.98 153.32 36.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.487 1.115 . . . . 3.55 109.164 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.9 123.75 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 106.824 -1.547 . . . . 1.87 106.824 174.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.9 t -100.91 109.32 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.898 -1.89 . . . . 3.07 105.898 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -88.25 137.4 32.36 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.323 -0.991 . . . . 7.7 108.323 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.06 1.68 41.88 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.73 -1.039 . . . . 1.09 113.455 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 48.3 mtm -71.45 71.02 0.65 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.44 1.62 . . . . 2.5 110.406 175.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -71.72 -19.17 62.09 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.678 -1.154 . . . . 2.09 113.768 -168.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -162.7 173.41 13.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 120.152 1.342 . . . . 0.88 111.022 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.59 -39.41 35.24 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.223 1.009 . . . . 1.74 111.54 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 m -59.61 -30.49 68.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.406 0.682 . . . . 1.98 112.146 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.1 m -71.07 -55.38 8.35 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.834 0.743 . . . . 1.0 109.898 168.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.28 -59.95 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.918 0.887 . . . . 1.7 110.886 -173.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.66 -31.72 71.04 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.236 -0.586 . . . . 1.09 111.707 -174.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -60.41 -51.69 68.4 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.75 -0.833 . . . . 4.12 108.75 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.0 mt -53.1 -64.47 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 108.63 -0.878 . . . . 2.06 108.63 174.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -49.46 -60.37 2.91 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 123.951 0.782 . . . . 3.8 110.031 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 t -52.96 -48.4 67.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.87 0.868 . . . . 1.4 110.442 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.1 m -59.9 -54.69 43.21 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.125 -0.694 . . . . 3.2 109.125 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.64 -37.19 65.37 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.739 0.815 . . . . 3.46 111.858 -173.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.3 p -54.97 -26.52 37.22 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.592 0.96 . . . . 2.92 113.592 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -4.18 37.55 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.941 1.246 . . . . 5.74 113.457 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -88.14 69.01 9.22 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 106.843 -1.54 . . . . 2.69 106.843 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -47.59 -16.14 0.06 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 118.017 2.599 . . . . 7.93 118.017 -161.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.07 -7.0 86.63 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 119.837 1.199 . . . . 1.29 113.114 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.16 137.32 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.442 -1.318 . . . . 3.25 107.442 168.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.5 mt -85.43 -39.76 17.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.267 1.027 . . . . 3.19 109.683 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -157.05 153.32 27.72 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.627 -0.879 . . . . 3.76 108.627 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.5 t -127.98 146.72 50.57 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.622 -0.881 . . . . 2.51 108.622 166.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 m -148.26 107.89 3.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.873 0.869 . . . . 2.83 109.933 164.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.74 145.3 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 125.951 1.7 . . . . 2.93 110.394 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.14 120.75 10.44 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 124.02 0.928 . . . . 2.08 109.462 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 pp -81.65 -12.34 58.73 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.271 1.029 . . . . 2.43 113.392 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.36 -49.4 34.34 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.134 -1.061 . . . . 2.51 108.134 172.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -79.47 -25.56 41.86 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.664 1.186 . . . . 2.58 111.221 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.8 m120 63.82 42.22 6.26 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 126.02 1.728 . . . . 1.9 109.666 -172.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.26 148.88 45.44 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 124.253 1.021 . . . . 3.9 108.319 -170.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.17 109.46 12.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.837 -1.171 . . . . 1.73 107.837 165.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -82.84 105.35 13.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.574 -1.639 . . . . 1.6 106.574 167.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.29 123.58 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.545 -1.65 . . . . 2.68 106.545 168.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.467 ' HZ2' ' CG ' ' A' ' 3' ' ' ASP . 22.8 mtpt -93.95 145.92 24.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.712 -1.218 . . . . 3.48 107.712 162.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -163.73 158.45 20.29 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.024 0.529 . . . . 2.77 110.304 -168.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -100.03 121.0 55.43 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 124.441 1.088 . . . . 3.4 108.098 170.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.57 -38.13 19.98 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.845 2.363 . . . . 2.04 112.898 -168.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -58.4 -40.54 82.68 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.978 0.511 . . . . 3.33 111.652 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -81.67 -50.75 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 123.104 0.562 . . . . 3.82 110.245 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.54 100.71 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.63 -0.878 . . . . 2.94 108.63 -173.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -63.9 140.6 44.14 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 108.763 -1.735 . . . . 1.61 108.763 168.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -56.93 -32.43 92.55 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.812 2.341 . . . . 1.41 112.005 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.475 HH11 ' CD2' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -58.36 -28.33 65.01 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 117.954 -1.022 . . . . 7.15 112.714 176.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.14 -55.69 23.08 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.431 1.469 . . . . 4.94 109.756 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.8 mt -51.74 -52.08 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.455 0.702 . . . . 1.75 109.168 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.7 mt -57.65 -49.27 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 118.707 -0.663 . . . . 2.89 110.323 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.475 ' CD2' HH11 ' A' ' 56' ' ' ARG . 27.7 m80 -54.09 -41.1 67.85 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.225 0.92 . . . . 3.96 111.294 174.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.7 m -58.62 -54.85 42.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.449 -0.945 . . . . 2.01 108.449 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.85 -55.46 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.598 0.759 . . . . 3.09 110.505 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -51.32 -59.4 4.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.57 0.748 . . . . 2.0 109.718 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.4 t -55.56 -48.4 74.83 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.572 1.149 . . . . 2.32 111.233 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.7 mt -59.04 -51.41 70.15 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.835 0.68 . . . . 3.15 112.835 -172.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.69 1.61 0.06 OUTLIER Glycine 0 CA--C 1.529 0.948 0 N-CA-C 117.156 1.623 . . . . 1.67 117.156 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -139.21 177.07 8.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.637 1.718 . . . . 2.91 111.712 -139.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.94 152.3 32.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.022 -1.473 . . . . 3.15 107.022 165.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.87 146.65 37.33 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.853 0.861 . . . . 2.59 109.251 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.6 m -147.92 107.93 4.04 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.766 0.826 . . . . 2.47 108.835 173.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.81 69.6 0.69 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.755 1.222 . . . . 3.94 111.936 -176.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.36 -46.87 92.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.295 0.638 . . . . 3.28 111.662 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? 32.5 72.83 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.127 1.771 . . . . 5.49 112.137 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.4 mt -54.06 145.58 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.318 -0.856 . . . . 9.5 109.821 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 C--O 1.249 1.073 0 C-N-CA 127.067 2.147 . . . . 8.63 105.604 171.779 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 113.516 0.932 . . . . 11.08 113.516 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.36 -93.43 0.15 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.588 -1.805 . . . . 4.91 108.588 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -155.34 159.87 40.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.507 0.723 . . . . 4.2 109.178 165.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.57 123.01 4.57 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 106.663 -2.575 . . . . 1.72 106.663 165.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.26 109.41 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 123.54 0.736 . . . . 3.12 109.347 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -104.23 87.3 2.72 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.226 -1.398 . . . . 4.22 107.226 166.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -82.06 91.93 6.73 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.586 -1.635 . . . . 4.35 106.586 160.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 pp -105.34 157.71 17.13 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.446 -0.797 . . . . 3.08 109.037 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 t -79.05 140.98 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 106.537 -1.653 . . . . 2.43 106.537 171.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.2 t -125.52 123.87 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 105.951 -1.87 . . . . 3.06 105.951 173.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.6 mtt-85 -112.56 152.72 28.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.396 -0.964 . . . . 8.33 108.396 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.49 -6.93 61.34 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.271 -0.738 . . . . 1.2 112.886 -171.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 57.0 mtm -69.94 74.46 0.45 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.892 1.346 . . . . 2.51 110.288 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -67.36 -34.48 77.38 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 119.255 -0.403 . . . . 2.34 111.757 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.1 p -152.95 172.86 16.17 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.09 0.859 . . . . 0.93 112.678 -173.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.34 -44.02 7.91 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.587 1.555 . . . . 2.18 111.854 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.2 m -58.9 -33.41 70.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.779 0.831 . . . . 1.84 112.387 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.2 m -71.05 -57.16 4.81 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 122.308 1.051 . . . . 0.93 109.252 170.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 71.5 t -49.26 -60.73 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.75 1.62 . . . . 2.2 110.297 -170.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.68 -28.54 67.77 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.784 -0.573 . . . . 1.14 111.389 -175.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -68.58 -39.26 81.04 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.503 -0.555 . . . . 6.78 109.503 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.2 mt -57.01 -61.29 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.125 -0.694 . . . . 2.14 109.125 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -45.97 -59.76 2.66 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.152 0.581 . . . . 3.36 111.343 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.8 t -56.56 -39.12 72.92 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.825 0.85 . . . . 1.22 111.917 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.8 t -70.46 -55.34 9.23 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.417 -1.327 . . . . 1.9 107.417 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.0 -35.47 80.33 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 121.96 -0.462 . . . . 3.63 110.589 -170.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.4 m -69.77 67.49 0.25 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.228 1.013 . . . . 3.14 110.238 171.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -158.39 -42.59 0.06 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 128.885 2.874 . . . . 6.05 109.249 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -66.69 110.89 3.41 Favored 'General case' 0 C--N 1.345 0.373 0 N-CA-C 108.786 -0.82 . . . . 2.2 108.786 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.76 -18.83 57.19 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.292 -0.88 . . . . 7.67 111.449 173.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -51.86 -39.64 48.23 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.717 0.675 . . . . 2.1 112.485 167.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -93.83 157.17 3.02 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 CA-C-N 117.588 0.694 . . . . 3.18 110.794 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.9 mt -105.98 -40.32 5.72 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.933 1.293 . . . . 2.85 109.685 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -153.6 156.95 38.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.044 0.384 . . . . 3.94 110.775 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.8 t -139.64 135.25 33.08 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.029 -1.841 . . . . 2.62 106.029 167.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 t -147.96 144.64 28.14 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.027 0.83 . . . . 3.25 110.277 154.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.4 m -113.22 166.57 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 123.939 0.895 . . . . 3.15 111.553 -168.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.93 139.76 29.32 Favored 'General case' 0 CA--C 1.52 -0.198 0 O-C-N 122.061 -0.399 . . . . 1.91 110.985 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 mp -72.0 -63.04 1.22 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.571 1.548 . . . . 4.66 109.845 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.76 -45.83 81.82 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 123.808 0.843 . . . . 3.47 111.141 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.25 -16.8 57.46 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.841 0.856 . . . . 2.34 110.857 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 55.12 62.57 2.44 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.125 1.37 . . . . 2.88 107.689 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.3 pttp -134.68 160.78 37.06 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.011 0.374 . . . . 2.9 112.011 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.12 112.9 9.54 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.388 1.475 . . . . 1.77 108.491 169.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -79.68 93.72 5.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.707 2.003 . . . . 1.74 107.006 169.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.0 mm -92.25 134.59 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.323 -1.362 . . . . 3.01 107.323 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -118.69 119.97 36.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 105.319 -2.104 . . . . 3.18 105.319 163.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -142.65 156.39 45.05 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 107.918 -1.141 . . . . 2.91 107.918 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -89.33 116.3 65.97 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.36 -0.829 . . . . 3.34 109.143 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.06 70.12 3.03 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.238 3.292 . . . . 2.89 110.976 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -161.66 -55.65 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 127.183 2.193 . . . . 3.28 106.675 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.4 pt -88.88 -11.19 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.906 0.883 . . . . 4.34 112.654 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 tt -158.35 156.31 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.078 -2.193 . . . . 2.88 105.078 171.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.9 -178.71 27.95 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 109.402 -1.479 . . . . 1.14 109.402 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.5 -40.75 9.89 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.866 1.71 . . . . 1.13 109.591 171.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -38.43 69.41 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 117.991 -1.004 . . . . 6.73 111.1 -171.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.57 -50.5 69.24 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.772 0.714 . . . . 2.46 110.284 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.6 mp -60.33 -47.54 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.204 -1.035 . . . . 3.07 108.204 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.4 mt -55.08 -43.44 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 116.325 -0.398 . . . . 2.37 110.954 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -32.04 73.29 Favored 'General case' 0 C--O 1.224 -0.273 0 O-C-N 120.858 -1.151 . . . . 5.82 111.034 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.2 m -63.8 -48.29 77.45 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.356 -0.979 . . . . 1.73 108.356 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 65.2 mt -54.37 -46.18 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.411 1.084 . . . . 2.58 110.458 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -55.57 -54.48 43.57 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.181 0.515 . . . . 2.06 110.362 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 t -56.76 -38.04 71.9 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 126.068 1.747 . . . . 2.15 111.722 -171.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.77 -92.6 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.605 -0.517 . . . . 3.57 109.605 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.87 30.13 0.33 Allowed Glycine 0 C--N 1.337 0.602 0 CA-C-O 118.712 -1.049 . . . . 1.16 112.802 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -129.81 160.74 32.53 Favored 'General case' 0 N--CA 1.458 -0.047 0 CA-C-N 118.797 1.299 . . . . 2.81 111.415 -159.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -104.6 154.38 20.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.571 1.549 . . . . 3.27 107.159 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.55 151.68 49.17 Favored 'General case' 0 C--O 1.23 0.054 0 C-N-CA 123.315 0.646 . . . . 2.23 110.176 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.1 m -152.17 104.85 3.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.275 -1.009 . . . . 2.41 108.275 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -59.3 130.71 48.27 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.279 -0.888 . . . . 3.68 109.964 174.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.9 t -78.35 66.64 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 121.812 0.815 . . . . 4.48 109.785 -171.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -104.54 -49.6 3.51 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.963 -1.495 . . . . 6.02 106.963 165.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 75.1 mt -136.14 134.27 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 106.889 -1.522 . . . . 8.88 106.889 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 . . . . . 0 C--O 1.256 1.437 0 N-CA-C 103.765 -2.679 . . . . 13.66 103.765 149.786 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 106.548 -1.649 . . . . 10.19 106.548 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.91 166.73 33.19 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 107.373 -2.291 . . . . 4.92 107.373 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -168.61 176.63 5.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.627 1.571 . . . . 5.57 107.314 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.29 66.27 0.52 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.288 -1.925 . . . . 2.48 108.288 164.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.8 t -78.57 126.02 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 107.943 -1.132 . . . . 4.01 107.943 170.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.1 tp -155.59 100.63 2.11 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.747 0.419 . . . . 4.22 111.387 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.76 89.39 4.01 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 122.766 1.269 . . . . 3.89 109.276 153.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pp -81.73 154.04 26.22 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 113.967 -1.469 . . . . 3.01 108.52 162.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.79 141.53 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.487 -2.042 . . . . 2.06 105.487 168.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.5 127.81 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 104.942 -2.244 . . . . 2.9 104.942 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.6 mtp-105 -120.34 160.82 22.26 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.205 0.911 . . . . 6.44 110.498 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.13 6.17 65.16 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.376 0.989 . . . . 1.16 111.691 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 73.4 mtp -74.39 62.79 1.0 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.569 1.148 . . . . 2.89 110.298 -177.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -69.66 -16.4 63.36 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.256 1.206 . . . . 1.83 114.256 -162.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.2 p -161.53 175.2 12.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 120.202 1.364 . . . . 0.65 110.678 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.96 -39.51 19.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.449 1.1 . . . . 1.78 111.718 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -59.67 -33.28 71.37 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.112 0.565 . . . . 3.26 111.3 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.8 m -71.65 -54.12 11.41 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.643 0.656 . . . . 0.69 109.674 170.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.7 t -47.09 -60.7 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.008 0.923 . . . . 1.82 110.821 -174.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.89 -31.12 68.76 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.321 -0.551 . . . . 0.8 111.624 -174.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -60.52 -51.98 67.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.902 -0.777 . . . . 3.94 108.902 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.6 mt -51.88 -58.94 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.202 0 C-N-CA 123.302 0.641 . . . . 2.03 109.453 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -53.93 -57.01 12.57 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 123.559 0.537 . . . . 3.73 109.845 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.8 t -53.29 -42.7 66.87 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.574 1.15 . . . . 1.4 111.427 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.4 m -70.78 -44.83 65.85 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.999 -0.741 . . . . 3.03 108.999 -175.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.0 mt -64.57 -55.66 18.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.459 -0.337 . . . . 3.67 110.818 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 t -56.68 -19.86 18.63 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.674 -0.641 . . . . 3.26 111.657 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -34.78 75.62 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.122 -0.986 . . . . 5.55 112.757 174.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -80.72 119.56 23.48 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.681 -1.229 . . . . 2.4 107.681 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -49.46 -28.92 5.83 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.883 1.068 . . . . 6.22 113.883 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.16 -22.37 70.73 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.017 -0.879 . . . . 1.25 113.227 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.3 mm -84.27 110.3 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.731 -1.211 . . . . 5.46 107.731 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.09 -33.28 29.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.07 0.548 . . . . 3.88 109.882 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -155.64 158.52 38.47 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.277 -0.638 . . . . 3.49 109.277 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.6 t -145.74 135.52 23.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.741 0.817 . . . . 2.95 108.897 168.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 t -126.13 94.67 4.16 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.858 -1.534 . . . . 2.64 106.858 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 m -78.7 148.43 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.61 1.564 . . . . 3.47 110.441 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.04 123.58 5.51 Favored 'General case' 0 C--N 1.339 0.13 0 O-C-N 122.088 -0.383 . . . . 2.09 111.097 164.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.02 -8.59 56.95 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.206 1.003 . . . . 2.36 113.001 174.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.56 -64.04 1.16 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.312 -0.996 . . . . 2.89 108.312 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 p -77.0 -5.92 50.6 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.849 -0.532 . . . . 2.86 110.455 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 57.57 57.49 4.29 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.889 1.276 . . . . 2.74 107.742 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 168.93 18.6 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.441 0.638 . . . . 2.77 111.68 -170.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -142.3 106.12 4.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.38 -1.736 . . . . 1.86 106.518 167.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -77.0 93.29 3.8 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 103.679 -2.711 . . . . 1.17 103.679 168.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.1 mt -89.33 143.88 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 106.577 -1.638 . . . . 2.89 106.577 174.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -124.16 119.79 30.44 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 105.181 -2.155 . . . . 4.14 105.181 163.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -139.89 162.37 35.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.324 0.649 . . . . 2.98 110.243 -174.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -93.28 109.87 42.86 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 107.803 -1.184 . . . . 3.47 107.803 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.43 60.51 7.56 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 124.331 3.354 . . . . 1.55 111.677 -167.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -171.5 -45.02 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.501 1.92 . . . . 3.01 108.21 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.0 mt -67.13 -38.2 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 108.889 -0.782 . . . . 4.16 108.889 170.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 tt -147.34 136.97 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.655 -1.609 . . . . 2.51 106.655 174.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.22 165.58 30.3 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.009 -0.837 . . . . 1.24 111.009 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -55.24 -47.34 26.67 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.24 1.96 . . . . 1.29 109.737 171.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -51.37 -37.83 50.08 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.314 0.646 . . . . 8.76 112.038 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -70.52 -47.75 58.93 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.284 -0.636 . . . . 2.38 109.284 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.4 mt -53.54 -52.09 36.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 122.846 0.458 . . . . 2.07 110.301 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.9 mm -51.81 -51.6 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.313 0.645 . . . . 3.05 109.655 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -56.22 -40.2 73.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.074 -0.391 . . . . 6.38 111.587 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.3 m -60.37 -56.71 18.2 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.084 -0.709 . . . . 2.06 109.084 175.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.2 mt -47.6 -53.18 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.607 1.163 . . . . 2.71 111.346 178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -59.27 -56.23 24.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.466 1.106 . . . . 2.22 110.362 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.3 t -59.12 -30.08 67.86 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.433 0.693 . . . . 2.28 111.841 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.9 mt -71.87 -74.86 0.14 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.349 0.522 . . . . 3.36 110.618 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.51 6.83 0.08 OUTLIER Glycine 0 CA--C 1.529 0.965 0 CA-C-O 117.862 -1.521 . . . . 1.15 116.231 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -130.85 158.31 40.52 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 120.2 2.0 . . . . 2.81 112.165 -146.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -92.55 167.53 11.87 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 107.509 -1.293 . . . . 3.08 107.509 170.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.25 169.16 24.83 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.901 0.381 . . . . 1.97 111.192 164.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.4 m -154.6 125.61 7.2 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.831 1.252 . . . . 2.18 108.059 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.37 68.64 1.55 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.516 0.727 . . . . 3.62 111.874 -175.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.6 p -62.53 -52.37 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 118.688 -0.672 . . . . 3.5 111.385 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.14 61.4 3.18 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.403 -0.962 . . . . 5.31 108.403 -176.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.9 tp -65.33 -47.07 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 114.716 -1.129 . . . . 9.51 113.217 -162.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--O 1.25 1.085 0 C-N-CA 124.403 1.081 . . . . 9.45 110.388 -169.262 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 119.36 -0.352 . . . . 8.09 111.486 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.3 165.26 24.98 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.124 0.42 . . . . 3.83 112.142 -169.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.418 ' OD2' ' NZ ' ' A' ' 47' ' ' LYS . 43.3 t0 -70.45 97.7 1.33 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.992 -0.744 . . . . 4.99 108.992 171.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.47 90.05 0.37 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 108.155 -1.978 . . . . 1.81 108.155 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.96 132.81 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.236 -1.394 . . . . 3.58 107.236 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.6 tp -148.48 143.31 26.62 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.293 -1.373 . . . . 4.04 107.293 172.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -133.72 113.82 12.75 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.322 -1.362 . . . . 3.98 107.322 172.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.79 153.68 39.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.379 0.672 . . . . 3.34 109.493 -179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.48 140.65 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.075 -1.454 . . . . 1.81 107.075 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.6 t -131.97 93.0 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 C-N-CA 127.062 2.145 . . . . 3.2 106.052 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.4 mtm105 -79.79 157.74 27.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.485 -0.561 . . . . 6.76 109.485 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.79 -6.08 56.92 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.403 1.002 . . . . 1.19 112.082 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 71.8 mtp -71.88 74.07 0.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.166 0.983 . . . . 3.3 110.958 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 t -70.76 -17.15 62.8 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 117.277 -1.344 . . . . 2.1 114.257 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.2 p -163.78 176.15 9.81 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 120.727 1.603 . . . . 0.71 111.381 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.65 -38.41 21.01 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.805 1.242 . . . . 1.7 111.892 175.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 t -49.07 -48.57 44.05 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 109.425 -0.583 . . . . 2.8 109.425 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.6 m -62.32 -46.03 90.58 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 122.258 0.223 . . . . 0.89 110.773 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 80.2 t -52.49 -65.1 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 109.921 -0.4 . . . . 2.4 109.921 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -30.58 67.67 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 118.986 -1.085 . . . . 1.11 111.842 -172.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -53.19 -53.43 50.76 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.37 -0.604 . . . . 4.29 109.37 169.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.9 mt -60.65 -58.37 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 118.461 -0.781 . . . . 1.86 110.024 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -49.51 -55.46 13.25 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.994 0.816 . . . . 3.88 110.548 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.1 t -56.58 -38.98 72.73 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.326 1.05 . . . . 1.64 111.388 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.3 t -71.13 -36.35 72.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.476 -0.765 . . . . 2.65 109.845 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.1 mt -66.99 -62.19 1.56 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 118.488 -0.768 . . . . 4.26 110.488 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.1 p -70.62 65.66 0.32 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.249 1.419 . . . . 2.79 111.697 -172.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.8 tptp -176.48 -48.2 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.55 1.14 . . . . 4.8 108.167 -151.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -73.29 90.59 1.64 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.897 -1.149 . . . . 2.55 107.897 166.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -51.76 105.1 0.1 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.526 -0.546 . . . . 7.6 109.526 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.79 -43.9 0.7 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 108.727 -1.749 . . . . 2.22 108.727 -164.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.45 131.57 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 105.436 -2.061 . . . . 3.78 105.436 161.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.7 mt -94.24 -42.72 8.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.909 1.284 . . . . 2.59 108.351 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -149.04 154.24 39.01 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.441 -0.578 . . . . 3.84 109.441 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.3 p -143.93 152.71 41.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.381 1.472 . . . . 3.05 108.306 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.9 m -155.25 82.78 1.06 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.673 1.189 . . . . 2.71 108.396 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.56 154.24 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 125.086 1.354 . . . . 3.74 108.871 174.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.04 130.06 11.82 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 120.736 -1.228 . . . . 1.8 110.786 172.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.59 -32.99 72.08 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.316 0.507 . . . . 2.98 110.159 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -47.59 -43.48 25.6 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.621 1.168 . . . . 2.31 112.449 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 t -121.76 1.97 10.0 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.706 0.403 . . . . 3.57 111.975 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 52.17 66.29 1.25 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.481 1.513 . . . . 2.81 108.46 174.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.48 166.02 27.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.427 1.091 . . . . 3.1 108.323 -175.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.48 108.85 12.04 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.832 2.053 . . . . 1.98 106.255 166.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -80.54 132.9 35.73 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 103.746 -2.687 . . . . 1.52 103.746 159.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.8 pt -138.84 151.27 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 106.796 -1.557 . . . . 4.71 106.796 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.418 ' NZ ' ' OD2' ' A' ' 3' ' ' ASP . 33.9 mttm -139.28 101.01 4.15 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 102.802 -3.036 . . . . 3.49 102.802 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -129.91 149.01 51.83 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.523 0.729 . . . . 2.76 109.205 -169.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -82.96 117.79 69.69 Favored Pre-proline 0 N--CA 1.451 -0.423 0 N-CA-C 107.809 -1.182 . . . . 2.87 107.809 173.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.11 -26.99 78.5 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.443 1.428 . . . . 1.93 111.625 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -80.8 42.04 0.6 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.145 0.884 . . . . 4.27 111.363 -174.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -175.5 -43.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.682 1.593 . . . . 3.86 110.277 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 tt -132.67 124.03 50.32 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 108.108 -1.071 . . . . 2.5 108.108 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.4 173.59 51.11 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 110.679 -0.968 . . . . 1.2 110.679 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.63 -54.73 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.45 2.1 . . . . 1.06 110.263 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -50.46 -42.94 54.97 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.297 0.639 . . . . 6.99 110.944 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.51 -49.32 18.68 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.816 2.046 . . . . 2.68 110.154 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 54.7 mt -70.32 -47.59 65.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.234 0.614 . . . . 2.54 110.312 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.3 mm -50.03 -47.24 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 118.132 0.424 . . . . 3.46 110.858 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -45.17 -44.99 11.25 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.316 1.446 . . . . 3.79 111.445 173.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.0 m -58.89 -55.09 39.61 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.565 -0.902 . . . . 2.18 108.565 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.5 -53.67 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.197 0.599 . . . . 3.16 109.966 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -61.78 -48.34 81.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.618 -0.433 . . . . 3.03 110.22 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.6 t -55.65 -48.41 75.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.174 0.59 . . . . 1.79 111.549 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.1 mt -54.97 -59.51 4.65 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.903 -0.498 . . . . 3.36 112.316 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.68 -0.01 0.06 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 116.961 1.544 . . . . 1.57 116.961 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -131.94 175.18 9.44 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 119.897 1.849 . . . . 2.95 113.371 -139.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -125.68 103.44 7.83 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.685 1.194 . . . . 4.12 107.977 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.79 157.27 21.03 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.96 0.356 . . . . 2.42 111.96 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.9 t -154.45 133.09 12.12 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.424 1.09 . . . . 2.97 108.315 165.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.6 mt -58.1 155.94 10.33 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.026 -0.731 . . . . 3.38 109.026 163.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.3 t -137.07 -62.17 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 107.396 -1.335 . . . . 3.41 107.396 169.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.7 tttp 67.34 -66.52 0.2 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.934 1.694 . . . . 5.54 111.961 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.275 6.7 tp 44.9 55.27 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.971 1.708 . . . . 6.76 111.618 -172.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 . . . . . 0 C--O 1.248 1.021 0 N-CA-C 103.4 -2.815 . . . . 9.92 103.4 166.77 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 107.925 -1.139 . . . . 9.19 107.925 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 124.52 -55.76 0.7 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 105.567 -3.013 . . . . 6.51 105.567 -165.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -44.5 151.03 0.29 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.492 -0.854 . . . . 6.06 109.526 138.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.49 -75.46 0.15 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.037 -1.625 . . . . 4.32 109.037 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 p -158.04 166.54 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.754 -1.572 . . . . 3.58 106.754 169.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 tp -133.27 128.45 35.85 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.468 -1.308 . . . . 3.14 107.468 151.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -121.89 133.28 54.86 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.385 1.474 . . . . 3.72 108.133 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.98 157.12 41.29 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.378 -0.601 . . . . 3.7 109.378 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.61 145.21 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.263 -1.754 . . . . 1.87 106.263 169.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.8 137.24 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 125.672 1.589 . . . . 2.92 108.467 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -130.36 163.19 27.41 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.093 0.957 . . . . 7.06 108.779 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.67 -15.4 63.22 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.455 0.55 . . . . 1.41 112.275 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.2 mtm -69.14 78.98 0.34 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.208 1.004 . . . . 2.42 110.097 175.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 t -71.46 -16.75 62.38 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.753 -1.117 . . . . 2.34 113.097 -174.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.5 p -161.72 172.68 15.81 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.94 1.245 . . . . 1.04 110.792 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.16 -41.12 25.98 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.782 1.233 . . . . 1.74 111.536 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.5 m -61.01 -29.29 69.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.523 0.729 . . . . 2.19 112.205 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.7 m -72.03 -56.62 5.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.161 0.892 . . . . 0.81 110.03 166.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.3 t -43.71 -62.35 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.588 1.155 . . . . 2.19 110.781 -173.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -25.31 63.53 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 120.586 -0.446 . . . . 0.93 111.898 -175.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -67.88 -41.17 83.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.205 -0.665 . . . . 3.78 109.205 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 mt -54.94 -59.03 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.494 -0.558 . . . . 2.21 109.494 173.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -52.97 -51.2 62.31 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.548 0.613 . . . . 3.72 111.388 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.2 t -54.93 -37.38 66.33 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.143 0.977 . . . . 1.71 111.205 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.3 t -71.29 -57.87 4.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.736 -1.209 . . . . 2.06 107.736 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.0 mt -51.17 -49.66 60.47 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.014 0.925 . . . . 3.68 112.085 -174.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.3 t -56.77 -17.92 10.85 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.456 -0.777 . . . . 3.74 112.61 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -30.45 71.3 Favored 'General case' 0 C--N 1.343 0.287 0 O-C-N 121.139 -0.976 . . . . 6.62 112.34 175.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -81.18 113.22 19.18 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 106.543 -1.651 . . . . 2.18 106.543 170.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -55.84 -26.33 46.18 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.524 0.565 . . . . 7.48 112.524 -173.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.82 -22.26 59.62 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.818 0.723 . . . . 1.37 113.437 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.2 mm -79.59 97.88 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.282 -1.377 . . . . 5.4 107.282 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.3 mt -77.68 -34.78 52.84 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.024 -0.732 . . . . 2.67 109.024 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -148.75 158.55 44.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.591 -0.892 . . . . 3.71 108.591 165.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.6 p -145.26 138.02 26.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.963 1.705 . . . . 3.22 107.717 173.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 t -142.16 106.93 4.87 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.496 -1.668 . . . . 2.27 106.496 170.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.9 m -84.87 171.78 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.159 0.436 . . . . 2.67 109.936 170.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -157.12 141.3 16.36 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.063 -0.717 . . . . 2.08 109.063 152.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.98 -38.07 53.92 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 108.521 -0.918 . . . . 3.43 108.521 166.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.36 -38.96 69.49 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.582 0.753 . . . . 2.78 110.609 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 m -112.1 14.52 20.71 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.389 1.076 . . . . 2.89 110.284 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.3 m120 32.29 53.08 0.29 Allowed 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 126.392 1.877 . . . . 2.33 113.512 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.68 168.47 17.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 122.864 0.465 . . . . 3.48 111.29 -171.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.26 135.59 32.46 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.29 -1.323 . . . . 1.65 109.22 150.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -110.4 107.34 17.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 104.288 -2.486 . . . . 1.42 104.288 168.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.74 146.56 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 105.889 -1.893 . . . . 3.05 105.889 175.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -113.16 93.21 4.3 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 105.307 -2.108 . . . . 3.65 105.307 170.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.78 150.89 20.87 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.318 1.047 . . . . 4.44 112.755 -174.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -87.22 126.5 62.41 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 107.066 -1.457 . . . . 3.09 107.066 150.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.02 -19.62 20.22 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.877 3.052 . . . . 1.82 113.447 -171.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -93.05 -45.1 8.07 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.874 -0.788 . . . . 3.44 108.874 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.1 mt -68.12 -35.76 72.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 109.553 -0.536 . . . . 3.96 109.553 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 mm -130.71 116.18 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.041 -1.466 . . . . 2.76 107.041 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.43 152.64 49.62 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 108.234 -1.946 . . . . 1.03 108.234 169.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -55.66 -38.55 94.12 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.028 1.819 . . . . 1.8 111.013 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -67.22 -23.83 65.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 118.841 -0.599 . . . . 7.8 112.408 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -65.59 -35.64 81.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 120.702 1.592 . . . . 2.44 112.285 -170.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.4 mt -53.47 -48.05 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 109.176 -0.676 . . . . 2.39 109.176 171.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.0 mt -62.69 -49.02 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.705 0.802 . . . . 2.54 109.733 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -48.89 -44.6 40.18 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.132 0.878 . . . . 4.98 110.66 175.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.6 m -65.0 -56.63 11.99 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.302 -0.629 . . . . 1.96 109.302 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.7 mt -46.89 -49.87 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.454 1.102 . . . . 2.62 110.88 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -58.1 -53.76 54.63 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.797 1.239 . . . . 2.15 111.0 174.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.2 p -60.06 -29.99 68.91 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.316 0.488 . . . . 3.24 112.316 -172.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.38 -97.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.59 -0.522 . . . . 3.9 109.59 167.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.29 35.94 0.44 Allowed Glycine 0 C--N 1.337 0.607 0 O-C-N 121.167 -0.958 . . . . 1.25 112.403 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -131.57 159.37 38.42 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.465 1.132 . . . . 3.68 110.283 -165.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -99.5 155.86 17.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.597 -0.89 . . . . 3.66 108.597 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.72 162.47 35.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.349 0.26 . . . . 2.3 110.953 162.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.0 m -155.44 116.93 4.0 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.79 0.836 . . . . 2.34 109.847 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.42 65.58 0.44 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.029 0.932 . . . . 3.22 110.743 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.8 p -74.46 65.41 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.406 1.082 . . . . 4.41 108.888 174.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -130.07 140.08 50.88 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.52 1.528 . . . . 5.16 107.966 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.6 mt -125.16 132.22 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 103.916 -2.624 . . . . 6.85 103.916 167.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 124.698 1.199 . . . . 11.12 110.114 -170.489 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 106.434 -1.691 . . . . 12.28 106.434 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.01 156.72 27.11 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 106.536 -2.626 . . . . 4.12 106.536 174.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t70 50.75 -139.6 0.91 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.401 -0.963 . . . . 4.04 108.401 -165.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.48 101.43 0.57 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 106.626 -2.59 . . . . 2.1 106.626 -172.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.5 p -129.57 134.89 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.458 -1.312 . . . . 3.13 107.458 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.4 tp -145.29 113.3 6.47 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.919 -1.141 . . . . 2.94 107.919 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -94.0 133.23 37.67 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.681 -0.488 . . . . 3.32 109.681 165.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -131.94 148.73 52.54 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.558 -1.275 . . . . 3.18 107.558 172.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 t -79.71 142.72 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 106.174 -1.788 . . . . 1.92 106.174 162.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 p -122.73 96.12 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 125.682 1.593 . . . . 3.55 107.678 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -80.87 59.76 3.85 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.388 -0.82 . . . . 8.26 109.768 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.57 0.42 0.21 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.988 -0.896 . . . . 2.39 114.419 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.5 mtm -77.13 76.88 3.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.411 1.605 . . . . 2.55 109.735 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -75.67 -11.63 60.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.886 -1.055 . . . . 2.68 112.963 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.8 p -160.75 172.51 16.92 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 120.008 1.276 . . . . 1.32 109.2 172.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.23 -44.98 11.52 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.459 1.104 . . . . 2.35 111.466 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -50.38 -40.94 51.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.745 0.418 . . . . 2.75 110.846 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.0 m -58.97 -34.6 71.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.41 0.522 . . . . 1.14 112.41 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.66 -67.94 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.738 0.78 . . . . 2.21 109.19 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.76 -32.25 73.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 118.399 -0.81 . . . . 1.58 111.279 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -53.85 -52.84 59.11 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.767 1.167 . . . . 3.84 109.975 172.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.5 mt -54.93 -64.3 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 109.032 -0.729 . . . . 1.91 109.032 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -56.42 -54.73 42.23 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.907 -0.717 . . . . 4.22 110.164 -171.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -51.64 -43.83 62.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.464 1.106 . . . . 1.58 111.98 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.4 t -70.67 -33.28 70.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.208 -0.933 . . . . 1.94 109.852 -175.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.01 -48.15 38.84 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 111.745 0.276 . . . . 3.61 111.745 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.2 p -60.29 -18.38 48.91 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.737 -1.227 . . . . 2.83 113.671 -165.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -39.3 63.11 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.138 0.792 . . . . 6.16 113.138 168.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -60.92 167.98 2.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.382 0.992 . . . . 2.5 109.13 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.66 -18.53 12.75 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.773 -0.579 . . . . 7.86 111.869 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.27 -22.8 78.49 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 118.63 0.65 . . . . 1.29 112.015 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.7 157.92 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 117.94 0.87 . . . . 4.09 109.785 174.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.5 mt -119.17 -46.43 2.51 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.02 1.328 . . . . 2.78 109.428 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -155.44 153.7 30.76 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 117.728 -1.13 . . . . 3.31 108.641 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.6 t -131.69 77.06 1.75 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.362 1.065 . . . . 2.95 109.472 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.51 85.05 3.89 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 120.75 -1.219 . . . . 4.03 109.82 -168.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.89 138.45 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 128.039 2.536 . . . . 3.9 111.841 -171.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.39 124.3 10.63 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 118.635 0.652 . . . . 2.11 111.629 172.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.4 mt -47.85 -43.79 28.59 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.97 0.908 . . . . 3.63 109.655 158.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.7 -24.71 1.48 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.49 1.116 . . . . 2.71 113.723 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 t -139.5 25.06 2.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.965 0.802 . . . . 3.78 112.438 169.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.2 m120 40.6 45.91 2.08 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.821 2.048 . . . . 1.88 112.816 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.99 170.81 14.82 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 118.543 0.611 . . . . 2.92 111.391 -171.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.11 130.19 23.34 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 125.176 1.547 . . . . 2.08 109.614 164.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -97.98 97.7 9.14 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.043 1.737 . . . . 1.12 107.618 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.5 mp -86.94 112.78 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 106.285 -1.746 . . . . 2.45 106.285 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -88.21 135.17 33.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.073 -1.825 . . . . 3.36 106.073 157.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -162.74 175.05 11.71 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.416 1.086 . . . . 2.86 109.253 -171.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -106.34 125.15 33.63 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 107.064 -1.458 . . . . 3.09 107.064 162.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.67 -6.36 18.11 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.696 2.93 . . . . 1.77 113.567 -171.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -108.33 -34.97 6.65 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.643 1.177 . . . . 3.93 109.074 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.0 mt -70.32 -33.51 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 O-C-N 121.765 -0.584 . . . . 4.55 110.648 169.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 tt -140.2 129.36 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.97 -1.122 . . . . 2.43 107.97 168.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.53 176.16 42.53 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.622 0.63 . . . . 1.81 111.902 -173.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.91 -57.0 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.797 2.332 . . . . 3.11 111.27 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.436 HH21 ' CD ' ' A' ' 63' ' ' GLU . 71.8 ttt180 -65.42 -33.65 76.46 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 117.958 -1.02 . . . . 7.23 110.695 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -35.6 -57.5 0.63 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.766 1.626 . . . . 2.32 111.486 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.6 mt -52.09 -58.89 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.937 1.295 . . . . 1.9 110.868 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.2 mm -50.66 -62.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 124.859 1.263 . . . . 3.01 109.409 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -49.68 -34.82 19.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.297 1.839 . . . . 5.64 112.03 176.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.2 m -65.34 -48.4 73.12 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.703 1.138 . . . . 1.91 108.82 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 59.3 mt -57.37 -47.07 85.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.584 0.753 . . . . 2.22 111.109 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.436 ' CD ' HH21 ' A' ' 56' ' ' ARG . 49.7 mt-10 -51.46 -57.73 8.19 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.956 0.902 . . . . 2.28 109.261 172.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 t -65.77 -27.31 68.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.394 1.078 . . . . 2.04 112.291 -171.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.0 mt -65.83 -81.32 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.859 0.754 . . . . 3.48 110.04 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.25 25.94 0.26 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.599 -1.112 . . . . 0.93 113.235 171.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -134.29 176.44 8.6 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 118.825 1.313 . . . . 3.03 112.276 -153.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -127.41 136.34 51.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.357 -2.09 . . . . 3.35 105.357 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.19 153.67 35.92 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.27 1.028 . . . . 1.88 110.391 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.1 m -154.67 132.0 11.14 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.757 0.823 . . . . 2.18 109.6 170.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mp -79.58 58.03 2.61 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.251 1.42 . . . . 4.61 109.017 -175.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.6 m -75.57 77.26 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 122.187 0.994 . . . . 4.81 111.192 -171.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -57.68 -27.88 63.28 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.561 -0.712 . . . . 6.97 111.109 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.7 mm -135.31 149.39 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 105.777 -1.935 . . . . 6.94 105.777 169.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 . . . . . 0 C--O 1.25 1.081 0 N-CA-C 104.225 -2.509 . . . . 13.14 104.225 157.701 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 105.515 -2.032 . . . . 12.63 105.515 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.63 160.74 40.48 Favored Glycine 0 CA--C 1.536 1.387 0 N-CA-C 107.765 -2.134 . . . . 5.08 107.765 135.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.401 ' OD1' ' NZ ' ' A' ' 47' ' ' LYS . 21.3 t0 -179.7 174.9 0.91 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.058 2.543 . . . . 4.22 105.172 175.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.3 -172.7 42.98 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 109.651 -1.38 . . . . 1.88 109.651 173.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 p -145.09 90.42 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.389 -0.967 . . . . 3.46 108.389 172.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -78.51 80.01 4.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.779 -1.934 . . . . 4.26 105.779 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -84.7 123.73 30.71 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 114.071 -1.422 . . . . 3.54 108.802 168.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 157.78 39.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 123.648 0.592 . . . . 3.5 110.617 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -79.06 115.77 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 106.476 -1.676 . . . . 1.87 106.476 170.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.04 73.55 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 105.952 -1.87 . . . . 3.31 105.952 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.03 100.98 5.09 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.904 -1.887 . . . . 8.34 105.904 -166.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.92 -43.65 0.24 Allowed Glycine 0 C--N 1.334 0.441 0 O-C-N 120.343 -1.473 . . . . 2.14 113.548 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.31 75.74 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.105 1.15 . . . . 3.65 114.105 -173.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.2 t -69.35 -13.1 62.19 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.723 1.379 . . . . 2.24 114.723 -166.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.7 p -155.12 170.33 22.05 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.078 1.308 . . . . 0.87 109.931 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.35 -45.73 8.98 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.962 1.305 . . . . 1.78 111.542 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -54.1 -39.53 66.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.339 1.456 . . . . 3.04 112.029 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.1 m -71.98 -55.12 8.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.994 -0.373 . . . . 0.72 109.994 170.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.7 t -47.56 -60.62 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 123.655 0.782 . . . . 1.95 110.623 -173.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.72 -24.66 65.4 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.657 -0.652 . . . . 0.89 111.863 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -67.14 -48.26 68.58 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.773 -0.825 . . . . 4.45 108.773 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.8 mt -57.4 -57.12 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 118.507 0.594 . . . . 2.01 109.432 174.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -53.53 -50.92 64.46 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.44 0.638 . . . . 3.53 110.386 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.0 t -56.72 -51.64 68.05 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 118.326 -0.845 . . . . 1.33 109.87 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 t -57.33 -44.61 84.4 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 119.494 1.043 . . . . 2.43 108.514 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.1 mt -56.44 -53.13 61.06 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.337 -0.847 . . . . 4.06 111.795 175.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.7 p -57.78 -10.41 1.65 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.923 1.083 . . . . 2.68 113.923 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -33.47 69.2 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.427 1.012 . . . . 8.11 110.863 173.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -78.65 148.44 33.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.614 -0.884 . . . . 2.5 108.614 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -95.34 -24.41 16.75 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.172 0.589 . . . . 7.86 111.29 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.31 -19.97 76.38 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 122.165 -0.335 . . . . 1.23 112.388 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -84.05 127.71 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 105.932 -1.877 . . . . 3.22 105.932 164.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.91 -38.0 33.48 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.442 -0.577 . . . . 3.8 109.442 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -155.48 153.54 30.45 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.752 -1.203 . . . . 3.78 107.752 -175.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.8 p -139.12 146.76 41.06 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 123.744 0.652 . . . . 3.12 109.359 168.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 t -144.5 105.17 4.15 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.154 -1.424 . . . . 2.05 107.154 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 m -90.45 159.05 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.703 0.801 . . . . 2.71 110.132 174.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.68 130.31 9.09 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 121.745 -0.597 . . . . 1.71 110.757 163.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 pp -68.1 -23.61 64.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 123.552 0.532 . . . . 2.31 111.957 165.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.43 -47.63 72.62 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.377 0.535 . . . . 1.99 110.084 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.99 -17.3 20.15 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.176 0.99 . . . . 2.61 112.144 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.56 38.26 25.35 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.883 1.273 . . . . 2.59 109.29 -162.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.55 160.83 16.81 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.311 0.645 . . . . 3.43 110.027 -173.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -134.4 122.21 22.24 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.147 -1.427 . . . . 1.65 107.147 159.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -96.36 108.89 21.48 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 104.455 -2.424 . . . . 1.11 104.455 166.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.8 mt -120.33 104.49 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.36 -1.348 . . . . 2.78 107.36 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' NZ ' ' OD1' ' A' ' 3' ' ' ASP . 6.3 mtpm? -79.97 138.68 37.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.367 -1.346 . . . . 3.59 107.367 172.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -159.58 147.78 17.44 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 119.196 -0.43 . . . . 3.11 110.828 -159.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -85.83 103.74 4.2 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 106.356 -1.72 . . . . 3.15 106.356 168.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.26 -54.64 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.573 2.182 . . . . 2.54 111.422 -165.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -53.83 -44.24 70.09 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.007 1.323 . . . . 3.38 111.819 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.2 -47.01 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 122.377 0.271 . . . . 4.04 110.624 -173.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -48.19 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 117.923 0.329 . . . . 3.98 110.87 -171.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.93 116.27 2.42 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 110.41 -1.076 . . . . 2.2 110.41 -170.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -59.95 -39.38 71.63 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 119.955 1.878 . . . . 1.34 109.653 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.4 HH21 ' CG ' ' A' ' 57' ' ' ASP . 22.5 ttp180 -37.89 -53.45 1.32 Allowed 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 125.378 1.471 . . . . 9.93 110.815 164.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.4 ' CG ' HH21 ' A' ' 56' ' ' ARG . 15.0 m-20 -73.74 -36.05 65.12 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.996 0.918 . . . . 3.01 113.159 -174.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.1 mt -53.48 -48.94 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.356 -0.84 . . . . 1.86 109.636 166.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.5 mt -58.71 -47.2 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 109.495 -0.558 . . . . 2.62 109.495 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -50.21 -42.49 51.58 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.692 0.678 . . . . 3.98 111.033 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.4 m -60.48 -54.48 45.06 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.279 0.945 . . . . 2.37 109.092 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.1 mt -52.13 -51.64 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.382 1.073 . . . . 2.66 111.758 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -60.06 -56.99 14.81 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.257 1.023 . . . . 2.24 110.463 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -52.93 -42.95 65.89 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.629 1.172 . . . . 2.36 110.632 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.5 mt -62.56 -70.91 0.18 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.437 -0.316 . . . . 3.36 110.573 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.64 -10.34 0.04 OUTLIER Glycine 0 CA--C 1.531 1.044 0 N-CA-C 117.614 1.805 . . . . 1.18 117.614 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -133.23 156.35 47.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.845 1.823 . . . . 2.97 111.533 -137.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -80.23 159.04 26.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.179 0.992 . . . . 3.63 108.551 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.15 141.96 50.63 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.577 1.151 . . . . 2.75 109.432 172.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.7 m -153.37 110.0 3.4 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.543 0.737 . . . . 2.15 109.72 170.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -58.77 130.97 49.45 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.768 0.713 . . . . 4.29 109.804 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.34 -94.41 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.241 -1.022 . . . . 3.42 108.241 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.2 mttp 70.22 -53.87 0.63 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.981 1.712 . . . . 6.17 111.927 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.19 165.52 17.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 124.326 1.051 . . . . 6.22 108.769 168.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--O 1.255 1.358 0 N-CA-C 104.48 -2.415 . . . . 11.07 104.48 174.969 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 109.244 -0.65 . . . . 7.84 109.244 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.24 67.06 1.84 Allowed Glycine 0 CA--C 1.527 0.811 0 N-CA-C 109.384 -1.486 . . . . 3.9 109.384 170.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -149.83 156.7 42.25 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.318 1.047 . . . . 4.1 108.996 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.72 163.37 27.63 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.813 -1.315 . . . . 2.13 109.813 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 m -109.77 101.22 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.856 1.662 . . . . 3.15 108.975 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.33 106.19 18.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.672 -1.233 . . . . 4.26 107.672 175.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -107.46 103.4 12.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.268 -1.012 . . . . 3.61 108.268 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.3 mt -106.09 144.58 32.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.081 0.953 . . . . 3.42 108.458 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.49 128.22 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 104.721 -2.326 . . . . 2.14 104.721 151.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 p -101.23 85.31 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.014 1.326 . . . . 3.72 107.554 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -83.27 59.25 4.9 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.312 1.045 . . . . 6.97 109.633 -169.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.67 -44.01 0.03 OUTLIER Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.849 -0.691 . . . . 1.87 112.959 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.18 131.78 52.04 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.674 -0.861 . . . . 3.62 108.674 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.2 p -94.08 -57.32 2.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.053 0.541 . . . . 3.53 110.317 -175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 p -134.44 176.97 8.13 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.477 0.711 . . . . 0.76 112.2 -160.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.43 -42.99 10.95 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.674 1.189 . . . . 1.73 111.9 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -54.4 -48.45 71.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.967 0.507 . . . . 2.78 109.72 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.6 m -67.29 -41.43 85.42 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 122.091 -0.381 . . . . 0.82 111.053 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.1 t -53.5 -63.96 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 122.591 0.357 . . . . 1.7 110.408 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.261 0.1 OUTLIER -70.68 -25.89 63.18 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.991 -1.068 . . . . 0.96 112.356 -175.639 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -55.01 -52.46 63.09 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.629 0.65 . . . . 4.38 109.703 167.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.1 mt -52.48 -63.83 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.235 0 N-CA-C 108.876 -0.787 . . . . 1.89 108.876 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -56.54 -51.38 68.76 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 120.595 -0.442 . . . . 3.58 111.366 -171.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.6 t -58.19 -43.46 87.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.5 -0.762 . . . . 1.52 110.408 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 t -63.18 -56.19 18.8 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 120.022 1.283 . . . . 2.05 108.1 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.41 -45.08 89.08 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.303 -0.862 . . . . 3.51 112.242 -175.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.8 p -58.59 -17.19 19.86 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.943 0.72 . . . . 2.73 112.943 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -65.93 -28.37 68.87 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.246 0.93 . . . . 7.7 111.088 173.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -83.88 105.23 14.61 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 108.565 -0.902 . . . . 3.03 108.565 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -57.11 -17.94 12.76 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.526 0.936 . . . . 6.89 113.526 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.8 -27.77 70.63 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.185 -0.786 . . . . 1.2 112.122 172.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.38 145.31 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 119.186 1.493 . . . . 3.15 108.38 169.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.4 mt -109.57 -39.42 5.16 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.678 1.191 . . . . 3.1 109.695 -168.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -155.16 149.54 26.13 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.715 -1.217 . . . . 3.09 107.715 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.9 m -124.89 147.39 48.84 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.679 -1.23 . . . . 2.29 107.679 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 m -154.48 85.04 1.12 Allowed 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.982 1.313 . . . . 2.62 108.921 172.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.11 157.74 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 123.291 0.636 . . . . 2.92 110.678 172.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.33 144.94 22.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.063 0.545 . . . . 1.76 110.332 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -85.53 -41.33 15.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.956 1.302 . . . . 3.9 108.675 170.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.45 -16.42 3.69 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.071 1.348 . . . . 2.77 112.977 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.6 m -140.79 20.03 2.33 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.432 -0.793 . . . . 2.61 110.392 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.3 m120 36.77 47.27 0.54 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.712 2.005 . . . . 2.24 113.834 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.45 171.7 13.93 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 117.986 0.357 . . . . 2.96 111.386 -165.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.59 108.03 5.56 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.54 2.336 . . . . 1.79 106.211 173.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -87.42 114.48 24.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.722 -2.325 . . . . 1.1 104.722 162.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 67.5 mt -123.16 111.5 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.399 -2.074 . . . . 3.08 105.399 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.96 134.23 36.24 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.014 -1.476 . . . . 3.6 107.014 170.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -148.32 149.57 32.06 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 117.815 0.279 . . . . 4.21 111.365 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -80.73 115.09 53.17 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 107.42 -1.326 . . . . 3.03 107.42 167.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -73.43 -13.11 25.24 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.124 2.55 . . . . 1.61 113.175 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -88.92 -44.87 10.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.513 -0.921 . . . . 2.93 108.513 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.5 mt -72.2 -42.26 66.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 122.848 0.459 . . . . 3.81 110.556 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 mm -125.14 115.47 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.18 -1.785 . . . . 2.48 106.18 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.58 148.51 51.24 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 108.178 -1.969 . . . . 1.09 108.178 171.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -57.44 -40.92 77.41 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 CA-C-N 119.493 1.646 . . . . 1.41 110.37 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -56.35 -28.56 59.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.553 -0.737 . . . . 7.26 112.153 174.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -71.7 -39.24 70.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 120.123 1.329 . . . . 2.5 112.046 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.5 mt -56.48 -47.46 81.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.604 -0.887 . . . . 2.09 108.604 171.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.6 mt -61.26 -45.23 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 118.851 -0.595 . . . . 2.29 110.204 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -50.85 -43.55 59.31 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.371 0.987 . . . . 4.77 110.201 173.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.6 m -65.54 -54.54 26.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.35 -0.981 . . . . 1.88 108.35 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.8 mt -49.02 -53.41 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.026 0.93 . . . . 2.43 110.823 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -52.48 -53.58 43.78 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.854 0.861 . . . . 2.18 110.145 174.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.1 t -62.73 -26.53 68.73 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 117.788 -1.101 . . . . 1.81 113.091 -174.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.16 -91.37 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.854 1.206 . . . . 3.33 109.937 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.98 40.89 0.42 Allowed Glycine 0 CA--C 1.524 0.604 0 O-C-N 120.936 -1.103 . . . . 1.16 111.646 174.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -138.82 176.44 8.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 117.954 0.877 . . . . 4.28 110.124 -162.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -133.64 164.61 26.82 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.434 -1.321 . . . . 4.22 107.434 167.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.12 166.78 23.27 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.97 0.908 . . . . 2.27 112.118 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.9 m -150.76 155.54 39.47 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 106.708 -1.589 . . . . 2.05 106.708 160.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp -71.63 144.5 49.4 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.557 1.072 . . . . 3.97 109.243 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 69.7 t -69.98 -65.9 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.754 -0.832 . . . . 5.54 108.754 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 165.83 18.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.233 -0.654 . . . . 4.71 109.233 173.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.9 pt -67.23 125.09 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.784 -1.561 . . . . 7.39 106.784 161.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 C--O 1.253 1.246 0 C-N-CA 124.86 1.264 . . . . 12.32 110.791 -175.291 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.407 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 4.9 ttm . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 107.493 -1.299 . . . . 12.21 107.493 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.37 64.36 2.49 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 109.193 -1.563 . . . . 6.96 109.193 167.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 1' ' ' MET . 20.5 m-20 -50.56 -60.63 2.83 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.844 1.258 . . . . 9.53 110.835 -168.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.76 -64.01 2.67 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.455 -1.058 . . . . 3.33 110.455 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -119.81 136.12 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 126.052 1.741 . . . . 3.03 110.407 -176.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.28 112.71 5.3 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 123.958 0.903 . . . . 4.13 108.822 176.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.62 113.8 27.61 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 122.992 0.517 . . . . 2.95 109.989 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.2 mt -86.51 157.07 19.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 124.645 1.215 . . . . 3.47 108.076 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.62 142.07 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 105.632 -1.988 . . . . 2.03 105.632 148.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.8 t -135.06 114.25 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 126.314 1.846 . . . . 3.03 106.821 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -110.37 170.97 7.73 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.73 1.212 . . . . 7.88 110.466 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.15 -47.78 2.42 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.723 -0.951 . . . . 1.3 110.723 -173.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -51.4 -45.71 62.63 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 121.964 0.888 . . . . 3.11 112.071 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.317 9.3 t 58.71 -63.25 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.986 2.114 . . . . 3.34 115.32 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 p -110.6 162.13 15.03 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 120.271 1.396 . . . . 1.67 112.82 -163.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.7 -48.17 5.5 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 125.58 1.552 . . . . 2.49 111.516 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -51.51 -48.43 62.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.098 1.359 . . . . 3.51 111.438 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.6 m -72.71 -42.89 63.69 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 122.147 -0.346 . . . . 0.95 110.858 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.3 t -52.1 -64.1 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 117.928 0.331 . . . . 2.2 110.553 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -28.46 68.2 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.847 -1.158 . . . . 1.74 111.716 -173.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -57.44 -55.23 37.49 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.389 0.675 . . . . 3.42 109.581 169.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.88 -52.07 53.36 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 108.996 -0.742 . . . . 2.0 108.996 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -50.83 -60.23 3.28 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.768 0.827 . . . . 3.54 109.785 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.2 t -53.65 -45.95 70.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.517 0.727 . . . . 1.75 110.417 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.7 t -58.96 -53.37 59.18 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.45 -0.944 . . . . 2.09 108.45 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.84 -50.76 44.14 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.911 0.884 . . . . 4.05 110.793 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.0 m -57.49 -24.88 58.43 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.732 0.641 . . . . 2.99 112.732 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -63.5 -33.1 74.82 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.356 -0.84 . . . . 8.79 110.792 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -55.18 143.1 28.67 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 108.558 -0.904 . . . . 3.24 108.558 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.79 159.65 16.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.084 -1.821 . . . . 7.84 106.084 163.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.45 -16.39 45.03 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 122.215 -0.303 . . . . 3.07 113.065 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 pp -78.86 141.14 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 108.191 -1.04 . . . . 4.1 108.191 170.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.6 -47.09 9.5 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.409 1.484 . . . . 4.27 108.318 172.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -156.98 158.09 35.93 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.706 -1.22 . . . . 3.72 107.706 -175.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 p -135.08 151.17 50.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.717 -1.216 . . . . 2.68 107.717 161.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 t -154.35 146.52 23.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.061 -0.718 . . . . 2.96 109.061 152.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.26 152.22 33.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 124.971 1.309 . . . . 2.73 110.207 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.25 155.97 34.75 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-O 121.026 0.441 . . . . 1.73 111.185 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.98 -8.51 14.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.77 1.628 . . . . 2.92 113.046 -165.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.53 -57.62 6.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.034 -1.099 . . . . 2.86 108.034 169.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -79.9 -28.99 39.76 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.203 0.601 . . . . 3.35 111.301 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 m120 73.91 56.59 0.1 Allowed 'General case' 0 C--N 1.343 0.3 0 C-N-CA 125.542 1.537 . . . . 1.67 108.235 -173.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -124.86 159.22 31.58 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.749 1.22 . . . . 5.17 110.793 -166.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -142.35 96.98 3.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 125.31 1.631 . . . . 1.81 107.894 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -81.16 102.42 10.29 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.506 -1.664 . . . . 1.3 106.506 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.33 150.11 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.027 -1.842 . . . . 2.77 106.027 167.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -120.57 137.64 54.3 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.931 -1.878 . . . . 4.36 105.931 161.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -150.69 154.8 38.09 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 123.579 0.752 . . . . 3.29 111.892 -167.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -74.75 126.02 88.92 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.308 -0.997 . . . . 3.67 108.308 159.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.57 -19.2 16.91 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.413 2.742 . . . . 1.71 113.296 -171.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -83.31 -47.34 11.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.625 -0.88 . . . . 3.46 108.625 -176.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 tp -71.98 -40.92 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 119.68 -0.2 . . . . 4.68 111.133 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mm -127.22 110.64 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.421 -1.326 . . . . 2.58 107.421 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.48 158.57 39.7 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 108.91 -1.676 . . . . 1.02 108.91 168.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -55.66 -40.47 85.1 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.25 1.967 . . . . 1.49 109.269 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -29.29 -58.23 0.15 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.119 2.168 . . . . 11.02 112.261 163.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -70.58 -43.5 69.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.7 0.762 . . . . 2.41 109.662 -168.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 mt -58.68 -51.54 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.87 -0.605 . . . . 1.98 109.405 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.2 mt -52.45 -55.48 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.218 -0.66 . . . . 2.16 109.218 176.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 56.0 m170 -51.53 -42.17 61.56 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.957 0.503 . . . . 4.44 111.284 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 31.2 m -62.18 -51.21 68.73 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.718 -0.614 . . . . 2.28 109.79 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -59.96 -40.85 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.465 1.106 . . . . 3.89 111.363 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.04 -53.54 57.15 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.871 0.868 . . . . 2.02 109.955 168.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.6 t -60.96 -27.41 68.24 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.495 0.718 . . . . 2.13 112.174 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.04 -85.9 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.719 -0.845 . . . . 3.16 108.719 166.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.74 18.54 0.18 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.489 -1.173 . . . . 1.26 114.608 169.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -132.58 151.85 51.8 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 119.441 1.62 . . . . 3.11 111.495 -148.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -78.5 163.96 25.13 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.119 -1.067 . . . . 4.86 108.119 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.12 158.09 42.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 121.395 -0.122 . . . . 1.81 110.902 160.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.5 t -155.18 134.52 12.46 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.543 -0.91 . . . . 3.01 108.543 173.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.14 120.93 24.36 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.6 -0.687 . . . . 3.15 109.283 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.6 p -156.74 151.9 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 O-C-N 121.92 -0.487 . . . . 3.89 110.946 -174.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 171.06 122.71 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 129.077 2.951 . . . . 5.88 106.475 169.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.1 pt -149.67 164.46 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 106.692 -1.596 . . . . 7.18 106.692 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 . . . . . 0 C--O 1.255 1.374 0 N-CA-C 104.945 -2.243 . . . . 10.73 104.945 173.58 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 107.275 -1.38 . . . . 12.72 107.275 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.04 -52.76 4.67 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.355 -1.098 . . . . 5.38 110.355 -173.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 3.98 95.99 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.537 2.735 . . . . 5.04 114.409 167.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.09 79.71 0.74 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.34 -1.504 . . . . 1.89 109.34 173.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.93 133.9 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 107.555 -1.276 . . . . 3.5 107.555 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 tp -136.09 121.06 18.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.215 -1.402 . . . . 3.39 107.215 162.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -109.53 70.81 0.74 Allowed 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 125.17 1.388 . . . . 3.58 108.361 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.32 149.96 33.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.13 -0.628 . . . . 3.87 109.439 178.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.47 135.26 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 105.52 -2.03 . . . . 1.8 105.52 164.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.08 131.75 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 125.509 1.524 . . . . 3.5 108.003 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -123.67 163.35 21.25 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.886 0.874 . . . . 6.49 109.834 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.56 -15.42 62.79 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.997 0.808 . . . . 1.23 111.856 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.8 mtm -70.33 77.61 0.54 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 117.891 0.846 . . . . 2.26 110.31 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -70.52 -14.87 62.69 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.984 -1.008 . . . . 2.43 113.35 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 p -161.64 169.93 20.68 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.652 1.114 . . . . 1.06 109.682 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.11 -36.73 30.9 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.331 1.052 . . . . 2.09 111.6 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -47.57 -38.84 15.17 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.334 1.853 . . . . 2.72 112.196 173.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.5 m -71.5 -54.81 9.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 122.039 -0.413 . . . . 0.73 110.117 172.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.4 t -49.05 -60.6 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.189 0.995 . . . . 1.91 110.494 -173.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -27.21 67.06 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.163 -0.615 . . . . 0.9 111.643 -175.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -64.69 -50.95 64.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.952 -0.759 . . . . 3.92 108.952 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.9 mt -53.09 -58.35 3.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 N-CA-C 108.946 -0.761 . . . . 2.29 108.946 172.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -49.13 -57.71 6.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.417 0.627 . . . . 3.87 110.921 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -62.26 -41.18 98.22 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.268 1.027 . . . . 1.34 111.112 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.8 t -67.0 -45.23 78.2 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.534 -0.913 . . . . 1.95 108.534 -176.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.91 -49.31 47.14 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 118.796 -0.621 . . . . 3.92 112.203 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.4 p -54.87 -25.43 28.75 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.883 0.765 . . . . 3.06 112.632 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -45.34 -44.28 11.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.894 1.278 . . . . 7.17 112.646 168.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -64.94 117.53 7.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.422 1.089 . . . . 2.43 108.869 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -75.2 36.11 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.523 1.129 . . . . 7.6 113.354 -169.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -132.46 -5.81 3.19 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.397 1.475 . . . . 1.47 111.519 168.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.5 mm -83.84 109.46 17.37 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 N-CA-C 107.021 -1.474 . . . . 5.28 107.021 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.9 mt -79.72 -38.88 32.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.803 0.841 . . . . 2.77 109.489 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -154.38 158.21 39.7 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 108.809 -0.812 . . . . 3.07 108.809 174.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.9 t -139.36 134.84 33.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.244 1.018 . . . . 2.47 108.516 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.1 t -134.54 85.38 2.18 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.054 -1.091 . . . . 2.05 108.054 169.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.1 m -78.9 149.76 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 125.234 1.413 . . . . 3.16 110.081 170.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.15 132.17 10.84 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.014 0.526 . . . . 1.71 109.756 166.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.88 -35.36 74.59 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 109.406 -0.591 . . . . 2.9 109.406 167.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.92 -35.82 64.58 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.786 0.835 . . . . 2.52 111.826 -174.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 m -119.26 18.04 13.04 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.868 0.867 . . . . 2.72 110.325 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.1 m120 33.95 48.89 0.25 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 126.279 1.831 . . . . 2.57 113.489 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.96 162.84 26.66 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.797 -0.446 . . . . 3.28 109.797 -169.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.43 100.92 3.42 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.713 -0.847 . . . . 1.86 108.713 169.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -80.3 100.41 8.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.621 -1.992 . . . . 1.31 105.621 166.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -94.35 135.36 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 105.797 -1.927 . . . . 2.74 105.797 165.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -100.45 117.02 33.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 104.831 -2.285 . . . . 3.02 104.831 158.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -117.14 168.81 9.95 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.544 0.738 . . . . 3.15 110.006 172.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.02 133.99 26.71 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 107.238 -1.393 . . . . 3.61 107.238 153.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -72.8 -10.69 25.2 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.558 2.172 . . . . 1.72 113.475 -174.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -83.22 -47.54 11.44 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.39 -0.967 . . . . 3.34 108.39 -173.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.8 mm -81.89 -36.72 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.723 -0.656 . . . . 3.54 110.927 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 mm -133.72 118.02 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 119.293 0.951 . . . . 2.49 108.534 -174.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.75 176.71 47.9 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 110.16 -1.176 . . . . 1.08 110.16 169.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.52 -42.17 22.52 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.663 2.242 . . . . 1.16 109.985 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.85 -54.71 5.04 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.212 1.405 . . . . 8.85 111.214 173.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -53.13 -55.93 20.2 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.462 0.574 . . . . 2.46 110.516 -176.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.9 mt -59.85 -53.26 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 116.236 -0.438 . . . . 1.83 110.012 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.9 mt -53.59 -54.66 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 109.487 -0.56 . . . . 1.94 109.487 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -52.06 -41.27 62.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.267 1.027 . . . . 5.66 111.531 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 44.9 m -69.85 -48.51 58.58 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.721 -0.474 . . . . 2.12 109.721 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.8 mt -51.47 -50.64 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 109.527 -0.546 . . . . 2.51 109.527 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.05 -55.58 31.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.934 0.893 . . . . 2.46 111.171 176.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.7 p -62.68 -32.12 73.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.899 -0.572 . . . . 2.47 112.054 -173.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.92 -85.44 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.57 0.623 . . . . 3.78 111.17 171.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.59 25.86 0.25 Allowed Glycine 0 CA--C 1.526 0.752 0 O-C-N 121.151 -0.968 . . . . 1.01 113.833 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -137.2 177.35 7.93 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.617 1.209 . . . . 2.76 111.069 -155.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -120.43 157.57 29.04 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.856 -1.164 . . . . 3.48 107.856 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.41 152.98 40.68 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.75 0.42 . . . . 1.95 111.253 167.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.3 m -156.4 135.44 11.97 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.604 1.162 . . . . 2.65 109.38 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.4 mp -53.28 -67.58 0.24 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.271 1.028 . . . . 3.95 110.442 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.316 7.6 p 59.22 -43.82 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 128.967 2.907 . . . . 4.98 116.961 177.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -65.35 88.92 0.09 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.391 1.077 . . . . 5.79 111.764 -175.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.1 pt -57.87 169.56 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.972 1.309 . . . . 6.07 111.303 167.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.254 1.337 0 C-N-CA 127.919 2.488 . . . . 8.72 111.872 -176.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 110.198 -0.297 . . . . 13.58 110.198 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.4 62.09 0.64 Allowed Glycine 0 CA--C 1.52 0.393 0 N-CA-C 105.748 -2.941 . . . . 5.81 105.748 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -149.87 168.64 23.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.284 -1.376 . . . . 6.37 107.284 -158.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.32 95.42 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 108.417 -1.873 . . . . 2.03 108.417 170.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.54 131.38 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 106.442 -1.688 . . . . 3.41 106.442 168.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.2 99.19 5.77 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.091 0.956 . . . . 3.91 108.63 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -87.46 106.75 18.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.194 -1.41 . . . . 3.03 107.194 161.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.91 150.16 30.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.51 -0.922 . . . . 3.6 108.51 168.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.55 142.7 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 104.787 -2.301 . . . . 1.79 104.787 159.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.9 p -139.66 135.54 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 106.796 -1.557 . . . . 3.42 106.796 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -134.51 168.78 18.34 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.294 1.438 . . . . 9.46 108.915 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.88 -14.59 61.41 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.903 0.764 . . . . 1.29 111.222 -163.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.1 mtp -68.51 77.6 0.28 Allowed 'General case' 0 C--N 1.341 0.225 0 CA-C-N 118.194 0.997 . . . . 3.14 110.799 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.5 p -61.09 -41.39 96.57 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.72 -0.657 . . . . 3.73 112.516 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.3 p -156.28 -179.37 8.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.171 0.896 . . . . 0.77 112.794 -166.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.09 -40.7 46.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.812 1.245 . . . . 2.01 111.577 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 m -60.81 -29.49 69.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.086 0.554 . . . . 1.99 111.898 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.7 m -71.85 -58.58 3.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.902 0.774 . . . . 0.67 109.927 167.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.0 t -38.7 -64.78 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.937 1.295 . . . . 2.2 111.481 -177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -28.45 65.98 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.181 -0.608 . . . . 1.08 111.69 -172.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -66.56 -52.49 45.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.88 -0.785 . . . . 4.33 108.88 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.6 -59.37 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 N-CA-C 108.341 -0.985 . . . . 1.95 108.341 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -50.15 -62.99 1.25 Allowed 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 124.057 0.848 . . . . 3.8 110.097 -175.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.6 t -56.32 -41.28 75.73 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.484 0.714 . . . . 1.27 111.163 -177.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 t -65.58 -54.13 32.19 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.417 -0.957 . . . . 2.04 108.417 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 mp -52.42 -46.58 66.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.794 0.438 . . . . 3.55 110.911 175.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.1 m -62.8 -9.83 10.87 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.964 0.728 . . . . 2.73 112.964 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -25.1 62.11 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.718 -1.239 . . . . 6.34 111.963 169.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -69.54 140.89 53.93 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 107.553 -1.277 . . . . 2.6 107.553 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.9 ttm-85 -81.81 -28.02 33.34 Favored 'General case' 0 C--O 1.226 -0.154 0 O-C-N 121.41 -0.807 . . . . 6.34 111.846 -177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.8 5.47 83.7 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.454 -0.636 . . . . 1.35 113.802 -173.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.39 159.06 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 118.513 1.157 . . . . 3.88 109.415 164.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.4 mt -113.88 -39.78 3.9 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.466 1.506 . . . . 3.18 109.316 176.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -156.15 156.61 34.53 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.449 -0.575 . . . . 3.52 109.449 174.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.1 m -138.16 135.21 35.46 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.495 -1.669 . . . . 2.79 106.495 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.5 t -147.97 143.77 27.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.684 -1.598 . . . . 2.35 106.684 163.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 m -137.5 144.03 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.399 1.079 . . . . 2.68 108.741 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.29 111.55 6.81 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.638 1.175 . . . . 1.79 110.002 -175.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.94 -22.89 61.4 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.309 1.444 . . . . 2.21 113.152 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.51 -50.28 53.37 Favored 'General case' 0 C--O 1.226 -0.159 0 N-CA-C 108.38 -0.97 . . . . 2.3 108.38 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.61 -19.96 51.5 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.192 0.997 . . . . 2.49 110.878 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.4 m120 57.84 46.48 16.84 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 126.118 1.767 . . . . 1.9 109.971 -172.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.47 157.86 45.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.97 -0.381 . . . . 4.11 109.97 -170.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.69 127.65 25.71 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.844 -1.169 . . . . 1.95 107.844 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -99.17 98.27 9.28 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 105.332 -2.099 . . . . 1.07 105.332 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.0 mm -94.58 147.65 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 106.135 -1.802 . . . . 2.87 106.135 170.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -124.62 135.75 53.37 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.428 -2.434 . . . . 4.84 104.428 159.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -156.34 160.66 39.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.255 0.622 . . . . 3.15 109.902 -162.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -93.44 125.79 52.72 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.752 -0.833 . . . . 3.15 108.752 171.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.0 -14.28 29.15 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.824 2.35 . . . . 1.77 113.875 -172.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -121.19 25.4 9.56 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.866 1.212 . . . . 3.15 112.402 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.7 tp -132.39 -63.56 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 118.988 -0.529 . . . . 4.66 110.283 159.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.95 -44.28 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 119.669 1.122 . . . . 3.03 108.321 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.22 168.51 18.77 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.109 -0.567 . . . . 3.4 111.805 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -71.52 -57.28 0.1 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.043 1.829 . . . . 1.37 111.731 -170.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 ttt-85 -70.64 -20.16 62.75 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.064 0.765 . . . . 7.18 113.064 -167.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.31 -35.1 71.14 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.438 1.017 . . . . 3.8 112.93 -175.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.3 mt -48.84 -50.22 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 121.432 -0.793 . . . . 2.38 109.236 164.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mt -63.15 -42.6 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 117.715 -1.136 . . . . 2.2 110.727 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -49.55 -44.05 46.32 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.39 1.45 . . . . 4.52 110.152 170.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.4 m -66.29 -50.49 63.49 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.32 -0.622 . . . . 1.9 109.32 -175.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 64.0 mt -52.97 -52.81 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.537 1.135 . . . . 2.65 110.959 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -53.96 -53.92 46.06 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.107 1.363 . . . . 1.9 110.293 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t -58.91 -41.77 88.05 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.111 0.964 . . . . 2.16 111.436 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.3 mt -64.13 -84.05 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.584 0.353 . . . . 3.1 110.897 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.24 22.51 0.22 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.638 -1.09 . . . . 0.98 113.818 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -134.92 162.62 31.9 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 118.945 1.372 . . . . 2.79 111.047 -156.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -115.78 152.1 33.93 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.335 1.454 . . . . 3.84 107.412 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.85 166.53 33.12 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.424 1.011 . . . . 2.51 113.276 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 p -155.33 123.21 5.73 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.193 1.397 . . . . 2.57 109.791 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -54.48 135.34 45.8 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.342 0.657 . . . . 3.31 109.942 170.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.9 t -95.4 -74.35 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.044 -1.095 . . . . 4.05 108.044 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? 62.59 -65.14 0.09 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.492 1.917 . . . . 6.62 113.931 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.3 mm 54.65 42.68 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.223 1.409 . . . . 6.22 109.381 -165.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 . . . . . 0 C--O 1.259 1.579 0 C-N-CA 130.398 3.479 . . . . 11.56 102.366 -172.89 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mmm . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 106.696 -1.594 . . . . 10.67 106.696 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 58.69 60.08 9.59 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 107.741 -2.144 . . . . 4.77 107.741 -163.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -136.11 176.56 8.58 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.416 0.524 . . . . 4.19 112.416 -145.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.04 66.06 0.32 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 106.955 -2.458 . . . . 2.12 106.955 172.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.33 129.2 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 109.416 -0.587 . . . . 3.13 109.416 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.36 136.8 39.95 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.259 1.024 . . . . 3.63 108.529 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.21 144.01 48.83 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.617 -1.994 . . . . 4.87 105.617 167.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.14 147.8 24.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.696 -0.853 . . . . 3.18 108.696 167.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.31 134.58 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 105.665 -1.976 . . . . 2.12 105.665 173.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.3 t -116.44 117.91 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 106.873 -1.528 . . . . 3.14 106.873 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.1 mtt180 -85.59 143.83 28.23 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.09 -1.078 . . . . 7.95 108.09 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.14 -1.0 58.98 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.088 -0.84 . . . . 1.2 113.684 173.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.3 mtp -71.4 72.38 0.69 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.138 1.469 . . . . 2.81 110.436 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -73.97 -17.0 61.06 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 117.683 -1.151 . . . . 2.35 113.819 -169.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.2 p -159.01 172.75 17.62 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 120.23 1.377 . . . . 0.89 110.724 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.58 -36.7 35.98 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.406 1.082 . . . . 2.04 111.794 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 t -56.53 -45.4 81.16 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.873 -0.417 . . . . 2.72 109.873 175.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.9 m -63.7 -47.81 79.63 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.684 -0.635 . . . . 0.7 110.527 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.2 t -49.66 -66.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.439 -0.578 . . . . 2.0 109.439 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.288 0.1 OUTLIER -71.19 -23.45 62.04 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 118.954 -1.098 . . . . 1.32 112.804 -173.523 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -52.99 -49.44 66.17 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.718 1.144 . . . . 4.34 109.15 169.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.7 mt -56.95 -59.05 3.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 109.529 -0.545 . . . . 1.97 109.529 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.3 -47.65 84.58 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.125 0.488 . . . . 4.65 111.064 -171.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -57.07 -33.91 67.74 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.818 1.247 . . . . 1.85 110.826 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.7 m -71.72 -60.64 2.13 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.705 -0.622 . . . . 2.72 109.409 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -54.6 -42.82 71.59 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.433 0.693 . . . . 3.73 112.179 -171.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.2 p -57.39 -18.77 19.33 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.462 0.542 . . . . 2.55 112.462 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -70.79 -27.81 64.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.041 0.937 . . . . 7.09 111.743 175.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -70.74 -12.05 61.32 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.039 1.125 . . . . 3.17 114.039 -165.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.6 mmp_? 72.17 -44.54 0.6 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 126.281 1.832 . . . . 8.18 113.567 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.15 53.21 1.79 Allowed Glycine 0 CA--C 1.525 0.689 0 CA-C-N 119.036 0.835 . . . . 1.65 111.223 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.44 133.55 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 106.722 -1.584 . . . . 4.38 106.722 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.0 mt -88.66 -45.55 9.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.833 -1.173 . . . . 3.33 107.833 167.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -157.15 154.32 29.14 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 122.198 -0.314 . . . . 4.07 111.017 -178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.3 t -130.2 110.63 11.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.777 1.231 . . . . 2.88 109.932 170.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.1 t -115.71 84.9 2.18 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.224 1.81 . . . . 2.07 107.86 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.76 152.15 3.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.343 1.057 . . . . 3.13 110.341 174.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.08 135.06 12.95 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 119.394 -0.336 . . . . 1.93 110.137 170.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.55 -32.3 71.02 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 123.409 0.443 . . . . 2.65 110.203 168.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.86 -48.17 60.2 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.386 0.674 . . . . 2.02 111.281 -176.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -105.52 10.06 33.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.327 1.451 . . . . 3.03 111.451 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.3 m120 41.17 47.66 2.88 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.185 1.794 . . . . 2.17 112.299 -175.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.71 171.2 11.38 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.149 0.58 . . . . 3.29 111.679 -165.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.99 87.41 1.41 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.954 1.302 . . . . 1.77 109.809 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -79.25 96.47 5.93 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.797 -1.557 . . . . 1.12 106.797 171.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.32 141.31 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.983 -1.488 . . . . 2.51 106.983 171.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -114.52 116.42 28.79 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 104.207 -2.516 . . . . 3.56 104.207 165.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -125.69 157.3 37.66 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.874 0.87 . . . . 3.0 111.65 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.92 114.9 59.51 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.905 1.682 . . . . 5.05 107.879 176.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.79 36.2 0.6 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.481 2.121 . . . . 2.38 113.762 -166.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -140.22 33.23 1.91 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.421 1.088 . . . . 3.3 110.18 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 tp -171.83 -49.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 124.891 1.276 . . . . 4.93 108.671 -170.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mm -122.91 132.73 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 105.384 -2.08 . . . . 2.44 105.384 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.72 -179.7 19.48 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.839 1.685 . . . . 1.38 109.311 167.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.65 -40.59 28.97 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.338 2.025 . . . . 1.16 110.306 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -42.19 69.8 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.187 0.595 . . . . 10.99 111.469 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -58.98 -54.14 50.49 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.305 -0.628 . . . . 2.2 109.305 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.5 mt -56.9 -50.41 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 123.616 0.766 . . . . 1.79 109.933 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.6 mt -53.09 -57.42 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.316 0.646 . . . . 2.27 109.957 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -52.34 -44.59 65.27 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.236 0.614 . . . . 4.26 110.44 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.6 m -64.11 -51.2 65.13 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.308 -0.627 . . . . 1.9 109.308 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.3 mt -51.9 -59.7 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.792 0.837 . . . . 2.42 109.157 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -63.14 -47.91 80.71 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 119.676 -0.81 . . . . 2.97 109.979 -169.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 t -54.23 -39.95 67.23 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.154 0.582 . . . . 2.24 111.863 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.4 mt -61.23 -59.63 5.0 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.825 0.739 . . . . 3.35 112.431 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.31 16.0 0.14 Allowed Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.409 -1.217 . . . . 1.57 115.432 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -143.07 -179.74 6.55 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.008 1.404 . . . . 3.66 111.44 -142.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -127.91 154.4 45.57 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 105.765 -1.939 . . . . 3.67 105.765 163.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.95 154.52 27.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.98 0.809 . . . . 2.36 110.532 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.3 m -155.26 103.45 2.35 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.102 1.361 . . . . 2.66 109.453 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 mt -52.57 135.55 34.1 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.215 0.606 . . . . 3.78 109.453 169.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.8 m -137.13 141.78 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.977 -1.12 . . . . 3.92 107.977 176.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.79 176.32 1.23 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.728 2.011 . . . . 6.62 106.414 176.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.84 -175.94 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 106.227 -1.768 . . . . 7.08 106.227 160.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 . . . . . 0 C--O 1.249 1.044 0 C-N-CA 128.208 2.603 . . . . 10.13 104.483 163.42 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpt . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 110.033 -0.358 . . . . 9.57 110.033 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.08 44.87 1.4 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 106.301 -2.72 . . . . 5.0 106.301 169.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 167.48 157.05 0.03 OUTLIER 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.736 2.014 . . . . 4.49 106.737 -153.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.38 167.49 24.44 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 108.19 -1.964 . . . . 2.14 108.19 169.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.4 t -98.11 144.79 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 124.753 1.221 . . . . 3.69 108.909 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.8 tp -127.81 123.24 34.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 106.418 -1.697 . . . . 3.69 106.418 165.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -120.8 126.52 50.31 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 108.274 -1.01 . . . . 4.09 108.274 179.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.17 155.65 48.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 123.571 0.545 . . . . 3.89 109.994 178.186 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.45 112.24 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 104.435 -2.432 . . . . 2.13 104.435 166.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 p -79.6 137.6 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 106.889 -1.523 . . . . 3.94 106.889 166.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -139.28 173.54 11.44 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.194 1.398 . . . . 7.22 108.377 -179.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.39 -46.82 2.28 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.478 -0.649 . . . . 1.6 111.478 -176.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.16 136.92 46.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.531 -0.914 . . . . 3.46 108.531 -177.128 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -141.56 8.46 1.97 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.726 1.75 . . . . 2.15 115.726 -156.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.6 p -159.39 173.19 16.62 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 121.173 1.806 . . . . 0.78 111.782 174.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.59 -42.64 56.01 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.207 1.003 . . . . 1.64 111.135 175.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 m -65.93 -20.95 66.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.761 0.824 . . . . 2.25 112.286 178.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.3 m -73.51 -62.1 1.6 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.036 0.835 . . . . 0.82 111.222 158.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.1 t -39.43 -63.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 124.588 1.155 . . . . 1.95 111.457 -173.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.87 -29.87 70.38 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.439 -0.505 . . . . 0.92 111.579 -173.603 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -70.45 -44.78 67.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.68 0.792 . . . . 4.24 108.976 -178.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.2 mt -55.2 -59.14 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.393 -0.966 . . . . 2.17 108.393 175.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -55.77 -53.92 50.78 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 117.979 0.354 . . . . 3.87 111.014 -178.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -55.37 -36.51 66.42 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.005 0.922 . . . . 1.43 111.973 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 t -70.1 -54.72 11.8 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.132 -1.062 . . . . 1.87 108.132 177.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 mp -57.46 -42.72 83.12 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.155 0.582 . . . . 3.44 112.179 -174.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.3 p -60.09 -12.46 8.4 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.265 -0.897 . . . . 2.6 113.029 178.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.4 -32.59 74.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.093 0.86 . . . . 4.71 110.561 172.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -78.29 106.91 10.53 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.218 -0.66 . . . . 2.14 109.218 178.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -57.66 -20.82 36.18 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.871 -1.143 . . . . 7.02 112.62 171.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.3 -32.47 72.29 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.902 -0.943 . . . . 1.21 112.323 172.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -88.92 137.36 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 118.671 1.236 . . . . 3.37 108.098 170.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 mt -95.86 -36.53 11.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.552 0.741 . . . . 2.75 109.471 177.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -150.11 153.69 36.82 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.774 0.261 . . . . 2.94 110.483 173.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -137.28 130.46 30.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.421 1.888 . . . . 2.73 106.728 171.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.4 t -128.18 110.45 12.45 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 106.526 -1.657 . . . . 2.1 106.526 168.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.59 150.91 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.255 1.022 . . . . 3.88 110.72 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.17 122.54 5.59 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.856 -0.528 . . . . 1.8 111.177 174.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.12 -26.36 67.41 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.371 0.668 . . . . 2.48 109.936 161.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.2 -49.19 77.91 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.259 0.481 . . . . 2.25 109.884 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.45 -37.51 36.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.793 0.437 . . . . 2.43 110.349 173.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 m120 68.89 71.75 0.27 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.774 -1.565 . . . . 1.88 106.774 -151.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.33 158.11 43.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.173 -0.329 . . . . 3.39 110.251 173.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.27 129.58 47.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.547 -2.02 . . . . 1.93 105.547 151.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -107.4 116.53 32.11 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 102.85 -3.019 . . . . 1.19 102.85 166.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mm -107.9 149.5 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 104.728 -2.323 . . . . 2.97 104.728 174.2 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.94 139.8 47.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.2 -1.037 . . . . 3.19 108.2 157.155 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -162.82 160.83 25.65 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 124.092 0.87 . . . . 3.68 109.718 -153.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -93.37 124.61 57.03 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 108.882 -0.785 . . . . 3.57 108.882 168.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.74 -19.08 24.47 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.935 2.424 . . . . 2.04 113.689 -173.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.32 -48.7 10.88 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.003 -1.11 . . . . 4.28 108.003 176.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.4 mt -63.9 -40.13 87.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-O 119.227 -0.416 . . . . 4.04 110.038 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.3 tt -137.34 109.32 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.346 0.594 . . . . 2.6 110.91 173.079 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.88 141.01 47.26 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.411 -1.476 . . . . 1.41 109.411 172.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -55.71 -40.16 86.91 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.741 2.294 . . . . 1.27 111.815 -172.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -56.9 -29.53 63.09 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 118.178 -0.915 . . . . 7.56 112.369 178.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.23 -44.18 92.68 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 120.015 1.279 . . . . 4.12 110.35 -179.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.2 mt -56.56 -52.97 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.308 -0.627 . . . . 1.83 109.308 175.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.1 mm -51.04 -56.87 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.089 0.556 . . . . 3.18 109.833 177.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.33 -34.98 69.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.788 0.835 . . . . 5.73 111.465 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.3 m -65.47 -52.99 48.98 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.881 -1.155 . . . . 1.8 107.881 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.1 mt -50.9 -50.74 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.12 0.568 . . . . 2.24 110.237 176.018 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -53.54 -50.28 65.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.047 0.451 . . . . 2.25 110.39 175.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.7 t -67.28 -14.66 63.12 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.512 1.125 . . . . 2.01 113.305 -173.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 mp -72.13 -91.01 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.911 1.232 . . . . 3.28 107.709 165.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.44 35.88 0.48 Allowed Glycine 0 CA--C 1.523 0.586 0 O-C-N 121.347 -0.845 . . . . 1.18 111.815 169.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -130.61 177.52 7.32 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.552 0.676 . . . . 2.78 110.927 -156.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -119.73 148.43 43.41 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.593 -1.632 . . . . 3.67 106.593 175.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.58 133.42 32.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.919 0.887 . . . . 2.03 108.736 170.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.3 t -133.77 103.39 5.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.34 1.056 . . . . 2.59 109.002 -177.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.08 58.08 0.67 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.809 1.244 . . . . 3.81 110.879 178.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 p -64.28 -37.15 79.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.848 0.859 . . . . 4.97 110.484 176.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.9 tttm 40.08 79.72 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.726 2.011 . . . . 4.73 113.414 -178.245 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.2 tp -70.49 73.28 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.665 0.786 . . . . 8.33 110.068 170.26 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 . . . . . 0 C--O 1.254 1.298 0 C-N-CA 127.551 2.34 . . . . 10.25 109.675 -173.284 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.3 mtm . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 106.46 -1.682 . . . . 10.07 106.46 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.63 114.58 2.68 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 108.257 -1.937 . . . . 4.76 108.257 178.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -159.2 165.53 33.43 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.0 -1.482 . . . . 4.24 107.0 177.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.35 154.41 12.59 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 107.437 -2.265 . . . . 1.71 107.437 -176.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.74 91.57 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.678 1.191 . . . . 3.38 109.65 -177.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.71 79.24 7.38 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.277 -1.379 . . . . 3.92 107.277 175.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.411 ' CD ' ' HZ3' ' A' ' 73' ' ' LYS . 3.0 tm-20 -102.23 116.01 31.75 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.096 -0.956 . . . . 3.85 109.615 174.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.91 166.42 24.52 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.915 1.286 . . . . 2.86 110.421 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.33 143.55 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 106.54 -1.652 . . . . 2.03 106.54 173.187 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.0 t -136.53 130.49 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 126.025 1.73 . . . . 3.07 107.356 175.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -132.03 156.43 46.28 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.262 1.425 . . . . 6.95 108.618 -174.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.34 -24.56 28.51 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.641 -0.533 . . . . 1.26 112.253 177.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.75 76.25 0.85 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.396 1.093 . . . . 2.95 110.201 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -70.21 -12.34 61.52 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 115.399 1.629 . . . . 2.38 115.399 -157.827 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.6 p -157.14 174.02 16.11 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 120.523 1.511 . . . . 0.76 110.724 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.91 -44.54 14.73 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.814 1.245 . . . . 1.96 111.529 177.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 m -57.67 -37.32 73.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.525 0.73 . . . . 2.05 111.854 178.507 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.6 m -71.43 -50.35 32.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.438 0.563 . . . . 0.78 110.306 171.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.9 t -52.38 -56.6 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 122.737 0.415 . . . . 2.09 111.01 -175.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -27.96 64.22 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.613 -0.679 . . . . 0.99 112.065 -177.325 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -57.77 -48.04 80.79 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.776 -0.824 . . . . 4.45 108.776 170.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 81.9 mt -56.67 -66.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 108.743 -0.836 . . . . 1.85 108.743 171.509 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -46.11 -56.43 5.64 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.176 0.99 . . . . 3.79 110.765 -169.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.4 t -57.63 -51.4 69.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.562 0.745 . . . . 1.68 110.175 -176.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -59.78 -40.66 89.0 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.438 0.637 . . . . 2.06 109.724 -178.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -49.83 75.01 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.547 0.739 . . . . 3.81 110.759 178.069 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.1 p -56.01 -41.48 74.96 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.202 0.91 . . . . 2.53 110.759 175.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -57.53 -9.67 1.21 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.96 1.304 . . . . 5.43 113.154 175.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -56.43 -32.83 65.26 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 119.975 -1.703 . . . . 4.42 111.334 164.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 70.62 -51.05 0.67 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 126.606 1.962 . . . . 8.48 110.927 -168.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.37 53.39 1.89 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.672 0.653 . . . . 1.74 112.775 178.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -136.54 172.02 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.399 -1.334 . . . . 4.06 107.399 172.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.9 mt -117.57 -42.12 2.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.197 0.999 . . . . 3.05 109.346 -178.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -155.8 156.22 34.39 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 108.659 -0.867 . . . . 3.78 108.659 175.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.1 m -132.8 130.4 39.81 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 105.613 -1.995 . . . . 2.82 105.613 176.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.6 p -144.74 98.01 3.12 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.643 -0.873 . . . . 3.9 108.643 173.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 p -116.13 139.81 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.493 1.517 . . . . 3.53 109.342 -172.116 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.67 123.65 6.28 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.072 0.549 . . . . 1.91 110.294 -172.136 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.48 -32.77 74.56 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 109.56 -0.533 . . . . 2.98 109.56 167.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.9 -34.44 67.9 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.792 0.837 . . . . 2.3 111.825 -176.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.0 m -117.44 21.9 12.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.843 0.857 . . . . 2.84 109.787 175.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.3 m120 25.6 61.4 0.07 Allowed 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 126.834 2.054 . . . . 2.29 113.66 -172.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.57 166.54 26.17 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 120.619 0.247 . . . . 3.15 111.277 -173.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -139.02 125.9 20.98 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 124.663 1.227 . . . . 1.64 108.395 160.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -108.26 102.16 11.31 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.075 -2.194 . . . . 1.08 105.075 171.123 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.38 118.37 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 105.402 -2.073 . . . . 2.86 105.402 171.65 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -81.14 130.17 34.9 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.267 -1.753 . . . . 3.54 106.267 164.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -139.74 149.18 43.29 Favored 'General case' 0 N--CA 1.46 0.068 0 C-N-CA 124.265 1.026 . . . . 3.06 109.736 -168.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.76 131.48 70.52 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.465 -1.309 . . . . 2.97 107.465 161.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -82.75 0.13 9.82 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.807 2.338 . . . . 1.48 114.268 -172.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -93.09 -50.39 5.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 119.677 1.126 . . . . 4.02 108.148 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.8 tt -70.88 -29.89 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.734 0.642 . . . . 3.51 112.734 -174.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mm -142.69 144.47 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 105.6 -2.0 . . . . 2.47 105.6 -172.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.53 -178.14 15.72 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.187 1.375 . . . . 1.44 110.902 171.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.48 -48.13 22.08 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.208 2.605 . . . . 1.92 110.511 174.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.4 -61.29 1.07 Allowed 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 125.016 1.326 . . . . 8.18 110.895 176.31 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -53.74 -54.38 38.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.644 0.735 . . . . 2.62 110.387 -173.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.2 mt -58.86 -53.75 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.808 -0.633 . . . . 1.85 110.023 -177.415 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.1 mt -54.11 -53.23 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.416 -0.587 . . . . 2.24 109.416 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 52.3 m170 -55.1 -41.25 71.37 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.332 0.653 . . . . 4.36 110.651 179.03 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.5 m -62.08 -52.11 65.25 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.11 -0.7 . . . . 1.86 109.11 178.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.52 -51.06 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 123.495 0.718 . . . . 2.95 111.086 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -58.31 -58.12 9.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.602 1.161 . . . . 2.13 110.197 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -51.52 -46.94 63.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.317 1.047 . . . . 2.0 110.471 -178.841 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.32 -53.74 52.88 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.404 -0.331 . . . . 3.17 111.225 177.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.82 -41.48 0.02 OUTLIER Glycine 0 CA--C 1.529 0.919 0 N-CA-C 115.641 1.017 . . . . 1.51 115.641 174.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -122.39 160.83 24.63 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.7 0.63 . . . . 2.93 112.7 -127.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -82.45 150.55 26.99 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.09 -1.078 . . . . 3.68 108.09 -179.233 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.72 160.04 43.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.81 0.444 . . . . 2.12 111.661 172.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.4 m -155.92 128.0 7.54 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.473 0.709 . . . . 2.12 110.871 177.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.5 mt -71.27 66.52 0.44 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.938 0.895 . . . . 3.93 109.546 169.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.54 97.78 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 109.217 -0.66 . . . . 4.14 109.217 178.425 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.411 ' HZ3' ' CD ' ' A' ' 7' ' ' GLU . 38.0 mttp -141.95 122.29 13.98 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.457 -0.942 . . . . 5.32 108.457 173.7 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.8 mm -145.98 -62.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 104.161 -2.533 . . . . 7.52 104.161 178.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 C--O 1.248 1.017 0 N-CA-C 106.698 -1.593 . . . . 10.71 106.698 143.745 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 105.767 -1.938 . . . . 10.38 105.767 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.23 159.19 20.07 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 107.689 -2.164 . . . . 5.54 107.689 134.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -150.82 168.14 25.33 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.464 -1.68 . . . . 5.28 106.464 177.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.04 -2.48 12.48 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.239 1.4 . . . . 3.84 113.447 -178.344 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.8 t -80.79 129.23 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 120.094 1.947 . . . . 4.72 109.127 174.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -150.94 123.05 8.25 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.845 0.748 . . . . 4.2 110.102 -175.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.39 121.7 45.9 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.945 1.298 . . . . 5.39 110.926 175.042 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 mt -104.06 160.81 14.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.996 -1.112 . . . . 3.94 107.996 164.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -85.08 143.61 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 106.246 -1.761 . . . . 2.05 106.246 147.316 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.2 144.64 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 106.139 -1.8 . . . . 3.68 106.139 175.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -146.07 164.77 31.1 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.313 0.645 . . . . 6.75 109.958 -178.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.83 -10.14 40.83 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.577 1.084 . . . . 1.16 111.048 -173.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -73.23 79.16 1.3 Allowed 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.045 0.923 . . . . 2.45 110.144 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -64.33 -15.84 61.08 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.479 -1.248 . . . . 2.04 113.358 -177.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.0 p -165.12 175.84 9.02 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 120.511 1.505 . . . . 0.75 110.753 177.165 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.99 -40.07 43.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.935 0.894 . . . . 1.81 111.499 175.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -57.62 -27.27 62.62 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.83 1.252 . . . . 2.72 111.905 178.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.1 m -73.85 -64.02 1.09 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.414 0.552 . . . . 0.72 110.941 162.411 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.7 t -44.75 -55.95 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 124.369 1.067 . . . . 2.01 111.646 -168.545 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -30.71 69.57 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.074 0.464 . . . . 1.79 111.559 -175.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -38.4 71.61 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.594 1.158 . . . . 5.05 109.447 -172.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.0 mt -55.93 -64.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.583 -0.895 . . . . 2.07 108.583 176.491 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -57.51 9.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.407 0.683 . . . . 4.43 109.813 178.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 t -54.75 -43.7 72.93 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.514 -0.741 . . . . 1.93 111.791 -175.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t -71.52 -49.1 44.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.886 -0.508 . . . . 2.23 110.222 -177.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.4 tp -73.35 -52.29 14.37 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 124.813 1.245 . . . . 4.05 112.852 -173.098 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.7 m -59.54 -21.76 60.71 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.288 0.848 . . . . 3.22 113.288 -171.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -22.18 66.92 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.166 -0.959 . . . . 5.25 113.451 172.218 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -66.2 106.03 1.55 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.042 -1.096 . . . . 2.56 108.042 175.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -52.69 100.43 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.274 1.029 . . . . 6.79 109.862 175.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 144.4 -32.06 1.77 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.04 -1.224 . . . . 2.14 110.04 -169.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.1 mm -79.63 151.1 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.26 -1.385 . . . . 5.54 107.26 161.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 50.7 mt -114.21 -47.68 2.93 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.906 1.283 . . . . 3.26 109.42 175.161 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -156.19 150.33 25.37 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 108.117 -1.068 . . . . 4.44 108.117 -175.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.9 m -125.86 80.72 1.93 Allowed 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.149 0.98 . . . . 3.37 110.301 174.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 t -78.26 77.97 4.74 Favored 'General case' 0 C--O 1.237 0.43 0 O-C-N 120.787 -1.196 . . . . 1.94 109.203 178.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -91.13 141.04 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 125.035 1.334 . . . . 3.96 110.456 171.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.77 118.44 6.58 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.218 0.463 . . . . 2.38 110.662 169.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -55.57 -19.61 10.65 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.5 1.12 . . . . 2.28 113.624 177.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.14 -34.63 78.04 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.318 0.647 . . . . 1.95 110.939 175.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.74 -8.22 10.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.904 0.882 . . . . 3.88 111.651 -178.32 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m120 60.97 26.29 16.24 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 125.023 1.329 . . . . 2.26 110.976 176.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.66 161.98 13.67 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.026 -1.472 . . . . 3.64 107.026 -176.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -139.6 90.49 2.41 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 105.533 -2.025 . . . . 2.14 105.533 165.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -78.88 83.81 4.97 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 103.25 -2.87 . . . . 1.96 103.25 167.125 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.0 pt -81.46 165.24 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 106.503 -1.666 . . . . 4.15 106.503 170.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -127.78 133.86 49.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 105.352 -2.092 . . . . 4.39 105.352 160.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.93 176.41 9.3 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 126.13 1.772 . . . . 3.35 108.181 -169.359 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -111.62 132.99 21.62 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 107.568 -1.271 . . . . 3.08 107.568 155.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.26 -17.68 18.8 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.414 2.743 . . . . 1.93 113.489 -172.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -89.6 -50.17 6.23 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 118.878 0.763 . . . . 3.09 109.217 -176.098 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.2 pt -85.96 1.64 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 113.33 0.863 . . . . 4.25 113.33 -176.294 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -152.13 123.55 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 106.624 -1.621 . . . . 2.5 106.624 171.063 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.63 148.6 42.12 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 109.804 -1.318 . . . . 1.42 109.804 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -56.58 -44.05 49.28 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 CA-C-N 119.402 1.601 . . . . 1.23 108.504 165.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.438 HH11 ' CD2' ' A' ' 60' ' ' HIS . 6.8 tpp180 -51.16 -32.91 24.8 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 117.952 -1.023 . . . . 6.97 112.015 170.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -72.47 -43.39 63.79 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 121.173 1.806 . . . . 2.39 113.112 176.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mt -48.91 -50.99 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.221 -0.592 . . . . 1.91 109.469 165.022 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.7 mm -58.66 -44.88 90.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 118.246 -0.883 . . . . 3.4 111.45 175.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.438 ' CD2' HH11 ' A' ' 56' ' ' ARG . 21.7 m170 -50.44 -45.73 56.07 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.31 1.414 . . . . 4.15 109.348 177.1 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.0 m -65.49 -53.47 42.07 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.291 -0.633 . . . . 1.86 109.291 -177.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.1 mt -50.98 -52.07 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.636 1.174 . . . . 2.51 110.854 178.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -54.12 -55.88 23.4 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.151 1.38 . . . . 2.34 110.182 173.015 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -63.78 -26.23 68.54 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 118.224 -0.893 . . . . 2.27 112.84 -171.362 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.9 mp -73.55 -95.41 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.251 -1.018 . . . . 3.32 108.251 168.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.97 34.11 0.44 Allowed Glycine 0 C--N 1.336 0.549 0 CA-C-O 119.012 -0.882 . . . . 0.99 112.635 173.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -130.42 163.59 26.59 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.483 1.141 . . . . 3.67 110.408 -163.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -117.03 157.52 25.69 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 108.051 -1.092 . . . . 3.01 108.051 174.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.54 165.53 36.31 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 118.446 0.566 . . . . 2.41 111.735 172.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 p -155.11 147.95 24.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.284 1.433 . . . . 2.88 108.652 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.01 125.09 26.81 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 107.79 -1.189 . . . . 3.49 107.79 165.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.1 p -118.3 138.71 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 106.755 -1.572 . . . . 3.66 106.755 168.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.73 -44.64 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.608 1.563 . . . . 4.98 109.086 176.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.1 mm -100.4 -53.46 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.717 -1.216 . . . . 7.26 107.717 167.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 C--O 1.25 1.107 0 C-N-CA 125.318 1.447 . . . . 11.58 107.935 -168.736 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 107.079 -1.452 . . . . 12.81 107.079 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.8 -79.65 0.22 Allowed Glycine 0 CA--C 1.52 0.358 0 N-CA-C 107.95 -2.06 . . . . 4.11 107.95 178.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -157.16 170.24 22.95 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.945 -1.502 . . . . 4.67 106.945 163.643 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.11 108.96 0.38 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 106.372 -2.691 . . . . 1.77 106.372 171.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.55 96.18 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 125.368 1.467 . . . . 3.2 108.379 -177.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.9 tp -110.16 101.47 10.25 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.427 1.091 . . . . 3.4 108.21 -176.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -99.08 94.82 6.72 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.537 -0.912 . . . . 3.06 108.537 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -85.42 156.69 20.73 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.967 -0.753 . . . . 3.93 108.967 177.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.58 144.36 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.107 -1.442 . . . . 1.77 107.107 149.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.52 133.47 42.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.095 1.358 . . . . 3.5 109.237 177.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -137.37 166.12 24.58 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.04 0.536 . . . . 7.57 110.977 -177.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.55 -11.43 70.09 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.403 1.001 . . . . 1.33 110.726 -165.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 29.0 mtm -74.86 73.39 2.11 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.419 1.088 . . . . 2.1 110.192 -177.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.9 t -60.69 -37.09 80.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.459 1.104 . . . . 2.53 113.029 -170.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.4 p -145.04 167.27 23.09 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 118.81 0.732 . . . . 0.83 110.77 -173.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.5 -47.54 2.67 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.288 1.435 . . . . 1.97 111.965 -178.901 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 m -43.74 -42.43 5.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.445 1.098 . . . . 2.22 112.387 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.7 m -55.95 -36.0 67.29 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.393 0.677 . . . . 0.94 112.458 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.7 t -55.67 -60.29 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.2 0.524 . . . . 2.46 109.872 -177.139 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -71.25 -30.83 66.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.485 -0.769 . . . . 2.08 111.497 178.027 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -48.88 -45.52 41.2 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.137 0.881 . . . . 4.17 109.495 171.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.2 mt -69.59 -74.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 109.656 -0.498 . . . . 2.55 109.656 168.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -57.25 -48.4 78.96 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.435 0.561 . . . . 3.85 111.764 -161.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 t -63.39 -28.13 69.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.098 -0.477 . . . . 1.48 110.993 -178.137 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.2 t -71.99 -69.26 0.4 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.048 -0.723 . . . . 2.02 109.048 168.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.2 tp -54.62 -32.38 58.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.22 1.808 . . . . 4.24 113.165 -168.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.0 m -58.14 -19.74 35.08 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.151 -0.968 . . . . 3.28 112.656 176.216 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -57.04 -25.04 57.94 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.896 -1.127 . . . . 5.59 112.272 170.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -89.04 93.79 9.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.965 -1.124 . . . . 2.69 107.965 175.465 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.63 5.27 0.46 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.105 1.15 . . . . 7.51 114.105 -174.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.73 -26.86 73.95 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.243 -0.911 . . . . 1.25 111.423 164.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -79.75 146.28 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.438 -1.319 . . . . 3.22 107.438 170.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.9 mt -102.32 -42.51 5.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.368 1.467 . . . . 2.94 108.872 175.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -155.46 155.03 32.78 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 118.075 -0.964 . . . . 3.99 109.965 173.209 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -131.07 81.7 2.01 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.969 0.908 . . . . 2.83 109.519 178.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -77.69 78.89 4.19 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.019 -1.051 . . . . 1.81 108.945 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.0 t -79.86 140.01 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 126.311 1.844 . . . . 3.9 109.138 176.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.57 152.14 28.43 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.237 0.542 . . . . 1.87 110.789 169.12 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -95.84 -36.06 11.26 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.266 1.427 . . . . 2.67 109.938 -178.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.15 -36.99 32.41 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.114 0.966 . . . . 2.07 112.807 179.182 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.2 7.3 15.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.739 0.816 . . . . 2.74 111.445 174.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.3 m120 45.82 51.47 10.42 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.986 0.914 . . . . 2.71 111.744 -175.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -121.39 158.75 27.61 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.578 1.151 . . . . 5.54 110.253 -170.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.76 96.75 2.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.785 -1.098 . . . . 1.79 108.712 168.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -81.24 94.4 6.69 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.352 -1.351 . . . . 1.23 107.352 171.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.09 122.89 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 107.235 -1.394 . . . . 2.76 107.235 171.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -97.18 129.45 44.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.346 -2.094 . . . . 3.16 105.346 161.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -154.6 160.84 41.71 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.004 0.922 . . . . 3.84 109.757 -173.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.22 118.47 69.19 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 108.263 -1.014 . . . . 3.4 108.263 169.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -79.24 61.08 8.06 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.989 3.126 . . . . 2.19 111.877 -167.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -169.35 -45.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.08 1.352 . . . . 3.41 109.519 -174.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.2 mt -66.79 -33.12 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 122.77 0.428 . . . . 4.2 110.007 176.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.8 tt -146.78 134.9 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.241 -1.392 . . . . 2.77 107.241 178.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.17 161.69 37.88 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 111.304 -0.719 . . . . 1.11 111.304 178.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -60.21 -45.03 25.02 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.69 2.26 . . . . 1.04 110.382 177.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.443 HH11 ' CD2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -64.88 -30.59 71.6 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 118.739 -0.648 . . . . 7.89 110.988 177.057 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -66.66 -48.64 68.74 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.814 1.188 . . . . 2.62 109.547 177.378 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.8 mt -49.74 -57.77 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.996 -0.742 . . . . 1.87 108.996 170.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.5 mt -55.69 -47.16 79.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 118.72 -0.657 . . . . 2.09 111.53 -177.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.443 ' CD2' HH11 ' A' ' 56' ' ' ARG . 27.3 m80 -49.12 -45.52 43.62 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.611 0.764 . . . . 4.39 109.821 172.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.5 m -65.16 -48.94 71.75 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.435 -0.95 . . . . 2.08 108.435 -176.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.0 -61.65 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.2 0 N-CA-C 109.584 -0.524 . . . . 2.72 109.584 177.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -60.46 -37.84 82.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.464 -0.334 . . . . 3.05 110.344 -164.39 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.6 m -54.14 -33.9 59.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.84 0.856 . . . . 2.99 113.184 177.566 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.66 -60.17 3.43 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.368 0.986 . . . . 3.32 111.409 -176.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.95 22.61 0.19 Allowed Glycine 0 CA--C 1.526 0.742 0 O-C-N 120.645 -1.284 . . . . 1.36 112.925 166.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -134.28 176.58 8.47 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.537 1.168 . . . . 3.56 113.093 -143.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -128.89 160.02 33.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.891 -1.522 . . . . 3.83 106.891 167.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.71 163.53 31.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.02 0.528 . . . . 1.87 110.577 171.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -155.18 177.55 11.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.086 1.354 . . . . 2.49 107.773 173.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -121.4 143.86 48.99 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.213 1.005 . . . . 4.03 109.09 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.0 p -149.86 26.3 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.272 0.629 . . . . 3.73 110.162 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -102.04 103.45 14.05 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.373 -0.973 . . . . 5.25 108.373 179.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.2 mt -68.61 135.14 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.043 -1.465 . . . . 6.45 107.043 166.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 C--O 1.255 1.38 0 N-CA-C 103.964 -2.606 . . . . 10.86 103.964 -176.666 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 64.4 mtt . . . . . 0 N--CA 1.468 0.435 0 N-CA-C 108.792 -0.818 . . . . 9.93 108.792 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.64 -148.26 17.88 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 106.585 -2.606 . . . . 3.76 106.585 177.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -134.53 166.64 22.42 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.192 -1.781 . . . . 5.12 106.192 155.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.26 72.28 0.25 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 107.737 -2.145 . . . . 2.34 107.737 172.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.7 85.57 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 122.662 1.22 . . . . 3.42 108.864 173.241 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 tp -77.76 72.95 4.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.165 -1.05 . . . . 4.19 108.165 167.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.54 125.53 29.48 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.216 -1.356 . . . . 3.22 108.402 153.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -148.39 160.89 42.57 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 125.384 1.678 . . . . 2.93 109.208 178.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.88 137.57 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.705 -1.961 . . . . 2.11 105.705 168.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.3 t -116.43 135.21 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 105.612 -1.996 . . . . 3.15 105.612 165.123 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -110.01 169.25 8.85 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.838 -1.171 . . . . 8.72 107.838 162.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.39 -119.9 6.34 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 106.373 -2.691 . . . . 2.48 106.373 -152.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 47.0 mtm 36.14 60.84 0.82 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.075 1.75 . . . . 2.77 113.095 178.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.7 t -85.59 -9.81 56.78 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 117.916 -1.04 . . . . 1.86 112.964 -176.306 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.7 p -163.69 171.7 15.26 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.843 1.201 . . . . 0.76 109.708 173.63 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.97 -43.2 29.27 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.538 1.135 . . . . 1.71 111.538 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.9 m -65.6 -25.91 67.6 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.623 -0.703 . . . . 2.24 112.619 -179.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.1 m -73.36 -57.49 3.97 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 119.093 0.86 . . . . 0.82 110.455 163.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.1 t -43.79 -63.17 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 124.04 0.936 . . . . 2.15 109.971 -175.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -68.01 -10.55 54.49 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 119.732 -0.787 . . . . 1.59 113.052 -173.372 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -70.23 -41.29 73.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.0 -1.111 . . . . 3.92 108.0 -178.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.6 mt -55.74 -62.97 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.243 -1.021 . . . . 2.33 108.243 177.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -53.21 -57.65 9.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.993 0.517 . . . . 3.3 110.457 -179.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.8 t -51.43 -48.75 62.6 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.058 0.543 . . . . 1.79 111.422 -179.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 t -70.34 -33.22 71.23 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.801 -0.814 . . . . 2.0 108.801 -172.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.2 mt -70.32 -45.71 65.69 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.624 -0.672 . . . . 3.41 111.16 174.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.4 p -57.76 -15.67 8.81 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.513 1.671 . . . . 2.99 115.513 -168.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.94 -36.43 74.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.603 1.092 . . . . 6.51 112.136 168.578 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -66.85 138.86 57.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.687 -0.857 . . . . 2.62 108.687 177.03 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -92.03 -5.88 52.12 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.274 0.23 . . . . 7.23 110.963 169.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.4 -30.58 58.28 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.585 -0.606 . . . . 1.22 111.585 174.358 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.79 146.19 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.6 -1.63 . . . . 3.29 106.6 168.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.0 mt -109.97 -37.79 5.51 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.989 1.716 . . . . 2.82 109.288 -175.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -153.27 150.29 28.8 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.412 -0.958 . . . . 3.51 108.412 176.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.0 m -130.79 142.45 50.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.168 -1.419 . . . . 2.58 107.168 172.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.9 t -152.26 157.23 41.11 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.271 -1.381 . . . . 2.33 107.271 159.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.43 138.83 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 124.573 1.149 . . . . 3.04 109.257 -178.025 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.84 95.95 4.49 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.017 0.927 . . . . 2.51 109.03 177.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -25.59 44.34 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.89 0.33 . . . . 4.47 111.89 167.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.55 -40.48 68.76 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.301 0.64 . . . . 1.93 111.552 178.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.5 t -110.27 -15.34 13.99 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.836 0.855 . . . . 3.77 111.301 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 65.88 74.31 0.37 Allowed 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 126.493 1.917 . . . . 2.38 110.339 -171.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.46 145.92 21.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.17 -0.678 . . . . 5.1 109.17 171.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.19 132.38 54.17 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 106.818 -1.549 . . . . 1.76 106.818 167.274 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -109.07 99.25 8.59 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 127.496 2.319 . . . . 1.17 104.953 176.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.2 mm -108.18 110.93 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 106.077 -1.823 . . . . 3.19 106.077 176.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.2 mmtt -82.45 128.83 34.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.3 -1.741 . . . . 4.26 106.3 165.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -141.88 157.2 45.27 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.84 0.856 . . . . 3.21 108.946 174.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.5 121.89 63.95 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 107.113 -1.44 . . . . 3.48 107.113 173.281 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.56 44.1 1.57 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.196 2.597 . . . . 1.99 112.588 -172.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' OE1' ' N ' ' A' ' 1' ' ' MET . 80.9 mt-10 -132.88 6.47 3.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.946 1.698 . . . . 3.57 110.838 -179.021 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -157.19 -30.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.866 0.866 . . . . 3.62 112.525 -162.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 tt -139.25 145.03 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.765 -1.939 . . . . 2.48 105.765 165.383 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.03 154.53 24.57 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.134 -1.186 . . . . 1.29 110.134 176.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -59.06 -38.5 86.94 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.056 1.838 . . . . 1.21 109.792 173.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -54.35 -39.52 67.19 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.678 0.791 . . . . 7.11 111.864 173.43 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -70.09 -44.83 68.24 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.797 0.726 . . . . 2.44 109.356 -177.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.7 mt -53.95 -52.27 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.394 -0.595 . . . . 2.06 109.394 173.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.4 mt -52.33 -53.93 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.164 0.585 . . . . 2.33 110.34 176.199 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -51.28 -44.24 61.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.858 0.754 . . . . 3.79 110.882 175.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.7 m -66.25 -40.75 90.43 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 110.075 -0.343 . . . . 2.0 110.075 -174.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.8 mt -56.55 -67.58 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.791 -0.818 . . . . 2.31 108.791 168.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -61.82 -43.51 98.71 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.548 -0.296 . . . . 3.8 111.372 -161.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.2 m -63.56 -13.1 38.26 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.249 0.833 . . . . 3.44 113.249 -174.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.7 mt -70.76 -80.16 0.06 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.322 -0.992 . . . . 2.99 108.322 171.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.94 42.41 0.45 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-O 118.759 -1.023 . . . . 1.13 110.828 165.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -131.25 177.16 7.68 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.823 0.812 . . . . 3.04 110.586 -161.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -134.51 145.95 49.26 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.915 -1.513 . . . . 5.0 106.915 176.367 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.44 150.94 48.99 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 120.57 1.532 . . . . 1.88 113.082 -178.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.8 t -155.31 129.18 8.66 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 109.064 -0.717 . . . . 3.32 109.064 166.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 pp -56.84 152.56 12.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.314 -0.625 . . . . 3.56 109.314 162.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.6 t -130.83 -86.58 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 106.157 -1.794 . . . . 3.92 106.157 174.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.4 mttp 61.63 171.05 0.11 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.054 . . . . 5.7 111.654 -173.336 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.7 mp 53.78 63.86 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 106.482 -1.674 . . . . 6.71 106.482 -157.354 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 . . . . . 0 C--O 1.256 1.442 0 N-CA-C 103.121 -2.918 . . . . 10.64 103.121 -152.258 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 106.896 -1.52 . . . . 11.83 106.896 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 166.89 140.36 2.88 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.07 -2.412 . . . . 4.19 107.07 178.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -76.53 110.63 11.24 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 118.028 0.914 . . . . 4.76 109.024 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.21 137.55 28.12 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 106.872 -2.491 . . . . 1.7 106.872 165.308 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -121.87 74.89 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 118.672 1.236 . . . . 3.6 109.058 -176.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 tp -79.99 71.8 6.72 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.766 -0.827 . . . . 3.4 108.766 -177.787 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -78.03 69.43 4.25 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.645 0.736 . . . . 3.55 109.153 -178.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.81 156.33 26.21 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.437 0.695 . . . . 3.28 111.097 -176.705 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.94 123.51 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.246 -1.39 . . . . 1.92 107.246 172.033 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.2 t -112.06 125.08 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.073 -1.825 . . . . 2.99 106.073 176.287 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.22 176.83 5.4 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.391 1.476 . . . . 6.87 109.231 -173.478 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.46 -69.52 3.24 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 108.767 -1.733 . . . . 2.41 108.767 -177.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.6 mtp 2.31 66.42 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.864 2.866 . . . . 2.71 115.477 -178.468 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.5 t -87.69 -11.43 48.35 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 117.59 -1.195 . . . . 2.14 113.694 -161.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.6 p -164.78 178.9 6.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 120.418 1.463 . . . . 0.78 110.479 175.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.41 -39.64 47.72 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.538 1.135 . . . . 1.77 111.599 175.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -52.4 -43.05 64.53 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.552 -0.536 . . . . 2.86 109.552 175.684 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.7 m -65.33 -57.23 8.91 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 121.504 -0.748 . . . . 0.94 109.153 -178.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 83.7 t -40.47 -68.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.567 1.147 . . . . 2.02 111.33 177.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -31.43 68.99 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 119.474 -0.891 . . . . 0.86 111.876 -169.875 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -65.6 -48.12 73.37 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 121.617 -0.677 . . . . 4.48 109.319 178.169 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.4 mt -53.21 -61.23 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.048 -1.093 . . . . 2.14 108.048 173.33 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -51.3 -49.71 60.77 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.246 0.618 . . . . 3.71 111.793 -176.428 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 t -55.12 -53.42 56.09 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.999 0.519 . . . . 2.19 109.862 176.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.4 m -59.86 -40.1 87.44 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.223 0.535 . . . . 2.92 110.08 -176.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -51.52 63.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.922 0.889 . . . . 3.76 110.376 -179.608 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 26.5 m -58.01 -29.47 65.32 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.767 -0.651 . . . . 3.12 110.183 176.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -5.67 8.67 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.412 1.264 . . . . 5.83 114.412 174.446 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -74.02 -122.26 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 120.437 1.471 . . . . 4.48 111.378 -178.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.18 -62.45 0.09 Allowed 'General case' 0 C--N 1.342 0.259 0 O-C-N 120.928 -1.108 . . . . 14.09 110.466 177.707 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.72 47.28 3.62 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.575 -0.61 . . . . 1.94 111.575 -177.817 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -115.06 136.6 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.8 -1.185 . . . . 4.1 107.8 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.9 mt -97.73 -42.22 7.72 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.156 0.983 . . . . 2.92 108.671 175.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -156.11 154.04 30.3 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 110.017 -0.364 . . . . 3.37 110.017 -178.278 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 p -132.22 144.34 50.56 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.639 0.775 . . . . 3.54 109.453 162.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 m -154.07 122.58 6.2 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.881 1.272 . . . . 3.22 107.914 161.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -115.18 154.67 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.021 0.529 . . . . 2.75 109.886 -178.12 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.22 123.25 14.53 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.891 0.476 . . . . 1.9 109.918 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.96 -15.0 60.24 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.806 1.242 . . . . 2.45 112.546 177.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.58 -50.4 37.66 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.872 -0.788 . . . . 2.11 108.872 173.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.73 -24.53 41.57 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.586 0.754 . . . . 2.55 110.695 177.392 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.5 m120 62.75 47.9 4.44 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 125.69 1.596 . . . . 1.85 108.881 -170.542 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.48 153.28 51.76 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.796 -0.446 . . . . 3.1 109.796 -172.679 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.74 99.99 6.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 124.523 1.139 . . . . 1.74 108.83 173.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -78.45 89.26 4.42 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 105.751 -1.944 . . . . 1.29 105.751 172.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.2 pt -93.27 140.95 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 107.65 -1.241 . . . . 4.23 107.65 165.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -112.21 130.33 55.96 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 106.309 -1.737 . . . . 3.54 106.309 160.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -141.07 161.27 38.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.598 0.759 . . . . 2.88 111.361 -166.399 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -93.02 103.8 10.15 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 125.785 1.634 . . . . 4.34 108.105 178.656 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.25 59.6 7.46 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.909 3.073 . . . . 2.45 111.221 -168.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -173.39 -49.01 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.283 1.833 . . . . 3.29 108.04 -172.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.3 mt -74.65 -37.7 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 109.818 -0.438 . . . . 4.24 109.818 173.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 tt -128.87 126.42 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 106.593 -1.632 . . . . 2.47 106.593 177.45 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.14 174.86 52.99 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.437 -1.865 . . . . 1.1 108.437 168.145 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.11 -48.51 4.88 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.687 1.592 . . . . 1.33 110.137 175.48 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.25 31.4 ttt85 -70.1 -20.82 63.17 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.271 0.841 . . . . 7.13 113.271 -169.559 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -46.63 -57.18 5.03 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.638 0.654 . . . . 2.84 109.719 167.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.02 -48.21 84.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 109.425 -0.583 . . . . 2.6 109.425 -176.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.5 mt -56.59 -40.89 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.937 -0.574 . . . . 2.47 110.473 -176.34 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -52.52 -40.76 62.8 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 118.938 0.79 . . . . 4.07 111.644 172.772 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.2 m -66.47 -51.17 59.68 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.741 0.701 . . . . 2.21 109.314 178.296 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.87 -52.56 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.0 0.92 . . . . 3.36 110.735 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.2 -56.2 24.92 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.456 1.102 . . . . 1.88 110.322 174.178 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 t -65.57 -21.19 66.57 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 118.231 -0.89 . . . . 2.46 112.921 -171.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.2 mt -71.23 -96.27 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.008 -1.108 . . . . 3.07 108.008 166.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.71 36.93 0.47 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.575 -1.125 . . . . 1.14 112.053 171.053 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -131.86 127.65 37.0 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 118.569 1.184 . . . . 2.99 110.406 -166.106 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -78.73 159.63 27.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.555 -0.905 . . . . 4.16 108.555 178.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.34 142.4 50.08 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.883 0.873 . . . . 2.75 110.338 -173.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -155.23 124.24 6.2 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.654 -0.869 . . . . 2.97 108.654 167.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.0 142.89 49.35 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.256 -0.646 . . . . 3.91 109.256 172.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.0 m -139.92 150.05 22.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 106.014 -1.847 . . . . 3.79 106.014 178.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -146.21 -35.95 0.27 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 115.199 1.555 . . . . 5.2 115.199 -179.537 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 99.0 mt -128.23 -63.71 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 104.687 -2.338 . . . . 6.8 104.687 175.03 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 . . . . . 0 C--O 1.258 1.537 0 N-CA-C 105.409 -2.071 . . . . 11.91 105.409 139.569 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtt . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 108.893 -0.78 . . . . 8.08 108.893 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.67 63.93 3.02 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.607 -1.397 . . . . 5.08 109.607 175.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -168.59 167.36 11.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.228 1.411 . . . . 5.24 108.699 -166.388 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.78 150.49 6.19 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 106.997 -2.441 . . . . 1.74 106.997 -173.374 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.69 78.4 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.091 1.356 . . . . 3.8 109.632 -173.076 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.1 82.33 5.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.305 -0.872 . . . . 4.08 109.257 -175.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -85.15 117.21 23.97 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.655 -0.869 . . . . 4.4 108.655 165.113 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.86 169.78 16.86 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.088 0.955 . . . . 2.99 109.995 170.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -90.08 142.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.396 -0.965 . . . . 1.79 108.396 170.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.18 130.46 74.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 125.713 1.605 . . . . 3.75 108.353 174.085 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -121.94 144.55 48.8 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.208 1.803 . . . . 6.74 107.72 -174.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.78 -125.34 7.36 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 106.288 -2.725 . . . . 2.78 106.288 -163.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.8 mtm 49.73 68.61 0.71 Allowed 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.791 1.236 . . . . 2.6 112.288 178.015 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 p -61.39 -28.86 69.54 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.674 0.62 . . . . 3.97 112.674 178.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.56 171.22 16.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.751 0.705 . . . . 1.49 110.259 -171.402 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.45 -37.36 17.04 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.344 1.058 . . . . 2.16 111.45 176.113 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -47.95 -33.84 8.3 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.294 2.238 . . . . 2.88 113.06 174.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.7 m -74.89 -60.99 2.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.305 1.042 . . . . 0.79 111.445 166.554 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.3 t -45.62 -58.4 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.799 1.24 . . . . 2.19 110.947 -171.245 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.47 -30.58 71.36 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.175 0.512 . . . . 1.82 111.363 -176.454 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -71.29 -49.24 44.88 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.192 -1.04 . . . . 4.56 108.192 -176.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 77.0 mt -54.03 -56.15 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 108.572 -0.899 . . . . 1.86 108.572 174.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -64.98 -44.75 88.28 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.59 0.233 . . . . 3.9 111.627 -171.326 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.5 t -63.59 -42.29 98.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.209 0.603 . . . . 1.8 110.617 177.044 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.9 t -62.96 -50.82 69.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.365 -1.346 . . . . 2.09 107.365 -178.255 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.1 mt -47.17 -53.6 12.66 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 122.983 0.513 . . . . 4.1 111.459 174.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.8 p -58.4 -12.22 3.62 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.082 1.142 . . . . 2.63 114.082 -178.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -32.48 73.99 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.709 1.141 . . . . 5.81 111.956 172.599 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -88.24 110.26 20.58 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 108.067 -1.086 . . . . 2.25 108.067 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.8 -17.12 33.29 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.309 -0.869 . . . . 7.08 112.005 172.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.47 -33.99 67.74 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.911 -0.938 . . . . 1.22 112.686 169.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.24 128.34 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.783 -1.562 . . . . 3.5 106.783 172.71 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.3 mt -86.58 -35.53 19.41 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.821 1.248 . . . . 2.98 109.35 -176.117 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -154.8 147.36 24.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.295 -1.002 . . . . 3.23 108.295 177.393 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.8 p -124.75 147.18 48.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.02 0.928 . . . . 2.74 109.046 169.221 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.9 t -152.39 101.28 2.66 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.979 -1.119 . . . . 2.0 107.979 169.725 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.6 m -90.26 161.74 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.048 1.339 . . . . 2.88 110.441 176.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.64 138.39 14.23 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.281 -0.637 . . . . 1.97 109.281 155.19 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 pp -76.13 -32.47 59.15 Favored 'General case' 0 C--O 1.227 -0.099 0 N-CA-C 108.841 -0.8 . . . . 2.6 108.841 159.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.08 -15.45 23.31 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.282 1.033 . . . . 2.53 111.938 179.156 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.9 m -139.3 20.35 2.58 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 121.535 -0.728 . . . . 2.89 110.575 172.557 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.7 m120 33.41 43.72 0.06 Allowed 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 125.757 1.623 . . . . 2.47 114.121 -176.273 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.3 158.49 30.88 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.233 0.613 . . . . 3.47 110.089 -170.69 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.37 115.32 9.18 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.633 -1.247 . . . . 1.62 107.633 163.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -99.16 105.32 17.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 106.07 -1.826 . . . . 1.18 106.07 170.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.58 110.29 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 105.921 -1.881 . . . . 2.95 105.921 175.371 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -82.91 136.29 34.63 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.717 -1.586 . . . . 4.76 106.717 164.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -158.65 155.55 28.38 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 118.956 0.798 . . . . 2.79 112.864 -168.076 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -87.19 120.28 71.3 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.184 0.993 . . . . 3.17 108.432 167.03 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.07 -14.55 23.49 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.066 2.511 . . . . 1.96 113.695 -174.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -84.67 -47.7 10.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.175 -1.046 . . . . 4.2 108.175 176.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.2 mt -66.47 -36.91 78.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 119.256 -0.402 . . . . 4.05 110.569 -178.388 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.0 tt -144.03 124.2 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.845 -0.798 . . . . 2.51 108.845 176.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.79 154.37 52.17 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.335 -1.106 . . . . 1.15 110.335 179.421 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -57.87 -41.28 70.85 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.923 1.749 . . . . 1.2 109.88 174.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -62.88 -30.09 71.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.922 -0.561 . . . . 6.81 111.911 176.127 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -70.38 -44.94 67.01 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.556 1.071 . . . . 2.26 109.19 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 mt -52.47 -55.94 8.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.15 -0.685 . . . . 1.94 109.15 171.133 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.4 mt -52.2 -53.41 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 119.401 -0.333 . . . . 2.04 110.632 179.411 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -50.65 -43.49 57.21 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.024 0.53 . . . . 4.03 110.938 175.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.8 m -62.44 -49.49 75.24 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.561 -0.533 . . . . 1.77 109.561 -177.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.82 -54.47 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.209 0.604 . . . . 2.9 109.96 176.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -58.19 -50.66 72.76 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.428 0.691 . . . . 2.59 110.582 -176.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -54.99 -33.39 62.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.443 1.497 . . . . 2.03 112.217 -172.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.8 mt -63.55 -82.89 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.047 0.385 . . . . 3.15 110.612 178.461 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.98 33.12 0.43 Allowed Glycine 0 CA--C 1.525 0.701 0 O-C-N 121.217 -0.927 . . . . 0.99 112.775 173.355 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -135.08 176.06 9.01 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.26 1.03 . . . . 2.78 110.316 -159.671 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -130.3 136.57 49.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.507 -1.294 . . . . 3.78 107.507 172.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.73 156.97 16.31 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.559 0.744 . . . . 2.14 109.774 177.029 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.2 m -151.33 114.25 4.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.455 -0.942 . . . . 2.51 108.455 170.012 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.28 65.42 0.61 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.323 1.049 . . . . 4.45 110.849 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 t -55.44 124.41 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.083 -1.08 . . . . 3.75 108.083 169.547 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -167.25 148.08 5.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 104.44 -2.43 . . . . 5.25 104.44 179.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.2 mt -131.44 -64.48 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.085 0 N-CA-C 105.78 -1.933 . . . . 7.08 105.78 -178.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 . . . . . 0 C--O 1.248 1.002 0 N-CA-C 103.64 -2.726 . . . . 10.46 103.64 136.761 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 108.239 -1.023 . . . . 8.19 108.239 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.27 -118.29 0.88 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 103.314 -3.914 . . . . 4.28 103.314 136.14 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 63.02 28.47 16.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 117.662 0.731 . . . . 6.34 111.74 157.16 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.4 -168.97 36.95 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.461 1.029 . . . . 2.2 114.2 -160.281 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.98 133.44 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 125.974 1.71 . . . . 3.29 107.066 176.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 tt -139.13 103.56 4.8 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.425 -1.695 . . . . 3.95 106.425 173.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -112.29 117.28 32.06 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.524 0.602 . . . . 3.83 110.667 177.532 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.78 161.32 35.92 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.531 1.132 . . . . 3.9 111.08 -171.068 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.5 t -82.71 111.98 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 125.378 1.471 . . . . 2.29 107.411 176.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -86.85 73.75 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.679 1.192 . . . . 3.67 108.336 172.629 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.11 66.21 3.67 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.445 1.098 . . . . 7.84 109.71 -172.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.36 -44.4 0.02 OUTLIER Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.854 -0.899 . . . . 2.33 110.854 -175.416 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -61.4 120.05 9.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.562 0.681 . . . . 2.83 109.193 177.75 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 t -98.53 -45.65 6.02 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.988 0.515 . . . . 2.28 111.751 -172.91 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.0 p -130.59 172.75 11.59 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.758 0.708 . . . . 0.96 110.868 -175.125 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.46 -45.47 9.15 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.9 1.28 . . . . 2.07 111.922 179.422 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 m -54.41 -42.12 70.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.217 1.007 . . . . 2.59 111.584 177.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.6 m -71.41 -51.36 24.4 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.031 0.532 . . . . 0.96 110.643 174.736 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.3 t -44.75 -59.02 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.299 1.039 . . . . 2.16 109.988 -179.049 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.306 0.2 OUTLIER -69.14 -14.88 63.24 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 119.257 -0.977 . . . . 1.71 112.028 -175.238 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.1 tttt -71.34 -46.56 60.24 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 120.766 -1.209 . . . . 3.86 108.269 -175.763 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.4 mt -52.74 -67.67 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.221 -1.029 . . . . 2.44 108.221 177.378 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.73 -66.09 0.46 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.177 0.806 . . . . 4.25 113.177 178.466 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.2 m -50.69 -39.33 50.92 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 118.433 0.561 . . . . 3.45 112.216 -177.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.3 t -70.57 -60.78 2.06 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.441 -0.948 . . . . 2.15 108.441 179.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -52.58 -34.8 52.22 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.447 1.099 . . . . 3.64 112.296 -174.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.3 m -55.28 -22.59 19.22 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.947 0.721 . . . . 3.18 112.947 179.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -66.06 -23.76 66.6 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 120.101 1.319 . . . . 5.92 112.507 174.099 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -81.62 103.7 11.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.09 -1.448 . . . . 2.64 107.09 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 25.3 mtp-105 -57.19 -21.86 36.41 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.498 1.045 . . . . 8.24 112.13 173.256 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.82 0.97 18.0 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.743 -1.032 . . . . 1.67 113.951 173.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 pp -120.06 128.57 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 119.315 1.558 . . . . 3.65 106.933 159.175 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.4 mt -83.71 -30.66 26.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 110.257 -0.275 . . . . 2.84 110.257 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -157.07 151.6 25.42 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.589 -1.263 . . . . 3.4 107.589 178.085 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.5 t -128.65 119.14 24.14 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.882 1.273 . . . . 2.9 108.723 169.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 t -120.91 93.89 4.17 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.019 1.328 . . . . 2.08 109.975 -173.405 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -92.98 149.74 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.973 1.709 . . . . 3.51 111.719 -169.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.9 139.65 18.02 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.237 0.615 . . . . 1.95 111.666 168.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.0 mt -78.89 -54.52 5.96 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 125.541 1.536 . . . . 3.77 108.694 170.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -45.81 -42.61 12.47 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.63 0.772 . . . . 2.57 111.866 -177.28 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -101.02 -5.05 26.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.051 0.94 . . . . 2.99 112.247 -178.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.02 69.23 0.63 Allowed 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.988 1.315 . . . . 2.41 111.041 -178.574 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.98 163.52 39.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.177 0.513 . . . . 3.52 111.56 -172.501 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -147.01 103.5 3.61 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.959 2.104 . . . . 2.01 107.427 171.097 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -80.37 106.41 12.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.37 -1.715 . . . . 1.28 106.37 172.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.0 mt -105.98 114.41 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 106.66 -1.607 . . . . 2.87 106.66 177.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -78.63 71.93 5.13 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.836 -1.172 . . . . 3.91 107.836 172.719 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.91 153.62 43.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.755 -0.657 . . . . 3.81 111.232 -179.122 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -106.17 117.53 57.19 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 108.869 -0.789 . . . . 3.13 108.869 162.041 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -67.27 -23.16 45.3 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.153 2.568 . . . . 1.63 113.009 -173.539 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -74.52 -43.46 55.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.302 0.955 . . . . 3.8 109.283 -174.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.6 tp -89.16 -34.96 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.339 0.496 . . . . 4.72 112.339 -179.129 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mm -133.47 112.68 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.487 -0.931 . . . . 2.68 108.487 -170.065 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.94 163.28 49.33 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 110.831 -0.908 . . . . 1.39 110.831 177.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -55.97 -43.26 58.5 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.721 2.281 . . . . 1.55 109.957 175.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -32.87 65.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.307 0.643 . . . . 7.68 112.66 176.201 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -70.12 -49.42 50.93 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.879 0.763 . . . . 2.6 109.012 179.139 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.6 mt -53.64 -57.25 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.034 -0.358 . . . . 2.29 110.034 174.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.9 mt -49.58 -54.95 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 123.646 0.778 . . . . 2.56 109.139 178.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -55.39 -41.4 72.61 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 111.51 0.189 . . . . 5.65 111.51 178.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 64.5 m -62.94 -49.6 74.11 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.794 -0.817 . . . . 2.16 108.794 -177.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.78 -53.85 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.487 -0.56 . . . . 2.56 109.487 174.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -56.02 -37.63 69.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.146 0.578 . . . . 2.21 111.522 -178.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.1 m -63.67 -15.88 59.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.461 -0.78 . . . . 3.21 113.094 -178.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.31 -96.6 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.593 1.088 . . . . 3.23 108.754 169.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.33 44.97 0.47 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.928 -1.269 . . . . 1.34 109.928 174.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -134.15 176.62 8.43 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.592 1.157 . . . . 3.02 109.169 -163.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -139.68 167.79 21.31 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.737 -1.208 . . . . 3.51 107.737 164.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -135.22 152.41 51.53 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.567 1.147 . . . . 1.88 110.384 -167.076 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.6 m -150.87 124.17 8.88 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.803 -0.56 . . . . 2.36 110.257 168.305 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.75 148.9 51.02 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.929 -0.767 . . . . 4.8 108.929 169.193 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -139.64 130.09 31.28 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 N-CA-C 105.069 -2.197 . . . . 3.45 105.069 176.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.267 0.1 OUTLIER 70.04 152.92 0.11 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.616 1.566 . . . . 4.57 111.374 -168.501 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.2 pt -68.95 149.49 11.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 O-C-N 122.12 -0.362 . . . . 9.08 111.23 -176.076 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 . . . . . 0 C--O 1.256 1.397 0 C-N-CA 129.217 3.007 . . . . 12.0 105.265 178.266 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.553 0 N-CA-C 107.421 -1.326 . . . . 9.63 107.421 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.39 80.63 0.15 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 108.636 -1.786 . . . . 4.35 108.636 161.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.3 156.43 12.6 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.246 0.618 . . . . 4.45 112.191 -173.02 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.16 142.62 15.53 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.23 -1.948 . . . . 2.26 108.23 170.347 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.47 158.47 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.517 0.727 . . . . 3.58 109.148 173.226 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.03 131.74 17.9 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.84 -1.541 . . . . 3.64 106.84 169.732 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -117.34 112.92 21.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.837 -0.801 . . . . 3.31 108.837 175.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.7 mt -109.93 136.16 49.66 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.244 1.417 . . . . 3.4 108.08 -179.349 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -78.54 96.45 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.255 -2.498 . . . . 2.23 104.255 156.678 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.5 t -82.69 131.21 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.004 -1.48 . . . . 2.77 107.004 172.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -144.2 136.85 26.93 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.771 0.828 . . . . 6.25 108.877 -169.717 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.4 -25.91 9.46 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.47 1.033 . . . . 1.31 110.775 -169.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -70.57 74.22 0.55 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 122.173 0.987 . . . . 2.79 110.972 179.461 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -50.68 -36.0 33.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.865 1.266 . . . . 2.5 114.303 -168.42 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 p -146.6 170.62 16.54 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.146 0.885 . . . . 0.92 111.978 -168.505 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.79 -41.8 24.36 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.583 1.153 . . . . 1.85 111.457 176.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 m -59.98 -33.2 71.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.158 0.583 . . . . 2.33 111.724 178.272 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.5 m -72.62 -46.26 54.95 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 119.007 0.821 . . . . 1.24 112.045 167.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.0 t -51.18 -60.98 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 118.262 0.483 . . . . 1.9 110.8 -178.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -27.65 65.0 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.383 -0.823 . . . . 1.03 111.931 -174.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -55.56 -54.68 41.05 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 108.698 -0.852 . . . . 4.25 108.698 169.496 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.8 mt -54.56 -59.39 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 118.451 -0.785 . . . . 1.88 109.012 176.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -50.83 -59.78 3.75 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 123.779 0.674 . . . . 4.24 110.288 -173.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.9 t -58.1 -45.78 86.64 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.653 0.781 . . . . 2.01 110.861 -176.122 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.5 t -64.78 -56.83 11.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.126 -0.694 . . . . 2.11 109.126 -178.038 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.5 tp -52.57 -51.4 59.94 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 125.012 1.325 . . . . 3.34 111.021 -177.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.6 m -62.87 -9.31 9.18 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.954 0.724 . . . . 3.08 112.954 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -31.28 72.44 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.557 -1.339 . . . . 5.45 111.523 168.481 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -79.75 71.87 6.43 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.948 -0.76 . . . . 2.59 108.948 -178.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -42.97 102.23 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.197 1.399 . . . . 7.7 110.137 177.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.24 -39.33 0.81 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.22 -1.552 . . . . 2.69 109.22 -164.167 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.31 140.86 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 104.346 -2.464 . . . . 4.18 104.346 148.579 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.5 mt -104.24 -42.56 5.47 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.576 1.15 . . . . 2.61 109.715 -175.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -146.71 153.06 39.82 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.856 -0.424 . . . . 3.11 109.856 176.162 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.3 t -136.93 136.37 38.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.484 1.914 . . . . 2.95 107.986 174.696 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -131.13 82.17 2.03 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.891 1.277 . . . . 3.32 107.876 172.108 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -78.58 141.71 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.102 0.961 . . . . 2.86 110.268 172.341 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.77 151.07 26.82 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.196 0.598 . . . . 1.99 110.107 169.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.2 -11.97 14.52 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.812 1.245 . . . . 2.21 113.346 -165.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.99 -51.01 52.11 Favored 'General case' 0 C--O 1.226 -0.174 0 N-CA-C 108.576 -0.898 . . . . 2.72 108.576 173.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 m -79.81 -29.17 40.17 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.983 -0.553 . . . . 3.16 111.416 174.252 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.7 m120 67.2 79.71 0.23 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.242 -1.392 . . . . 1.82 107.242 -165.574 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -147.91 158.9 44.28 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.534 -0.543 . . . . 6.06 109.534 -176.186 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.64 108.86 4.44 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.519 1.928 . . . . 1.89 106.612 163.503 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -86.26 117.16 24.89 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.781 -2.303 . . . . 1.44 104.781 164.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.29 148.36 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 105.293 -2.114 . . . . 2.93 105.293 171.358 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.48 141.25 51.05 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.692 -0.855 . . . . 3.29 108.692 156.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -154.46 153.93 32.34 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.315 1.046 . . . . 3.83 109.211 -163.03 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -84.93 114.25 54.62 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 107.665 -1.235 . . . . 3.52 107.665 173.163 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.23 52.51 4.31 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.07 3.18 . . . . 2.09 111.777 -170.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -144.82 -59.7 0.36 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.094 1.758 . . . . 2.93 106.874 -177.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.6 tt -72.63 -25.49 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.203 1.401 . . . . 3.49 111.972 179.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.8 tt -145.93 143.08 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.723 -1.584 . . . . 2.75 106.723 172.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -99.55 161.82 19.66 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.367 -1.093 . . . . 1.13 110.367 174.018 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -56.54 -41.12 79.38 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.501 2.134 . . . . 1.27 110.03 174.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.445 HH22 ' CD ' ' A' ' 63' ' ' GLU . 37.4 tpt85 -56.28 -36.03 68.14 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.09 -0.957 . . . . 7.1 111.726 179.175 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -71.26 -48.17 52.65 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.524 0.73 . . . . 2.19 110.026 -177.37 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 mt -49.63 -56.48 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 108.21 -1.033 . . . . 1.9 108.21 171.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.2 mt -56.05 -43.1 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.893 -0.594 . . . . 2.06 109.999 -179.787 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -56.7 -40.62 75.96 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.397 0.679 . . . . 5.73 111.414 176.308 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.16 -43.92 77.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 119.443 -0.903 . . . . 2.99 109.293 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.9 -52.0 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 124.52 1.128 . . . . 3.16 111.057 174.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.445 ' CD ' HH22 ' A' ' 56' ' ' ARG . 35.6 mt-10 -57.92 -55.52 33.8 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.595 1.158 . . . . 1.94 110.019 175.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.2 t -53.48 -43.42 68.18 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.262 1.025 . . . . 1.97 110.851 -175.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.2 mt -62.59 -66.14 0.58 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 110.312 -0.255 . . . . 3.05 110.312 173.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.99 -24.94 0.02 OUTLIER Glycine 0 CA--C 1.53 0.993 0 N-CA-C 117.504 1.762 . . . . 1.31 117.504 -178.223 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -126.6 152.16 47.01 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 119.055 1.427 . . . . 2.88 110.535 -137.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -84.41 152.42 24.04 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.521 -1.289 . . . . 4.06 107.521 172.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -122.12 129.51 52.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.78 0.832 . . . . 2.21 109.478 163.514 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -108.36 104.41 13.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.496 -1.298 . . . . 2.86 107.496 169.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -53.69 126.42 21.84 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.019 0.827 . . . . 4.87 110.633 175.081 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.1 m -87.36 -34.45 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 117.966 0.348 . . . . 4.52 110.369 176.239 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -165.13 176.07 8.81 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.717 0.807 . . . . 5.59 109.354 172.056 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.5 mm -131.13 147.25 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 126.896 2.078 . . . . 12.4 105.393 173.501 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.254 1.317 0 N-CA-C 105.026 -2.213 . . . . 12.79 105.026 164.119 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 tpt . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 108.022 -1.103 . . . . 8.86 108.022 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.16 52.35 51.95 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 108.392 -1.883 . . . . 4.54 108.392 -161.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.339 2.6 p30 36.64 -108.5 0.05 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.737 1.215 . . . . 4.34 112.251 -153.293 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.3 126.43 2.28 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 106.239 -2.744 . . . . 2.01 106.239 -164.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.5 82.79 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 124.549 1.14 . . . . 4.12 110.635 -172.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 tp -81.55 81.67 7.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.201 -1.037 . . . . 4.27 108.201 175.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -95.0 102.77 14.6 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.155 -0.929 . . . . 2.89 109.029 171.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.6 151.0 40.88 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.755 1.222 . . . . 3.16 109.376 -177.55 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 t -77.6 129.87 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 105.717 -1.957 . . . . 2.1 105.717 166.046 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.4 t -111.35 97.7 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 105.452 -2.055 . . . . 3.44 105.452 174.068 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -81.68 146.43 30.02 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.267 -1.012 . . . . 8.54 108.267 178.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.13 -9.51 56.37 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.06 0.838 . . . . 1.06 112.1 -174.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.7 ttm -65.96 71.95 0.06 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.605 1.562 . . . . 3.12 110.935 176.676 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -71.98 -31.47 66.3 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.697 0.629 . . . . 2.13 112.697 -167.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.9 p -154.18 174.81 14.25 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.255 0.934 . . . . 0.89 112.397 -169.359 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.89 -41.26 45.27 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.503 1.121 . . . . 1.93 111.046 175.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.9 m -63.72 -24.79 67.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.174 0.589 . . . . 2.12 112.235 178.498 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.3 m -72.57 -62.6 1.39 Allowed 'General case' 0 C--N 1.337 0.05 0 CA-C-N 119.478 1.035 . . . . 0.95 110.086 163.207 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.7 t -36.24 -66.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 125.538 1.535 . . . . 1.9 111.072 -177.002 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.33 -27.6 66.41 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.705 -0.398 . . . . 0.95 111.604 -172.555 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -69.43 -55.63 9.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.912 -1.144 . . . . 4.47 107.912 -179.533 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.4 mt -50.02 -59.44 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.293 -1.003 . . . . 2.0 108.293 177.52 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.65 -56.01 25.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.186 -0.915 . . . . 3.88 110.338 -174.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.5 t -66.08 -29.59 69.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.168 -0.92 . . . . 1.9 112.271 -176.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.6 m -70.93 -50.66 32.23 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.957 -1.127 . . . . 3.42 107.957 179.38 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.2 mt -53.54 -46.57 70.24 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.468 -0.333 . . . . 3.42 110.831 175.163 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.2 m -56.4 -9.12 0.63 Allowed 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.964 1.098 . . . . 2.57 113.964 -179.252 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -75.92 -29.81 58.53 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.527 -1.358 . . . . 8.23 112.024 172.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -75.18 161.68 29.16 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.017 0.927 . . . . 2.26 109.509 -173.571 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.45 -42.76 7.57 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-O 119.131 -0.462 . . . . 9.5 111.479 -175.285 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.29 -12.75 69.67 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 119.112 0.869 . . . . 1.55 113.207 -176.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -77.54 159.31 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 107.785 -1.191 . . . . 3.48 107.785 168.18 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.3 mt -129.39 -41.1 1.4 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.223 1.009 . . . . 3.34 110.112 -172.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -149.84 148.22 28.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.646 -1.613 . . . . 3.21 106.646 174.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -128.87 126.25 39.36 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.232 -2.136 . . . . 2.75 105.232 178.473 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.1 t -144.54 104.93 4.11 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.831 -0.803 . . . . 1.88 108.831 178.233 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.95 148.64 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 123.63 0.772 . . . . 2.62 111.428 -175.766 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.74 109.43 3.45 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 122.08 -0.387 . . . . 1.8 111.759 -176.849 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.65 -15.42 19.08 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.919 1.081 . . . . 2.51 113.919 177.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.36 -35.27 76.99 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.874 0.47 . . . . 2.01 110.656 171.589 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -116.49 -6.21 11.7 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.748 1.219 . . . . 4.16 111.467 178.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.9 m120 56.64 29.32 15.48 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.838 1.655 . . . . 1.89 110.764 -179.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.66 144.64 37.73 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.495 -1.668 . . . . 4.29 106.495 -176.89 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.82 114.2 20.73 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.465 -1.68 . . . . 2.01 106.465 165.445 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -91.2 104.7 17.22 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 105.418 -2.067 . . . . 2.03 105.418 172.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.1 mp -103.99 115.86 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 105.987 -1.857 . . . . 2.57 105.987 170.302 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -78.51 133.9 37.35 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 105.645 -1.983 . . . . 3.9 105.645 162.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -151.53 163.57 38.73 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.548 0.739 . . . . 2.88 109.84 -173.559 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -100.18 124.92 41.53 Favored Pre-proline 0 N--CA 1.449 -0.513 0 N-CA-C 108.552 -0.907 . . . . 3.48 108.552 163.04 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.79 -17.02 33.2 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.663 2.909 . . . . 2.03 113.663 -174.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.56 -44.47 11.89 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.416 -0.957 . . . . 3.38 108.416 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.6 mt -71.25 -43.09 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 122.244 -0.285 . . . . 4.41 110.82 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.59 118.93 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 105.83 -1.915 . . . . 2.66 105.83 -178.574 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.95 150.38 51.92 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 108.718 -1.753 . . . . 1.32 108.718 171.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -57.64 -40.48 79.63 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 CA-C-N 119.248 1.524 . . . . 1.2 109.736 175.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -42.8 -42.23 3.52 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.182 1.393 . . . . 8.66 112.578 168.134 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -71.28 -43.05 67.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.996 0.816 . . . . 2.2 110.121 -172.034 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.5 mt -57.78 -48.3 83.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 109.133 -0.691 . . . . 1.67 109.133 173.503 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.2 mt -54.41 -53.22 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.842 -0.429 . . . . 2.45 109.842 176.09 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -50.63 -45.71 57.82 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.599 0.636 . . . . 4.16 110.422 176.016 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.2 m -60.14 -52.08 66.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.269 -0.641 . . . . 2.39 109.269 -176.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.29 -61.96 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.534 0.734 . . . . 2.4 110.035 175.337 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -66.19 -25.24 66.84 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.308 -0.406 . . . . 3.22 111.438 -167.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.8 t -63.47 -15.73 58.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 117.789 -1.1 . . . . 2.42 112.891 175.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.38 -96.56 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 120.065 1.302 . . . . 4.16 108.664 170.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.72 50.65 0.42 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.739 -1.344 . . . . 1.36 109.739 177.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -135.92 175.03 9.97 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.351 1.06 . . . . 3.67 108.971 -170.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -141.01 140.89 34.38 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.254 -1.387 . . . . 4.87 107.254 173.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.54 159.7 18.55 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.476 0.655 . . . . 2.19 112.611 -173.108 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.4 133.86 10.8 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 125.03 1.332 . . . . 2.74 108.21 172.376 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.0 mt -53.57 141.65 24.97 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.646 1.112 . . . . 3.3 110.19 173.419 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -127.51 -64.11 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-O 118.88 -0.581 . . . . 4.28 110.46 171.186 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp 55.55 98.49 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.635 1.174 . . . . 5.13 112.167 -172.259 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.0 tt -68.0 74.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.667 1.187 . . . . 12.41 111.786 -178.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 127.776 2.43 . . . . 11.11 107.98 -165.546 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.897 0 N-CA-C 111.236 -0.746 . . . . 1.98 111.236 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 p -75.54 123.47 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.784 -0.821 . . . . 2.18 108.784 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 tp -146.26 77.37 1.48 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.024 0.44 . . . . 2.82 110.412 -168.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -78.55 76.0 5.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.602 0.715 . . . . 4.23 110.101 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -78.91 156.9 28.38 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.922 0.889 . . . . 2.53 110.908 176.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.24 139.07 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.365 -1.717 . . . . 0.92 106.365 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.9 t -130.83 122.84 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 C-N-CA 126.844 2.058 . . . . 2.07 105.841 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.1 mtp-105 -117.75 164.25 15.28 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.828 1.251 . . . . 5.32 109.815 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.55 -6.88 77.79 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.206 0.908 . . . . 1.19 111.625 -171.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 30.3 mtm -72.81 69.64 0.94 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.189 0.996 . . . . 1.6 110.269 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -69.01 -16.77 63.8 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.165 1.172 . . . . 1.48 114.165 -166.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.0 p -160.53 173.77 15.05 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 120.205 1.366 . . . . 0.73 110.699 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.13 -40.18 45.41 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.991 0.916 . . . . 0.69 111.341 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 m -61.87 -27.41 68.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.625 0.77 . . . . 1.69 112.291 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.4 m -71.15 -61.72 1.66 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.913 -0.773 . . . . 0.67 108.913 164.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.6 t -45.42 -59.23 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.769 0.828 . . . . 0.72 111.572 -170.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.55 -28.32 68.44 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.58 -0.7 . . . . 0.77 112.01 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -70.55 -47.64 59.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.737 -0.838 . . . . 4.05 108.737 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.9 mt -54.09 -55.58 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 108.273 -1.01 . . . . 0.98 108.273 174.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -48.74 -66.98 0.31 Allowed 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 124.357 1.035 . . . . 3.99 110.174 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.4 t -54.83 -39.4 68.52 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.801 0.84 . . . . 0.89 110.88 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.7 t -66.59 -51.12 59.94 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.72 -0.844 . . . . 1.16 108.72 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -60.06 -43.5 95.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.383 -0.823 . . . . 2.54 111.301 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.5 m -59.44 -11.43 4.45 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.87 0.868 . . . . 2.12 112.813 176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -61.79 -35.38 78.0 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.905 -1.122 . . . . 5.65 111.426 167.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -59.57 135.03 57.54 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.308 -0.997 . . . . 2.98 108.308 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -26.54 61.65 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.143 0.883 . . . . 9.84 108.777 162.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.48 41.41 2.08 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 121.604 -0.685 . . . . 1.96 112.643 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 pp -146.17 150.74 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 105.643 -1.984 . . . . 2.58 105.643 172.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.3 mt -104.28 -25.7 12.78 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 123.306 0.379 . . . . 2.05 111.381 167.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -156.34 152.92 28.22 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 118.668 0.667 . . . . 2.38 109.378 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.7 t -143.95 128.24 17.79 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.248 1.019 . . . . 2.27 109.25 164.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.1 t -135.5 92.92 2.89 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.191 1.396 . . . . 1.47 108.708 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.35 152.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 126.009 1.724 . . . . 1.98 111.563 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.23 129.31 8.81 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.705 0.402 . . . . 0.72 110.973 171.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 pp -76.07 -10.25 59.27 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.688 0.795 . . . . 1.32 112.787 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.99 -54.9 17.27 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.025 -0.731 . . . . 1.15 109.025 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -27.38 40.58 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.615 0.766 . . . . 2.09 110.812 174.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 71.13 57.81 0.2 Allowed 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 125.352 1.461 . . . . 1.49 107.964 -169.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.44 170.42 15.74 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 112.484 0.549 . . . . 2.3 112.484 -169.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.72 100.17 3.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.631 1.972 . . . . 0.87 109.317 174.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -77.34 82.49 3.8 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 105.307 -2.109 . . . . 1.22 105.307 169.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 pt -85.3 147.63 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-N 114.486 -1.234 . . . . 3.08 108.322 166.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -113.33 104.7 12.58 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 103.54 -2.763 . . . . 3.17 103.54 157.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -98.46 135.47 39.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 124.168 0.917 . . . . 2.56 109.282 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.92 120.38 81.34 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 123.716 0.806 . . . . 3.22 109.221 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.07 2.68 7.8 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.1 1.867 . . . . 1.87 114.524 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -86.55 -43.01 13.04 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 121.414 1.916 . . . . 5.59 109.073 167.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.2 mm -88.15 -46.31 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 112.074 0.398 . . . . 3.12 112.074 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mm -120.71 146.32 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.921 -1.14 . . . . 1.61 107.921 -162.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.0 160.92 12.86 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 108.999 -1.641 . . . . 1.33 108.999 165.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -53.15 -38.38 80.97 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.828 2.352 . . . . 1.62 111.221 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -41.04 20.71 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.565 0.746 . . . . 8.13 111.658 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -66.43 -50.61 62.82 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.105 0.866 . . . . 2.14 109.481 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.1 mp -54.05 -47.05 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mt -55.87 -51.89 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 119.206 -0.426 . . . . 1.38 109.955 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -52.6 -42.75 64.83 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.612 0.642 . . . . 3.4 110.672 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 35.0 m -63.67 -54.84 29.3 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.348 -0.612 . . . . 0.82 109.348 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.462 HG23 ' HB2' ' A' ' 67' ' ' PHE . 49.3 mt -48.05 -49.59 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.528 1.531 . . . . 1.47 111.042 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -59.55 -49.77 76.5 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.182 0.993 . . . . 2.05 110.483 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.2 t -62.57 -22.82 66.64 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 118.201 -0.904 . . . . 1.44 112.542 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.26 -102.43 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.195 -1.039 . . . . 2.54 108.195 160.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.46 39.22 0.48 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.313 -0.715 . . . . 0.79 111.386 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.462 ' HB2' HG23 ' A' ' 62' ' ' ILE . 32.0 m-85 -128.25 171.37 12.03 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.937 0.869 . . . . 1.66 110.393 -167.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.12 166.15 21.73 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.523 1.129 . . . . 3.11 108.55 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.43 161.8 40.91 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.549 0.613 . . . . 1.12 111.998 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.9 m -156.59 131.54 9.04 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.091 1.356 . . . . 1.61 109.787 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 CA--C 1.53 0.198 0 N-CA-C 108.229 -1.026 . . . . 3.14 108.229 173.499 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.647 0 CA-C-O 119.818 -0.435 . . . . 2.19 113.14 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.3 p -145.77 137.91 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 117.582 0.691 . . . . 2.23 110.178 170.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.5 tp -148.37 119.3 7.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.543 -0.91 . . . . 2.15 108.543 167.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -108.4 121.51 45.09 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.947 -1.501 . . . . 2.94 106.947 167.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -131.02 146.13 52.28 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.629 -0.878 . . . . 2.34 108.629 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -76.22 135.5 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 104.595 -2.372 . . . . 0.75 104.595 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.4 t -125.21 115.92 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 105.088 -2.19 . . . . 1.98 105.088 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -108.44 153.3 23.51 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.779 0.431 . . . . 6.15 110.115 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.24 -5.51 55.62 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.651 1.12 . . . . 1.05 111.985 -171.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 38.1 mtm -74.17 66.94 1.3 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.512 1.156 . . . . 1.65 110.677 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -68.88 -15.3 63.46 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.267 1.21 . . . . 1.62 114.267 -164.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.9 p -160.1 173.05 16.39 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 120.289 1.404 . . . . 0.72 110.508 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.54 -37.21 38.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.864 0.866 . . . . 0.81 111.326 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 t -61.08 -29.27 69.64 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 118.867 -0.587 . . . . 1.87 111.523 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.4 m -71.67 -57.08 4.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.89 0.768 . . . . 0.85 109.551 168.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.9 t -49.6 -60.46 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.472 0.709 . . . . 0.89 111.451 -172.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.86 -29.2 69.05 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.621 -0.674 . . . . 0.84 111.568 -175.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -65.28 -48.35 73.49 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.386 -0.968 . . . . 3.01 108.386 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 79.4 mt -55.4 -55.64 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 108.668 -0.864 . . . . 0.65 108.668 174.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -54.99 -49.95 70.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.425 0.631 . . . . 3.49 110.87 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -56.55 -48.96 76.18 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.885 0.874 . . . . 0.85 110.682 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.3 m -61.65 -42.13 98.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.7 -0.625 . . . . 2.09 110.539 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.495 HD11 HG23 ' A' ' 58' ' ' ILE . 1.7 mm? -63.64 -54.19 39.69 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.844 1.258 . . . . 2.45 110.671 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.0 p -59.17 -18.59 37.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.151 0.426 . . . . 2.03 112.151 -173.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -50.24 -41.88 50.85 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.271 -0.871 . . . . 4.65 113.008 166.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -67.44 163.73 20.28 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.34 0.973 . . . . 2.26 111.661 -170.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.01 -29.13 11.11 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.391 0.677 . . . . 6.42 112.021 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.57 -14.76 77.57 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 119.918 -0.379 . . . . 1.16 112.491 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -77.86 149.93 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 117.782 0.791 . . . . 2.91 109.113 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 36.6 tp -109.08 -42.89 4.3 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.521 1.928 . . . . 3.55 108.708 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -155.79 163.88 39.27 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.22 0.464 . . . . 2.14 110.949 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.7 t -144.19 118.81 9.77 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 127.084 2.154 . . . . 2.14 106.846 174.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.97 96.74 5.14 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.204 -1.406 . . . . 1.63 107.204 175.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -107.64 141.32 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.23 0.612 . . . . 2.23 111.294 -174.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.47 125.72 9.34 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 123.729 0.811 . . . . 0.76 111.377 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.61 -15.04 60.39 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.522 1.129 . . . . 1.45 112.236 172.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.2 -51.7 68.64 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.012 -0.736 . . . . 1.24 109.012 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.87 -45.28 18.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.625 -0.88 . . . . 2.03 108.625 171.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 83.92 52.9 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 127.696 2.398 . . . . 2.48 107.39 -163.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.61 160.24 40.56 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 122.501 0.32 . . . . 2.36 110.705 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.12 120.06 30.35 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.61 -1.255 . . . . 0.64 107.61 168.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -93.86 94.44 8.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.863 -1.903 . . . . 1.18 105.863 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.45 152.22 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 107.58 -1.267 . . . . 1.57 107.58 174.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -131.95 134.14 45.3 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.416 -2.439 . . . . 2.23 104.416 159.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -161.65 153.69 19.47 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.066 1.346 . . . . 2.49 107.39 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -80.91 124.2 81.65 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 119.044 0.838 . . . . 3.41 109.732 170.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -63.59 -21.17 70.39 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.995 2.463 . . . . 1.8 115.467 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -79.33 -45.59 19.34 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.991 1.269 . . . . 3.67 108.758 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.2 mt -71.71 -38.83 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 120.724 -0.39 . . . . 3.15 111.482 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.48 122.9 45.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 N-CA-C 106.029 -1.841 . . . . 1.56 106.029 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.02 168.29 44.82 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.187 -1.165 . . . . 0.8 110.187 172.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -59.58 -43.08 41.72 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.116 1.878 . . . . 1.08 109.564 170.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -46.0 35.86 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.039 1.335 . . . . 5.75 112.455 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.06 -55.59 31.05 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.864 0.756 . . . . 2.46 110.148 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.495 HG23 HD11 ' A' ' 26' ' ' LEU . 37.6 mt -63.21 -54.37 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.12 -0.491 . . . . 0.78 109.745 -174.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.8 mt -49.52 -50.03 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.219 -0.66 . . . . 1.26 109.219 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -70.04 -29.21 66.19 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.622 -0.674 . . . . 4.41 111.813 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.2 m -61.88 -47.27 85.73 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.309 -0.997 . . . . 0.79 108.309 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' A' ' 67' ' ' PHE . 78.7 mt -57.37 -43.0 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.234 1.014 . . . . 1.22 111.006 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -57.21 -57.13 13.97 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 109.181 -0.674 . . . . 2.61 109.181 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -55.38 -42.44 73.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.168 1.387 . . . . 1.4 111.144 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.9 mt -61.75 -82.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.565 0.346 . . . . 2.17 111.241 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.66 17.85 0.17 Allowed Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.356 -1.247 . . . . 0.74 114.621 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.441 ' HB2' HG23 ' A' ' 62' ' ' ILE . 25.5 m-85 -137.4 175.13 9.88 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 119.352 1.576 . . . . 2.17 110.916 -153.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -126.44 161.28 28.28 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 107.65 -1.241 . . . . 3.34 107.65 172.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.02 160.03 40.94 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 112.325 0.491 . . . . 0.91 112.325 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 m -155.79 146.59 22.16 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.845 1.658 . . . . 1.96 107.613 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 CA--C 1.534 0.35 0 CA-C-N 118.775 0.716 . . . . 2.5 111.187 -177.669 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.735 0 N-CA-C 109.08 -1.608 . . . . 1.64 109.08 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.96 148.82 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 O-C-N 122.162 -0.61 . . . . 2.05 110.152 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.2 tp -151.43 159.63 44.12 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.077 -1.083 . . . . 3.13 108.077 162.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -141.65 117.29 10.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.43 -1.693 . . . . 4.15 106.43 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.6 mt -118.58 142.43 47.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.33 1.452 . . . . 2.98 107.184 -177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.48 129.69 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.098 -1.816 . . . . 1.14 106.098 163.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.2 t -117.79 102.85 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 126.099 1.76 . . . . 1.96 106.964 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -96.08 134.57 38.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.653 1.581 . . . . 6.87 108.134 -172.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.43 -9.41 38.47 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.307 0.956 . . . . 1.06 112.455 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.4 ttp -70.08 69.76 0.35 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.252 1.821 . . . . 1.77 109.831 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 t -79.42 -2.59 42.58 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.281 1.585 . . . . 1.63 115.281 -159.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -159.62 164.48 34.09 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.052 1.296 . . . . 1.22 110.892 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.61 -39.81 51.08 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.326 1.05 . . . . 0.7 110.306 173.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -46.59 -43.97 17.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.16 1.384 . . . . 1.59 111.676 171.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . 0.258 73.5 m -72.61 -48.19 41.61 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 118.408 -0.806 . . . . 1.08 113.159 173.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.9 t -41.83 -66.31 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.514 0.726 . . . . 0.95 110.65 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -31.07 67.59 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 119.906 -0.717 . . . . 0.79 112.436 -172.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -58.03 -54.4 47.36 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.703 0.683 . . . . 3.4 109.436 173.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.5 mt -50.61 -61.57 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 108.445 -0.946 . . . . 0.69 108.445 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -55.37 -55.88 26.52 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.066 0.46 . . . . 3.24 111.766 -173.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -54.03 -43.77 70.42 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.023 0.929 . . . . 0.79 110.443 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -68.07 -55.25 13.21 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.177 -1.046 . . . . 1.22 108.177 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -57.87 -43.35 85.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.052 -0.405 . . . . 2.72 111.884 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.9 m -57.24 -16.91 9.45 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.238 0.459 . . . . 1.91 112.238 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.35 -41.66 63.24 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.134 -0.979 . . . . 6.04 111.187 168.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -86.87 109.04 19.04 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.82 -0.807 . . . . 2.21 108.82 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.3 mtm105 -52.76 -21.8 4.54 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.584 0.957 . . . . 6.89 113.584 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -52.19 -37.07 46.02 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.385 -0.675 . . . . 0.88 112.081 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.5 129.28 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.959 -1.126 . . . . 2.52 107.959 170.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.38 -44.85 8.48 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.607 -0.886 . . . . 3.84 108.607 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -142.09 144.18 33.42 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.562 -0.533 . . . . 2.07 109.562 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.5 p -131.08 144.43 51.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.333 1.853 . . . . 2.3 106.767 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -152.11 83.35 1.26 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.772 -1.195 . . . . 1.55 107.772 -166.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 m -101.85 153.38 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 123.868 0.867 . . . . 1.6 111.077 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.36 136.16 13.58 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.478 -0.564 . . . . 0.93 109.478 173.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -81.42 -11.42 59.26 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.459 1.104 . . . . 1.35 112.697 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.07 -49.51 77.07 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.158 -0.682 . . . . 1.14 109.158 173.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -86.01 -40.33 15.92 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.154 0.582 . . . . 2.59 109.597 171.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 80.89 61.79 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 127.25 2.22 . . . . 2.66 107.415 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.32 166.31 25.11 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 123.065 0.546 . . . . 2.29 110.187 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.24 110.6 11.23 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 127.288 2.235 . . . . 0.63 106.862 163.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -86.3 134.9 33.71 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.301 -2.111 . . . . 0.91 105.301 162.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.8 pt -139.18 151.63 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 124.682 1.193 . . . . 3.4 107.82 -172.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -139.28 99.84 3.85 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 102.591 -3.115 . . . . 2.95 102.591 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -145.11 142.24 29.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.221 1.409 . . . . 2.02 108.801 -162.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -80.3 119.69 77.19 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 108.848 -0.797 . . . . 2.82 108.848 175.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.63 -32.8 47.25 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.47 1.447 . . . . 2.03 111.909 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.2 44.67 0.42 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.914 0.779 . . . . 3.72 112.42 -175.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -172.49 -38.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.886 1.674 . . . . 3.44 110.25 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 tt -138.05 118.63 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.318 -1.364 . . . . 1.6 107.318 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.29 156.28 53.31 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.196 -1.562 . . . . 0.83 109.196 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -53.88 -45.39 41.37 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.527 1.484 . . . . 1.29 109.197 171.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -50.96 -37.73 46.38 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 112.268 0.47 . . . . 6.89 112.268 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.15 -40.37 74.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.099 0.863 . . . . 2.73 109.522 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.8 mt -57.98 -46.77 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 118.841 -0.599 . . . . 0.73 109.933 170.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.7 mm -51.73 -57.73 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.825 0.739 . . . . 1.83 110.081 173.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -50.14 -43.34 51.95 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.285 1.034 . . . . 4.03 110.541 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.9 m -64.48 -49.6 70.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.756 -0.461 . . . . 1.12 109.756 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.555 HG21 ' HB2' ' A' ' 69' ' ' ALA . 1.1 mt -53.69 -47.32 61.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.261 0.624 . . . . 1.27 111.324 176.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -58.27 -51.91 67.81 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.169 0.588 . . . . 2.23 109.7 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.8 t -52.16 -48.25 65.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.768 0.827 . . . . 1.18 110.905 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.4 -60.01 4.17 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.939 -0.476 . . . . 2.17 111.032 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.66 -42.02 0.02 OUTLIER Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.091 1.196 . . . . 1.7 116.091 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -118.01 164.85 14.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 117.642 0.721 . . . . 1.73 112.769 -136.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.81 98.92 10.25 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.983 -1.488 . . . . 4.47 106.983 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.555 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -83.32 139.95 32.74 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.811 -0.44 . . . . 1.27 109.811 169.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.0 t -144.21 128.94 18.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.596 -1.631 . . . . 2.06 106.596 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 CA--C 1.534 0.334 0 C-N-CA 119.675 -0.81 . . . . 3.56 109.148 159.793 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.874 0 N-CA-C 108.269 -1.932 . . . . 1.69 108.269 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 p -78.66 120.75 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.432 -1.321 . . . . 2.03 107.432 168.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.16 112.85 12.08 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.019 -1.104 . . . . 3.05 108.019 -172.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -88.01 113.21 23.43 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.76 -1.2 . . . . 3.5 107.76 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -101.24 150.46 22.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.686 -0.857 . . . . 2.5 108.686 166.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 t -81.82 139.82 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 105.107 -2.183 . . . . 0.87 105.107 151.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.65 133.04 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.377 -1.712 . . . . 2.27 106.377 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 mtp85 -129.09 158.68 38.26 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.697 0.799 . . . . 6.0 109.411 -176.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.92 -18.91 55.72 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.727 0.68 . . . . 1.13 112.055 -174.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -74.57 69.48 1.72 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.198 0.999 . . . . 1.4 111.229 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.1 t -62.05 -17.23 56.75 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 116.028 1.862 . . . . 1.52 116.028 -162.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.5 p -160.74 -179.92 8.0 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 121.306 1.866 . . . . 0.66 112.502 -172.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.5 -44.19 35.74 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.714 1.206 . . . . 0.62 111.413 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.6 m -63.99 -22.71 67.04 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.814 0.845 . . . . 1.48 112.322 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.3 m -73.64 -64.18 1.05 Allowed 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.524 -0.735 . . . . 0.69 110.733 161.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.7 t -38.08 -64.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.945 1.298 . . . . 0.93 112.12 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -65.11 -29.39 70.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.621 -0.431 . . . . 0.99 111.194 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -70.67 -46.55 62.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.682 -0.859 . . . . 3.22 108.682 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.3 mt -54.85 -58.32 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.702 -0.851 . . . . 0.82 108.702 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -59.29 -53.71 55.15 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.642 0.258 . . . . 3.51 111.477 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.5 t -53.86 -45.6 71.04 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.975 -0.453 . . . . 0.76 110.629 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 t -66.07 -50.85 62.69 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.955 -1.128 . . . . 1.19 107.955 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.0 mt -48.57 -51.68 26.59 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.915 0.486 . . . . 2.88 111.376 176.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.4 p -57.81 -14.43 5.92 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.609 0.966 . . . . 2.25 113.609 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -28.37 68.3 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.415 1.007 . . . . 4.22 112.39 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -90.37 104.97 17.49 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 107.755 -1.202 . . . . 1.73 107.755 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -26.25 9.43 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.28 -0.888 . . . . 8.91 111.669 172.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -48.89 -40.64 27.24 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.103 -0.832 . . . . 0.9 112.811 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.83 123.3 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.513 -1.662 . . . . 2.43 106.513 171.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.3 tp -79.93 -38.05 33.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.574 1.15 . . . . 3.27 109.163 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -151.32 154.29 36.45 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.651 -0.5 . . . . 1.84 109.651 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.4 p -133.96 147.7 51.07 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 125.184 1.394 . . . . 2.53 108.827 169.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.4 t -155.02 99.64 2.12 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.695 1.598 . . . . 1.51 107.097 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 m -91.82 167.87 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 122.627 0.371 . . . . 1.68 110.405 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.5 131.68 10.17 Favored 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 121.879 -0.513 . . . . 0.8 110.866 165.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.8 mt -49.8 -50.8 43.58 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 124.488 1.115 . . . . 2.02 108.684 159.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.64 -53.6 17.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.802 0.841 . . . . 1.58 112.113 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.52 -2.42 54.37 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.037 0.935 . . . . 2.02 111.996 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m120 50.02 39.69 19.54 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 125.047 1.339 . . . . 1.98 110.33 -166.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.61 170.38 8.36 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 120.983 0.42 . . . . 2.53 111.257 -167.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -151.31 97.07 2.37 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 126.64 1.976 . . . . 0.67 108.113 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -79.48 106.09 11.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.708 -2.33 . . . . 1.34 104.708 165.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.77 145.52 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 105.256 -2.127 . . . . 1.58 105.256 163.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.2 mtmt -114.52 129.41 56.66 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.937 -1.875 . . . . 2.87 105.937 158.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -138.03 144.6 41.1 Favored 'General case' 0 C--N 1.338 0.089 0 CA-C-N 118.745 0.702 . . . . 2.53 111.607 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -75.44 117.82 66.17 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 107.36 -1.348 . . . . 3.83 107.36 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -80.67 56.36 6.05 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.202 3.268 . . . . 2.07 112.014 -165.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -145.61 -53.74 0.28 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.536 1.934 . . . . 3.69 107.55 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.8 mt -74.43 -33.26 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.411 1.084 . . . . 2.74 110.738 -172.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.6 tt -147.39 138.37 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.432 -1.322 . . . . 1.71 107.432 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.45 168.23 27.97 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.359 0.981 . . . . 0.86 111.66 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.08 -43.45 15.24 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.788 2.325 . . . . 1.01 109.534 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -54.29 -44.19 71.72 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 122.479 0.312 . . . . 6.13 110.405 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -63.98 -47.21 81.29 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.343 -0.614 . . . . 2.65 109.343 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.9 mt -52.79 -52.48 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 O-C-N 122.015 -0.428 . . . . 0.69 110.153 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.4 mt -54.25 -53.31 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 122.053 -0.404 . . . . 1.2 110.177 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.4 -32.76 67.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.219 0.608 . . . . 4.48 111.265 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.5 m -65.2 -49.47 69.61 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.067 -1.021 . . . . 1.07 108.45 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.0 mt -54.62 -41.41 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.703 0.801 . . . . 1.33 110.692 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -57.62 -54.98 40.76 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.207 0.458 . . . . 2.3 110.364 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.5 m -57.53 -29.16 64.13 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.231 1.012 . . . . 2.22 112.465 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.7 -89.42 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.882 -0.785 . . . . 2.4 108.882 166.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.47 25.0 0.24 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-O 118.517 -1.157 . . . . 0.89 113.955 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.75 175.57 9.07 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.011 1.406 . . . . 2.19 112.596 -153.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -112.58 149.7 32.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.299 -1.741 . . . . 3.78 106.299 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.18 161.49 41.19 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.989 0.813 . . . . 1.25 111.68 166.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.0 t -151.75 149.32 28.92 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.543 -1.651 . . . . 3.33 106.543 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 108.95 -0.759 . . . . 2.77 108.95 162.781 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 N-CA-C 109.567 -1.413 . . . . 1.57 109.567 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.08 141.8 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 107.97 -1.122 . . . . 2.12 107.97 173.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -150.8 148.54 28.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.277 -0.638 . . . . 2.67 109.277 164.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -93.48 127.3 39.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.077 -1.823 . . . . 3.16 106.077 152.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.416 HD11 ' HB3' ' A' ' 44' ' ' ALA . 4.1 pp -107.32 151.18 25.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.384 -1.339 . . . . 2.54 107.384 164.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.61 143.93 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 104.831 -2.285 . . . . 1.28 104.831 161.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 p -141.78 133.51 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 124.007 0.923 . . . . 2.26 108.545 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -134.87 165.53 25.1 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.22 1.408 . . . . 7.1 109.065 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.09 -39.38 2.78 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.12 0.867 . . . . 1.48 111.378 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.407 ' SD ' HD12 ' A' ' 22' ' ' ILE . 13.0 ptt? -67.34 65.27 0.07 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.4 1.48 . . . . 1.92 112.88 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -71.62 19.1 0.07 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.117 1.525 . . . . 1.77 115.117 -165.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -166.57 158.57 13.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.589 1.086 . . . . 1.14 110.187 177.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.24 -37.41 35.5 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.152 0.981 . . . . 0.91 111.12 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.7 p -58.16 -33.21 68.96 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.727 0.411 . . . . 1.89 111.425 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . 0.259 72.6 m -75.77 -44.71 40.21 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 120.819 -1.176 . . . . 1.61 113.676 168.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.7 t -50.01 -60.03 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.168 0.44 . . . . 0.92 110.738 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -25.44 63.05 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.445 -0.784 . . . . 1.07 112.159 -176.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.16 -51.86 67.26 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 108.562 -0.903 . . . . 3.81 108.562 173.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.407 HD12 ' SD ' ' A' ' 13' ' ' MET . 64.3 mt -52.58 -60.8 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 108.447 -0.946 . . . . 0.79 108.447 172.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -53.09 -56.45 16.16 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.336 0.589 . . . . 3.27 110.605 -170.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.1 t -56.09 -48.37 76.25 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.916 1.286 . . . . 0.84 111.103 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.8 t -64.64 -57.82 8.01 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.04 -0.726 . . . . 1.29 109.04 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.3 tp -54.21 -49.12 70.13 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.336 1.454 . . . . 2.46 111.111 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.5 p -59.47 -12.76 6.75 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.601 0.963 . . . . 2.24 113.601 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -24.88 66.77 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.889 1.222 . . . . 4.82 112.322 175.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -80.67 130.77 35.29 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.44 0.564 . . . . 2.33 109.653 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -58.31 151.85 18.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.461 -0.94 . . . . 6.39 108.461 169.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.24 -27.82 15.44 Favored Glycine 0 C--O 1.224 -0.495 0 N-CA-C 111.035 -0.826 . . . . 1.02 111.035 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.1 mm -79.22 121.19 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 119.138 1.469 . . . . 4.08 107.217 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.3 mt -94.99 -44.59 7.63 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.125 -0.695 . . . . 1.87 109.125 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -153.49 153.63 32.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.199 -0.667 . . . . 2.52 109.199 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.5 m -138.75 132.97 31.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 105.481 -2.044 . . . . 2.29 105.481 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -134.87 89.67 2.56 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 105.88 -1.896 . . . . 1.93 105.88 166.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 p -97.94 137.61 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.309 1.043 . . . . 2.39 111.156 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 134.07 21.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.811 0.845 . . . . 0.87 111.091 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 pp -72.05 -34.38 68.71 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 124.661 1.185 . . . . 2.03 110.672 170.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.64 -32.47 42.11 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.648 0.779 . . . . 1.34 111.674 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -120.55 11.79 11.4 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.801 1.24 . . . . 2.56 111.496 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.0 m120 35.32 52.08 0.65 Allowed 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.887 1.675 . . . . 2.12 112.778 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.23 151.97 40.18 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.117 -0.698 . . . . 3.47 109.117 -171.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.416 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -133.97 118.26 17.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.758 -0.83 . . . . 0.66 108.758 170.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -84.76 106.16 16.09 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.135 -1.802 . . . . 1.02 106.135 170.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.2 mp -106.95 136.3 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.792 -1.558 . . . . 1.73 106.792 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -116.09 140.2 49.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.458 -1.682 . . . . 2.93 106.458 163.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -158.69 161.04 37.06 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.724 0.81 . . . . 1.71 110.013 -167.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -87.78 110.94 38.86 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 107.122 -1.436 . . . . 4.04 107.122 173.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.23 59.23 7.3 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.088 3.192 . . . . 2.04 110.799 -168.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -167.26 -46.72 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.53 1.532 . . . . 2.9 108.857 -173.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.2 mm -65.96 -39.18 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.517 -0.549 . . . . 2.51 109.517 170.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.07 154.73 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 105.835 -1.913 . . . . 1.29 105.835 -175.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -116.77 174.22 15.11 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.875 1.226 . . . . 1.06 112.145 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.15 -39.38 31.31 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.231 2.621 . . . . 1.07 110.413 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -47.57 -56.65 6.69 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.804 0.842 . . . . 7.27 110.368 170.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.0 -54.85 29.11 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.716 -0.475 . . . . 2.28 109.716 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.3 mt -52.69 -60.16 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.059 0.544 . . . . 0.79 111.149 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.8 mt -52.11 -51.79 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 C-N-CA 123.715 0.806 . . . . 1.2 110.133 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -68.08 -33.33 74.34 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.215 -0.448 . . . . 4.25 111.07 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.9 m -60.88 -46.62 89.9 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 108.091 -1.077 . . . . 0.77 108.091 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.505 HG21 ' HB2' ' A' ' 69' ' ' ALA . 19.2 mt -56.25 -58.15 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.263 -0.643 . . . . 1.31 109.263 173.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -53.99 -43.77 70.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.913 0.387 . . . . 2.35 110.356 -168.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.5 m -62.74 -15.62 53.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.356 1.462 . . . . 2.53 114.125 -172.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.97 -83.27 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.885 -1.154 . . . . 3.02 107.885 170.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.03 42.62 0.48 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.476 -1.449 . . . . 1.25 109.476 166.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -126.88 176.65 7.14 Favored 'General case' 0 CA--C 1.524 -0.04 0 CA-C-N 117.311 0.555 . . . . 2.18 111.328 -159.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.36 145.52 47.81 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 104.923 -2.251 . . . . 4.82 104.923 170.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.505 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -149.44 146.0 27.21 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 123.688 0.617 . . . . 1.93 111.036 165.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t -155.57 131.0 9.63 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.831 -0.433 . . . . 3.07 109.831 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 CA--C 1.535 0.367 0 C-N-CA 124.165 0.986 . . . . 2.36 111.627 177.284 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 109.932 -1.267 . . . . 2.1 109.932 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.31 130.6 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.028 -1.471 . . . . 2.34 107.028 170.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.3 tp -124.65 139.62 53.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.025 -1.472 . . . . 2.53 107.025 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.41 143.24 48.77 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.64 -1.244 . . . . 4.39 107.64 176.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.47 HD23 ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -156.78 150.09 24.22 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.122 0.969 . . . . 2.8 108.931 176.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.35 112.35 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 104.186 -2.524 . . . . 0.97 104.186 169.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.82 142.73 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.158 -1.423 . . . . 2.66 107.158 162.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -131.84 166.05 22.47 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.254 -0.647 . . . . 6.1 109.254 167.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.63 -38.72 3.18 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 121.757 -0.59 . . . . 1.13 112.252 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.04 77.36 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.418 1.487 . . . . 2.99 111.93 176.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.4 t -74.52 -16.95 60.82 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 115.069 1.507 . . . . 1.58 115.069 -161.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 p -158.36 176.44 12.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 120.605 1.548 . . . . 0.65 111.747 -172.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.62 -46.15 9.96 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.288 1.435 . . . . 0.61 111.464 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 m -61.98 -30.67 71.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.679 0.792 . . . . 1.53 112.271 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.3 m -72.88 -56.69 4.83 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.862 0.756 . . . . 0.64 110.333 166.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.4 t -42.8 -61.71 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.593 1.157 . . . . 0.81 111.39 -176.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.99 -28.26 67.28 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 120.046 -0.662 . . . . 0.83 111.692 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -64.86 -48.53 73.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.301 -0.999 . . . . 2.84 108.301 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.7 mt -53.98 -63.48 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.64 -0.874 . . . . 0.69 108.64 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -52.95 -50.43 64.06 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.174 0.443 . . . . 3.83 111.729 -173.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.0 t -55.97 -46.79 78.51 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.4 1.08 . . . . 0.76 111.317 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.2 p -69.02 -37.43 78.65 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.695 -0.628 . . . . 2.31 110.098 -173.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.7 mp -72.2 -48.25 44.48 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.748 1.219 . . . . 2.63 111.631 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 t -71.88 65.36 0.53 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 123.325 1.536 . . . . 2.66 112.027 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.61 -23.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.635 2.774 . . . . 4.75 111.935 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -60.51 -14.38 19.36 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.169 1.174 . . . . 2.95 114.169 176.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? 70.83 -54.35 0.66 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.402 1.881 . . . . 6.14 110.843 -171.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.94 -32.14 55.84 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 117.953 0.342 . . . . 1.14 112.32 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 38.5 mt -79.37 104.88 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.23 -1.396 . . . . 4.15 107.23 167.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.2 mt -78.98 -28.12 43.49 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.152 0.581 . . . . 1.71 109.648 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -156.71 157.2 34.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.414 -0.958 . . . . 2.04 108.414 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.6 p -138.59 140.28 38.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.024 1.73 . . . . 2.6 107.136 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.9 t -146.99 101.3 3.41 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.836 -1.542 . . . . 1.54 106.836 169.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 44' ' ' ALA . 2.2 p -100.72 152.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 124.294 1.038 . . . . 2.75 109.848 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.05 127.51 7.89 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 121.66 -0.65 . . . . 0.76 111.328 170.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.48 -28.69 68.07 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.419 0.687 . . . . 1.7 110.714 162.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.44 -49.77 69.23 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 120.97 0.414 . . . . 1.19 110.001 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.36 -35.11 25.38 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.17 0.588 . . . . 2.08 111.096 173.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.26 76.04 0.36 Allowed 'General case' 0 C--N 1.344 0.339 0 N-CA-C 106.926 -1.509 . . . . 2.03 106.926 -151.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.62 163.13 39.26 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.02 0.528 . . . . 2.63 109.89 177.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.457 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -146.15 94.12 2.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.889 1.276 . . . . 0.78 109.916 169.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -77.99 104.19 8.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 105.967 -1.864 . . . . 1.02 105.967 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.457 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -106.69 115.61 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 105.923 -1.88 . . . . 1.78 105.923 174.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -82.03 75.46 8.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.793 -1.188 . . . . 3.63 107.793 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.67 161.44 23.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.055 -0.521 . . . . 2.9 110.794 170.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -104.85 133.49 20.13 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 107.227 -1.397 . . . . 3.22 107.227 142.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.57 -31.79 59.65 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.138 2.558 . . . . 2.14 114.472 -171.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -81.19 -43.37 19.4 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 120.473 1.488 . . . . 2.97 110.251 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 tp -73.42 -26.19 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 118.85 -0.595 . . . . 2.73 111.459 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.1 tt -148.09 124.27 2.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-N 120.171 1.351 . . . . 1.61 109.96 167.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.08 159.56 49.24 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 109.67 -1.372 . . . . 0.89 109.67 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -58.85 -39.89 77.21 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.087 1.858 . . . . 1.08 109.247 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -41.65 -48.55 4.12 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.214 1.406 . . . . 8.98 111.007 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -72.31 -45.11 61.4 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.0 0.92 . . . . 2.31 109.539 -169.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.2 mt -54.04 -50.55 53.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.037 -0.727 . . . . 0.62 109.037 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.4 mt -55.48 -52.42 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 119.582 -0.247 . . . . 1.11 110.467 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -52.25 -39.67 60.65 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.476 0.71 . . . . 3.44 110.861 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 31.1 m -64.83 -50.46 66.57 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.238 -0.652 . . . . 0.71 109.238 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.4 mt -55.06 -48.26 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.21 1.004 . . . . 1.26 110.579 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -56.32 -57.12 13.6 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.59 0.756 . . . . 2.14 110.492 173.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.8 t -51.02 -43.6 60.88 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.813 1.245 . . . . 1.5 110.895 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.63 -73.7 0.08 Allowed 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.359 -0.213 . . . . 2.17 110.44 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.41 -5.52 0.05 OUTLIER Glycine 0 CA--C 1.529 0.948 0 N-CA-C 117.41 1.724 . . . . 1.18 117.41 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -131.33 172.21 12.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.758 1.779 . . . . 1.74 112.999 -137.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.48 150.27 20.49 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.834 -1.543 . . . . 4.8 106.834 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.47 ' HB1' HD23 ' A' ' 8' ' ' LEU . . . -149.7 124.88 10.09 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.898 0.38 . . . . 1.54 111.457 162.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 p -129.14 122.45 29.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.964 1.305 . . . . 2.12 109.18 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 113.631 0.974 . . . . 3.02 113.631 -172.04 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.817 0 N-CA-C 110.733 -0.947 . . . . 1.5 110.733 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -78.26 97.16 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.845 0.858 . . . . 2.09 108.973 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.03 155.67 19.57 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.937 0.875 . . . . 4.34 109.071 171.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -146.23 136.75 24.02 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 105.846 -1.909 . . . . 4.32 105.846 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 pp -152.61 148.66 27.59 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.601 1.161 . . . . 2.01 109.217 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.89 125.62 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 105.569 -2.012 . . . . 0.77 105.569 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.9 t -104.71 138.03 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 106.356 -1.72 . . . . 1.74 106.356 168.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.16 175.3 9.98 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.777 1.631 . . . . 5.02 108.55 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.43 -50.17 4.3 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.186 -1.166 . . . . 1.64 110.186 -172.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -50.33 126.66 15.48 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.034 0.534 . . . . 1.91 111.556 175.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 p -88.68 -41.37 12.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.971 0.73 . . . . 3.09 112.971 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.4 p -152.41 177.06 11.0 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.843 0.747 . . . . 0.69 112.543 -161.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.0 -42.09 17.44 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.876 1.27 . . . . 0.73 111.585 175.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.0 t -60.56 -34.39 74.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.507 0.723 . . . . 1.86 110.912 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.2 m -71.53 -54.97 8.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.375 0.534 . . . . 0.67 109.85 169.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 37' ' ' VAL . 49.1 t -45.8 -62.35 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.592 0.757 . . . . 0.8 111.45 -175.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.7 -27.0 66.45 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 120.046 -0.661 . . . . 0.96 111.632 -174.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -68.06 -48.89 64.36 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.744 0.818 . . . . 2.85 109.224 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.7 mt -53.8 -58.72 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 N-CA-C 107.899 -1.148 . . . . 0.86 107.899 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.46 -53.82 33.19 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.369 0.604 . . . . 3.58 110.412 -176.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 t -57.76 -37.72 74.13 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.641 1.176 . . . . 0.82 111.754 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.9 t -71.46 -40.78 70.11 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.788 0.835 . . . . 1.17 110.67 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.5 mp -66.86 -51.78 51.42 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.457 1.103 . . . . 2.44 109.26 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.1 t -71.71 60.95 0.37 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.258 1.028 . . . . 2.76 110.734 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.05 -48.1 0.32 Allowed 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 128.895 2.878 . . . . 6.83 108.045 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -69.99 26.2 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.281 1.586 . . . . 3.19 115.281 -165.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 66.02 -60.75 0.29 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.651 2.38 . . . . 6.15 114.177 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.47 -15.92 62.21 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.715 -0.492 . . . . 1.04 113.23 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.2 mm -79.43 105.42 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.901 1.28 . . . . 4.3 107.734 176.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.73 -38.97 37.57 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.308 -0.627 . . . . 3.1 109.308 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -152.41 152.08 31.58 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.996 -0.742 . . . . 2.11 108.996 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.0 t -136.26 132.34 35.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.804 1.642 . . . . 2.11 106.586 174.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.1 t -134.85 103.73 5.72 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.927 -1.509 . . . . 1.47 106.927 165.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 19' ' ' VAL . 8.8 p -104.23 147.84 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.824 1.25 . . . . 2.68 109.82 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.35 142.32 19.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 O-C-N 121.401 -0.812 . . . . 0.94 110.868 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -83.82 -38.09 21.68 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 123.952 0.901 . . . . 2.0 109.753 170.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.24 -35.86 60.43 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.458 0.703 . . . . 1.45 110.755 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -117.54 16.47 14.61 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.62 1.168 . . . . 2.75 110.35 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.4 m120 23.23 70.83 0.03 OUTLIER 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.646 1.978 . . . . 1.78 112.737 -173.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 166.59 26.67 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.576 0.35 . . . . 2.87 110.342 -172.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.99 92.91 1.68 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.365 1.466 . . . . 0.91 109.343 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -78.33 108.27 11.55 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.738 -2.319 . . . . 1.51 104.738 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.0 mp -110.92 127.14 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 106.662 -1.607 . . . . 1.58 106.662 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -92.44 104.66 16.96 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 104.869 -2.271 . . . . 2.32 104.869 160.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -122.05 134.6 54.78 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 118.592 0.633 . . . . 1.99 109.344 175.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -72.63 117.68 61.32 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 120.167 -0.613 . . . . 3.01 109.37 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -81.76 64.56 8.55 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.05 2.5 . . . . 2.37 112.471 -163.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -158.38 -52.66 0.07 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.526 1.13 . . . . 2.95 109.035 168.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -57.99 -35.16 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.788 1.235 . . . . 2.96 111.659 172.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mm -139.17 139.32 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.748 -1.945 . . . . 1.39 105.748 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.57 167.9 15.01 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.3 1.428 . . . . 0.79 110.374 169.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -61.87 -41.95 34.28 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.534 2.156 . . . . 1.03 110.17 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.9 -35.95 25.54 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 118.119 -0.943 . . . . 5.73 112.127 174.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -68.64 -49.81 56.23 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 119.711 1.141 . . . . 2.08 110.147 -176.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 mt -53.74 -53.23 27.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.922 -0.77 . . . . 0.68 108.922 172.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.4 mt -53.52 -44.14 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 118.512 -0.756 . . . . 1.15 110.642 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -53.12 -38.42 62.64 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 119.275 0.943 . . . . 3.15 110.776 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.1 m -67.01 -53.44 31.32 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.004 0.82 . . . . 1.12 108.875 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mp -50.81 -51.81 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.339 0.656 . . . . 1.32 110.28 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.51 -51.58 64.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.839 1.256 . . . . 2.35 110.612 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.0 t -65.71 -20.05 66.13 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 118.009 -0.996 . . . . 1.43 112.866 -171.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.8 -101.55 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 119.551 1.069 . . . . 2.84 108.388 163.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.46 36.68 0.48 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.411 -1.076 . . . . 1.13 110.411 173.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -126.74 154.62 43.94 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.819 -0.808 . . . . 2.37 108.819 -162.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -109.49 152.77 24.99 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.553 -0.906 . . . . 3.6 108.553 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.09 148.45 50.57 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 125.563 1.545 . . . . 1.03 110.246 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.1 m -154.15 99.7 2.26 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.787 0.835 . . . . 1.86 110.402 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mt . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 108.075 -1.083 . . . . 3.33 108.075 164.374 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.438 0 N-CA-C 106.984 -2.446 . . . . 1.32 106.984 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.9 t -136.76 134.37 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.998 -1.482 . . . . 2.47 106.998 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.5 mt -135.19 117.13 15.24 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.324 -1.362 . . . . 2.53 107.324 171.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -79.42 89.38 5.01 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.918 -1.882 . . . . 3.52 105.918 155.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.2 mt -78.67 134.88 37.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.709 -1.589 . . . . 2.33 106.709 172.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.83 119.2 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 104.977 -2.231 . . . . 1.1 104.977 162.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -124.86 110.41 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 105.708 -1.96 . . . . 2.41 105.708 -175.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.6 mtp-105 -117.63 160.02 21.97 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.381 1.073 . . . . 5.97 109.768 -165.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.36 0.59 88.35 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.876 -0.889 . . . . 1.16 110.876 -163.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.6 ttm -69.44 68.2 0.22 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.534 1.534 . . . . 2.28 109.805 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -67.36 -31.55 71.89 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.465 0.542 . . . . 1.58 112.465 -166.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.6 p -155.04 174.94 14.47 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.993 0.815 . . . . 0.65 112.117 -170.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.02 -41.97 17.42 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.119 1.368 . . . . 0.92 111.786 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 m -54.2 -43.62 70.9 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 122.953 0.501 . . . . 1.4 110.894 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.3 m -66.12 -50.68 63.18 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.291 0.496 . . . . 0.73 109.96 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.2 t -46.19 -64.12 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.377 0.671 . . . . 1.1 110.378 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -31.0 67.13 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.233 -0.587 . . . . 0.93 112.218 -174.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -51.85 67.72 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.701 0.682 . . . . 5.35 109.467 174.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.3 mt -56.01 -62.67 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 108.099 -1.074 . . . . 0.89 108.099 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -49.33 -56.34 9.83 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 123.744 0.652 . . . . 3.89 110.167 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.6 t -57.66 -48.64 78.93 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.959 0.504 . . . . 0.97 111.209 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.5 t -71.81 -22.9 61.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.759 -0.588 . . . . 1.49 110.78 -171.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mp -73.65 -63.79 1.13 Allowed 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 121.349 -0.844 . . . . 2.54 110.569 163.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 84.8 m -54.63 -23.55 17.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.38 1.072 . . . . 2.3 113.1 -170.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -53.0 -34.95 58.68 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.072 1.138 . . . . 5.36 114.072 170.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -70.25 120.45 15.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.572 -0.899 . . . . 1.97 108.572 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -74.43 56.61 0.67 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.506 0.593 . . . . 7.02 110.66 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.08 42.33 0.44 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.115 -1.594 . . . . 1.97 109.115 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.6 pp -147.51 163.47 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 127.057 2.143 . . . . 2.94 105.243 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -111.36 -43.01 3.77 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.785 0.834 . . . . 2.66 109.833 171.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -156.26 158.05 36.84 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.272 0.942 . . . . 1.88 110.9 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.0 m -143.23 124.87 14.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.318 1.847 . . . . 2.43 106.368 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.54 106.3 6.94 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.975 0.91 . . . . 1.95 108.705 173.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.6 m -100.85 147.86 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 125.274 1.43 . . . . 2.6 110.727 -173.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.28 125.5 18.71 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.814 -0.81 . . . . 0.83 108.814 166.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.533 HD12 ' N ' ' A' ' 40' ' ' ALA . 1.4 pp -64.93 -37.34 87.33 Favored 'General case' 0 C--N 1.338 0.098 0 O-C-N 123.395 0.435 . . . . 1.6 110.436 168.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.533 ' N ' HD12 ' A' ' 39' ' ' LEU . . . -50.55 -49.77 55.2 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.458 1.103 . . . . 1.72 111.123 -174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.5 8.5 33.44 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.256 0.622 . . . . 3.01 110.983 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.264 0.0 OUTLIER 47.12 61.22 2.98 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 126.355 1.862 . . . . 1.78 109.907 173.453 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.24 166.29 31.36 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.303 -0.862 . . . . 2.35 111.944 -173.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.05 110.24 6.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.014 2.526 . . . . 0.91 107.823 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -78.74 97.08 5.76 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 105.467 -2.049 . . . . 1.03 105.467 167.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.9 mt -104.22 138.91 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 107.001 -1.481 . . . . 1.71 107.001 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -127.44 135.99 51.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.904 -1.888 . . . . 3.31 105.904 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -161.53 158.99 27.28 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.4 1.08 . . . . 2.41 108.149 -167.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -79.63 126.92 79.64 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.397 -1.334 . . . . 3.55 107.397 169.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -80.97 46.28 2.23 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.01 2.473 . . . . 2.04 109.801 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -137.45 -62.03 0.62 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.931 1.292 . . . . 4.08 108.181 -165.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 tt -74.13 -26.95 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 121.946 -0.471 . . . . 2.64 111.4 176.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.25 129.96 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.269 -1.752 . . . . 1.41 106.269 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.28 -179.53 53.06 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 110.498 -1.041 . . . . 1.22 110.498 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.66 -54.52 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.211 1.941 . . . . 1.3 111.347 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -67.09 -25.69 66.34 Favored 'General case' 0 C--O 1.221 -0.411 0 O-C-N 121.7 -0.625 . . . . 6.22 111.773 -172.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.77 -50.55 5.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.384 1.874 . . . . 2.97 110.744 172.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.9 mt -66.4 -52.16 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.082 -0.71 . . . . 0.66 109.082 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mt -53.68 -45.97 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 122.801 0.44 . . . . 1.17 110.656 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -50.67 -41.3 55.44 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.636 1.174 . . . . 3.69 110.674 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.8 m -65.45 -48.51 72.44 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.169 -0.678 . . . . 0.91 109.169 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.07 -55.82 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.045 0.538 . . . . 1.35 110.121 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -53.3 -53.52 49.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.149 0.98 . . . . 2.27 110.081 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.9 t -55.01 -40.36 70.07 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.014 1.326 . . . . 1.18 111.452 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.6 mt -60.02 -86.22 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 117.946 0.339 . . . . 2.25 111.593 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.03 32.82 0.38 Allowed Glycine 0 CA--C 1.524 0.623 0 CA-C-O 118.653 -1.082 . . . . 0.96 113.118 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -133.06 163.34 29.47 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 118.715 1.257 . . . . 2.1 113.064 -158.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -97.21 144.86 26.61 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.219 2.208 . . . . 3.54 105.157 171.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.95 140.12 40.09 Favored 'General case' 0 CA--C 1.526 0.024 0 CA-C-N 118.772 0.715 . . . . 1.74 111.416 -168.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.6 p -155.76 175.44 13.93 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.235 1.014 . . . . 2.41 108.43 165.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 N-CA-C 105.314 -2.106 . . . . 2.45 105.314 158.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.594 0 N-CA-C 110.107 -1.197 . . . . 1.66 110.107 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.53 66.91 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 124.912 1.285 . . . . 2.8 108.696 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.33 79.63 4.76 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.037 -1.468 . . . . 2.73 107.037 -176.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -99.12 99.74 10.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.343 -1.299 . . . . 2.98 107.942 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.98 153.32 36.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.487 1.115 . . . . 2.69 109.164 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.9 123.75 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 106.824 -1.547 . . . . 0.81 106.824 174.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.9 t -100.91 109.32 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.898 -1.89 . . . . 2.09 105.898 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -88.25 137.4 32.36 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.323 -0.991 . . . . 6.71 108.323 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.06 1.68 41.88 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.73 -1.039 . . . . 1.07 113.455 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 48.3 mtm -71.45 71.02 0.65 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.44 1.62 . . . . 1.52 110.406 175.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -71.72 -19.17 62.09 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.678 -1.154 . . . . 1.69 113.768 -168.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -162.7 173.41 13.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 120.152 1.342 . . . . 0.79 111.022 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.59 -39.41 35.24 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.223 1.009 . . . . 0.59 111.54 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 m -59.61 -30.49 68.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.406 0.682 . . . . 1.66 112.146 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.1 m -71.07 -55.38 8.35 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.834 0.743 . . . . 1.0 109.898 168.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.28 -59.95 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.918 0.887 . . . . 0.67 110.886 -173.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.66 -31.72 71.04 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.236 -0.586 . . . . 1.0 111.707 -174.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -60.41 -51.69 68.4 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.75 -0.833 . . . . 3.31 108.75 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.0 mt -53.1 -64.47 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 108.63 -0.878 . . . . 0.73 108.63 174.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -49.46 -60.37 2.91 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 123.951 0.782 . . . . 3.8 110.031 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 t -52.96 -48.4 67.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.87 0.868 . . . . 0.87 110.442 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.1 m -59.9 -54.69 43.21 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.125 -0.694 . . . . 2.22 109.125 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.64 -37.19 65.37 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.739 0.815 . . . . 2.42 111.858 -173.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.3 p -54.97 -26.52 37.22 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.592 0.96 . . . . 2.56 113.592 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -4.18 37.55 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.941 1.246 . . . . 4.89 113.457 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -88.14 69.01 9.22 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 106.843 -1.54 . . . . 2.12 106.843 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -47.59 -16.14 0.06 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 118.017 2.599 . . . . 6.95 118.017 -161.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.07 -7.0 86.63 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 119.837 1.199 . . . . 1.08 113.114 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.16 137.32 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.442 -1.318 . . . . 2.41 107.442 168.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.5 mt -85.43 -39.76 17.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.267 1.027 . . . . 2.16 109.683 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -157.05 153.32 27.72 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.627 -0.879 . . . . 2.34 108.627 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.5 t -127.98 146.72 50.57 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.622 -0.881 . . . . 2.26 108.622 166.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 m -148.26 107.89 3.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.873 0.869 . . . . 2.13 109.933 164.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.74 145.3 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 125.951 1.7 . . . . 1.99 110.394 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.14 120.75 10.44 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 124.02 0.928 . . . . 0.91 109.462 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 pp -81.65 -12.34 58.73 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.271 1.029 . . . . 1.5 113.392 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.36 -49.4 34.34 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.134 -1.061 . . . . 1.46 108.134 172.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -79.47 -25.56 41.86 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.664 1.186 . . . . 1.69 111.221 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 63.82 42.22 6.26 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 126.02 1.728 . . . . 1.48 109.666 -172.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.26 148.88 45.44 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 124.253 1.021 . . . . 2.79 108.319 -170.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.17 109.46 12.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.837 -1.171 . . . . 0.8 107.837 165.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -82.84 105.35 13.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.574 -1.639 . . . . 1.36 106.574 167.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.29 123.58 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.545 -1.65 . . . . 1.65 106.545 168.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -93.95 145.92 24.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.712 -1.218 . . . . 2.58 107.712 162.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -163.73 158.45 20.29 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.024 0.529 . . . . 1.74 110.304 -168.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -100.03 121.0 55.43 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 124.441 1.088 . . . . 3.4 108.098 170.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.57 -38.13 19.98 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.845 2.363 . . . . 2.04 112.898 -168.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -58.4 -40.54 82.68 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.978 0.511 . . . . 3.33 111.652 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -81.67 -50.75 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 123.104 0.562 . . . . 2.9 110.245 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.54 100.71 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.63 -0.878 . . . . 1.77 108.63 -173.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -63.9 140.6 44.14 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 108.763 -1.735 . . . . 1.41 108.763 168.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -56.93 -32.43 92.55 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.812 2.341 . . . . 1.26 112.005 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.491 HH11 ' CD2' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -58.36 -28.33 65.01 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 117.954 -1.022 . . . . 6.17 112.714 176.502 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.14 -55.69 23.08 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.431 1.469 . . . . 4.94 109.756 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.8 mt -51.74 -52.08 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.455 0.702 . . . . 0.79 109.168 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.7 mt -57.65 -49.27 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 118.707 -0.663 . . . . 1.58 110.323 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.491 ' CD2' HH11 ' A' ' 56' ' ' ARG . 27.7 m80 -54.09 -41.1 67.85 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.225 0.92 . . . . 2.93 111.294 174.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.7 m -58.62 -54.85 42.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.449 -0.945 . . . . 0.85 108.449 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.85 -55.46 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.598 0.759 . . . . 1.88 110.505 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -51.32 -59.4 4.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.57 0.748 . . . . 2.0 109.718 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.4 t -55.56 -48.4 74.83 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.572 1.149 . . . . 1.45 111.233 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.7 mt -59.04 -51.41 70.15 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.835 0.68 . . . . 2.17 112.835 -172.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.69 1.61 0.06 OUTLIER Glycine 0 CA--C 1.529 0.948 0 N-CA-C 117.156 1.623 . . . . 1.13 117.156 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -139.21 177.07 8.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.637 1.718 . . . . 1.8 111.712 -139.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.94 152.3 32.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.022 -1.473 . . . . 3.15 107.022 165.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.87 146.65 37.33 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.853 0.861 . . . . 1.45 109.251 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.6 m -147.92 107.93 4.04 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.766 0.826 . . . . 2.14 108.835 173.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.279 0 C-N-CA 124.755 1.222 . . . . 3.11 111.936 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.819 0 N-CA-C 106.663 -2.575 . . . . 1.46 106.663 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.26 109.41 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 123.54 0.736 . . . . 2.33 109.347 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -104.23 87.3 2.72 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.226 -1.398 . . . . 3.24 107.226 166.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -82.06 91.93 6.73 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.586 -1.635 . . . . 4.35 106.586 160.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 pp -105.34 157.71 17.13 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.446 -0.797 . . . . 2.11 109.037 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 t -79.05 140.98 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 106.537 -1.653 . . . . 1.26 106.537 171.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.2 t -125.52 123.87 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 105.951 -1.87 . . . . 1.98 105.951 173.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.6 mtt-85 -112.56 152.72 28.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.396 -0.964 . . . . 7.06 108.396 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.49 -6.93 61.34 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.271 -0.738 . . . . 1.12 112.886 -171.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 57.0 mtm -69.94 74.46 0.45 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.892 1.346 . . . . 1.53 110.288 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -67.36 -34.48 77.38 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 119.255 -0.403 . . . . 1.62 111.757 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.1 p -152.95 172.86 16.17 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.09 0.859 . . . . 0.81 112.678 -173.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.34 -44.02 7.91 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.587 1.555 . . . . 0.94 111.854 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.2 m -58.9 -33.41 70.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.779 0.831 . . . . 1.54 112.387 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.2 m -71.05 -57.16 4.81 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 122.308 1.051 . . . . 0.93 109.252 170.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.498 HG13 HG23 ' A' ' 37' ' ' VAL . 71.5 t -49.26 -60.73 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.75 1.62 . . . . 1.11 110.297 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.68 -28.54 67.77 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.784 -0.573 . . . . 0.92 111.389 -175.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -68.58 -39.26 81.04 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.503 -0.555 . . . . 5.81 109.503 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.2 mt -57.01 -61.29 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.125 -0.694 . . . . 0.75 109.125 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -45.97 -59.76 2.66 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.152 0.581 . . . . 3.36 111.343 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.8 t -56.56 -39.12 72.92 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.825 0.85 . . . . 1.12 111.917 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.8 t -70.46 -55.34 9.23 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.417 -1.327 . . . . 1.17 107.417 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.0 -35.47 80.33 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 121.96 -0.462 . . . . 2.74 110.589 -170.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.4 m -69.77 67.49 0.25 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.228 1.013 . . . . 2.73 110.238 171.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -158.39 -42.59 0.06 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 128.885 2.874 . . . . 5.39 109.249 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -66.69 110.89 3.41 Favored 'General case' 0 C--N 1.345 0.373 0 N-CA-C 108.786 -0.82 . . . . 1.57 108.786 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.76 -18.83 57.19 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.292 -0.88 . . . . 6.6 111.449 173.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -51.86 -39.64 48.23 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.717 0.675 . . . . 1.6 112.485 167.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -93.83 157.17 3.02 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 CA-C-N 117.588 0.694 . . . . 2.3 110.794 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.9 mt -105.98 -40.32 5.72 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.933 1.293 . . . . 1.9 109.685 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -153.6 156.95 38.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.044 0.384 . . . . 2.75 110.775 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.8 t -139.64 135.25 33.08 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.029 -1.841 . . . . 2.22 106.029 167.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 t -147.96 144.64 28.14 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.027 0.83 . . . . 2.84 110.277 154.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.498 HG23 HG13 ' A' ' 19' ' ' VAL . 20.4 m -113.22 166.57 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 123.939 0.895 . . . . 2.04 111.553 -168.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.93 139.76 29.32 Favored 'General case' 0 CA--C 1.52 -0.198 0 O-C-N 122.061 -0.399 . . . . 1.12 110.985 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 mp -72.0 -63.04 1.22 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.571 1.548 . . . . 3.56 109.845 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.76 -45.83 81.82 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 123.808 0.843 . . . . 1.98 111.141 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.25 -16.8 57.46 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.841 0.856 . . . . 1.77 110.857 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 55.12 62.57 2.44 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.125 1.37 . . . . 2.24 107.689 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.3 pttp -134.68 160.78 37.06 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.011 0.374 . . . . 2.14 112.011 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.12 112.9 9.54 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.388 1.475 . . . . 0.75 108.491 169.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -79.68 93.72 5.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.707 2.003 . . . . 1.55 107.006 169.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.0 mm -92.25 134.59 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.323 -1.362 . . . . 1.59 107.323 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -118.69 119.97 36.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 105.319 -2.104 . . . . 2.27 105.319 163.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -142.65 156.39 45.05 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 107.918 -1.141 . . . . 1.9 107.918 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -89.33 116.3 65.97 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.36 -0.829 . . . . 3.34 109.143 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.06 70.12 3.03 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.238 3.292 . . . . 2.89 110.976 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -161.66 -55.65 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 127.183 2.193 . . . . 3.05 106.675 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.4 pt -88.88 -11.19 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.906 0.883 . . . . 3.28 112.654 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 tt -158.35 156.31 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.078 -2.193 . . . . 1.68 105.078 171.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.9 -178.71 27.95 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 109.402 -1.479 . . . . 1.11 109.402 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.5 -40.75 9.89 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.866 1.71 . . . . 0.97 109.591 171.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -38.43 69.41 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 117.991 -1.004 . . . . 5.72 111.1 -171.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.57 -50.5 69.24 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.772 0.714 . . . . 2.46 110.284 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 58' ' ' ILE . 4.6 mp -60.33 -47.54 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.204 -1.035 . . . . 1.56 108.204 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.4 mt -55.08 -43.44 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 116.325 -0.398 . . . . 1.39 110.954 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -32.04 73.29 Favored 'General case' 0 C--O 1.224 -0.273 0 O-C-N 120.858 -1.151 . . . . 5.04 111.034 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.2 m -63.8 -48.29 77.45 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.356 -0.979 . . . . 0.76 108.356 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.421 HG23 ' HB2' ' A' ' 67' ' ' PHE . 65.2 mt -54.37 -46.18 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.411 1.084 . . . . 1.44 110.458 175.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -55.57 -54.48 43.57 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.181 0.515 . . . . 2.06 110.362 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 t -56.76 -38.04 71.9 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 126.068 1.747 . . . . 1.2 111.722 -171.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.77 -92.6 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.605 -0.517 . . . . 2.42 109.605 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.87 30.13 0.33 Allowed Glycine 0 C--N 1.337 0.602 0 CA-C-O 118.712 -1.049 . . . . 1.06 112.802 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.421 ' HB2' HG23 ' A' ' 62' ' ' ILE . 19.7 m-85 -129.81 160.74 32.53 Favored 'General case' 0 N--CA 1.458 -0.047 0 CA-C-N 118.797 1.299 . . . . 1.68 111.415 -159.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -104.6 154.38 20.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.571 1.549 . . . . 3.27 107.159 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.55 151.68 49.17 Favored 'General case' 0 C--O 1.23 0.054 0 C-N-CA 123.315 0.646 . . . . 1.27 110.176 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.1 m -152.17 104.85 3.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.275 -1.009 . . . . 1.72 108.275 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 CA--C 1.53 0.2 0 O-C-N 121.279 -0.888 . . . . 2.5 109.964 174.157 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.674 0 N-CA-C 108.288 -1.925 . . . . 2.01 108.288 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.8 t -78.57 126.02 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 107.943 -1.132 . . . . 2.73 107.943 170.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.1 tp -155.59 100.63 2.11 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.747 0.419 . . . . 3.0 111.387 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.76 89.39 4.01 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 122.766 1.269 . . . . 3.89 109.276 153.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pp -81.73 154.04 26.22 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 113.967 -1.469 . . . . 2.06 108.52 162.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.79 141.53 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.487 -2.042 . . . . 0.95 105.487 168.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.5 127.81 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 104.942 -2.244 . . . . 1.89 104.942 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.6 mtp-105 -120.34 160.82 22.26 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.205 0.911 . . . . 5.43 110.498 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.13 6.17 65.16 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.376 0.989 . . . . 1.16 111.691 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 73.4 mtp -74.39 62.79 1.0 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.569 1.148 . . . . 1.91 110.298 -177.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -69.66 -16.4 63.36 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.256 1.206 . . . . 1.46 114.256 -162.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.2 p -161.53 175.2 12.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 120.202 1.364 . . . . 0.58 110.678 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.96 -39.51 19.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.449 1.1 . . . . 0.56 111.718 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -59.67 -33.28 71.37 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.112 0.565 . . . . 2.29 111.3 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.8 m -71.65 -54.12 11.41 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.643 0.656 . . . . 0.69 109.674 170.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.7 t -47.09 -60.7 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.008 0.923 . . . . 0.79 110.821 -174.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.89 -31.12 68.76 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.321 -0.551 . . . . 0.74 111.624 -174.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -60.52 -51.98 67.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.902 -0.777 . . . . 2.98 108.902 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.6 mt -51.88 -58.94 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.202 0 C-N-CA 123.302 0.641 . . . . 0.9 109.453 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -53.93 -57.01 12.57 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 123.559 0.537 . . . . 3.73 109.845 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.8 t -53.29 -42.7 66.87 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.574 1.15 . . . . 0.85 111.427 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.4 m -70.78 -44.83 65.85 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.999 -0.741 . . . . 1.93 108.999 -175.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.0 mt -64.57 -55.66 18.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.459 -0.337 . . . . 2.71 110.818 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 t -56.68 -19.86 18.63 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.674 -0.641 . . . . 2.64 111.657 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -34.78 75.62 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.122 -0.986 . . . . 4.73 112.757 174.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -80.72 119.56 23.48 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.681 -1.229 . . . . 1.73 107.681 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -49.46 -28.92 5.83 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.883 1.068 . . . . 5.56 113.883 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.16 -22.37 70.73 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.017 -0.879 . . . . 0.97 113.227 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.3 mm -84.27 110.3 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.731 -1.211 . . . . 4.39 107.731 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.09 -33.28 29.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.07 0.548 . . . . 2.78 109.882 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -155.64 158.52 38.47 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.277 -0.638 . . . . 2.32 109.277 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.6 t -145.74 135.52 23.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.741 0.817 . . . . 2.84 108.897 168.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 t -126.13 94.67 4.16 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.858 -1.534 . . . . 2.18 106.858 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 m -78.7 148.43 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.61 1.564 . . . . 2.46 110.441 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.04 123.58 5.51 Favored 'General case' 0 C--N 1.339 0.13 0 O-C-N 122.088 -0.383 . . . . 0.94 111.097 164.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.02 -8.59 56.95 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.206 1.003 . . . . 1.44 113.001 174.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.56 -64.04 1.16 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.312 -0.996 . . . . 2.19 108.312 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 p -77.0 -5.92 50.6 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.849 -0.532 . . . . 2.03 110.455 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 57.57 57.49 4.29 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.889 1.276 . . . . 2.36 107.742 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 168.93 18.6 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.441 0.638 . . . . 2.13 111.68 -170.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -142.3 106.12 4.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.38 -1.736 . . . . 0.62 106.518 167.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -77.0 93.29 3.8 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 103.679 -2.711 . . . . 1.03 103.679 168.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.1 mt -89.33 143.88 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 106.577 -1.638 . . . . 1.83 106.577 174.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -124.16 119.79 30.44 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 105.181 -2.155 . . . . 3.25 105.181 163.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -139.89 162.37 35.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.324 0.649 . . . . 2.02 110.243 -174.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -93.28 109.87 42.86 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 107.803 -1.184 . . . . 3.47 107.803 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.43 60.51 7.56 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 124.331 3.354 . . . . 1.55 111.677 -167.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -171.5 -45.02 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.501 1.92 . . . . 2.94 108.21 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.0 mt -67.13 -38.2 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 108.889 -0.782 . . . . 3.26 108.889 170.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 tt -147.34 136.97 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.655 -1.609 . . . . 1.41 106.655 174.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.22 165.58 30.3 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.009 -0.837 . . . . 0.93 111.009 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -55.24 -47.34 26.67 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.24 1.96 . . . . 1.13 109.737 171.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -51.37 -37.83 50.08 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.314 0.646 . . . . 7.54 112.038 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -70.52 -47.75 58.93 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.284 -0.636 . . . . 2.38 109.284 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.4 mt -53.54 -52.09 36.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 122.846 0.458 . . . . 0.91 110.301 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.9 mm -51.81 -51.6 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.313 0.645 . . . . 1.86 109.655 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -56.22 -40.2 73.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.074 -0.391 . . . . 4.98 111.587 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.3 m -60.37 -56.71 18.2 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.084 -0.709 . . . . 0.87 109.084 175.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.437 HG21 ' HB2' ' A' ' 69' ' ' ALA . 32.2 mt -47.6 -53.18 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.607 1.163 . . . . 1.56 111.346 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -59.27 -56.23 24.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.466 1.106 . . . . 2.22 110.362 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.3 t -59.12 -30.08 67.86 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.433 0.693 . . . . 1.47 111.841 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.9 mt -71.87 -74.86 0.14 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.349 0.522 . . . . 2.32 110.618 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.51 6.83 0.08 OUTLIER Glycine 0 CA--C 1.529 0.965 0 CA-C-O 117.862 -1.521 . . . . 0.84 116.231 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -130.85 158.31 40.52 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 120.2 2.0 . . . . 1.66 112.165 -146.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -92.55 167.53 11.87 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 107.509 -1.293 . . . . 3.08 107.509 170.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.437 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -155.25 169.16 24.83 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.901 0.381 . . . . 0.88 111.192 164.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.4 m -154.6 125.61 7.2 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.831 1.252 . . . . 1.65 108.059 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 C-N-CA 123.516 0.727 . . . . 2.84 111.874 -175.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 108.155 -1.978 . . . . 1.81 108.155 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.96 132.81 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.236 -1.394 . . . . 2.64 107.236 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.6 tp -148.48 143.31 26.62 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.293 -1.373 . . . . 2.89 107.293 172.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -133.72 113.82 12.75 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.322 -1.362 . . . . 3.98 107.322 172.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.421 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -122.79 153.68 39.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.379 0.672 . . . . 2.23 109.493 -179.314 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.48 140.65 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.075 -1.454 . . . . 0.79 107.075 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.6 t -131.97 93.0 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 C-N-CA 127.062 2.145 . . . . 2.04 106.052 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.4 mtm105 -79.79 157.74 27.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.485 -0.561 . . . . 5.71 109.485 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.79 -6.08 56.92 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.403 1.002 . . . . 1.07 112.082 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 71.8 mtp -71.88 74.07 0.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.166 0.983 . . . . 1.92 110.958 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 t -70.76 -17.15 62.8 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 117.277 -1.344 . . . . 1.61 114.257 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.2 p -163.78 176.15 9.81 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 120.727 1.603 . . . . 0.61 111.381 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.65 -38.41 21.01 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.805 1.242 . . . . 0.64 111.892 175.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 t -49.07 -48.57 44.05 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 109.425 -0.583 . . . . 2.57 109.425 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.6 m -62.32 -46.03 90.58 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 122.258 0.223 . . . . 0.89 110.773 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 80.2 t -52.49 -65.1 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 109.921 -0.4 . . . . 1.0 109.921 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -30.58 67.67 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 118.986 -1.085 . . . . 0.86 111.842 -172.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -53.19 -53.43 50.76 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.37 -0.604 . . . . 3.47 109.37 169.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.9 mt -60.65 -58.37 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 118.461 -0.781 . . . . 0.64 110.024 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -49.51 -55.46 13.25 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.994 0.816 . . . . 3.88 110.548 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.1 t -56.58 -38.98 72.73 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.326 1.05 . . . . 0.91 111.388 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.3 t -71.13 -36.35 72.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.476 -0.765 . . . . 1.51 109.845 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.1 mt -66.99 -62.19 1.56 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 118.488 -0.768 . . . . 3.24 110.488 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.1 p -70.62 65.66 0.32 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.249 1.419 . . . . 1.94 111.697 -172.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.8 tptp -176.48 -48.2 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.55 1.14 . . . . 4.16 108.167 -151.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -73.29 90.59 1.64 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.897 -1.149 . . . . 1.89 107.897 166.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -51.76 105.1 0.1 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.526 -0.546 . . . . 6.44 109.526 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.79 -43.9 0.7 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 108.727 -1.749 . . . . 0.94 108.727 -164.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.45 131.57 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 105.436 -2.061 . . . . 2.5 105.436 161.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.7 mt -94.24 -42.72 8.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.909 1.284 . . . . 1.76 108.351 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -149.04 154.24 39.01 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.441 -0.578 . . . . 2.42 109.441 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.3 p -143.93 152.71 41.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.381 1.472 . . . . 2.14 108.306 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.9 m -155.25 82.78 1.06 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.673 1.189 . . . . 2.03 108.396 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.56 154.24 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 125.086 1.354 . . . . 2.61 108.871 174.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.04 130.06 11.82 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 120.736 -1.228 . . . . 0.92 110.786 172.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.59 -32.99 72.08 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.316 0.507 . . . . 1.87 110.159 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -47.59 -43.48 25.6 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.621 1.168 . . . . 1.34 112.449 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 t -121.76 1.97 10.0 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.706 0.403 . . . . 2.93 111.975 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 52.17 66.29 1.25 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.481 1.513 . . . . 1.78 108.46 174.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.48 166.02 27.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.427 1.091 . . . . 2.3 108.323 -175.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.48 108.85 12.04 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.832 2.053 . . . . 1.07 106.255 166.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -80.54 132.9 35.73 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 103.746 -2.687 . . . . 1.3 103.746 159.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.8 pt -138.84 151.27 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 106.796 -1.557 . . . . 3.58 106.796 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -139.28 101.01 4.15 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 102.802 -3.036 . . . . 2.46 102.802 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -129.91 149.01 51.83 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.523 0.729 . . . . 1.78 109.205 -169.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -82.96 117.79 69.69 Favored Pre-proline 0 N--CA 1.451 -0.423 0 N-CA-C 107.809 -1.182 . . . . 2.87 107.809 173.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.11 -26.99 78.5 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.443 1.428 . . . . 1.93 111.625 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -80.8 42.04 0.6 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.145 0.884 . . . . 4.27 111.363 -174.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -175.5 -43.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.682 1.593 . . . . 2.89 110.277 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 tt -132.67 124.03 50.32 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 108.108 -1.071 . . . . 1.19 108.108 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.4 173.59 51.11 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 110.679 -0.968 . . . . 0.91 110.679 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.63 -54.73 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.45 2.1 . . . . 0.99 110.263 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -50.46 -42.94 54.97 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.297 0.639 . . . . 6.04 110.944 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.51 -49.32 18.68 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.816 2.046 . . . . 2.68 110.154 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 54.7 mt -70.32 -47.59 65.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.234 0.614 . . . . 1.34 110.312 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.3 mm -50.03 -47.24 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 118.132 0.424 . . . . 1.95 110.858 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -45.17 -44.99 11.25 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.316 1.446 . . . . 2.85 111.445 173.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.0 m -58.89 -55.09 39.61 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.565 -0.902 . . . . 1.08 108.565 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.5 -53.67 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.197 0.599 . . . . 1.79 109.966 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -61.78 -48.34 81.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.618 -0.433 . . . . 2.48 110.22 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.6 t -55.65 -48.41 75.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.174 0.59 . . . . 1.49 111.549 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.1 mt -54.97 -59.51 4.65 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.903 -0.498 . . . . 2.32 112.316 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.68 -0.01 0.06 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 116.961 1.544 . . . . 1.09 116.961 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -131.94 175.18 9.44 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 119.897 1.849 . . . . 1.85 113.371 -139.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -125.68 103.44 7.83 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.685 1.194 . . . . 4.12 107.977 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.79 157.27 21.03 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.96 0.356 . . . . 1.47 111.96 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.9 t -154.45 133.09 12.12 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.424 1.09 . . . . 2.08 108.315 165.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.6 mt . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 109.026 -0.731 . . . . 2.32 109.026 163.401 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.437 0 N-CA-C 109.037 -1.625 . . . . 3.76 109.037 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 p -158.04 166.54 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.754 -1.572 . . . . 2.51 106.754 169.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 tp -133.27 128.45 35.85 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.468 -1.308 . . . . 2.23 107.468 151.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -121.89 133.28 54.86 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.385 1.474 . . . . 3.72 108.133 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.98 157.12 41.29 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.378 -0.601 . . . . 2.73 109.378 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.61 145.21 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.263 -1.754 . . . . 0.75 106.263 169.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.8 137.24 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 125.672 1.589 . . . . 1.72 108.467 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -130.36 163.19 27.41 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.093 0.957 . . . . 5.81 108.779 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.67 -15.4 63.22 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.455 0.55 . . . . 1.41 112.275 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.458 ' SD ' HD12 ' A' ' 22' ' ' ILE . 64.2 mtm -69.14 78.98 0.34 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.208 1.004 . . . . 1.67 110.097 175.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 t -71.46 -16.75 62.38 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.753 -1.117 . . . . 1.77 113.097 -174.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.5 p -161.72 172.68 15.81 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.94 1.245 . . . . 0.97 110.792 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.16 -41.12 25.98 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.782 1.233 . . . . 0.71 111.536 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.5 m -61.01 -29.29 69.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.523 0.729 . . . . 1.62 112.205 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.7 m -72.03 -56.62 5.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.161 0.892 . . . . 0.81 110.03 166.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.705 HG13 HG23 ' A' ' 37' ' ' VAL . 88.3 t -43.71 -62.35 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.588 1.155 . . . . 0.9 110.781 -173.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -25.31 63.53 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 120.586 -0.446 . . . . 0.82 111.898 -175.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -67.88 -41.17 83.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.205 -0.665 . . . . 2.9 109.205 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.458 HD12 ' SD ' ' A' ' 13' ' ' MET . 12.8 mt -54.94 -59.03 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.494 -0.558 . . . . 0.87 109.494 173.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.443 ' OE2' HG22 ' A' ' 37' ' ' VAL . 93.4 mt-10 -52.97 -51.2 62.31 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.548 0.613 . . . . 3.72 111.388 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.2 t -54.93 -37.38 66.33 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.143 0.977 . . . . 0.95 111.205 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.3 t -71.29 -57.87 4.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.736 -1.209 . . . . 1.45 107.736 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.0 mt -51.17 -49.66 60.47 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.014 0.925 . . . . 2.6 112.085 -174.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.3 t -56.77 -17.92 10.85 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.456 -0.777 . . . . 2.67 112.61 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -30.45 71.3 Favored 'General case' 0 C--N 1.343 0.287 0 O-C-N 121.139 -0.976 . . . . 5.76 112.34 175.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -81.18 113.22 19.18 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 106.543 -1.651 . . . . 1.74 106.543 170.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -55.84 -26.33 46.18 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.524 0.565 . . . . 6.58 112.524 -173.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.82 -22.26 59.62 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.818 0.723 . . . . 1.37 113.437 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.2 mm -79.59 97.88 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.282 -1.377 . . . . 4.13 107.282 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.3 mt -77.68 -34.78 52.84 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.024 -0.732 . . . . 1.81 109.024 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -148.75 158.55 44.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.591 -0.892 . . . . 2.27 108.591 165.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.6 p -145.26 138.02 26.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.963 1.705 . . . . 2.35 107.717 173.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 t -142.16 106.93 4.87 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.496 -1.668 . . . . 1.77 106.496 170.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.705 HG23 HG13 ' A' ' 19' ' ' VAL . 35.9 m -84.87 171.78 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.159 0.436 . . . . 1.71 109.936 170.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -157.12 141.3 16.36 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.063 -0.717 . . . . 0.94 109.063 152.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.98 -38.07 53.92 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 108.521 -0.918 . . . . 2.11 108.521 166.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.36 -38.96 69.49 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.582 0.753 . . . . 1.46 110.609 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 m -112.1 14.52 20.71 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.389 1.076 . . . . 2.41 110.284 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.3 m120 32.29 53.08 0.29 Allowed 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 126.392 1.877 . . . . 1.57 113.512 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.68 168.47 17.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 122.864 0.465 . . . . 2.74 111.29 -171.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -140.26 135.59 32.46 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.29 -1.323 . . . . 1.13 109.22 150.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -110.4 107.34 17.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 104.288 -2.486 . . . . 1.28 104.288 168.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.433 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -106.74 146.56 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 105.889 -1.893 . . . . 1.86 105.889 175.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -113.16 93.21 4.3 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 105.307 -2.108 . . . . 2.61 105.307 170.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.78 150.89 20.87 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.318 1.047 . . . . 3.02 112.755 -174.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -87.22 126.5 62.41 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 107.066 -1.457 . . . . 3.09 107.066 150.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.02 -19.62 20.22 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.877 3.052 . . . . 1.82 113.447 -171.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -93.05 -45.1 8.07 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.874 -0.788 . . . . 3.44 108.874 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.1 mt -68.12 -35.76 72.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 109.553 -0.536 . . . . 2.92 109.553 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 mm -130.71 116.18 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.041 -1.466 . . . . 1.49 107.041 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.43 152.64 49.62 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 108.234 -1.946 . . . . 0.88 108.234 169.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -55.66 -38.55 94.12 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.028 1.819 . . . . 1.79 111.013 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -67.22 -23.83 65.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 118.841 -0.599 . . . . 6.74 112.408 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -65.59 -35.64 81.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 120.702 1.592 . . . . 2.44 112.285 -170.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.4 mt -53.47 -48.05 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 109.176 -0.676 . . . . 1.29 109.176 171.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.0 mt -62.69 -49.02 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.705 0.802 . . . . 1.31 109.733 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -48.89 -44.6 40.18 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.132 0.878 . . . . 3.91 110.66 175.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.6 m -65.0 -56.63 11.99 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.302 -0.629 . . . . 0.82 109.302 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.403 HG23 ' HB2' ' A' ' 67' ' ' PHE . 74.7 mt -46.89 -49.87 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.454 1.102 . . . . 1.47 110.88 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -58.1 -53.76 54.63 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.797 1.239 . . . . 2.15 111.0 174.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.2 p -60.06 -29.99 68.91 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.316 0.488 . . . . 2.28 112.316 -172.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.38 -97.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.59 -0.522 . . . . 2.88 109.59 167.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.29 35.94 0.44 Allowed Glycine 0 C--N 1.337 0.607 0 O-C-N 121.167 -0.958 . . . . 0.81 112.403 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.403 ' HB2' HG23 ' A' ' 62' ' ' ILE . 26.0 m-85 -131.57 159.37 38.42 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.465 1.132 . . . . 2.22 110.283 -165.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -99.5 155.86 17.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.597 -0.89 . . . . 3.66 108.597 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.72 162.47 35.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.349 0.26 . . . . 1.15 110.953 162.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.0 m -155.44 116.93 4.0 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.79 0.836 . . . . 1.85 109.847 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.374 0 C-N-CA 124.029 0.932 . . . . 2.51 110.743 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 106.626 -2.59 . . . . 1.63 106.626 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.5 p -129.57 134.89 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.458 -1.312 . . . . 1.94 107.458 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.4 tp -145.29 113.3 6.47 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.919 -1.141 . . . . 2.09 107.919 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -94.0 133.23 37.67 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.681 -0.488 . . . . 3.32 109.681 165.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -131.94 148.73 52.54 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.558 -1.275 . . . . 2.24 107.558 172.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 t -79.71 142.72 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 106.174 -1.788 . . . . 0.81 106.174 162.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 p -122.73 96.12 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 125.682 1.593 . . . . 2.46 107.678 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -80.87 59.76 3.85 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.388 -0.82 . . . . 6.84 109.768 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.57 0.42 0.21 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.988 -0.896 . . . . 1.46 114.419 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.5 mtm -77.13 76.88 3.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.411 1.605 . . . . 1.64 109.735 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -75.67 -11.63 60.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.886 -1.055 . . . . 1.97 112.963 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.8 p -160.75 172.51 16.92 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 120.008 1.276 . . . . 1.03 109.2 172.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.23 -44.98 11.52 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.459 1.104 . . . . 1.24 111.466 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -50.38 -40.94 51.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.745 0.418 . . . . 2.48 110.846 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.0 m -58.97 -34.6 71.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.41 0.522 . . . . 1.14 112.41 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.66 -67.94 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.738 0.78 . . . . 0.94 109.19 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.76 -32.25 73.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 118.399 -0.81 . . . . 1.38 111.279 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -53.85 -52.84 59.11 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.767 1.167 . . . . 2.96 109.975 172.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.5 mt -54.93 -64.3 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 109.032 -0.729 . . . . 0.81 109.032 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -56.42 -54.73 42.23 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.907 -0.717 . . . . 4.22 110.164 -171.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -51.64 -43.83 62.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.464 1.106 . . . . 0.8 111.98 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.4 t -70.67 -33.28 70.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.208 -0.933 . . . . 1.3 109.852 -175.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.01 -48.15 38.84 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 111.745 0.276 . . . . 2.64 111.745 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.43 ' HA ' HD11 ' A' ' 32' ' ' ILE . 16.2 p -60.29 -18.38 48.91 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.737 -1.227 . . . . 2.12 113.671 -165.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -39.3 63.11 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.138 0.792 . . . . 5.35 113.138 168.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -60.92 167.98 2.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.382 0.992 . . . . 2.5 109.13 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.66 -18.53 12.75 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.773 -0.579 . . . . 6.9 111.869 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.27 -22.8 78.49 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 118.63 0.65 . . . . 1.15 112.015 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.43 HD11 ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -78.7 157.92 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 117.94 0.87 . . . . 3.29 109.785 174.689 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.5 mt -119.17 -46.43 2.51 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.02 1.328 . . . . 1.98 109.428 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -155.44 153.7 30.76 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 117.728 -1.13 . . . . 2.17 108.641 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.6 t -131.69 77.06 1.75 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.362 1.065 . . . . 2.77 109.472 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.51 85.05 3.89 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 120.75 -1.219 . . . . 3.43 109.82 -168.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.89 138.45 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 128.039 2.536 . . . . 2.67 111.841 -171.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.39 124.3 10.63 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 118.635 0.652 . . . . 1.14 111.629 172.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.4 mt -47.85 -43.79 28.59 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.97 0.908 . . . . 2.16 109.655 158.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.7 -24.71 1.48 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.49 1.116 . . . . 2.38 113.723 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 t -139.5 25.06 2.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.965 0.802 . . . . 3.05 112.438 169.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.2 m120 40.6 45.91 2.08 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.821 2.048 . . . . 1.8 112.816 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.99 170.81 14.82 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 118.543 0.611 . . . . 2.29 111.391 -171.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.11 130.19 23.34 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 125.176 1.547 . . . . 0.89 109.614 164.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -97.98 97.7 9.14 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.043 1.737 . . . . 0.99 107.618 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.5 mp -86.94 112.78 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 106.285 -1.746 . . . . 1.55 106.285 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -88.21 135.17 33.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.073 -1.825 . . . . 2.72 106.073 157.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -162.74 175.05 11.71 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.416 1.086 . . . . 1.85 109.253 -171.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -106.34 125.15 33.63 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 107.064 -1.458 . . . . 3.09 107.064 162.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.67 -6.36 18.11 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.696 2.93 . . . . 1.77 113.567 -171.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -108.33 -34.97 6.65 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.643 1.177 . . . . 3.93 109.074 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.0 mt -70.32 -33.51 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 O-C-N 121.765 -0.584 . . . . 3.55 110.648 169.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 tt -140.2 129.36 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.97 -1.122 . . . . 1.29 107.97 168.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.53 176.16 42.53 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.622 0.63 . . . . 1.57 111.902 -173.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.91 -57.0 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.797 2.332 . . . . 2.62 111.27 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.428 HH21 ' CD ' ' A' ' 63' ' ' GLU . 71.8 ttt180 -65.42 -33.65 76.46 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 117.958 -1.02 . . . . 6.34 110.695 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -35.6 -57.5 0.63 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.766 1.626 . . . . 2.32 111.486 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.6 mt -52.09 -58.89 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.937 1.295 . . . . 0.83 110.868 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.2 mm -50.66 -62.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 124.859 1.263 . . . . 1.72 109.409 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -49.68 -34.82 19.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.297 1.839 . . . . 4.89 112.03 176.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.2 m -65.34 -48.4 73.12 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.703 1.138 . . . . 0.77 108.82 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 59.3 mt -57.37 -47.07 85.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.584 0.753 . . . . 1.22 111.109 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 56' ' ' ARG . 49.7 mt-10 -51.46 -57.73 8.19 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.956 0.902 . . . . 2.28 109.261 172.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 t -65.77 -27.31 68.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.394 1.078 . . . . 1.32 112.291 -171.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.0 mt -65.83 -81.32 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.859 0.754 . . . . 2.31 110.04 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.25 25.94 0.26 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.599 -1.112 . . . . 0.77 113.235 171.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -134.29 176.44 8.6 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 118.825 1.313 . . . . 1.88 112.276 -153.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -127.41 136.34 51.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.357 -2.09 . . . . 3.24 105.357 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.19 153.67 35.92 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.27 1.028 . . . . 0.87 110.391 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.1 m -154.67 132.0 11.14 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.757 0.823 . . . . 1.73 109.6 170.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 CA--C 1.534 0.359 0 C-N-CA 125.251 1.42 . . . . 3.37 109.017 -175.532 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 109.651 -1.38 . . . . 1.88 109.651 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 p -145.09 90.42 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.389 -0.967 . . . . 2.49 108.389 172.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 6' ' ' LEU . 1.4 tm? -78.51 80.01 4.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.779 -1.934 . . . . 3.12 105.779 170.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -84.7 123.73 30.71 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 114.071 -1.422 . . . . 3.54 108.802 168.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 157.78 39.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 123.648 0.592 . . . . 2.56 110.617 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -79.06 115.77 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 106.476 -1.676 . . . . 0.71 106.476 170.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.04 73.55 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 105.952 -1.87 . . . . 2.22 105.952 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.03 100.98 5.09 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.904 -1.887 . . . . 7.08 105.904 -166.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.92 -43.65 0.24 Allowed Glycine 0 C--N 1.334 0.441 0 O-C-N 120.343 -1.473 . . . . 1.43 113.548 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.31 75.74 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.105 1.15 . . . . 2.61 114.105 -173.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.2 t -69.35 -13.1 62.19 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.723 1.379 . . . . 1.98 114.723 -166.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.7 p -155.12 170.33 22.05 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.078 1.308 . . . . 0.72 109.931 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.35 -45.73 8.98 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.962 1.305 . . . . 0.67 111.542 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -54.1 -39.53 66.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.339 1.456 . . . . 1.79 112.029 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.1 m -71.98 -55.12 8.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.994 -0.373 . . . . 0.72 109.994 170.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.449 HG13 HG23 ' A' ' 37' ' ' VAL . 93.7 t -47.56 -60.62 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 123.655 0.782 . . . . 0.85 110.623 -173.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.72 -24.66 65.4 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.657 -0.652 . . . . 0.8 111.863 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -67.14 -48.26 68.58 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.773 -0.825 . . . . 3.56 108.773 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 67' ' ' PHE . 15.8 mt -57.4 -57.12 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 118.507 0.594 . . . . 0.83 109.432 174.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -53.53 -50.92 64.46 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.44 0.638 . . . . 3.53 110.386 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.0 t -56.72 -51.64 68.05 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 118.326 -0.845 . . . . 1.0 109.87 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 t -57.33 -44.61 84.4 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 119.494 1.043 . . . . 1.31 108.514 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.1 mt -56.44 -53.13 61.06 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.337 -0.847 . . . . 3.07 111.795 175.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.7 p -57.78 -10.41 1.65 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.923 1.083 . . . . 2.25 113.923 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -33.47 69.2 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.427 1.012 . . . . 7.16 110.863 173.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -78.65 148.44 33.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.614 -0.884 . . . . 2.27 108.614 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -95.34 -24.41 16.75 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.172 0.589 . . . . 7.07 111.29 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.31 -19.97 76.38 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 122.165 -0.335 . . . . 0.93 112.388 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -84.05 127.71 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 105.932 -1.877 . . . . 2.38 105.932 164.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.91 -38.0 33.48 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.442 -0.577 . . . . 2.47 109.442 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -155.48 153.54 30.45 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.752 -1.203 . . . . 2.32 107.752 -175.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.8 p -139.12 146.76 41.06 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 123.744 0.652 . . . . 2.14 109.359 168.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 t -144.5 105.17 4.15 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.154 -1.424 . . . . 1.58 107.154 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.449 HG23 HG13 ' A' ' 19' ' ' VAL . 9.1 m -90.45 159.05 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.703 0.801 . . . . 1.8 110.132 174.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.68 130.31 9.09 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 121.745 -0.597 . . . . 0.66 110.757 163.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 pp -68.1 -23.61 64.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 123.552 0.532 . . . . 1.47 111.957 165.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.43 -47.63 72.62 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.377 0.535 . . . . 1.21 110.084 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.99 -17.3 20.15 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.176 0.99 . . . . 1.97 112.144 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.56 38.26 25.35 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.883 1.273 . . . . 2.59 109.29 -162.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.55 160.83 16.81 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.311 0.645 . . . . 2.59 110.027 -173.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.433 ' HB2' HG12 ' A' ' 37' ' ' VAL . . . -134.4 122.21 22.24 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.147 -1.427 . . . . 0.71 107.147 159.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -96.36 108.89 21.48 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 104.455 -2.424 . . . . 0.93 104.455 166.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.8 mt -120.33 104.49 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.36 -1.348 . . . . 1.75 107.36 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -79.97 138.68 37.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.367 -1.346 . . . . 2.71 107.367 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -159.58 147.78 17.44 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 119.196 -0.43 . . . . 1.99 110.828 -159.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -85.83 103.74 4.2 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 106.356 -1.72 . . . . 3.15 106.356 168.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.26 -54.64 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.573 2.182 . . . . 2.54 111.422 -165.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -53.83 -44.24 70.09 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.007 1.323 . . . . 3.02 111.819 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.2 -47.01 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 122.377 0.271 . . . . 2.96 110.624 -173.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -48.19 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 117.923 0.329 . . . . 3.98 110.87 -171.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.93 116.27 2.42 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 110.41 -1.076 . . . . 1.24 110.41 -170.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -59.95 -39.38 71.63 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 119.955 1.878 . . . . 1.13 109.653 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -37.89 -53.45 1.32 Allowed 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 125.378 1.471 . . . . 8.61 110.815 164.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -73.74 -36.05 65.12 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.996 0.918 . . . . 3.01 113.159 -174.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.1 mt -53.48 -48.94 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.356 -0.84 . . . . 0.78 109.636 166.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.5 mt -58.71 -47.2 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 109.495 -0.558 . . . . 1.52 109.495 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -50.21 -42.49 51.58 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.692 0.678 . . . . 3.04 111.033 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.4 m -60.48 -54.48 45.06 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.279 0.945 . . . . 1.21 109.092 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.1 mt -52.13 -51.64 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.382 1.073 . . . . 1.52 111.758 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -60.06 -56.99 14.81 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.257 1.023 . . . . 2.24 110.463 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -52.93 -42.95 65.89 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.629 1.172 . . . . 1.46 110.632 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.5 mt -62.56 -70.91 0.18 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.437 -0.316 . . . . 2.32 110.573 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.64 -10.34 0.04 OUTLIER Glycine 0 CA--C 1.531 1.044 0 N-CA-C 117.614 1.805 . . . . 1.17 117.614 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.482 ' CD2' HD11 ' A' ' 22' ' ' ILE . 30.5 m-85 -133.23 156.35 47.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.845 1.823 . . . . 1.82 111.533 -137.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -80.23 159.04 26.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.179 0.992 . . . . 3.63 108.551 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.15 141.96 50.63 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.577 1.151 . . . . 1.42 109.432 172.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.7 m -153.37 110.0 3.4 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.543 0.737 . . . . 1.69 109.72 170.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.533 0.299 0 CA-C-N 118.768 0.713 . . . . 3.25 109.804 176.537 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.721 0 N-CA-C 109.813 -1.315 . . . . 1.42 109.813 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 m -109.77 101.22 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.856 1.662 . . . . 2.32 108.975 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.33 106.19 18.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.672 -1.233 . . . . 3.19 107.672 175.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -107.46 103.4 12.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.268 -1.012 . . . . 3.61 108.268 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.3 mt -106.09 144.58 32.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.081 0.953 . . . . 2.35 108.458 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.49 128.22 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 104.721 -2.326 . . . . 1.09 104.721 151.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 p -101.23 85.31 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.014 1.326 . . . . 2.57 107.554 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -83.27 59.25 4.9 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.312 1.045 . . . . 6.21 109.633 -169.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.67 -44.01 0.03 OUTLIER Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.849 -0.691 . . . . 1.35 112.959 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.18 131.78 52.04 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.674 -0.861 . . . . 2.73 108.674 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.2 p -94.08 -57.32 2.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.053 0.541 . . . . 3.27 110.317 -175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 p -134.44 176.97 8.13 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.477 0.711 . . . . 0.69 112.2 -160.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.43 -42.99 10.95 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.674 1.189 . . . . 0.63 111.9 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -54.4 -48.45 71.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.967 0.507 . . . . 2.44 109.72 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.6 m -67.29 -41.43 85.42 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 122.091 -0.381 . . . . 0.82 111.053 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.45 HG13 HG23 ' A' ' 37' ' ' VAL . 93.1 t -53.5 -63.96 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 122.591 0.357 . . . . 0.73 110.408 176.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.261 0.1 OUTLIER -70.68 -25.89 63.18 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.991 -1.068 . . . . 0.89 112.356 -175.639 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -55.01 -52.46 63.09 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.629 0.65 . . . . 3.52 109.703 167.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.1 mt -52.48 -63.83 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.235 0 N-CA-C 108.876 -0.787 . . . . 0.82 108.876 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -56.54 -51.38 68.76 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 120.595 -0.442 . . . . 3.58 111.366 -171.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.6 t -58.19 -43.46 87.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.5 -0.762 . . . . 0.98 110.408 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 t -63.18 -56.19 18.8 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 120.022 1.283 . . . . 1.25 108.1 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.41 -45.08 89.08 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.303 -0.862 . . . . 2.42 112.242 -175.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.418 ' HA ' HD11 ' A' ' 32' ' ' ILE . 32.8 p -58.59 -17.19 19.86 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.943 0.72 . . . . 2.11 112.943 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -65.93 -28.37 68.87 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.246 0.93 . . . . 6.85 111.088 173.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -83.88 105.23 14.61 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 108.565 -0.902 . . . . 2.09 108.565 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -57.11 -17.94 12.76 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.526 0.936 . . . . 5.96 113.526 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.8 -27.77 70.63 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.185 -0.786 . . . . 0.89 112.122 172.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -84.38 145.31 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 119.186 1.493 . . . . 2.47 108.38 169.24 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.4 mt -109.57 -39.42 5.16 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.678 1.191 . . . . 2.01 109.695 -168.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -155.16 149.54 26.13 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.715 -1.217 . . . . 1.95 107.715 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.9 m -124.89 147.39 48.84 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.679 -1.23 . . . . 2.01 107.679 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 m -154.48 85.04 1.12 Allowed 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.982 1.313 . . . . 2.02 108.921 172.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG23 HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -79.11 157.74 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 123.291 0.636 . . . . 1.75 110.678 172.136 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.33 144.94 22.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.063 0.545 . . . . 0.9 110.332 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -85.53 -41.33 15.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.956 1.302 . . . . 2.67 108.675 170.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.45 -16.42 3.69 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.071 1.348 . . . . 2.36 112.977 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.6 m -140.79 20.03 2.33 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.432 -0.793 . . . . 2.2 110.392 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.3 m120 36.77 47.27 0.54 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.712 2.005 . . . . 2.24 113.834 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.45 171.7 13.93 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 117.986 0.357 . . . . 2.18 111.386 -165.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.59 108.03 5.56 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.54 2.336 . . . . 0.77 106.211 173.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -87.42 114.48 24.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.722 -2.325 . . . . 0.88 104.722 162.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 67.5 mt -123.16 111.5 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.399 -2.074 . . . . 1.99 105.399 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.96 134.23 36.24 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.014 -1.476 . . . . 2.65 107.014 170.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -148.32 149.57 32.06 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 117.815 0.279 . . . . 2.69 111.365 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -80.73 115.09 53.17 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 107.42 -1.326 . . . . 3.03 107.42 167.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -73.43 -13.11 25.24 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.124 2.55 . . . . 1.61 113.175 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -88.92 -44.87 10.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.513 -0.921 . . . . 2.82 108.513 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.5 mt -72.2 -42.26 66.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 122.848 0.459 . . . . 2.88 110.556 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 mm -125.14 115.47 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.18 -1.785 . . . . 1.25 106.18 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.58 148.51 51.24 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 108.178 -1.969 . . . . 0.89 108.178 171.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -57.44 -40.92 77.41 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 CA-C-N 119.493 1.646 . . . . 1.28 110.37 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.418 ' HG3' ' CE1' ' A' ' 60' ' ' HIS . 26.9 tpt180 -56.35 -28.56 59.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.553 -0.737 . . . . 6.12 112.153 174.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -71.7 -39.24 70.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 120.123 1.329 . . . . 2.5 112.046 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.5 mt -56.48 -47.46 81.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.604 -0.887 . . . . 0.83 108.604 171.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.6 mt -61.26 -45.23 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 118.851 -0.595 . . . . 1.19 110.204 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.418 ' CE1' ' HG3' ' A' ' 56' ' ' ARG . 29.4 m170 -50.85 -43.55 59.31 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.371 0.987 . . . . 3.72 110.201 173.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.6 m -65.54 -54.54 26.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.35 -0.981 . . . . 0.98 108.35 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.8 mt -49.02 -53.41 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.026 0.93 . . . . 1.46 110.823 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -52.48 -53.58 43.78 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.854 0.861 . . . . 2.18 110.145 174.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.1 t -62.73 -26.53 68.73 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 117.788 -1.101 . . . . 1.3 113.091 -174.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.16 -91.37 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.854 1.206 . . . . 2.2 109.937 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.98 40.89 0.42 Allowed Glycine 0 CA--C 1.524 0.604 0 O-C-N 120.936 -1.103 . . . . 0.97 111.646 174.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -138.82 176.44 8.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 117.954 0.877 . . . . 2.71 110.124 -162.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -133.64 164.61 26.82 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.434 -1.321 . . . . 4.22 107.434 167.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.12 166.78 23.27 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.97 0.908 . . . . 1.27 112.118 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.9 m -150.76 155.54 39.47 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 106.708 -1.589 . . . . 1.78 106.708 160.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 CA--C 1.535 0.375 0 CA-C-N 119.557 1.072 . . . . 2.68 109.243 179.061 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.665 0 N-CA-C 110.455 -1.058 . . . . 1.86 110.455 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -119.81 136.12 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 126.052 1.741 . . . . 2.14 110.407 -176.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.28 112.71 5.3 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 123.958 0.903 . . . . 3.14 108.822 176.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.62 113.8 27.61 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 122.992 0.517 . . . . 2.95 109.989 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.2 mt -86.51 157.07 19.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 124.645 1.215 . . . . 2.51 108.076 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.62 142.07 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 105.632 -1.988 . . . . 1.02 105.632 148.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.8 t -135.06 114.25 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 126.314 1.846 . . . . 2.01 106.821 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -110.37 170.97 7.73 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.73 1.212 . . . . 6.57 110.466 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.15 -47.78 2.42 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.723 -0.951 . . . . 1.3 110.723 -173.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -51.4 -45.71 62.63 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 121.964 0.888 . . . . 2.92 112.071 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.317 9.3 t 58.71 -63.25 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.986 2.114 . . . . 3.21 115.32 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 p -110.6 162.13 15.03 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 120.271 1.396 . . . . 1.44 112.82 -163.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.7 -48.17 5.5 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 125.58 1.552 . . . . 1.22 111.516 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -51.51 -48.43 62.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.098 1.359 . . . . 2.39 111.438 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.6 m -72.71 -42.89 63.69 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 122.147 -0.346 . . . . 0.95 110.858 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.3 t -52.1 -64.1 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 117.928 0.331 . . . . 1.17 110.553 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -28.46 68.2 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.847 -1.158 . . . . 1.57 111.716 -173.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -57.44 -55.23 37.49 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.389 0.675 . . . . 2.67 109.581 169.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.88 -52.07 53.36 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 108.996 -0.742 . . . . 0.95 108.996 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -50.83 -60.23 3.28 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.768 0.827 . . . . 3.54 109.785 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.2 t -53.65 -45.95 70.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.517 0.727 . . . . 1.17 110.417 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.7 t -58.96 -53.37 59.18 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.45 -0.944 . . . . 1.3 108.45 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.84 -50.76 44.14 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.911 0.884 . . . . 2.78 110.793 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.0 m -57.49 -24.88 58.43 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.732 0.641 . . . . 2.01 112.732 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -63.5 -33.1 74.82 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.356 -0.84 . . . . 7.89 110.792 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -55.18 143.1 28.67 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 108.558 -0.904 . . . . 2.51 108.558 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.79 159.65 16.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.084 -1.821 . . . . 6.93 106.084 163.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.45 -16.39 45.03 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 122.215 -0.303 . . . . 1.59 113.065 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 pp -78.86 141.14 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 108.191 -1.04 . . . . 3.16 108.191 170.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.6 -47.09 9.5 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.409 1.484 . . . . 3.26 108.318 172.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -156.98 158.09 35.93 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.706 -1.22 . . . . 2.27 107.706 -175.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 p -135.08 151.17 50.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.717 -1.216 . . . . 2.66 107.717 161.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 t -154.35 146.52 23.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.061 -0.718 . . . . 2.42 109.061 152.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.26 152.22 33.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 124.971 1.309 . . . . 1.83 110.207 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.25 155.97 34.75 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-O 121.026 0.441 . . . . 0.8 111.185 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.98 -8.51 14.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.77 1.628 . . . . 1.92 113.046 -165.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.53 -57.62 6.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.034 -1.099 . . . . 1.96 108.034 169.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -79.9 -28.99 39.76 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.203 0.601 . . . . 2.52 111.301 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 m120 73.91 56.59 0.1 Allowed 'General case' 0 C--N 1.343 0.3 0 C-N-CA 125.542 1.537 . . . . 1.61 108.235 -173.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -124.86 159.22 31.58 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.749 1.22 . . . . 4.07 110.793 -166.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -142.35 96.98 3.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 125.31 1.631 . . . . 1.05 107.894 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -81.16 102.42 10.29 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.506 -1.664 . . . . 1.16 106.506 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 46' ' ' ILE . 1.6 mp -101.33 150.11 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.027 -1.842 . . . . 1.74 106.027 167.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -120.57 137.64 54.3 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.931 -1.878 . . . . 3.15 105.931 161.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -150.69 154.8 38.09 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 123.579 0.752 . . . . 2.1 111.892 -167.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -74.75 126.02 88.92 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.308 -0.997 . . . . 3.67 108.308 159.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.57 -19.2 16.91 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.413 2.742 . . . . 1.71 113.296 -171.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -83.31 -47.34 11.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.625 -0.88 . . . . 3.46 108.625 -176.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 tp -71.98 -40.92 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 119.68 -0.2 . . . . 3.7 111.133 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mm -127.22 110.64 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.421 -1.326 . . . . 1.43 107.421 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.48 158.57 39.7 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 108.91 -1.676 . . . . 0.82 108.91 168.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -55.66 -40.47 85.1 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.25 1.967 . . . . 1.23 109.269 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -29.29 -58.23 0.15 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.119 2.168 . . . . 9.53 112.261 163.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -70.58 -43.5 69.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.7 0.762 . . . . 2.41 109.662 -168.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 mt -58.68 -51.54 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.87 -0.605 . . . . 0.85 109.405 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.2 mt -52.45 -55.48 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.218 -0.66 . . . . 1.18 109.218 176.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 56.0 m170 -51.53 -42.17 61.56 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.957 0.503 . . . . 3.51 111.284 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 31.2 m -62.18 -51.21 68.73 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.718 -0.614 . . . . 1.04 109.79 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -59.96 -40.85 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.465 1.106 . . . . 2.6 111.363 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.04 -53.54 57.15 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.871 0.868 . . . . 2.02 109.955 168.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.6 t -60.96 -27.41 68.24 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.495 0.718 . . . . 1.44 112.174 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.04 -85.9 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.719 -0.845 . . . . 2.02 108.719 166.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.74 18.54 0.18 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.489 -1.173 . . . . 1.24 114.608 169.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -132.58 151.85 51.8 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 119.441 1.62 . . . . 1.99 111.495 -148.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -78.5 163.96 25.13 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.119 -1.067 . . . . 4.86 108.119 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.12 158.09 42.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 121.395 -0.122 . . . . 0.94 110.902 160.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.5 t -155.18 134.52 12.46 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.543 -0.91 . . . . 2.53 108.543 173.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.208 0 O-C-N 121.6 -0.687 . . . . 2.33 109.283 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.685 0 N-CA-C 109.34 -1.504 . . . . 1.89 109.34 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.93 133.9 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 107.555 -1.276 . . . . 2.45 107.555 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 tp -136.09 121.06 18.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.215 -1.402 . . . . 2.29 107.215 162.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -109.53 70.81 0.74 Allowed 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 125.17 1.388 . . . . 3.58 108.361 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.615 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -78.32 149.96 33.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.13 -0.628 . . . . 2.79 109.439 178.253 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.47 135.26 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 105.52 -2.03 . . . . 0.66 105.52 164.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.08 131.75 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 125.509 1.524 . . . . 2.36 108.003 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -123.67 163.35 21.25 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.886 0.874 . . . . 5.58 109.834 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.56 -15.42 62.79 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.997 0.808 . . . . 1.23 111.856 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.481 ' SD ' HD12 ' A' ' 22' ' ' ILE . 50.8 mtm -70.33 77.61 0.54 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 117.891 0.846 . . . . 1.69 110.31 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -70.52 -14.87 62.69 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.984 -1.008 . . . . 1.59 113.35 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 p -161.64 169.93 20.68 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.652 1.114 . . . . 0.74 109.682 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.11 -36.73 30.9 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.331 1.052 . . . . 1.01 111.6 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -47.57 -38.84 15.17 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.334 1.853 . . . . 1.87 112.196 173.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.5 m -71.5 -54.81 9.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 122.039 -0.413 . . . . 0.73 110.117 172.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.4 t -49.05 -60.6 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.189 0.995 . . . . 0.98 110.494 -173.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -27.21 67.06 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.163 -0.615 . . . . 0.8 111.643 -175.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -64.69 -50.95 64.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.952 -0.759 . . . . 2.96 108.952 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.481 HD12 ' SD ' ' A' ' 13' ' ' MET . 19.9 mt -53.09 -58.35 3.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 N-CA-C 108.946 -0.761 . . . . 1.05 108.946 172.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -49.13 -57.71 6.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.417 0.627 . . . . 3.87 110.921 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -62.26 -41.18 98.22 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.268 1.027 . . . . 0.81 111.112 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.8 t -67.0 -45.23 78.2 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.534 -0.913 . . . . 1.16 108.534 -176.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.91 -49.31 47.14 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 118.796 -0.621 . . . . 2.85 112.203 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.4 p -54.87 -25.43 28.75 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.883 0.765 . . . . 1.94 112.632 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -45.34 -44.28 11.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.894 1.278 . . . . 6.19 112.646 168.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -64.94 117.53 7.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.422 1.089 . . . . 1.67 108.869 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -75.2 36.11 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.523 1.129 . . . . 6.54 113.354 -169.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -132.46 -5.81 3.19 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.397 1.475 . . . . 0.96 111.519 168.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.5 mm -83.84 109.46 17.37 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 N-CA-C 107.021 -1.474 . . . . 3.98 107.021 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.9 mt -79.72 -38.88 32.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.803 0.841 . . . . 1.93 109.489 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -154.38 158.21 39.7 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 108.809 -0.812 . . . . 1.93 108.809 174.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.9 t -139.36 134.84 33.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.244 1.018 . . . . 2.32 108.516 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.1 t -134.54 85.38 2.18 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.054 -1.091 . . . . 1.67 108.054 169.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 44' ' ' ALA . 1.1 m -78.9 149.76 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 125.234 1.413 . . . . 1.93 110.081 170.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.15 132.17 10.84 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.014 0.526 . . . . 0.77 109.756 166.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.88 -35.36 74.59 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 109.406 -0.591 . . . . 1.75 109.406 167.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.92 -35.82 64.58 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.786 0.835 . . . . 1.33 111.826 -174.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 m -119.26 18.04 13.04 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.868 0.867 . . . . 2.12 110.325 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.1 m120 33.95 48.89 0.25 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 126.279 1.831 . . . . 1.86 113.489 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.96 162.84 26.66 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.797 -0.446 . . . . 2.39 109.797 -169.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 37' ' ' VAL . . . -146.43 100.92 3.42 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.713 -0.847 . . . . 0.69 108.713 169.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -80.3 100.41 8.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.621 -1.992 . . . . 1.14 105.621 166.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.421 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.8 mp -94.35 135.36 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 105.797 -1.927 . . . . 1.62 105.797 165.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -100.45 117.02 33.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 104.831 -2.285 . . . . 2.19 104.831 158.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -117.14 168.81 9.95 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.544 0.738 . . . . 1.95 110.006 172.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.02 133.99 26.71 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 107.238 -1.393 . . . . 3.61 107.238 153.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -72.8 -10.69 25.2 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.558 2.172 . . . . 1.72 113.475 -174.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -83.22 -47.54 11.44 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.39 -0.967 . . . . 3.34 108.39 -173.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.8 mm -81.89 -36.72 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.723 -0.656 . . . . 2.66 110.927 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 mm -133.72 118.02 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 119.293 0.951 . . . . 1.38 108.534 -174.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.75 176.71 47.9 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 110.16 -1.176 . . . . 0.91 110.16 169.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.52 -42.17 22.52 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.663 2.242 . . . . 1.01 109.985 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.85 -54.71 5.04 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.212 1.405 . . . . 7.51 111.214 173.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -53.13 -55.93 20.2 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.462 0.574 . . . . 2.46 110.516 -176.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.9 mt -59.85 -53.26 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 116.236 -0.438 . . . . 0.77 110.012 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.9 mt -53.59 -54.66 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 109.487 -0.56 . . . . 1.08 109.487 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -52.06 -41.27 62.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.267 1.027 . . . . 4.31 111.531 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 44.9 m -69.85 -48.51 58.58 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.721 -0.474 . . . . 1.01 109.721 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.8 mt -51.47 -50.64 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 109.527 -0.546 . . . . 1.26 109.527 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.05 -55.58 31.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.934 0.893 . . . . 2.46 111.171 176.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.7 p -62.68 -32.12 73.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.899 -0.572 . . . . 1.78 112.054 -173.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.92 -85.44 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.57 0.623 . . . . 2.65 111.17 171.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.59 25.86 0.25 Allowed Glycine 0 CA--C 1.526 0.752 0 O-C-N 121.151 -0.968 . . . . 0.98 113.833 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.409 ' CD2' HD11 ' A' ' 22' ' ' ILE . 29.2 m-85 -137.2 177.35 7.93 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.617 1.209 . . . . 1.64 111.069 -155.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -120.43 157.57 29.04 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.856 -1.164 . . . . 3.48 107.856 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.41 152.98 40.68 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.75 0.42 . . . . 0.9 111.253 167.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.3 m -156.4 135.44 11.97 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.604 1.162 . . . . 2.2 109.38 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 N--CA 1.467 0.409 0 C-N-CA 124.271 1.028 . . . . 2.79 110.442 -179.695 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.542 0 N-CA-C 108.417 -1.873 . . . . 1.29 108.417 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.54 131.38 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 106.442 -1.688 . . . . 2.21 106.442 168.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.2 99.19 5.77 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.091 0.956 . . . . 2.72 108.63 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -87.46 106.75 18.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.194 -1.41 . . . . 3.03 107.194 161.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.91 150.16 30.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.51 -0.922 . . . . 2.4 108.51 168.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.55 142.7 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 104.787 -2.301 . . . . 0.76 104.787 159.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.9 p -139.66 135.54 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 106.796 -1.557 . . . . 2.26 106.796 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -134.51 168.78 18.34 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.294 1.438 . . . . 8.18 108.915 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.88 -14.59 61.41 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.903 0.764 . . . . 1.29 111.222 -163.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.1 mtp -68.51 77.6 0.28 Allowed 'General case' 0 C--N 1.341 0.225 0 CA-C-N 118.194 0.997 . . . . 1.85 110.799 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.5 p -61.09 -41.39 96.57 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.72 -0.657 . . . . 3.05 112.516 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.3 p -156.28 -179.37 8.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.171 0.896 . . . . 0.7 112.794 -166.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.09 -40.7 46.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.812 1.245 . . . . 0.85 111.577 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 m -60.81 -29.49 69.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.086 0.554 . . . . 1.47 111.898 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.7 m -71.85 -58.58 3.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.902 0.774 . . . . 0.67 109.927 167.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.0 t -38.7 -64.78 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.937 1.295 . . . . 1.2 111.481 -177.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -28.45 65.98 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.181 -0.608 . . . . 0.96 111.69 -172.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -66.56 -52.49 45.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.88 -0.785 . . . . 3.44 108.88 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.6 -59.37 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 N-CA-C 108.341 -0.985 . . . . 0.7 108.341 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -50.15 -62.99 1.25 Allowed 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 124.057 0.848 . . . . 3.8 110.097 -175.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.6 t -56.32 -41.28 75.73 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.484 0.714 . . . . 0.82 111.163 -177.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 t -65.58 -54.13 32.19 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.417 -0.957 . . . . 1.17 108.417 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 mp -52.42 -46.58 66.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.794 0.438 . . . . 2.69 110.911 175.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.1 m -62.8 -9.83 10.87 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.964 0.728 . . . . 2.09 112.964 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -25.1 62.11 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.718 -1.239 . . . . 5.57 111.963 169.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -69.54 140.89 53.93 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 107.553 -1.277 . . . . 1.81 107.553 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.9 ttm-85 -81.81 -28.02 33.34 Favored 'General case' 0 C--O 1.226 -0.154 0 O-C-N 121.41 -0.807 . . . . 5.52 111.846 -177.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.8 5.47 83.7 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.454 -0.636 . . . . 0.91 113.802 -173.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.39 159.06 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 118.513 1.157 . . . . 2.99 109.415 164.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.4 mt -113.88 -39.78 3.9 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.466 1.506 . . . . 2.25 109.316 176.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -156.15 156.61 34.53 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.449 -0.575 . . . . 2.1 109.449 174.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.1 m -138.16 135.21 35.46 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.495 -1.669 . . . . 2.65 106.495 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.5 t -147.97 143.77 27.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.684 -1.598 . . . . 1.96 106.684 163.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 m -137.5 144.03 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.399 1.079 . . . . 1.79 108.741 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.29 111.55 6.81 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.638 1.175 . . . . 0.75 110.002 -175.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.94 -22.89 61.4 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.309 1.444 . . . . 1.38 113.152 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.51 -50.28 53.37 Favored 'General case' 0 C--O 1.226 -0.159 0 N-CA-C 108.38 -0.97 . . . . 1.55 108.38 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.61 -19.96 51.5 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.192 0.997 . . . . 2.09 110.878 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.4 m120 57.84 46.48 16.84 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 126.118 1.767 . . . . 1.55 109.971 -172.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.47 157.86 45.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.97 -0.381 . . . . 3.32 109.97 -170.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.69 127.65 25.71 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.844 -1.169 . . . . 0.98 107.844 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -99.17 98.27 9.28 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 105.332 -2.099 . . . . 0.96 105.332 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.0 mm -94.58 147.65 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 106.135 -1.802 . . . . 1.79 106.135 170.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -124.62 135.75 53.37 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.428 -2.434 . . . . 3.73 104.428 159.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -156.34 160.66 39.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.255 0.622 . . . . 2.08 109.902 -162.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -93.44 125.79 52.72 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.752 -0.833 . . . . 3.15 108.752 171.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.0 -14.28 29.15 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.824 2.35 . . . . 1.77 113.875 -172.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -121.19 25.4 9.56 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.866 1.212 . . . . 3.15 112.402 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.7 tp -132.39 -63.56 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 118.988 -0.529 . . . . 3.57 110.283 159.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.95 -44.28 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 119.669 1.122 . . . . 3.03 108.321 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.22 168.51 18.77 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.109 -0.567 . . . . 1.75 111.805 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -71.52 -57.28 0.1 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.043 1.829 . . . . 1.26 111.731 -170.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 ttt-85 -70.64 -20.16 62.75 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.064 0.765 . . . . 6.3 113.064 -167.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.31 -35.1 71.14 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.438 1.017 . . . . 3.8 112.93 -175.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.3 mt -48.84 -50.22 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 121.432 -0.793 . . . . 0.99 109.236 164.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mt -63.15 -42.6 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 117.715 -1.136 . . . . 1.18 110.727 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -49.55 -44.05 46.32 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.39 1.45 . . . . 3.46 110.152 170.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.4 m -66.29 -50.49 63.49 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.32 -0.622 . . . . 0.77 109.32 -175.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.476 HG23 ' HB2' ' A' ' 67' ' ' PHE . 64.0 mt -52.97 -52.81 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.537 1.135 . . . . 1.4 110.959 176.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -53.96 -53.92 46.06 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.107 1.363 . . . . 1.9 110.293 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t -58.91 -41.77 88.05 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.111 0.964 . . . . 1.24 111.436 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.3 mt -64.13 -84.05 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.584 0.353 . . . . 1.99 110.897 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.24 22.51 0.22 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.638 -1.09 . . . . 0.87 113.818 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.476 ' HB2' HG23 ' A' ' 62' ' ' ILE . 39.0 m-85 -134.92 162.62 31.9 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 118.945 1.372 . . . . 1.66 111.047 -156.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -115.78 152.1 33.93 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.335 1.454 . . . . 3.84 107.412 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.85 166.53 33.12 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.424 1.011 . . . . 1.34 113.276 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 p -155.33 123.21 5.73 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.193 1.397 . . . . 2.07 109.791 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.465 0.292 0 C-N-CA 123.342 0.657 . . . . 2.22 109.942 170.102 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.537 0 N-CA-C 106.955 -2.458 . . . . 2.05 106.955 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.33 129.2 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 109.416 -0.587 . . . . 2.15 109.416 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.36 136.8 39.95 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.259 1.024 . . . . 2.79 108.529 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.21 144.01 48.83 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.617 -1.994 . . . . 4.87 105.617 167.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.14 147.8 24.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.696 -0.853 . . . . 2.18 108.696 167.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.31 134.58 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 105.665 -1.976 . . . . 0.99 105.665 173.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.3 t -116.44 117.91 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 106.873 -1.528 . . . . 2.16 106.873 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.1 mtt180 -85.59 143.83 28.23 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.09 -1.078 . . . . 6.89 108.09 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.14 -1.0 58.98 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.088 -0.84 . . . . 1.2 113.684 173.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.3 mtp -71.4 72.38 0.69 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.138 1.469 . . . . 1.68 110.436 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -73.97 -17.0 61.06 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 117.683 -1.151 . . . . 1.55 113.819 -169.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.2 p -159.01 172.75 17.62 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 120.23 1.377 . . . . 0.89 110.724 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.58 -36.7 35.98 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.406 1.082 . . . . 0.88 111.794 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 t -56.53 -45.4 81.16 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.873 -0.417 . . . . 2.27 109.873 175.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.9 m -63.7 -47.81 79.63 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.684 -0.635 . . . . 0.7 110.527 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.2 t -49.66 -66.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.439 -0.578 . . . . 0.88 109.439 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.288 0.1 OUTLIER -71.19 -23.45 62.04 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 118.954 -1.098 . . . . 1.14 112.804 -173.523 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -52.99 -49.44 66.17 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.718 1.144 . . . . 3.43 109.15 169.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.7 mt -56.95 -59.05 3.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 109.529 -0.545 . . . . 0.79 109.529 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.3 -47.65 84.58 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.125 0.488 . . . . 4.65 111.064 -171.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -57.07 -33.91 67.74 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.818 1.247 . . . . 1.03 110.826 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.7 m -71.72 -60.64 2.13 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.705 -0.622 . . . . 1.67 109.409 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -54.6 -42.82 71.59 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.433 0.693 . . . . 2.74 112.179 -171.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.2 p -57.39 -18.77 19.33 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.462 0.542 . . . . 2.26 112.462 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -70.79 -27.81 64.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.041 0.937 . . . . 6.34 111.743 175.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -70.74 -12.05 61.32 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.039 1.125 . . . . 3.17 114.039 -165.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.6 mmp_? 72.17 -44.54 0.6 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 126.281 1.832 . . . . 6.91 113.567 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.15 53.21 1.79 Allowed Glycine 0 CA--C 1.525 0.689 0 CA-C-N 119.036 0.835 . . . . 1.65 111.223 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.44 133.55 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 106.722 -1.584 . . . . 3.4 106.722 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.0 mt -88.66 -45.55 9.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.833 -1.173 . . . . 2.28 107.833 167.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -157.15 154.32 29.14 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 122.198 -0.314 . . . . 2.6 111.017 -178.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.3 t -130.2 110.63 11.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.777 1.231 . . . . 2.08 109.932 170.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.1 t -115.71 84.9 2.18 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.224 1.81 . . . . 1.73 107.86 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.76 152.15 3.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.343 1.057 . . . . 2.1 110.341 174.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.08 135.06 12.95 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 119.394 -0.336 . . . . 0.84 110.137 170.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.55 -32.3 71.02 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 123.409 0.443 . . . . 1.54 110.203 168.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.86 -48.17 60.2 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.386 0.674 . . . . 1.28 111.281 -176.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -105.52 10.06 33.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.327 1.451 . . . . 2.24 111.451 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.3 m120 41.17 47.66 2.88 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.185 1.794 . . . . 1.61 112.299 -175.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.71 171.2 11.38 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.149 0.58 . . . . 2.45 111.679 -165.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.99 87.41 1.41 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.954 1.302 . . . . 0.92 109.809 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -79.25 96.47 5.93 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.797 -1.557 . . . . 1.06 106.797 171.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.32 141.31 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.983 -1.488 . . . . 1.67 106.983 171.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -114.52 116.42 28.79 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 104.207 -2.516 . . . . 2.6 104.207 165.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -125.69 157.3 37.66 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.874 0.87 . . . . 1.98 111.65 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.92 114.9 59.51 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.905 1.682 . . . . 5.05 107.879 176.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.79 36.2 0.6 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.481 2.121 . . . . 2.38 113.762 -166.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -140.22 33.23 1.91 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.421 1.088 . . . . 3.3 110.18 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 tp -171.83 -49.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 124.891 1.276 . . . . 4.01 108.671 -170.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mm -122.91 132.73 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 105.384 -2.08 . . . . 1.33 105.384 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.72 -179.7 19.48 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.839 1.685 . . . . 1.09 109.311 167.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.65 -40.59 28.97 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.338 2.025 . . . . 0.99 110.306 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -42.19 69.8 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.187 0.595 . . . . 9.59 111.469 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -58.98 -54.14 50.49 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.305 -0.628 . . . . 2.2 109.305 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.5 mt -56.9 -50.41 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 123.616 0.766 . . . . 0.69 109.933 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.6 mt -53.09 -57.42 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.316 0.646 . . . . 1.38 109.957 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -52.34 -44.59 65.27 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.236 0.614 . . . . 3.5 110.44 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.6 m -64.11 -51.2 65.13 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.308 -0.627 . . . . 0.81 109.308 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.3 mt -51.9 -59.7 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.792 0.837 . . . . 1.39 109.157 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -63.14 -47.91 80.71 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 119.676 -0.81 . . . . 1.91 109.979 -169.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 t -54.23 -39.95 67.23 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.154 0.582 . . . . 1.49 111.863 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.4 mt -61.23 -59.63 5.0 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.825 0.739 . . . . 2.33 112.431 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.31 16.0 0.14 Allowed Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.409 -1.217 . . . . 1.15 115.432 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -143.07 -179.74 6.55 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.008 1.404 . . . . 2.15 111.44 -142.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -127.91 154.4 45.57 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 105.765 -1.939 . . . . 3.67 105.765 163.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.95 154.52 27.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.98 0.809 . . . . 1.16 110.532 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.3 m -155.26 103.45 2.35 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.102 1.361 . . . . 2.39 109.453 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.463 0.201 0 C-N-CA 123.215 0.606 . . . . 2.43 109.453 169.326 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.799 0 N-CA-C 108.19 -1.964 . . . . 1.37 108.19 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.4 t -98.11 144.79 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 124.753 1.221 . . . . 2.66 108.909 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.8 tp -127.81 123.24 34.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 106.418 -1.697 . . . . 2.66 106.418 165.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -120.8 126.52 50.31 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 108.274 -1.01 . . . . 4.09 108.274 179.018 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.17 155.65 48.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 123.571 0.545 . . . . 3.05 109.994 178.186 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.45 112.24 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 104.435 -2.432 . . . . 1.03 104.435 166.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 p -79.6 137.6 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 106.889 -1.523 . . . . 2.81 106.889 166.61 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -139.28 173.54 11.44 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.194 1.398 . . . . 6.23 108.377 -179.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.39 -46.82 2.28 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.478 -0.649 . . . . 1.55 111.478 -176.486 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.16 136.92 46.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.531 -0.914 . . . . 2.45 108.531 -177.128 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -141.56 8.46 1.97 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.726 1.75 . . . . 1.93 115.726 -156.176 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.6 p -159.39 173.19 16.62 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 121.173 1.806 . . . . 0.7 111.782 174.334 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.59 -42.64 56.01 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.207 1.003 . . . . 0.59 111.135 175.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 m -65.93 -20.95 66.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.761 0.824 . . . . 1.7 112.286 178.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.3 m -73.51 -62.1 1.6 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.036 0.835 . . . . 0.82 111.222 158.526 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.1 t -39.43 -63.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 124.588 1.155 . . . . 0.91 111.457 -173.136 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -29.87 70.38 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.439 -0.505 . . . . 0.77 111.579 -173.603 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -70.45 -44.78 67.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.68 0.792 . . . . 3.36 108.976 -178.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.2 mt -55.2 -59.14 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.393 -0.966 . . . . 0.95 108.393 175.244 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -55.77 -53.92 50.78 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 117.979 0.354 . . . . 3.87 111.014 -178.184 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -55.37 -36.51 66.42 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.005 0.922 . . . . 0.79 111.973 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 t -70.1 -54.72 11.8 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.132 -1.062 . . . . 1.2 108.132 177.655 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 mp -57.46 -42.72 83.12 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.155 0.582 . . . . 2.48 112.179 -174.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.3 p -60.09 -12.46 8.4 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.265 -0.897 . . . . 1.9 113.029 178.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.4 -32.59 74.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.093 0.86 . . . . 4.09 110.561 172.055 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -78.29 106.91 10.53 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.218 -0.66 . . . . 1.93 109.218 178.774 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -57.66 -20.82 36.18 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.871 -1.143 . . . . 6.07 112.62 171.086 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.3 -32.47 72.29 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.902 -0.943 . . . . 0.93 112.323 172.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -88.92 137.36 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 118.671 1.236 . . . . 2.43 108.098 170.545 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 mt -95.86 -36.53 11.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.552 0.741 . . . . 1.68 109.471 177.267 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -150.11 153.69 36.82 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.774 0.261 . . . . 1.78 110.483 173.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -137.28 130.46 30.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.421 1.888 . . . . 2.56 106.728 171.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.4 t -128.18 110.45 12.45 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 106.526 -1.657 . . . . 1.7 106.526 168.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.59 150.91 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.255 1.022 . . . . 2.67 110.72 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.17 122.54 5.59 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.856 -0.528 . . . . 0.79 111.177 174.085 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.12 -26.36 67.41 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.371 0.668 . . . . 1.6 109.936 161.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.2 -49.19 77.91 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.259 0.481 . . . . 1.17 109.884 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.45 -37.51 36.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.793 0.437 . . . . 1.99 110.349 173.222 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 m120 68.89 71.75 0.27 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.774 -1.565 . . . . 1.84 106.774 -151.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.33 158.11 43.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.173 -0.329 . . . . 2.46 110.251 173.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.27 129.58 47.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.547 -2.02 . . . . 1.14 105.547 151.424 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -107.4 116.53 32.11 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 102.85 -3.019 . . . . 1.01 102.85 166.236 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mm -107.9 149.5 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 104.728 -2.323 . . . . 1.69 104.728 174.2 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.94 139.8 47.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.2 -1.037 . . . . 2.44 108.2 157.155 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -162.82 160.83 25.65 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 124.092 0.87 . . . . 2.19 109.718 -153.653 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -93.37 124.61 57.03 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 108.882 -0.785 . . . . 3.57 108.882 168.673 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.74 -19.08 24.47 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.935 2.424 . . . . 2.04 113.689 -173.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.32 -48.7 10.88 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.003 -1.11 . . . . 4.17 108.003 176.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.4 mt -63.9 -40.13 87.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-O 119.227 -0.416 . . . . 3.11 110.038 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.3 tt -137.34 109.32 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.346 0.594 . . . . 1.39 110.91 173.079 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.88 141.01 47.26 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.411 -1.476 . . . . 1.17 109.411 172.52 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -55.71 -40.16 86.91 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.741 2.294 . . . . 1.08 111.815 -172.553 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -56.9 -29.53 63.09 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 118.178 -0.915 . . . . 6.45 112.369 178.327 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.23 -44.18 92.68 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 120.015 1.279 . . . . 4.12 110.35 -179.421 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.2 mt -56.56 -52.97 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.308 -0.627 . . . . 0.62 109.308 175.611 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.1 mm -51.04 -56.87 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.089 0.556 . . . . 1.96 109.833 177.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.33 -34.98 69.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.788 0.835 . . . . 4.69 111.465 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.3 m -65.47 -52.99 48.98 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.881 -1.155 . . . . 0.89 107.881 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.1 mt -50.9 -50.74 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.12 0.568 . . . . 1.22 110.237 176.018 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -53.54 -50.28 65.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.047 0.451 . . . . 2.25 110.39 175.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.7 t -67.28 -14.66 63.12 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.512 1.125 . . . . 1.26 113.305 -173.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 mp -72.13 -91.01 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.911 1.232 . . . . 2.15 107.709 165.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.44 35.88 0.48 Allowed Glycine 0 CA--C 1.523 0.586 0 O-C-N 121.347 -0.845 . . . . 0.82 111.815 169.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -130.61 177.52 7.32 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.552 0.676 . . . . 1.65 110.927 -156.767 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -119.73 148.43 43.41 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.593 -1.632 . . . . 3.67 106.593 175.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.58 133.42 32.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.919 0.887 . . . . 1.01 108.736 170.227 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.3 t -133.77 103.39 5.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.34 1.056 . . . . 1.77 109.002 -177.478 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.374 0 C-N-CA 124.809 1.244 . . . . 3.11 110.879 178.625 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.74 0 N-CA-C 107.437 -2.265 . . . . 1.33 107.437 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.74 91.57 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.678 1.191 . . . . 2.25 109.65 -177.173 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -80.71 79.24 7.38 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.277 -1.379 . . . . 2.74 107.277 175.453 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -102.23 116.01 31.75 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.096 -0.956 . . . . 3.85 109.615 174.167 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.91 166.42 24.52 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.915 1.286 . . . . 1.98 110.421 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.33 143.55 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 106.54 -1.652 . . . . 0.93 106.54 173.187 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.0 t -136.53 130.49 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 126.025 1.73 . . . . 1.89 107.356 175.897 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -132.03 156.43 46.28 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.262 1.425 . . . . 5.92 108.618 -174.756 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.34 -24.56 28.51 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.641 -0.533 . . . . 1.1 112.253 177.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.75 76.25 0.85 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.396 1.093 . . . . 2.23 110.201 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -70.21 -12.34 61.52 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 115.399 1.629 . . . . 1.6 115.399 -157.827 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.6 p -157.14 174.02 16.11 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 120.523 1.511 . . . . 0.73 110.724 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.91 -44.54 14.73 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.814 1.245 . . . . 0.74 111.529 177.648 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 m -57.67 -37.32 73.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.525 0.73 . . . . 1.5 111.854 178.507 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.6 m -71.43 -50.35 32.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.438 0.563 . . . . 0.78 110.306 171.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.9 t -52.38 -56.6 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 122.737 0.415 . . . . 0.9 111.01 -175.676 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -27.96 64.22 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.613 -0.679 . . . . 0.86 112.065 -177.325 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -57.77 -48.04 80.79 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.776 -0.824 . . . . 3.47 108.776 170.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 81.9 mt -56.67 -66.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 108.743 -0.836 . . . . 0.7 108.743 171.509 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -46.11 -56.43 5.64 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.176 0.99 . . . . 3.79 110.765 -169.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.4 t -57.63 -51.4 69.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.562 0.745 . . . . 0.88 110.175 -176.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -59.78 -40.66 89.0 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.438 0.637 . . . . 1.44 109.724 -178.337 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -49.83 75.01 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.547 0.739 . . . . 2.81 110.759 178.069 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.1 p -56.01 -41.48 74.96 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.202 0.91 . . . . 2.13 110.759 175.861 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -57.53 -9.67 1.21 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.96 1.304 . . . . 4.63 113.154 175.235 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -56.43 -32.83 65.26 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 119.975 -1.703 . . . . 3.24 111.334 164.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 70.62 -51.05 0.67 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 126.606 1.962 . . . . 7.56 110.927 -168.008 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.37 53.39 1.89 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.672 0.653 . . . . 1.6 112.775 178.55 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -136.54 172.02 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.399 -1.334 . . . . 3.17 107.399 172.711 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.9 mt -117.57 -42.12 2.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.197 0.999 . . . . 2.16 109.346 -178.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -155.8 156.22 34.39 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 108.659 -0.867 . . . . 2.36 108.659 175.784 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.1 m -132.8 130.4 39.81 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 105.613 -1.995 . . . . 2.76 105.613 176.596 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.6 p -144.74 98.01 3.12 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.643 -0.873 . . . . 2.67 108.643 173.073 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 p -116.13 139.81 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.493 1.517 . . . . 2.32 109.342 -172.116 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.67 123.65 6.28 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.072 0.549 . . . . 0.9 110.294 -172.136 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.48 -32.77 74.56 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 109.56 -0.533 . . . . 1.82 109.56 167.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.9 -34.44 67.9 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.792 0.837 . . . . 1.47 111.825 -176.14 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.0 m -117.44 21.9 12.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.843 0.857 . . . . 2.16 109.787 175.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.3 m120 25.6 61.4 0.07 Allowed 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 126.834 2.054 . . . . 1.56 113.66 -172.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.57 166.54 26.17 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 120.619 0.247 . . . . 2.47 111.277 -173.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.411 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -139.02 125.9 20.98 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 124.663 1.227 . . . . 0.68 108.395 160.103 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -108.26 102.16 11.31 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.075 -2.194 . . . . 0.85 105.075 171.123 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.411 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -102.38 118.37 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 105.402 -2.073 . . . . 1.74 105.402 171.65 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -81.14 130.17 34.9 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.267 -1.753 . . . . 2.59 106.267 164.573 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -139.74 149.18 43.29 Favored 'General case' 0 N--CA 1.46 0.068 0 C-N-CA 124.265 1.026 . . . . 2.04 109.736 -168.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.76 131.48 70.52 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.465 -1.309 . . . . 2.97 107.465 161.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -82.75 0.13 9.82 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.807 2.338 . . . . 1.48 114.268 -172.68 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -93.09 -50.39 5.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 119.677 1.126 . . . . 4.02 108.148 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.8 tt -70.88 -29.89 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.734 0.642 . . . . 2.64 112.734 -174.229 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mm -142.69 144.47 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 105.6 -2.0 . . . . 1.38 105.6 -172.407 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.53 -178.14 15.72 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.187 1.375 . . . . 1.2 110.902 171.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.48 -48.13 22.08 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.208 2.605 . . . . 1.51 110.511 174.08 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.4 -61.29 1.07 Allowed 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 125.016 1.326 . . . . 6.86 110.895 176.31 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -53.74 -54.38 38.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.644 0.735 . . . . 2.62 110.387 -173.408 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.2 mt -58.86 -53.75 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.808 -0.633 . . . . 0.72 110.023 -177.415 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.1 mt -54.11 -53.23 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.416 -0.587 . . . . 1.19 109.416 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 52.3 m170 -55.1 -41.25 71.37 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.332 0.653 . . . . 3.52 110.651 179.03 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.5 m -62.08 -52.11 65.25 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.11 -0.7 . . . . 0.75 109.11 178.188 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.52 -51.06 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 123.495 0.718 . . . . 1.72 111.086 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -58.31 -58.12 9.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.602 1.161 . . . . 2.13 110.197 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -51.52 -46.94 63.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.317 1.047 . . . . 1.22 110.471 -178.841 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.32 -53.74 52.88 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.404 -0.331 . . . . 2.25 111.225 177.184 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.82 -41.48 0.02 OUTLIER Glycine 0 CA--C 1.529 0.919 0 N-CA-C 115.641 1.017 . . . . 1.5 115.641 174.77 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -122.39 160.83 24.63 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.7 0.63 . . . . 1.78 112.7 -127.75 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -82.45 150.55 26.99 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.09 -1.078 . . . . 3.68 108.09 -179.233 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.72 160.04 43.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.81 0.444 . . . . 1.15 111.661 172.694 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.4 m -155.92 128.0 7.54 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.473 0.709 . . . . 1.71 110.871 177.246 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 CA--C 1.535 0.375 0 C-N-CA 123.938 0.895 . . . . 3.14 109.546 169.702 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.946 0 CA-C-O 118.587 -1.118 . . . . 2.4 113.447 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.8 t -80.79 129.23 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 120.094 1.947 . . . . 3.87 109.127 174.285 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -150.94 123.05 8.25 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.845 0.748 . . . . 3.17 110.102 -175.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.39 121.7 45.9 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.945 1.298 . . . . 5.39 110.926 175.042 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 mt -104.06 160.81 14.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.996 -1.112 . . . . 2.83 107.996 164.017 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -85.08 143.61 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 106.246 -1.761 . . . . 1.23 106.246 147.316 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.2 144.64 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 106.139 -1.8 . . . . 2.44 106.139 175.466 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -146.07 164.77 31.1 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.313 0.645 . . . . 5.89 109.958 -178.718 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.83 -10.14 40.83 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.577 1.084 . . . . 1.09 111.048 -173.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -73.23 79.16 1.3 Allowed 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.045 0.923 . . . . 2.1 110.144 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -64.33 -15.84 61.08 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.479 -1.248 . . . . 1.64 113.358 -177.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.0 p -165.12 175.84 9.02 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 120.511 1.505 . . . . 0.68 110.753 177.165 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.99 -40.07 43.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.935 0.894 . . . . 0.78 111.499 175.819 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -57.62 -27.27 62.62 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.83 1.252 . . . . 1.57 111.905 178.586 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.1 m -73.85 -64.02 1.09 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.414 0.552 . . . . 0.72 110.941 162.411 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.7 t -44.75 -55.95 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 124.369 1.067 . . . . 0.92 111.646 -168.545 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -30.71 69.57 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.074 0.464 . . . . 1.67 111.559 -175.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -38.4 71.61 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.594 1.158 . . . . 4.18 109.447 -172.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.0 mt -55.93 -64.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.583 -0.895 . . . . 0.76 108.583 176.491 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -57.51 9.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.407 0.683 . . . . 4.43 109.813 178.654 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 t -54.75 -43.7 72.93 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.514 -0.741 . . . . 1.02 111.791 -175.75 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t -71.52 -49.1 44.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.886 -0.508 . . . . 1.46 110.222 -177.835 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.4 tp -73.35 -52.29 14.37 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 124.813 1.245 . . . . 3.15 112.852 -173.098 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.7 m -59.54 -21.76 60.71 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.288 0.848 . . . . 2.9 113.288 -171.463 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -22.18 66.92 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.166 -0.959 . . . . 4.52 113.451 172.218 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -66.2 106.03 1.55 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.042 -1.096 . . . . 2.12 108.042 175.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -52.69 100.43 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.274 1.029 . . . . 6.09 109.862 175.43 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 144.4 -32.06 1.77 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.04 -1.224 . . . . 0.94 110.04 -169.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.1 mm -79.63 151.1 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.26 -1.385 . . . . 4.2 107.26 161.651 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 50.7 mt -114.21 -47.68 2.93 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.906 1.283 . . . . 2.11 109.42 175.161 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -156.19 150.33 25.37 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 108.117 -1.068 . . . . 2.97 108.117 -175.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.9 m -125.86 80.72 1.93 Allowed 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.149 0.98 . . . . 2.64 110.301 174.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 t -78.26 77.97 4.74 Favored 'General case' 0 C--O 1.237 0.43 0 O-C-N 120.787 -1.196 . . . . 1.49 109.203 178.697 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -91.13 141.04 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 125.035 1.334 . . . . 2.66 110.456 171.271 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.77 118.44 6.58 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.218 0.463 . . . . 1.24 110.662 169.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -55.57 -19.61 10.65 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.5 1.12 . . . . 1.33 113.624 177.756 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.14 -34.63 78.04 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.318 0.647 . . . . 1.34 110.939 175.416 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.74 -8.22 10.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.904 0.882 . . . . 2.89 111.651 -178.32 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m120 60.97 26.29 16.24 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 125.023 1.329 . . . . 2.26 110.976 176.44 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.66 161.98 13.67 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.026 -1.472 . . . . 2.68 107.026 -176.46 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -139.6 90.49 2.41 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 105.533 -2.025 . . . . 1.03 105.533 165.911 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -78.88 83.81 4.97 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 103.25 -2.87 . . . . 1.63 103.25 167.125 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.0 pt -81.46 165.24 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 106.503 -1.666 . . . . 2.97 106.503 170.309 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -127.78 133.86 49.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 105.352 -2.092 . . . . 3.44 105.352 160.197 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.93 176.41 9.3 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 126.13 1.772 . . . . 2.13 108.181 -169.359 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -111.62 132.99 21.62 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 107.568 -1.271 . . . . 3.08 107.568 155.472 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.26 -17.68 18.8 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.414 2.743 . . . . 1.93 113.489 -172.652 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -89.6 -50.17 6.23 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 118.878 0.763 . . . . 3.06 109.217 -176.098 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.2 pt -85.96 1.64 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 113.33 0.863 . . . . 3.22 113.33 -176.294 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -152.13 123.55 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 106.624 -1.621 . . . . 1.34 106.624 171.063 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.63 148.6 42.12 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 109.804 -1.318 . . . . 1.15 109.804 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -56.58 -44.05 49.28 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 CA-C-N 119.402 1.601 . . . . 1.05 108.504 165.942 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.489 HH11 ' CD2' ' A' ' 60' ' ' HIS . 6.8 tpp180 -51.16 -32.91 24.8 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 117.952 -1.023 . . . . 5.83 112.015 170.72 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -72.47 -43.39 63.79 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 121.173 1.806 . . . . 2.39 113.112 176.445 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mt -48.91 -50.99 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.221 -0.592 . . . . 0.72 109.469 165.022 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.7 mm -58.66 -44.88 90.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 118.246 -0.883 . . . . 2.08 111.45 175.57 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.489 ' CD2' HH11 ' A' ' 56' ' ' ARG . 21.7 m170 -50.44 -45.73 56.07 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.31 1.414 . . . . 3.14 109.348 177.1 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.0 m -65.49 -53.47 42.07 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.291 -0.633 . . . . 0.84 109.291 -177.489 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.1 mt -50.98 -52.07 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.636 1.174 . . . . 1.45 110.854 178.645 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -54.12 -55.88 23.4 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.151 1.38 . . . . 2.34 110.182 173.015 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -63.78 -26.23 68.54 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 118.224 -0.893 . . . . 1.39 112.84 -171.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.9 mp -73.55 -95.41 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.251 -1.018 . . . . 2.1 108.251 168.886 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.97 34.11 0.44 Allowed Glycine 0 C--N 1.336 0.549 0 CA-C-O 119.012 -0.882 . . . . 0.89 112.635 173.603 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -130.42 163.59 26.59 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.483 1.141 . . . . 2.15 110.408 -163.018 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -117.03 157.52 25.69 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 108.051 -1.092 . . . . 3.01 108.051 174.661 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.54 165.53 36.31 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 118.446 0.566 . . . . 1.41 111.735 172.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 p -155.11 147.95 24.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.284 1.433 . . . . 2.44 108.652 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.154 0 N-CA-C 107.79 -1.189 . . . . 2.72 107.79 165.183 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.626 0 N-CA-C 106.372 -2.691 . . . . 1.3 106.372 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.55 96.18 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 125.368 1.467 . . . . 2.21 108.379 -177.201 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.9 tp -110.16 101.47 10.25 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.427 1.091 . . . . 2.33 108.21 -176.459 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -99.08 94.82 6.72 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.537 -0.912 . . . . 3.06 108.537 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -85.42 156.69 20.73 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.967 -0.753 . . . . 3.01 108.967 177.63 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.58 144.36 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.107 -1.442 . . . . 0.7 107.107 149.835 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.52 133.47 42.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.095 1.358 . . . . 2.31 109.237 177.568 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -137.37 166.12 24.58 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.04 0.536 . . . . 6.72 110.977 -177.099 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.55 -11.43 70.09 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.403 1.001 . . . . 1.33 110.726 -165.69 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 29.0 mtm -74.86 73.39 2.11 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.419 1.088 . . . . 1.71 110.192 -177.652 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.9 t -60.69 -37.09 80.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.459 1.104 . . . . 1.73 113.029 -170.175 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.4 p -145.04 167.27 23.09 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 118.81 0.732 . . . . 0.74 110.77 -173.347 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.5 -47.54 2.67 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.288 1.435 . . . . 1.07 111.965 -178.901 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 m -43.74 -42.43 5.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.445 1.098 . . . . 1.64 112.387 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.7 m -55.95 -36.0 67.29 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.393 0.677 . . . . 0.94 112.458 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.7 t -55.67 -60.29 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.2 0.524 . . . . 1.57 109.872 -177.139 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -71.25 -30.83 66.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.485 -0.769 . . . . 1.57 111.497 178.027 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -48.88 -45.52 41.2 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.137 0.881 . . . . 3.49 109.495 171.291 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.2 mt -69.59 -74.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 109.656 -0.498 . . . . 1.33 109.656 168.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -57.25 -48.4 78.96 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.435 0.561 . . . . 3.85 111.764 -161.296 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 t -63.39 -28.13 69.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.098 -0.477 . . . . 1.25 110.993 -178.137 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.2 t -71.99 -69.26 0.4 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.048 -0.723 . . . . 1.46 109.048 168.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.2 tp -54.62 -32.38 58.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.22 1.808 . . . . 3.2 113.165 -168.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.0 m -58.14 -19.74 35.08 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.151 -0.968 . . . . 2.02 112.656 176.216 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -57.04 -25.04 57.94 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.896 -1.127 . . . . 4.84 112.272 170.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -89.04 93.79 9.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.965 -1.124 . . . . 2.11 107.965 175.465 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.63 5.27 0.46 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.105 1.15 . . . . 6.14 114.105 -174.917 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.73 -26.86 73.95 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.243 -0.911 . . . . 0.96 111.423 164.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.48 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -79.75 146.28 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.438 -1.319 . . . . 2.45 107.438 170.803 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.9 mt -102.32 -42.51 5.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.368 1.467 . . . . 1.95 108.872 175.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -155.46 155.03 32.78 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 118.075 -0.964 . . . . 3.14 109.965 173.209 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -131.07 81.7 2.01 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.969 0.908 . . . . 2.77 109.519 178.256 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -77.69 78.89 4.19 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.019 -1.051 . . . . 1.47 108.945 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.0 t -79.86 140.01 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 126.311 1.844 . . . . 2.86 109.138 176.712 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.57 152.14 28.43 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.237 0.542 . . . . 1.15 110.789 169.12 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -95.84 -36.06 11.26 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.266 1.427 . . . . 1.68 109.938 -178.127 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.15 -36.99 32.41 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.114 0.966 . . . . 1.24 112.807 179.182 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.2 7.3 15.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.739 0.816 . . . . 1.92 111.445 174.481 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.3 m120 45.82 51.47 10.42 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.986 0.914 . . . . 2.06 111.744 -175.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -121.39 158.75 27.61 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.578 1.151 . . . . 4.46 110.253 -170.787 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.76 96.75 2.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.785 -1.098 . . . . 0.67 108.712 168.312 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -81.24 94.4 6.69 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.352 -1.351 . . . . 1.09 107.352 171.136 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.09 122.89 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 107.235 -1.394 . . . . 1.63 107.235 171.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -97.18 129.45 44.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.346 -2.094 . . . . 2.36 105.346 161.195 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -154.6 160.84 41.71 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.004 0.922 . . . . 2.3 109.757 -173.641 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.22 118.47 69.19 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 108.263 -1.014 . . . . 3.4 108.263 169.628 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -79.24 61.08 8.06 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.989 3.126 . . . . 2.19 111.877 -167.599 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -169.35 -45.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.08 1.352 . . . . 3.41 109.519 -174.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.2 mt -66.79 -33.12 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 122.77 0.428 . . . . 3.29 110.007 176.533 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.8 tt -146.78 134.9 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.241 -1.392 . . . . 1.54 107.241 178.664 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.17 161.69 37.88 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 111.304 -0.719 . . . . 0.86 111.304 178.522 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -60.21 -45.03 25.02 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.69 2.26 . . . . 0.93 110.382 177.234 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.44 HH11 ' CD2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -64.88 -30.59 71.6 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 118.739 -0.648 . . . . 7.01 110.988 177.057 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -66.66 -48.64 68.74 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.814 1.188 . . . . 2.62 109.547 177.378 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.8 mt -49.74 -57.77 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.996 -0.742 . . . . 0.77 108.996 170.448 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.5 mt -55.69 -47.16 79.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 118.72 -0.657 . . . . 1.03 111.53 -177.262 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.44 ' CD2' HH11 ' A' ' 56' ' ' ARG . 27.3 m80 -49.12 -45.52 43.62 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.611 0.764 . . . . 3.26 109.821 172.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.5 m -65.16 -48.94 71.75 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.435 -0.95 . . . . 1.01 108.435 -176.101 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.0 -61.65 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.2 0 N-CA-C 109.584 -0.524 . . . . 1.64 109.584 177.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -60.46 -37.84 82.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.464 -0.334 . . . . 2.15 110.344 -164.39 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.6 m -54.14 -33.9 59.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.84 0.856 . . . . 1.84 113.184 177.566 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.66 -60.17 3.43 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.368 0.986 . . . . 2.37 111.409 -176.289 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.95 22.61 0.19 Allowed Glycine 0 CA--C 1.526 0.742 0 O-C-N 120.645 -1.284 . . . . 1.13 112.925 166.74 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -134.28 176.58 8.47 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.537 1.168 . . . . 2.07 113.093 -143.467 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -128.89 160.02 33.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.891 -1.522 . . . . 3.83 106.891 167.51 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.71 163.53 31.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.02 0.528 . . . . 0.92 110.577 171.439 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -155.18 177.55 11.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.086 1.354 . . . . 1.94 107.773 173.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 C--N 1.332 -0.195 0 C-N-CA 124.213 1.005 . . . . 3.17 109.09 -179.988 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 107.737 -2.145 . . . . 1.99 107.737 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.7 85.57 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 122.662 1.22 . . . . 2.45 108.864 173.241 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 tp -77.76 72.95 4.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.165 -1.05 . . . . 3.29 108.165 167.762 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.54 125.53 29.48 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.216 -1.356 . . . . 3.22 108.402 153.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -148.39 160.89 42.57 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 125.384 1.678 . . . . 1.9 109.208 178.377 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 42' ' ' ASN . 0.9 OUTLIER -77.88 137.57 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.705 -1.961 . . . . 0.97 105.705 168.732 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.3 t -116.43 135.21 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 105.612 -1.996 . . . . 2.03 105.612 165.123 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -110.01 169.25 8.85 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.838 -1.171 . . . . 7.41 107.838 162.5 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.39 -119.9 6.34 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 106.373 -2.691 . . . . 2.48 106.373 -152.476 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 47.0 mtm 36.14 60.84 0.82 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.075 1.75 . . . . 1.7 113.095 178.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.7 t -85.59 -9.81 56.78 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 117.916 -1.04 . . . . 1.51 112.964 -176.306 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.7 p -163.69 171.7 15.26 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.843 1.201 . . . . 0.71 109.708 173.63 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.97 -43.2 29.27 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.538 1.135 . . . . 0.57 111.538 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.9 m -65.6 -25.91 67.6 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.623 -0.703 . . . . 1.63 112.619 -179.329 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.1 m -73.36 -57.49 3.97 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 119.093 0.86 . . . . 0.82 110.455 163.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.1 t -43.79 -63.17 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 124.04 0.936 . . . . 1.19 109.971 -175.343 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.453 ' HA ' ' CG ' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -68.01 -10.55 54.49 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 119.732 -0.787 . . . . 1.24 113.052 -173.372 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -70.23 -41.29 73.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.0 -1.111 . . . . 3.1 108.0 -178.507 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.6 mt -55.74 -62.97 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.243 -1.021 . . . . 1.1 108.243 177.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 1.6 pt-20 -53.21 -57.65 9.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.993 0.517 . . . . 3.3 110.457 -179.596 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.8 t -51.43 -48.75 62.6 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.058 0.543 . . . . 1.12 111.422 -179.567 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 t -70.34 -33.22 71.23 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.801 -0.814 . . . . 1.35 108.801 -172.476 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.2 mt -70.32 -45.71 65.69 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.624 -0.672 . . . . 2.22 111.16 174.072 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.4 p -57.76 -15.67 8.81 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.513 1.671 . . . . 2.25 115.513 -168.522 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.94 -36.43 74.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.603 1.092 . . . . 5.49 112.136 168.578 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -66.85 138.86 57.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.687 -0.857 . . . . 2.06 108.687 177.03 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -92.03 -5.88 52.12 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.274 0.23 . . . . 6.25 110.963 169.234 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.4 -30.58 58.28 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.585 -0.606 . . . . 0.97 111.585 174.358 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.516 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -78.79 146.19 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.6 -1.63 . . . . 2.46 106.6 168.709 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.0 mt -109.97 -37.79 5.51 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.989 1.716 . . . . 1.91 109.288 -175.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -153.27 150.29 28.8 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.412 -0.958 . . . . 2.09 108.412 176.741 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.0 m -130.79 142.45 50.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.168 -1.419 . . . . 2.57 107.168 172.057 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.9 t -152.26 157.23 41.11 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.271 -1.381 . . . . 1.88 107.271 159.92 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.43 138.83 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 124.573 1.149 . . . . 1.73 109.257 -178.025 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.84 95.95 4.49 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.017 0.927 . . . . 1.52 109.03 177.346 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -25.59 44.34 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.89 0.33 . . . . 3.02 111.89 167.249 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.55 -40.48 68.76 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.301 0.64 . . . . 1.3 111.552 178.505 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.5 t -110.27 -15.34 13.99 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.836 0.855 . . . . 3.21 111.301 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.44 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.3 m-80 65.88 74.31 0.37 Allowed 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 126.493 1.917 . . . . 2.38 110.339 -171.072 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.46 145.92 21.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.17 -0.678 . . . . 4.17 109.17 171.081 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 46' ' ' ILE . . . -109.19 132.38 54.17 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 106.818 -1.549 . . . . 0.78 106.818 167.274 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -109.07 99.25 8.59 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 127.496 2.319 . . . . 1.01 104.953 176.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.467 HD11 ' HB1' ' A' ' 44' ' ' ALA . 3.2 mm -108.18 110.93 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 106.077 -1.823 . . . . 2.02 106.077 176.746 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.2 mmtt -82.45 128.83 34.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.3 -1.741 . . . . 3.14 106.3 165.515 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -141.88 157.2 45.27 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.84 0.856 . . . . 2.18 108.946 174.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.5 121.89 63.95 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 107.113 -1.44 . . . . 3.48 107.113 173.281 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.56 44.1 1.57 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.196 2.597 . . . . 1.99 112.588 -172.738 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -132.88 6.47 3.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.946 1.698 . . . . 3.57 110.838 -179.021 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -157.19 -30.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.866 0.866 . . . . 2.7 112.525 -162.437 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 tt -139.25 145.03 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.765 -1.939 . . . . 1.26 105.765 165.383 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.03 154.53 24.57 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.134 -1.186 . . . . 1.01 110.134 176.505 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -59.06 -38.5 86.94 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.056 1.838 . . . . 1.04 109.792 173.867 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -54.35 -39.52 67.19 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.678 0.791 . . . . 5.95 111.864 173.43 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -70.09 -44.83 68.24 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.797 0.726 . . . . 2.44 109.356 -177.51 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.7 mt -53.95 -52.27 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.394 -0.595 . . . . 0.84 109.394 173.048 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.4 mt -52.33 -53.93 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.164 0.585 . . . . 1.13 110.34 176.199 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -51.28 -44.24 61.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.858 0.754 . . . . 2.87 110.882 175.935 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.7 m -66.25 -40.75 90.43 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 110.075 -0.343 . . . . 1.25 110.075 -174.661 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.8 mt -56.55 -67.58 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.791 -0.818 . . . . 1.36 108.791 168.606 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -61.82 -43.51 98.71 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.548 -0.296 . . . . 3.8 111.372 -161.422 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.2 m -63.56 -13.1 38.26 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.249 0.833 . . . . 2.49 113.249 -174.991 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.7 mt -70.76 -80.16 0.06 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.322 -0.992 . . . . 1.97 108.322 171.629 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.94 42.41 0.45 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-O 118.759 -1.023 . . . . 1.01 110.828 165.792 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -131.25 177.16 7.68 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.823 0.812 . . . . 1.87 110.586 -161.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -134.51 145.95 49.26 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.915 -1.513 . . . . 5.0 106.915 176.367 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.44 150.94 48.99 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 120.57 1.532 . . . . 1.01 113.082 -178.724 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.8 t -155.31 129.18 8.66 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 109.064 -0.717 . . . . 2.69 109.064 166.648 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 C--O 1.234 0.254 0 N-CA-C 109.314 -0.625 . . . . 2.49 109.314 162.264 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.729 0 N-CA-C 106.872 -2.491 . . . . 1.29 106.872 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -121.87 74.89 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 118.672 1.236 . . . . 2.59 109.058 -176.648 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 tp -79.99 71.8 6.72 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.766 -0.827 . . . . 2.45 108.766 -177.787 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -78.03 69.43 4.25 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.645 0.736 . . . . 3.55 109.153 -178.659 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.81 156.33 26.21 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.437 0.695 . . . . 2.21 111.097 -176.705 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.94 123.51 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.246 -1.39 . . . . 0.85 107.246 172.033 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.2 t -112.06 125.08 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.073 -1.825 . . . . 2.11 106.073 176.287 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.22 176.83 5.4 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.391 1.476 . . . . 6.09 109.231 -173.478 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.46 -69.52 3.24 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 108.767 -1.733 . . . . 2.41 108.767 -177.558 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.6 mtp 2.31 66.42 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.864 2.866 . . . . 2.06 115.477 -178.468 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.5 t -87.69 -11.43 48.35 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 117.59 -1.195 . . . . 1.44 113.694 -161.82 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.6 p -164.78 178.9 6.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 120.418 1.463 . . . . 0.71 110.479 175.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.41 -39.64 47.72 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.538 1.135 . . . . 0.64 111.599 175.586 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -52.4 -43.05 64.53 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.552 -0.536 . . . . 2.63 109.552 175.684 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.7 m -65.33 -57.23 8.91 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 121.504 -0.748 . . . . 0.94 109.153 -178.672 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 83.7 t -40.47 -68.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.567 1.147 . . . . 0.99 111.33 177.386 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -31.43 68.99 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 119.474 -0.891 . . . . 0.74 111.876 -169.875 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -65.6 -48.12 73.37 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 121.617 -0.677 . . . . 3.82 109.319 178.169 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.4 mt -53.21 -61.23 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.048 -1.093 . . . . 0.8 108.048 173.33 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -51.3 -49.71 60.77 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.246 0.618 . . . . 3.71 111.793 -176.428 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 t -55.12 -53.42 56.09 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.999 0.519 . . . . 0.97 109.862 176.743 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.4 m -59.86 -40.1 87.44 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.223 0.535 . . . . 1.86 110.08 -176.699 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -51.52 63.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.922 0.889 . . . . 2.74 110.376 -179.608 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 26.5 m -58.01 -29.47 65.32 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.767 -0.651 . . . . 1.92 110.183 176.678 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -5.67 8.67 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.412 1.264 . . . . 5.03 114.412 174.446 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -74.02 -122.26 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 120.437 1.471 . . . . 3.44 111.378 -178.879 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.18 -62.45 0.09 Allowed 'General case' 0 C--N 1.342 0.259 0 O-C-N 120.928 -1.108 . . . . 12.63 110.466 177.707 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.72 47.28 3.62 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.575 -0.61 . . . . 1.13 111.575 -177.817 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -115.06 136.6 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.8 -1.185 . . . . 3.11 107.8 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.9 mt -97.73 -42.22 7.72 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.156 0.983 . . . . 2.06 108.671 175.209 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -156.11 154.04 30.3 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 110.017 -0.364 . . . . 2.16 110.017 -178.278 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 p -132.22 144.34 50.56 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.639 0.775 . . . . 2.69 109.453 162.24 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 m -154.07 122.58 6.2 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.881 1.272 . . . . 2.75 107.914 161.809 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -115.18 154.67 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.021 0.529 . . . . 1.58 109.886 -178.12 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.22 123.25 14.53 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.891 0.476 . . . . 0.81 109.918 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.96 -15.0 60.24 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.806 1.242 . . . . 1.46 112.546 177.438 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.58 -50.4 37.66 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.872 -0.788 . . . . 1.57 108.872 173.358 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.73 -24.53 41.57 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.586 0.754 . . . . 1.81 110.695 177.392 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.5 m120 62.75 47.9 4.44 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 125.69 1.596 . . . . 1.57 108.881 -170.542 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.48 153.28 51.76 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.796 -0.446 . . . . 2.22 109.796 -172.679 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.74 99.99 6.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 124.523 1.139 . . . . 0.98 108.83 173.182 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -78.45 89.26 4.42 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 105.751 -1.944 . . . . 1.13 105.751 172.356 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.2 pt -93.27 140.95 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 107.65 -1.241 . . . . 3.12 107.65 165.549 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -112.21 130.33 55.96 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 106.309 -1.737 . . . . 2.49 106.309 160.944 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -141.07 161.27 38.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.598 0.759 . . . . 1.8 111.361 -166.399 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -93.02 103.8 10.15 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 125.785 1.634 . . . . 4.34 108.105 178.656 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.25 59.6 7.46 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.909 3.073 . . . . 2.45 111.221 -168.37 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -173.39 -49.01 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.283 1.833 . . . . 3.29 108.04 -172.611 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.3 mt -74.65 -37.7 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 109.818 -0.438 . . . . 3.14 109.818 173.618 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 tt -128.87 126.42 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 106.593 -1.632 . . . . 1.26 106.593 177.45 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.14 174.86 52.99 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.437 -1.865 . . . . 0.99 108.437 168.145 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.11 -48.51 4.88 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.687 1.592 . . . . 1.12 110.137 175.48 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.25 31.4 ttt85 -70.1 -20.82 63.17 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.271 0.841 . . . . 6.18 113.271 -169.559 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -46.63 -57.18 5.03 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.638 0.654 . . . . 2.84 109.719 167.444 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.02 -48.21 84.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 109.425 -0.583 . . . . 1.29 109.425 -176.697 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.5 mt -56.59 -40.89 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.937 -0.574 . . . . 1.23 110.473 -176.34 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -52.52 -40.76 62.8 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 118.938 0.79 . . . . 3.05 111.644 172.772 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.2 m -66.47 -51.17 59.68 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.741 0.701 . . . . 1.23 109.314 178.296 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.87 -52.56 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.0 0.92 . . . . 2.05 110.735 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.2 -56.2 24.92 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.456 1.102 . . . . 1.88 110.322 174.178 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 t -65.57 -21.19 66.57 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 118.231 -0.89 . . . . 1.56 112.921 -171.988 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.2 mt -71.23 -96.27 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.008 -1.108 . . . . 2.03 108.008 166.478 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.71 36.93 0.47 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.575 -1.125 . . . . 1.14 112.053 171.053 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -131.86 127.65 37.0 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 118.569 1.184 . . . . 1.84 110.406 -166.106 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -78.73 159.63 27.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.555 -0.905 . . . . 4.16 108.555 178.636 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.34 142.4 50.08 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.883 0.873 . . . . 1.5 110.338 -173.862 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -155.23 124.24 6.2 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.654 -0.869 . . . . 2.28 108.654 167.738 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 CA--C 1.529 0.137 0 N-CA-C 109.256 -0.646 . . . . 2.83 109.256 172.589 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 106.997 -2.441 . . . . 1.32 106.997 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.69 78.4 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.091 1.356 . . . . 2.6 109.632 -173.076 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.1 82.33 5.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.305 -0.872 . . . . 3.06 109.257 -175.946 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -85.15 117.21 23.97 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.655 -0.869 . . . . 4.4 108.655 165.113 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.86 169.78 16.86 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.088 0.955 . . . . 1.98 109.995 170.874 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -90.08 142.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.396 -0.965 . . . . 0.71 108.396 170.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.18 130.46 74.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 125.713 1.605 . . . . 2.47 108.353 174.085 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -121.94 144.55 48.8 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.208 1.803 . . . . 5.62 107.72 -174.282 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.78 -125.34 7.36 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 106.288 -2.725 . . . . 2.78 106.288 -163.91 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.8 mtm 49.73 68.61 0.71 Allowed 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.791 1.236 . . . . 1.55 112.288 178.015 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 p -61.39 -28.86 69.54 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.674 0.62 . . . . 3.49 112.674 178.489 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.56 171.22 16.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.751 0.705 . . . . 1.31 110.259 -171.402 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.45 -37.36 17.04 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.344 1.058 . . . . 1.0 111.45 176.113 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -47.95 -33.84 8.3 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.294 2.238 . . . . 1.59 113.06 174.328 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.7 m -74.89 -60.99 2.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.305 1.042 . . . . 0.79 111.445 166.554 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.3 t -45.62 -58.4 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.799 1.24 . . . . 0.93 110.947 -171.245 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -30.58 71.36 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.175 0.512 . . . . 1.63 111.363 -176.454 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -71.29 -49.24 44.88 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.192 -1.04 . . . . 3.65 108.192 -176.39 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 77.0 mt -54.03 -56.15 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 108.572 -0.899 . . . . 0.66 108.572 174.849 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -64.98 -44.75 88.28 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.59 0.233 . . . . 3.9 111.627 -171.326 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.5 t -63.59 -42.29 98.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.209 0.603 . . . . 0.84 110.617 177.044 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.9 t -62.96 -50.82 69.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.365 -1.346 . . . . 1.5 107.365 -178.255 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.1 mt -47.17 -53.6 12.66 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 122.983 0.513 . . . . 3.09 111.459 174.287 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.8 p -58.4 -12.22 3.62 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.082 1.142 . . . . 1.98 114.082 -178.392 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -32.48 73.99 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.709 1.141 . . . . 5.05 111.956 172.599 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -88.24 110.26 20.58 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 108.067 -1.086 . . . . 1.99 108.067 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.8 -17.12 33.29 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.309 -0.869 . . . . 6.19 112.005 172.942 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.47 -33.99 67.74 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.911 -0.938 . . . . 1.01 112.686 169.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.24 128.34 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.783 -1.562 . . . . 2.56 106.783 172.71 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.3 mt -86.58 -35.53 19.41 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.821 1.248 . . . . 2.03 109.35 -176.117 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -154.8 147.36 24.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.295 -1.002 . . . . 2.09 108.295 177.393 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.8 p -124.75 147.18 48.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.02 0.928 . . . . 2.74 109.046 169.221 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.9 t -152.39 101.28 2.66 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.979 -1.119 . . . . 1.55 107.979 169.725 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.6 m -90.26 161.74 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.048 1.339 . . . . 1.92 110.441 176.419 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.64 138.39 14.23 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.281 -0.637 . . . . 0.79 109.281 155.19 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 pp -76.13 -32.47 59.15 Favored 'General case' 0 C--O 1.227 -0.099 0 N-CA-C 108.841 -0.8 . . . . 1.65 108.841 159.7 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.08 -15.45 23.31 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.282 1.033 . . . . 1.87 111.938 179.156 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.9 m -139.3 20.35 2.58 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 121.535 -0.728 . . . . 2.4 110.575 172.557 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.7 m120 33.41 43.72 0.06 Allowed 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 125.757 1.623 . . . . 1.7 114.121 -176.273 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.3 158.49 30.88 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.233 0.613 . . . . 2.64 110.089 -170.69 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.37 115.32 9.18 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.633 -1.247 . . . . 0.69 107.633 163.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -99.16 105.32 17.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 106.07 -1.826 . . . . 1.0 106.07 170.628 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.58 110.29 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 105.921 -1.881 . . . . 1.82 105.921 175.371 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -82.91 136.29 34.63 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.717 -1.586 . . . . 3.89 106.717 164.892 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -158.65 155.55 28.38 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 118.956 0.798 . . . . 1.72 112.864 -168.076 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -87.19 120.28 71.3 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.184 0.993 . . . . 3.17 108.432 167.03 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.07 -14.55 23.49 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.066 2.511 . . . . 1.96 113.695 -174.12 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -84.67 -47.7 10.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.175 -1.046 . . . . 4.11 108.175 176.693 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.2 mt -66.47 -36.91 78.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 119.256 -0.402 . . . . 3.14 110.569 -178.388 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.0 tt -144.03 124.2 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.845 -0.798 . . . . 1.31 108.845 176.39 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.79 154.37 52.17 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.335 -1.106 . . . . 0.87 110.335 179.421 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -57.87 -41.28 70.85 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.923 1.749 . . . . 1.01 109.88 174.228 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -62.88 -30.09 71.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.922 -0.561 . . . . 5.78 111.911 176.127 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -70.38 -44.94 67.01 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.556 1.071 . . . . 2.26 109.19 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 mt -52.47 -55.94 8.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.15 -0.685 . . . . 0.77 109.15 171.133 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.4 mt -52.2 -53.41 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 119.401 -0.333 . . . . 1.21 110.632 179.411 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -50.65 -43.49 57.21 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.024 0.53 . . . . 3.13 110.938 175.274 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.8 m -62.44 -49.49 75.24 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.561 -0.533 . . . . 0.78 109.561 -177.891 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.82 -54.47 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.209 0.604 . . . . 1.75 109.96 176.283 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -58.19 -50.66 72.76 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.428 0.691 . . . . 2.59 110.582 -176.377 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -54.99 -33.39 62.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.443 1.497 . . . . 1.16 112.217 -172.61 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.8 mt -63.55 -82.89 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.047 0.385 . . . . 2.07 110.612 178.461 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.98 33.12 0.43 Allowed Glycine 0 CA--C 1.525 0.701 0 O-C-N 121.217 -0.927 . . . . 0.95 112.775 173.355 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -135.08 176.06 9.01 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.26 1.03 . . . . 1.64 110.316 -159.671 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -130.3 136.57 49.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.507 -1.294 . . . . 3.78 107.507 172.387 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.73 156.97 16.31 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.559 0.744 . . . . 1.11 109.774 177.029 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.2 m -151.33 114.25 4.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.455 -0.942 . . . . 2.29 108.455 170.012 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.365 0 C-N-CA 124.323 1.049 . . . . 3.42 110.849 179.594 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 CA-C-O 121.805 0.669 . . . . 1.86 114.2 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.98 133.44 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 125.974 1.71 . . . . 2.25 107.066 176.689 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 tt -139.13 103.56 4.8 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.425 -1.695 . . . . 2.86 106.425 173.214 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -112.29 117.28 32.06 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.524 0.602 . . . . 3.83 110.667 177.532 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.78 161.32 35.92 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.531 1.132 . . . . 2.8 111.08 -171.068 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.5 t -82.71 111.98 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 125.378 1.471 . . . . 1.08 107.411 176.879 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -86.85 73.75 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.679 1.192 . . . . 2.58 108.336 172.629 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.11 66.21 3.67 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.445 1.098 . . . . 6.77 109.71 -172.648 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.36 -44.4 0.02 OUTLIER Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.854 -0.899 . . . . 1.46 110.854 -175.416 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -61.4 120.05 9.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.562 0.681 . . . . 1.7 109.193 177.75 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 t -98.53 -45.65 6.02 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.988 0.515 . . . . 1.42 111.751 -172.91 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.0 p -130.59 172.75 11.59 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.758 0.708 . . . . 0.76 110.868 -175.125 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.46 -45.47 9.15 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.9 1.28 . . . . 0.86 111.922 179.422 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 m -54.41 -42.12 70.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.217 1.007 . . . . 1.5 111.584 177.814 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.6 m -71.41 -51.36 24.4 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.031 0.532 . . . . 0.96 110.643 174.736 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.3 t -44.75 -59.02 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.299 1.039 . . . . 1.0 109.988 -179.049 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.43 ' HA ' ' CG ' ' A' ' 23' ' ' GLU 0.306 0.0 OUTLIER -69.14 -14.88 63.24 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 119.257 -0.977 . . . . 1.25 112.028 -175.238 . . . . . . . . 4 4 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.1 tttt -71.34 -46.56 60.24 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 120.766 -1.209 . . . . 2.98 108.269 -175.763 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.4 mt -52.74 -67.67 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.221 -1.029 . . . . 1.1 108.221 177.378 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.43 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -47.73 -66.09 0.46 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.177 0.806 . . . . 4.25 113.177 178.466 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.2 m -50.69 -39.33 50.92 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 118.433 0.561 . . . . 2.41 112.216 -177.965 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.3 t -70.57 -60.78 2.06 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.441 -0.948 . . . . 1.24 108.441 179.224 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -52.58 -34.8 52.22 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.447 1.099 . . . . 2.56 112.296 -174.638 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.3 m -55.28 -22.59 19.22 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.947 0.721 . . . . 1.91 112.947 179.496 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -66.06 -23.76 66.6 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 120.101 1.319 . . . . 5.17 112.507 174.099 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -81.62 103.7 11.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.09 -1.448 . . . . 2.1 107.09 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 25.3 mtp-105 -57.19 -21.86 36.41 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.498 1.045 . . . . 7.09 112.13 173.256 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.82 0.97 18.0 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.743 -1.032 . . . . 1.67 113.951 173.191 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 pp -120.06 128.57 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 119.315 1.558 . . . . 2.57 106.933 159.175 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.4 mt -83.71 -30.66 26.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 110.257 -0.275 . . . . 1.78 110.257 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -157.07 151.6 25.42 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.589 -1.263 . . . . 2.26 107.589 178.085 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.5 t -128.65 119.14 24.14 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.882 1.273 . . . . 2.63 108.723 169.423 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 t -120.91 93.89 4.17 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.019 1.328 . . . . 1.51 109.975 -173.405 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -92.98 149.74 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.973 1.709 . . . . 2.49 111.719 -169.621 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.9 139.65 18.02 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.237 0.615 . . . . 0.85 111.666 168.592 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.0 mt -78.89 -54.52 5.96 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 125.541 1.536 . . . . 2.29 108.694 170.467 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -45.81 -42.61 12.47 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.63 0.772 . . . . 1.47 111.866 -177.28 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.4 ' HB ' ' CG ' ' A' ' 43' ' ' LYS . 3.1 m -101.02 -5.05 26.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.051 0.94 . . . . 2.63 112.247 -178.705 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.02 69.23 0.63 Allowed 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.988 1.315 . . . . 1.89 111.041 -178.574 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.4 ' CG ' ' HB ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -155.98 163.52 39.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.177 0.513 . . . . 2.17 111.56 -172.501 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -147.01 103.5 3.61 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.959 2.104 . . . . 0.85 107.427 171.097 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -80.37 106.41 12.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.37 -1.715 . . . . 1.04 106.37 172.811 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.0 mt -105.98 114.41 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 106.66 -1.607 . . . . 1.79 106.66 177.464 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -78.63 71.93 5.13 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.836 -1.172 . . . . 3.07 107.836 172.719 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.91 153.62 43.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.755 -0.657 . . . . 2.73 111.232 -179.122 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -106.17 117.53 57.19 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 108.869 -0.789 . . . . 3.13 108.869 162.041 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -67.27 -23.16 45.3 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.153 2.568 . . . . 1.63 113.009 -173.539 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -74.52 -43.46 55.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.302 0.955 . . . . 3.8 109.283 -174.609 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.6 tp -89.16 -34.96 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.339 0.496 . . . . 3.51 112.339 -179.129 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mm -133.47 112.68 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.487 -0.931 . . . . 1.65 108.487 -170.065 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.94 163.28 49.33 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 110.831 -0.908 . . . . 1.27 110.831 177.456 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -55.97 -43.26 58.5 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.721 2.281 . . . . 1.4 109.957 175.701 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -32.87 65.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.307 0.643 . . . . 6.89 112.66 176.201 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -70.12 -49.42 50.93 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.879 0.763 . . . . 2.6 109.012 179.139 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.6 mt -53.64 -57.25 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.034 -0.358 . . . . 1.21 110.034 174.936 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.9 mt -49.58 -54.95 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 123.646 0.778 . . . . 1.45 109.139 178.873 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -55.39 -41.4 72.61 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 111.51 0.189 . . . . 4.26 111.51 178.515 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 64.5 m -62.94 -49.6 74.11 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.794 -0.817 . . . . 1.16 108.794 -177.648 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.78 -53.85 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.487 -0.56 . . . . 1.41 109.487 174.627 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -56.02 -37.63 69.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.146 0.578 . . . . 2.21 111.522 -178.938 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.1 m -63.67 -15.88 59.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.461 -0.78 . . . . 2.2 113.094 -178.548 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.31 -96.6 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.593 1.088 . . . . 2.27 108.754 169.936 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.33 44.97 0.47 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.928 -1.269 . . . . 1.02 109.928 174.437 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -134.15 176.62 8.43 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.592 1.157 . . . . 1.86 109.169 -163.956 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -139.68 167.79 21.31 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.737 -1.208 . . . . 3.51 107.737 164.308 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -135.22 152.41 51.53 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.567 1.147 . . . . 0.9 110.384 -167.076 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.6 m -150.87 124.17 8.88 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.803 -0.56 . . . . 1.98 110.257 168.305 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 108.929 -0.767 . . . . 3.53 108.929 169.193 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.685 0 N-CA-C 108.23 -1.948 . . . . 1.59 108.23 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.47 158.47 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.517 0.727 . . . . 2.83 109.148 173.226 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.03 131.74 17.9 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.84 -1.541 . . . . 2.58 106.84 169.732 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -117.34 112.92 21.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.837 -0.801 . . . . 3.31 108.837 175.158 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.7 mt -109.93 136.16 49.66 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.244 1.417 . . . . 2.27 108.08 -179.349 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 42' ' ' ASN . 1.0 OUTLIER -78.54 96.45 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.255 -2.498 . . . . 1.66 104.255 156.678 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.5 t -82.69 131.21 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.004 -1.48 . . . . 1.73 107.004 172.571 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -144.2 136.85 26.93 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.771 0.828 . . . . 5.31 108.877 -169.717 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.4 -25.91 9.46 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.47 1.033 . . . . 1.31 110.775 -169.803 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -70.57 74.22 0.55 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 122.173 0.987 . . . . 1.61 110.972 179.461 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -50.68 -36.0 33.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.865 1.266 . . . . 1.61 114.303 -168.42 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 p -146.6 170.62 16.54 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.146 0.885 . . . . 0.92 111.978 -168.505 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.79 -41.8 24.36 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.583 1.153 . . . . 0.64 111.457 176.827 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 m -59.98 -33.2 71.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.158 0.583 . . . . 1.73 111.724 178.272 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.5 m -72.62 -46.26 54.95 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 119.007 0.821 . . . . 1.24 112.045 167.178 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.0 t -51.18 -60.98 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 118.262 0.483 . . . . 0.73 110.8 -178.611 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -27.65 65.0 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.383 -0.823 . . . . 0.91 111.931 -174.949 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -55.56 -54.68 41.05 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 108.698 -0.852 . . . . 3.33 108.698 169.496 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.468 HD11 ' CD2' ' A' ' 67' ' ' PHE . 61.8 mt -54.56 -59.39 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 118.451 -0.785 . . . . 0.74 109.012 176.564 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -50.83 -59.78 3.75 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 123.779 0.674 . . . . 4.24 110.288 -173.322 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.9 t -58.1 -45.78 86.64 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.653 0.781 . . . . 0.99 110.861 -176.122 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.5 t -64.78 -56.83 11.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.126 -0.694 . . . . 1.18 109.126 -178.038 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.5 tp -52.57 -51.4 59.94 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 125.012 1.325 . . . . 2.43 111.021 -177.626 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.6 m -62.87 -9.31 9.18 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.954 0.724 . . . . 2.8 112.954 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -31.28 72.44 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.557 -1.339 . . . . 4.82 111.523 168.481 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -79.75 71.87 6.43 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.948 -0.76 . . . . 2.25 108.948 -178.209 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -42.97 102.23 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.197 1.399 . . . . 6.68 110.137 177.945 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.24 -39.33 0.81 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.22 -1.552 . . . . 1.26 109.22 -164.167 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.31 140.86 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 104.346 -2.464 . . . . 2.83 104.346 148.579 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.5 mt -104.24 -42.56 5.47 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.576 1.15 . . . . 1.73 109.715 -175.658 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -146.71 153.06 39.82 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.856 -0.424 . . . . 1.99 109.856 176.162 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.3 t -136.93 136.37 38.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.484 1.914 . . . . 2.82 107.986 174.696 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -131.13 82.17 2.03 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.891 1.277 . . . . 2.02 107.876 172.108 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.407 HG12 ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -78.58 141.71 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.102 0.961 . . . . 1.8 110.268 172.341 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.77 151.07 26.82 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.196 0.598 . . . . 0.92 110.107 169.178 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.2 -11.97 14.52 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.812 1.245 . . . . 1.36 113.346 -165.935 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.99 -51.01 52.11 Favored 'General case' 0 C--O 1.226 -0.174 0 N-CA-C 108.576 -0.898 . . . . 1.73 108.576 173.824 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 m -79.81 -29.17 40.17 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.983 -0.553 . . . . 2.22 111.416 174.252 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.526 ' O ' HG22 ' A' ' 9' ' ' VAL . 63.6 m-20 67.2 79.71 0.23 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.242 -1.392 . . . . 1.66 107.242 -165.574 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -147.91 158.9 44.28 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.534 -0.543 . . . . 4.98 109.534 -176.186 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.407 ' HB2' HG12 ' A' ' 37' ' ' VAL . . . -146.64 108.86 4.44 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.519 1.928 . . . . 1.03 106.612 163.503 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -86.26 117.16 24.89 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.781 -2.303 . . . . 1.18 104.781 164.184 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.405 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.8 mp -109.29 148.36 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 105.293 -2.114 . . . . 1.89 105.293 171.358 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.48 141.25 51.05 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.692 -0.855 . . . . 2.36 108.692 156.995 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -154.46 153.93 32.34 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.315 1.046 . . . . 2.32 109.211 -163.03 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -84.93 114.25 54.62 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 107.665 -1.235 . . . . 3.52 107.665 173.163 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.23 52.51 4.31 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.07 3.18 . . . . 2.09 111.777 -170.399 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -144.82 -59.7 0.36 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.094 1.758 . . . . 2.82 106.874 -177.981 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.6 tt -72.63 -25.49 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.203 1.401 . . . . 2.37 111.972 179.721 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.8 tt -145.93 143.08 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.723 -1.584 . . . . 1.46 106.723 172.462 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -99.55 161.82 19.66 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.367 -1.093 . . . . 0.92 110.367 174.018 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -56.54 -41.12 79.38 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.501 2.134 . . . . 1.11 110.03 174.767 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.4 tpt85 -56.28 -36.03 68.14 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.09 -0.957 . . . . 6.11 111.726 179.175 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -71.26 -48.17 52.65 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.524 0.73 . . . . 2.19 110.026 -177.37 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 mt -49.63 -56.48 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 108.21 -1.033 . . . . 0.81 108.21 171.761 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.2 mt -56.05 -43.1 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.893 -0.594 . . . . 1.01 109.999 -179.787 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -56.7 -40.62 75.96 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.397 0.679 . . . . 4.34 111.414 176.308 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.16 -43.92 77.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 119.443 -0.903 . . . . 2.1 109.293 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.9 -52.0 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 124.52 1.128 . . . . 1.76 111.057 174.217 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -57.92 -55.52 33.8 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.595 1.158 . . . . 1.94 110.019 175.901 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.2 t -53.48 -43.42 68.18 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.262 1.025 . . . . 1.34 110.851 -175.589 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.2 mt -62.59 -66.14 0.58 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 110.312 -0.255 . . . . 2.12 110.312 173.697 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.99 -24.94 0.02 OUTLIER Glycine 0 CA--C 1.53 0.993 0 N-CA-C 117.504 1.762 . . . . 1.31 117.504 -178.223 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.468 ' CD2' HD11 ' A' ' 22' ' ' ILE . 13.5 m-85 -126.6 152.16 47.01 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 119.055 1.427 . . . . 1.74 110.535 -137.779 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -84.41 152.42 24.04 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.521 -1.289 . . . . 4.06 107.521 172.876 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -122.12 129.51 52.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.78 0.832 . . . . 1.05 109.478 163.514 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -108.36 104.41 13.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.496 -1.298 . . . . 2.75 107.496 169.954 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 CA--C 1.533 0.312 0 CA-C-N 119.019 0.827 . . . . 3.75 110.633 175.081 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.906 0 N-CA-C 106.239 -2.744 . . . . 1.41 106.239 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.5 82.79 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 124.549 1.14 . . . . 3.25 110.635 -172.267 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 tp -81.55 81.67 7.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.201 -1.037 . . . . 3.38 108.201 175.998 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -95.0 102.77 14.6 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.155 -0.929 . . . . 2.89 109.029 171.377 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.6 151.0 40.88 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.755 1.222 . . . . 2.24 109.376 -177.55 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 t -77.6 129.87 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 105.717 -1.957 . . . . 1.01 105.717 166.046 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.4 t -111.35 97.7 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 105.452 -2.055 . . . . 2.3 105.452 174.068 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -81.68 146.43 30.02 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.267 -1.012 . . . . 7.22 108.267 178.756 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.13 -9.51 56.37 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.06 0.838 . . . . 1.04 112.1 -174.324 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.7 ttm -65.96 71.95 0.06 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.605 1.562 . . . . 1.95 110.935 176.676 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -71.98 -31.47 66.3 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.697 0.629 . . . . 1.52 112.697 -167.526 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.9 p -154.18 174.81 14.25 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.255 0.934 . . . . 0.83 112.397 -169.359 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.89 -41.26 45.27 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.503 1.121 . . . . 0.72 111.046 175.89 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.9 m -63.72 -24.79 67.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.174 0.589 . . . . 1.65 112.235 178.498 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.3 m -72.57 -62.6 1.39 Allowed 'General case' 0 C--N 1.337 0.05 0 CA-C-N 119.478 1.035 . . . . 0.95 110.086 163.207 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.7 t -36.24 -66.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 125.538 1.535 . . . . 0.88 111.072 -177.002 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.33 -27.6 66.41 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.705 -0.398 . . . . 0.83 111.604 -172.555 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -69.43 -55.63 9.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.912 -1.144 . . . . 3.54 107.912 -179.533 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.4 mt -50.02 -59.44 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.293 -1.003 . . . . 0.81 108.293 177.52 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.65 -56.01 25.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.186 -0.915 . . . . 3.88 110.338 -174.788 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.5 t -66.08 -29.59 69.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.168 -0.92 . . . . 1.56 112.271 -176.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.6 m -70.93 -50.66 32.23 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.957 -1.127 . . . . 2.34 107.957 179.38 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.2 mt -53.54 -46.57 70.24 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.468 -0.333 . . . . 2.4 110.831 175.163 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.2 m -56.4 -9.12 0.63 Allowed 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.964 1.098 . . . . 2.16 113.964 -179.252 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -75.92 -29.81 58.53 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.527 -1.358 . . . . 7.4 112.024 172.53 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -75.18 161.68 29.16 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.017 0.927 . . . . 2.05 109.509 -173.571 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.45 -42.76 7.57 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-O 119.131 -0.462 . . . . 8.24 111.479 -175.285 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.29 -12.75 69.67 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 119.112 0.869 . . . . 1.08 113.207 -176.588 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -77.54 159.31 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 107.785 -1.191 . . . . 2.59 107.785 168.18 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.3 mt -129.39 -41.1 1.4 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.223 1.009 . . . . 2.39 110.112 -172.916 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -149.84 148.22 28.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.646 -1.613 . . . . 2.06 106.646 174.952 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -128.87 126.25 39.36 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.232 -2.136 . . . . 2.65 105.232 178.473 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.1 t -144.54 104.93 4.11 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.831 -0.803 . . . . 1.49 108.831 178.233 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.95 148.64 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 123.63 0.772 . . . . 1.63 111.428 -175.766 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.74 109.43 3.45 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 122.08 -0.387 . . . . 1.13 111.759 -176.849 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.65 -15.42 19.08 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.919 1.081 . . . . 1.47 113.919 177.236 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.36 -35.27 76.99 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.874 0.47 . . . . 1.27 110.656 171.589 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -116.49 -6.21 11.7 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.748 1.219 . . . . 3.17 111.467 178.892 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.9 m120 56.64 29.32 15.48 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.838 1.655 . . . . 1.47 110.764 -179.762 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.66 144.64 37.73 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.495 -1.668 . . . . 3.19 106.495 -176.89 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.82 114.2 20.73 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.465 -1.68 . . . . 0.99 106.465 165.445 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -91.2 104.7 17.22 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 105.418 -2.067 . . . . 1.75 105.418 172.757 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 46' ' ' ILE . 2.1 mp -103.99 115.86 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 105.987 -1.857 . . . . 1.66 105.987 170.302 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -78.51 133.9 37.35 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 105.645 -1.983 . . . . 2.98 105.645 162.95 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -151.53 163.57 38.73 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.548 0.739 . . . . 1.85 109.84 -173.559 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -100.18 124.92 41.53 Favored Pre-proline 0 N--CA 1.449 -0.513 0 N-CA-C 108.552 -0.907 . . . . 3.48 108.552 163.04 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.79 -17.02 33.2 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.663 2.909 . . . . 2.03 113.663 -174.553 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.56 -44.47 11.89 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.416 -0.957 . . . . 3.1 108.416 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.6 mt -71.25 -43.09 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 122.244 -0.285 . . . . 3.41 110.82 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.59 118.93 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 105.83 -1.915 . . . . 1.46 105.83 -178.574 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.95 150.38 51.92 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 108.718 -1.753 . . . . 1.13 108.718 171.917 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -57.64 -40.48 79.63 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 CA-C-N 119.248 1.524 . . . . 1.06 109.736 175.059 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -42.8 -42.23 3.52 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.182 1.393 . . . . 7.44 112.578 168.134 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -71.28 -43.05 67.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.996 0.816 . . . . 2.2 110.121 -172.034 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.5 mt -57.78 -48.3 83.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 109.133 -0.691 . . . . 0.63 109.133 173.503 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.2 mt -54.41 -53.22 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.842 -0.429 . . . . 1.46 109.842 176.09 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -50.63 -45.71 57.82 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.599 0.636 . . . . 3.14 110.422 176.016 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.2 m -60.14 -52.08 66.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.269 -0.641 . . . . 1.06 109.269 -176.382 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.29 -61.96 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.534 0.734 . . . . 1.23 110.035 175.337 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -66.19 -25.24 66.84 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.308 -0.406 . . . . 3.22 111.438 -167.877 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.8 t -63.47 -15.73 58.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 117.789 -1.1 . . . . 1.58 112.891 175.419 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.38 -96.56 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 120.065 1.302 . . . . 2.91 108.664 170.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.72 50.65 0.42 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.739 -1.344 . . . . 0.97 109.739 177.856 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -135.92 175.03 9.97 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.351 1.06 . . . . 2.18 108.971 -170.826 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -141.01 140.89 34.38 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.254 -1.387 . . . . 4.87 107.254 173.824 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.54 159.7 18.55 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.476 0.655 . . . . 1.16 112.611 -173.108 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.4 133.86 10.8 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 125.03 1.332 . . . . 1.91 108.21 172.376 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 CA--C 1.534 0.335 0 CA-C-N 119.646 1.112 . . . . 2.45 110.19 173.419 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 106.465 -1.68 . . . . 9.91 106.465 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.32 154.52 24.46 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.945 -1.662 . . . . 6.05 108.945 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -72.67 174.25 7.85 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.075 1.75 . . . . 6.21 111.569 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.72 81.18 0.06 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.917 1.246 . . . . 1.98 111.236 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 p -75.54 123.47 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.784 -0.821 . . . . 2.18 108.784 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 tp -146.26 77.37 1.48 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.024 0.44 . . . . 2.82 110.412 -168.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -78.55 76.0 5.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.602 0.715 . . . . 4.23 110.101 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -78.91 156.9 28.38 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.922 0.889 . . . . 2.53 110.908 176.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.24 139.07 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.365 -1.717 . . . . 0.92 106.365 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.9 t -130.83 122.84 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 C-N-CA 126.844 2.058 . . . . 2.07 105.841 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.1 mtp-105 -117.75 164.25 15.28 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.828 1.251 . . . . 5.32 109.815 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.55 -6.88 77.79 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.206 0.908 . . . . 1.19 111.625 -171.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 30.3 mtm -72.81 69.64 0.94 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.189 0.996 . . . . 1.6 110.269 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -69.01 -16.77 63.8 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.165 1.172 . . . . 1.48 114.165 -166.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.0 p -160.53 173.77 15.05 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 120.205 1.366 . . . . 0.73 110.699 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.13 -40.18 45.41 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.991 0.916 . . . . 0.69 111.341 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 m -61.87 -27.41 68.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.625 0.77 . . . . 1.69 112.291 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.4 m -71.15 -61.72 1.66 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.913 -0.773 . . . . 0.67 108.913 164.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.6 t -45.42 -59.23 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.769 0.828 . . . . 0.72 111.572 -170.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.55 -28.32 68.44 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.58 -0.7 . . . . 0.77 112.01 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -70.55 -47.64 59.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.737 -0.838 . . . . 4.05 108.737 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.9 mt -54.09 -55.58 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 108.273 -1.01 . . . . 0.98 108.273 174.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -48.74 -66.98 0.31 Allowed 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 124.357 1.035 . . . . 3.99 110.174 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.4 t -54.83 -39.4 68.52 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.801 0.84 . . . . 0.89 110.88 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.7 t -66.59 -51.12 59.94 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.72 -0.844 . . . . 1.16 108.72 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -60.06 -43.5 95.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.383 -0.823 . . . . 2.54 111.301 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.5 m -59.44 -11.43 4.45 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.87 0.868 . . . . 2.12 112.813 176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -61.79 -35.38 78.0 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.905 -1.122 . . . . 5.65 111.426 167.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -59.57 135.03 57.54 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.308 -0.997 . . . . 2.98 108.308 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -26.54 61.65 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.143 0.883 . . . . 9.84 108.777 162.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.48 41.41 2.08 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 121.604 -0.685 . . . . 1.96 112.643 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 pp -146.17 150.74 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 105.643 -1.984 . . . . 2.58 105.643 172.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.3 mt -104.28 -25.7 12.78 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 123.306 0.379 . . . . 2.05 111.381 167.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -156.34 152.92 28.22 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 118.668 0.667 . . . . 2.38 109.378 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.7 t -143.95 128.24 17.79 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.248 1.019 . . . . 2.27 109.25 164.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.1 t -135.5 92.92 2.89 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.191 1.396 . . . . 1.47 108.708 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.35 152.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 126.009 1.724 . . . . 1.98 111.563 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.23 129.31 8.81 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.705 0.402 . . . . 0.72 110.973 171.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 pp -76.07 -10.25 59.27 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.688 0.795 . . . . 1.32 112.787 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.99 -54.9 17.27 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.025 -0.731 . . . . 1.15 109.025 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -27.38 40.58 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.615 0.766 . . . . 2.09 110.812 174.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 71.13 57.81 0.2 Allowed 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 125.352 1.461 . . . . 1.49 107.964 -169.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.44 170.42 15.74 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 112.484 0.549 . . . . 2.3 112.484 -169.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.72 100.17 3.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.631 1.972 . . . . 0.87 109.317 174.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -77.34 82.49 3.8 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 105.307 -2.109 . . . . 1.22 105.307 169.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 pt -85.3 147.63 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-N 114.486 -1.234 . . . . 3.08 108.322 166.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -113.33 104.7 12.58 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 103.54 -2.763 . . . . 3.17 103.54 157.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -98.46 135.47 39.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 124.168 0.917 . . . . 2.56 109.282 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.92 120.38 81.34 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 123.716 0.806 . . . . 3.22 109.221 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.07 2.68 7.8 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.1 1.867 . . . . 1.87 114.524 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -86.55 -43.01 13.04 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 121.414 1.916 . . . . 5.59 109.073 167.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.2 mm -88.15 -46.31 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 112.074 0.398 . . . . 3.12 112.074 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mm -120.71 146.32 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.921 -1.14 . . . . 1.61 107.921 -162.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.0 160.92 12.86 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 108.999 -1.641 . . . . 1.33 108.999 165.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -53.15 -38.38 80.97 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.828 2.352 . . . . 1.62 111.221 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -41.04 20.71 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.565 0.746 . . . . 8.13 111.658 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -66.43 -50.61 62.82 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.105 0.866 . . . . 2.14 109.481 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.1 mp -54.05 -47.05 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mt -55.87 -51.89 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 119.206 -0.426 . . . . 1.38 109.955 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -52.6 -42.75 64.83 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.612 0.642 . . . . 3.4 110.672 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 35.0 m -63.67 -54.84 29.3 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.348 -0.612 . . . . 0.82 109.348 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.462 HG23 ' HB2' ' A' ' 67' ' ' PHE . 49.3 mt -48.05 -49.59 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.528 1.531 . . . . 1.47 111.042 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -59.55 -49.77 76.5 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.182 0.993 . . . . 2.05 110.483 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.2 t -62.57 -22.82 66.64 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 118.201 -0.904 . . . . 1.44 112.542 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.26 -102.43 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.195 -1.039 . . . . 2.54 108.195 160.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.46 39.22 0.48 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.313 -0.715 . . . . 0.79 111.386 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.462 ' HB2' HG23 ' A' ' 62' ' ' ILE . 32.0 m-85 -128.25 171.37 12.03 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.937 0.869 . . . . 1.66 110.393 -167.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.12 166.15 21.73 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.523 1.129 . . . . 3.11 108.55 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.43 161.8 40.91 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.549 0.613 . . . . 1.12 111.998 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.9 m -156.59 131.54 9.04 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.091 1.356 . . . . 1.61 109.787 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.2 mp -69.35 106.34 2.89 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.229 -1.026 . . . . 3.14 108.229 173.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -62.78 -48.12 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.671 -0.863 . . . . 2.81 108.671 170.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.72 71.39 2.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.697 0.799 . . . . 4.71 109.192 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.3 mm -61.43 -79.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.193 -1.04 . . . . 8.6 108.193 171.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 117.479 -1.248 . . . . 10.77 109.031 179.245 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.8 mtt . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.075 0.464 . . . . 11.08 110.57 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.59 39.53 0.08 OUTLIER Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.055 -1.618 . . . . 4.07 109.055 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -148.81 26.52 0.91 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.489 1.916 . . . . 7.65 109.257 -152.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.31 86.68 1.53 Allowed Glycine 0 N--CA 1.446 -0.647 0 O-C-N 121.918 -0.489 . . . . 2.19 113.14 -162.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.3 p -145.77 137.91 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 117.582 0.691 . . . . 2.23 110.178 170.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.5 tp -148.37 119.3 7.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.543 -0.91 . . . . 2.15 108.543 167.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -108.4 121.51 45.09 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.947 -1.501 . . . . 2.94 106.947 167.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -131.02 146.13 52.28 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.629 -0.878 . . . . 2.34 108.629 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -76.22 135.5 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 104.595 -2.372 . . . . 0.75 104.595 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.4 t -125.21 115.92 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 105.088 -2.19 . . . . 1.98 105.088 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -108.44 153.3 23.51 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.779 0.431 . . . . 6.15 110.115 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.24 -5.51 55.62 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.651 1.12 . . . . 1.05 111.985 -171.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 38.1 mtm -74.17 66.94 1.3 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.512 1.156 . . . . 1.65 110.677 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -68.88 -15.3 63.46 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.267 1.21 . . . . 1.62 114.267 -164.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.9 p -160.1 173.05 16.39 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 120.289 1.404 . . . . 0.72 110.508 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.54 -37.21 38.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.864 0.866 . . . . 0.81 111.326 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 t -61.08 -29.27 69.64 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 118.867 -0.587 . . . . 1.87 111.523 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.4 m -71.67 -57.08 4.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.89 0.768 . . . . 0.85 109.551 168.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.9 t -49.6 -60.46 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.472 0.709 . . . . 0.89 111.451 -172.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.86 -29.2 69.05 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.621 -0.674 . . . . 0.84 111.568 -175.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -65.28 -48.35 73.49 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.386 -0.968 . . . . 3.01 108.386 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 79.4 mt -55.4 -55.64 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 108.668 -0.864 . . . . 0.65 108.668 174.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -54.99 -49.95 70.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.425 0.631 . . . . 3.49 110.87 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -56.55 -48.96 76.18 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.885 0.874 . . . . 0.85 110.682 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.3 m -61.65 -42.13 98.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.7 -0.625 . . . . 2.09 110.539 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.495 HD11 HG23 ' A' ' 58' ' ' ILE . 1.7 mm? -63.64 -54.19 39.69 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.844 1.258 . . . . 2.45 110.671 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.0 p -59.17 -18.59 37.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.151 0.426 . . . . 2.03 112.151 -173.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -50.24 -41.88 50.85 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.271 -0.871 . . . . 4.65 113.008 166.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.6 m80 -67.44 163.73 20.28 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.34 0.973 . . . . 2.26 111.661 -170.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.01 -29.13 11.11 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.391 0.677 . . . . 6.42 112.021 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.57 -14.76 77.57 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 119.918 -0.379 . . . . 1.16 112.491 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -77.86 149.93 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 117.782 0.791 . . . . 2.91 109.113 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 36.6 tp -109.08 -42.89 4.3 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.521 1.928 . . . . 3.55 108.708 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -155.79 163.88 39.27 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.22 0.464 . . . . 2.14 110.949 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.7 t -144.19 118.81 9.77 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 127.084 2.154 . . . . 2.14 106.846 174.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.97 96.74 5.14 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.204 -1.406 . . . . 1.63 107.204 175.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -107.64 141.32 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.23 0.612 . . . . 2.23 111.294 -174.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.47 125.72 9.34 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 123.729 0.811 . . . . 0.76 111.377 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.61 -15.04 60.39 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.522 1.129 . . . . 1.45 112.236 172.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.2 -51.7 68.64 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.012 -0.736 . . . . 1.24 109.012 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.87 -45.28 18.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.625 -0.88 . . . . 2.03 108.625 171.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 83.92 52.9 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 127.696 2.398 . . . . 2.48 107.39 -163.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.61 160.24 40.56 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 122.501 0.32 . . . . 2.36 110.705 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.12 120.06 30.35 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.61 -1.255 . . . . 0.64 107.61 168.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -93.86 94.44 8.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.863 -1.903 . . . . 1.18 105.863 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.45 152.22 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 107.58 -1.267 . . . . 1.57 107.58 174.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -131.95 134.14 45.3 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.416 -2.439 . . . . 2.23 104.416 159.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -161.65 153.69 19.47 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.066 1.346 . . . . 2.49 107.39 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -80.91 124.2 81.65 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 119.044 0.838 . . . . 3.41 109.732 170.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -63.59 -21.17 70.39 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.995 2.463 . . . . 1.8 115.467 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -79.33 -45.59 19.34 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.991 1.269 . . . . 3.67 108.758 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.2 mt -71.71 -38.83 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 120.724 -0.39 . . . . 3.15 111.482 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.48 122.9 45.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 N-CA-C 106.029 -1.841 . . . . 1.56 106.029 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.02 168.29 44.82 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.187 -1.165 . . . . 0.8 110.187 172.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -59.58 -43.08 41.72 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.116 1.878 . . . . 1.08 109.564 170.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -46.0 35.86 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.039 1.335 . . . . 5.75 112.455 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.06 -55.59 31.05 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.864 0.756 . . . . 2.46 110.148 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.495 HG23 HD11 ' A' ' 26' ' ' LEU . 37.6 mt -63.21 -54.37 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.12 -0.491 . . . . 0.78 109.745 -174.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.8 mt -49.52 -50.03 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.219 -0.66 . . . . 1.26 109.219 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -70.04 -29.21 66.19 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.622 -0.674 . . . . 4.41 111.813 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.2 m -61.88 -47.27 85.73 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.309 -0.997 . . . . 0.79 108.309 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' A' ' 67' ' ' PHE . 78.7 mt -57.37 -43.0 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.234 1.014 . . . . 1.22 111.006 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -57.21 -57.13 13.97 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 109.181 -0.674 . . . . 2.61 109.181 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -55.38 -42.44 73.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.168 1.387 . . . . 1.4 111.144 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.9 mt -61.75 -82.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.565 0.346 . . . . 2.17 111.241 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.66 17.85 0.17 Allowed Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.356 -1.247 . . . . 0.74 114.621 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.441 ' HB2' HG23 ' A' ' 62' ' ' ILE . 25.5 m-85 -137.4 175.13 9.88 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 119.352 1.576 . . . . 2.17 110.916 -153.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -126.44 161.28 28.28 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 107.65 -1.241 . . . . 3.34 107.65 172.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.02 160.03 40.94 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 112.325 0.491 . . . . 0.91 112.325 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 m -155.79 146.59 22.16 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.845 1.658 . . . . 1.96 107.613 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.3 mt -59.24 151.83 22.15 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.775 0.716 . . . . 2.5 111.187 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.1 120.59 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 108.272 -1.01 . . . . 3.7 108.272 174.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -167.6 -53.77 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.606 1.562 . . . . 5.3 109.966 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.1 mt -77.33 -71.9 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 106.2 -1.778 . . . . 5.91 106.2 174.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 . . . . . 0 C--O 1.256 1.411 0 CA-C-O 117.191 -1.385 . . . . 10.13 108.151 156.247 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 108.399 -0.963 . . . . 7.89 108.399 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -54.35 -54.82 29.91 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 108.789 -1.724 . . . . 5.58 108.789 165.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.25 -176.82 4.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.691 1.596 . . . . 5.33 107.247 156.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.38 141.62 12.7 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.08 -1.608 . . . . 1.64 109.08 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.96 148.82 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 O-C-N 122.162 -0.61 . . . . 2.05 110.152 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.2 tp -151.43 159.63 44.12 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.077 -1.083 . . . . 3.13 108.077 162.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -141.65 117.29 10.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.43 -1.693 . . . . 4.15 106.43 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.6 mt -118.58 142.43 47.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.33 1.452 . . . . 2.98 107.184 -177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.48 129.69 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.098 -1.816 . . . . 1.14 106.098 163.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.2 t -117.79 102.85 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 126.099 1.76 . . . . 1.96 106.964 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -96.08 134.57 38.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.653 1.581 . . . . 6.87 108.134 -172.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.43 -9.41 38.47 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.307 0.956 . . . . 1.06 112.455 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.4 ttp -70.08 69.76 0.35 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.252 1.821 . . . . 1.77 109.831 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 t -79.42 -2.59 42.58 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.281 1.585 . . . . 1.63 115.281 -159.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -159.62 164.48 34.09 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.052 1.296 . . . . 1.22 110.892 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.61 -39.81 51.08 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.326 1.05 . . . . 0.7 110.306 173.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -46.59 -43.97 17.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.16 1.384 . . . . 1.59 111.676 171.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . 0.258 73.5 m -72.61 -48.19 41.61 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 118.408 -0.806 . . . . 1.08 113.159 173.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.9 t -41.83 -66.31 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.514 0.726 . . . . 0.95 110.65 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -31.07 67.59 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 119.906 -0.717 . . . . 0.79 112.436 -172.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -58.03 -54.4 47.36 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.703 0.683 . . . . 3.4 109.436 173.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.5 mt -50.61 -61.57 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 108.445 -0.946 . . . . 0.69 108.445 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -55.37 -55.88 26.52 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.066 0.46 . . . . 3.24 111.766 -173.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -54.03 -43.77 70.42 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.023 0.929 . . . . 0.79 110.443 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -68.07 -55.25 13.21 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.177 -1.046 . . . . 1.22 108.177 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -57.87 -43.35 85.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.052 -0.405 . . . . 2.72 111.884 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.9 m -57.24 -16.91 9.45 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.238 0.459 . . . . 1.91 112.238 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.35 -41.66 63.24 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.134 -0.979 . . . . 6.04 111.187 168.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -86.87 109.04 19.04 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.82 -0.807 . . . . 2.21 108.82 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.3 mtm105 -52.76 -21.8 4.54 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.584 0.957 . . . . 6.89 113.584 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -52.19 -37.07 46.02 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.385 -0.675 . . . . 0.88 112.081 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.5 129.28 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.959 -1.126 . . . . 2.52 107.959 170.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.38 -44.85 8.48 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.607 -0.886 . . . . 3.84 108.607 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -142.09 144.18 33.42 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.562 -0.533 . . . . 2.07 109.562 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.5 p -131.08 144.43 51.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.333 1.853 . . . . 2.3 106.767 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -152.11 83.35 1.26 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.772 -1.195 . . . . 1.55 107.772 -166.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 m -101.85 153.38 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 123.868 0.867 . . . . 1.6 111.077 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.36 136.16 13.58 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.478 -0.564 . . . . 0.93 109.478 173.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -81.42 -11.42 59.26 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.459 1.104 . . . . 1.35 112.697 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.07 -49.51 77.07 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.158 -0.682 . . . . 1.14 109.158 173.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -86.01 -40.33 15.92 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.154 0.582 . . . . 2.59 109.597 171.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 80.89 61.79 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 127.25 2.22 . . . . 2.66 107.415 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.32 166.31 25.11 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 123.065 0.546 . . . . 2.29 110.187 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.24 110.6 11.23 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 127.288 2.235 . . . . 0.63 106.862 163.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -86.3 134.9 33.71 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.301 -2.111 . . . . 0.91 105.301 162.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.8 pt -139.18 151.63 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 124.682 1.193 . . . . 3.4 107.82 -172.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -139.28 99.84 3.85 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 102.591 -3.115 . . . . 2.95 102.591 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -145.11 142.24 29.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.221 1.409 . . . . 2.02 108.801 -162.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -80.3 119.69 77.19 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 108.848 -0.797 . . . . 2.82 108.848 175.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.63 -32.8 47.25 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.47 1.447 . . . . 2.03 111.909 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.2 44.67 0.42 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.914 0.779 . . . . 3.72 112.42 -175.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -172.49 -38.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.886 1.674 . . . . 3.44 110.25 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 tt -138.05 118.63 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.318 -1.364 . . . . 1.6 107.318 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.29 156.28 53.31 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.196 -1.562 . . . . 0.83 109.196 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -53.88 -45.39 41.37 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.527 1.484 . . . . 1.29 109.197 171.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -50.96 -37.73 46.38 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 112.268 0.47 . . . . 6.89 112.268 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.15 -40.37 74.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.099 0.863 . . . . 2.73 109.522 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.8 mt -57.98 -46.77 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 118.841 -0.599 . . . . 0.73 109.933 170.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.7 mm -51.73 -57.73 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.825 0.739 . . . . 1.83 110.081 173.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -50.14 -43.34 51.95 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.285 1.034 . . . . 4.03 110.541 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.9 m -64.48 -49.6 70.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.756 -0.461 . . . . 1.12 109.756 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.555 HG21 ' HB2' ' A' ' 69' ' ' ALA . 1.1 mt -53.69 -47.32 61.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.261 0.624 . . . . 1.27 111.324 176.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -58.27 -51.91 67.81 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.169 0.588 . . . . 2.23 109.7 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.8 t -52.16 -48.25 65.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.768 0.827 . . . . 1.18 110.905 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.4 -60.01 4.17 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.939 -0.476 . . . . 2.17 111.032 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.66 -42.02 0.02 OUTLIER Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.091 1.196 . . . . 1.7 116.091 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -118.01 164.85 14.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 117.642 0.721 . . . . 1.73 112.769 -136.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.81 98.92 10.25 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.983 -1.488 . . . . 4.47 106.983 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.555 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -83.32 139.95 32.74 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.811 -0.44 . . . . 1.27 109.811 169.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.0 t -144.21 128.94 18.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.596 -1.631 . . . . 2.06 106.596 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -60.97 161.91 7.7 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 119.675 -0.81 . . . . 3.56 109.148 159.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.5 p -159.89 95.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 106.454 -1.684 . . . . 2.78 106.454 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -147.26 -64.58 0.27 Allowed 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 105.397 -2.075 . . . . 4.99 105.397 173.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.6 tp -73.16 150.47 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.688 -1.597 . . . . 7.31 106.688 144.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 C--O 1.256 1.404 0 N-CA-C 103.989 -2.597 . . . . 11.94 103.989 159.18 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.0 mtp . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 107.836 -1.172 . . . . 10.92 107.836 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.12 32.82 77.21 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 109.323 -1.511 . . . . 3.76 109.323 -160.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.99 123.04 18.75 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.18 1.392 . . . . 4.94 109.535 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.64 107.94 2.24 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 108.269 -1.932 . . . . 1.69 108.269 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 p -78.66 120.75 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.432 -1.321 . . . . 2.03 107.432 168.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.16 112.85 12.08 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.019 -1.104 . . . . 3.05 108.019 -172.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -88.01 113.21 23.43 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.76 -1.2 . . . . 3.5 107.76 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -101.24 150.46 22.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.686 -0.857 . . . . 2.5 108.686 166.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 t -81.82 139.82 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 105.107 -2.183 . . . . 0.87 105.107 151.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.65 133.04 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.377 -1.712 . . . . 2.27 106.377 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 mtp85 -129.09 158.68 38.26 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.697 0.799 . . . . 6.0 109.411 -176.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.92 -18.91 55.72 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.727 0.68 . . . . 1.13 112.055 -174.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -74.57 69.48 1.72 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.198 0.999 . . . . 1.4 111.229 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.1 t -62.05 -17.23 56.75 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 116.028 1.862 . . . . 1.52 116.028 -162.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.5 p -160.74 -179.92 8.0 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 121.306 1.866 . . . . 0.66 112.502 -172.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.5 -44.19 35.74 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.714 1.206 . . . . 0.62 111.413 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.6 m -63.99 -22.71 67.04 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.814 0.845 . . . . 1.48 112.322 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.3 m -73.64 -64.18 1.05 Allowed 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.524 -0.735 . . . . 0.69 110.733 161.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.7 t -38.08 -64.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.945 1.298 . . . . 0.93 112.12 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -65.11 -29.39 70.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.621 -0.431 . . . . 0.99 111.194 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -70.67 -46.55 62.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.682 -0.859 . . . . 3.22 108.682 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.3 mt -54.85 -58.32 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.702 -0.851 . . . . 0.82 108.702 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -59.29 -53.71 55.15 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.642 0.258 . . . . 3.51 111.477 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.5 t -53.86 -45.6 71.04 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.975 -0.453 . . . . 0.76 110.629 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 t -66.07 -50.85 62.69 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.955 -1.128 . . . . 1.19 107.955 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.0 mt -48.57 -51.68 26.59 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.915 0.486 . . . . 2.88 111.376 176.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.4 p -57.81 -14.43 5.92 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.609 0.966 . . . . 2.25 113.609 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -28.37 68.3 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.415 1.007 . . . . 4.22 112.39 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -90.37 104.97 17.49 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 107.755 -1.202 . . . . 1.73 107.755 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -26.25 9.43 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.28 -0.888 . . . . 8.91 111.669 172.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -48.89 -40.64 27.24 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.103 -0.832 . . . . 0.9 112.811 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.83 123.3 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.513 -1.662 . . . . 2.43 106.513 171.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.3 tp -79.93 -38.05 33.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.574 1.15 . . . . 3.27 109.163 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -151.32 154.29 36.45 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.651 -0.5 . . . . 1.84 109.651 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.4 p -133.96 147.7 51.07 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 125.184 1.394 . . . . 2.53 108.827 169.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.4 t -155.02 99.64 2.12 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.695 1.598 . . . . 1.51 107.097 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 m -91.82 167.87 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 122.627 0.371 . . . . 1.68 110.405 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.5 131.68 10.17 Favored 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 121.879 -0.513 . . . . 0.8 110.866 165.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.8 mt -49.8 -50.8 43.58 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 124.488 1.115 . . . . 2.02 108.684 159.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.64 -53.6 17.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.802 0.841 . . . . 1.58 112.113 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.52 -2.42 54.37 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.037 0.935 . . . . 2.02 111.996 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m120 50.02 39.69 19.54 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 125.047 1.339 . . . . 1.98 110.33 -166.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.61 170.38 8.36 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 120.983 0.42 . . . . 2.53 111.257 -167.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -151.31 97.07 2.37 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 126.64 1.976 . . . . 0.67 108.113 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -79.48 106.09 11.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.708 -2.33 . . . . 1.34 104.708 165.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.77 145.52 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 105.256 -2.127 . . . . 1.58 105.256 163.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.2 mtmt -114.52 129.41 56.66 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.937 -1.875 . . . . 2.87 105.937 158.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -138.03 144.6 41.1 Favored 'General case' 0 C--N 1.338 0.089 0 CA-C-N 118.745 0.702 . . . . 2.53 111.607 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -75.44 117.82 66.17 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 107.36 -1.348 . . . . 3.83 107.36 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -80.67 56.36 6.05 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.202 3.268 . . . . 2.07 112.014 -165.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -145.61 -53.74 0.28 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.536 1.934 . . . . 3.69 107.55 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.8 mt -74.43 -33.26 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.411 1.084 . . . . 2.74 110.738 -172.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.6 tt -147.39 138.37 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.432 -1.322 . . . . 1.71 107.432 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.45 168.23 27.97 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.359 0.981 . . . . 0.86 111.66 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.08 -43.45 15.24 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.788 2.325 . . . . 1.01 109.534 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -54.29 -44.19 71.72 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 122.479 0.312 . . . . 6.13 110.405 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -63.98 -47.21 81.29 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.343 -0.614 . . . . 2.65 109.343 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.9 mt -52.79 -52.48 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 O-C-N 122.015 -0.428 . . . . 0.69 110.153 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.4 mt -54.25 -53.31 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 122.053 -0.404 . . . . 1.2 110.177 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.4 -32.76 67.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.219 0.608 . . . . 4.48 111.265 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.5 m -65.2 -49.47 69.61 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.067 -1.021 . . . . 1.07 108.45 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.0 mt -54.62 -41.41 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.703 0.801 . . . . 1.33 110.692 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -57.62 -54.98 40.76 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.207 0.458 . . . . 2.3 110.364 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.5 m -57.53 -29.16 64.13 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.231 1.012 . . . . 2.22 112.465 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.7 -89.42 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.882 -0.785 . . . . 2.4 108.882 166.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.47 25.0 0.24 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-O 118.517 -1.157 . . . . 0.89 113.955 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.75 175.57 9.07 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.011 1.406 . . . . 2.19 112.596 -153.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -112.58 149.7 32.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.299 -1.741 . . . . 3.78 106.299 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.18 161.49 41.19 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.989 0.813 . . . . 1.25 111.68 166.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.0 t -151.75 149.32 28.92 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.543 -1.651 . . . . 3.33 106.543 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -53.46 144.43 16.95 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.95 -0.759 . . . . 2.77 108.95 162.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.6 p -125.92 130.74 72.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 109.646 -0.501 . . . . 3.42 109.646 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.73 -50.32 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.235 1.014 . . . . 4.32 108.838 174.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.4 mt -81.88 104.87 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.063 -1.458 . . . . 6.53 107.063 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 C--O 1.255 1.356 0 N-CA-C 104.84 -2.281 . . . . 11.35 104.84 172.692 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.404 ' H2 ' ' CG ' ' A' ' 3' ' ' ASP . 56.6 mtt . . . . . 0 N--CA 1.473 0.675 0 N-CA-C 106.694 -1.595 . . . . 8.84 106.694 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.98 21.71 73.63 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 123.652 0.595 . . . . 3.57 111.76 -171.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.404 ' CG ' ' H2 ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -85.34 65.72 9.34 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.447 -1.031 . . . . 6.07 108.844 -170.012 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.98 113.21 5.66 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.567 -1.413 . . . . 1.57 109.567 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.08 141.8 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 107.97 -1.122 . . . . 2.12 107.97 173.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -150.8 148.54 28.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.277 -0.638 . . . . 2.67 109.277 164.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -93.48 127.3 39.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.077 -1.823 . . . . 3.16 106.077 152.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.416 HD11 ' HB3' ' A' ' 44' ' ' ALA . 4.1 pp -107.32 151.18 25.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.384 -1.339 . . . . 2.54 107.384 164.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.61 143.93 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 104.831 -2.285 . . . . 1.28 104.831 161.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 p -141.78 133.51 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 124.007 0.923 . . . . 2.26 108.545 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -134.87 165.53 25.1 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.22 1.408 . . . . 7.1 109.065 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.09 -39.38 2.78 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.12 0.867 . . . . 1.48 111.378 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.407 ' SD ' HD12 ' A' ' 22' ' ' ILE . 13.0 ptt? -67.34 65.27 0.07 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.4 1.48 . . . . 1.92 112.88 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -71.62 19.1 0.07 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.117 1.525 . . . . 1.77 115.117 -165.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -166.57 158.57 13.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.589 1.086 . . . . 1.14 110.187 177.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.24 -37.41 35.5 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.152 0.981 . . . . 0.91 111.12 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.7 p -58.16 -33.21 68.96 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.727 0.411 . . . . 1.89 111.425 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . 0.259 72.6 m -75.77 -44.71 40.21 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 120.819 -1.176 . . . . 1.61 113.676 168.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.7 t -50.01 -60.03 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.168 0.44 . . . . 0.92 110.738 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -25.44 63.05 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.445 -0.784 . . . . 1.07 112.159 -176.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.16 -51.86 67.26 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 108.562 -0.903 . . . . 3.81 108.562 173.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.407 HD12 ' SD ' ' A' ' 13' ' ' MET . 64.3 mt -52.58 -60.8 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 108.447 -0.946 . . . . 0.79 108.447 172.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -53.09 -56.45 16.16 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.336 0.589 . . . . 3.27 110.605 -170.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.1 t -56.09 -48.37 76.25 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.916 1.286 . . . . 0.84 111.103 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.8 t -64.64 -57.82 8.01 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.04 -0.726 . . . . 1.29 109.04 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.3 tp -54.21 -49.12 70.13 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.336 1.454 . . . . 2.46 111.111 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.5 p -59.47 -12.76 6.75 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.601 0.963 . . . . 2.24 113.601 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -24.88 66.77 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.889 1.222 . . . . 4.82 112.322 175.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -80.67 130.77 35.29 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.44 0.564 . . . . 2.33 109.653 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -58.31 151.85 18.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.461 -0.94 . . . . 6.39 108.461 169.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.24 -27.82 15.44 Favored Glycine 0 C--O 1.224 -0.495 0 N-CA-C 111.035 -0.826 . . . . 1.02 111.035 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.1 mm -79.22 121.19 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 119.138 1.469 . . . . 4.08 107.217 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.3 mt -94.99 -44.59 7.63 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.125 -0.695 . . . . 1.87 109.125 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -153.49 153.63 32.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.199 -0.667 . . . . 2.52 109.199 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.5 m -138.75 132.97 31.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 105.481 -2.044 . . . . 2.29 105.481 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -134.87 89.67 2.56 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 105.88 -1.896 . . . . 1.93 105.88 166.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 p -97.94 137.61 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.309 1.043 . . . . 2.39 111.156 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 134.07 21.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.811 0.845 . . . . 0.87 111.091 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 pp -72.05 -34.38 68.71 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 124.661 1.185 . . . . 2.03 110.672 170.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.64 -32.47 42.11 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.648 0.779 . . . . 1.34 111.674 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -120.55 11.79 11.4 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.801 1.24 . . . . 2.56 111.496 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.0 m120 35.32 52.08 0.65 Allowed 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.887 1.675 . . . . 2.12 112.778 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.23 151.97 40.18 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.117 -0.698 . . . . 3.47 109.117 -171.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.416 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -133.97 118.26 17.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.758 -0.83 . . . . 0.66 108.758 170.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -84.76 106.16 16.09 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.135 -1.802 . . . . 1.02 106.135 170.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.2 mp -106.95 136.3 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.792 -1.558 . . . . 1.73 106.792 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -116.09 140.2 49.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.458 -1.682 . . . . 2.93 106.458 163.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -158.69 161.04 37.06 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.724 0.81 . . . . 1.71 110.013 -167.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -87.78 110.94 38.86 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 107.122 -1.436 . . . . 4.04 107.122 173.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.23 59.23 7.3 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.088 3.192 . . . . 2.04 110.799 -168.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -167.26 -46.72 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.53 1.532 . . . . 2.9 108.857 -173.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.2 mm -65.96 -39.18 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.517 -0.549 . . . . 2.51 109.517 170.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.07 154.73 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 105.835 -1.913 . . . . 1.29 105.835 -175.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -116.77 174.22 15.11 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.875 1.226 . . . . 1.06 112.145 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.15 -39.38 31.31 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.231 2.621 . . . . 1.07 110.413 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -47.57 -56.65 6.69 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.804 0.842 . . . . 7.27 110.368 170.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.0 -54.85 29.11 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.716 -0.475 . . . . 2.28 109.716 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.3 mt -52.69 -60.16 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.059 0.544 . . . . 0.79 111.149 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.8 mt -52.11 -51.79 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 C-N-CA 123.715 0.806 . . . . 1.2 110.133 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -68.08 -33.33 74.34 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.215 -0.448 . . . . 4.25 111.07 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.9 m -60.88 -46.62 89.9 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 108.091 -1.077 . . . . 0.77 108.091 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.505 HG21 ' HB2' ' A' ' 69' ' ' ALA . 19.2 mt -56.25 -58.15 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.263 -0.643 . . . . 1.31 109.263 173.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -53.99 -43.77 70.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.913 0.387 . . . . 2.35 110.356 -168.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.5 m -62.74 -15.62 53.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.356 1.462 . . . . 2.53 114.125 -172.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.97 -83.27 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.885 -1.154 . . . . 3.02 107.885 170.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.03 42.62 0.48 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.476 -1.449 . . . . 1.25 109.476 166.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -126.88 176.65 7.14 Favored 'General case' 0 CA--C 1.524 -0.04 0 CA-C-N 117.311 0.555 . . . . 2.18 111.328 -159.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.36 145.52 47.81 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 104.923 -2.251 . . . . 4.82 104.923 170.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.505 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -149.44 146.0 27.21 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 123.688 0.617 . . . . 1.93 111.036 165.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t -155.57 131.0 9.63 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.831 -0.433 . . . . 3.07 109.831 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -53.73 140.38 29.79 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.165 0.986 . . . . 2.36 111.627 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.84 154.36 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.363 0.665 . . . . 3.28 110.002 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -167.35 173.04 9.19 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.744 -1.947 . . . . 5.98 105.744 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.0 170.04 18.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.851 -1.537 . . . . 6.92 106.851 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 . . . . . 0 C--O 1.256 1.438 0 N-CA-C 104.445 -2.428 . . . . 9.31 104.445 170.703 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 107.388 -1.338 . . . . 8.62 107.388 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.4 112.6 1.99 Allowed Glycine 0 CA--C 1.526 0.727 1 N-CA-C 102.66 -4.176 . . . . 4.45 102.66 -135.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 148.07 177.67 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 128.552 2.741 . . . . 5.26 107.609 -145.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.81 175.02 35.18 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.932 -1.267 . . . . 2.1 109.932 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.31 130.6 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.028 -1.471 . . . . 2.34 107.028 170.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.3 tp -124.65 139.62 53.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.025 -1.472 . . . . 2.53 107.025 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.41 143.24 48.77 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.64 -1.244 . . . . 4.39 107.64 176.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.47 HD23 ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -156.78 150.09 24.22 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.122 0.969 . . . . 2.8 108.931 176.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.35 112.35 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 104.186 -2.524 . . . . 0.97 104.186 169.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.82 142.73 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.158 -1.423 . . . . 2.66 107.158 162.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -131.84 166.05 22.47 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.254 -0.647 . . . . 6.1 109.254 167.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.63 -38.72 3.18 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 121.757 -0.59 . . . . 1.13 112.252 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.04 77.36 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.418 1.487 . . . . 2.99 111.93 176.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.4 t -74.52 -16.95 60.82 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 115.069 1.507 . . . . 1.58 115.069 -161.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 p -158.36 176.44 12.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 120.605 1.548 . . . . 0.65 111.747 -172.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.62 -46.15 9.96 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.288 1.435 . . . . 0.61 111.464 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 m -61.98 -30.67 71.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.679 0.792 . . . . 1.53 112.271 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.3 m -72.88 -56.69 4.83 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.862 0.756 . . . . 0.64 110.333 166.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.4 t -42.8 -61.71 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.593 1.157 . . . . 0.81 111.39 -176.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.99 -28.26 67.28 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 120.046 -0.662 . . . . 0.83 111.692 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -64.86 -48.53 73.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.301 -0.999 . . . . 2.84 108.301 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.7 mt -53.98 -63.48 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.64 -0.874 . . . . 0.69 108.64 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -52.95 -50.43 64.06 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.174 0.443 . . . . 3.83 111.729 -173.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.0 t -55.97 -46.79 78.51 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.4 1.08 . . . . 0.76 111.317 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.2 p -69.02 -37.43 78.65 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.695 -0.628 . . . . 2.31 110.098 -173.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.7 mp -72.2 -48.25 44.48 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.748 1.219 . . . . 2.63 111.631 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 t -71.88 65.36 0.53 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 123.325 1.536 . . . . 2.66 112.027 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.61 -23.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.635 2.774 . . . . 4.75 111.935 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -60.51 -14.38 19.36 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.169 1.174 . . . . 2.95 114.169 176.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? 70.83 -54.35 0.66 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.402 1.881 . . . . 6.14 110.843 -171.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.94 -32.14 55.84 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 117.953 0.342 . . . . 1.14 112.32 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 38.5 mt -79.37 104.88 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.23 -1.396 . . . . 4.15 107.23 167.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.2 mt -78.98 -28.12 43.49 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.152 0.581 . . . . 1.71 109.648 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -156.71 157.2 34.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.414 -0.958 . . . . 2.04 108.414 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.6 p -138.59 140.28 38.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.024 1.73 . . . . 2.6 107.136 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.9 t -146.99 101.3 3.41 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.836 -1.542 . . . . 1.54 106.836 169.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 44' ' ' ALA . 2.2 p -100.72 152.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 124.294 1.038 . . . . 2.75 109.848 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.05 127.51 7.89 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 121.66 -0.65 . . . . 0.76 111.328 170.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.48 -28.69 68.07 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.419 0.687 . . . . 1.7 110.714 162.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.44 -49.77 69.23 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 120.97 0.414 . . . . 1.19 110.001 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.36 -35.11 25.38 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.17 0.588 . . . . 2.08 111.096 173.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.26 76.04 0.36 Allowed 'General case' 0 C--N 1.344 0.339 0 N-CA-C 106.926 -1.509 . . . . 2.03 106.926 -151.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.62 163.13 39.26 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.02 0.528 . . . . 2.63 109.89 177.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.457 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -146.15 94.12 2.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.889 1.276 . . . . 0.78 109.916 169.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -77.99 104.19 8.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 105.967 -1.864 . . . . 1.02 105.967 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.457 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -106.69 115.61 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 105.923 -1.88 . . . . 1.78 105.923 174.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -82.03 75.46 8.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.793 -1.188 . . . . 3.63 107.793 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.67 161.44 23.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.055 -0.521 . . . . 2.9 110.794 170.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -104.85 133.49 20.13 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 107.227 -1.397 . . . . 3.22 107.227 142.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.57 -31.79 59.65 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.138 2.558 . . . . 2.14 114.472 -171.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -81.19 -43.37 19.4 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 120.473 1.488 . . . . 2.97 110.251 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 tp -73.42 -26.19 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 118.85 -0.595 . . . . 2.73 111.459 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.1 tt -148.09 124.27 2.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-N 120.171 1.351 . . . . 1.61 109.96 167.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.08 159.56 49.24 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 109.67 -1.372 . . . . 0.89 109.67 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -58.85 -39.89 77.21 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.087 1.858 . . . . 1.08 109.247 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -41.65 -48.55 4.12 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.214 1.406 . . . . 8.98 111.007 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -72.31 -45.11 61.4 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.0 0.92 . . . . 2.31 109.539 -169.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.2 mt -54.04 -50.55 53.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.037 -0.727 . . . . 0.62 109.037 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.4 mt -55.48 -52.42 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 119.582 -0.247 . . . . 1.11 110.467 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -52.25 -39.67 60.65 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.476 0.71 . . . . 3.44 110.861 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 31.1 m -64.83 -50.46 66.57 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.238 -0.652 . . . . 0.71 109.238 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.4 mt -55.06 -48.26 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.21 1.004 . . . . 1.26 110.579 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -56.32 -57.12 13.6 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.59 0.756 . . . . 2.14 110.492 173.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.8 t -51.02 -43.6 60.88 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.813 1.245 . . . . 1.5 110.895 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.63 -73.7 0.08 Allowed 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.359 -0.213 . . . . 2.17 110.44 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.41 -5.52 0.05 OUTLIER Glycine 0 CA--C 1.529 0.948 0 N-CA-C 117.41 1.724 . . . . 1.18 117.41 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -131.33 172.21 12.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.758 1.779 . . . . 1.74 112.999 -137.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.48 150.27 20.49 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.834 -1.543 . . . . 4.8 106.834 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.47 ' HB1' HD23 ' A' ' 8' ' ' LEU . . . -149.7 124.88 10.09 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.898 0.38 . . . . 1.54 111.457 162.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 p -129.14 122.45 29.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.964 1.305 . . . . 2.12 109.18 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -55.28 -41.86 72.83 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.631 0.974 . . . . 3.02 113.631 -172.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.9 t 64.38 -73.52 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.866 1.266 . . . . 3.44 111.177 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.1 tptm 45.11 53.25 7.96 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.338 1.855 . . . . 3.76 112.225 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.96 118.31 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.893 -1.892 . . . . 6.36 105.893 165.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 C--O 1.249 1.06 0 N-CA-C 104.289 -2.486 . . . . 8.99 104.289 -164.793 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptp . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 114.595 1.331 . . . . 10.17 114.595 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 124.29 173.78 13.93 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 120.451 1.478 . . . . 4.15 112.671 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -17.0 -66.38 0.01 OUTLIER 'General case' 0 C--N 1.339 0.147 0 C-N-CA 129.774 3.23 . . . . 4.97 117.187 -172.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 50.96 71.47 0.64 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.733 -0.947 . . . . 1.5 110.733 -167.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -78.26 97.16 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.845 0.858 . . . . 2.09 108.973 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.03 155.67 19.57 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.937 0.875 . . . . 4.34 109.071 171.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -146.23 136.75 24.02 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 105.846 -1.909 . . . . 4.32 105.846 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 pp -152.61 148.66 27.59 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.601 1.161 . . . . 2.01 109.217 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.89 125.62 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 105.569 -2.012 . . . . 0.77 105.569 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.9 t -104.71 138.03 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 106.356 -1.72 . . . . 1.74 106.356 168.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.16 175.3 9.98 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.777 1.631 . . . . 5.02 108.55 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.43 -50.17 4.3 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.186 -1.166 . . . . 1.64 110.186 -172.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -50.33 126.66 15.48 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.034 0.534 . . . . 1.91 111.556 175.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 p -88.68 -41.37 12.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.971 0.73 . . . . 3.09 112.971 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.4 p -152.41 177.06 11.0 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.843 0.747 . . . . 0.69 112.543 -161.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.0 -42.09 17.44 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.876 1.27 . . . . 0.73 111.585 175.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.0 t -60.56 -34.39 74.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.507 0.723 . . . . 1.86 110.912 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.2 m -71.53 -54.97 8.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.375 0.534 . . . . 0.67 109.85 169.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 37' ' ' VAL . 49.1 t -45.8 -62.35 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.592 0.757 . . . . 0.8 111.45 -175.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.7 -27.0 66.45 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 120.046 -0.661 . . . . 0.96 111.632 -174.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -68.06 -48.89 64.36 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.744 0.818 . . . . 2.85 109.224 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.7 mt -53.8 -58.72 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 N-CA-C 107.899 -1.148 . . . . 0.86 107.899 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.46 -53.82 33.19 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.369 0.604 . . . . 3.58 110.412 -176.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 t -57.76 -37.72 74.13 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.641 1.176 . . . . 0.82 111.754 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.9 t -71.46 -40.78 70.11 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.788 0.835 . . . . 1.17 110.67 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.5 mp -66.86 -51.78 51.42 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.457 1.103 . . . . 2.44 109.26 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.1 t -71.71 60.95 0.37 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.258 1.028 . . . . 2.76 110.734 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.05 -48.1 0.32 Allowed 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 128.895 2.878 . . . . 6.83 108.045 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -69.99 26.2 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.281 1.586 . . . . 3.19 115.281 -165.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 66.02 -60.75 0.29 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.651 2.38 . . . . 6.15 114.177 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.47 -15.92 62.21 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.715 -0.492 . . . . 1.04 113.23 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.2 mm -79.43 105.42 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.901 1.28 . . . . 4.3 107.734 176.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.73 -38.97 37.57 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.308 -0.627 . . . . 3.1 109.308 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -152.41 152.08 31.58 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.996 -0.742 . . . . 2.11 108.996 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.0 t -136.26 132.34 35.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.804 1.642 . . . . 2.11 106.586 174.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.1 t -134.85 103.73 5.72 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.927 -1.509 . . . . 1.47 106.927 165.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 19' ' ' VAL . 8.8 p -104.23 147.84 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.824 1.25 . . . . 2.68 109.82 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.35 142.32 19.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 O-C-N 121.401 -0.812 . . . . 0.94 110.868 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -83.82 -38.09 21.68 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 123.952 0.901 . . . . 2.0 109.753 170.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.24 -35.86 60.43 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.458 0.703 . . . . 1.45 110.755 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -117.54 16.47 14.61 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.62 1.168 . . . . 2.75 110.35 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.4 m120 23.23 70.83 0.03 OUTLIER 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.646 1.978 . . . . 1.78 112.737 -173.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 166.59 26.67 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.576 0.35 . . . . 2.87 110.342 -172.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.99 92.91 1.68 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.365 1.466 . . . . 0.91 109.343 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -78.33 108.27 11.55 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.738 -2.319 . . . . 1.51 104.738 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.0 mp -110.92 127.14 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 106.662 -1.607 . . . . 1.58 106.662 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -92.44 104.66 16.96 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 104.869 -2.271 . . . . 2.32 104.869 160.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -122.05 134.6 54.78 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 118.592 0.633 . . . . 1.99 109.344 175.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -72.63 117.68 61.32 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 120.167 -0.613 . . . . 3.01 109.37 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -81.76 64.56 8.55 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.05 2.5 . . . . 2.37 112.471 -163.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -158.38 -52.66 0.07 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.526 1.13 . . . . 2.95 109.035 168.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -57.99 -35.16 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.788 1.235 . . . . 2.96 111.659 172.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mm -139.17 139.32 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.748 -1.945 . . . . 1.39 105.748 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.57 167.9 15.01 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.3 1.428 . . . . 0.79 110.374 169.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -61.87 -41.95 34.28 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.534 2.156 . . . . 1.03 110.17 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.9 -35.95 25.54 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 118.119 -0.943 . . . . 5.73 112.127 174.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -68.64 -49.81 56.23 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 119.711 1.141 . . . . 2.08 110.147 -176.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 mt -53.74 -53.23 27.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.922 -0.77 . . . . 0.68 108.922 172.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.4 mt -53.52 -44.14 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 118.512 -0.756 . . . . 1.15 110.642 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -53.12 -38.42 62.64 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 119.275 0.943 . . . . 3.15 110.776 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.1 m -67.01 -53.44 31.32 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.004 0.82 . . . . 1.12 108.875 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mp -50.81 -51.81 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.339 0.656 . . . . 1.32 110.28 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.51 -51.58 64.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.839 1.256 . . . . 2.35 110.612 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.0 t -65.71 -20.05 66.13 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 118.009 -0.996 . . . . 1.43 112.866 -171.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.8 -101.55 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 119.551 1.069 . . . . 2.84 108.388 163.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.46 36.68 0.48 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.411 -1.076 . . . . 1.13 110.411 173.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -126.74 154.62 43.94 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.819 -0.808 . . . . 2.37 108.819 -162.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -109.49 152.77 24.99 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.553 -0.906 . . . . 3.6 108.553 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.09 148.45 50.57 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 125.563 1.545 . . . . 1.03 110.246 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.1 m -154.15 99.7 2.26 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.787 0.835 . . . . 1.86 110.402 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mt -54.98 126.31 24.02 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.075 -1.083 . . . . 3.33 108.075 164.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.26 144.5 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 105.13 -2.174 . . . . 3.0 105.13 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -125.86 -48.56 1.63 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.429 1.092 . . . . 4.48 110.166 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.465 HG23 ' H ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -147.76 -54.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 105.574 -2.01 . . . . 6.28 105.574 170.317 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.465 ' H ' HG23 ' A' ' 74' ' ' ILE . 49.3 mt-10 . . . . . 0 C--O 1.248 0.997 0 N-CA-C 106.184 -1.784 . . . . 11.54 106.184 142.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttm . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 119.333 -0.365 . . . . 8.01 110.648 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -145.55 58.24 0.51 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 106.523 -2.631 . . . . 3.36 106.523 174.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -134.26 125.75 28.39 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.501 -1.296 . . . . 5.16 107.501 -159.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.45 136.67 8.53 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 106.984 -2.446 . . . . 1.32 106.984 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.9 t -136.76 134.37 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.998 -1.482 . . . . 2.47 106.998 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.5 mt -135.19 117.13 15.24 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.324 -1.362 . . . . 2.53 107.324 171.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -79.42 89.38 5.01 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.918 -1.882 . . . . 3.52 105.918 155.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.2 mt -78.67 134.88 37.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.709 -1.589 . . . . 2.33 106.709 172.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.83 119.2 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 104.977 -2.231 . . . . 1.1 104.977 162.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -124.86 110.41 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 105.708 -1.96 . . . . 2.41 105.708 -175.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.6 mtp-105 -117.63 160.02 21.97 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.381 1.073 . . . . 5.97 109.768 -165.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.36 0.59 88.35 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.876 -0.889 . . . . 1.16 110.876 -163.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.6 ttm -69.44 68.2 0.22 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.534 1.534 . . . . 2.28 109.805 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -67.36 -31.55 71.89 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.465 0.542 . . . . 1.58 112.465 -166.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.6 p -155.04 174.94 14.47 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.993 0.815 . . . . 0.65 112.117 -170.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.02 -41.97 17.42 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.119 1.368 . . . . 0.92 111.786 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 m -54.2 -43.62 70.9 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 122.953 0.501 . . . . 1.4 110.894 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.3 m -66.12 -50.68 63.18 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.291 0.496 . . . . 0.73 109.96 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.2 t -46.19 -64.12 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.377 0.671 . . . . 1.1 110.378 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -31.0 67.13 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.233 -0.587 . . . . 0.93 112.218 -174.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -51.85 67.72 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.701 0.682 . . . . 5.35 109.467 174.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.3 mt -56.01 -62.67 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 108.099 -1.074 . . . . 0.89 108.099 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -49.33 -56.34 9.83 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 123.744 0.652 . . . . 3.89 110.167 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.6 t -57.66 -48.64 78.93 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.959 0.504 . . . . 0.97 111.209 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.5 t -71.81 -22.9 61.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.759 -0.588 . . . . 1.49 110.78 -171.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mp -73.65 -63.79 1.13 Allowed 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 121.349 -0.844 . . . . 2.54 110.569 163.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 84.8 m -54.63 -23.55 17.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.38 1.072 . . . . 2.3 113.1 -170.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -53.0 -34.95 58.68 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.072 1.138 . . . . 5.36 114.072 170.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -70.25 120.45 15.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.572 -0.899 . . . . 1.97 108.572 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -74.43 56.61 0.67 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.506 0.593 . . . . 7.02 110.66 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.08 42.33 0.44 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.115 -1.594 . . . . 1.97 109.115 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.6 pp -147.51 163.47 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 127.057 2.143 . . . . 2.94 105.243 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -111.36 -43.01 3.77 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.785 0.834 . . . . 2.66 109.833 171.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -156.26 158.05 36.84 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.272 0.942 . . . . 1.88 110.9 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.0 m -143.23 124.87 14.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.318 1.847 . . . . 2.43 106.368 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.54 106.3 6.94 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.975 0.91 . . . . 1.95 108.705 173.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.6 m -100.85 147.86 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 125.274 1.43 . . . . 2.6 110.727 -173.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.28 125.5 18.71 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.814 -0.81 . . . . 0.83 108.814 166.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.533 HD12 ' N ' ' A' ' 40' ' ' ALA . 1.4 pp -64.93 -37.34 87.33 Favored 'General case' 0 C--N 1.338 0.098 0 O-C-N 123.395 0.435 . . . . 1.6 110.436 168.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.533 ' N ' HD12 ' A' ' 39' ' ' LEU . . . -50.55 -49.77 55.2 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.458 1.103 . . . . 1.72 111.123 -174.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.5 8.5 33.44 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.256 0.622 . . . . 3.01 110.983 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.264 0.0 OUTLIER 47.12 61.22 2.98 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 126.355 1.862 . . . . 1.78 109.907 173.453 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.24 166.29 31.36 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.303 -0.862 . . . . 2.35 111.944 -173.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.05 110.24 6.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.014 2.526 . . . . 0.91 107.823 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -78.74 97.08 5.76 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 105.467 -2.049 . . . . 1.03 105.467 167.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.9 mt -104.22 138.91 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 107.001 -1.481 . . . . 1.71 107.001 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -127.44 135.99 51.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.904 -1.888 . . . . 3.31 105.904 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -161.53 158.99 27.28 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.4 1.08 . . . . 2.41 108.149 -167.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -79.63 126.92 79.64 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.397 -1.334 . . . . 3.55 107.397 169.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -80.97 46.28 2.23 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.01 2.473 . . . . 2.04 109.801 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -137.45 -62.03 0.62 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.931 1.292 . . . . 4.08 108.181 -165.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 tt -74.13 -26.95 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 121.946 -0.471 . . . . 2.64 111.4 176.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.25 129.96 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.269 -1.752 . . . . 1.41 106.269 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.28 -179.53 53.06 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 110.498 -1.041 . . . . 1.22 110.498 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.66 -54.52 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.211 1.941 . . . . 1.3 111.347 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -67.09 -25.69 66.34 Favored 'General case' 0 C--O 1.221 -0.411 0 O-C-N 121.7 -0.625 . . . . 6.22 111.773 -172.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.77 -50.55 5.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.384 1.874 . . . . 2.97 110.744 172.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.9 mt -66.4 -52.16 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.082 -0.71 . . . . 0.66 109.082 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mt -53.68 -45.97 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 122.801 0.44 . . . . 1.17 110.656 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -50.67 -41.3 55.44 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.636 1.174 . . . . 3.69 110.674 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.8 m -65.45 -48.51 72.44 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.169 -0.678 . . . . 0.91 109.169 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.07 -55.82 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.045 0.538 . . . . 1.35 110.121 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -53.3 -53.52 49.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.149 0.98 . . . . 2.27 110.081 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.9 t -55.01 -40.36 70.07 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.014 1.326 . . . . 1.18 111.452 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.6 mt -60.02 -86.22 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 117.946 0.339 . . . . 2.25 111.593 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.03 32.82 0.38 Allowed Glycine 0 CA--C 1.524 0.623 0 CA-C-O 118.653 -1.082 . . . . 0.96 113.118 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -133.06 163.34 29.47 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 118.715 1.257 . . . . 2.1 113.064 -158.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -97.21 144.86 26.61 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.219 2.208 . . . . 3.54 105.157 171.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.95 140.12 40.09 Favored 'General case' 0 CA--C 1.526 0.024 0 CA-C-N 118.772 0.715 . . . . 1.74 111.416 -168.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.6 p -155.76 175.44 13.93 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.235 1.014 . . . . 2.41 108.43 165.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.02 151.68 29.03 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 105.314 -2.106 . . . . 2.45 105.314 158.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.0 t -129.8 136.03 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 107.979 -1.119 . . . . 2.54 107.979 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -170.55 -179.26 2.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.236 1.814 . . . . 4.96 106.18 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.0 tp -84.81 -66.04 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.259 0.624 . . . . 6.11 112.557 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.258 0 C-N-CA 127.907 2.483 . . . . 9.23 113.919 -167.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 107.636 -1.246 . . . . 8.48 107.636 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.18 176.52 28.78 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 107.079 -2.409 . . . . 4.15 107.079 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -155.07 164.39 38.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.697 -1.594 . . . . 4.31 106.697 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.4 126.45 5.56 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.107 -1.197 . . . . 1.66 110.107 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.53 66.91 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 124.912 1.285 . . . . 2.8 108.696 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.33 79.63 4.76 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.037 -1.468 . . . . 2.73 107.037 -176.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -99.12 99.74 10.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.343 -1.299 . . . . 2.98 107.942 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.98 153.32 36.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.487 1.115 . . . . 2.69 109.164 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.9 123.75 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 106.824 -1.547 . . . . 0.81 106.824 174.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.9 t -100.91 109.32 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.898 -1.89 . . . . 2.09 105.898 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -88.25 137.4 32.36 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.323 -0.991 . . . . 6.71 108.323 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.06 1.68 41.88 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.73 -1.039 . . . . 1.07 113.455 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 48.3 mtm -71.45 71.02 0.65 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.44 1.62 . . . . 1.52 110.406 175.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -71.72 -19.17 62.09 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.678 -1.154 . . . . 1.69 113.768 -168.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -162.7 173.41 13.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 120.152 1.342 . . . . 0.79 111.022 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.59 -39.41 35.24 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.223 1.009 . . . . 0.59 111.54 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 m -59.61 -30.49 68.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.406 0.682 . . . . 1.66 112.146 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.1 m -71.07 -55.38 8.35 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.834 0.743 . . . . 1.0 109.898 168.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.28 -59.95 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.918 0.887 . . . . 0.67 110.886 -173.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.66 -31.72 71.04 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.236 -0.586 . . . . 1.0 111.707 -174.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -60.41 -51.69 68.4 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.75 -0.833 . . . . 3.31 108.75 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.0 mt -53.1 -64.47 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 108.63 -0.878 . . . . 0.73 108.63 174.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -49.46 -60.37 2.91 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 123.951 0.782 . . . . 3.8 110.031 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 t -52.96 -48.4 67.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.87 0.868 . . . . 0.87 110.442 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.1 m -59.9 -54.69 43.21 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.125 -0.694 . . . . 2.22 109.125 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.64 -37.19 65.37 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.739 0.815 . . . . 2.42 111.858 -173.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.3 p -54.97 -26.52 37.22 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.592 0.96 . . . . 2.56 113.592 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -4.18 37.55 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.941 1.246 . . . . 4.89 113.457 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -88.14 69.01 9.22 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 106.843 -1.54 . . . . 2.12 106.843 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -47.59 -16.14 0.06 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 118.017 2.599 . . . . 6.95 118.017 -161.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.07 -7.0 86.63 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 119.837 1.199 . . . . 1.08 113.114 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.16 137.32 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.442 -1.318 . . . . 2.41 107.442 168.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.5 mt -85.43 -39.76 17.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.267 1.027 . . . . 2.16 109.683 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -157.05 153.32 27.72 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.627 -0.879 . . . . 2.34 108.627 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.5 t -127.98 146.72 50.57 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.622 -0.881 . . . . 2.26 108.622 166.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 m -148.26 107.89 3.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.873 0.869 . . . . 2.13 109.933 164.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.74 145.3 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 125.951 1.7 . . . . 1.99 110.394 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.14 120.75 10.44 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 124.02 0.928 . . . . 0.91 109.462 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 pp -81.65 -12.34 58.73 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.271 1.029 . . . . 1.5 113.392 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.36 -49.4 34.34 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.134 -1.061 . . . . 1.46 108.134 172.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -79.47 -25.56 41.86 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.664 1.186 . . . . 1.69 111.221 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 63.82 42.22 6.26 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 126.02 1.728 . . . . 1.48 109.666 -172.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.26 148.88 45.44 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 124.253 1.021 . . . . 2.79 108.319 -170.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.17 109.46 12.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.837 -1.171 . . . . 0.8 107.837 165.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -82.84 105.35 13.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.574 -1.639 . . . . 1.36 106.574 167.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.29 123.58 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.545 -1.65 . . . . 1.65 106.545 168.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -93.95 145.92 24.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.712 -1.218 . . . . 2.58 107.712 162.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -163.73 158.45 20.29 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.024 0.529 . . . . 1.74 110.304 -168.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -100.03 121.0 55.43 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 124.441 1.088 . . . . 3.4 108.098 170.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.57 -38.13 19.98 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.845 2.363 . . . . 2.04 112.898 -168.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -58.4 -40.54 82.68 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.978 0.511 . . . . 3.33 111.652 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -81.67 -50.75 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 123.104 0.562 . . . . 2.9 110.245 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.54 100.71 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.63 -0.878 . . . . 1.77 108.63 -173.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -63.9 140.6 44.14 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 108.763 -1.735 . . . . 1.41 108.763 168.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -56.93 -32.43 92.55 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.812 2.341 . . . . 1.26 112.005 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.491 HH11 ' CD2' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -58.36 -28.33 65.01 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 117.954 -1.022 . . . . 6.17 112.714 176.502 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.14 -55.69 23.08 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.431 1.469 . . . . 4.94 109.756 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.8 mt -51.74 -52.08 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.455 0.702 . . . . 0.79 109.168 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.7 mt -57.65 -49.27 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 118.707 -0.663 . . . . 1.58 110.323 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.491 ' CD2' HH11 ' A' ' 56' ' ' ARG . 27.7 m80 -54.09 -41.1 67.85 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.225 0.92 . . . . 2.93 111.294 174.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.7 m -58.62 -54.85 42.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.449 -0.945 . . . . 0.85 108.449 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.85 -55.46 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.598 0.759 . . . . 1.88 110.505 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -51.32 -59.4 4.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.57 0.748 . . . . 2.0 109.718 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.4 t -55.56 -48.4 74.83 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.572 1.149 . . . . 1.45 111.233 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.7 mt -59.04 -51.41 70.15 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.835 0.68 . . . . 2.17 112.835 -172.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.69 1.61 0.06 OUTLIER Glycine 0 CA--C 1.529 0.948 0 N-CA-C 117.156 1.623 . . . . 1.13 117.156 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -139.21 177.07 8.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.637 1.718 . . . . 1.8 111.712 -139.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.94 152.3 32.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.022 -1.473 . . . . 3.15 107.022 165.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.87 146.65 37.33 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.853 0.861 . . . . 1.45 109.251 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.6 m -147.92 107.93 4.04 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.766 0.826 . . . . 2.14 108.835 173.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.81 69.6 0.69 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.755 1.222 . . . . 3.11 111.936 -176.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.36 -46.87 92.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.295 0.638 . . . . 2.3 111.662 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? 32.5 72.83 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.127 1.771 . . . . 4.74 112.137 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.4 mt -54.06 145.58 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.318 -0.856 . . . . 8.65 109.821 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 C--O 1.249 1.073 0 C-N-CA 127.067 2.147 . . . . 8.63 105.604 171.779 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 113.516 0.932 . . . . 10.2 113.516 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.36 -93.43 0.15 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.588 -1.805 . . . . 4.27 108.588 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -155.34 159.87 40.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.507 0.723 . . . . 4.2 109.178 165.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.57 123.01 4.57 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 106.663 -2.575 . . . . 1.46 106.663 165.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.26 109.41 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 123.54 0.736 . . . . 2.33 109.347 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -104.23 87.3 2.72 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.226 -1.398 . . . . 3.24 107.226 166.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -82.06 91.93 6.73 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.586 -1.635 . . . . 4.35 106.586 160.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 pp -105.34 157.71 17.13 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.446 -0.797 . . . . 2.11 109.037 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 t -79.05 140.98 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 106.537 -1.653 . . . . 1.26 106.537 171.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.2 t -125.52 123.87 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 105.951 -1.87 . . . . 1.98 105.951 173.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.6 mtt-85 -112.56 152.72 28.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.396 -0.964 . . . . 7.06 108.396 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.49 -6.93 61.34 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.271 -0.738 . . . . 1.12 112.886 -171.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 57.0 mtm -69.94 74.46 0.45 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.892 1.346 . . . . 1.53 110.288 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -67.36 -34.48 77.38 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 119.255 -0.403 . . . . 1.62 111.757 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.1 p -152.95 172.86 16.17 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.09 0.859 . . . . 0.81 112.678 -173.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.34 -44.02 7.91 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.587 1.555 . . . . 0.94 111.854 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.2 m -58.9 -33.41 70.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.779 0.831 . . . . 1.54 112.387 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.2 m -71.05 -57.16 4.81 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 122.308 1.051 . . . . 0.93 109.252 170.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.498 HG13 HG23 ' A' ' 37' ' ' VAL . 71.5 t -49.26 -60.73 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.75 1.62 . . . . 1.11 110.297 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.68 -28.54 67.77 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.784 -0.573 . . . . 0.92 111.389 -175.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -68.58 -39.26 81.04 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.503 -0.555 . . . . 5.81 109.503 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.2 mt -57.01 -61.29 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.125 -0.694 . . . . 0.75 109.125 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -45.97 -59.76 2.66 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.152 0.581 . . . . 3.36 111.343 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.8 t -56.56 -39.12 72.92 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.825 0.85 . . . . 1.12 111.917 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.8 t -70.46 -55.34 9.23 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.417 -1.327 . . . . 1.17 107.417 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.0 -35.47 80.33 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 121.96 -0.462 . . . . 2.74 110.589 -170.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.4 m -69.77 67.49 0.25 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.228 1.013 . . . . 2.73 110.238 171.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -158.39 -42.59 0.06 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 128.885 2.874 . . . . 5.39 109.249 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -66.69 110.89 3.41 Favored 'General case' 0 C--N 1.345 0.373 0 N-CA-C 108.786 -0.82 . . . . 1.57 108.786 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.76 -18.83 57.19 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.292 -0.88 . . . . 6.6 111.449 173.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -51.86 -39.64 48.23 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.717 0.675 . . . . 1.6 112.485 167.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -93.83 157.17 3.02 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 CA-C-N 117.588 0.694 . . . . 2.3 110.794 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.9 mt -105.98 -40.32 5.72 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.933 1.293 . . . . 1.9 109.685 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -153.6 156.95 38.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.044 0.384 . . . . 2.75 110.775 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.8 t -139.64 135.25 33.08 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.029 -1.841 . . . . 2.22 106.029 167.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 t -147.96 144.64 28.14 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.027 0.83 . . . . 2.84 110.277 154.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.498 HG23 HG13 ' A' ' 19' ' ' VAL . 20.4 m -113.22 166.57 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 123.939 0.895 . . . . 2.04 111.553 -168.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.93 139.76 29.32 Favored 'General case' 0 CA--C 1.52 -0.198 0 O-C-N 122.061 -0.399 . . . . 1.12 110.985 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 mp -72.0 -63.04 1.22 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.571 1.548 . . . . 3.56 109.845 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.76 -45.83 81.82 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 123.808 0.843 . . . . 1.98 111.141 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.25 -16.8 57.46 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.841 0.856 . . . . 1.77 110.857 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 55.12 62.57 2.44 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.125 1.37 . . . . 2.24 107.689 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.3 pttp -134.68 160.78 37.06 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.011 0.374 . . . . 2.14 112.011 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.12 112.9 9.54 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.388 1.475 . . . . 0.75 108.491 169.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -79.68 93.72 5.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.707 2.003 . . . . 1.55 107.006 169.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.0 mm -92.25 134.59 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.323 -1.362 . . . . 1.59 107.323 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -118.69 119.97 36.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 105.319 -2.104 . . . . 2.27 105.319 163.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -142.65 156.39 45.05 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 107.918 -1.141 . . . . 1.9 107.918 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -89.33 116.3 65.97 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.36 -0.829 . . . . 3.34 109.143 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.06 70.12 3.03 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.238 3.292 . . . . 2.89 110.976 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -161.66 -55.65 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 127.183 2.193 . . . . 3.05 106.675 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.4 pt -88.88 -11.19 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.906 0.883 . . . . 3.28 112.654 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 tt -158.35 156.31 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.078 -2.193 . . . . 1.68 105.078 171.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.9 -178.71 27.95 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 109.402 -1.479 . . . . 1.11 109.402 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.5 -40.75 9.89 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.866 1.71 . . . . 0.97 109.591 171.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -38.43 69.41 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 117.991 -1.004 . . . . 5.72 111.1 -171.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.57 -50.5 69.24 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.772 0.714 . . . . 2.46 110.284 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 58' ' ' ILE . 4.6 mp -60.33 -47.54 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.204 -1.035 . . . . 1.56 108.204 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.4 mt -55.08 -43.44 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 116.325 -0.398 . . . . 1.39 110.954 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -32.04 73.29 Favored 'General case' 0 C--O 1.224 -0.273 0 O-C-N 120.858 -1.151 . . . . 5.04 111.034 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.2 m -63.8 -48.29 77.45 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.356 -0.979 . . . . 0.76 108.356 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.421 HG23 ' HB2' ' A' ' 67' ' ' PHE . 65.2 mt -54.37 -46.18 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.411 1.084 . . . . 1.44 110.458 175.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -55.57 -54.48 43.57 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.181 0.515 . . . . 2.06 110.362 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 t -56.76 -38.04 71.9 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 126.068 1.747 . . . . 1.2 111.722 -171.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.77 -92.6 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.605 -0.517 . . . . 2.42 109.605 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.87 30.13 0.33 Allowed Glycine 0 C--N 1.337 0.602 0 CA-C-O 118.712 -1.049 . . . . 1.06 112.802 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.421 ' HB2' HG23 ' A' ' 62' ' ' ILE . 19.7 m-85 -129.81 160.74 32.53 Favored 'General case' 0 N--CA 1.458 -0.047 0 CA-C-N 118.797 1.299 . . . . 1.68 111.415 -159.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -104.6 154.38 20.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.571 1.549 . . . . 3.27 107.159 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.55 151.68 49.17 Favored 'General case' 0 C--O 1.23 0.054 0 C-N-CA 123.315 0.646 . . . . 1.27 110.176 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.1 m -152.17 104.85 3.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.275 -1.009 . . . . 1.72 108.275 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -59.3 130.71 48.27 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.279 -0.888 . . . . 2.5 109.964 174.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.9 t -78.35 66.64 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 121.812 0.815 . . . . 3.51 109.785 -171.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -104.54 -49.6 3.51 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.963 -1.495 . . . . 5.32 106.963 165.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 75.1 mt -136.14 134.27 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 106.889 -1.522 . . . . 8.18 106.889 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 . . . . . 0 C--O 1.256 1.437 0 N-CA-C 103.765 -2.679 . . . . 13.66 103.765 149.786 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 106.548 -1.649 . . . . 9.45 106.548 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.91 166.73 33.19 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 107.373 -2.291 . . . . 4.03 107.373 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -168.61 176.63 5.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.627 1.571 . . . . 5.57 107.314 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.29 66.27 0.52 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.288 -1.925 . . . . 2.01 108.288 164.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.8 t -78.57 126.02 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 107.943 -1.132 . . . . 2.73 107.943 170.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.1 tp -155.59 100.63 2.11 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.747 0.419 . . . . 3.0 111.387 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.76 89.39 4.01 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 122.766 1.269 . . . . 3.89 109.276 153.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pp -81.73 154.04 26.22 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 113.967 -1.469 . . . . 2.06 108.52 162.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.79 141.53 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.487 -2.042 . . . . 0.95 105.487 168.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.5 127.81 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 104.942 -2.244 . . . . 1.89 104.942 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.6 mtp-105 -120.34 160.82 22.26 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.205 0.911 . . . . 5.43 110.498 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.13 6.17 65.16 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.376 0.989 . . . . 1.16 111.691 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 73.4 mtp -74.39 62.79 1.0 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.569 1.148 . . . . 1.91 110.298 -177.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -69.66 -16.4 63.36 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.256 1.206 . . . . 1.46 114.256 -162.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.2 p -161.53 175.2 12.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 120.202 1.364 . . . . 0.58 110.678 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.96 -39.51 19.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.449 1.1 . . . . 0.56 111.718 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -59.67 -33.28 71.37 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.112 0.565 . . . . 2.29 111.3 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.8 m -71.65 -54.12 11.41 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.643 0.656 . . . . 0.69 109.674 170.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.7 t -47.09 -60.7 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.008 0.923 . . . . 0.79 110.821 -174.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.89 -31.12 68.76 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.321 -0.551 . . . . 0.74 111.624 -174.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -60.52 -51.98 67.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.902 -0.777 . . . . 2.98 108.902 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.6 mt -51.88 -58.94 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.202 0 C-N-CA 123.302 0.641 . . . . 0.9 109.453 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -53.93 -57.01 12.57 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 123.559 0.537 . . . . 3.73 109.845 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.8 t -53.29 -42.7 66.87 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.574 1.15 . . . . 0.85 111.427 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.4 m -70.78 -44.83 65.85 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.999 -0.741 . . . . 1.93 108.999 -175.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.0 mt -64.57 -55.66 18.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.459 -0.337 . . . . 2.71 110.818 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 t -56.68 -19.86 18.63 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.674 -0.641 . . . . 2.64 111.657 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -34.78 75.62 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.122 -0.986 . . . . 4.73 112.757 174.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -80.72 119.56 23.48 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.681 -1.229 . . . . 1.73 107.681 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -49.46 -28.92 5.83 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.883 1.068 . . . . 5.56 113.883 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.16 -22.37 70.73 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.017 -0.879 . . . . 0.97 113.227 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.3 mm -84.27 110.3 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.731 -1.211 . . . . 4.39 107.731 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.09 -33.28 29.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.07 0.548 . . . . 2.78 109.882 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -155.64 158.52 38.47 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.277 -0.638 . . . . 2.32 109.277 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.6 t -145.74 135.52 23.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.741 0.817 . . . . 2.84 108.897 168.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 t -126.13 94.67 4.16 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.858 -1.534 . . . . 2.18 106.858 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 m -78.7 148.43 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.61 1.564 . . . . 2.46 110.441 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.04 123.58 5.51 Favored 'General case' 0 C--N 1.339 0.13 0 O-C-N 122.088 -0.383 . . . . 0.94 111.097 164.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.02 -8.59 56.95 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.206 1.003 . . . . 1.44 113.001 174.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.56 -64.04 1.16 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.312 -0.996 . . . . 2.19 108.312 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 p -77.0 -5.92 50.6 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.849 -0.532 . . . . 2.03 110.455 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 57.57 57.49 4.29 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.889 1.276 . . . . 2.36 107.742 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 168.93 18.6 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.441 0.638 . . . . 2.13 111.68 -170.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -142.3 106.12 4.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.38 -1.736 . . . . 0.62 106.518 167.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -77.0 93.29 3.8 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 103.679 -2.711 . . . . 1.03 103.679 168.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.1 mt -89.33 143.88 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 106.577 -1.638 . . . . 1.83 106.577 174.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -124.16 119.79 30.44 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 105.181 -2.155 . . . . 3.25 105.181 163.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -139.89 162.37 35.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.324 0.649 . . . . 2.02 110.243 -174.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -93.28 109.87 42.86 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 107.803 -1.184 . . . . 3.47 107.803 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.43 60.51 7.56 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 124.331 3.354 . . . . 1.55 111.677 -167.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -171.5 -45.02 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.501 1.92 . . . . 2.94 108.21 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.0 mt -67.13 -38.2 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 108.889 -0.782 . . . . 3.26 108.889 170.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 tt -147.34 136.97 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.655 -1.609 . . . . 1.41 106.655 174.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.22 165.58 30.3 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.009 -0.837 . . . . 0.93 111.009 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -55.24 -47.34 26.67 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.24 1.96 . . . . 1.13 109.737 171.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -51.37 -37.83 50.08 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.314 0.646 . . . . 7.54 112.038 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -70.52 -47.75 58.93 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.284 -0.636 . . . . 2.38 109.284 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.4 mt -53.54 -52.09 36.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 122.846 0.458 . . . . 0.91 110.301 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.9 mm -51.81 -51.6 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.313 0.645 . . . . 1.86 109.655 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -56.22 -40.2 73.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.074 -0.391 . . . . 4.98 111.587 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.3 m -60.37 -56.71 18.2 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.084 -0.709 . . . . 0.87 109.084 175.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.437 HG21 ' HB2' ' A' ' 69' ' ' ALA . 32.2 mt -47.6 -53.18 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.607 1.163 . . . . 1.56 111.346 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -59.27 -56.23 24.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.466 1.106 . . . . 2.22 110.362 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.3 t -59.12 -30.08 67.86 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.433 0.693 . . . . 1.47 111.841 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.9 mt -71.87 -74.86 0.14 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.349 0.522 . . . . 2.32 110.618 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.51 6.83 0.08 OUTLIER Glycine 0 CA--C 1.529 0.965 0 CA-C-O 117.862 -1.521 . . . . 0.84 116.231 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -130.85 158.31 40.52 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 120.2 2.0 . . . . 1.66 112.165 -146.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -92.55 167.53 11.87 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 107.509 -1.293 . . . . 3.08 107.509 170.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.437 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -155.25 169.16 24.83 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.901 0.381 . . . . 0.88 111.192 164.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.4 m -154.6 125.61 7.2 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.831 1.252 . . . . 1.65 108.059 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.37 68.64 1.55 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.516 0.727 . . . . 2.84 111.874 -175.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.6 p -62.53 -52.37 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 118.688 -0.672 . . . . 2.49 111.385 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.14 61.4 3.18 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.403 -0.962 . . . . 4.67 108.403 -176.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.9 tp -65.33 -47.07 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 114.716 -1.129 . . . . 8.64 113.217 -162.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--O 1.25 1.085 0 C-N-CA 124.403 1.081 . . . . 9.45 110.388 -169.262 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 119.36 -0.352 . . . . 7.3 111.486 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.3 165.26 24.98 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.124 0.42 . . . . 3.31 112.142 -169.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -70.45 97.7 1.33 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.992 -0.744 . . . . 4.99 108.992 171.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.47 90.05 0.37 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 108.155 -1.978 . . . . 1.81 108.155 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.96 132.81 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.236 -1.394 . . . . 2.64 107.236 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.6 tp -148.48 143.31 26.62 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.293 -1.373 . . . . 2.89 107.293 172.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -133.72 113.82 12.75 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.322 -1.362 . . . . 3.98 107.322 172.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.421 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -122.79 153.68 39.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.379 0.672 . . . . 2.23 109.493 -179.314 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.48 140.65 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.075 -1.454 . . . . 0.79 107.075 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.6 t -131.97 93.0 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 C-N-CA 127.062 2.145 . . . . 2.04 106.052 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.4 mtm105 -79.79 157.74 27.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.485 -0.561 . . . . 5.71 109.485 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.79 -6.08 56.92 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.403 1.002 . . . . 1.07 112.082 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 71.8 mtp -71.88 74.07 0.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.166 0.983 . . . . 1.92 110.958 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 t -70.76 -17.15 62.8 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 117.277 -1.344 . . . . 1.61 114.257 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.2 p -163.78 176.15 9.81 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 120.727 1.603 . . . . 0.61 111.381 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.65 -38.41 21.01 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.805 1.242 . . . . 0.64 111.892 175.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 t -49.07 -48.57 44.05 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 109.425 -0.583 . . . . 2.57 109.425 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.6 m -62.32 -46.03 90.58 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 122.258 0.223 . . . . 0.89 110.773 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 80.2 t -52.49 -65.1 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 109.921 -0.4 . . . . 1.0 109.921 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -30.58 67.67 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 118.986 -1.085 . . . . 0.86 111.842 -172.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -53.19 -53.43 50.76 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.37 -0.604 . . . . 3.47 109.37 169.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.9 mt -60.65 -58.37 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 118.461 -0.781 . . . . 0.64 110.024 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -49.51 -55.46 13.25 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.994 0.816 . . . . 3.88 110.548 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.1 t -56.58 -38.98 72.73 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.326 1.05 . . . . 0.91 111.388 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.3 t -71.13 -36.35 72.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.476 -0.765 . . . . 1.51 109.845 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.1 mt -66.99 -62.19 1.56 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 118.488 -0.768 . . . . 3.24 110.488 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.1 p -70.62 65.66 0.32 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.249 1.419 . . . . 1.94 111.697 -172.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.8 tptp -176.48 -48.2 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.55 1.14 . . . . 4.16 108.167 -151.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -73.29 90.59 1.64 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.897 -1.149 . . . . 1.89 107.897 166.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -51.76 105.1 0.1 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.526 -0.546 . . . . 6.44 109.526 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.79 -43.9 0.7 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 108.727 -1.749 . . . . 0.94 108.727 -164.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.45 131.57 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 105.436 -2.061 . . . . 2.5 105.436 161.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.7 mt -94.24 -42.72 8.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.909 1.284 . . . . 1.76 108.351 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -149.04 154.24 39.01 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.441 -0.578 . . . . 2.42 109.441 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.3 p -143.93 152.71 41.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.381 1.472 . . . . 2.14 108.306 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.9 m -155.25 82.78 1.06 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.673 1.189 . . . . 2.03 108.396 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.56 154.24 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 125.086 1.354 . . . . 2.61 108.871 174.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.04 130.06 11.82 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 120.736 -1.228 . . . . 0.92 110.786 172.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.59 -32.99 72.08 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.316 0.507 . . . . 1.87 110.159 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -47.59 -43.48 25.6 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.621 1.168 . . . . 1.34 112.449 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 t -121.76 1.97 10.0 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.706 0.403 . . . . 2.93 111.975 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 52.17 66.29 1.25 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.481 1.513 . . . . 1.78 108.46 174.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.48 166.02 27.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.427 1.091 . . . . 2.3 108.323 -175.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.48 108.85 12.04 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.832 2.053 . . . . 1.07 106.255 166.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -80.54 132.9 35.73 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 103.746 -2.687 . . . . 1.3 103.746 159.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.8 pt -138.84 151.27 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 106.796 -1.557 . . . . 3.58 106.796 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -139.28 101.01 4.15 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 102.802 -3.036 . . . . 2.46 102.802 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -129.91 149.01 51.83 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.523 0.729 . . . . 1.78 109.205 -169.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -82.96 117.79 69.69 Favored Pre-proline 0 N--CA 1.451 -0.423 0 N-CA-C 107.809 -1.182 . . . . 2.87 107.809 173.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.11 -26.99 78.5 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.443 1.428 . . . . 1.93 111.625 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -80.8 42.04 0.6 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.145 0.884 . . . . 4.27 111.363 -174.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -175.5 -43.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.682 1.593 . . . . 2.89 110.277 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 tt -132.67 124.03 50.32 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 108.108 -1.071 . . . . 1.19 108.108 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.4 173.59 51.11 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 110.679 -0.968 . . . . 0.91 110.679 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.63 -54.73 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.45 2.1 . . . . 0.99 110.263 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -50.46 -42.94 54.97 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.297 0.639 . . . . 6.04 110.944 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.51 -49.32 18.68 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.816 2.046 . . . . 2.68 110.154 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 54.7 mt -70.32 -47.59 65.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.234 0.614 . . . . 1.34 110.312 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.3 mm -50.03 -47.24 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 118.132 0.424 . . . . 1.95 110.858 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -45.17 -44.99 11.25 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.316 1.446 . . . . 2.85 111.445 173.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.0 m -58.89 -55.09 39.61 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.565 -0.902 . . . . 1.08 108.565 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.5 -53.67 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.197 0.599 . . . . 1.79 109.966 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -61.78 -48.34 81.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.618 -0.433 . . . . 2.48 110.22 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.6 t -55.65 -48.41 75.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.174 0.59 . . . . 1.49 111.549 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.1 mt -54.97 -59.51 4.65 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.903 -0.498 . . . . 2.32 112.316 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.68 -0.01 0.06 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 116.961 1.544 . . . . 1.09 116.961 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -131.94 175.18 9.44 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 119.897 1.849 . . . . 1.85 113.371 -139.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -125.68 103.44 7.83 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.685 1.194 . . . . 4.12 107.977 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.79 157.27 21.03 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.96 0.356 . . . . 1.47 111.96 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.9 t -154.45 133.09 12.12 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.424 1.09 . . . . 2.08 108.315 165.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.6 mt -58.1 155.94 10.33 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.026 -0.731 . . . . 2.32 109.026 163.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.3 t -137.07 -62.17 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 107.396 -1.335 . . . . 2.66 107.396 169.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.7 tttp 67.34 -66.52 0.2 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.934 1.694 . . . . 4.71 111.961 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.275 6.7 tp 44.9 55.27 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.971 1.708 . . . . 6.11 111.618 -172.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 . . . . . 0 C--O 1.248 1.021 0 N-CA-C 103.4 -2.815 . . . . 9.92 103.4 166.77 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 107.925 -1.139 . . . . 8.52 107.925 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 124.52 -55.76 0.7 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 105.567 -3.013 . . . . 5.99 105.567 -165.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -44.5 151.03 0.29 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.492 -0.854 . . . . 6.06 109.526 138.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.49 -75.46 0.15 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.037 -1.625 . . . . 3.76 109.037 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 p -158.04 166.54 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.754 -1.572 . . . . 2.51 106.754 169.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 tp -133.27 128.45 35.85 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.468 -1.308 . . . . 2.23 107.468 151.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -121.89 133.28 54.86 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.385 1.474 . . . . 3.72 108.133 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.98 157.12 41.29 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.378 -0.601 . . . . 2.73 109.378 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.61 145.21 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.263 -1.754 . . . . 0.75 106.263 169.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.8 137.24 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 125.672 1.589 . . . . 1.72 108.467 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -130.36 163.19 27.41 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.093 0.957 . . . . 5.81 108.779 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.67 -15.4 63.22 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.455 0.55 . . . . 1.41 112.275 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.458 ' SD ' HD12 ' A' ' 22' ' ' ILE . 64.2 mtm -69.14 78.98 0.34 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.208 1.004 . . . . 1.67 110.097 175.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 t -71.46 -16.75 62.38 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.753 -1.117 . . . . 1.77 113.097 -174.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.5 p -161.72 172.68 15.81 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.94 1.245 . . . . 0.97 110.792 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.16 -41.12 25.98 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.782 1.233 . . . . 0.71 111.536 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.5 m -61.01 -29.29 69.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.523 0.729 . . . . 1.62 112.205 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.7 m -72.03 -56.62 5.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.161 0.892 . . . . 0.81 110.03 166.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.705 HG13 HG23 ' A' ' 37' ' ' VAL . 88.3 t -43.71 -62.35 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.588 1.155 . . . . 0.9 110.781 -173.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -25.31 63.53 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 120.586 -0.446 . . . . 0.82 111.898 -175.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -67.88 -41.17 83.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.205 -0.665 . . . . 2.9 109.205 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.458 HD12 ' SD ' ' A' ' 13' ' ' MET . 12.8 mt -54.94 -59.03 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.494 -0.558 . . . . 0.87 109.494 173.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.443 ' OE2' HG22 ' A' ' 37' ' ' VAL . 93.4 mt-10 -52.97 -51.2 62.31 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.548 0.613 . . . . 3.72 111.388 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.2 t -54.93 -37.38 66.33 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.143 0.977 . . . . 0.95 111.205 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.3 t -71.29 -57.87 4.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.736 -1.209 . . . . 1.45 107.736 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.0 mt -51.17 -49.66 60.47 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.014 0.925 . . . . 2.6 112.085 -174.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.3 t -56.77 -17.92 10.85 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.456 -0.777 . . . . 2.67 112.61 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -30.45 71.3 Favored 'General case' 0 C--N 1.343 0.287 0 O-C-N 121.139 -0.976 . . . . 5.76 112.34 175.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -81.18 113.22 19.18 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 106.543 -1.651 . . . . 1.74 106.543 170.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -55.84 -26.33 46.18 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.524 0.565 . . . . 6.58 112.524 -173.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.82 -22.26 59.62 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.818 0.723 . . . . 1.37 113.437 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.2 mm -79.59 97.88 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.282 -1.377 . . . . 4.13 107.282 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.3 mt -77.68 -34.78 52.84 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.024 -0.732 . . . . 1.81 109.024 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -148.75 158.55 44.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.591 -0.892 . . . . 2.27 108.591 165.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.6 p -145.26 138.02 26.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.963 1.705 . . . . 2.35 107.717 173.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 t -142.16 106.93 4.87 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.496 -1.668 . . . . 1.77 106.496 170.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.705 HG23 HG13 ' A' ' 19' ' ' VAL . 35.9 m -84.87 171.78 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.159 0.436 . . . . 1.71 109.936 170.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -157.12 141.3 16.36 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.063 -0.717 . . . . 0.94 109.063 152.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.98 -38.07 53.92 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 108.521 -0.918 . . . . 2.11 108.521 166.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.36 -38.96 69.49 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.582 0.753 . . . . 1.46 110.609 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 m -112.1 14.52 20.71 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.389 1.076 . . . . 2.41 110.284 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.3 m120 32.29 53.08 0.29 Allowed 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 126.392 1.877 . . . . 1.57 113.512 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.68 168.47 17.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 122.864 0.465 . . . . 2.74 111.29 -171.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -140.26 135.59 32.46 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.29 -1.323 . . . . 1.13 109.22 150.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -110.4 107.34 17.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 104.288 -2.486 . . . . 1.28 104.288 168.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.433 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -106.74 146.56 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 105.889 -1.893 . . . . 1.86 105.889 175.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -113.16 93.21 4.3 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 105.307 -2.108 . . . . 2.61 105.307 170.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.78 150.89 20.87 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.318 1.047 . . . . 3.02 112.755 -174.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -87.22 126.5 62.41 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 107.066 -1.457 . . . . 3.09 107.066 150.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.02 -19.62 20.22 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.877 3.052 . . . . 1.82 113.447 -171.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -93.05 -45.1 8.07 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.874 -0.788 . . . . 3.44 108.874 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.1 mt -68.12 -35.76 72.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 109.553 -0.536 . . . . 2.92 109.553 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 mm -130.71 116.18 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.041 -1.466 . . . . 1.49 107.041 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.43 152.64 49.62 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 108.234 -1.946 . . . . 0.88 108.234 169.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -55.66 -38.55 94.12 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.028 1.819 . . . . 1.79 111.013 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -67.22 -23.83 65.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 118.841 -0.599 . . . . 6.74 112.408 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -65.59 -35.64 81.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 120.702 1.592 . . . . 2.44 112.285 -170.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.4 mt -53.47 -48.05 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 109.176 -0.676 . . . . 1.29 109.176 171.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.0 mt -62.69 -49.02 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.705 0.802 . . . . 1.31 109.733 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -48.89 -44.6 40.18 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.132 0.878 . . . . 3.91 110.66 175.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.6 m -65.0 -56.63 11.99 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.302 -0.629 . . . . 0.82 109.302 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.403 HG23 ' HB2' ' A' ' 67' ' ' PHE . 74.7 mt -46.89 -49.87 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.454 1.102 . . . . 1.47 110.88 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -58.1 -53.76 54.63 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.797 1.239 . . . . 2.15 111.0 174.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.2 p -60.06 -29.99 68.91 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.316 0.488 . . . . 2.28 112.316 -172.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.38 -97.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.59 -0.522 . . . . 2.88 109.59 167.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.29 35.94 0.44 Allowed Glycine 0 C--N 1.337 0.607 0 O-C-N 121.167 -0.958 . . . . 0.81 112.403 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.403 ' HB2' HG23 ' A' ' 62' ' ' ILE . 26.0 m-85 -131.57 159.37 38.42 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.465 1.132 . . . . 2.22 110.283 -165.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -99.5 155.86 17.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.597 -0.89 . . . . 3.66 108.597 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.72 162.47 35.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.349 0.26 . . . . 1.15 110.953 162.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.0 m -155.44 116.93 4.0 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.79 0.836 . . . . 1.85 109.847 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.42 65.58 0.44 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.029 0.932 . . . . 2.51 110.743 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.8 p -74.46 65.41 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.406 1.082 . . . . 3.32 108.888 174.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -130.07 140.08 50.88 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.52 1.528 . . . . 4.47 107.966 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.6 mt -125.16 132.22 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 103.916 -2.624 . . . . 6.13 103.916 167.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 124.698 1.199 . . . . 11.12 110.114 -170.489 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 106.434 -1.691 . . . . 11.58 106.434 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.01 156.72 27.11 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 106.536 -2.626 . . . . 3.57 106.536 174.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t70 50.75 -139.6 0.91 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.401 -0.963 . . . . 4.04 108.401 -165.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.48 101.43 0.57 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 106.626 -2.59 . . . . 1.63 106.626 -172.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.5 p -129.57 134.89 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.458 -1.312 . . . . 1.94 107.458 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.4 tp -145.29 113.3 6.47 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.919 -1.141 . . . . 2.09 107.919 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -94.0 133.23 37.67 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.681 -0.488 . . . . 3.32 109.681 165.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -131.94 148.73 52.54 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.558 -1.275 . . . . 2.24 107.558 172.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.42 ' HB ' HG22 ' A' ' 72' ' ' VAL . 1.5 t -79.71 142.72 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 106.174 -1.788 . . . . 0.81 106.174 162.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 p -122.73 96.12 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 125.682 1.593 . . . . 2.46 107.678 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -80.87 59.76 3.85 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.388 -0.82 . . . . 6.84 109.768 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.57 0.42 0.21 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.988 -0.896 . . . . 1.46 114.419 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.5 mtm -77.13 76.88 3.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.411 1.605 . . . . 1.64 109.735 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -75.67 -11.63 60.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.886 -1.055 . . . . 1.97 112.963 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.8 p -160.75 172.51 16.92 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 120.008 1.276 . . . . 1.03 109.2 172.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.23 -44.98 11.52 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.459 1.104 . . . . 1.24 111.466 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -50.38 -40.94 51.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.745 0.418 . . . . 2.48 110.846 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.0 m -58.97 -34.6 71.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.41 0.522 . . . . 1.14 112.41 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.66 -67.94 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.738 0.78 . . . . 0.94 109.19 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.76 -32.25 73.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 118.399 -0.81 . . . . 1.38 111.279 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -53.85 -52.84 59.11 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.767 1.167 . . . . 2.96 109.975 172.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.5 mt -54.93 -64.3 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 109.032 -0.729 . . . . 0.81 109.032 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -56.42 -54.73 42.23 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.907 -0.717 . . . . 4.22 110.164 -171.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -51.64 -43.83 62.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.464 1.106 . . . . 0.8 111.98 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.4 t -70.67 -33.28 70.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.208 -0.933 . . . . 1.3 109.852 -175.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.01 -48.15 38.84 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 111.745 0.276 . . . . 2.64 111.745 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.43 ' HA ' HD11 ' A' ' 32' ' ' ILE . 16.2 p -60.29 -18.38 48.91 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.737 -1.227 . . . . 2.12 113.671 -165.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -39.3 63.11 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.138 0.792 . . . . 5.35 113.138 168.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -60.92 167.98 2.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.382 0.992 . . . . 2.5 109.13 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.66 -18.53 12.75 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.773 -0.579 . . . . 6.9 111.869 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.27 -22.8 78.49 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 118.63 0.65 . . . . 1.15 112.015 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.43 HD11 ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -78.7 157.92 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 117.94 0.87 . . . . 3.29 109.785 174.689 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.5 mt -119.17 -46.43 2.51 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.02 1.328 . . . . 1.98 109.428 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -155.44 153.7 30.76 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 117.728 -1.13 . . . . 2.17 108.641 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.6 t -131.69 77.06 1.75 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.362 1.065 . . . . 2.77 109.472 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.51 85.05 3.89 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 120.75 -1.219 . . . . 3.43 109.82 -168.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.89 138.45 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 128.039 2.536 . . . . 2.67 111.841 -171.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.39 124.3 10.63 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 118.635 0.652 . . . . 1.14 111.629 172.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.4 mt -47.85 -43.79 28.59 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.97 0.908 . . . . 2.16 109.655 158.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.7 -24.71 1.48 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.49 1.116 . . . . 2.38 113.723 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 t -139.5 25.06 2.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.965 0.802 . . . . 3.05 112.438 169.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.2 m120 40.6 45.91 2.08 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.821 2.048 . . . . 1.8 112.816 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.99 170.81 14.82 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 118.543 0.611 . . . . 2.29 111.391 -171.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.11 130.19 23.34 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 125.176 1.547 . . . . 0.89 109.614 164.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -97.98 97.7 9.14 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.043 1.737 . . . . 0.99 107.618 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.5 mp -86.94 112.78 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 106.285 -1.746 . . . . 1.55 106.285 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -88.21 135.17 33.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.073 -1.825 . . . . 2.72 106.073 157.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -162.74 175.05 11.71 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.416 1.086 . . . . 1.85 109.253 -171.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -106.34 125.15 33.63 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 107.064 -1.458 . . . . 3.09 107.064 162.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.67 -6.36 18.11 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.696 2.93 . . . . 1.77 113.567 -171.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -108.33 -34.97 6.65 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.643 1.177 . . . . 3.93 109.074 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.0 mt -70.32 -33.51 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 O-C-N 121.765 -0.584 . . . . 3.55 110.648 169.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 tt -140.2 129.36 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.97 -1.122 . . . . 1.29 107.97 168.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.53 176.16 42.53 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.622 0.63 . . . . 1.57 111.902 -173.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.91 -57.0 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.797 2.332 . . . . 2.62 111.27 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.428 HH21 ' CD ' ' A' ' 63' ' ' GLU . 71.8 ttt180 -65.42 -33.65 76.46 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 117.958 -1.02 . . . . 6.34 110.695 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -35.6 -57.5 0.63 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.766 1.626 . . . . 2.32 111.486 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.6 mt -52.09 -58.89 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.937 1.295 . . . . 0.83 110.868 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.2 mm -50.66 -62.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 124.859 1.263 . . . . 1.72 109.409 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -49.68 -34.82 19.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.297 1.839 . . . . 4.89 112.03 176.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.2 m -65.34 -48.4 73.12 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.703 1.138 . . . . 0.77 108.82 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 59.3 mt -57.37 -47.07 85.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.584 0.753 . . . . 1.22 111.109 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 56' ' ' ARG . 49.7 mt-10 -51.46 -57.73 8.19 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.956 0.902 . . . . 2.28 109.261 172.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 t -65.77 -27.31 68.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.394 1.078 . . . . 1.32 112.291 -171.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.0 mt -65.83 -81.32 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.859 0.754 . . . . 2.31 110.04 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.25 25.94 0.26 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.599 -1.112 . . . . 0.77 113.235 171.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -134.29 176.44 8.6 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 118.825 1.313 . . . . 1.88 112.276 -153.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -127.41 136.34 51.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.357 -2.09 . . . . 3.24 105.357 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.19 153.67 35.92 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.27 1.028 . . . . 0.87 110.391 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.1 m -154.67 132.0 11.14 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.757 0.823 . . . . 1.73 109.6 170.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mp -79.58 58.03 2.61 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.251 1.42 . . . . 3.37 109.017 -175.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 9' ' ' VAL . 19.6 m -75.57 77.26 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 122.187 0.994 . . . . 3.81 111.192 -171.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -57.68 -27.88 63.28 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.561 -0.712 . . . . 5.82 111.109 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.7 mm -135.31 149.39 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 105.777 -1.935 . . . . 6.66 105.777 169.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 . . . . . 0 C--O 1.25 1.081 0 N-CA-C 104.225 -2.509 . . . . 13.14 104.225 157.701 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 105.515 -2.032 . . . . 11.53 105.515 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.63 160.74 40.48 Favored Glycine 0 CA--C 1.536 1.387 0 N-CA-C 107.765 -2.134 . . . . 4.19 107.765 135.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.401 ' OD1' ' NZ ' ' A' ' 47' ' ' LYS . 21.3 t0 -179.7 174.9 0.91 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.058 2.543 . . . . 4.22 105.172 175.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.3 -172.7 42.98 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 109.651 -1.38 . . . . 1.88 109.651 173.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 p -145.09 90.42 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.389 -0.967 . . . . 2.49 108.389 172.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 6' ' ' LEU . 1.4 tm? -78.51 80.01 4.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.779 -1.934 . . . . 3.12 105.779 170.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -84.7 123.73 30.71 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 114.071 -1.422 . . . . 3.54 108.802 168.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 157.78 39.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 123.648 0.592 . . . . 2.56 110.617 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -79.06 115.77 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 106.476 -1.676 . . . . 0.71 106.476 170.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.04 73.55 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 105.952 -1.87 . . . . 2.22 105.952 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.03 100.98 5.09 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.904 -1.887 . . . . 7.08 105.904 -166.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.92 -43.65 0.24 Allowed Glycine 0 C--N 1.334 0.441 0 O-C-N 120.343 -1.473 . . . . 1.43 113.548 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.31 75.74 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.105 1.15 . . . . 2.61 114.105 -173.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.2 t -69.35 -13.1 62.19 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.723 1.379 . . . . 1.98 114.723 -166.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.7 p -155.12 170.33 22.05 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.078 1.308 . . . . 0.72 109.931 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.35 -45.73 8.98 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.962 1.305 . . . . 0.67 111.542 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -54.1 -39.53 66.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.339 1.456 . . . . 1.79 112.029 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.1 m -71.98 -55.12 8.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.994 -0.373 . . . . 0.72 109.994 170.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.449 HG13 HG23 ' A' ' 37' ' ' VAL . 93.7 t -47.56 -60.62 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 123.655 0.782 . . . . 0.85 110.623 -173.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.72 -24.66 65.4 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.657 -0.652 . . . . 0.8 111.863 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -67.14 -48.26 68.58 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.773 -0.825 . . . . 3.56 108.773 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 67' ' ' PHE . 15.8 mt -57.4 -57.12 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 118.507 0.594 . . . . 0.83 109.432 174.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -53.53 -50.92 64.46 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.44 0.638 . . . . 3.53 110.386 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.0 t -56.72 -51.64 68.05 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 118.326 -0.845 . . . . 1.0 109.87 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 t -57.33 -44.61 84.4 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 119.494 1.043 . . . . 1.31 108.514 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.1 mt -56.44 -53.13 61.06 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.337 -0.847 . . . . 3.07 111.795 175.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.7 p -57.78 -10.41 1.65 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.923 1.083 . . . . 2.25 113.923 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -33.47 69.2 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.427 1.012 . . . . 7.16 110.863 173.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -78.65 148.44 33.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.614 -0.884 . . . . 2.27 108.614 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -95.34 -24.41 16.75 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.172 0.589 . . . . 7.07 111.29 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.31 -19.97 76.38 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 122.165 -0.335 . . . . 0.93 112.388 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -84.05 127.71 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 105.932 -1.877 . . . . 2.38 105.932 164.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.91 -38.0 33.48 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.442 -0.577 . . . . 2.47 109.442 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -155.48 153.54 30.45 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.752 -1.203 . . . . 2.32 107.752 -175.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.8 p -139.12 146.76 41.06 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 123.744 0.652 . . . . 2.14 109.359 168.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 t -144.5 105.17 4.15 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.154 -1.424 . . . . 1.58 107.154 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.449 HG23 HG13 ' A' ' 19' ' ' VAL . 9.1 m -90.45 159.05 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.703 0.801 . . . . 1.8 110.132 174.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.68 130.31 9.09 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 121.745 -0.597 . . . . 0.66 110.757 163.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 pp -68.1 -23.61 64.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 123.552 0.532 . . . . 1.47 111.957 165.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.43 -47.63 72.62 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.377 0.535 . . . . 1.21 110.084 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.99 -17.3 20.15 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.176 0.99 . . . . 1.97 112.144 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.56 38.26 25.35 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.883 1.273 . . . . 2.59 109.29 -162.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.55 160.83 16.81 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.311 0.645 . . . . 2.59 110.027 -173.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.433 ' HB2' HG12 ' A' ' 37' ' ' VAL . . . -134.4 122.21 22.24 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.147 -1.427 . . . . 0.71 107.147 159.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -96.36 108.89 21.48 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 104.455 -2.424 . . . . 0.93 104.455 166.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.8 mt -120.33 104.49 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.36 -1.348 . . . . 1.75 107.36 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' NZ ' ' OD1' ' A' ' 3' ' ' ASP . 6.3 mtpm? -79.97 138.68 37.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.367 -1.346 . . . . 2.71 107.367 172.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -159.58 147.78 17.44 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 119.196 -0.43 . . . . 1.99 110.828 -159.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -85.83 103.74 4.2 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 106.356 -1.72 . . . . 3.15 106.356 168.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.26 -54.64 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.573 2.182 . . . . 2.54 111.422 -165.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -53.83 -44.24 70.09 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.007 1.323 . . . . 3.02 111.819 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.2 -47.01 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 122.377 0.271 . . . . 2.96 110.624 -173.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -48.19 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 117.923 0.329 . . . . 3.98 110.87 -171.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.93 116.27 2.42 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 110.41 -1.076 . . . . 1.24 110.41 -170.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -59.95 -39.38 71.63 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 119.955 1.878 . . . . 1.13 109.653 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -37.89 -53.45 1.32 Allowed 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 125.378 1.471 . . . . 8.61 110.815 164.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -73.74 -36.05 65.12 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.996 0.918 . . . . 3.01 113.159 -174.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.1 mt -53.48 -48.94 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.356 -0.84 . . . . 0.78 109.636 166.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.5 mt -58.71 -47.2 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 109.495 -0.558 . . . . 1.52 109.495 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -50.21 -42.49 51.58 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.692 0.678 . . . . 3.04 111.033 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.4 m -60.48 -54.48 45.06 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.279 0.945 . . . . 1.21 109.092 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.1 mt -52.13 -51.64 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.382 1.073 . . . . 1.52 111.758 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -60.06 -56.99 14.81 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.257 1.023 . . . . 2.24 110.463 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -52.93 -42.95 65.89 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.629 1.172 . . . . 1.46 110.632 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.5 mt -62.56 -70.91 0.18 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.437 -0.316 . . . . 2.32 110.573 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.64 -10.34 0.04 OUTLIER Glycine 0 CA--C 1.531 1.044 0 N-CA-C 117.614 1.805 . . . . 1.17 117.614 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.482 ' CD2' HD11 ' A' ' 22' ' ' ILE . 30.5 m-85 -133.23 156.35 47.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.845 1.823 . . . . 1.82 111.533 -137.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -80.23 159.04 26.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.179 0.992 . . . . 3.63 108.551 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.15 141.96 50.63 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.577 1.151 . . . . 1.42 109.432 172.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.7 m -153.37 110.0 3.4 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.543 0.737 . . . . 1.69 109.72 170.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -58.77 130.97 49.45 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.768 0.713 . . . . 3.25 109.804 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.34 -94.41 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.241 -1.022 . . . . 2.49 108.241 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.2 mttp 70.22 -53.87 0.63 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.981 1.712 . . . . 5.37 111.927 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.44 HD13 ' H ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -122.19 165.52 17.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 124.326 1.051 . . . . 5.48 108.769 168.338 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--O 1.255 1.358 0 N-CA-C 104.48 -2.415 . . . . 11.07 104.48 174.969 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 109.244 -0.65 . . . . 7.19 109.244 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.24 67.06 1.84 Allowed Glycine 0 CA--C 1.527 0.811 0 N-CA-C 109.384 -1.486 . . . . 3.85 109.384 170.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -149.83 156.7 42.25 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.318 1.047 . . . . 4.1 108.996 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.72 163.37 27.63 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.813 -1.315 . . . . 1.42 109.813 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 m -109.77 101.22 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.856 1.662 . . . . 2.32 108.975 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.33 106.19 18.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.672 -1.233 . . . . 3.19 107.672 175.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -107.46 103.4 12.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.268 -1.012 . . . . 3.61 108.268 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.3 mt -106.09 144.58 32.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.081 0.953 . . . . 2.35 108.458 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.49 128.22 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 104.721 -2.326 . . . . 1.09 104.721 151.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 p -101.23 85.31 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.014 1.326 . . . . 2.57 107.554 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -83.27 59.25 4.9 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.312 1.045 . . . . 6.21 109.633 -169.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.67 -44.01 0.03 OUTLIER Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.849 -0.691 . . . . 1.35 112.959 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.18 131.78 52.04 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.674 -0.861 . . . . 2.73 108.674 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.2 p -94.08 -57.32 2.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.053 0.541 . . . . 3.27 110.317 -175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 p -134.44 176.97 8.13 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.477 0.711 . . . . 0.69 112.2 -160.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.43 -42.99 10.95 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.674 1.189 . . . . 0.63 111.9 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -54.4 -48.45 71.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.967 0.507 . . . . 2.44 109.72 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.6 m -67.29 -41.43 85.42 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 122.091 -0.381 . . . . 0.82 111.053 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.45 HG13 HG23 ' A' ' 37' ' ' VAL . 93.1 t -53.5 -63.96 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 122.591 0.357 . . . . 0.73 110.408 176.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.261 0.1 OUTLIER -70.68 -25.89 63.18 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.991 -1.068 . . . . 0.89 112.356 -175.639 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -55.01 -52.46 63.09 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.629 0.65 . . . . 3.52 109.703 167.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.1 mt -52.48 -63.83 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.235 0 N-CA-C 108.876 -0.787 . . . . 0.82 108.876 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -56.54 -51.38 68.76 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 120.595 -0.442 . . . . 3.58 111.366 -171.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.6 t -58.19 -43.46 87.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.5 -0.762 . . . . 0.98 110.408 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 t -63.18 -56.19 18.8 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 120.022 1.283 . . . . 1.25 108.1 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.41 -45.08 89.08 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.303 -0.862 . . . . 2.42 112.242 -175.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.418 ' HA ' HD11 ' A' ' 32' ' ' ILE . 32.8 p -58.59 -17.19 19.86 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.943 0.72 . . . . 2.11 112.943 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -65.93 -28.37 68.87 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.246 0.93 . . . . 6.85 111.088 173.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -83.88 105.23 14.61 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 108.565 -0.902 . . . . 2.09 108.565 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -57.11 -17.94 12.76 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.526 0.936 . . . . 5.96 113.526 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.8 -27.77 70.63 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.185 -0.786 . . . . 0.89 112.122 172.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -84.38 145.31 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 119.186 1.493 . . . . 2.47 108.38 169.24 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.4 mt -109.57 -39.42 5.16 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.678 1.191 . . . . 2.01 109.695 -168.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -155.16 149.54 26.13 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.715 -1.217 . . . . 1.95 107.715 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.9 m -124.89 147.39 48.84 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.679 -1.23 . . . . 2.01 107.679 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 m -154.48 85.04 1.12 Allowed 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.982 1.313 . . . . 2.02 108.921 172.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG23 HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -79.11 157.74 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 123.291 0.636 . . . . 1.75 110.678 172.136 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.33 144.94 22.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.063 0.545 . . . . 0.9 110.332 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -85.53 -41.33 15.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.956 1.302 . . . . 2.67 108.675 170.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.45 -16.42 3.69 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.071 1.348 . . . . 2.36 112.977 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.6 m -140.79 20.03 2.33 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.432 -0.793 . . . . 2.2 110.392 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.3 m120 36.77 47.27 0.54 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.712 2.005 . . . . 2.24 113.834 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.45 171.7 13.93 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 117.986 0.357 . . . . 2.18 111.386 -165.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.59 108.03 5.56 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.54 2.336 . . . . 0.77 106.211 173.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -87.42 114.48 24.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.722 -2.325 . . . . 0.88 104.722 162.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 67.5 mt -123.16 111.5 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.399 -2.074 . . . . 1.99 105.399 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.96 134.23 36.24 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.014 -1.476 . . . . 2.65 107.014 170.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -148.32 149.57 32.06 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 117.815 0.279 . . . . 2.69 111.365 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -80.73 115.09 53.17 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 107.42 -1.326 . . . . 3.03 107.42 167.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -73.43 -13.11 25.24 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.124 2.55 . . . . 1.61 113.175 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -88.92 -44.87 10.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.513 -0.921 . . . . 2.82 108.513 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.5 mt -72.2 -42.26 66.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 122.848 0.459 . . . . 2.88 110.556 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 mm -125.14 115.47 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.18 -1.785 . . . . 1.25 106.18 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.58 148.51 51.24 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 108.178 -1.969 . . . . 0.89 108.178 171.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -57.44 -40.92 77.41 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 CA-C-N 119.493 1.646 . . . . 1.28 110.37 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.418 ' HG3' ' CE1' ' A' ' 60' ' ' HIS . 26.9 tpt180 -56.35 -28.56 59.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.553 -0.737 . . . . 6.12 112.153 174.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -71.7 -39.24 70.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 120.123 1.329 . . . . 2.5 112.046 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.5 mt -56.48 -47.46 81.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.604 -0.887 . . . . 0.83 108.604 171.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.6 mt -61.26 -45.23 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 118.851 -0.595 . . . . 1.19 110.204 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.418 ' CE1' ' HG3' ' A' ' 56' ' ' ARG . 29.4 m170 -50.85 -43.55 59.31 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.371 0.987 . . . . 3.72 110.201 173.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.6 m -65.54 -54.54 26.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.35 -0.981 . . . . 0.98 108.35 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.8 mt -49.02 -53.41 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.026 0.93 . . . . 1.46 110.823 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -52.48 -53.58 43.78 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.854 0.861 . . . . 2.18 110.145 174.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.1 t -62.73 -26.53 68.73 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 117.788 -1.101 . . . . 1.3 113.091 -174.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.16 -91.37 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.854 1.206 . . . . 2.2 109.937 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.98 40.89 0.42 Allowed Glycine 0 CA--C 1.524 0.604 0 O-C-N 120.936 -1.103 . . . . 0.97 111.646 174.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -138.82 176.44 8.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 117.954 0.877 . . . . 2.71 110.124 -162.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -133.64 164.61 26.82 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.434 -1.321 . . . . 4.22 107.434 167.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.12 166.78 23.27 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.97 0.908 . . . . 1.27 112.118 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.9 m -150.76 155.54 39.47 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 106.708 -1.589 . . . . 1.78 106.708 160.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp -71.63 144.5 49.4 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.557 1.072 . . . . 2.68 109.243 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 69.7 t -69.98 -65.9 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.754 -0.832 . . . . 4.41 108.754 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 165.83 18.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.233 -0.654 . . . . 3.96 109.233 173.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.9 pt -67.23 125.09 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.784 -1.561 . . . . 6.42 106.784 161.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 C--O 1.253 1.246 0 C-N-CA 124.86 1.264 . . . . 12.32 110.791 -175.291 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ttm . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 107.493 -1.299 . . . . 11.37 107.493 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.37 64.36 2.49 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 109.193 -1.563 . . . . 6.37 109.193 167.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -50.56 -60.63 2.83 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.844 1.258 . . . . 9.53 110.835 -168.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.76 -64.01 2.67 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.455 -1.058 . . . . 1.86 110.455 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -119.81 136.12 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 126.052 1.741 . . . . 2.14 110.407 -176.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.28 112.71 5.3 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 123.958 0.903 . . . . 3.14 108.822 176.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.62 113.8 27.61 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 122.992 0.517 . . . . 2.95 109.989 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.2 mt -86.51 157.07 19.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 124.645 1.215 . . . . 2.51 108.076 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.62 142.07 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 105.632 -1.988 . . . . 1.02 105.632 148.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.8 t -135.06 114.25 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 126.314 1.846 . . . . 2.01 106.821 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -110.37 170.97 7.73 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.73 1.212 . . . . 6.57 110.466 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.15 -47.78 2.42 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.723 -0.951 . . . . 1.3 110.723 -173.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -51.4 -45.71 62.63 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 121.964 0.888 . . . . 2.92 112.071 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.317 9.3 t 58.71 -63.25 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.986 2.114 . . . . 3.21 115.32 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 p -110.6 162.13 15.03 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 120.271 1.396 . . . . 1.44 112.82 -163.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.7 -48.17 5.5 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 125.58 1.552 . . . . 1.22 111.516 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -51.51 -48.43 62.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.098 1.359 . . . . 2.39 111.438 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.6 m -72.71 -42.89 63.69 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 122.147 -0.346 . . . . 0.95 110.858 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.3 t -52.1 -64.1 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 117.928 0.331 . . . . 1.17 110.553 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -28.46 68.2 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.847 -1.158 . . . . 1.57 111.716 -173.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -57.44 -55.23 37.49 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.389 0.675 . . . . 2.67 109.581 169.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.88 -52.07 53.36 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 108.996 -0.742 . . . . 0.95 108.996 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -50.83 -60.23 3.28 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.768 0.827 . . . . 3.54 109.785 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.2 t -53.65 -45.95 70.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.517 0.727 . . . . 1.17 110.417 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.7 t -58.96 -53.37 59.18 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.45 -0.944 . . . . 1.3 108.45 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.84 -50.76 44.14 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.911 0.884 . . . . 2.78 110.793 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.0 m -57.49 -24.88 58.43 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.732 0.641 . . . . 2.01 112.732 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -63.5 -33.1 74.82 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.356 -0.84 . . . . 7.89 110.792 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -55.18 143.1 28.67 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 108.558 -0.904 . . . . 2.51 108.558 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.79 159.65 16.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.084 -1.821 . . . . 6.93 106.084 163.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.45 -16.39 45.03 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 122.215 -0.303 . . . . 1.59 113.065 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 pp -78.86 141.14 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 108.191 -1.04 . . . . 3.16 108.191 170.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.6 -47.09 9.5 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.409 1.484 . . . . 3.26 108.318 172.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -156.98 158.09 35.93 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.706 -1.22 . . . . 2.27 107.706 -175.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 p -135.08 151.17 50.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.717 -1.216 . . . . 2.66 107.717 161.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 t -154.35 146.52 23.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.061 -0.718 . . . . 2.42 109.061 152.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.26 152.22 33.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 124.971 1.309 . . . . 1.83 110.207 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.25 155.97 34.75 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-O 121.026 0.441 . . . . 0.8 111.185 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.98 -8.51 14.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.77 1.628 . . . . 1.92 113.046 -165.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.53 -57.62 6.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.034 -1.099 . . . . 1.96 108.034 169.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -79.9 -28.99 39.76 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.203 0.601 . . . . 2.52 111.301 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 m120 73.91 56.59 0.1 Allowed 'General case' 0 C--N 1.343 0.3 0 C-N-CA 125.542 1.537 . . . . 1.61 108.235 -173.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -124.86 159.22 31.58 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.749 1.22 . . . . 4.07 110.793 -166.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -142.35 96.98 3.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 125.31 1.631 . . . . 1.05 107.894 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -81.16 102.42 10.29 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.506 -1.664 . . . . 1.16 106.506 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 46' ' ' ILE . 1.6 mp -101.33 150.11 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.027 -1.842 . . . . 1.74 106.027 167.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -120.57 137.64 54.3 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.931 -1.878 . . . . 3.15 105.931 161.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -150.69 154.8 38.09 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 123.579 0.752 . . . . 2.1 111.892 -167.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -74.75 126.02 88.92 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.308 -0.997 . . . . 3.67 108.308 159.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.57 -19.2 16.91 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.413 2.742 . . . . 1.71 113.296 -171.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -83.31 -47.34 11.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.625 -0.88 . . . . 3.46 108.625 -176.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 tp -71.98 -40.92 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 119.68 -0.2 . . . . 3.7 111.133 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mm -127.22 110.64 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.421 -1.326 . . . . 1.43 107.421 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.48 158.57 39.7 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 108.91 -1.676 . . . . 0.82 108.91 168.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -55.66 -40.47 85.1 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.25 1.967 . . . . 1.23 109.269 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -29.29 -58.23 0.15 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.119 2.168 . . . . 9.53 112.261 163.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -70.58 -43.5 69.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.7 0.762 . . . . 2.41 109.662 -168.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 mt -58.68 -51.54 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.87 -0.605 . . . . 0.85 109.405 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.2 mt -52.45 -55.48 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.218 -0.66 . . . . 1.18 109.218 176.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 56.0 m170 -51.53 -42.17 61.56 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.957 0.503 . . . . 3.51 111.284 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 31.2 m -62.18 -51.21 68.73 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.718 -0.614 . . . . 1.04 109.79 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -59.96 -40.85 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.465 1.106 . . . . 2.6 111.363 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.04 -53.54 57.15 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.871 0.868 . . . . 2.02 109.955 168.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.6 t -60.96 -27.41 68.24 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.495 0.718 . . . . 1.44 112.174 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.04 -85.9 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.719 -0.845 . . . . 2.02 108.719 166.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.74 18.54 0.18 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.489 -1.173 . . . . 1.24 114.608 169.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -132.58 151.85 51.8 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 119.441 1.62 . . . . 1.99 111.495 -148.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -78.5 163.96 25.13 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.119 -1.067 . . . . 4.86 108.119 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.12 158.09 42.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 121.395 -0.122 . . . . 0.94 110.902 160.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.5 t -155.18 134.52 12.46 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.543 -0.91 . . . . 2.53 108.543 173.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.14 120.93 24.36 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.6 -0.687 . . . . 2.33 109.283 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.6 p -156.74 151.9 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 O-C-N 121.92 -0.487 . . . . 2.94 110.946 -174.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 171.06 122.71 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 129.077 2.951 . . . . 5.21 106.475 169.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.1 pt -149.67 164.46 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 106.692 -1.596 . . . . 6.28 106.692 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 . . . . . 0 C--O 1.255 1.374 0 N-CA-C 104.945 -2.243 . . . . 10.73 104.945 173.58 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 107.275 -1.38 . . . . 12.01 107.275 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.04 -52.76 4.67 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.355 -1.098 . . . . 4.8 110.355 -173.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 3.98 95.99 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.537 2.735 . . . . 5.04 114.409 167.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.09 79.71 0.74 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.34 -1.504 . . . . 1.89 109.34 173.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.93 133.9 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 107.555 -1.276 . . . . 2.45 107.555 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 tp -136.09 121.06 18.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.215 -1.402 . . . . 2.29 107.215 162.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -109.53 70.81 0.74 Allowed 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 125.17 1.388 . . . . 3.58 108.361 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.615 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -78.32 149.96 33.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.13 -0.628 . . . . 2.79 109.439 178.253 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.47 135.26 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 105.52 -2.03 . . . . 0.66 105.52 164.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.08 131.75 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 125.509 1.524 . . . . 2.36 108.003 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -123.67 163.35 21.25 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.886 0.874 . . . . 5.58 109.834 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.56 -15.42 62.79 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.997 0.808 . . . . 1.23 111.856 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.481 ' SD ' HD12 ' A' ' 22' ' ' ILE . 50.8 mtm -70.33 77.61 0.54 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 117.891 0.846 . . . . 1.69 110.31 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -70.52 -14.87 62.69 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.984 -1.008 . . . . 1.59 113.35 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 p -161.64 169.93 20.68 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.652 1.114 . . . . 0.74 109.682 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.11 -36.73 30.9 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.331 1.052 . . . . 1.01 111.6 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -47.57 -38.84 15.17 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.334 1.853 . . . . 1.87 112.196 173.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.5 m -71.5 -54.81 9.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 122.039 -0.413 . . . . 0.73 110.117 172.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.4 t -49.05 -60.6 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.189 0.995 . . . . 0.98 110.494 -173.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -27.21 67.06 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.163 -0.615 . . . . 0.8 111.643 -175.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -64.69 -50.95 64.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.952 -0.759 . . . . 2.96 108.952 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.481 HD12 ' SD ' ' A' ' 13' ' ' MET . 19.9 mt -53.09 -58.35 3.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 N-CA-C 108.946 -0.761 . . . . 1.05 108.946 172.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -49.13 -57.71 6.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.417 0.627 . . . . 3.87 110.921 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -62.26 -41.18 98.22 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.268 1.027 . . . . 0.81 111.112 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.8 t -67.0 -45.23 78.2 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.534 -0.913 . . . . 1.16 108.534 -176.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.91 -49.31 47.14 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 118.796 -0.621 . . . . 2.85 112.203 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.4 p -54.87 -25.43 28.75 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.883 0.765 . . . . 1.94 112.632 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -45.34 -44.28 11.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.894 1.278 . . . . 6.19 112.646 168.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -64.94 117.53 7.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.422 1.089 . . . . 1.67 108.869 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -75.2 36.11 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.523 1.129 . . . . 6.54 113.354 -169.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -132.46 -5.81 3.19 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.397 1.475 . . . . 0.96 111.519 168.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.5 mm -83.84 109.46 17.37 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 N-CA-C 107.021 -1.474 . . . . 3.98 107.021 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.9 mt -79.72 -38.88 32.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.803 0.841 . . . . 1.93 109.489 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -154.38 158.21 39.7 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 108.809 -0.812 . . . . 1.93 108.809 174.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.9 t -139.36 134.84 33.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.244 1.018 . . . . 2.32 108.516 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.1 t -134.54 85.38 2.18 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.054 -1.091 . . . . 1.67 108.054 169.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 44' ' ' ALA . 1.1 m -78.9 149.76 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 125.234 1.413 . . . . 1.93 110.081 170.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.15 132.17 10.84 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.014 0.526 . . . . 0.77 109.756 166.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.88 -35.36 74.59 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 109.406 -0.591 . . . . 1.75 109.406 167.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.92 -35.82 64.58 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.786 0.835 . . . . 1.33 111.826 -174.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 m -119.26 18.04 13.04 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.868 0.867 . . . . 2.12 110.325 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.1 m120 33.95 48.89 0.25 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 126.279 1.831 . . . . 1.86 113.489 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.96 162.84 26.66 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.797 -0.446 . . . . 2.39 109.797 -169.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 37' ' ' VAL . . . -146.43 100.92 3.42 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.713 -0.847 . . . . 0.69 108.713 169.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -80.3 100.41 8.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.621 -1.992 . . . . 1.14 105.621 166.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.421 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.8 mp -94.35 135.36 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 105.797 -1.927 . . . . 1.62 105.797 165.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -100.45 117.02 33.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 104.831 -2.285 . . . . 2.19 104.831 158.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -117.14 168.81 9.95 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.544 0.738 . . . . 1.95 110.006 172.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.02 133.99 26.71 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 107.238 -1.393 . . . . 3.61 107.238 153.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -72.8 -10.69 25.2 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.558 2.172 . . . . 1.72 113.475 -174.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -83.22 -47.54 11.44 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.39 -0.967 . . . . 3.34 108.39 -173.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.8 mm -81.89 -36.72 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.723 -0.656 . . . . 2.66 110.927 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 mm -133.72 118.02 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 119.293 0.951 . . . . 1.38 108.534 -174.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.75 176.71 47.9 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 110.16 -1.176 . . . . 0.91 110.16 169.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.52 -42.17 22.52 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.663 2.242 . . . . 1.01 109.985 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.85 -54.71 5.04 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.212 1.405 . . . . 7.51 111.214 173.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -53.13 -55.93 20.2 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.462 0.574 . . . . 2.46 110.516 -176.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.9 mt -59.85 -53.26 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 116.236 -0.438 . . . . 0.77 110.012 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.9 mt -53.59 -54.66 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 109.487 -0.56 . . . . 1.08 109.487 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -52.06 -41.27 62.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.267 1.027 . . . . 4.31 111.531 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 44.9 m -69.85 -48.51 58.58 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.721 -0.474 . . . . 1.01 109.721 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.8 mt -51.47 -50.64 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 109.527 -0.546 . . . . 1.26 109.527 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.05 -55.58 31.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.934 0.893 . . . . 2.46 111.171 176.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.7 p -62.68 -32.12 73.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.899 -0.572 . . . . 1.78 112.054 -173.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.92 -85.44 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.57 0.623 . . . . 2.65 111.17 171.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.59 25.86 0.25 Allowed Glycine 0 CA--C 1.526 0.752 0 O-C-N 121.151 -0.968 . . . . 0.98 113.833 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.409 ' CD2' HD11 ' A' ' 22' ' ' ILE . 29.2 m-85 -137.2 177.35 7.93 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.617 1.209 . . . . 1.64 111.069 -155.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -120.43 157.57 29.04 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.856 -1.164 . . . . 3.48 107.856 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.41 152.98 40.68 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.75 0.42 . . . . 0.9 111.253 167.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.3 m -156.4 135.44 11.97 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.604 1.162 . . . . 2.2 109.38 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.4 mp -53.28 -67.58 0.24 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.271 1.028 . . . . 2.79 110.442 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.316 7.6 p 59.22 -43.82 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 128.967 2.907 . . . . 3.8 116.961 177.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -65.35 88.92 0.09 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.391 1.077 . . . . 4.78 111.764 -175.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.1 pt -57.87 169.56 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.972 1.309 . . . . 5.36 111.303 167.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.254 1.337 0 C-N-CA 127.919 2.488 . . . . 8.72 111.872 -176.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 110.198 -0.297 . . . . 13.01 110.198 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.4 62.09 0.64 Allowed Glycine 0 CA--C 1.52 0.393 0 N-CA-C 105.748 -2.941 . . . . 5.53 105.748 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -149.87 168.64 23.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.284 -1.376 . . . . 6.37 107.284 -158.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.32 95.42 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 108.417 -1.873 . . . . 1.29 108.417 170.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.54 131.38 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 106.442 -1.688 . . . . 2.21 106.442 168.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.2 99.19 5.77 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.091 0.956 . . . . 2.72 108.63 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -87.46 106.75 18.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.194 -1.41 . . . . 3.03 107.194 161.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.91 150.16 30.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.51 -0.922 . . . . 2.4 108.51 168.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.55 142.7 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 104.787 -2.301 . . . . 0.76 104.787 159.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.9 p -139.66 135.54 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 106.796 -1.557 . . . . 2.26 106.796 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -134.51 168.78 18.34 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.294 1.438 . . . . 8.18 108.915 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.88 -14.59 61.41 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.903 0.764 . . . . 1.29 111.222 -163.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.1 mtp -68.51 77.6 0.28 Allowed 'General case' 0 C--N 1.341 0.225 0 CA-C-N 118.194 0.997 . . . . 1.85 110.799 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.5 p -61.09 -41.39 96.57 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.72 -0.657 . . . . 3.05 112.516 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.3 p -156.28 -179.37 8.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.171 0.896 . . . . 0.7 112.794 -166.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.09 -40.7 46.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.812 1.245 . . . . 0.85 111.577 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 m -60.81 -29.49 69.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.086 0.554 . . . . 1.47 111.898 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.7 m -71.85 -58.58 3.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.902 0.774 . . . . 0.67 109.927 167.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.0 t -38.7 -64.78 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.937 1.295 . . . . 1.2 111.481 -177.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -28.45 65.98 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.181 -0.608 . . . . 0.96 111.69 -172.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -66.56 -52.49 45.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.88 -0.785 . . . . 3.44 108.88 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.6 -59.37 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 N-CA-C 108.341 -0.985 . . . . 0.7 108.341 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -50.15 -62.99 1.25 Allowed 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 124.057 0.848 . . . . 3.8 110.097 -175.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.6 t -56.32 -41.28 75.73 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.484 0.714 . . . . 0.82 111.163 -177.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 t -65.58 -54.13 32.19 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.417 -0.957 . . . . 1.17 108.417 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 mp -52.42 -46.58 66.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.794 0.438 . . . . 2.69 110.911 175.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.1 m -62.8 -9.83 10.87 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.964 0.728 . . . . 2.09 112.964 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -25.1 62.11 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.718 -1.239 . . . . 5.57 111.963 169.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -69.54 140.89 53.93 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 107.553 -1.277 . . . . 1.81 107.553 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.9 ttm-85 -81.81 -28.02 33.34 Favored 'General case' 0 C--O 1.226 -0.154 0 O-C-N 121.41 -0.807 . . . . 5.52 111.846 -177.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.8 5.47 83.7 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.454 -0.636 . . . . 0.91 113.802 -173.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.39 159.06 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 118.513 1.157 . . . . 2.99 109.415 164.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.4 mt -113.88 -39.78 3.9 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.466 1.506 . . . . 2.25 109.316 176.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -156.15 156.61 34.53 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.449 -0.575 . . . . 2.1 109.449 174.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.1 m -138.16 135.21 35.46 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.495 -1.669 . . . . 2.65 106.495 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.5 t -147.97 143.77 27.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.684 -1.598 . . . . 1.96 106.684 163.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 m -137.5 144.03 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.399 1.079 . . . . 1.79 108.741 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.29 111.55 6.81 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.638 1.175 . . . . 0.75 110.002 -175.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.94 -22.89 61.4 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.309 1.444 . . . . 1.38 113.152 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.51 -50.28 53.37 Favored 'General case' 0 C--O 1.226 -0.159 0 N-CA-C 108.38 -0.97 . . . . 1.55 108.38 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.61 -19.96 51.5 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.192 0.997 . . . . 2.09 110.878 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.4 m120 57.84 46.48 16.84 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 126.118 1.767 . . . . 1.55 109.971 -172.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.47 157.86 45.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.97 -0.381 . . . . 3.32 109.97 -170.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.69 127.65 25.71 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.844 -1.169 . . . . 0.98 107.844 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -99.17 98.27 9.28 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 105.332 -2.099 . . . . 0.96 105.332 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.0 mm -94.58 147.65 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 106.135 -1.802 . . . . 1.79 106.135 170.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -124.62 135.75 53.37 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.428 -2.434 . . . . 3.73 104.428 159.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -156.34 160.66 39.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.255 0.622 . . . . 2.08 109.902 -162.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -93.44 125.79 52.72 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.752 -0.833 . . . . 3.15 108.752 171.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.0 -14.28 29.15 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.824 2.35 . . . . 1.77 113.875 -172.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -121.19 25.4 9.56 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.866 1.212 . . . . 3.15 112.402 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.7 tp -132.39 -63.56 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 118.988 -0.529 . . . . 3.57 110.283 159.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.95 -44.28 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 119.669 1.122 . . . . 3.03 108.321 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.22 168.51 18.77 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.109 -0.567 . . . . 1.75 111.805 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -71.52 -57.28 0.1 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.043 1.829 . . . . 1.26 111.731 -170.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 ttt-85 -70.64 -20.16 62.75 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.064 0.765 . . . . 6.3 113.064 -167.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.31 -35.1 71.14 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.438 1.017 . . . . 3.8 112.93 -175.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.3 mt -48.84 -50.22 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 121.432 -0.793 . . . . 0.99 109.236 164.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mt -63.15 -42.6 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 117.715 -1.136 . . . . 1.18 110.727 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -49.55 -44.05 46.32 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.39 1.45 . . . . 3.46 110.152 170.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.4 m -66.29 -50.49 63.49 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.32 -0.622 . . . . 0.77 109.32 -175.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.476 HG23 ' HB2' ' A' ' 67' ' ' PHE . 64.0 mt -52.97 -52.81 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.537 1.135 . . . . 1.4 110.959 176.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -53.96 -53.92 46.06 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.107 1.363 . . . . 1.9 110.293 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t -58.91 -41.77 88.05 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.111 0.964 . . . . 1.24 111.436 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.3 mt -64.13 -84.05 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.584 0.353 . . . . 1.99 110.897 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.24 22.51 0.22 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.638 -1.09 . . . . 0.87 113.818 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.476 ' HB2' HG23 ' A' ' 62' ' ' ILE . 39.0 m-85 -134.92 162.62 31.9 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 118.945 1.372 . . . . 1.66 111.047 -156.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -115.78 152.1 33.93 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.335 1.454 . . . . 3.84 107.412 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.85 166.53 33.12 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.424 1.011 . . . . 1.34 113.276 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 p -155.33 123.21 5.73 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.193 1.397 . . . . 2.07 109.791 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -54.48 135.34 45.8 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.342 0.657 . . . . 2.22 109.942 170.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.9 t -95.4 -74.35 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.044 -1.095 . . . . 2.9 108.044 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? 62.59 -65.14 0.09 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.492 1.917 . . . . 5.59 113.931 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.3 mm 54.65 42.68 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.223 1.409 . . . . 5.48 109.381 -165.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 . . . . . 0 C--O 1.259 1.579 0 C-N-CA 130.398 3.479 . . . . 11.56 102.366 -172.89 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mmm . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 106.696 -1.594 . . . . 10.28 106.696 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 58.69 60.08 9.59 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 107.741 -2.144 . . . . 4.46 107.741 -163.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -136.11 176.56 8.58 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.416 0.524 . . . . 4.19 112.416 -145.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.04 66.06 0.32 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 106.955 -2.458 . . . . 2.05 106.955 172.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.33 129.2 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 109.416 -0.587 . . . . 2.15 109.416 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.36 136.8 39.95 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.259 1.024 . . . . 2.79 108.529 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.21 144.01 48.83 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.617 -1.994 . . . . 4.87 105.617 167.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.14 147.8 24.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.696 -0.853 . . . . 2.18 108.696 167.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.31 134.58 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 105.665 -1.976 . . . . 0.99 105.665 173.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.3 t -116.44 117.91 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 106.873 -1.528 . . . . 2.16 106.873 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.1 mtt180 -85.59 143.83 28.23 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.09 -1.078 . . . . 6.89 108.09 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.14 -1.0 58.98 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.088 -0.84 . . . . 1.2 113.684 173.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.3 mtp -71.4 72.38 0.69 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.138 1.469 . . . . 1.68 110.436 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -73.97 -17.0 61.06 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 117.683 -1.151 . . . . 1.55 113.819 -169.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.2 p -159.01 172.75 17.62 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 120.23 1.377 . . . . 0.89 110.724 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.58 -36.7 35.98 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.406 1.082 . . . . 0.88 111.794 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 t -56.53 -45.4 81.16 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.873 -0.417 . . . . 2.27 109.873 175.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.9 m -63.7 -47.81 79.63 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.684 -0.635 . . . . 0.7 110.527 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.2 t -49.66 -66.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.439 -0.578 . . . . 0.88 109.439 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.288 0.1 OUTLIER -71.19 -23.45 62.04 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 118.954 -1.098 . . . . 1.14 112.804 -173.523 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -52.99 -49.44 66.17 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.718 1.144 . . . . 3.43 109.15 169.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.7 mt -56.95 -59.05 3.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 109.529 -0.545 . . . . 0.79 109.529 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.3 -47.65 84.58 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.125 0.488 . . . . 4.65 111.064 -171.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -57.07 -33.91 67.74 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.818 1.247 . . . . 1.03 110.826 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.7 m -71.72 -60.64 2.13 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.705 -0.622 . . . . 1.67 109.409 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -54.6 -42.82 71.59 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.433 0.693 . . . . 2.74 112.179 -171.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.2 p -57.39 -18.77 19.33 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.462 0.542 . . . . 2.26 112.462 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -70.79 -27.81 64.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.041 0.937 . . . . 6.34 111.743 175.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -70.74 -12.05 61.32 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.039 1.125 . . . . 3.17 114.039 -165.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.6 mmp_? 72.17 -44.54 0.6 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 126.281 1.832 . . . . 6.91 113.567 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.15 53.21 1.79 Allowed Glycine 0 CA--C 1.525 0.689 0 CA-C-N 119.036 0.835 . . . . 1.65 111.223 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.44 133.55 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 106.722 -1.584 . . . . 3.4 106.722 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.0 mt -88.66 -45.55 9.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.833 -1.173 . . . . 2.28 107.833 167.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -157.15 154.32 29.14 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 122.198 -0.314 . . . . 2.6 111.017 -178.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.3 t -130.2 110.63 11.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.777 1.231 . . . . 2.08 109.932 170.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.1 t -115.71 84.9 2.18 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.224 1.81 . . . . 1.73 107.86 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.76 152.15 3.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.343 1.057 . . . . 2.1 110.341 174.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.08 135.06 12.95 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 119.394 -0.336 . . . . 0.84 110.137 170.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.55 -32.3 71.02 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 123.409 0.443 . . . . 1.54 110.203 168.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.86 -48.17 60.2 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.386 0.674 . . . . 1.28 111.281 -176.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -105.52 10.06 33.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.327 1.451 . . . . 2.24 111.451 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.3 m120 41.17 47.66 2.88 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.185 1.794 . . . . 1.61 112.299 -175.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.71 171.2 11.38 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.149 0.58 . . . . 2.45 111.679 -165.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.99 87.41 1.41 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.954 1.302 . . . . 0.92 109.809 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -79.25 96.47 5.93 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.797 -1.557 . . . . 1.06 106.797 171.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.32 141.31 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.983 -1.488 . . . . 1.67 106.983 171.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -114.52 116.42 28.79 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 104.207 -2.516 . . . . 2.6 104.207 165.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -125.69 157.3 37.66 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.874 0.87 . . . . 1.98 111.65 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.92 114.9 59.51 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.905 1.682 . . . . 5.05 107.879 176.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.79 36.2 0.6 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.481 2.121 . . . . 2.38 113.762 -166.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -140.22 33.23 1.91 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.421 1.088 . . . . 3.3 110.18 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 tp -171.83 -49.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 124.891 1.276 . . . . 4.01 108.671 -170.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mm -122.91 132.73 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 105.384 -2.08 . . . . 1.33 105.384 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.72 -179.7 19.48 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.839 1.685 . . . . 1.09 109.311 167.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.65 -40.59 28.97 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.338 2.025 . . . . 0.99 110.306 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -42.19 69.8 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.187 0.595 . . . . 9.59 111.469 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -58.98 -54.14 50.49 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.305 -0.628 . . . . 2.2 109.305 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.5 mt -56.9 -50.41 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 123.616 0.766 . . . . 0.69 109.933 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.6 mt -53.09 -57.42 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.316 0.646 . . . . 1.38 109.957 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -52.34 -44.59 65.27 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.236 0.614 . . . . 3.5 110.44 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.6 m -64.11 -51.2 65.13 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.308 -0.627 . . . . 0.81 109.308 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.3 mt -51.9 -59.7 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.792 0.837 . . . . 1.39 109.157 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -63.14 -47.91 80.71 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 119.676 -0.81 . . . . 1.91 109.979 -169.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 t -54.23 -39.95 67.23 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.154 0.582 . . . . 1.49 111.863 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.4 mt -61.23 -59.63 5.0 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.825 0.739 . . . . 2.33 112.431 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.31 16.0 0.14 Allowed Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.409 -1.217 . . . . 1.15 115.432 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -143.07 -179.74 6.55 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.008 1.404 . . . . 2.15 111.44 -142.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -127.91 154.4 45.57 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 105.765 -1.939 . . . . 3.67 105.765 163.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.95 154.52 27.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.98 0.809 . . . . 1.16 110.532 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.3 m -155.26 103.45 2.35 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.102 1.361 . . . . 2.39 109.453 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 mt -52.57 135.55 34.1 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.215 0.606 . . . . 2.43 109.453 169.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.8 m -137.13 141.78 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.977 -1.12 . . . . 2.96 107.977 176.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.79 176.32 1.23 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.728 2.011 . . . . 5.6 106.414 176.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.481 HD13 ' H ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -129.84 -175.94 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 106.227 -1.768 . . . . 6.2 106.227 160.434 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 . . . . . 0 C--O 1.249 1.044 0 C-N-CA 128.208 2.603 . . . . 10.13 104.483 163.42 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpt . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 110.033 -0.358 . . . . 8.65 110.033 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.08 44.87 1.4 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 106.301 -2.72 . . . . 4.38 106.301 169.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 167.48 157.05 0.03 OUTLIER 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.736 2.014 . . . . 4.24 106.737 -153.013 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.38 167.49 24.44 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 108.19 -1.964 . . . . 1.37 108.19 169.163 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.4 t -98.11 144.79 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 124.753 1.221 . . . . 2.66 108.909 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.8 tp -127.81 123.24 34.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 106.418 -1.697 . . . . 2.66 106.418 165.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -120.8 126.52 50.31 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 108.274 -1.01 . . . . 4.09 108.274 179.018 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.17 155.65 48.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 123.571 0.545 . . . . 3.05 109.994 178.186 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.45 112.24 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 104.435 -2.432 . . . . 1.03 104.435 166.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 p -79.6 137.6 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 106.889 -1.523 . . . . 2.81 106.889 166.61 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -139.28 173.54 11.44 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.194 1.398 . . . . 6.23 108.377 -179.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.39 -46.82 2.28 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.478 -0.649 . . . . 1.55 111.478 -176.486 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.16 136.92 46.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.531 -0.914 . . . . 2.45 108.531 -177.128 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -141.56 8.46 1.97 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.726 1.75 . . . . 1.93 115.726 -156.176 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.6 p -159.39 173.19 16.62 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 121.173 1.806 . . . . 0.7 111.782 174.334 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.59 -42.64 56.01 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.207 1.003 . . . . 0.59 111.135 175.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 m -65.93 -20.95 66.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.761 0.824 . . . . 1.7 112.286 178.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.3 m -73.51 -62.1 1.6 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.036 0.835 . . . . 0.82 111.222 158.526 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.1 t -39.43 -63.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 124.588 1.155 . . . . 0.91 111.457 -173.136 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -65.87 -29.87 70.38 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.439 -0.505 . . . . 0.77 111.579 -173.603 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -70.45 -44.78 67.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.68 0.792 . . . . 3.36 108.976 -178.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.2 mt -55.2 -59.14 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.393 -0.966 . . . . 0.95 108.393 175.244 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -55.77 -53.92 50.78 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 117.979 0.354 . . . . 3.87 111.014 -178.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -55.37 -36.51 66.42 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.005 0.922 . . . . 0.79 111.973 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 t -70.1 -54.72 11.8 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.132 -1.062 . . . . 1.2 108.132 177.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 mp -57.46 -42.72 83.12 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.155 0.582 . . . . 2.48 112.179 -174.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.3 p -60.09 -12.46 8.4 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.265 -0.897 . . . . 1.9 113.029 178.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.4 -32.59 74.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.093 0.86 . . . . 4.09 110.561 172.055 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -78.29 106.91 10.53 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.218 -0.66 . . . . 1.93 109.218 178.774 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -57.66 -20.82 36.18 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.871 -1.143 . . . . 6.07 112.62 171.086 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.3 -32.47 72.29 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.902 -0.943 . . . . 0.93 112.323 172.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -88.92 137.36 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 118.671 1.236 . . . . 2.43 108.098 170.545 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 mt -95.86 -36.53 11.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.552 0.741 . . . . 1.68 109.471 177.267 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -150.11 153.69 36.82 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.774 0.261 . . . . 1.78 110.483 173.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -137.28 130.46 30.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.421 1.888 . . . . 2.56 106.728 171.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.4 t -128.18 110.45 12.45 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 106.526 -1.657 . . . . 1.7 106.526 168.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.59 150.91 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.255 1.022 . . . . 2.67 110.72 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.17 122.54 5.59 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.856 -0.528 . . . . 0.79 111.177 174.085 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.12 -26.36 67.41 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.371 0.668 . . . . 1.6 109.936 161.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.2 -49.19 77.91 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.259 0.481 . . . . 1.17 109.884 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.45 -37.51 36.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.793 0.437 . . . . 1.99 110.349 173.222 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 m120 68.89 71.75 0.27 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.774 -1.565 . . . . 1.84 106.774 -151.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.33 158.11 43.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.173 -0.329 . . . . 2.46 110.251 173.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.27 129.58 47.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.547 -2.02 . . . . 1.14 105.547 151.424 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -107.4 116.53 32.11 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 102.85 -3.019 . . . . 1.01 102.85 166.236 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mm -107.9 149.5 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 104.728 -2.323 . . . . 1.69 104.728 174.2 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.94 139.8 47.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.2 -1.037 . . . . 2.44 108.2 157.155 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -162.82 160.83 25.65 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 124.092 0.87 . . . . 2.19 109.718 -153.653 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -93.37 124.61 57.03 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 108.882 -0.785 . . . . 3.57 108.882 168.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.74 -19.08 24.47 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.935 2.424 . . . . 2.04 113.689 -173.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.32 -48.7 10.88 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.003 -1.11 . . . . 4.17 108.003 176.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.4 mt -63.9 -40.13 87.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-O 119.227 -0.416 . . . . 3.11 110.038 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.3 tt -137.34 109.32 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.346 0.594 . . . . 1.39 110.91 173.079 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.88 141.01 47.26 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.411 -1.476 . . . . 1.17 109.411 172.52 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -55.71 -40.16 86.91 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.741 2.294 . . . . 1.08 111.815 -172.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -56.9 -29.53 63.09 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 118.178 -0.915 . . . . 6.45 112.369 178.327 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.23 -44.18 92.68 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 120.015 1.279 . . . . 4.12 110.35 -179.421 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.2 mt -56.56 -52.97 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.308 -0.627 . . . . 0.62 109.308 175.611 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.1 mm -51.04 -56.87 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.089 0.556 . . . . 1.96 109.833 177.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.33 -34.98 69.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.788 0.835 . . . . 4.69 111.465 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.3 m -65.47 -52.99 48.98 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.881 -1.155 . . . . 0.89 107.881 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.1 mt -50.9 -50.74 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.12 0.568 . . . . 1.22 110.237 176.018 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -53.54 -50.28 65.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.047 0.451 . . . . 2.25 110.39 175.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.7 t -67.28 -14.66 63.12 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.512 1.125 . . . . 1.26 113.305 -173.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 mp -72.13 -91.01 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.911 1.232 . . . . 2.15 107.709 165.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.44 35.88 0.48 Allowed Glycine 0 CA--C 1.523 0.586 0 O-C-N 121.347 -0.845 . . . . 0.82 111.815 169.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -130.61 177.52 7.32 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.552 0.676 . . . . 1.65 110.927 -156.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -119.73 148.43 43.41 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.593 -1.632 . . . . 3.67 106.593 175.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.58 133.42 32.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.919 0.887 . . . . 1.01 108.736 170.227 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.3 t -133.77 103.39 5.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.34 1.056 . . . . 1.77 109.002 -177.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.08 58.08 0.67 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.809 1.244 . . . . 3.11 110.879 178.625 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 p -64.28 -37.15 79.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.848 0.859 . . . . 3.81 110.484 176.55 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.9 tttm 40.08 79.72 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.726 2.011 . . . . 3.87 113.414 -178.245 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.2 tp -70.49 73.28 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.665 0.786 . . . . 7.47 110.068 170.26 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 . . . . . 0 C--O 1.254 1.298 0 C-N-CA 127.551 2.34 . . . . 10.25 109.675 -173.284 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.3 mtm . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 106.46 -1.682 . . . . 9.22 106.46 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.63 114.58 2.68 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 108.257 -1.937 . . . . 4.06 108.257 178.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -159.2 165.53 33.43 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.0 -1.482 . . . . 4.24 107.0 177.261 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.35 154.41 12.59 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 107.437 -2.265 . . . . 1.33 107.437 -176.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.74 91.57 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.678 1.191 . . . . 2.25 109.65 -177.173 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -80.71 79.24 7.38 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.277 -1.379 . . . . 2.74 107.277 175.453 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -102.23 116.01 31.75 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.096 -0.956 . . . . 3.85 109.615 174.167 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.91 166.42 24.52 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.915 1.286 . . . . 1.98 110.421 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.33 143.55 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 106.54 -1.652 . . . . 0.93 106.54 173.187 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.0 t -136.53 130.49 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 126.025 1.73 . . . . 1.89 107.356 175.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -132.03 156.43 46.28 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.262 1.425 . . . . 5.92 108.618 -174.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.34 -24.56 28.51 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.641 -0.533 . . . . 1.1 112.253 177.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.75 76.25 0.85 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.396 1.093 . . . . 2.23 110.201 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -70.21 -12.34 61.52 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 115.399 1.629 . . . . 1.6 115.399 -157.827 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.6 p -157.14 174.02 16.11 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 120.523 1.511 . . . . 0.73 110.724 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.91 -44.54 14.73 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.814 1.245 . . . . 0.74 111.529 177.648 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 m -57.67 -37.32 73.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.525 0.73 . . . . 1.5 111.854 178.507 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.6 m -71.43 -50.35 32.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.438 0.563 . . . . 0.78 110.306 171.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.9 t -52.38 -56.6 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 122.737 0.415 . . . . 0.9 111.01 -175.676 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -27.96 64.22 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.613 -0.679 . . . . 0.86 112.065 -177.325 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -57.77 -48.04 80.79 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.776 -0.824 . . . . 3.47 108.776 170.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 81.9 mt -56.67 -66.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 108.743 -0.836 . . . . 0.7 108.743 171.509 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -46.11 -56.43 5.64 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.176 0.99 . . . . 3.79 110.765 -169.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.4 t -57.63 -51.4 69.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.562 0.745 . . . . 0.88 110.175 -176.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -59.78 -40.66 89.0 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.438 0.637 . . . . 1.44 109.724 -178.337 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -49.83 75.01 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.547 0.739 . . . . 2.81 110.759 178.069 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.1 p -56.01 -41.48 74.96 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.202 0.91 . . . . 2.13 110.759 175.861 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -57.53 -9.67 1.21 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.96 1.304 . . . . 4.63 113.154 175.235 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -56.43 -32.83 65.26 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 119.975 -1.703 . . . . 3.24 111.334 164.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 70.62 -51.05 0.67 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 126.606 1.962 . . . . 7.56 110.927 -168.008 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.37 53.39 1.89 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.672 0.653 . . . . 1.6 112.775 178.55 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -136.54 172.02 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.399 -1.334 . . . . 3.17 107.399 172.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.9 mt -117.57 -42.12 2.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.197 0.999 . . . . 2.16 109.346 -178.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -155.8 156.22 34.39 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 108.659 -0.867 . . . . 2.36 108.659 175.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.1 m -132.8 130.4 39.81 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 105.613 -1.995 . . . . 2.76 105.613 176.596 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.6 p -144.74 98.01 3.12 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.643 -0.873 . . . . 2.67 108.643 173.073 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 p -116.13 139.81 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.493 1.517 . . . . 2.32 109.342 -172.116 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.67 123.65 6.28 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.072 0.549 . . . . 0.9 110.294 -172.136 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.48 -32.77 74.56 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 109.56 -0.533 . . . . 1.82 109.56 167.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.9 -34.44 67.9 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.792 0.837 . . . . 1.47 111.825 -176.14 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.0 m -117.44 21.9 12.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.843 0.857 . . . . 2.16 109.787 175.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.3 m120 25.6 61.4 0.07 Allowed 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 126.834 2.054 . . . . 1.56 113.66 -172.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.57 166.54 26.17 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 120.619 0.247 . . . . 2.47 111.277 -173.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.411 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -139.02 125.9 20.98 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 124.663 1.227 . . . . 0.68 108.395 160.103 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -108.26 102.16 11.31 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.075 -2.194 . . . . 0.85 105.075 171.123 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.411 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -102.38 118.37 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 105.402 -2.073 . . . . 1.74 105.402 171.65 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -81.14 130.17 34.9 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.267 -1.753 . . . . 2.59 106.267 164.573 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -139.74 149.18 43.29 Favored 'General case' 0 N--CA 1.46 0.068 0 C-N-CA 124.265 1.026 . . . . 2.04 109.736 -168.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.76 131.48 70.52 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.465 -1.309 . . . . 2.97 107.465 161.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -82.75 0.13 9.82 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.807 2.338 . . . . 1.48 114.268 -172.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -93.09 -50.39 5.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 119.677 1.126 . . . . 4.02 108.148 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.8 tt -70.88 -29.89 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.734 0.642 . . . . 2.64 112.734 -174.229 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mm -142.69 144.47 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 105.6 -2.0 . . . . 1.38 105.6 -172.407 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.53 -178.14 15.72 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.187 1.375 . . . . 1.2 110.902 171.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.48 -48.13 22.08 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.208 2.605 . . . . 1.51 110.511 174.08 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.4 -61.29 1.07 Allowed 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 125.016 1.326 . . . . 6.86 110.895 176.31 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -53.74 -54.38 38.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.644 0.735 . . . . 2.62 110.387 -173.408 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.2 mt -58.86 -53.75 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.808 -0.633 . . . . 0.72 110.023 -177.415 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.1 mt -54.11 -53.23 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.416 -0.587 . . . . 1.19 109.416 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 52.3 m170 -55.1 -41.25 71.37 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.332 0.653 . . . . 3.52 110.651 179.03 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.5 m -62.08 -52.11 65.25 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.11 -0.7 . . . . 0.75 109.11 178.188 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.52 -51.06 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 123.495 0.718 . . . . 1.72 111.086 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -58.31 -58.12 9.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.602 1.161 . . . . 2.13 110.197 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -51.52 -46.94 63.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.317 1.047 . . . . 1.22 110.471 -178.841 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.32 -53.74 52.88 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.404 -0.331 . . . . 2.25 111.225 177.184 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.82 -41.48 0.02 OUTLIER Glycine 0 CA--C 1.529 0.919 0 N-CA-C 115.641 1.017 . . . . 1.5 115.641 174.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -122.39 160.83 24.63 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.7 0.63 . . . . 1.78 112.7 -127.75 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -82.45 150.55 26.99 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.09 -1.078 . . . . 3.68 108.09 -179.233 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.72 160.04 43.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.81 0.444 . . . . 1.15 111.661 172.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.4 m -155.92 128.0 7.54 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.473 0.709 . . . . 1.71 110.871 177.246 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.5 mt -71.27 66.52 0.44 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.938 0.895 . . . . 3.14 109.546 169.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.54 97.78 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 109.217 -0.66 . . . . 3.21 109.217 178.425 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -141.95 122.29 13.98 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.457 -0.942 . . . . 4.64 108.457 173.7 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.8 mm -145.98 -62.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 104.161 -2.533 . . . . 6.78 104.161 178.133 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 C--O 1.248 1.017 0 N-CA-C 106.698 -1.593 . . . . 10.71 106.698 143.745 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 105.767 -1.938 . . . . 9.41 105.767 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.23 159.19 20.07 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 107.689 -2.164 . . . . 5.21 107.689 134.585 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -150.82 168.14 25.33 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.464 -1.68 . . . . 5.16 106.464 177.386 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.04 -2.48 12.48 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.239 1.4 . . . . 2.4 113.447 -178.344 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.8 t -80.79 129.23 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 120.094 1.947 . . . . 3.87 109.127 174.285 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -150.94 123.05 8.25 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.845 0.748 . . . . 3.17 110.102 -175.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.39 121.7 45.9 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.945 1.298 . . . . 5.39 110.926 175.042 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 mt -104.06 160.81 14.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.996 -1.112 . . . . 2.83 107.996 164.017 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -85.08 143.61 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 106.246 -1.761 . . . . 1.23 106.246 147.316 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.2 144.64 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 106.139 -1.8 . . . . 2.44 106.139 175.466 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -146.07 164.77 31.1 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.313 0.645 . . . . 5.89 109.958 -178.718 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.83 -10.14 40.83 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.577 1.084 . . . . 1.09 111.048 -173.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -73.23 79.16 1.3 Allowed 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.045 0.923 . . . . 2.1 110.144 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -64.33 -15.84 61.08 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.479 -1.248 . . . . 1.64 113.358 -177.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.0 p -165.12 175.84 9.02 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 120.511 1.505 . . . . 0.68 110.753 177.165 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.99 -40.07 43.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.935 0.894 . . . . 0.78 111.499 175.819 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -57.62 -27.27 62.62 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.83 1.252 . . . . 1.57 111.905 178.586 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.1 m -73.85 -64.02 1.09 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.414 0.552 . . . . 0.72 110.941 162.411 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.7 t -44.75 -55.95 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 124.369 1.067 . . . . 0.92 111.646 -168.545 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -30.71 69.57 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.074 0.464 . . . . 1.67 111.559 -175.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -38.4 71.61 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.594 1.158 . . . . 4.18 109.447 -172.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.0 mt -55.93 -64.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.583 -0.895 . . . . 0.76 108.583 176.491 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -57.51 9.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.407 0.683 . . . . 4.43 109.813 178.654 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 t -54.75 -43.7 72.93 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.514 -0.741 . . . . 1.02 111.791 -175.75 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t -71.52 -49.1 44.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.886 -0.508 . . . . 1.46 110.222 -177.835 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.4 tp -73.35 -52.29 14.37 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 124.813 1.245 . . . . 3.15 112.852 -173.098 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.7 m -59.54 -21.76 60.71 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.288 0.848 . . . . 2.9 113.288 -171.463 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -22.18 66.92 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.166 -0.959 . . . . 4.52 113.451 172.218 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -66.2 106.03 1.55 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.042 -1.096 . . . . 2.12 108.042 175.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -52.69 100.43 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.274 1.029 . . . . 6.09 109.862 175.43 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 144.4 -32.06 1.77 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.04 -1.224 . . . . 0.94 110.04 -169.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.1 mm -79.63 151.1 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.26 -1.385 . . . . 4.2 107.26 161.651 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 50.7 mt -114.21 -47.68 2.93 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.906 1.283 . . . . 2.11 109.42 175.161 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -156.19 150.33 25.37 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 108.117 -1.068 . . . . 2.97 108.117 -175.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.9 m -125.86 80.72 1.93 Allowed 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.149 0.98 . . . . 2.64 110.301 174.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 t -78.26 77.97 4.74 Favored 'General case' 0 C--O 1.237 0.43 0 O-C-N 120.787 -1.196 . . . . 1.49 109.203 178.697 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -91.13 141.04 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 125.035 1.334 . . . . 2.66 110.456 171.271 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.77 118.44 6.58 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.218 0.463 . . . . 1.24 110.662 169.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -55.57 -19.61 10.65 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.5 1.12 . . . . 1.33 113.624 177.756 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.14 -34.63 78.04 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.318 0.647 . . . . 1.34 110.939 175.416 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.74 -8.22 10.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.904 0.882 . . . . 2.89 111.651 -178.32 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m120 60.97 26.29 16.24 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 125.023 1.329 . . . . 2.26 110.976 176.44 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.66 161.98 13.67 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.026 -1.472 . . . . 2.68 107.026 -176.46 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -139.6 90.49 2.41 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 105.533 -2.025 . . . . 1.03 105.533 165.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -78.88 83.81 4.97 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 103.25 -2.87 . . . . 1.63 103.25 167.125 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.0 pt -81.46 165.24 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 106.503 -1.666 . . . . 2.97 106.503 170.309 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -127.78 133.86 49.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 105.352 -2.092 . . . . 3.44 105.352 160.197 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.93 176.41 9.3 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 126.13 1.772 . . . . 2.13 108.181 -169.359 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -111.62 132.99 21.62 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 107.568 -1.271 . . . . 3.08 107.568 155.472 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.26 -17.68 18.8 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.414 2.743 . . . . 1.93 113.489 -172.652 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -89.6 -50.17 6.23 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 118.878 0.763 . . . . 3.06 109.217 -176.098 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.2 pt -85.96 1.64 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 113.33 0.863 . . . . 3.22 113.33 -176.294 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -152.13 123.55 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 106.624 -1.621 . . . . 1.34 106.624 171.063 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.63 148.6 42.12 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 109.804 -1.318 . . . . 1.15 109.804 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -56.58 -44.05 49.28 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 CA-C-N 119.402 1.601 . . . . 1.05 108.504 165.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.489 HH11 ' CD2' ' A' ' 60' ' ' HIS . 6.8 tpp180 -51.16 -32.91 24.8 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 117.952 -1.023 . . . . 5.83 112.015 170.72 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -72.47 -43.39 63.79 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 121.173 1.806 . . . . 2.39 113.112 176.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mt -48.91 -50.99 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.221 -0.592 . . . . 0.72 109.469 165.022 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.7 mm -58.66 -44.88 90.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 118.246 -0.883 . . . . 2.08 111.45 175.57 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.489 ' CD2' HH11 ' A' ' 56' ' ' ARG . 21.7 m170 -50.44 -45.73 56.07 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.31 1.414 . . . . 3.14 109.348 177.1 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.0 m -65.49 -53.47 42.07 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.291 -0.633 . . . . 0.84 109.291 -177.489 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.1 mt -50.98 -52.07 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.636 1.174 . . . . 1.45 110.854 178.645 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -54.12 -55.88 23.4 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.151 1.38 . . . . 2.34 110.182 173.015 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -63.78 -26.23 68.54 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 118.224 -0.893 . . . . 1.39 112.84 -171.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.9 mp -73.55 -95.41 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.251 -1.018 . . . . 2.1 108.251 168.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.97 34.11 0.44 Allowed Glycine 0 C--N 1.336 0.549 0 CA-C-O 119.012 -0.882 . . . . 0.89 112.635 173.603 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -130.42 163.59 26.59 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.483 1.141 . . . . 2.15 110.408 -163.018 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -117.03 157.52 25.69 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 108.051 -1.092 . . . . 3.01 108.051 174.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.54 165.53 36.31 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 118.446 0.566 . . . . 1.41 111.735 172.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 p -155.11 147.95 24.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.284 1.433 . . . . 2.44 108.652 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.01 125.09 26.81 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 107.79 -1.189 . . . . 2.72 107.79 165.183 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.1 p -118.3 138.71 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 106.755 -1.572 . . . . 2.67 106.755 168.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.73 -44.64 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.608 1.563 . . . . 4.1 109.086 176.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.1 mm -100.4 -53.46 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.717 -1.216 . . . . 6.33 107.717 167.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 C--O 1.25 1.107 0 C-N-CA 125.318 1.447 . . . . 11.58 107.935 -168.736 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 107.079 -1.452 . . . . 11.88 107.079 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.8 -79.65 0.22 Allowed Glycine 0 CA--C 1.52 0.358 0 N-CA-C 107.95 -2.06 . . . . 3.86 107.95 178.161 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -157.16 170.24 22.95 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.945 -1.502 . . . . 4.67 106.945 163.643 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.11 108.96 0.38 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 106.372 -2.691 . . . . 1.3 106.372 171.495 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.55 96.18 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 125.368 1.467 . . . . 2.21 108.379 -177.201 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.9 tp -110.16 101.47 10.25 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.427 1.091 . . . . 2.33 108.21 -176.459 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -99.08 94.82 6.72 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.537 -0.912 . . . . 3.06 108.537 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -85.42 156.69 20.73 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.967 -0.753 . . . . 3.01 108.967 177.63 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.58 144.36 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.107 -1.442 . . . . 0.7 107.107 149.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.52 133.47 42.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.095 1.358 . . . . 2.31 109.237 177.568 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -137.37 166.12 24.58 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.04 0.536 . . . . 6.72 110.977 -177.099 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.55 -11.43 70.09 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.403 1.001 . . . . 1.33 110.726 -165.69 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 29.0 mtm -74.86 73.39 2.11 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.419 1.088 . . . . 1.71 110.192 -177.652 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.9 t -60.69 -37.09 80.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.459 1.104 . . . . 1.73 113.029 -170.175 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.4 p -145.04 167.27 23.09 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 118.81 0.732 . . . . 0.74 110.77 -173.347 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.5 -47.54 2.67 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.288 1.435 . . . . 1.07 111.965 -178.901 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 m -43.74 -42.43 5.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.445 1.098 . . . . 1.64 112.387 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.7 m -55.95 -36.0 67.29 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.393 0.677 . . . . 0.94 112.458 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.7 t -55.67 -60.29 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.2 0.524 . . . . 1.57 109.872 -177.139 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -71.25 -30.83 66.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.485 -0.769 . . . . 1.57 111.497 178.027 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -48.88 -45.52 41.2 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.137 0.881 . . . . 3.49 109.495 171.291 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.2 mt -69.59 -74.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 109.656 -0.498 . . . . 1.33 109.656 168.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -57.25 -48.4 78.96 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.435 0.561 . . . . 3.85 111.764 -161.296 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 t -63.39 -28.13 69.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.098 -0.477 . . . . 1.25 110.993 -178.137 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.2 t -71.99 -69.26 0.4 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.048 -0.723 . . . . 1.46 109.048 168.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.2 tp -54.62 -32.38 58.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.22 1.808 . . . . 3.2 113.165 -168.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.0 m -58.14 -19.74 35.08 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.151 -0.968 . . . . 2.02 112.656 176.216 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -57.04 -25.04 57.94 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.896 -1.127 . . . . 4.84 112.272 170.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -89.04 93.79 9.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.965 -1.124 . . . . 2.11 107.965 175.465 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.63 5.27 0.46 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.105 1.15 . . . . 6.14 114.105 -174.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.73 -26.86 73.95 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.243 -0.911 . . . . 0.96 111.423 164.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.48 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -79.75 146.28 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.438 -1.319 . . . . 2.45 107.438 170.803 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.9 mt -102.32 -42.51 5.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.368 1.467 . . . . 1.95 108.872 175.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -155.46 155.03 32.78 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 118.075 -0.964 . . . . 3.14 109.965 173.209 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -131.07 81.7 2.01 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.969 0.908 . . . . 2.77 109.519 178.256 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -77.69 78.89 4.19 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.019 -1.051 . . . . 1.47 108.945 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.0 t -79.86 140.01 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 126.311 1.844 . . . . 2.86 109.138 176.712 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.57 152.14 28.43 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.237 0.542 . . . . 1.15 110.789 169.12 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -95.84 -36.06 11.26 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.266 1.427 . . . . 1.68 109.938 -178.127 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.15 -36.99 32.41 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.114 0.966 . . . . 1.24 112.807 179.182 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.2 7.3 15.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.739 0.816 . . . . 1.92 111.445 174.481 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.3 m120 45.82 51.47 10.42 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.986 0.914 . . . . 2.06 111.744 -175.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -121.39 158.75 27.61 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.578 1.151 . . . . 4.46 110.253 -170.787 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.76 96.75 2.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.785 -1.098 . . . . 0.67 108.712 168.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -81.24 94.4 6.69 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.352 -1.351 . . . . 1.09 107.352 171.136 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.09 122.89 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 107.235 -1.394 . . . . 1.63 107.235 171.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -97.18 129.45 44.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.346 -2.094 . . . . 2.36 105.346 161.195 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -154.6 160.84 41.71 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.004 0.922 . . . . 2.3 109.757 -173.641 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.22 118.47 69.19 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 108.263 -1.014 . . . . 3.4 108.263 169.628 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -79.24 61.08 8.06 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.989 3.126 . . . . 2.19 111.877 -167.599 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -169.35 -45.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.08 1.352 . . . . 3.41 109.519 -174.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.2 mt -66.79 -33.12 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 122.77 0.428 . . . . 3.29 110.007 176.533 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.8 tt -146.78 134.9 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.241 -1.392 . . . . 1.54 107.241 178.664 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.17 161.69 37.88 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 111.304 -0.719 . . . . 0.86 111.304 178.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -60.21 -45.03 25.02 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.69 2.26 . . . . 0.93 110.382 177.234 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.44 HH11 ' CD2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -64.88 -30.59 71.6 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 118.739 -0.648 . . . . 7.01 110.988 177.057 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -66.66 -48.64 68.74 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.814 1.188 . . . . 2.62 109.547 177.378 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.8 mt -49.74 -57.77 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.996 -0.742 . . . . 0.77 108.996 170.448 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.5 mt -55.69 -47.16 79.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 118.72 -0.657 . . . . 1.03 111.53 -177.262 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.44 ' CD2' HH11 ' A' ' 56' ' ' ARG . 27.3 m80 -49.12 -45.52 43.62 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.611 0.764 . . . . 3.26 109.821 172.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.5 m -65.16 -48.94 71.75 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.435 -0.95 . . . . 1.01 108.435 -176.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.0 -61.65 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.2 0 N-CA-C 109.584 -0.524 . . . . 1.64 109.584 177.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -60.46 -37.84 82.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.464 -0.334 . . . . 2.15 110.344 -164.39 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.6 m -54.14 -33.9 59.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.84 0.856 . . . . 1.84 113.184 177.566 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.66 -60.17 3.43 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.368 0.986 . . . . 2.37 111.409 -176.289 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.95 22.61 0.19 Allowed Glycine 0 CA--C 1.526 0.742 0 O-C-N 120.645 -1.284 . . . . 1.13 112.925 166.74 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -134.28 176.58 8.47 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.537 1.168 . . . . 2.07 113.093 -143.467 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -128.89 160.02 33.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.891 -1.522 . . . . 3.83 106.891 167.51 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.71 163.53 31.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.02 0.528 . . . . 0.92 110.577 171.439 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -155.18 177.55 11.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.086 1.354 . . . . 1.94 107.773 173.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -121.4 143.86 48.99 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.213 1.005 . . . . 3.17 109.09 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.0 p -149.86 26.3 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.272 0.629 . . . . 2.97 110.162 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -102.04 103.45 14.05 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.373 -0.973 . . . . 4.45 108.373 179.587 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.2 mt -68.61 135.14 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.043 -1.465 . . . . 5.76 107.043 166.509 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 C--O 1.255 1.38 0 N-CA-C 103.964 -2.606 . . . . 10.86 103.964 -176.666 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.409 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 64.4 mtt . . . . . 0 N--CA 1.468 0.435 0 N-CA-C 108.792 -0.818 . . . . 9.3 108.792 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.64 -148.26 17.88 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 106.585 -2.606 . . . . 3.17 106.585 177.279 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -134.53 166.64 22.42 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.192 -1.781 . . . . 5.12 106.192 155.742 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.26 72.28 0.25 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 107.737 -2.145 . . . . 1.99 107.737 172.677 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.7 85.57 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 122.662 1.22 . . . . 2.45 108.864 173.241 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 tp -77.76 72.95 4.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.165 -1.05 . . . . 3.29 108.165 167.762 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.54 125.53 29.48 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.216 -1.356 . . . . 3.22 108.402 153.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -148.39 160.89 42.57 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 125.384 1.678 . . . . 1.9 109.208 178.377 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 42' ' ' ASN . 0.9 OUTLIER -77.88 137.57 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.705 -1.961 . . . . 0.97 105.705 168.732 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.3 t -116.43 135.21 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 105.612 -1.996 . . . . 2.03 105.612 165.123 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -110.01 169.25 8.85 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.838 -1.171 . . . . 7.41 107.838 162.5 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.39 -119.9 6.34 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 106.373 -2.691 . . . . 2.48 106.373 -152.476 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 47.0 mtm 36.14 60.84 0.82 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.075 1.75 . . . . 1.7 113.095 178.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.7 t -85.59 -9.81 56.78 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 117.916 -1.04 . . . . 1.51 112.964 -176.306 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.7 p -163.69 171.7 15.26 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.843 1.201 . . . . 0.71 109.708 173.63 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.97 -43.2 29.27 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.538 1.135 . . . . 0.57 111.538 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.9 m -65.6 -25.91 67.6 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.623 -0.703 . . . . 1.63 112.619 -179.329 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.1 m -73.36 -57.49 3.97 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 119.093 0.86 . . . . 0.82 110.455 163.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.1 t -43.79 -63.17 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 124.04 0.936 . . . . 1.19 109.971 -175.343 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.453 ' HA ' ' CG ' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -68.01 -10.55 54.49 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 119.732 -0.787 . . . . 1.24 113.052 -173.372 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -70.23 -41.29 73.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.0 -1.111 . . . . 3.1 108.0 -178.507 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.6 mt -55.74 -62.97 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.243 -1.021 . . . . 1.1 108.243 177.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 1.6 pt-20 -53.21 -57.65 9.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.993 0.517 . . . . 3.3 110.457 -179.596 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.8 t -51.43 -48.75 62.6 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.058 0.543 . . . . 1.12 111.422 -179.567 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 t -70.34 -33.22 71.23 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.801 -0.814 . . . . 1.35 108.801 -172.476 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.2 mt -70.32 -45.71 65.69 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.624 -0.672 . . . . 2.22 111.16 174.072 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.4 p -57.76 -15.67 8.81 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.513 1.671 . . . . 2.25 115.513 -168.522 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.94 -36.43 74.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.603 1.092 . . . . 5.49 112.136 168.578 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -66.85 138.86 57.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.687 -0.857 . . . . 2.06 108.687 177.03 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -92.03 -5.88 52.12 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.274 0.23 . . . . 6.25 110.963 169.234 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.4 -30.58 58.28 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.585 -0.606 . . . . 0.97 111.585 174.358 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.516 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -78.79 146.19 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.6 -1.63 . . . . 2.46 106.6 168.709 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.0 mt -109.97 -37.79 5.51 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.989 1.716 . . . . 1.91 109.288 -175.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -153.27 150.29 28.8 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.412 -0.958 . . . . 2.09 108.412 176.741 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.0 m -130.79 142.45 50.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.168 -1.419 . . . . 2.57 107.168 172.057 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.9 t -152.26 157.23 41.11 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.271 -1.381 . . . . 1.88 107.271 159.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.43 138.83 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 124.573 1.149 . . . . 1.73 109.257 -178.025 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.84 95.95 4.49 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.017 0.927 . . . . 1.52 109.03 177.346 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -25.59 44.34 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.89 0.33 . . . . 3.02 111.89 167.249 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.55 -40.48 68.76 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.301 0.64 . . . . 1.3 111.552 178.505 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.5 t -110.27 -15.34 13.99 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.836 0.855 . . . . 3.21 111.301 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.44 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.3 m-80 65.88 74.31 0.37 Allowed 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 126.493 1.917 . . . . 2.38 110.339 -171.072 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.46 145.92 21.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.17 -0.678 . . . . 4.17 109.17 171.081 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 46' ' ' ILE . . . -109.19 132.38 54.17 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 106.818 -1.549 . . . . 0.78 106.818 167.274 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -109.07 99.25 8.59 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 127.496 2.319 . . . . 1.01 104.953 176.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.467 HD11 ' HB1' ' A' ' 44' ' ' ALA . 3.2 mm -108.18 110.93 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 106.077 -1.823 . . . . 2.02 106.077 176.746 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.2 mmtt -82.45 128.83 34.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.3 -1.741 . . . . 3.14 106.3 165.515 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -141.88 157.2 45.27 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.84 0.856 . . . . 2.18 108.946 174.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.5 121.89 63.95 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 107.113 -1.44 . . . . 3.48 107.113 173.281 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.56 44.1 1.57 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.196 2.597 . . . . 1.99 112.588 -172.738 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' OE1' ' N ' ' A' ' 1' ' ' MET . 80.9 mt-10 -132.88 6.47 3.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.946 1.698 . . . . 3.57 110.838 -179.021 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -157.19 -30.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.866 0.866 . . . . 2.7 112.525 -162.437 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 tt -139.25 145.03 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.765 -1.939 . . . . 1.26 105.765 165.383 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.03 154.53 24.57 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.134 -1.186 . . . . 1.01 110.134 176.505 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -59.06 -38.5 86.94 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.056 1.838 . . . . 1.04 109.792 173.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -54.35 -39.52 67.19 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.678 0.791 . . . . 5.95 111.864 173.43 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -70.09 -44.83 68.24 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.797 0.726 . . . . 2.44 109.356 -177.51 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.7 mt -53.95 -52.27 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.394 -0.595 . . . . 0.84 109.394 173.048 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.4 mt -52.33 -53.93 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.164 0.585 . . . . 1.13 110.34 176.199 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -51.28 -44.24 61.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.858 0.754 . . . . 2.87 110.882 175.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.7 m -66.25 -40.75 90.43 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 110.075 -0.343 . . . . 1.25 110.075 -174.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.8 mt -56.55 -67.58 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.791 -0.818 . . . . 1.36 108.791 168.606 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -61.82 -43.51 98.71 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.548 -0.296 . . . . 3.8 111.372 -161.422 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.2 m -63.56 -13.1 38.26 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.249 0.833 . . . . 2.49 113.249 -174.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.7 mt -70.76 -80.16 0.06 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.322 -0.992 . . . . 1.97 108.322 171.629 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.94 42.41 0.45 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-O 118.759 -1.023 . . . . 1.01 110.828 165.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -131.25 177.16 7.68 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.823 0.812 . . . . 1.87 110.586 -161.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -134.51 145.95 49.26 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.915 -1.513 . . . . 5.0 106.915 176.367 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.44 150.94 48.99 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 120.57 1.532 . . . . 1.01 113.082 -178.724 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.8 t -155.31 129.18 8.66 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 109.064 -0.717 . . . . 2.69 109.064 166.648 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 pp -56.84 152.56 12.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.314 -0.625 . . . . 2.49 109.314 162.264 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.6 t -130.83 -86.58 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 106.157 -1.794 . . . . 2.96 106.157 174.284 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.4 mttp 61.63 171.05 0.11 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.054 . . . . 5.04 111.654 -173.336 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.7 mp 53.78 63.86 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 106.482 -1.674 . . . . 5.77 106.482 -157.354 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 . . . . . 0 C--O 1.256 1.442 0 N-CA-C 103.121 -2.918 . . . . 10.64 103.121 -152.258 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 106.896 -1.52 . . . . 10.92 106.896 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 166.89 140.36 2.88 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.07 -2.412 . . . . 3.22 107.07 178.115 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -76.53 110.63 11.24 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 118.028 0.914 . . . . 4.76 109.024 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.21 137.55 28.12 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 106.872 -2.491 . . . . 1.29 106.872 165.308 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -121.87 74.89 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 118.672 1.236 . . . . 2.59 109.058 -176.648 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 tp -79.99 71.8 6.72 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.766 -0.827 . . . . 2.45 108.766 -177.787 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -78.03 69.43 4.25 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.645 0.736 . . . . 3.55 109.153 -178.659 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.81 156.33 26.21 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.437 0.695 . . . . 2.21 111.097 -176.705 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.94 123.51 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.246 -1.39 . . . . 0.85 107.246 172.033 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.2 t -112.06 125.08 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.073 -1.825 . . . . 2.11 106.073 176.287 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.22 176.83 5.4 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.391 1.476 . . . . 6.09 109.231 -173.478 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.46 -69.52 3.24 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 108.767 -1.733 . . . . 2.41 108.767 -177.558 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.6 mtp 2.31 66.42 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.864 2.866 . . . . 2.06 115.477 -178.468 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.5 t -87.69 -11.43 48.35 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 117.59 -1.195 . . . . 1.44 113.694 -161.82 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.6 p -164.78 178.9 6.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 120.418 1.463 . . . . 0.71 110.479 175.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.41 -39.64 47.72 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.538 1.135 . . . . 0.64 111.599 175.586 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -52.4 -43.05 64.53 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.552 -0.536 . . . . 2.63 109.552 175.684 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.7 m -65.33 -57.23 8.91 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 121.504 -0.748 . . . . 0.94 109.153 -178.672 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 83.7 t -40.47 -68.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.567 1.147 . . . . 0.99 111.33 177.386 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -31.43 68.99 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 119.474 -0.891 . . . . 0.74 111.876 -169.875 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -65.6 -48.12 73.37 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 121.617 -0.677 . . . . 3.82 109.319 178.169 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.4 mt -53.21 -61.23 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.048 -1.093 . . . . 0.8 108.048 173.33 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -51.3 -49.71 60.77 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.246 0.618 . . . . 3.71 111.793 -176.428 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 t -55.12 -53.42 56.09 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.999 0.519 . . . . 0.97 109.862 176.743 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.4 m -59.86 -40.1 87.44 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.223 0.535 . . . . 1.86 110.08 -176.699 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -51.52 63.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.922 0.889 . . . . 2.74 110.376 -179.608 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 26.5 m -58.01 -29.47 65.32 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.767 -0.651 . . . . 1.92 110.183 176.678 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -5.67 8.67 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.412 1.264 . . . . 5.03 114.412 174.446 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -74.02 -122.26 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 120.437 1.471 . . . . 3.44 111.378 -178.879 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.18 -62.45 0.09 Allowed 'General case' 0 C--N 1.342 0.259 0 O-C-N 120.928 -1.108 . . . . 12.63 110.466 177.707 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.72 47.28 3.62 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.575 -0.61 . . . . 1.13 111.575 -177.817 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -115.06 136.6 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.8 -1.185 . . . . 3.11 107.8 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.9 mt -97.73 -42.22 7.72 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.156 0.983 . . . . 2.06 108.671 175.209 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -156.11 154.04 30.3 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 110.017 -0.364 . . . . 2.16 110.017 -178.278 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 p -132.22 144.34 50.56 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.639 0.775 . . . . 2.69 109.453 162.24 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 m -154.07 122.58 6.2 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.881 1.272 . . . . 2.75 107.914 161.809 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -115.18 154.67 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.021 0.529 . . . . 1.58 109.886 -178.12 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.22 123.25 14.53 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.891 0.476 . . . . 0.81 109.918 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.96 -15.0 60.24 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.806 1.242 . . . . 1.46 112.546 177.438 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.58 -50.4 37.66 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.872 -0.788 . . . . 1.57 108.872 173.358 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.73 -24.53 41.57 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.586 0.754 . . . . 1.81 110.695 177.392 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.5 m120 62.75 47.9 4.44 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 125.69 1.596 . . . . 1.57 108.881 -170.542 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.48 153.28 51.76 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.796 -0.446 . . . . 2.22 109.796 -172.679 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.74 99.99 6.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 124.523 1.139 . . . . 0.98 108.83 173.182 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -78.45 89.26 4.42 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 105.751 -1.944 . . . . 1.13 105.751 172.356 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.2 pt -93.27 140.95 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 107.65 -1.241 . . . . 3.12 107.65 165.549 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -112.21 130.33 55.96 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 106.309 -1.737 . . . . 2.49 106.309 160.944 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -141.07 161.27 38.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.598 0.759 . . . . 1.8 111.361 -166.399 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -93.02 103.8 10.15 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 125.785 1.634 . . . . 4.34 108.105 178.656 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.25 59.6 7.46 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.909 3.073 . . . . 2.45 111.221 -168.37 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -173.39 -49.01 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.283 1.833 . . . . 3.29 108.04 -172.611 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.3 mt -74.65 -37.7 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 109.818 -0.438 . . . . 3.14 109.818 173.618 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 tt -128.87 126.42 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 106.593 -1.632 . . . . 1.26 106.593 177.45 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.14 174.86 52.99 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.437 -1.865 . . . . 0.99 108.437 168.145 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.11 -48.51 4.88 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.687 1.592 . . . . 1.12 110.137 175.48 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.25 31.4 ttt85 -70.1 -20.82 63.17 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.271 0.841 . . . . 6.18 113.271 -169.559 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -46.63 -57.18 5.03 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.638 0.654 . . . . 2.84 109.719 167.444 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.02 -48.21 84.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 109.425 -0.583 . . . . 1.29 109.425 -176.697 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.5 mt -56.59 -40.89 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.937 -0.574 . . . . 1.23 110.473 -176.34 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -52.52 -40.76 62.8 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 118.938 0.79 . . . . 3.05 111.644 172.772 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.2 m -66.47 -51.17 59.68 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.741 0.701 . . . . 1.23 109.314 178.296 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.87 -52.56 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.0 0.92 . . . . 2.05 110.735 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.2 -56.2 24.92 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.456 1.102 . . . . 1.88 110.322 174.178 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 t -65.57 -21.19 66.57 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 118.231 -0.89 . . . . 1.56 112.921 -171.988 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.2 mt -71.23 -96.27 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.008 -1.108 . . . . 2.03 108.008 166.478 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.71 36.93 0.47 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.575 -1.125 . . . . 1.14 112.053 171.053 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -131.86 127.65 37.0 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 118.569 1.184 . . . . 1.84 110.406 -166.106 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -78.73 159.63 27.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.555 -0.905 . . . . 4.16 108.555 178.636 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.34 142.4 50.08 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.883 0.873 . . . . 1.5 110.338 -173.862 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -155.23 124.24 6.2 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.654 -0.869 . . . . 2.28 108.654 167.738 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.0 142.89 49.35 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.256 -0.646 . . . . 2.83 109.256 172.589 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.0 m -139.92 150.05 22.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 106.014 -1.847 . . . . 2.68 106.014 178.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -146.21 -35.95 0.27 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 115.199 1.555 . . . . 4.33 115.199 -179.537 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 99.0 mt -128.23 -63.71 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 104.687 -2.338 . . . . 6.11 104.687 175.03 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 . . . . . 0 C--O 1.258 1.537 0 N-CA-C 105.409 -2.071 . . . . 11.91 105.409 139.569 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtt . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 108.893 -0.78 . . . . 7.45 108.893 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.67 63.93 3.02 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.607 -1.397 . . . . 4.3 109.607 175.165 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -168.59 167.36 11.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.228 1.411 . . . . 5.24 108.699 -166.388 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.78 150.49 6.19 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 106.997 -2.441 . . . . 1.32 106.997 -173.374 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.69 78.4 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.091 1.356 . . . . 2.6 109.632 -173.076 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.1 82.33 5.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.305 -0.872 . . . . 3.06 109.257 -175.946 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -85.15 117.21 23.97 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.655 -0.869 . . . . 4.4 108.655 165.113 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.86 169.78 16.86 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.088 0.955 . . . . 1.98 109.995 170.874 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -90.08 142.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.396 -0.965 . . . . 0.71 108.396 170.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.18 130.46 74.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 125.713 1.605 . . . . 2.47 108.353 174.085 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -121.94 144.55 48.8 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.208 1.803 . . . . 5.62 107.72 -174.282 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.78 -125.34 7.36 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 106.288 -2.725 . . . . 2.78 106.288 -163.91 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.8 mtm 49.73 68.61 0.71 Allowed 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.791 1.236 . . . . 1.55 112.288 178.015 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 p -61.39 -28.86 69.54 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.674 0.62 . . . . 3.49 112.674 178.489 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.56 171.22 16.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.751 0.705 . . . . 1.31 110.259 -171.402 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.45 -37.36 17.04 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.344 1.058 . . . . 1.0 111.45 176.113 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -47.95 -33.84 8.3 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.294 2.238 . . . . 1.59 113.06 174.328 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.7 m -74.89 -60.99 2.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.305 1.042 . . . . 0.79 111.445 166.554 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.3 t -45.62 -58.4 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.799 1.24 . . . . 0.93 110.947 -171.245 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.47 -30.58 71.36 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.175 0.512 . . . . 1.63 111.363 -176.454 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -71.29 -49.24 44.88 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.192 -1.04 . . . . 3.65 108.192 -176.39 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 77.0 mt -54.03 -56.15 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 108.572 -0.899 . . . . 0.66 108.572 174.849 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -64.98 -44.75 88.28 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.59 0.233 . . . . 3.9 111.627 -171.326 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.5 t -63.59 -42.29 98.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.209 0.603 . . . . 0.84 110.617 177.044 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.9 t -62.96 -50.82 69.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.365 -1.346 . . . . 1.5 107.365 -178.255 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.1 mt -47.17 -53.6 12.66 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 122.983 0.513 . . . . 3.09 111.459 174.287 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.8 p -58.4 -12.22 3.62 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.082 1.142 . . . . 1.98 114.082 -178.392 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -32.48 73.99 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.709 1.141 . . . . 5.05 111.956 172.599 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -88.24 110.26 20.58 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 108.067 -1.086 . . . . 1.99 108.067 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.8 -17.12 33.29 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.309 -0.869 . . . . 6.19 112.005 172.942 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.47 -33.99 67.74 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.911 -0.938 . . . . 1.01 112.686 169.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.24 128.34 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.783 -1.562 . . . . 2.56 106.783 172.71 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.3 mt -86.58 -35.53 19.41 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.821 1.248 . . . . 2.03 109.35 -176.117 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -154.8 147.36 24.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.295 -1.002 . . . . 2.09 108.295 177.393 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.8 p -124.75 147.18 48.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.02 0.928 . . . . 2.74 109.046 169.221 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.9 t -152.39 101.28 2.66 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.979 -1.119 . . . . 1.55 107.979 169.725 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.6 m -90.26 161.74 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.048 1.339 . . . . 1.92 110.441 176.419 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.64 138.39 14.23 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.281 -0.637 . . . . 0.79 109.281 155.19 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 pp -76.13 -32.47 59.15 Favored 'General case' 0 C--O 1.227 -0.099 0 N-CA-C 108.841 -0.8 . . . . 1.65 108.841 159.7 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.08 -15.45 23.31 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.282 1.033 . . . . 1.87 111.938 179.156 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.9 m -139.3 20.35 2.58 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 121.535 -0.728 . . . . 2.4 110.575 172.557 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.7 m120 33.41 43.72 0.06 Allowed 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 125.757 1.623 . . . . 1.7 114.121 -176.273 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.3 158.49 30.88 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.233 0.613 . . . . 2.64 110.089 -170.69 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.37 115.32 9.18 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.633 -1.247 . . . . 0.69 107.633 163.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -99.16 105.32 17.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 106.07 -1.826 . . . . 1.0 106.07 170.628 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.58 110.29 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 105.921 -1.881 . . . . 1.82 105.921 175.371 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -82.91 136.29 34.63 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.717 -1.586 . . . . 3.89 106.717 164.892 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -158.65 155.55 28.38 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 118.956 0.798 . . . . 1.72 112.864 -168.076 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -87.19 120.28 71.3 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.184 0.993 . . . . 3.17 108.432 167.03 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.07 -14.55 23.49 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.066 2.511 . . . . 1.96 113.695 -174.12 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -84.67 -47.7 10.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.175 -1.046 . . . . 4.11 108.175 176.693 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.2 mt -66.47 -36.91 78.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 119.256 -0.402 . . . . 3.14 110.569 -178.388 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.0 tt -144.03 124.2 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.845 -0.798 . . . . 1.31 108.845 176.39 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.79 154.37 52.17 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.335 -1.106 . . . . 0.87 110.335 179.421 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -57.87 -41.28 70.85 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.923 1.749 . . . . 1.01 109.88 174.228 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -62.88 -30.09 71.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.922 -0.561 . . . . 5.78 111.911 176.127 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -70.38 -44.94 67.01 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.556 1.071 . . . . 2.26 109.19 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 mt -52.47 -55.94 8.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.15 -0.685 . . . . 0.77 109.15 171.133 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.4 mt -52.2 -53.41 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 119.401 -0.333 . . . . 1.21 110.632 179.411 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -50.65 -43.49 57.21 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.024 0.53 . . . . 3.13 110.938 175.274 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.8 m -62.44 -49.49 75.24 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.561 -0.533 . . . . 0.78 109.561 -177.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.82 -54.47 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.209 0.604 . . . . 1.75 109.96 176.283 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -58.19 -50.66 72.76 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.428 0.691 . . . . 2.59 110.582 -176.377 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -54.99 -33.39 62.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.443 1.497 . . . . 1.16 112.217 -172.61 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.8 mt -63.55 -82.89 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.047 0.385 . . . . 2.07 110.612 178.461 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.98 33.12 0.43 Allowed Glycine 0 CA--C 1.525 0.701 0 O-C-N 121.217 -0.927 . . . . 0.95 112.775 173.355 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -135.08 176.06 9.01 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.26 1.03 . . . . 1.64 110.316 -159.671 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -130.3 136.57 49.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.507 -1.294 . . . . 3.78 107.507 172.387 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.73 156.97 16.31 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.559 0.744 . . . . 1.11 109.774 177.029 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.2 m -151.33 114.25 4.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.455 -0.942 . . . . 2.29 108.455 170.012 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.28 65.42 0.61 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.323 1.049 . . . . 3.42 110.849 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 t -55.44 124.41 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.083 -1.08 . . . . 2.9 108.083 169.547 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -167.25 148.08 5.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 104.44 -2.43 . . . . 4.53 104.44 179.9 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.2 mt -131.44 -64.48 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.085 0 N-CA-C 105.78 -1.933 . . . . 6.17 105.78 -178.455 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 . . . . . 0 C--O 1.248 1.002 0 N-CA-C 103.64 -2.726 . . . . 10.46 103.64 136.761 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 108.239 -1.023 . . . . 7.63 108.239 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.27 -118.29 0.88 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 103.314 -3.914 . . . . 3.48 103.314 136.14 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 63.02 28.47 16.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 117.662 0.731 . . . . 6.34 111.74 157.16 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.4 -168.97 36.95 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.461 1.029 . . . . 1.86 114.2 -160.281 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.98 133.44 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 125.974 1.71 . . . . 2.25 107.066 176.689 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 tt -139.13 103.56 4.8 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.425 -1.695 . . . . 2.86 106.425 173.214 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -112.29 117.28 32.06 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.524 0.602 . . . . 3.83 110.667 177.532 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.78 161.32 35.92 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.531 1.132 . . . . 2.8 111.08 -171.068 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.5 t -82.71 111.98 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 125.378 1.471 . . . . 1.08 107.411 176.879 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -86.85 73.75 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.679 1.192 . . . . 2.58 108.336 172.629 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.11 66.21 3.67 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.445 1.098 . . . . 6.77 109.71 -172.648 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.36 -44.4 0.02 OUTLIER Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.854 -0.899 . . . . 1.46 110.854 -175.416 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -61.4 120.05 9.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.562 0.681 . . . . 1.7 109.193 177.75 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 t -98.53 -45.65 6.02 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.988 0.515 . . . . 1.42 111.751 -172.91 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.0 p -130.59 172.75 11.59 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.758 0.708 . . . . 0.76 110.868 -175.125 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.46 -45.47 9.15 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.9 1.28 . . . . 0.86 111.922 179.422 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 m -54.41 -42.12 70.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.217 1.007 . . . . 1.5 111.584 177.814 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.6 m -71.41 -51.36 24.4 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.031 0.532 . . . . 0.96 110.643 174.736 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.3 t -44.75 -59.02 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.299 1.039 . . . . 1.0 109.988 -179.049 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.43 ' HA ' ' CG ' ' A' ' 23' ' ' GLU 0.306 0.0 OUTLIER -69.14 -14.88 63.24 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 119.257 -0.977 . . . . 1.25 112.028 -175.238 . . . . . . . . 4 4 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.1 tttt -71.34 -46.56 60.24 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 120.766 -1.209 . . . . 2.98 108.269 -175.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.4 mt -52.74 -67.67 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.221 -1.029 . . . . 1.1 108.221 177.378 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.43 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -47.73 -66.09 0.46 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.177 0.806 . . . . 4.25 113.177 178.466 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.2 m -50.69 -39.33 50.92 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 118.433 0.561 . . . . 2.41 112.216 -177.965 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.3 t -70.57 -60.78 2.06 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.441 -0.948 . . . . 1.24 108.441 179.224 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -52.58 -34.8 52.22 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.447 1.099 . . . . 2.56 112.296 -174.638 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.3 m -55.28 -22.59 19.22 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.947 0.721 . . . . 1.91 112.947 179.496 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -66.06 -23.76 66.6 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 120.101 1.319 . . . . 5.17 112.507 174.099 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -81.62 103.7 11.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.09 -1.448 . . . . 2.1 107.09 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 25.3 mtp-105 -57.19 -21.86 36.41 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.498 1.045 . . . . 7.09 112.13 173.256 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.82 0.97 18.0 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.743 -1.032 . . . . 1.67 113.951 173.191 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 pp -120.06 128.57 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 119.315 1.558 . . . . 2.57 106.933 159.175 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.4 mt -83.71 -30.66 26.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 110.257 -0.275 . . . . 1.78 110.257 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -157.07 151.6 25.42 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.589 -1.263 . . . . 2.26 107.589 178.085 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.5 t -128.65 119.14 24.14 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.882 1.273 . . . . 2.63 108.723 169.423 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 t -120.91 93.89 4.17 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.019 1.328 . . . . 1.51 109.975 -173.405 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -92.98 149.74 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.973 1.709 . . . . 2.49 111.719 -169.621 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.9 139.65 18.02 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.237 0.615 . . . . 0.85 111.666 168.592 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.0 mt -78.89 -54.52 5.96 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 125.541 1.536 . . . . 2.29 108.694 170.467 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -45.81 -42.61 12.47 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.63 0.772 . . . . 1.47 111.866 -177.28 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.4 ' HB ' ' CG ' ' A' ' 43' ' ' LYS . 3.1 m -101.02 -5.05 26.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.051 0.94 . . . . 2.63 112.247 -178.705 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.02 69.23 0.63 Allowed 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.988 1.315 . . . . 1.89 111.041 -178.574 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.4 ' CG ' ' HB ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -155.98 163.52 39.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.177 0.513 . . . . 2.17 111.56 -172.501 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -147.01 103.5 3.61 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.959 2.104 . . . . 0.85 107.427 171.097 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -80.37 106.41 12.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.37 -1.715 . . . . 1.04 106.37 172.811 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.0 mt -105.98 114.41 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 106.66 -1.607 . . . . 1.79 106.66 177.464 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -78.63 71.93 5.13 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.836 -1.172 . . . . 3.07 107.836 172.719 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.91 153.62 43.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.755 -0.657 . . . . 2.73 111.232 -179.122 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -106.17 117.53 57.19 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 108.869 -0.789 . . . . 3.13 108.869 162.041 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -67.27 -23.16 45.3 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.153 2.568 . . . . 1.63 113.009 -173.539 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -74.52 -43.46 55.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.302 0.955 . . . . 3.8 109.283 -174.609 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.6 tp -89.16 -34.96 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.339 0.496 . . . . 3.51 112.339 -179.129 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mm -133.47 112.68 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.487 -0.931 . . . . 1.65 108.487 -170.065 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.94 163.28 49.33 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 110.831 -0.908 . . . . 1.27 110.831 177.456 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -55.97 -43.26 58.5 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.721 2.281 . . . . 1.4 109.957 175.701 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -32.87 65.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.307 0.643 . . . . 6.89 112.66 176.201 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -70.12 -49.42 50.93 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.879 0.763 . . . . 2.6 109.012 179.139 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.6 mt -53.64 -57.25 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.034 -0.358 . . . . 1.21 110.034 174.936 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.9 mt -49.58 -54.95 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 123.646 0.778 . . . . 1.45 109.139 178.873 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -55.39 -41.4 72.61 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 111.51 0.189 . . . . 4.26 111.51 178.515 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 64.5 m -62.94 -49.6 74.11 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.794 -0.817 . . . . 1.16 108.794 -177.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.78 -53.85 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.487 -0.56 . . . . 1.41 109.487 174.627 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -56.02 -37.63 69.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.146 0.578 . . . . 2.21 111.522 -178.938 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.1 m -63.67 -15.88 59.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.461 -0.78 . . . . 2.2 113.094 -178.548 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.31 -96.6 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.593 1.088 . . . . 2.27 108.754 169.936 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.33 44.97 0.47 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.928 -1.269 . . . . 1.02 109.928 174.437 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -134.15 176.62 8.43 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.592 1.157 . . . . 1.86 109.169 -163.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -139.68 167.79 21.31 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.737 -1.208 . . . . 3.51 107.737 164.308 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -135.22 152.41 51.53 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.567 1.147 . . . . 0.9 110.384 -167.076 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.6 m -150.87 124.17 8.88 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.803 -0.56 . . . . 1.98 110.257 168.305 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.75 148.9 51.02 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.929 -0.767 . . . . 3.53 108.929 169.193 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -139.64 130.09 31.28 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 N-CA-C 105.069 -2.197 . . . . 2.65 105.069 176.566 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.267 0.1 OUTLIER 70.04 152.92 0.11 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.616 1.566 . . . . 3.79 111.374 -168.501 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.2 pt -68.95 149.49 11.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 O-C-N 122.12 -0.362 . . . . 8.11 111.23 -176.076 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 . . . . . 0 C--O 1.256 1.397 0 C-N-CA 129.217 3.007 . . . . 12.0 105.265 178.266 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.553 0 N-CA-C 107.421 -1.326 . . . . 8.81 107.421 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.39 80.63 0.15 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 108.636 -1.786 . . . . 3.43 108.636 161.746 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.3 156.43 12.6 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.246 0.618 . . . . 4.45 112.191 -173.02 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.16 142.62 15.53 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.23 -1.948 . . . . 1.59 108.23 170.347 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.47 158.47 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.517 0.727 . . . . 2.83 109.148 173.226 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.03 131.74 17.9 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.84 -1.541 . . . . 2.58 106.84 169.732 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -117.34 112.92 21.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.837 -0.801 . . . . 3.31 108.837 175.158 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.7 mt -109.93 136.16 49.66 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.244 1.417 . . . . 2.27 108.08 -179.349 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 42' ' ' ASN . 1.0 OUTLIER -78.54 96.45 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.255 -2.498 . . . . 1.66 104.255 156.678 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.5 t -82.69 131.21 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.004 -1.48 . . . . 1.73 107.004 172.571 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -144.2 136.85 26.93 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.771 0.828 . . . . 5.31 108.877 -169.717 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.4 -25.91 9.46 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.47 1.033 . . . . 1.31 110.775 -169.803 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -70.57 74.22 0.55 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 122.173 0.987 . . . . 1.61 110.972 179.461 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -50.68 -36.0 33.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.865 1.266 . . . . 1.61 114.303 -168.42 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 p -146.6 170.62 16.54 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.146 0.885 . . . . 0.92 111.978 -168.505 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.79 -41.8 24.36 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.583 1.153 . . . . 0.64 111.457 176.827 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 m -59.98 -33.2 71.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.158 0.583 . . . . 1.73 111.724 178.272 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.5 m -72.62 -46.26 54.95 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 119.007 0.821 . . . . 1.24 112.045 167.178 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.0 t -51.18 -60.98 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 118.262 0.483 . . . . 0.73 110.8 -178.611 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -27.65 65.0 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.383 -0.823 . . . . 0.91 111.931 -174.949 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -55.56 -54.68 41.05 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 108.698 -0.852 . . . . 3.33 108.698 169.496 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.468 HD11 ' CD2' ' A' ' 67' ' ' PHE . 61.8 mt -54.56 -59.39 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 118.451 -0.785 . . . . 0.74 109.012 176.564 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -50.83 -59.78 3.75 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 123.779 0.674 . . . . 4.24 110.288 -173.322 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.9 t -58.1 -45.78 86.64 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.653 0.781 . . . . 0.99 110.861 -176.122 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.5 t -64.78 -56.83 11.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.126 -0.694 . . . . 1.18 109.126 -178.038 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.5 tp -52.57 -51.4 59.94 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 125.012 1.325 . . . . 2.43 111.021 -177.626 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.6 m -62.87 -9.31 9.18 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.954 0.724 . . . . 2.8 112.954 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -31.28 72.44 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.557 -1.339 . . . . 4.82 111.523 168.481 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -79.75 71.87 6.43 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.948 -0.76 . . . . 2.25 108.948 -178.209 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -42.97 102.23 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.197 1.399 . . . . 6.68 110.137 177.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.24 -39.33 0.81 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.22 -1.552 . . . . 1.26 109.22 -164.167 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.31 140.86 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 104.346 -2.464 . . . . 2.83 104.346 148.579 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.5 mt -104.24 -42.56 5.47 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.576 1.15 . . . . 1.73 109.715 -175.658 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -146.71 153.06 39.82 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.856 -0.424 . . . . 1.99 109.856 176.162 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.3 t -136.93 136.37 38.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.484 1.914 . . . . 2.82 107.986 174.696 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -131.13 82.17 2.03 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.891 1.277 . . . . 2.02 107.876 172.108 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.407 HG12 ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -78.58 141.71 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.102 0.961 . . . . 1.8 110.268 172.341 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.77 151.07 26.82 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.196 0.598 . . . . 0.92 110.107 169.178 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.2 -11.97 14.52 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.812 1.245 . . . . 1.36 113.346 -165.935 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.99 -51.01 52.11 Favored 'General case' 0 C--O 1.226 -0.174 0 N-CA-C 108.576 -0.898 . . . . 1.73 108.576 173.824 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 m -79.81 -29.17 40.17 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.983 -0.553 . . . . 2.22 111.416 174.252 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.526 ' O ' HG22 ' A' ' 9' ' ' VAL . 63.6 m-20 67.2 79.71 0.23 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.242 -1.392 . . . . 1.66 107.242 -165.574 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -147.91 158.9 44.28 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.534 -0.543 . . . . 4.98 109.534 -176.186 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.407 ' HB2' HG12 ' A' ' 37' ' ' VAL . . . -146.64 108.86 4.44 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.519 1.928 . . . . 1.03 106.612 163.503 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -86.26 117.16 24.89 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.781 -2.303 . . . . 1.18 104.781 164.184 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.405 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.8 mp -109.29 148.36 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 105.293 -2.114 . . . . 1.89 105.293 171.358 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.48 141.25 51.05 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.692 -0.855 . . . . 2.36 108.692 156.995 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -154.46 153.93 32.34 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.315 1.046 . . . . 2.32 109.211 -163.03 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -84.93 114.25 54.62 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 107.665 -1.235 . . . . 3.52 107.665 173.163 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.23 52.51 4.31 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.07 3.18 . . . . 2.09 111.777 -170.399 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -144.82 -59.7 0.36 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.094 1.758 . . . . 2.82 106.874 -177.981 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.6 tt -72.63 -25.49 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.203 1.401 . . . . 2.37 111.972 179.721 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.8 tt -145.93 143.08 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.723 -1.584 . . . . 1.46 106.723 172.462 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -99.55 161.82 19.66 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.367 -1.093 . . . . 0.92 110.367 174.018 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -56.54 -41.12 79.38 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.501 2.134 . . . . 1.11 110.03 174.767 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.4 tpt85 -56.28 -36.03 68.14 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.09 -0.957 . . . . 6.11 111.726 179.175 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -71.26 -48.17 52.65 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.524 0.73 . . . . 2.19 110.026 -177.37 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 mt -49.63 -56.48 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 108.21 -1.033 . . . . 0.81 108.21 171.761 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.2 mt -56.05 -43.1 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.893 -0.594 . . . . 1.01 109.999 -179.787 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -56.7 -40.62 75.96 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.397 0.679 . . . . 4.34 111.414 176.308 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.16 -43.92 77.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 119.443 -0.903 . . . . 2.1 109.293 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.9 -52.0 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 124.52 1.128 . . . . 1.76 111.057 174.217 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -57.92 -55.52 33.8 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.595 1.158 . . . . 1.94 110.019 175.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.2 t -53.48 -43.42 68.18 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.262 1.025 . . . . 1.34 110.851 -175.589 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.2 mt -62.59 -66.14 0.58 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 110.312 -0.255 . . . . 2.12 110.312 173.697 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.99 -24.94 0.02 OUTLIER Glycine 0 CA--C 1.53 0.993 0 N-CA-C 117.504 1.762 . . . . 1.31 117.504 -178.223 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.468 ' CD2' HD11 ' A' ' 22' ' ' ILE . 13.5 m-85 -126.6 152.16 47.01 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 119.055 1.427 . . . . 1.74 110.535 -137.779 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -84.41 152.42 24.04 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.521 -1.289 . . . . 4.06 107.521 172.876 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -122.12 129.51 52.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.78 0.832 . . . . 1.05 109.478 163.514 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -108.36 104.41 13.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.496 -1.298 . . . . 2.75 107.496 169.954 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -53.69 126.42 21.84 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.019 0.827 . . . . 3.75 110.633 175.081 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.1 m -87.36 -34.45 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 117.966 0.348 . . . . 3.57 110.369 176.239 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -165.13 176.07 8.81 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.717 0.807 . . . . 5.59 109.354 172.056 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.5 mm -131.13 147.25 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 126.896 2.078 . . . . 11.25 105.393 173.501 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.254 1.317 0 N-CA-C 105.026 -2.213 . . . . 12.79 105.026 164.119 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 tpt . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 108.022 -1.103 . . . . 8.11 108.022 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.16 52.35 51.95 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 108.392 -1.883 . . . . 4.35 108.392 -161.892 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.339 2.6 p30 36.64 -108.5 0.05 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.737 1.215 . . . . 4.34 112.251 -153.293 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.3 126.43 2.28 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 106.239 -2.744 . . . . 1.41 106.239 -164.897 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.5 82.79 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 124.549 1.14 . . . . 3.25 110.635 -172.267 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 tp -81.55 81.67 7.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.201 -1.037 . . . . 3.38 108.201 175.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -95.0 102.77 14.6 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.155 -0.929 . . . . 2.89 109.029 171.377 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.6 151.0 40.88 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.755 1.222 . . . . 2.24 109.376 -177.55 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 t -77.6 129.87 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 105.717 -1.957 . . . . 1.01 105.717 166.046 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.4 t -111.35 97.7 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 105.452 -2.055 . . . . 2.3 105.452 174.068 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -81.68 146.43 30.02 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.267 -1.012 . . . . 7.22 108.267 178.756 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.13 -9.51 56.37 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.06 0.838 . . . . 1.04 112.1 -174.324 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.7 ttm -65.96 71.95 0.06 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.605 1.562 . . . . 1.95 110.935 176.676 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -71.98 -31.47 66.3 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.697 0.629 . . . . 1.52 112.697 -167.526 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.9 p -154.18 174.81 14.25 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.255 0.934 . . . . 0.83 112.397 -169.359 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.89 -41.26 45.27 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.503 1.121 . . . . 0.72 111.046 175.89 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.9 m -63.72 -24.79 67.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.174 0.589 . . . . 1.65 112.235 178.498 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.3 m -72.57 -62.6 1.39 Allowed 'General case' 0 C--N 1.337 0.05 0 CA-C-N 119.478 1.035 . . . . 0.95 110.086 163.207 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.7 t -36.24 -66.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 125.538 1.535 . . . . 0.88 111.072 -177.002 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.33 -27.6 66.41 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.705 -0.398 . . . . 0.83 111.604 -172.555 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -69.43 -55.63 9.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.912 -1.144 . . . . 3.54 107.912 -179.533 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.4 mt -50.02 -59.44 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.293 -1.003 . . . . 0.81 108.293 177.52 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.65 -56.01 25.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.186 -0.915 . . . . 3.88 110.338 -174.788 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.5 t -66.08 -29.59 69.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.168 -0.92 . . . . 1.56 112.271 -176.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.6 m -70.93 -50.66 32.23 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.957 -1.127 . . . . 2.34 107.957 179.38 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.2 mt -53.54 -46.57 70.24 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.468 -0.333 . . . . 2.4 110.831 175.163 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.2 m -56.4 -9.12 0.63 Allowed 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.964 1.098 . . . . 2.16 113.964 -179.252 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -75.92 -29.81 58.53 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.527 -1.358 . . . . 7.4 112.024 172.53 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -75.18 161.68 29.16 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.017 0.927 . . . . 2.05 109.509 -173.571 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.45 -42.76 7.57 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-O 119.131 -0.462 . . . . 8.24 111.479 -175.285 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.29 -12.75 69.67 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 119.112 0.869 . . . . 1.08 113.207 -176.588 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -77.54 159.31 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 107.785 -1.191 . . . . 2.59 107.785 168.18 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.3 mt -129.39 -41.1 1.4 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.223 1.009 . . . . 2.39 110.112 -172.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -149.84 148.22 28.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.646 -1.613 . . . . 2.06 106.646 174.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -128.87 126.25 39.36 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.232 -2.136 . . . . 2.65 105.232 178.473 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.1 t -144.54 104.93 4.11 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.831 -0.803 . . . . 1.49 108.831 178.233 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.95 148.64 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 123.63 0.772 . . . . 1.63 111.428 -175.766 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.74 109.43 3.45 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 122.08 -0.387 . . . . 1.13 111.759 -176.849 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.65 -15.42 19.08 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.919 1.081 . . . . 1.47 113.919 177.236 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.36 -35.27 76.99 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.874 0.47 . . . . 1.27 110.656 171.589 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -116.49 -6.21 11.7 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.748 1.219 . . . . 3.17 111.467 178.892 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.9 m120 56.64 29.32 15.48 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.838 1.655 . . . . 1.47 110.764 -179.762 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.66 144.64 37.73 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.495 -1.668 . . . . 3.19 106.495 -176.89 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.82 114.2 20.73 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.465 -1.68 . . . . 0.99 106.465 165.445 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -91.2 104.7 17.22 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 105.418 -2.067 . . . . 1.75 105.418 172.757 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 46' ' ' ILE . 2.1 mp -103.99 115.86 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 105.987 -1.857 . . . . 1.66 105.987 170.302 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -78.51 133.9 37.35 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 105.645 -1.983 . . . . 2.98 105.645 162.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -151.53 163.57 38.73 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.548 0.739 . . . . 1.85 109.84 -173.559 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -100.18 124.92 41.53 Favored Pre-proline 0 N--CA 1.449 -0.513 0 N-CA-C 108.552 -0.907 . . . . 3.48 108.552 163.04 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.79 -17.02 33.2 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.663 2.909 . . . . 2.03 113.663 -174.553 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.56 -44.47 11.89 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.416 -0.957 . . . . 3.1 108.416 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.6 mt -71.25 -43.09 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 122.244 -0.285 . . . . 3.41 110.82 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.59 118.93 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 105.83 -1.915 . . . . 1.46 105.83 -178.574 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.95 150.38 51.92 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 108.718 -1.753 . . . . 1.13 108.718 171.917 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -57.64 -40.48 79.63 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 CA-C-N 119.248 1.524 . . . . 1.06 109.736 175.059 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -42.8 -42.23 3.52 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.182 1.393 . . . . 7.44 112.578 168.134 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -71.28 -43.05 67.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.996 0.816 . . . . 2.2 110.121 -172.034 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.5 mt -57.78 -48.3 83.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 109.133 -0.691 . . . . 0.63 109.133 173.503 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.2 mt -54.41 -53.22 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.842 -0.429 . . . . 1.46 109.842 176.09 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -50.63 -45.71 57.82 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.599 0.636 . . . . 3.14 110.422 176.016 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.2 m -60.14 -52.08 66.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.269 -0.641 . . . . 1.06 109.269 -176.382 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.29 -61.96 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.534 0.734 . . . . 1.23 110.035 175.337 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -66.19 -25.24 66.84 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.308 -0.406 . . . . 3.22 111.438 -167.877 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.8 t -63.47 -15.73 58.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 117.789 -1.1 . . . . 1.58 112.891 175.419 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.38 -96.56 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 120.065 1.302 . . . . 2.91 108.664 170.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.72 50.65 0.42 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.739 -1.344 . . . . 0.97 109.739 177.856 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -135.92 175.03 9.97 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.351 1.06 . . . . 2.18 108.971 -170.826 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -141.01 140.89 34.38 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.254 -1.387 . . . . 4.87 107.254 173.824 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.54 159.7 18.55 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.476 0.655 . . . . 1.16 112.611 -173.108 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.4 133.86 10.8 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 125.03 1.332 . . . . 1.91 108.21 172.376 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.0 mt -53.57 141.65 24.97 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.646 1.112 . . . . 2.45 110.19 173.419 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -127.51 -64.11 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-O 118.88 -0.581 . . . . 3.38 110.46 171.186 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp 55.55 98.49 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.635 1.174 . . . . 4.26 112.167 -172.259 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 74' ' ' ILE . 17.0 tt -68.0 74.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.667 1.187 . . . . 11.53 111.786 -178.69 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 127.776 2.43 . . . . 11.11 107.98 -165.546 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.897 0 N-CA-C 111.236 -0.746 . . . . 1.98 111.236 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 p -75.54 123.47 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.784 -0.821 . . . . 2.18 108.784 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 tp -146.26 77.37 1.48 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.024 0.44 . . . . 2.82 110.412 -168.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -78.55 76.0 5.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.602 0.715 . . . . 4.23 110.101 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -78.91 156.9 28.38 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.922 0.889 . . . . 2.53 110.908 176.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.24 139.07 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.365 -1.717 . . . . 0.92 106.365 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.9 t -130.83 122.84 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 C-N-CA 126.844 2.058 . . . . 2.07 105.841 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.1 mtp-105 -117.75 164.25 15.28 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.828 1.251 . . . . 5.32 109.815 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.55 -6.88 77.79 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.206 0.908 . . . . 1.19 111.625 -171.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 30.3 mtm -72.81 69.64 0.94 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.189 0.996 . . . . 1.6 110.269 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -69.01 -16.77 63.8 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.165 1.172 . . . . 1.48 114.165 -166.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.0 p -160.53 173.77 15.05 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 120.205 1.366 . . . . 0.73 110.699 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.13 -40.18 45.41 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.991 0.916 . . . . 0.69 111.341 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 m -61.87 -27.41 68.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.625 0.77 . . . . 1.69 112.291 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.4 m -71.15 -61.72 1.66 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.913 -0.773 . . . . 0.67 108.913 164.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.6 t -45.42 -59.23 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.769 0.828 . . . . 0.72 111.572 -170.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -28.32 68.44 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.58 -0.7 . . . . 0.77 112.01 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -70.55 -47.64 59.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.737 -0.838 . . . . 4.05 108.737 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.9 mt -54.09 -55.58 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 108.273 -1.01 . . . . 0.98 108.273 174.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -48.74 -66.98 0.31 Allowed 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 124.357 1.035 . . . . 3.99 110.174 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.4 t -54.83 -39.4 68.52 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.801 0.84 . . . . 0.89 110.88 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.7 t -66.59 -51.12 59.94 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.72 -0.844 . . . . 1.16 108.72 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -60.06 -43.5 95.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.383 -0.823 . . . . 2.54 111.301 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.5 m -59.44 -11.43 4.45 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.87 0.868 . . . . 2.12 112.813 176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -61.79 -35.38 78.0 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.905 -1.122 . . . . 5.65 111.426 167.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -59.57 135.03 57.54 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.308 -0.997 . . . . 2.98 108.308 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -26.54 61.65 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.143 0.883 . . . . 9.84 108.777 162.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.48 41.41 2.08 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 121.604 -0.685 . . . . 1.96 112.643 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 pp -146.17 150.74 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 105.643 -1.984 . . . . 2.58 105.643 172.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.3 mt -104.28 -25.7 12.78 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 123.306 0.379 . . . . 2.05 111.381 167.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -156.34 152.92 28.22 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 118.668 0.667 . . . . 2.38 109.378 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.7 t -143.95 128.24 17.79 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.248 1.019 . . . . 2.27 109.25 164.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.1 t -135.5 92.92 2.89 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.191 1.396 . . . . 1.47 108.708 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.35 152.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 126.009 1.724 . . . . 1.98 111.563 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.23 129.31 8.81 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.705 0.402 . . . . 0.72 110.973 171.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 pp -76.07 -10.25 59.27 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.688 0.795 . . . . 1.32 112.787 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.99 -54.9 17.27 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.025 -0.731 . . . . 1.15 109.025 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -27.38 40.58 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.615 0.766 . . . . 2.09 110.812 174.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.9 m120 71.13 57.81 0.2 Allowed 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 125.352 1.461 . . . . 1.49 107.964 -169.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.44 170.42 15.74 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 112.484 0.549 . . . . 2.3 112.484 -169.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.72 100.17 3.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.631 1.972 . . . . 0.87 109.317 174.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -77.34 82.49 3.8 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 105.307 -2.109 . . . . 1.22 105.307 169.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 pt -85.3 147.63 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-N 114.486 -1.234 . . . . 3.08 108.322 166.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -113.33 104.7 12.58 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 103.54 -2.763 . . . . 3.17 103.54 157.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -98.46 135.47 39.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 124.168 0.917 . . . . 2.56 109.282 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.92 120.38 81.34 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 123.716 0.806 . . . . 3.22 109.221 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.07 2.68 7.8 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.1 1.867 . . . . 1.87 114.524 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -86.55 -43.01 13.04 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 121.414 1.916 . . . . 5.59 109.073 167.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.2 mm -88.15 -46.31 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 112.074 0.398 . . . . 3.12 112.074 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mm -120.71 146.32 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.921 -1.14 . . . . 1.61 107.921 -162.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.0 160.92 12.86 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 108.999 -1.641 . . . . 1.33 108.999 165.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -53.15 -38.38 80.97 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.828 2.352 . . . . 1.62 111.221 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -41.04 20.71 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.565 0.746 . . . . 8.13 111.658 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -66.43 -50.61 62.82 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.105 0.866 . . . . 2.14 109.481 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.1 mp -54.05 -47.05 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mt -55.87 -51.89 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 119.206 -0.426 . . . . 1.38 109.955 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -52.6 -42.75 64.83 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.612 0.642 . . . . 3.4 110.672 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 35.0 m -63.67 -54.84 29.3 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.348 -0.612 . . . . 0.82 109.348 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.462 HG23 ' HB2' ' A' ' 67' ' ' PHE . 49.3 mt -48.05 -49.59 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.528 1.531 . . . . 1.47 111.042 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -59.55 -49.77 76.5 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.182 0.993 . . . . 2.05 110.483 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.2 t -62.57 -22.82 66.64 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 118.201 -0.904 . . . . 1.44 112.542 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.26 -102.43 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.195 -1.039 . . . . 2.54 108.195 160.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.46 39.22 0.48 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.313 -0.715 . . . . 0.79 111.386 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.462 ' HB2' HG23 ' A' ' 62' ' ' ILE . 32.0 m-85 -128.25 171.37 12.03 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.937 0.869 . . . . 1.66 110.393 -167.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.12 166.15 21.73 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.523 1.129 . . . . 3.11 108.55 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.43 161.8 40.91 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.549 0.613 . . . . 1.12 111.998 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.9 m -156.59 131.54 9.04 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.091 1.356 . . . . 1.61 109.787 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 CA--C 1.53 0.198 0 N-CA-C 108.229 -1.026 . . . . 3.14 108.229 173.499 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.647 0 CA-C-O 119.818 -0.435 . . . . 2.19 113.14 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.3 p -145.77 137.91 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 117.582 0.691 . . . . 2.23 110.178 170.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.5 tp -148.37 119.3 7.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.543 -0.91 . . . . 2.15 108.543 167.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -108.4 121.51 45.09 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.947 -1.501 . . . . 2.94 106.947 167.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -131.02 146.13 52.28 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.629 -0.878 . . . . 2.34 108.629 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -76.22 135.5 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 104.595 -2.372 . . . . 0.75 104.595 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.4 t -125.21 115.92 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 105.088 -2.19 . . . . 1.98 105.088 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -108.44 153.3 23.51 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.779 0.431 . . . . 6.15 110.115 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.24 -5.51 55.62 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.651 1.12 . . . . 1.05 111.985 -171.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 38.1 mtm -74.17 66.94 1.3 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.512 1.156 . . . . 1.65 110.677 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -68.88 -15.3 63.46 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.267 1.21 . . . . 1.62 114.267 -164.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.9 p -160.1 173.05 16.39 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 120.289 1.404 . . . . 0.72 110.508 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.54 -37.21 38.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.864 0.866 . . . . 0.81 111.326 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 t -61.08 -29.27 69.64 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 118.867 -0.587 . . . . 1.87 111.523 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.4 m -71.67 -57.08 4.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.89 0.768 . . . . 0.85 109.551 168.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.9 t -49.6 -60.46 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.472 0.709 . . . . 0.89 111.451 -172.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.86 -29.2 69.05 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.621 -0.674 . . . . 0.84 111.568 -175.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -65.28 -48.35 73.49 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.386 -0.968 . . . . 3.01 108.386 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 79.4 mt -55.4 -55.64 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 108.668 -0.864 . . . . 0.65 108.668 174.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -54.99 -49.95 70.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.425 0.631 . . . . 3.49 110.87 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -56.55 -48.96 76.18 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.885 0.874 . . . . 0.85 110.682 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.3 m -61.65 -42.13 98.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.7 -0.625 . . . . 2.09 110.539 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.495 HD11 HG23 ' A' ' 58' ' ' ILE . 1.7 mm? -63.64 -54.19 39.69 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.844 1.258 . . . . 2.45 110.671 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.0 p -59.17 -18.59 37.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.151 0.426 . . . . 2.03 112.151 -173.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -50.24 -41.88 50.85 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.271 -0.871 . . . . 4.65 113.008 166.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -67.44 163.73 20.28 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.34 0.973 . . . . 2.26 111.661 -170.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.01 -29.13 11.11 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.391 0.677 . . . . 6.42 112.021 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.57 -14.76 77.57 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 119.918 -0.379 . . . . 1.16 112.491 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -77.86 149.93 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 117.782 0.791 . . . . 2.91 109.113 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 36.6 tp -109.08 -42.89 4.3 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.521 1.928 . . . . 3.55 108.708 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -155.79 163.88 39.27 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.22 0.464 . . . . 2.14 110.949 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.7 t -144.19 118.81 9.77 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 127.084 2.154 . . . . 2.14 106.846 174.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.97 96.74 5.14 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.204 -1.406 . . . . 1.63 107.204 175.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -107.64 141.32 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.23 0.612 . . . . 2.23 111.294 -174.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.47 125.72 9.34 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 123.729 0.811 . . . . 0.76 111.377 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.61 -15.04 60.39 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.522 1.129 . . . . 1.45 112.236 172.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.2 -51.7 68.64 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.012 -0.736 . . . . 1.24 109.012 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.87 -45.28 18.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.625 -0.88 . . . . 2.03 108.625 171.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 83.92 52.9 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 127.696 2.398 . . . . 2.48 107.39 -163.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.61 160.24 40.56 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 122.501 0.32 . . . . 2.36 110.705 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.12 120.06 30.35 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.61 -1.255 . . . . 0.64 107.61 168.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -93.86 94.44 8.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.863 -1.903 . . . . 1.18 105.863 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.45 152.22 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 107.58 -1.267 . . . . 1.57 107.58 174.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -131.95 134.14 45.3 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.416 -2.439 . . . . 2.23 104.416 159.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -161.65 153.69 19.47 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.066 1.346 . . . . 2.49 107.39 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -80.91 124.2 81.65 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 119.044 0.838 . . . . 3.41 109.732 170.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -63.59 -21.17 70.39 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.995 2.463 . . . . 1.8 115.467 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -79.33 -45.59 19.34 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.991 1.269 . . . . 3.67 108.758 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.2 mt -71.71 -38.83 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 120.724 -0.39 . . . . 3.15 111.482 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.48 122.9 45.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 N-CA-C 106.029 -1.841 . . . . 1.56 106.029 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.02 168.29 44.82 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.187 -1.165 . . . . 0.8 110.187 172.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -59.58 -43.08 41.72 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.116 1.878 . . . . 1.08 109.564 170.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -46.0 35.86 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.039 1.335 . . . . 5.75 112.455 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.06 -55.59 31.05 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.864 0.756 . . . . 2.46 110.148 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.495 HG23 HD11 ' A' ' 26' ' ' LEU . 37.6 mt -63.21 -54.37 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.12 -0.491 . . . . 0.78 109.745 -174.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.8 mt -49.52 -50.03 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.219 -0.66 . . . . 1.26 109.219 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -70.04 -29.21 66.19 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.622 -0.674 . . . . 4.41 111.813 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.2 m -61.88 -47.27 85.73 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.309 -0.997 . . . . 0.79 108.309 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' A' ' 67' ' ' PHE . 78.7 mt -57.37 -43.0 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.234 1.014 . . . . 1.22 111.006 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -57.21 -57.13 13.97 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 109.181 -0.674 . . . . 2.61 109.181 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -55.38 -42.44 73.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.168 1.387 . . . . 1.4 111.144 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.9 mt -61.75 -82.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.565 0.346 . . . . 2.17 111.241 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.66 17.85 0.17 Allowed Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.356 -1.247 . . . . 0.74 114.621 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.441 ' HB2' HG23 ' A' ' 62' ' ' ILE . 25.5 m-85 -137.4 175.13 9.88 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 119.352 1.576 . . . . 2.17 110.916 -153.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -126.44 161.28 28.28 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 107.65 -1.241 . . . . 3.34 107.65 172.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.02 160.03 40.94 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 112.325 0.491 . . . . 0.91 112.325 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 m -155.79 146.59 22.16 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.845 1.658 . . . . 1.96 107.613 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.3 mt . . . . . 0 CA--C 1.534 0.35 0 CA-C-N 118.775 0.716 . . . . 2.5 111.187 -177.669 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.735 0 N-CA-C 109.08 -1.608 . . . . 1.64 109.08 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.96 148.82 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 O-C-N 122.162 -0.61 . . . . 2.05 110.152 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.2 tp -151.43 159.63 44.12 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.077 -1.083 . . . . 3.13 108.077 162.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -141.65 117.29 10.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.43 -1.693 . . . . 4.15 106.43 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.6 mt -118.58 142.43 47.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.33 1.452 . . . . 2.98 107.184 -177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.48 129.69 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.098 -1.816 . . . . 1.14 106.098 163.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.2 t -117.79 102.85 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 126.099 1.76 . . . . 1.96 106.964 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -96.08 134.57 38.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.653 1.581 . . . . 6.87 108.134 -172.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.43 -9.41 38.47 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.307 0.956 . . . . 1.06 112.455 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.4 ttp -70.08 69.76 0.35 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.252 1.821 . . . . 1.77 109.831 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 t -79.42 -2.59 42.58 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.281 1.585 . . . . 1.63 115.281 -159.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -159.62 164.48 34.09 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.052 1.296 . . . . 1.22 110.892 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.61 -39.81 51.08 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.326 1.05 . . . . 0.7 110.306 173.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -46.59 -43.97 17.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.16 1.384 . . . . 1.59 111.676 171.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . 0.258 73.5 m -72.61 -48.19 41.61 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 118.408 -0.806 . . . . 1.08 113.159 173.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.9 t -41.83 -66.31 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.514 0.726 . . . . 0.95 110.65 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -31.07 67.59 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 119.906 -0.717 . . . . 0.79 112.436 -172.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -58.03 -54.4 47.36 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.703 0.683 . . . . 3.4 109.436 173.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.5 mt -50.61 -61.57 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 108.445 -0.946 . . . . 0.69 108.445 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -55.37 -55.88 26.52 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.066 0.46 . . . . 3.24 111.766 -173.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -54.03 -43.77 70.42 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.023 0.929 . . . . 0.79 110.443 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -68.07 -55.25 13.21 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.177 -1.046 . . . . 1.22 108.177 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -57.87 -43.35 85.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.052 -0.405 . . . . 2.72 111.884 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.9 m -57.24 -16.91 9.45 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.238 0.459 . . . . 1.91 112.238 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.35 -41.66 63.24 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.134 -0.979 . . . . 6.04 111.187 168.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -86.87 109.04 19.04 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.82 -0.807 . . . . 2.21 108.82 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.3 mtm105 -52.76 -21.8 4.54 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.584 0.957 . . . . 6.89 113.584 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -52.19 -37.07 46.02 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.385 -0.675 . . . . 0.88 112.081 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.5 129.28 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.959 -1.126 . . . . 2.52 107.959 170.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.38 -44.85 8.48 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.607 -0.886 . . . . 3.84 108.607 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -142.09 144.18 33.42 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.562 -0.533 . . . . 2.07 109.562 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.5 p -131.08 144.43 51.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.333 1.853 . . . . 2.3 106.767 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -152.11 83.35 1.26 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.772 -1.195 . . . . 1.55 107.772 -166.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 m -101.85 153.38 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 123.868 0.867 . . . . 1.6 111.077 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.36 136.16 13.58 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.478 -0.564 . . . . 0.93 109.478 173.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -81.42 -11.42 59.26 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.459 1.104 . . . . 1.35 112.697 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.07 -49.51 77.07 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.158 -0.682 . . . . 1.14 109.158 173.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -86.01 -40.33 15.92 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.154 0.582 . . . . 2.59 109.597 171.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 80.89 61.79 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 127.25 2.22 . . . . 2.66 107.415 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.32 166.31 25.11 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 123.065 0.546 . . . . 2.29 110.187 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.24 110.6 11.23 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 127.288 2.235 . . . . 0.63 106.862 163.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -86.3 134.9 33.71 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.301 -2.111 . . . . 0.91 105.301 162.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.8 pt -139.18 151.63 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 124.682 1.193 . . . . 3.4 107.82 -172.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -139.28 99.84 3.85 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 102.591 -3.115 . . . . 2.95 102.591 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -145.11 142.24 29.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.221 1.409 . . . . 2.02 108.801 -162.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -80.3 119.69 77.19 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 108.848 -0.797 . . . . 2.82 108.848 175.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.63 -32.8 47.25 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.47 1.447 . . . . 2.03 111.909 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.2 44.67 0.42 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.914 0.779 . . . . 3.72 112.42 -175.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -172.49 -38.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.886 1.674 . . . . 3.44 110.25 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 tt -138.05 118.63 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.318 -1.364 . . . . 1.6 107.318 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.29 156.28 53.31 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.196 -1.562 . . . . 0.83 109.196 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -53.88 -45.39 41.37 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.527 1.484 . . . . 1.29 109.197 171.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -50.96 -37.73 46.38 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 112.268 0.47 . . . . 6.89 112.268 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.15 -40.37 74.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.099 0.863 . . . . 2.73 109.522 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.8 mt -57.98 -46.77 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 118.841 -0.599 . . . . 0.73 109.933 170.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.7 mm -51.73 -57.73 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.825 0.739 . . . . 1.83 110.081 173.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -50.14 -43.34 51.95 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.285 1.034 . . . . 4.03 110.541 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.9 m -64.48 -49.6 70.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.756 -0.461 . . . . 1.12 109.756 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.555 HG21 ' HB2' ' A' ' 69' ' ' ALA . 1.1 mt -53.69 -47.32 61.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.261 0.624 . . . . 1.27 111.324 176.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -58.27 -51.91 67.81 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.169 0.588 . . . . 2.23 109.7 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.8 t -52.16 -48.25 65.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.768 0.827 . . . . 1.18 110.905 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.4 -60.01 4.17 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.939 -0.476 . . . . 2.17 111.032 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.66 -42.02 0.02 OUTLIER Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.091 1.196 . . . . 1.7 116.091 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -118.01 164.85 14.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 117.642 0.721 . . . . 1.73 112.769 -136.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.81 98.92 10.25 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.983 -1.488 . . . . 4.47 106.983 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.555 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -83.32 139.95 32.74 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.811 -0.44 . . . . 1.27 109.811 169.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.0 t -144.21 128.94 18.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.596 -1.631 . . . . 2.06 106.596 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 CA--C 1.534 0.334 0 C-N-CA 119.675 -0.81 . . . . 3.56 109.148 159.793 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.874 0 N-CA-C 108.269 -1.932 . . . . 1.69 108.269 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 p -78.66 120.75 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.432 -1.321 . . . . 2.03 107.432 168.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.16 112.85 12.08 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.019 -1.104 . . . . 3.05 108.019 -172.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -88.01 113.21 23.43 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.76 -1.2 . . . . 3.5 107.76 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -101.24 150.46 22.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.686 -0.857 . . . . 2.5 108.686 166.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 t -81.82 139.82 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 105.107 -2.183 . . . . 0.87 105.107 151.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.65 133.04 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.377 -1.712 . . . . 2.27 106.377 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 mtp85 -129.09 158.68 38.26 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.697 0.799 . . . . 6.0 109.411 -176.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.92 -18.91 55.72 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.727 0.68 . . . . 1.13 112.055 -174.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -74.57 69.48 1.72 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.198 0.999 . . . . 1.4 111.229 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.1 t -62.05 -17.23 56.75 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 116.028 1.862 . . . . 1.52 116.028 -162.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.5 p -160.74 -179.92 8.0 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 121.306 1.866 . . . . 0.66 112.502 -172.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.5 -44.19 35.74 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.714 1.206 . . . . 0.62 111.413 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.6 m -63.99 -22.71 67.04 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.814 0.845 . . . . 1.48 112.322 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.3 m -73.64 -64.18 1.05 Allowed 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.524 -0.735 . . . . 0.69 110.733 161.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.7 t -38.08 -64.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.945 1.298 . . . . 0.93 112.12 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.11 -29.39 70.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.621 -0.431 . . . . 0.99 111.194 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -70.67 -46.55 62.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.682 -0.859 . . . . 3.22 108.682 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.3 mt -54.85 -58.32 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.702 -0.851 . . . . 0.82 108.702 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -59.29 -53.71 55.15 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.642 0.258 . . . . 3.51 111.477 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.5 t -53.86 -45.6 71.04 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.975 -0.453 . . . . 0.76 110.629 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 t -66.07 -50.85 62.69 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.955 -1.128 . . . . 1.19 107.955 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.0 mt -48.57 -51.68 26.59 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.915 0.486 . . . . 2.88 111.376 176.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.4 p -57.81 -14.43 5.92 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.609 0.966 . . . . 2.25 113.609 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -28.37 68.3 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.415 1.007 . . . . 4.22 112.39 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -90.37 104.97 17.49 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 107.755 -1.202 . . . . 1.73 107.755 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -26.25 9.43 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.28 -0.888 . . . . 8.91 111.669 172.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -48.89 -40.64 27.24 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.103 -0.832 . . . . 0.9 112.811 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.83 123.3 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.513 -1.662 . . . . 2.43 106.513 171.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.3 tp -79.93 -38.05 33.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.574 1.15 . . . . 3.27 109.163 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -151.32 154.29 36.45 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.651 -0.5 . . . . 1.84 109.651 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.4 p -133.96 147.7 51.07 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 125.184 1.394 . . . . 2.53 108.827 169.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.4 t -155.02 99.64 2.12 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.695 1.598 . . . . 1.51 107.097 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 m -91.82 167.87 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 122.627 0.371 . . . . 1.68 110.405 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.5 131.68 10.17 Favored 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 121.879 -0.513 . . . . 0.8 110.866 165.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.8 mt -49.8 -50.8 43.58 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 124.488 1.115 . . . . 2.02 108.684 159.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.64 -53.6 17.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.802 0.841 . . . . 1.58 112.113 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.52 -2.42 54.37 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.037 0.935 . . . . 2.02 111.996 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m120 50.02 39.69 19.54 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 125.047 1.339 . . . . 1.98 110.33 -166.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.61 170.38 8.36 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 120.983 0.42 . . . . 2.53 111.257 -167.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -151.31 97.07 2.37 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 126.64 1.976 . . . . 0.67 108.113 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -79.48 106.09 11.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.708 -2.33 . . . . 1.34 104.708 165.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.77 145.52 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 105.256 -2.127 . . . . 1.58 105.256 163.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.2 mtmt -114.52 129.41 56.66 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.937 -1.875 . . . . 2.87 105.937 158.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -138.03 144.6 41.1 Favored 'General case' 0 C--N 1.338 0.089 0 CA-C-N 118.745 0.702 . . . . 2.53 111.607 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -75.44 117.82 66.17 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 107.36 -1.348 . . . . 3.83 107.36 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -80.67 56.36 6.05 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.202 3.268 . . . . 2.07 112.014 -165.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -145.61 -53.74 0.28 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.536 1.934 . . . . 3.69 107.55 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.8 mt -74.43 -33.26 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.411 1.084 . . . . 2.74 110.738 -172.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.6 tt -147.39 138.37 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.432 -1.322 . . . . 1.71 107.432 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.45 168.23 27.97 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.359 0.981 . . . . 0.86 111.66 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.08 -43.45 15.24 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.788 2.325 . . . . 1.01 109.534 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -54.29 -44.19 71.72 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 122.479 0.312 . . . . 6.13 110.405 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -63.98 -47.21 81.29 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.343 -0.614 . . . . 2.65 109.343 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.9 mt -52.79 -52.48 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 O-C-N 122.015 -0.428 . . . . 0.69 110.153 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.4 mt -54.25 -53.31 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 122.053 -0.404 . . . . 1.2 110.177 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.4 -32.76 67.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.219 0.608 . . . . 4.48 111.265 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.5 m -65.2 -49.47 69.61 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.067 -1.021 . . . . 1.07 108.45 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.0 mt -54.62 -41.41 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.703 0.801 . . . . 1.33 110.692 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -57.62 -54.98 40.76 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.207 0.458 . . . . 2.3 110.364 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.5 m -57.53 -29.16 64.13 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.231 1.012 . . . . 2.22 112.465 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.7 -89.42 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.882 -0.785 . . . . 2.4 108.882 166.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.47 25.0 0.24 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-O 118.517 -1.157 . . . . 0.89 113.955 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.75 175.57 9.07 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.011 1.406 . . . . 2.19 112.596 -153.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -112.58 149.7 32.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.299 -1.741 . . . . 3.78 106.299 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.18 161.49 41.19 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.989 0.813 . . . . 1.25 111.68 166.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.0 t -151.75 149.32 28.92 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.543 -1.651 . . . . 3.33 106.543 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 CA--C 1.534 0.362 0 N-CA-C 108.95 -0.759 . . . . 2.77 108.95 162.781 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.821 0 N-CA-C 109.567 -1.413 . . . . 1.57 109.567 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.08 141.8 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 107.97 -1.122 . . . . 2.12 107.97 173.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -150.8 148.54 28.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.277 -0.638 . . . . 2.67 109.277 164.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -93.48 127.3 39.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.077 -1.823 . . . . 3.16 106.077 152.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.416 HD11 ' HB3' ' A' ' 44' ' ' ALA . 4.1 pp -107.32 151.18 25.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.384 -1.339 . . . . 2.54 107.384 164.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.61 143.93 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 104.831 -2.285 . . . . 1.28 104.831 161.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 p -141.78 133.51 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 124.007 0.923 . . . . 2.26 108.545 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -134.87 165.53 25.1 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.22 1.408 . . . . 7.1 109.065 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.09 -39.38 2.78 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.12 0.867 . . . . 1.48 111.378 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.407 ' SD ' HD12 ' A' ' 22' ' ' ILE . 13.0 ptt? -67.34 65.27 0.07 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.4 1.48 . . . . 1.92 112.88 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -71.62 19.1 0.07 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.117 1.525 . . . . 1.77 115.117 -165.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -166.57 158.57 13.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.589 1.086 . . . . 1.14 110.187 177.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.24 -37.41 35.5 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.152 0.981 . . . . 0.91 111.12 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.7 p -58.16 -33.21 68.96 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.727 0.411 . . . . 1.89 111.425 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . 0.259 72.6 m -75.77 -44.71 40.21 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 120.819 -1.176 . . . . 1.61 113.676 168.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.7 t -50.01 -60.03 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.168 0.44 . . . . 0.92 110.738 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -25.44 63.05 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.445 -0.784 . . . . 1.07 112.159 -176.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.16 -51.86 67.26 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 108.562 -0.903 . . . . 3.81 108.562 173.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.407 HD12 ' SD ' ' A' ' 13' ' ' MET . 64.3 mt -52.58 -60.8 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 108.447 -0.946 . . . . 0.79 108.447 172.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -53.09 -56.45 16.16 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.336 0.589 . . . . 3.27 110.605 -170.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.1 t -56.09 -48.37 76.25 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.916 1.286 . . . . 0.84 111.103 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.8 t -64.64 -57.82 8.01 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.04 -0.726 . . . . 1.29 109.04 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.3 tp -54.21 -49.12 70.13 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.336 1.454 . . . . 2.46 111.111 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.5 p -59.47 -12.76 6.75 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.601 0.963 . . . . 2.24 113.601 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -24.88 66.77 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.889 1.222 . . . . 4.82 112.322 175.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -80.67 130.77 35.29 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.44 0.564 . . . . 2.33 109.653 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -58.31 151.85 18.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.461 -0.94 . . . . 6.39 108.461 169.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.24 -27.82 15.44 Favored Glycine 0 C--O 1.224 -0.495 0 N-CA-C 111.035 -0.826 . . . . 1.02 111.035 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.1 mm -79.22 121.19 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 119.138 1.469 . . . . 4.08 107.217 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.3 mt -94.99 -44.59 7.63 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.125 -0.695 . . . . 1.87 109.125 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -153.49 153.63 32.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.199 -0.667 . . . . 2.52 109.199 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.5 m -138.75 132.97 31.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 105.481 -2.044 . . . . 2.29 105.481 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -134.87 89.67 2.56 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 105.88 -1.896 . . . . 1.93 105.88 166.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 p -97.94 137.61 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.309 1.043 . . . . 2.39 111.156 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 134.07 21.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.811 0.845 . . . . 0.87 111.091 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 pp -72.05 -34.38 68.71 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 124.661 1.185 . . . . 2.03 110.672 170.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.64 -32.47 42.11 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.648 0.779 . . . . 1.34 111.674 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -120.55 11.79 11.4 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.801 1.24 . . . . 2.56 111.496 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.0 m120 35.32 52.08 0.65 Allowed 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.887 1.675 . . . . 2.12 112.778 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.23 151.97 40.18 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.117 -0.698 . . . . 3.47 109.117 -171.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.416 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -133.97 118.26 17.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.758 -0.83 . . . . 0.66 108.758 170.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -84.76 106.16 16.09 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.135 -1.802 . . . . 1.02 106.135 170.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.2 mp -106.95 136.3 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.792 -1.558 . . . . 1.73 106.792 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -116.09 140.2 49.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.458 -1.682 . . . . 2.93 106.458 163.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -158.69 161.04 37.06 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.724 0.81 . . . . 1.71 110.013 -167.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -87.78 110.94 38.86 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 107.122 -1.436 . . . . 4.04 107.122 173.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.23 59.23 7.3 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.088 3.192 . . . . 2.04 110.799 -168.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -167.26 -46.72 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.53 1.532 . . . . 2.9 108.857 -173.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.2 mm -65.96 -39.18 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.517 -0.549 . . . . 2.51 109.517 170.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.07 154.73 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 105.835 -1.913 . . . . 1.29 105.835 -175.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -116.77 174.22 15.11 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.875 1.226 . . . . 1.06 112.145 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.15 -39.38 31.31 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.231 2.621 . . . . 1.07 110.413 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -47.57 -56.65 6.69 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.804 0.842 . . . . 7.27 110.368 170.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.0 -54.85 29.11 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.716 -0.475 . . . . 2.28 109.716 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.3 mt -52.69 -60.16 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.059 0.544 . . . . 0.79 111.149 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.8 mt -52.11 -51.79 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 C-N-CA 123.715 0.806 . . . . 1.2 110.133 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -68.08 -33.33 74.34 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.215 -0.448 . . . . 4.25 111.07 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.9 m -60.88 -46.62 89.9 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 108.091 -1.077 . . . . 0.77 108.091 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.505 HG21 ' HB2' ' A' ' 69' ' ' ALA . 19.2 mt -56.25 -58.15 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.263 -0.643 . . . . 1.31 109.263 173.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -53.99 -43.77 70.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.913 0.387 . . . . 2.35 110.356 -168.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.5 m -62.74 -15.62 53.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.356 1.462 . . . . 2.53 114.125 -172.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.97 -83.27 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.885 -1.154 . . . . 3.02 107.885 170.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.03 42.62 0.48 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.476 -1.449 . . . . 1.25 109.476 166.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -126.88 176.65 7.14 Favored 'General case' 0 CA--C 1.524 -0.04 0 CA-C-N 117.311 0.555 . . . . 2.18 111.328 -159.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.36 145.52 47.81 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 104.923 -2.251 . . . . 4.82 104.923 170.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.505 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -149.44 146.0 27.21 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 123.688 0.617 . . . . 1.93 111.036 165.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t -155.57 131.0 9.63 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.831 -0.433 . . . . 3.07 109.831 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 CA--C 1.535 0.367 0 C-N-CA 124.165 0.986 . . . . 2.36 111.627 177.284 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.673 0 N-CA-C 109.932 -1.267 . . . . 2.1 109.932 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.31 130.6 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.028 -1.471 . . . . 2.34 107.028 170.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.3 tp -124.65 139.62 53.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.025 -1.472 . . . . 2.53 107.025 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.41 143.24 48.77 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.64 -1.244 . . . . 4.39 107.64 176.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.47 HD23 ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -156.78 150.09 24.22 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.122 0.969 . . . . 2.8 108.931 176.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.35 112.35 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 104.186 -2.524 . . . . 0.97 104.186 169.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.82 142.73 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.158 -1.423 . . . . 2.66 107.158 162.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -131.84 166.05 22.47 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.254 -0.647 . . . . 6.1 109.254 167.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.63 -38.72 3.18 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 121.757 -0.59 . . . . 1.13 112.252 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.04 77.36 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.418 1.487 . . . . 2.99 111.93 176.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.4 t -74.52 -16.95 60.82 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 115.069 1.507 . . . . 1.58 115.069 -161.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 p -158.36 176.44 12.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 120.605 1.548 . . . . 0.65 111.747 -172.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.62 -46.15 9.96 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.288 1.435 . . . . 0.61 111.464 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 m -61.98 -30.67 71.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.679 0.792 . . . . 1.53 112.271 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.3 m -72.88 -56.69 4.83 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.862 0.756 . . . . 0.64 110.333 166.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.4 t -42.8 -61.71 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.593 1.157 . . . . 0.81 111.39 -176.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.99 -28.26 67.28 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 120.046 -0.662 . . . . 0.83 111.692 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -64.86 -48.53 73.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.301 -0.999 . . . . 2.84 108.301 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.7 mt -53.98 -63.48 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.64 -0.874 . . . . 0.69 108.64 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -52.95 -50.43 64.06 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.174 0.443 . . . . 3.83 111.729 -173.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.0 t -55.97 -46.79 78.51 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.4 1.08 . . . . 0.76 111.317 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.2 p -69.02 -37.43 78.65 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.695 -0.628 . . . . 2.31 110.098 -173.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.7 mp -72.2 -48.25 44.48 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.748 1.219 . . . . 2.63 111.631 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 t -71.88 65.36 0.53 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 123.325 1.536 . . . . 2.66 112.027 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.61 -23.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.635 2.774 . . . . 4.75 111.935 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -60.51 -14.38 19.36 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.169 1.174 . . . . 2.95 114.169 176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? 70.83 -54.35 0.66 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.402 1.881 . . . . 6.14 110.843 -171.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.94 -32.14 55.84 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 117.953 0.342 . . . . 1.14 112.32 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 38.5 mt -79.37 104.88 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.23 -1.396 . . . . 4.15 107.23 167.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.2 mt -78.98 -28.12 43.49 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.152 0.581 . . . . 1.71 109.648 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -156.71 157.2 34.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.414 -0.958 . . . . 2.04 108.414 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.6 p -138.59 140.28 38.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.024 1.73 . . . . 2.6 107.136 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.9 t -146.99 101.3 3.41 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.836 -1.542 . . . . 1.54 106.836 169.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 44' ' ' ALA . 2.2 p -100.72 152.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 124.294 1.038 . . . . 2.75 109.848 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.05 127.51 7.89 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 121.66 -0.65 . . . . 0.76 111.328 170.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.48 -28.69 68.07 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.419 0.687 . . . . 1.7 110.714 162.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.44 -49.77 69.23 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 120.97 0.414 . . . . 1.19 110.001 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.36 -35.11 25.38 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.17 0.588 . . . . 2.08 111.096 173.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.26 76.04 0.36 Allowed 'General case' 0 C--N 1.344 0.339 0 N-CA-C 106.926 -1.509 . . . . 2.03 106.926 -151.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.62 163.13 39.26 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.02 0.528 . . . . 2.63 109.89 177.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.457 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -146.15 94.12 2.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.889 1.276 . . . . 0.78 109.916 169.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -77.99 104.19 8.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 105.967 -1.864 . . . . 1.02 105.967 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.457 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -106.69 115.61 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 105.923 -1.88 . . . . 1.78 105.923 174.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -82.03 75.46 8.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.793 -1.188 . . . . 3.63 107.793 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.67 161.44 23.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.055 -0.521 . . . . 2.9 110.794 170.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -104.85 133.49 20.13 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 107.227 -1.397 . . . . 3.22 107.227 142.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.57 -31.79 59.65 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.138 2.558 . . . . 2.14 114.472 -171.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -81.19 -43.37 19.4 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 120.473 1.488 . . . . 2.97 110.251 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 tp -73.42 -26.19 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 118.85 -0.595 . . . . 2.73 111.459 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.1 tt -148.09 124.27 2.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-N 120.171 1.351 . . . . 1.61 109.96 167.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.08 159.56 49.24 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 109.67 -1.372 . . . . 0.89 109.67 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -58.85 -39.89 77.21 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.087 1.858 . . . . 1.08 109.247 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -41.65 -48.55 4.12 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.214 1.406 . . . . 8.98 111.007 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -72.31 -45.11 61.4 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.0 0.92 . . . . 2.31 109.539 -169.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.2 mt -54.04 -50.55 53.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.037 -0.727 . . . . 0.62 109.037 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.4 mt -55.48 -52.42 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 119.582 -0.247 . . . . 1.11 110.467 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -52.25 -39.67 60.65 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.476 0.71 . . . . 3.44 110.861 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 31.1 m -64.83 -50.46 66.57 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.238 -0.652 . . . . 0.71 109.238 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.4 mt -55.06 -48.26 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.21 1.004 . . . . 1.26 110.579 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -56.32 -57.12 13.6 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.59 0.756 . . . . 2.14 110.492 173.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.8 t -51.02 -43.6 60.88 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.813 1.245 . . . . 1.5 110.895 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.63 -73.7 0.08 Allowed 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.359 -0.213 . . . . 2.17 110.44 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.41 -5.52 0.05 OUTLIER Glycine 0 CA--C 1.529 0.948 0 N-CA-C 117.41 1.724 . . . . 1.18 117.41 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -131.33 172.21 12.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.758 1.779 . . . . 1.74 112.999 -137.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.48 150.27 20.49 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.834 -1.543 . . . . 4.8 106.834 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.47 ' HB1' HD23 ' A' ' 8' ' ' LEU . . . -149.7 124.88 10.09 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.898 0.38 . . . . 1.54 111.457 162.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 p -129.14 122.45 29.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.964 1.305 . . . . 2.12 109.18 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 113.631 0.974 . . . . 3.02 113.631 -172.04 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.817 0 N-CA-C 110.733 -0.947 . . . . 1.5 110.733 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -78.26 97.16 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.845 0.858 . . . . 2.09 108.973 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.03 155.67 19.57 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.937 0.875 . . . . 4.34 109.071 171.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -146.23 136.75 24.02 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 105.846 -1.909 . . . . 4.32 105.846 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 pp -152.61 148.66 27.59 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.601 1.161 . . . . 2.01 109.217 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.89 125.62 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 105.569 -2.012 . . . . 0.77 105.569 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.9 t -104.71 138.03 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 106.356 -1.72 . . . . 1.74 106.356 168.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.16 175.3 9.98 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.777 1.631 . . . . 5.02 108.55 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.43 -50.17 4.3 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.186 -1.166 . . . . 1.64 110.186 -172.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -50.33 126.66 15.48 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.034 0.534 . . . . 1.91 111.556 175.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 p -88.68 -41.37 12.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.971 0.73 . . . . 3.09 112.971 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.4 p -152.41 177.06 11.0 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.843 0.747 . . . . 0.69 112.543 -161.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.0 -42.09 17.44 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.876 1.27 . . . . 0.73 111.585 175.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.0 t -60.56 -34.39 74.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.507 0.723 . . . . 1.86 110.912 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.2 m -71.53 -54.97 8.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.375 0.534 . . . . 0.67 109.85 169.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 37' ' ' VAL . 49.1 t -45.8 -62.35 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.592 0.757 . . . . 0.8 111.45 -175.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.7 -27.0 66.45 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 120.046 -0.661 . . . . 0.96 111.632 -174.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -68.06 -48.89 64.36 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.744 0.818 . . . . 2.85 109.224 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.7 mt -53.8 -58.72 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 N-CA-C 107.899 -1.148 . . . . 0.86 107.899 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.46 -53.82 33.19 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.369 0.604 . . . . 3.58 110.412 -176.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 t -57.76 -37.72 74.13 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.641 1.176 . . . . 0.82 111.754 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.9 t -71.46 -40.78 70.11 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.788 0.835 . . . . 1.17 110.67 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.5 mp -66.86 -51.78 51.42 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.457 1.103 . . . . 2.44 109.26 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.1 t -71.71 60.95 0.37 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.258 1.028 . . . . 2.76 110.734 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.05 -48.1 0.32 Allowed 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 128.895 2.878 . . . . 6.83 108.045 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -69.99 26.2 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.281 1.586 . . . . 3.19 115.281 -165.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 66.02 -60.75 0.29 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.651 2.38 . . . . 6.15 114.177 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.47 -15.92 62.21 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.715 -0.492 . . . . 1.04 113.23 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.2 mm -79.43 105.42 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.901 1.28 . . . . 4.3 107.734 176.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.73 -38.97 37.57 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.308 -0.627 . . . . 3.1 109.308 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -152.41 152.08 31.58 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.996 -0.742 . . . . 2.11 108.996 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.0 t -136.26 132.34 35.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.804 1.642 . . . . 2.11 106.586 174.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.1 t -134.85 103.73 5.72 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.927 -1.509 . . . . 1.47 106.927 165.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 19' ' ' VAL . 8.8 p -104.23 147.84 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.824 1.25 . . . . 2.68 109.82 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.35 142.32 19.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 O-C-N 121.401 -0.812 . . . . 0.94 110.868 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -83.82 -38.09 21.68 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 123.952 0.901 . . . . 2.0 109.753 170.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.24 -35.86 60.43 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.458 0.703 . . . . 1.45 110.755 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -117.54 16.47 14.61 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.62 1.168 . . . . 2.75 110.35 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.4 m120 23.23 70.83 0.03 OUTLIER 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.646 1.978 . . . . 1.78 112.737 -173.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 166.59 26.67 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.576 0.35 . . . . 2.87 110.342 -172.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.99 92.91 1.68 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.365 1.466 . . . . 0.91 109.343 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -78.33 108.27 11.55 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.738 -2.319 . . . . 1.51 104.738 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.0 mp -110.92 127.14 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 106.662 -1.607 . . . . 1.58 106.662 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -92.44 104.66 16.96 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 104.869 -2.271 . . . . 2.32 104.869 160.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -122.05 134.6 54.78 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 118.592 0.633 . . . . 1.99 109.344 175.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -72.63 117.68 61.32 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 120.167 -0.613 . . . . 3.01 109.37 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -81.76 64.56 8.55 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.05 2.5 . . . . 2.37 112.471 -163.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -158.38 -52.66 0.07 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.526 1.13 . . . . 2.95 109.035 168.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -57.99 -35.16 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.788 1.235 . . . . 2.96 111.659 172.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mm -139.17 139.32 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.748 -1.945 . . . . 1.39 105.748 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.57 167.9 15.01 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.3 1.428 . . . . 0.79 110.374 169.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -61.87 -41.95 34.28 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.534 2.156 . . . . 1.03 110.17 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.9 -35.95 25.54 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 118.119 -0.943 . . . . 5.73 112.127 174.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -68.64 -49.81 56.23 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 119.711 1.141 . . . . 2.08 110.147 -176.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 mt -53.74 -53.23 27.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.922 -0.77 . . . . 0.68 108.922 172.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.4 mt -53.52 -44.14 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 118.512 -0.756 . . . . 1.15 110.642 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -53.12 -38.42 62.64 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 119.275 0.943 . . . . 3.15 110.776 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.1 m -67.01 -53.44 31.32 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.004 0.82 . . . . 1.12 108.875 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mp -50.81 -51.81 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.339 0.656 . . . . 1.32 110.28 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.51 -51.58 64.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.839 1.256 . . . . 2.35 110.612 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.0 t -65.71 -20.05 66.13 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 118.009 -0.996 . . . . 1.43 112.866 -171.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.8 -101.55 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 119.551 1.069 . . . . 2.84 108.388 163.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.46 36.68 0.48 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.411 -1.076 . . . . 1.13 110.411 173.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -126.74 154.62 43.94 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.819 -0.808 . . . . 2.37 108.819 -162.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -109.49 152.77 24.99 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.553 -0.906 . . . . 3.6 108.553 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.09 148.45 50.57 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 125.563 1.545 . . . . 1.03 110.246 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.1 m -154.15 99.7 2.26 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.787 0.835 . . . . 1.86 110.402 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mt . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 108.075 -1.083 . . . . 3.33 108.075 164.374 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.438 0 N-CA-C 106.984 -2.446 . . . . 1.32 106.984 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.9 t -136.76 134.37 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.998 -1.482 . . . . 2.47 106.998 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.5 mt -135.19 117.13 15.24 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.324 -1.362 . . . . 2.53 107.324 171.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -79.42 89.38 5.01 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.918 -1.882 . . . . 3.52 105.918 155.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.2 mt -78.67 134.88 37.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.709 -1.589 . . . . 2.33 106.709 172.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.83 119.2 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 104.977 -2.231 . . . . 1.1 104.977 162.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -124.86 110.41 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 105.708 -1.96 . . . . 2.41 105.708 -175.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.6 mtp-105 -117.63 160.02 21.97 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.381 1.073 . . . . 5.97 109.768 -165.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.36 0.59 88.35 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.876 -0.889 . . . . 1.16 110.876 -163.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.6 ttm -69.44 68.2 0.22 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.534 1.534 . . . . 2.28 109.805 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -67.36 -31.55 71.89 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.465 0.542 . . . . 1.58 112.465 -166.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.6 p -155.04 174.94 14.47 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.993 0.815 . . . . 0.65 112.117 -170.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.02 -41.97 17.42 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.119 1.368 . . . . 0.92 111.786 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 m -54.2 -43.62 70.9 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 122.953 0.501 . . . . 1.4 110.894 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.3 m -66.12 -50.68 63.18 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.291 0.496 . . . . 0.73 109.96 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.2 t -46.19 -64.12 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.377 0.671 . . . . 1.1 110.378 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -31.0 67.13 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.233 -0.587 . . . . 0.93 112.218 -174.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -51.85 67.72 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.701 0.682 . . . . 5.35 109.467 174.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.3 mt -56.01 -62.67 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 108.099 -1.074 . . . . 0.89 108.099 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -49.33 -56.34 9.83 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 123.744 0.652 . . . . 3.89 110.167 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.6 t -57.66 -48.64 78.93 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.959 0.504 . . . . 0.97 111.209 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.5 t -71.81 -22.9 61.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.759 -0.588 . . . . 1.49 110.78 -171.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mp -73.65 -63.79 1.13 Allowed 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 121.349 -0.844 . . . . 2.54 110.569 163.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 84.8 m -54.63 -23.55 17.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.38 1.072 . . . . 2.3 113.1 -170.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -53.0 -34.95 58.68 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.072 1.138 . . . . 5.36 114.072 170.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -70.25 120.45 15.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.572 -0.899 . . . . 1.97 108.572 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -74.43 56.61 0.67 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.506 0.593 . . . . 7.02 110.66 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.08 42.33 0.44 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.115 -1.594 . . . . 1.97 109.115 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.6 pp -147.51 163.47 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 127.057 2.143 . . . . 2.94 105.243 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -111.36 -43.01 3.77 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.785 0.834 . . . . 2.66 109.833 171.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -156.26 158.05 36.84 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.272 0.942 . . . . 1.88 110.9 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.0 m -143.23 124.87 14.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.318 1.847 . . . . 2.43 106.368 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.54 106.3 6.94 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.975 0.91 . . . . 1.95 108.705 173.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.6 m -100.85 147.86 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 125.274 1.43 . . . . 2.6 110.727 -173.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.28 125.5 18.71 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.814 -0.81 . . . . 0.83 108.814 166.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.533 HD12 ' N ' ' A' ' 40' ' ' ALA . 1.4 pp -64.93 -37.34 87.33 Favored 'General case' 0 C--N 1.338 0.098 0 O-C-N 123.395 0.435 . . . . 1.6 110.436 168.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.533 ' N ' HD12 ' A' ' 39' ' ' LEU . . . -50.55 -49.77 55.2 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.458 1.103 . . . . 1.72 111.123 -174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.5 8.5 33.44 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.256 0.622 . . . . 3.01 110.983 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.264 0.0 OUTLIER 47.12 61.22 2.98 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 126.355 1.862 . . . . 1.78 109.907 173.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.24 166.29 31.36 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.303 -0.862 . . . . 2.35 111.944 -173.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.05 110.24 6.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.014 2.526 . . . . 0.91 107.823 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -78.74 97.08 5.76 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 105.467 -2.049 . . . . 1.03 105.467 167.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.9 mt -104.22 138.91 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 107.001 -1.481 . . . . 1.71 107.001 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -127.44 135.99 51.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.904 -1.888 . . . . 3.31 105.904 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -161.53 158.99 27.28 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.4 1.08 . . . . 2.41 108.149 -167.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -79.63 126.92 79.64 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.397 -1.334 . . . . 3.55 107.397 169.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -80.97 46.28 2.23 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.01 2.473 . . . . 2.04 109.801 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -137.45 -62.03 0.62 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.931 1.292 . . . . 4.08 108.181 -165.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 tt -74.13 -26.95 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 121.946 -0.471 . . . . 2.64 111.4 176.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.25 129.96 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.269 -1.752 . . . . 1.41 106.269 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.28 -179.53 53.06 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 110.498 -1.041 . . . . 1.22 110.498 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.66 -54.52 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.211 1.941 . . . . 1.3 111.347 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -67.09 -25.69 66.34 Favored 'General case' 0 C--O 1.221 -0.411 0 O-C-N 121.7 -0.625 . . . . 6.22 111.773 -172.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.77 -50.55 5.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.384 1.874 . . . . 2.97 110.744 172.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.9 mt -66.4 -52.16 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.082 -0.71 . . . . 0.66 109.082 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mt -53.68 -45.97 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 122.801 0.44 . . . . 1.17 110.656 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -50.67 -41.3 55.44 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.636 1.174 . . . . 3.69 110.674 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.8 m -65.45 -48.51 72.44 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.169 -0.678 . . . . 0.91 109.169 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.07 -55.82 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.045 0.538 . . . . 1.35 110.121 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -53.3 -53.52 49.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.149 0.98 . . . . 2.27 110.081 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.9 t -55.01 -40.36 70.07 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.014 1.326 . . . . 1.18 111.452 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.6 mt -60.02 -86.22 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 117.946 0.339 . . . . 2.25 111.593 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.03 32.82 0.38 Allowed Glycine 0 CA--C 1.524 0.623 0 CA-C-O 118.653 -1.082 . . . . 0.96 113.118 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -133.06 163.34 29.47 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 118.715 1.257 . . . . 2.1 113.064 -158.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -97.21 144.86 26.61 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.219 2.208 . . . . 3.54 105.157 171.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.95 140.12 40.09 Favored 'General case' 0 CA--C 1.526 0.024 0 CA-C-N 118.772 0.715 . . . . 1.74 111.416 -168.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.6 p -155.76 175.44 13.93 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.235 1.014 . . . . 2.41 108.43 165.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 N-CA-C 105.314 -2.106 . . . . 2.45 105.314 158.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.594 0 N-CA-C 110.107 -1.197 . . . . 1.66 110.107 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.53 66.91 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 124.912 1.285 . . . . 2.8 108.696 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.33 79.63 4.76 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.037 -1.468 . . . . 2.73 107.037 -176.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -99.12 99.74 10.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.343 -1.299 . . . . 2.98 107.942 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.98 153.32 36.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.487 1.115 . . . . 2.69 109.164 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.9 123.75 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 106.824 -1.547 . . . . 0.81 106.824 174.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.9 t -100.91 109.32 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.898 -1.89 . . . . 2.09 105.898 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -88.25 137.4 32.36 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.323 -0.991 . . . . 6.71 108.323 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.06 1.68 41.88 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.73 -1.039 . . . . 1.07 113.455 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 48.3 mtm -71.45 71.02 0.65 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.44 1.62 . . . . 1.52 110.406 175.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -71.72 -19.17 62.09 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.678 -1.154 . . . . 1.69 113.768 -168.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -162.7 173.41 13.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 120.152 1.342 . . . . 0.79 111.022 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.59 -39.41 35.24 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.223 1.009 . . . . 0.59 111.54 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 m -59.61 -30.49 68.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.406 0.682 . . . . 1.66 112.146 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.1 m -71.07 -55.38 8.35 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.834 0.743 . . . . 1.0 109.898 168.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.28 -59.95 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.918 0.887 . . . . 0.67 110.886 -173.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.66 -31.72 71.04 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.236 -0.586 . . . . 1.0 111.707 -174.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -60.41 -51.69 68.4 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.75 -0.833 . . . . 3.31 108.75 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.0 mt -53.1 -64.47 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 108.63 -0.878 . . . . 0.73 108.63 174.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -49.46 -60.37 2.91 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 123.951 0.782 . . . . 3.8 110.031 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 t -52.96 -48.4 67.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.87 0.868 . . . . 0.87 110.442 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.1 m -59.9 -54.69 43.21 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.125 -0.694 . . . . 2.22 109.125 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.64 -37.19 65.37 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.739 0.815 . . . . 2.42 111.858 -173.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.3 p -54.97 -26.52 37.22 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.592 0.96 . . . . 2.56 113.592 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -4.18 37.55 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.941 1.246 . . . . 4.89 113.457 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -88.14 69.01 9.22 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 106.843 -1.54 . . . . 2.12 106.843 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -47.59 -16.14 0.06 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 118.017 2.599 . . . . 6.95 118.017 -161.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.07 -7.0 86.63 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 119.837 1.199 . . . . 1.08 113.114 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.16 137.32 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.442 -1.318 . . . . 2.41 107.442 168.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.5 mt -85.43 -39.76 17.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.267 1.027 . . . . 2.16 109.683 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -157.05 153.32 27.72 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.627 -0.879 . . . . 2.34 108.627 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.5 t -127.98 146.72 50.57 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.622 -0.881 . . . . 2.26 108.622 166.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 m -148.26 107.89 3.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.873 0.869 . . . . 2.13 109.933 164.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.74 145.3 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 125.951 1.7 . . . . 1.99 110.394 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.14 120.75 10.44 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 124.02 0.928 . . . . 0.91 109.462 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 pp -81.65 -12.34 58.73 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.271 1.029 . . . . 1.5 113.392 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.36 -49.4 34.34 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.134 -1.061 . . . . 1.46 108.134 172.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -79.47 -25.56 41.86 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.664 1.186 . . . . 1.69 111.221 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.8 m120 63.82 42.22 6.26 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 126.02 1.728 . . . . 1.48 109.666 -172.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.26 148.88 45.44 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 124.253 1.021 . . . . 2.79 108.319 -170.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.17 109.46 12.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.837 -1.171 . . . . 0.8 107.837 165.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -82.84 105.35 13.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.574 -1.639 . . . . 1.36 106.574 167.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.29 123.58 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.545 -1.65 . . . . 1.65 106.545 168.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -93.95 145.92 24.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.712 -1.218 . . . . 2.58 107.712 162.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -163.73 158.45 20.29 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.024 0.529 . . . . 1.74 110.304 -168.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -100.03 121.0 55.43 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 124.441 1.088 . . . . 3.4 108.098 170.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.57 -38.13 19.98 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.845 2.363 . . . . 2.04 112.898 -168.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -58.4 -40.54 82.68 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.978 0.511 . . . . 3.33 111.652 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -81.67 -50.75 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 123.104 0.562 . . . . 2.9 110.245 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.54 100.71 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.63 -0.878 . . . . 1.77 108.63 -173.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -63.9 140.6 44.14 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 108.763 -1.735 . . . . 1.41 108.763 168.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -56.93 -32.43 92.55 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.812 2.341 . . . . 1.26 112.005 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.491 HH11 ' CD2' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -58.36 -28.33 65.01 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 117.954 -1.022 . . . . 6.17 112.714 176.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.14 -55.69 23.08 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.431 1.469 . . . . 4.94 109.756 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.8 mt -51.74 -52.08 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.455 0.702 . . . . 0.79 109.168 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.7 mt -57.65 -49.27 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 118.707 -0.663 . . . . 1.58 110.323 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.491 ' CD2' HH11 ' A' ' 56' ' ' ARG . 27.7 m80 -54.09 -41.1 67.85 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.225 0.92 . . . . 2.93 111.294 174.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.7 m -58.62 -54.85 42.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.449 -0.945 . . . . 0.85 108.449 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.85 -55.46 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.598 0.759 . . . . 1.88 110.505 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -51.32 -59.4 4.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.57 0.748 . . . . 2.0 109.718 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.4 t -55.56 -48.4 74.83 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.572 1.149 . . . . 1.45 111.233 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.7 mt -59.04 -51.41 70.15 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.835 0.68 . . . . 2.17 112.835 -172.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.69 1.61 0.06 OUTLIER Glycine 0 CA--C 1.529 0.948 0 N-CA-C 117.156 1.623 . . . . 1.13 117.156 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -139.21 177.07 8.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.637 1.718 . . . . 1.8 111.712 -139.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.94 152.3 32.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.022 -1.473 . . . . 3.15 107.022 165.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.87 146.65 37.33 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.853 0.861 . . . . 1.45 109.251 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.6 m -147.92 107.93 4.04 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.766 0.826 . . . . 2.14 108.835 173.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.279 0 C-N-CA 124.755 1.222 . . . . 3.11 111.936 -176.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.819 0 N-CA-C 106.663 -2.575 . . . . 1.46 106.663 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.26 109.41 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 123.54 0.736 . . . . 2.33 109.347 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -104.23 87.3 2.72 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.226 -1.398 . . . . 3.24 107.226 166.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -82.06 91.93 6.73 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.586 -1.635 . . . . 4.35 106.586 160.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 pp -105.34 157.71 17.13 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.446 -0.797 . . . . 2.11 109.037 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 t -79.05 140.98 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 106.537 -1.653 . . . . 1.26 106.537 171.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.2 t -125.52 123.87 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 105.951 -1.87 . . . . 1.98 105.951 173.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.6 mtt-85 -112.56 152.72 28.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.396 -0.964 . . . . 7.06 108.396 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.49 -6.93 61.34 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.271 -0.738 . . . . 1.12 112.886 -171.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 57.0 mtm -69.94 74.46 0.45 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.892 1.346 . . . . 1.53 110.288 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -67.36 -34.48 77.38 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 119.255 -0.403 . . . . 1.62 111.757 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.1 p -152.95 172.86 16.17 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.09 0.859 . . . . 0.81 112.678 -173.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.34 -44.02 7.91 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.587 1.555 . . . . 0.94 111.854 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.2 m -58.9 -33.41 70.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.779 0.831 . . . . 1.54 112.387 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.2 m -71.05 -57.16 4.81 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 122.308 1.051 . . . . 0.93 109.252 170.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.498 HG13 HG23 ' A' ' 37' ' ' VAL . 71.5 t -49.26 -60.73 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.75 1.62 . . . . 1.11 110.297 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.68 -28.54 67.77 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.784 -0.573 . . . . 0.92 111.389 -175.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -68.58 -39.26 81.04 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.503 -0.555 . . . . 5.81 109.503 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.2 mt -57.01 -61.29 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.125 -0.694 . . . . 0.75 109.125 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -45.97 -59.76 2.66 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.152 0.581 . . . . 3.36 111.343 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.8 t -56.56 -39.12 72.92 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.825 0.85 . . . . 1.12 111.917 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.8 t -70.46 -55.34 9.23 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.417 -1.327 . . . . 1.17 107.417 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.0 -35.47 80.33 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 121.96 -0.462 . . . . 2.74 110.589 -170.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.4 m -69.77 67.49 0.25 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.228 1.013 . . . . 2.73 110.238 171.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -158.39 -42.59 0.06 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 128.885 2.874 . . . . 5.39 109.249 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -66.69 110.89 3.41 Favored 'General case' 0 C--N 1.345 0.373 0 N-CA-C 108.786 -0.82 . . . . 1.57 108.786 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.76 -18.83 57.19 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.292 -0.88 . . . . 6.6 111.449 173.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -51.86 -39.64 48.23 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.717 0.675 . . . . 1.6 112.485 167.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -93.83 157.17 3.02 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 CA-C-N 117.588 0.694 . . . . 2.3 110.794 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.9 mt -105.98 -40.32 5.72 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.933 1.293 . . . . 1.9 109.685 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -153.6 156.95 38.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.044 0.384 . . . . 2.75 110.775 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.8 t -139.64 135.25 33.08 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.029 -1.841 . . . . 2.22 106.029 167.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 t -147.96 144.64 28.14 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.027 0.83 . . . . 2.84 110.277 154.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.498 HG23 HG13 ' A' ' 19' ' ' VAL . 20.4 m -113.22 166.57 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 123.939 0.895 . . . . 2.04 111.553 -168.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.93 139.76 29.32 Favored 'General case' 0 CA--C 1.52 -0.198 0 O-C-N 122.061 -0.399 . . . . 1.12 110.985 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 mp -72.0 -63.04 1.22 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.571 1.548 . . . . 3.56 109.845 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.76 -45.83 81.82 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 123.808 0.843 . . . . 1.98 111.141 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.25 -16.8 57.46 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.841 0.856 . . . . 1.77 110.857 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 55.12 62.57 2.44 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.125 1.37 . . . . 2.24 107.689 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.3 pttp -134.68 160.78 37.06 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.011 0.374 . . . . 2.14 112.011 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.12 112.9 9.54 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.388 1.475 . . . . 0.75 108.491 169.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -79.68 93.72 5.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.707 2.003 . . . . 1.55 107.006 169.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.0 mm -92.25 134.59 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.323 -1.362 . . . . 1.59 107.323 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -118.69 119.97 36.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 105.319 -2.104 . . . . 2.27 105.319 163.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -142.65 156.39 45.05 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 107.918 -1.141 . . . . 1.9 107.918 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -89.33 116.3 65.97 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.36 -0.829 . . . . 3.34 109.143 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.06 70.12 3.03 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.238 3.292 . . . . 2.89 110.976 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -161.66 -55.65 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 127.183 2.193 . . . . 3.05 106.675 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.4 pt -88.88 -11.19 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.906 0.883 . . . . 3.28 112.654 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 tt -158.35 156.31 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.078 -2.193 . . . . 1.68 105.078 171.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.9 -178.71 27.95 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 109.402 -1.479 . . . . 1.11 109.402 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.5 -40.75 9.89 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.866 1.71 . . . . 0.97 109.591 171.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -38.43 69.41 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 117.991 -1.004 . . . . 5.72 111.1 -171.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.57 -50.5 69.24 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.772 0.714 . . . . 2.46 110.284 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 58' ' ' ILE . 4.6 mp -60.33 -47.54 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.204 -1.035 . . . . 1.56 108.204 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.4 mt -55.08 -43.44 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 116.325 -0.398 . . . . 1.39 110.954 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -32.04 73.29 Favored 'General case' 0 C--O 1.224 -0.273 0 O-C-N 120.858 -1.151 . . . . 5.04 111.034 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.2 m -63.8 -48.29 77.45 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.356 -0.979 . . . . 0.76 108.356 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.421 HG23 ' HB2' ' A' ' 67' ' ' PHE . 65.2 mt -54.37 -46.18 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.411 1.084 . . . . 1.44 110.458 175.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -55.57 -54.48 43.57 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.181 0.515 . . . . 2.06 110.362 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 t -56.76 -38.04 71.9 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 126.068 1.747 . . . . 1.2 111.722 -171.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.77 -92.6 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.605 -0.517 . . . . 2.42 109.605 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.87 30.13 0.33 Allowed Glycine 0 C--N 1.337 0.602 0 CA-C-O 118.712 -1.049 . . . . 1.06 112.802 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.421 ' HB2' HG23 ' A' ' 62' ' ' ILE . 19.7 m-85 -129.81 160.74 32.53 Favored 'General case' 0 N--CA 1.458 -0.047 0 CA-C-N 118.797 1.299 . . . . 1.68 111.415 -159.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -104.6 154.38 20.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.571 1.549 . . . . 3.27 107.159 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.55 151.68 49.17 Favored 'General case' 0 C--O 1.23 0.054 0 C-N-CA 123.315 0.646 . . . . 1.27 110.176 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.1 m -152.17 104.85 3.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.275 -1.009 . . . . 1.72 108.275 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 CA--C 1.53 0.2 0 O-C-N 121.279 -0.888 . . . . 2.5 109.964 174.157 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.674 0 N-CA-C 108.288 -1.925 . . . . 2.01 108.288 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.8 t -78.57 126.02 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 107.943 -1.132 . . . . 2.73 107.943 170.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.1 tp -155.59 100.63 2.11 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.747 0.419 . . . . 3.0 111.387 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.76 89.39 4.01 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 122.766 1.269 . . . . 3.89 109.276 153.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pp -81.73 154.04 26.22 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 113.967 -1.469 . . . . 2.06 108.52 162.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.79 141.53 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.487 -2.042 . . . . 0.95 105.487 168.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.5 127.81 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 104.942 -2.244 . . . . 1.89 104.942 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.6 mtp-105 -120.34 160.82 22.26 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.205 0.911 . . . . 5.43 110.498 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.13 6.17 65.16 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.376 0.989 . . . . 1.16 111.691 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 73.4 mtp -74.39 62.79 1.0 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.569 1.148 . . . . 1.91 110.298 -177.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -69.66 -16.4 63.36 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.256 1.206 . . . . 1.46 114.256 -162.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.2 p -161.53 175.2 12.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 120.202 1.364 . . . . 0.58 110.678 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.96 -39.51 19.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.449 1.1 . . . . 0.56 111.718 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -59.67 -33.28 71.37 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.112 0.565 . . . . 2.29 111.3 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.8 m -71.65 -54.12 11.41 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.643 0.656 . . . . 0.69 109.674 170.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.7 t -47.09 -60.7 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.008 0.923 . . . . 0.79 110.821 -174.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.89 -31.12 68.76 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.321 -0.551 . . . . 0.74 111.624 -174.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -60.52 -51.98 67.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.902 -0.777 . . . . 2.98 108.902 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.6 mt -51.88 -58.94 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.202 0 C-N-CA 123.302 0.641 . . . . 0.9 109.453 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -53.93 -57.01 12.57 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 123.559 0.537 . . . . 3.73 109.845 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.8 t -53.29 -42.7 66.87 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.574 1.15 . . . . 0.85 111.427 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.4 m -70.78 -44.83 65.85 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.999 -0.741 . . . . 1.93 108.999 -175.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.0 mt -64.57 -55.66 18.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.459 -0.337 . . . . 2.71 110.818 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 t -56.68 -19.86 18.63 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.674 -0.641 . . . . 2.64 111.657 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -34.78 75.62 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.122 -0.986 . . . . 4.73 112.757 174.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -80.72 119.56 23.48 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.681 -1.229 . . . . 1.73 107.681 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -49.46 -28.92 5.83 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.883 1.068 . . . . 5.56 113.883 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.16 -22.37 70.73 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.017 -0.879 . . . . 0.97 113.227 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.3 mm -84.27 110.3 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.731 -1.211 . . . . 4.39 107.731 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.09 -33.28 29.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.07 0.548 . . . . 2.78 109.882 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -155.64 158.52 38.47 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.277 -0.638 . . . . 2.32 109.277 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.6 t -145.74 135.52 23.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.741 0.817 . . . . 2.84 108.897 168.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 t -126.13 94.67 4.16 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.858 -1.534 . . . . 2.18 106.858 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 m -78.7 148.43 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.61 1.564 . . . . 2.46 110.441 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.04 123.58 5.51 Favored 'General case' 0 C--N 1.339 0.13 0 O-C-N 122.088 -0.383 . . . . 0.94 111.097 164.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.02 -8.59 56.95 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.206 1.003 . . . . 1.44 113.001 174.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.56 -64.04 1.16 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.312 -0.996 . . . . 2.19 108.312 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 p -77.0 -5.92 50.6 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.849 -0.532 . . . . 2.03 110.455 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 57.57 57.49 4.29 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.889 1.276 . . . . 2.36 107.742 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 168.93 18.6 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.441 0.638 . . . . 2.13 111.68 -170.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -142.3 106.12 4.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.38 -1.736 . . . . 0.62 106.518 167.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -77.0 93.29 3.8 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 103.679 -2.711 . . . . 1.03 103.679 168.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.1 mt -89.33 143.88 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 106.577 -1.638 . . . . 1.83 106.577 174.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -124.16 119.79 30.44 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 105.181 -2.155 . . . . 3.25 105.181 163.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -139.89 162.37 35.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.324 0.649 . . . . 2.02 110.243 -174.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -93.28 109.87 42.86 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 107.803 -1.184 . . . . 3.47 107.803 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.43 60.51 7.56 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 124.331 3.354 . . . . 1.55 111.677 -167.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -171.5 -45.02 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.501 1.92 . . . . 2.94 108.21 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.0 mt -67.13 -38.2 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 108.889 -0.782 . . . . 3.26 108.889 170.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 tt -147.34 136.97 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.655 -1.609 . . . . 1.41 106.655 174.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.22 165.58 30.3 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.009 -0.837 . . . . 0.93 111.009 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -55.24 -47.34 26.67 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.24 1.96 . . . . 1.13 109.737 171.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -51.37 -37.83 50.08 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.314 0.646 . . . . 7.54 112.038 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -70.52 -47.75 58.93 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.284 -0.636 . . . . 2.38 109.284 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.4 mt -53.54 -52.09 36.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 122.846 0.458 . . . . 0.91 110.301 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.9 mm -51.81 -51.6 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.313 0.645 . . . . 1.86 109.655 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -56.22 -40.2 73.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.074 -0.391 . . . . 4.98 111.587 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.3 m -60.37 -56.71 18.2 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.084 -0.709 . . . . 0.87 109.084 175.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.437 HG21 ' HB2' ' A' ' 69' ' ' ALA . 32.2 mt -47.6 -53.18 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.607 1.163 . . . . 1.56 111.346 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -59.27 -56.23 24.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.466 1.106 . . . . 2.22 110.362 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.3 t -59.12 -30.08 67.86 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.433 0.693 . . . . 1.47 111.841 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.9 mt -71.87 -74.86 0.14 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.349 0.522 . . . . 2.32 110.618 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.51 6.83 0.08 OUTLIER Glycine 0 CA--C 1.529 0.965 0 CA-C-O 117.862 -1.521 . . . . 0.84 116.231 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -130.85 158.31 40.52 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 120.2 2.0 . . . . 1.66 112.165 -146.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -92.55 167.53 11.87 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 107.509 -1.293 . . . . 3.08 107.509 170.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.437 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -155.25 169.16 24.83 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.901 0.381 . . . . 0.88 111.192 164.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.4 m -154.6 125.61 7.2 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.831 1.252 . . . . 1.65 108.059 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 C-N-CA 123.516 0.727 . . . . 2.84 111.874 -175.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 108.155 -1.978 . . . . 1.81 108.155 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.96 132.81 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.236 -1.394 . . . . 2.64 107.236 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.6 tp -148.48 143.31 26.62 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.293 -1.373 . . . . 2.89 107.293 172.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -133.72 113.82 12.75 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.322 -1.362 . . . . 3.98 107.322 172.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.421 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -122.79 153.68 39.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.379 0.672 . . . . 2.23 109.493 -179.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.48 140.65 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.075 -1.454 . . . . 0.79 107.075 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.6 t -131.97 93.0 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 C-N-CA 127.062 2.145 . . . . 2.04 106.052 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.4 mtm105 -79.79 157.74 27.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.485 -0.561 . . . . 5.71 109.485 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.79 -6.08 56.92 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.403 1.002 . . . . 1.07 112.082 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 71.8 mtp -71.88 74.07 0.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.166 0.983 . . . . 1.92 110.958 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 t -70.76 -17.15 62.8 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 117.277 -1.344 . . . . 1.61 114.257 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.2 p -163.78 176.15 9.81 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 120.727 1.603 . . . . 0.61 111.381 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.65 -38.41 21.01 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.805 1.242 . . . . 0.64 111.892 175.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 t -49.07 -48.57 44.05 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 109.425 -0.583 . . . . 2.57 109.425 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.6 m -62.32 -46.03 90.58 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 122.258 0.223 . . . . 0.89 110.773 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 80.2 t -52.49 -65.1 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 109.921 -0.4 . . . . 1.0 109.921 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -30.58 67.67 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 118.986 -1.085 . . . . 0.86 111.842 -172.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -53.19 -53.43 50.76 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.37 -0.604 . . . . 3.47 109.37 169.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.9 mt -60.65 -58.37 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 118.461 -0.781 . . . . 0.64 110.024 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -49.51 -55.46 13.25 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.994 0.816 . . . . 3.88 110.548 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.1 t -56.58 -38.98 72.73 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.326 1.05 . . . . 0.91 111.388 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.3 t -71.13 -36.35 72.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.476 -0.765 . . . . 1.51 109.845 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.1 mt -66.99 -62.19 1.56 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 118.488 -0.768 . . . . 3.24 110.488 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.1 p -70.62 65.66 0.32 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.249 1.419 . . . . 1.94 111.697 -172.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.8 tptp -176.48 -48.2 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.55 1.14 . . . . 4.16 108.167 -151.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -73.29 90.59 1.64 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.897 -1.149 . . . . 1.89 107.897 166.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -51.76 105.1 0.1 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.526 -0.546 . . . . 6.44 109.526 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.79 -43.9 0.7 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 108.727 -1.749 . . . . 0.94 108.727 -164.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.45 131.57 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 105.436 -2.061 . . . . 2.5 105.436 161.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.7 mt -94.24 -42.72 8.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.909 1.284 . . . . 1.76 108.351 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -149.04 154.24 39.01 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.441 -0.578 . . . . 2.42 109.441 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.3 p -143.93 152.71 41.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.381 1.472 . . . . 2.14 108.306 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.9 m -155.25 82.78 1.06 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.673 1.189 . . . . 2.03 108.396 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.56 154.24 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 125.086 1.354 . . . . 2.61 108.871 174.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.04 130.06 11.82 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 120.736 -1.228 . . . . 0.92 110.786 172.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.59 -32.99 72.08 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.316 0.507 . . . . 1.87 110.159 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -47.59 -43.48 25.6 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.621 1.168 . . . . 1.34 112.449 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 t -121.76 1.97 10.0 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.706 0.403 . . . . 2.93 111.975 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 52.17 66.29 1.25 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.481 1.513 . . . . 1.78 108.46 174.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.48 166.02 27.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.427 1.091 . . . . 2.3 108.323 -175.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.48 108.85 12.04 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.832 2.053 . . . . 1.07 106.255 166.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -80.54 132.9 35.73 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 103.746 -2.687 . . . . 1.3 103.746 159.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.8 pt -138.84 151.27 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 106.796 -1.557 . . . . 3.58 106.796 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -139.28 101.01 4.15 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 102.802 -3.036 . . . . 2.46 102.802 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -129.91 149.01 51.83 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.523 0.729 . . . . 1.78 109.205 -169.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -82.96 117.79 69.69 Favored Pre-proline 0 N--CA 1.451 -0.423 0 N-CA-C 107.809 -1.182 . . . . 2.87 107.809 173.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.11 -26.99 78.5 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.443 1.428 . . . . 1.93 111.625 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -80.8 42.04 0.6 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.145 0.884 . . . . 4.27 111.363 -174.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -175.5 -43.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.682 1.593 . . . . 2.89 110.277 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 tt -132.67 124.03 50.32 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 108.108 -1.071 . . . . 1.19 108.108 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.4 173.59 51.11 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 110.679 -0.968 . . . . 0.91 110.679 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.63 -54.73 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.45 2.1 . . . . 0.99 110.263 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -50.46 -42.94 54.97 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.297 0.639 . . . . 6.04 110.944 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.51 -49.32 18.68 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.816 2.046 . . . . 2.68 110.154 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 54.7 mt -70.32 -47.59 65.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.234 0.614 . . . . 1.34 110.312 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.3 mm -50.03 -47.24 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 118.132 0.424 . . . . 1.95 110.858 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -45.17 -44.99 11.25 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.316 1.446 . . . . 2.85 111.445 173.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.0 m -58.89 -55.09 39.61 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.565 -0.902 . . . . 1.08 108.565 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.5 -53.67 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.197 0.599 . . . . 1.79 109.966 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -61.78 -48.34 81.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.618 -0.433 . . . . 2.48 110.22 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.6 t -55.65 -48.41 75.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.174 0.59 . . . . 1.49 111.549 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.1 mt -54.97 -59.51 4.65 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.903 -0.498 . . . . 2.32 112.316 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.68 -0.01 0.06 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 116.961 1.544 . . . . 1.09 116.961 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -131.94 175.18 9.44 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 119.897 1.849 . . . . 1.85 113.371 -139.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -125.68 103.44 7.83 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.685 1.194 . . . . 4.12 107.977 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.79 157.27 21.03 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.96 0.356 . . . . 1.47 111.96 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.9 t -154.45 133.09 12.12 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.424 1.09 . . . . 2.08 108.315 165.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.6 mt . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 109.026 -0.731 . . . . 2.32 109.026 163.401 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.437 0 N-CA-C 109.037 -1.625 . . . . 3.76 109.037 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 p -158.04 166.54 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.754 -1.572 . . . . 2.51 106.754 169.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 tp -133.27 128.45 35.85 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.468 -1.308 . . . . 2.23 107.468 151.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -121.89 133.28 54.86 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.385 1.474 . . . . 3.72 108.133 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.98 157.12 41.29 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.378 -0.601 . . . . 2.73 109.378 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.61 145.21 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.263 -1.754 . . . . 0.75 106.263 169.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.8 137.24 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 125.672 1.589 . . . . 1.72 108.467 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -130.36 163.19 27.41 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.093 0.957 . . . . 5.81 108.779 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.67 -15.4 63.22 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.455 0.55 . . . . 1.41 112.275 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.458 ' SD ' HD12 ' A' ' 22' ' ' ILE . 64.2 mtm -69.14 78.98 0.34 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.208 1.004 . . . . 1.67 110.097 175.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 t -71.46 -16.75 62.38 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.753 -1.117 . . . . 1.77 113.097 -174.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.5 p -161.72 172.68 15.81 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.94 1.245 . . . . 0.97 110.792 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.16 -41.12 25.98 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.782 1.233 . . . . 0.71 111.536 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.5 m -61.01 -29.29 69.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.523 0.729 . . . . 1.62 112.205 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.7 m -72.03 -56.62 5.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.161 0.892 . . . . 0.81 110.03 166.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.705 HG13 HG23 ' A' ' 37' ' ' VAL . 88.3 t -43.71 -62.35 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.588 1.155 . . . . 0.9 110.781 -173.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -25.31 63.53 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 120.586 -0.446 . . . . 0.82 111.898 -175.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -67.88 -41.17 83.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.205 -0.665 . . . . 2.9 109.205 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.458 HD12 ' SD ' ' A' ' 13' ' ' MET . 12.8 mt -54.94 -59.03 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.494 -0.558 . . . . 0.87 109.494 173.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.443 ' OE2' HG22 ' A' ' 37' ' ' VAL . 93.4 mt-10 -52.97 -51.2 62.31 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.548 0.613 . . . . 3.72 111.388 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.2 t -54.93 -37.38 66.33 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.143 0.977 . . . . 0.95 111.205 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.3 t -71.29 -57.87 4.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.736 -1.209 . . . . 1.45 107.736 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.0 mt -51.17 -49.66 60.47 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.014 0.925 . . . . 2.6 112.085 -174.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.3 t -56.77 -17.92 10.85 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.456 -0.777 . . . . 2.67 112.61 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -30.45 71.3 Favored 'General case' 0 C--N 1.343 0.287 0 O-C-N 121.139 -0.976 . . . . 5.76 112.34 175.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -81.18 113.22 19.18 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 106.543 -1.651 . . . . 1.74 106.543 170.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -55.84 -26.33 46.18 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.524 0.565 . . . . 6.58 112.524 -173.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.82 -22.26 59.62 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.818 0.723 . . . . 1.37 113.437 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.2 mm -79.59 97.88 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.282 -1.377 . . . . 4.13 107.282 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.3 mt -77.68 -34.78 52.84 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.024 -0.732 . . . . 1.81 109.024 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -148.75 158.55 44.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.591 -0.892 . . . . 2.27 108.591 165.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.6 p -145.26 138.02 26.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.963 1.705 . . . . 2.35 107.717 173.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 t -142.16 106.93 4.87 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.496 -1.668 . . . . 1.77 106.496 170.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.705 HG23 HG13 ' A' ' 19' ' ' VAL . 35.9 m -84.87 171.78 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.159 0.436 . . . . 1.71 109.936 170.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -157.12 141.3 16.36 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.063 -0.717 . . . . 0.94 109.063 152.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.98 -38.07 53.92 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 108.521 -0.918 . . . . 2.11 108.521 166.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.36 -38.96 69.49 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.582 0.753 . . . . 1.46 110.609 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 m -112.1 14.52 20.71 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.389 1.076 . . . . 2.41 110.284 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.3 m120 32.29 53.08 0.29 Allowed 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 126.392 1.877 . . . . 1.57 113.512 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.68 168.47 17.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 122.864 0.465 . . . . 2.74 111.29 -171.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -140.26 135.59 32.46 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.29 -1.323 . . . . 1.13 109.22 150.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -110.4 107.34 17.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 104.288 -2.486 . . . . 1.28 104.288 168.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.433 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -106.74 146.56 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 105.889 -1.893 . . . . 1.86 105.889 175.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -113.16 93.21 4.3 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 105.307 -2.108 . . . . 2.61 105.307 170.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.78 150.89 20.87 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.318 1.047 . . . . 3.02 112.755 -174.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -87.22 126.5 62.41 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 107.066 -1.457 . . . . 3.09 107.066 150.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.02 -19.62 20.22 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.877 3.052 . . . . 1.82 113.447 -171.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -93.05 -45.1 8.07 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.874 -0.788 . . . . 3.44 108.874 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.1 mt -68.12 -35.76 72.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 109.553 -0.536 . . . . 2.92 109.553 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 mm -130.71 116.18 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.041 -1.466 . . . . 1.49 107.041 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.43 152.64 49.62 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 108.234 -1.946 . . . . 0.88 108.234 169.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -55.66 -38.55 94.12 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.028 1.819 . . . . 1.79 111.013 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -67.22 -23.83 65.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 118.841 -0.599 . . . . 6.74 112.408 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -65.59 -35.64 81.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 120.702 1.592 . . . . 2.44 112.285 -170.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.4 mt -53.47 -48.05 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 109.176 -0.676 . . . . 1.29 109.176 171.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.0 mt -62.69 -49.02 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.705 0.802 . . . . 1.31 109.733 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -48.89 -44.6 40.18 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.132 0.878 . . . . 3.91 110.66 175.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.6 m -65.0 -56.63 11.99 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.302 -0.629 . . . . 0.82 109.302 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.403 HG23 ' HB2' ' A' ' 67' ' ' PHE . 74.7 mt -46.89 -49.87 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.454 1.102 . . . . 1.47 110.88 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -58.1 -53.76 54.63 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.797 1.239 . . . . 2.15 111.0 174.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.2 p -60.06 -29.99 68.91 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.316 0.488 . . . . 2.28 112.316 -172.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.38 -97.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.59 -0.522 . . . . 2.88 109.59 167.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.29 35.94 0.44 Allowed Glycine 0 C--N 1.337 0.607 0 O-C-N 121.167 -0.958 . . . . 0.81 112.403 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.403 ' HB2' HG23 ' A' ' 62' ' ' ILE . 26.0 m-85 -131.57 159.37 38.42 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.465 1.132 . . . . 2.22 110.283 -165.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -99.5 155.86 17.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.597 -0.89 . . . . 3.66 108.597 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.72 162.47 35.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.349 0.26 . . . . 1.15 110.953 162.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.0 m -155.44 116.93 4.0 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.79 0.836 . . . . 1.85 109.847 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.374 0 C-N-CA 124.029 0.932 . . . . 2.51 110.743 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 106.626 -2.59 . . . . 1.63 106.626 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.5 p -129.57 134.89 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.458 -1.312 . . . . 1.94 107.458 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.4 tp -145.29 113.3 6.47 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.919 -1.141 . . . . 2.09 107.919 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -94.0 133.23 37.67 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.681 -0.488 . . . . 3.32 109.681 165.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -131.94 148.73 52.54 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.558 -1.275 . . . . 2.24 107.558 172.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.5 t -79.71 142.72 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 106.174 -1.788 . . . . 0.81 106.174 162.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 p -122.73 96.12 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 125.682 1.593 . . . . 2.46 107.678 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -80.87 59.76 3.85 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.388 -0.82 . . . . 6.84 109.768 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.57 0.42 0.21 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.988 -0.896 . . . . 1.46 114.419 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.5 mtm -77.13 76.88 3.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.411 1.605 . . . . 1.64 109.735 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -75.67 -11.63 60.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.886 -1.055 . . . . 1.97 112.963 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.8 p -160.75 172.51 16.92 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 120.008 1.276 . . . . 1.03 109.2 172.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.23 -44.98 11.52 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.459 1.104 . . . . 1.24 111.466 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -50.38 -40.94 51.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.745 0.418 . . . . 2.48 110.846 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.0 m -58.97 -34.6 71.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.41 0.522 . . . . 1.14 112.41 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.66 -67.94 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.738 0.78 . . . . 0.94 109.19 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.76 -32.25 73.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 118.399 -0.81 . . . . 1.38 111.279 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -53.85 -52.84 59.11 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.767 1.167 . . . . 2.96 109.975 172.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.5 mt -54.93 -64.3 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 109.032 -0.729 . . . . 0.81 109.032 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -56.42 -54.73 42.23 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.907 -0.717 . . . . 4.22 110.164 -171.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -51.64 -43.83 62.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.464 1.106 . . . . 0.8 111.98 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.4 t -70.67 -33.28 70.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.208 -0.933 . . . . 1.3 109.852 -175.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.01 -48.15 38.84 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 111.745 0.276 . . . . 2.64 111.745 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.43 ' HA ' HD11 ' A' ' 32' ' ' ILE . 16.2 p -60.29 -18.38 48.91 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.737 -1.227 . . . . 2.12 113.671 -165.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -39.3 63.11 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.138 0.792 . . . . 5.35 113.138 168.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -60.92 167.98 2.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.382 0.992 . . . . 2.5 109.13 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.66 -18.53 12.75 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.773 -0.579 . . . . 6.9 111.869 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.27 -22.8 78.49 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 118.63 0.65 . . . . 1.15 112.015 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.43 HD11 ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -78.7 157.92 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 117.94 0.87 . . . . 3.29 109.785 174.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.5 mt -119.17 -46.43 2.51 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.02 1.328 . . . . 1.98 109.428 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -155.44 153.7 30.76 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 117.728 -1.13 . . . . 2.17 108.641 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.6 t -131.69 77.06 1.75 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.362 1.065 . . . . 2.77 109.472 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.51 85.05 3.89 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 120.75 -1.219 . . . . 3.43 109.82 -168.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.89 138.45 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 128.039 2.536 . . . . 2.67 111.841 -171.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.39 124.3 10.63 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 118.635 0.652 . . . . 1.14 111.629 172.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.4 mt -47.85 -43.79 28.59 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.97 0.908 . . . . 2.16 109.655 158.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.7 -24.71 1.48 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.49 1.116 . . . . 2.38 113.723 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 t -139.5 25.06 2.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.965 0.802 . . . . 3.05 112.438 169.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.2 m120 40.6 45.91 2.08 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.821 2.048 . . . . 1.8 112.816 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.99 170.81 14.82 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 118.543 0.611 . . . . 2.29 111.391 -171.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.11 130.19 23.34 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 125.176 1.547 . . . . 0.89 109.614 164.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -97.98 97.7 9.14 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.043 1.737 . . . . 0.99 107.618 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.5 mp -86.94 112.78 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 106.285 -1.746 . . . . 1.55 106.285 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -88.21 135.17 33.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.073 -1.825 . . . . 2.72 106.073 157.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -162.74 175.05 11.71 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.416 1.086 . . . . 1.85 109.253 -171.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -106.34 125.15 33.63 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 107.064 -1.458 . . . . 3.09 107.064 162.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.67 -6.36 18.11 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.696 2.93 . . . . 1.77 113.567 -171.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -108.33 -34.97 6.65 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.643 1.177 . . . . 3.93 109.074 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.0 mt -70.32 -33.51 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 O-C-N 121.765 -0.584 . . . . 3.55 110.648 169.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 tt -140.2 129.36 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.97 -1.122 . . . . 1.29 107.97 168.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.53 176.16 42.53 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.622 0.63 . . . . 1.57 111.902 -173.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.91 -57.0 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.797 2.332 . . . . 2.62 111.27 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.428 HH21 ' CD ' ' A' ' 63' ' ' GLU . 71.8 ttt180 -65.42 -33.65 76.46 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 117.958 -1.02 . . . . 6.34 110.695 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -35.6 -57.5 0.63 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.766 1.626 . . . . 2.32 111.486 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.6 mt -52.09 -58.89 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.937 1.295 . . . . 0.83 110.868 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.2 mm -50.66 -62.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 124.859 1.263 . . . . 1.72 109.409 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -49.68 -34.82 19.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.297 1.839 . . . . 4.89 112.03 176.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.2 m -65.34 -48.4 73.12 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.703 1.138 . . . . 0.77 108.82 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 59.3 mt -57.37 -47.07 85.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.584 0.753 . . . . 1.22 111.109 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 56' ' ' ARG . 49.7 mt-10 -51.46 -57.73 8.19 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.956 0.902 . . . . 2.28 109.261 172.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 t -65.77 -27.31 68.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.394 1.078 . . . . 1.32 112.291 -171.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.0 mt -65.83 -81.32 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.859 0.754 . . . . 2.31 110.04 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.25 25.94 0.26 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.599 -1.112 . . . . 0.77 113.235 171.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -134.29 176.44 8.6 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 118.825 1.313 . . . . 1.88 112.276 -153.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -127.41 136.34 51.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.357 -2.09 . . . . 3.24 105.357 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.19 153.67 35.92 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.27 1.028 . . . . 0.87 110.391 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.1 m -154.67 132.0 11.14 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.757 0.823 . . . . 1.73 109.6 170.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mp . . . . . 0 CA--C 1.534 0.359 0 C-N-CA 125.251 1.42 . . . . 3.37 109.017 -175.532 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 109.651 -1.38 . . . . 1.88 109.651 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 p -145.09 90.42 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.389 -0.967 . . . . 2.49 108.389 172.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 6' ' ' LEU . 1.4 tm? -78.51 80.01 4.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.779 -1.934 . . . . 3.12 105.779 170.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -84.7 123.73 30.71 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 114.071 -1.422 . . . . 3.54 108.802 168.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 157.78 39.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 123.648 0.592 . . . . 2.56 110.617 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -79.06 115.77 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 106.476 -1.676 . . . . 0.71 106.476 170.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.04 73.55 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 105.952 -1.87 . . . . 2.22 105.952 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.03 100.98 5.09 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.904 -1.887 . . . . 7.08 105.904 -166.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.92 -43.65 0.24 Allowed Glycine 0 C--N 1.334 0.441 0 O-C-N 120.343 -1.473 . . . . 1.43 113.548 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.31 75.74 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.105 1.15 . . . . 2.61 114.105 -173.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.2 t -69.35 -13.1 62.19 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.723 1.379 . . . . 1.98 114.723 -166.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.7 p -155.12 170.33 22.05 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.078 1.308 . . . . 0.72 109.931 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.35 -45.73 8.98 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.962 1.305 . . . . 0.67 111.542 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -54.1 -39.53 66.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.339 1.456 . . . . 1.79 112.029 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.1 m -71.98 -55.12 8.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.994 -0.373 . . . . 0.72 109.994 170.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.449 HG13 HG23 ' A' ' 37' ' ' VAL . 93.7 t -47.56 -60.62 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 123.655 0.782 . . . . 0.85 110.623 -173.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.72 -24.66 65.4 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.657 -0.652 . . . . 0.8 111.863 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -67.14 -48.26 68.58 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.773 -0.825 . . . . 3.56 108.773 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 67' ' ' PHE . 15.8 mt -57.4 -57.12 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 118.507 0.594 . . . . 0.83 109.432 174.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -53.53 -50.92 64.46 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.44 0.638 . . . . 3.53 110.386 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.0 t -56.72 -51.64 68.05 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 118.326 -0.845 . . . . 1.0 109.87 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 t -57.33 -44.61 84.4 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 119.494 1.043 . . . . 1.31 108.514 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.1 mt -56.44 -53.13 61.06 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.337 -0.847 . . . . 3.07 111.795 175.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.7 p -57.78 -10.41 1.65 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.923 1.083 . . . . 2.25 113.923 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -33.47 69.2 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.427 1.012 . . . . 7.16 110.863 173.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -78.65 148.44 33.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.614 -0.884 . . . . 2.27 108.614 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -95.34 -24.41 16.75 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.172 0.589 . . . . 7.07 111.29 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.31 -19.97 76.38 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 122.165 -0.335 . . . . 0.93 112.388 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -84.05 127.71 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 105.932 -1.877 . . . . 2.38 105.932 164.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.91 -38.0 33.48 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.442 -0.577 . . . . 2.47 109.442 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -155.48 153.54 30.45 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.752 -1.203 . . . . 2.32 107.752 -175.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.8 p -139.12 146.76 41.06 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 123.744 0.652 . . . . 2.14 109.359 168.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 t -144.5 105.17 4.15 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.154 -1.424 . . . . 1.58 107.154 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.449 HG23 HG13 ' A' ' 19' ' ' VAL . 9.1 m -90.45 159.05 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.703 0.801 . . . . 1.8 110.132 174.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.68 130.31 9.09 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 121.745 -0.597 . . . . 0.66 110.757 163.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 pp -68.1 -23.61 64.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 123.552 0.532 . . . . 1.47 111.957 165.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.43 -47.63 72.62 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.377 0.535 . . . . 1.21 110.084 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.99 -17.3 20.15 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.176 0.99 . . . . 1.97 112.144 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.56 38.26 25.35 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.883 1.273 . . . . 2.59 109.29 -162.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.55 160.83 16.81 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.311 0.645 . . . . 2.59 110.027 -173.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.433 ' HB2' HG12 ' A' ' 37' ' ' VAL . . . -134.4 122.21 22.24 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.147 -1.427 . . . . 0.71 107.147 159.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -96.36 108.89 21.48 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 104.455 -2.424 . . . . 0.93 104.455 166.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.8 mt -120.33 104.49 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.36 -1.348 . . . . 1.75 107.36 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -79.97 138.68 37.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.367 -1.346 . . . . 2.71 107.367 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -159.58 147.78 17.44 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 119.196 -0.43 . . . . 1.99 110.828 -159.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -85.83 103.74 4.2 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 106.356 -1.72 . . . . 3.15 106.356 168.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.26 -54.64 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.573 2.182 . . . . 2.54 111.422 -165.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -53.83 -44.24 70.09 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.007 1.323 . . . . 3.02 111.819 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.2 -47.01 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 122.377 0.271 . . . . 2.96 110.624 -173.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -48.19 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 117.923 0.329 . . . . 3.98 110.87 -171.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.93 116.27 2.42 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 110.41 -1.076 . . . . 1.24 110.41 -170.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -59.95 -39.38 71.63 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 119.955 1.878 . . . . 1.13 109.653 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -37.89 -53.45 1.32 Allowed 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 125.378 1.471 . . . . 8.61 110.815 164.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -73.74 -36.05 65.12 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.996 0.918 . . . . 3.01 113.159 -174.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.1 mt -53.48 -48.94 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.356 -0.84 . . . . 0.78 109.636 166.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.5 mt -58.71 -47.2 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 109.495 -0.558 . . . . 1.52 109.495 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -50.21 -42.49 51.58 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.692 0.678 . . . . 3.04 111.033 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.4 m -60.48 -54.48 45.06 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.279 0.945 . . . . 1.21 109.092 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.1 mt -52.13 -51.64 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.382 1.073 . . . . 1.52 111.758 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -60.06 -56.99 14.81 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.257 1.023 . . . . 2.24 110.463 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -52.93 -42.95 65.89 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.629 1.172 . . . . 1.46 110.632 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.5 mt -62.56 -70.91 0.18 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.437 -0.316 . . . . 2.32 110.573 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.64 -10.34 0.04 OUTLIER Glycine 0 CA--C 1.531 1.044 0 N-CA-C 117.614 1.805 . . . . 1.17 117.614 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.482 ' CD2' HD11 ' A' ' 22' ' ' ILE . 30.5 m-85 -133.23 156.35 47.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.845 1.823 . . . . 1.82 111.533 -137.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -80.23 159.04 26.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.179 0.992 . . . . 3.63 108.551 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.15 141.96 50.63 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.577 1.151 . . . . 1.42 109.432 172.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.7 m -153.37 110.0 3.4 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.543 0.737 . . . . 1.69 109.72 170.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 CA--C 1.533 0.299 0 CA-C-N 118.768 0.713 . . . . 3.25 109.804 176.537 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.721 0 N-CA-C 109.813 -1.315 . . . . 1.42 109.813 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 m -109.77 101.22 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.856 1.662 . . . . 2.32 108.975 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.33 106.19 18.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.672 -1.233 . . . . 3.19 107.672 175.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -107.46 103.4 12.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.268 -1.012 . . . . 3.61 108.268 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.3 mt -106.09 144.58 32.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.081 0.953 . . . . 2.35 108.458 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.49 128.22 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 104.721 -2.326 . . . . 1.09 104.721 151.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 p -101.23 85.31 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.014 1.326 . . . . 2.57 107.554 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -83.27 59.25 4.9 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.312 1.045 . . . . 6.21 109.633 -169.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.67 -44.01 0.03 OUTLIER Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.849 -0.691 . . . . 1.35 112.959 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.18 131.78 52.04 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.674 -0.861 . . . . 2.73 108.674 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.2 p -94.08 -57.32 2.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.053 0.541 . . . . 3.27 110.317 -175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 p -134.44 176.97 8.13 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.477 0.711 . . . . 0.69 112.2 -160.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.43 -42.99 10.95 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.674 1.189 . . . . 0.63 111.9 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -54.4 -48.45 71.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.967 0.507 . . . . 2.44 109.72 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.6 m -67.29 -41.43 85.42 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 122.091 -0.381 . . . . 0.82 111.053 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.45 HG13 HG23 ' A' ' 37' ' ' VAL . 93.1 t -53.5 -63.96 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 122.591 0.357 . . . . 0.73 110.408 176.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.261 0.1 OUTLIER -70.68 -25.89 63.18 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.991 -1.068 . . . . 0.89 112.356 -175.639 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -55.01 -52.46 63.09 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.629 0.65 . . . . 3.52 109.703 167.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.1 mt -52.48 -63.83 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.235 0 N-CA-C 108.876 -0.787 . . . . 0.82 108.876 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -56.54 -51.38 68.76 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 120.595 -0.442 . . . . 3.58 111.366 -171.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.6 t -58.19 -43.46 87.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.5 -0.762 . . . . 0.98 110.408 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 t -63.18 -56.19 18.8 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 120.022 1.283 . . . . 1.25 108.1 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.41 -45.08 89.08 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.303 -0.862 . . . . 2.42 112.242 -175.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.418 ' HA ' HD11 ' A' ' 32' ' ' ILE . 32.8 p -58.59 -17.19 19.86 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.943 0.72 . . . . 2.11 112.943 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -65.93 -28.37 68.87 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.246 0.93 . . . . 6.85 111.088 173.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -83.88 105.23 14.61 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 108.565 -0.902 . . . . 2.09 108.565 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -57.11 -17.94 12.76 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.526 0.936 . . . . 5.96 113.526 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.8 -27.77 70.63 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.185 -0.786 . . . . 0.89 112.122 172.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -84.38 145.31 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 119.186 1.493 . . . . 2.47 108.38 169.24 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.4 mt -109.57 -39.42 5.16 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.678 1.191 . . . . 2.01 109.695 -168.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -155.16 149.54 26.13 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.715 -1.217 . . . . 1.95 107.715 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.9 m -124.89 147.39 48.84 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.679 -1.23 . . . . 2.01 107.679 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 m -154.48 85.04 1.12 Allowed 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.982 1.313 . . . . 2.02 108.921 172.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG23 HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -79.11 157.74 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 123.291 0.636 . . . . 1.75 110.678 172.136 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.33 144.94 22.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.063 0.545 . . . . 0.9 110.332 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -85.53 -41.33 15.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.956 1.302 . . . . 2.67 108.675 170.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.45 -16.42 3.69 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.071 1.348 . . . . 2.36 112.977 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.6 m -140.79 20.03 2.33 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.432 -0.793 . . . . 2.2 110.392 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.3 m120 36.77 47.27 0.54 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.712 2.005 . . . . 2.24 113.834 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.45 171.7 13.93 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 117.986 0.357 . . . . 2.18 111.386 -165.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.59 108.03 5.56 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.54 2.336 . . . . 0.77 106.211 173.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -87.42 114.48 24.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.722 -2.325 . . . . 0.88 104.722 162.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 67.5 mt -123.16 111.5 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.399 -2.074 . . . . 1.99 105.399 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.96 134.23 36.24 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.014 -1.476 . . . . 2.65 107.014 170.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -148.32 149.57 32.06 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 117.815 0.279 . . . . 2.69 111.365 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -80.73 115.09 53.17 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 107.42 -1.326 . . . . 3.03 107.42 167.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -73.43 -13.11 25.24 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.124 2.55 . . . . 1.61 113.175 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -88.92 -44.87 10.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.513 -0.921 . . . . 2.82 108.513 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.5 mt -72.2 -42.26 66.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 122.848 0.459 . . . . 2.88 110.556 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 mm -125.14 115.47 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.18 -1.785 . . . . 1.25 106.18 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.58 148.51 51.24 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 108.178 -1.969 . . . . 0.89 108.178 171.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -57.44 -40.92 77.41 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 CA-C-N 119.493 1.646 . . . . 1.28 110.37 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.418 ' HG3' ' CE1' ' A' ' 60' ' ' HIS . 26.9 tpt180 -56.35 -28.56 59.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.553 -0.737 . . . . 6.12 112.153 174.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -71.7 -39.24 70.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 120.123 1.329 . . . . 2.5 112.046 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.5 mt -56.48 -47.46 81.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.604 -0.887 . . . . 0.83 108.604 171.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.6 mt -61.26 -45.23 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 118.851 -0.595 . . . . 1.19 110.204 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.418 ' CE1' ' HG3' ' A' ' 56' ' ' ARG . 29.4 m170 -50.85 -43.55 59.31 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.371 0.987 . . . . 3.72 110.201 173.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.6 m -65.54 -54.54 26.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.35 -0.981 . . . . 0.98 108.35 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.8 mt -49.02 -53.41 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.026 0.93 . . . . 1.46 110.823 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -52.48 -53.58 43.78 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.854 0.861 . . . . 2.18 110.145 174.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.1 t -62.73 -26.53 68.73 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 117.788 -1.101 . . . . 1.3 113.091 -174.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.16 -91.37 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.854 1.206 . . . . 2.2 109.937 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.98 40.89 0.42 Allowed Glycine 0 CA--C 1.524 0.604 0 O-C-N 120.936 -1.103 . . . . 0.97 111.646 174.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -138.82 176.44 8.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 117.954 0.877 . . . . 2.71 110.124 -162.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -133.64 164.61 26.82 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.434 -1.321 . . . . 4.22 107.434 167.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.12 166.78 23.27 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.97 0.908 . . . . 1.27 112.118 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.9 m -150.76 155.54 39.47 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 106.708 -1.589 . . . . 1.78 106.708 160.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 CA--C 1.535 0.375 0 CA-C-N 119.557 1.072 . . . . 2.68 109.243 179.061 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.665 0 N-CA-C 110.455 -1.058 . . . . 1.86 110.455 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -119.81 136.12 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 126.052 1.741 . . . . 2.14 110.407 -176.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.28 112.71 5.3 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 123.958 0.903 . . . . 3.14 108.822 176.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.62 113.8 27.61 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 122.992 0.517 . . . . 2.95 109.989 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.2 mt -86.51 157.07 19.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 124.645 1.215 . . . . 2.51 108.076 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.62 142.07 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 105.632 -1.988 . . . . 1.02 105.632 148.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.8 t -135.06 114.25 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 126.314 1.846 . . . . 2.01 106.821 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -110.37 170.97 7.73 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.73 1.212 . . . . 6.57 110.466 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.15 -47.78 2.42 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.723 -0.951 . . . . 1.3 110.723 -173.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -51.4 -45.71 62.63 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 121.964 0.888 . . . . 2.92 112.071 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.317 9.3 t 58.71 -63.25 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.986 2.114 . . . . 3.21 115.32 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 p -110.6 162.13 15.03 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 120.271 1.396 . . . . 1.44 112.82 -163.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.7 -48.17 5.5 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 125.58 1.552 . . . . 1.22 111.516 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -51.51 -48.43 62.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.098 1.359 . . . . 2.39 111.438 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.6 m -72.71 -42.89 63.69 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 122.147 -0.346 . . . . 0.95 110.858 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.3 t -52.1 -64.1 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 117.928 0.331 . . . . 1.17 110.553 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -28.46 68.2 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.847 -1.158 . . . . 1.57 111.716 -173.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -57.44 -55.23 37.49 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.389 0.675 . . . . 2.67 109.581 169.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.88 -52.07 53.36 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 108.996 -0.742 . . . . 0.95 108.996 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -50.83 -60.23 3.28 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.768 0.827 . . . . 3.54 109.785 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.2 t -53.65 -45.95 70.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.517 0.727 . . . . 1.17 110.417 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.7 t -58.96 -53.37 59.18 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.45 -0.944 . . . . 1.3 108.45 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.84 -50.76 44.14 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.911 0.884 . . . . 2.78 110.793 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.0 m -57.49 -24.88 58.43 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.732 0.641 . . . . 2.01 112.732 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -63.5 -33.1 74.82 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.356 -0.84 . . . . 7.89 110.792 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -55.18 143.1 28.67 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 108.558 -0.904 . . . . 2.51 108.558 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.79 159.65 16.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.084 -1.821 . . . . 6.93 106.084 163.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.45 -16.39 45.03 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 122.215 -0.303 . . . . 1.59 113.065 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 pp -78.86 141.14 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 108.191 -1.04 . . . . 3.16 108.191 170.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.6 -47.09 9.5 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.409 1.484 . . . . 3.26 108.318 172.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -156.98 158.09 35.93 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.706 -1.22 . . . . 2.27 107.706 -175.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 p -135.08 151.17 50.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.717 -1.216 . . . . 2.66 107.717 161.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 t -154.35 146.52 23.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.061 -0.718 . . . . 2.42 109.061 152.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.26 152.22 33.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 124.971 1.309 . . . . 1.83 110.207 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.25 155.97 34.75 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-O 121.026 0.441 . . . . 0.8 111.185 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.98 -8.51 14.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.77 1.628 . . . . 1.92 113.046 -165.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.53 -57.62 6.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.034 -1.099 . . . . 1.96 108.034 169.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -79.9 -28.99 39.76 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.203 0.601 . . . . 2.52 111.301 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 m120 73.91 56.59 0.1 Allowed 'General case' 0 C--N 1.343 0.3 0 C-N-CA 125.542 1.537 . . . . 1.61 108.235 -173.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -124.86 159.22 31.58 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.749 1.22 . . . . 4.07 110.793 -166.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -142.35 96.98 3.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 125.31 1.631 . . . . 1.05 107.894 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -81.16 102.42 10.29 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.506 -1.664 . . . . 1.16 106.506 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 46' ' ' ILE . 1.6 mp -101.33 150.11 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.027 -1.842 . . . . 1.74 106.027 167.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -120.57 137.64 54.3 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.931 -1.878 . . . . 3.15 105.931 161.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -150.69 154.8 38.09 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 123.579 0.752 . . . . 2.1 111.892 -167.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -74.75 126.02 88.92 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.308 -0.997 . . . . 3.67 108.308 159.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.57 -19.2 16.91 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.413 2.742 . . . . 1.71 113.296 -171.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -83.31 -47.34 11.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.625 -0.88 . . . . 3.46 108.625 -176.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 tp -71.98 -40.92 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 119.68 -0.2 . . . . 3.7 111.133 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mm -127.22 110.64 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.421 -1.326 . . . . 1.43 107.421 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.48 158.57 39.7 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 108.91 -1.676 . . . . 0.82 108.91 168.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -55.66 -40.47 85.1 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.25 1.967 . . . . 1.23 109.269 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -29.29 -58.23 0.15 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.119 2.168 . . . . 9.53 112.261 163.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -70.58 -43.5 69.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.7 0.762 . . . . 2.41 109.662 -168.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 mt -58.68 -51.54 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.87 -0.605 . . . . 0.85 109.405 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.2 mt -52.45 -55.48 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.218 -0.66 . . . . 1.18 109.218 176.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 56.0 m170 -51.53 -42.17 61.56 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.957 0.503 . . . . 3.51 111.284 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 31.2 m -62.18 -51.21 68.73 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.718 -0.614 . . . . 1.04 109.79 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -59.96 -40.85 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.465 1.106 . . . . 2.6 111.363 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.04 -53.54 57.15 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.871 0.868 . . . . 2.02 109.955 168.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.6 t -60.96 -27.41 68.24 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.495 0.718 . . . . 1.44 112.174 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.04 -85.9 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.719 -0.845 . . . . 2.02 108.719 166.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.74 18.54 0.18 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.489 -1.173 . . . . 1.24 114.608 169.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -132.58 151.85 51.8 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 119.441 1.62 . . . . 1.99 111.495 -148.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -78.5 163.96 25.13 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.119 -1.067 . . . . 4.86 108.119 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.12 158.09 42.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 121.395 -0.122 . . . . 0.94 110.902 160.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.5 t -155.18 134.52 12.46 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.543 -0.91 . . . . 2.53 108.543 173.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.208 0 O-C-N 121.6 -0.687 . . . . 2.33 109.283 177.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.685 0 N-CA-C 109.34 -1.504 . . . . 1.89 109.34 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.93 133.9 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 107.555 -1.276 . . . . 2.45 107.555 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 tp -136.09 121.06 18.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.215 -1.402 . . . . 2.29 107.215 162.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -109.53 70.81 0.74 Allowed 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 125.17 1.388 . . . . 3.58 108.361 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.615 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -78.32 149.96 33.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.13 -0.628 . . . . 2.79 109.439 178.253 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.47 135.26 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 105.52 -2.03 . . . . 0.66 105.52 164.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.08 131.75 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 125.509 1.524 . . . . 2.36 108.003 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -123.67 163.35 21.25 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.886 0.874 . . . . 5.58 109.834 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.56 -15.42 62.79 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.997 0.808 . . . . 1.23 111.856 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.481 ' SD ' HD12 ' A' ' 22' ' ' ILE . 50.8 mtm -70.33 77.61 0.54 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 117.891 0.846 . . . . 1.69 110.31 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -70.52 -14.87 62.69 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.984 -1.008 . . . . 1.59 113.35 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 p -161.64 169.93 20.68 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.652 1.114 . . . . 0.74 109.682 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.11 -36.73 30.9 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.331 1.052 . . . . 1.01 111.6 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -47.57 -38.84 15.17 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.334 1.853 . . . . 1.87 112.196 173.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.5 m -71.5 -54.81 9.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 122.039 -0.413 . . . . 0.73 110.117 172.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.4 t -49.05 -60.6 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.189 0.995 . . . . 0.98 110.494 -173.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -27.21 67.06 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.163 -0.615 . . . . 0.8 111.643 -175.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -64.69 -50.95 64.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.952 -0.759 . . . . 2.96 108.952 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.481 HD12 ' SD ' ' A' ' 13' ' ' MET . 19.9 mt -53.09 -58.35 3.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 N-CA-C 108.946 -0.761 . . . . 1.05 108.946 172.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -49.13 -57.71 6.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.417 0.627 . . . . 3.87 110.921 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -62.26 -41.18 98.22 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.268 1.027 . . . . 0.81 111.112 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.8 t -67.0 -45.23 78.2 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.534 -0.913 . . . . 1.16 108.534 -176.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.91 -49.31 47.14 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 118.796 -0.621 . . . . 2.85 112.203 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.4 p -54.87 -25.43 28.75 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.883 0.765 . . . . 1.94 112.632 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -45.34 -44.28 11.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.894 1.278 . . . . 6.19 112.646 168.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -64.94 117.53 7.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.422 1.089 . . . . 1.67 108.869 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -75.2 36.11 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.523 1.129 . . . . 6.54 113.354 -169.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -132.46 -5.81 3.19 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.397 1.475 . . . . 0.96 111.519 168.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.5 mm -83.84 109.46 17.37 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 N-CA-C 107.021 -1.474 . . . . 3.98 107.021 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.9 mt -79.72 -38.88 32.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.803 0.841 . . . . 1.93 109.489 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -154.38 158.21 39.7 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 108.809 -0.812 . . . . 1.93 108.809 174.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.9 t -139.36 134.84 33.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.244 1.018 . . . . 2.32 108.516 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.1 t -134.54 85.38 2.18 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.054 -1.091 . . . . 1.67 108.054 169.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 44' ' ' ALA . 1.1 m -78.9 149.76 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 125.234 1.413 . . . . 1.93 110.081 170.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.15 132.17 10.84 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.014 0.526 . . . . 0.77 109.756 166.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.88 -35.36 74.59 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 109.406 -0.591 . . . . 1.75 109.406 167.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.92 -35.82 64.58 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.786 0.835 . . . . 1.33 111.826 -174.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 m -119.26 18.04 13.04 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.868 0.867 . . . . 2.12 110.325 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.1 m120 33.95 48.89 0.25 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 126.279 1.831 . . . . 1.86 113.489 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.96 162.84 26.66 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.797 -0.446 . . . . 2.39 109.797 -169.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 37' ' ' VAL . . . -146.43 100.92 3.42 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.713 -0.847 . . . . 0.69 108.713 169.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -80.3 100.41 8.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.621 -1.992 . . . . 1.14 105.621 166.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.421 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.8 mp -94.35 135.36 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 105.797 -1.927 . . . . 1.62 105.797 165.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -100.45 117.02 33.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 104.831 -2.285 . . . . 2.19 104.831 158.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -117.14 168.81 9.95 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.544 0.738 . . . . 1.95 110.006 172.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.02 133.99 26.71 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 107.238 -1.393 . . . . 3.61 107.238 153.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -72.8 -10.69 25.2 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.558 2.172 . . . . 1.72 113.475 -174.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -83.22 -47.54 11.44 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.39 -0.967 . . . . 3.34 108.39 -173.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.8 mm -81.89 -36.72 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.723 -0.656 . . . . 2.66 110.927 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 mm -133.72 118.02 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 119.293 0.951 . . . . 1.38 108.534 -174.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.75 176.71 47.9 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 110.16 -1.176 . . . . 0.91 110.16 169.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.52 -42.17 22.52 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.663 2.242 . . . . 1.01 109.985 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.85 -54.71 5.04 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.212 1.405 . . . . 7.51 111.214 173.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -53.13 -55.93 20.2 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.462 0.574 . . . . 2.46 110.516 -176.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.9 mt -59.85 -53.26 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 116.236 -0.438 . . . . 0.77 110.012 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.9 mt -53.59 -54.66 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 109.487 -0.56 . . . . 1.08 109.487 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -52.06 -41.27 62.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.267 1.027 . . . . 4.31 111.531 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 44.9 m -69.85 -48.51 58.58 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.721 -0.474 . . . . 1.01 109.721 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.8 mt -51.47 -50.64 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 109.527 -0.546 . . . . 1.26 109.527 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.05 -55.58 31.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.934 0.893 . . . . 2.46 111.171 176.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.7 p -62.68 -32.12 73.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.899 -0.572 . . . . 1.78 112.054 -173.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.92 -85.44 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.57 0.623 . . . . 2.65 111.17 171.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.59 25.86 0.25 Allowed Glycine 0 CA--C 1.526 0.752 0 O-C-N 121.151 -0.968 . . . . 0.98 113.833 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.409 ' CD2' HD11 ' A' ' 22' ' ' ILE . 29.2 m-85 -137.2 177.35 7.93 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.617 1.209 . . . . 1.64 111.069 -155.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -120.43 157.57 29.04 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.856 -1.164 . . . . 3.48 107.856 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.41 152.98 40.68 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.75 0.42 . . . . 0.9 111.253 167.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.3 m -156.4 135.44 11.97 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.604 1.162 . . . . 2.2 109.38 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 N--CA 1.467 0.409 0 C-N-CA 124.271 1.028 . . . . 2.79 110.442 -179.695 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.542 0 N-CA-C 108.417 -1.873 . . . . 1.29 108.417 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.54 131.38 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 106.442 -1.688 . . . . 2.21 106.442 168.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.2 99.19 5.77 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.091 0.956 . . . . 2.72 108.63 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -87.46 106.75 18.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.194 -1.41 . . . . 3.03 107.194 161.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.91 150.16 30.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.51 -0.922 . . . . 2.4 108.51 168.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.55 142.7 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 104.787 -2.301 . . . . 0.76 104.787 159.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.9 p -139.66 135.54 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 106.796 -1.557 . . . . 2.26 106.796 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -134.51 168.78 18.34 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.294 1.438 . . . . 8.18 108.915 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.88 -14.59 61.41 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.903 0.764 . . . . 1.29 111.222 -163.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.1 mtp -68.51 77.6 0.28 Allowed 'General case' 0 C--N 1.341 0.225 0 CA-C-N 118.194 0.997 . . . . 1.85 110.799 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.5 p -61.09 -41.39 96.57 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.72 -0.657 . . . . 3.05 112.516 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.3 p -156.28 -179.37 8.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.171 0.896 . . . . 0.7 112.794 -166.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.09 -40.7 46.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.812 1.245 . . . . 0.85 111.577 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 m -60.81 -29.49 69.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.086 0.554 . . . . 1.47 111.898 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.7 m -71.85 -58.58 3.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.902 0.774 . . . . 0.67 109.927 167.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.0 t -38.7 -64.78 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.937 1.295 . . . . 1.2 111.481 -177.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -28.45 65.98 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.181 -0.608 . . . . 0.96 111.69 -172.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -66.56 -52.49 45.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.88 -0.785 . . . . 3.44 108.88 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.6 -59.37 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 N-CA-C 108.341 -0.985 . . . . 0.7 108.341 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -50.15 -62.99 1.25 Allowed 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 124.057 0.848 . . . . 3.8 110.097 -175.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.6 t -56.32 -41.28 75.73 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.484 0.714 . . . . 0.82 111.163 -177.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 t -65.58 -54.13 32.19 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.417 -0.957 . . . . 1.17 108.417 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 mp -52.42 -46.58 66.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.794 0.438 . . . . 2.69 110.911 175.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.1 m -62.8 -9.83 10.87 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.964 0.728 . . . . 2.09 112.964 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -25.1 62.11 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.718 -1.239 . . . . 5.57 111.963 169.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -69.54 140.89 53.93 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 107.553 -1.277 . . . . 1.81 107.553 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.9 ttm-85 -81.81 -28.02 33.34 Favored 'General case' 0 C--O 1.226 -0.154 0 O-C-N 121.41 -0.807 . . . . 5.52 111.846 -177.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.8 5.47 83.7 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.454 -0.636 . . . . 0.91 113.802 -173.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.39 159.06 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 118.513 1.157 . . . . 2.99 109.415 164.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.4 mt -113.88 -39.78 3.9 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.466 1.506 . . . . 2.25 109.316 176.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -156.15 156.61 34.53 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.449 -0.575 . . . . 2.1 109.449 174.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.1 m -138.16 135.21 35.46 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.495 -1.669 . . . . 2.65 106.495 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.5 t -147.97 143.77 27.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.684 -1.598 . . . . 1.96 106.684 163.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 m -137.5 144.03 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.399 1.079 . . . . 1.79 108.741 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.29 111.55 6.81 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.638 1.175 . . . . 0.75 110.002 -175.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.94 -22.89 61.4 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.309 1.444 . . . . 1.38 113.152 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.51 -50.28 53.37 Favored 'General case' 0 C--O 1.226 -0.159 0 N-CA-C 108.38 -0.97 . . . . 1.55 108.38 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.61 -19.96 51.5 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.192 0.997 . . . . 2.09 110.878 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.4 m120 57.84 46.48 16.84 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 126.118 1.767 . . . . 1.55 109.971 -172.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.47 157.86 45.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.97 -0.381 . . . . 3.32 109.97 -170.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.69 127.65 25.71 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.844 -1.169 . . . . 0.98 107.844 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -99.17 98.27 9.28 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 105.332 -2.099 . . . . 0.96 105.332 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.0 mm -94.58 147.65 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 106.135 -1.802 . . . . 1.79 106.135 170.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -124.62 135.75 53.37 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.428 -2.434 . . . . 3.73 104.428 159.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -156.34 160.66 39.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.255 0.622 . . . . 2.08 109.902 -162.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -93.44 125.79 52.72 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.752 -0.833 . . . . 3.15 108.752 171.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.0 -14.28 29.15 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.824 2.35 . . . . 1.77 113.875 -172.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -121.19 25.4 9.56 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.866 1.212 . . . . 3.15 112.402 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.7 tp -132.39 -63.56 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 118.988 -0.529 . . . . 3.57 110.283 159.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.95 -44.28 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 119.669 1.122 . . . . 3.03 108.321 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.22 168.51 18.77 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.109 -0.567 . . . . 1.75 111.805 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -71.52 -57.28 0.1 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.043 1.829 . . . . 1.26 111.731 -170.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 ttt-85 -70.64 -20.16 62.75 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.064 0.765 . . . . 6.3 113.064 -167.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.31 -35.1 71.14 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.438 1.017 . . . . 3.8 112.93 -175.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.3 mt -48.84 -50.22 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 121.432 -0.793 . . . . 0.99 109.236 164.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mt -63.15 -42.6 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 117.715 -1.136 . . . . 1.18 110.727 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -49.55 -44.05 46.32 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.39 1.45 . . . . 3.46 110.152 170.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.4 m -66.29 -50.49 63.49 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.32 -0.622 . . . . 0.77 109.32 -175.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.476 HG23 ' HB2' ' A' ' 67' ' ' PHE . 64.0 mt -52.97 -52.81 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.537 1.135 . . . . 1.4 110.959 176.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -53.96 -53.92 46.06 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.107 1.363 . . . . 1.9 110.293 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t -58.91 -41.77 88.05 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.111 0.964 . . . . 1.24 111.436 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.3 mt -64.13 -84.05 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.584 0.353 . . . . 1.99 110.897 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.24 22.51 0.22 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.638 -1.09 . . . . 0.87 113.818 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.476 ' HB2' HG23 ' A' ' 62' ' ' ILE . 39.0 m-85 -134.92 162.62 31.9 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 118.945 1.372 . . . . 1.66 111.047 -156.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -115.78 152.1 33.93 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.335 1.454 . . . . 3.84 107.412 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.85 166.53 33.12 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.424 1.011 . . . . 1.34 113.276 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 p -155.33 123.21 5.73 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.193 1.397 . . . . 2.07 109.791 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.465 0.292 0 C-N-CA 123.342 0.657 . . . . 2.22 109.942 170.102 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.537 0 N-CA-C 106.955 -2.458 . . . . 2.05 106.955 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.33 129.2 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 109.416 -0.587 . . . . 2.15 109.416 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.36 136.8 39.95 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.259 1.024 . . . . 2.79 108.529 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.21 144.01 48.83 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.617 -1.994 . . . . 4.87 105.617 167.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.14 147.8 24.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.696 -0.853 . . . . 2.18 108.696 167.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.31 134.58 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 105.665 -1.976 . . . . 0.99 105.665 173.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.3 t -116.44 117.91 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 106.873 -1.528 . . . . 2.16 106.873 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.1 mtt180 -85.59 143.83 28.23 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.09 -1.078 . . . . 6.89 108.09 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.14 -1.0 58.98 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.088 -0.84 . . . . 1.2 113.684 173.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.3 mtp -71.4 72.38 0.69 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.138 1.469 . . . . 1.68 110.436 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -73.97 -17.0 61.06 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 117.683 -1.151 . . . . 1.55 113.819 -169.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.2 p -159.01 172.75 17.62 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 120.23 1.377 . . . . 0.89 110.724 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.58 -36.7 35.98 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.406 1.082 . . . . 0.88 111.794 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 t -56.53 -45.4 81.16 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.873 -0.417 . . . . 2.27 109.873 175.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.9 m -63.7 -47.81 79.63 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.684 -0.635 . . . . 0.7 110.527 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.2 t -49.66 -66.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.439 -0.578 . . . . 0.88 109.439 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.288 0.1 OUTLIER -71.19 -23.45 62.04 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 118.954 -1.098 . . . . 1.14 112.804 -173.523 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -52.99 -49.44 66.17 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.718 1.144 . . . . 3.43 109.15 169.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.7 mt -56.95 -59.05 3.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 109.529 -0.545 . . . . 0.79 109.529 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.3 -47.65 84.58 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.125 0.488 . . . . 4.65 111.064 -171.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -57.07 -33.91 67.74 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.818 1.247 . . . . 1.03 110.826 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.7 m -71.72 -60.64 2.13 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.705 -0.622 . . . . 1.67 109.409 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -54.6 -42.82 71.59 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.433 0.693 . . . . 2.74 112.179 -171.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.2 p -57.39 -18.77 19.33 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.462 0.542 . . . . 2.26 112.462 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -70.79 -27.81 64.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.041 0.937 . . . . 6.34 111.743 175.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -70.74 -12.05 61.32 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.039 1.125 . . . . 3.17 114.039 -165.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.6 mmp_? 72.17 -44.54 0.6 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 126.281 1.832 . . . . 6.91 113.567 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.15 53.21 1.79 Allowed Glycine 0 CA--C 1.525 0.689 0 CA-C-N 119.036 0.835 . . . . 1.65 111.223 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.44 133.55 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 106.722 -1.584 . . . . 3.4 106.722 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.0 mt -88.66 -45.55 9.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.833 -1.173 . . . . 2.28 107.833 167.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -157.15 154.32 29.14 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 122.198 -0.314 . . . . 2.6 111.017 -178.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.3 t -130.2 110.63 11.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.777 1.231 . . . . 2.08 109.932 170.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.1 t -115.71 84.9 2.18 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.224 1.81 . . . . 1.73 107.86 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.76 152.15 3.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.343 1.057 . . . . 2.1 110.341 174.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.08 135.06 12.95 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 119.394 -0.336 . . . . 0.84 110.137 170.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.55 -32.3 71.02 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 123.409 0.443 . . . . 1.54 110.203 168.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.86 -48.17 60.2 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.386 0.674 . . . . 1.28 111.281 -176.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -105.52 10.06 33.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.327 1.451 . . . . 2.24 111.451 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.3 m120 41.17 47.66 2.88 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.185 1.794 . . . . 1.61 112.299 -175.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.71 171.2 11.38 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.149 0.58 . . . . 2.45 111.679 -165.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.99 87.41 1.41 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.954 1.302 . . . . 0.92 109.809 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -79.25 96.47 5.93 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.797 -1.557 . . . . 1.06 106.797 171.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.32 141.31 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.983 -1.488 . . . . 1.67 106.983 171.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -114.52 116.42 28.79 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 104.207 -2.516 . . . . 2.6 104.207 165.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -125.69 157.3 37.66 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.874 0.87 . . . . 1.98 111.65 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.92 114.9 59.51 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.905 1.682 . . . . 5.05 107.879 176.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.79 36.2 0.6 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.481 2.121 . . . . 2.38 113.762 -166.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -140.22 33.23 1.91 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.421 1.088 . . . . 3.3 110.18 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 tp -171.83 -49.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 124.891 1.276 . . . . 4.01 108.671 -170.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mm -122.91 132.73 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 105.384 -2.08 . . . . 1.33 105.384 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.72 -179.7 19.48 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.839 1.685 . . . . 1.09 109.311 167.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.65 -40.59 28.97 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.338 2.025 . . . . 0.99 110.306 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -42.19 69.8 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.187 0.595 . . . . 9.59 111.469 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -58.98 -54.14 50.49 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.305 -0.628 . . . . 2.2 109.305 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.5 mt -56.9 -50.41 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 123.616 0.766 . . . . 0.69 109.933 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.6 mt -53.09 -57.42 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.316 0.646 . . . . 1.38 109.957 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -52.34 -44.59 65.27 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.236 0.614 . . . . 3.5 110.44 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.6 m -64.11 -51.2 65.13 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.308 -0.627 . . . . 0.81 109.308 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.3 mt -51.9 -59.7 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.792 0.837 . . . . 1.39 109.157 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -63.14 -47.91 80.71 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 119.676 -0.81 . . . . 1.91 109.979 -169.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 t -54.23 -39.95 67.23 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.154 0.582 . . . . 1.49 111.863 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.4 mt -61.23 -59.63 5.0 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.825 0.739 . . . . 2.33 112.431 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.31 16.0 0.14 Allowed Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.409 -1.217 . . . . 1.15 115.432 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -143.07 -179.74 6.55 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.008 1.404 . . . . 2.15 111.44 -142.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -127.91 154.4 45.57 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 105.765 -1.939 . . . . 3.67 105.765 163.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.95 154.52 27.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.98 0.809 . . . . 1.16 110.532 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.3 m -155.26 103.45 2.35 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.102 1.361 . . . . 2.39 109.453 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.463 0.201 0 C-N-CA 123.215 0.606 . . . . 2.43 109.453 169.326 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.799 0 N-CA-C 108.19 -1.964 . . . . 1.37 108.19 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.4 t -98.11 144.79 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 124.753 1.221 . . . . 2.66 108.909 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.8 tp -127.81 123.24 34.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 106.418 -1.697 . . . . 2.66 106.418 165.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -120.8 126.52 50.31 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 108.274 -1.01 . . . . 4.09 108.274 179.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.17 155.65 48.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 123.571 0.545 . . . . 3.05 109.994 178.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.45 112.24 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 104.435 -2.432 . . . . 1.03 104.435 166.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 p -79.6 137.6 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 106.889 -1.523 . . . . 2.81 106.889 166.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -139.28 173.54 11.44 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.194 1.398 . . . . 6.23 108.377 -179.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.39 -46.82 2.28 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.478 -0.649 . . . . 1.55 111.478 -176.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.16 136.92 46.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.531 -0.914 . . . . 2.45 108.531 -177.128 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -141.56 8.46 1.97 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.726 1.75 . . . . 1.93 115.726 -156.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.6 p -159.39 173.19 16.62 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 121.173 1.806 . . . . 0.7 111.782 174.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.59 -42.64 56.01 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.207 1.003 . . . . 0.59 111.135 175.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 m -65.93 -20.95 66.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.761 0.824 . . . . 1.7 112.286 178.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.3 m -73.51 -62.1 1.6 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.036 0.835 . . . . 0.82 111.222 158.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.1 t -39.43 -63.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 124.588 1.155 . . . . 0.91 111.457 -173.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.87 -29.87 70.38 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.439 -0.505 . . . . 0.77 111.579 -173.603 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -70.45 -44.78 67.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.68 0.792 . . . . 3.36 108.976 -178.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.2 mt -55.2 -59.14 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.393 -0.966 . . . . 0.95 108.393 175.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -55.77 -53.92 50.78 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 117.979 0.354 . . . . 3.87 111.014 -178.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -55.37 -36.51 66.42 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.005 0.922 . . . . 0.79 111.973 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 t -70.1 -54.72 11.8 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.132 -1.062 . . . . 1.2 108.132 177.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 mp -57.46 -42.72 83.12 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.155 0.582 . . . . 2.48 112.179 -174.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.3 p -60.09 -12.46 8.4 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.265 -0.897 . . . . 1.9 113.029 178.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.4 -32.59 74.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.093 0.86 . . . . 4.09 110.561 172.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -78.29 106.91 10.53 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.218 -0.66 . . . . 1.93 109.218 178.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -57.66 -20.82 36.18 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.871 -1.143 . . . . 6.07 112.62 171.086 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.3 -32.47 72.29 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.902 -0.943 . . . . 0.93 112.323 172.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -88.92 137.36 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 118.671 1.236 . . . . 2.43 108.098 170.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 mt -95.86 -36.53 11.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.552 0.741 . . . . 1.68 109.471 177.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -150.11 153.69 36.82 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.774 0.261 . . . . 1.78 110.483 173.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -137.28 130.46 30.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.421 1.888 . . . . 2.56 106.728 171.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.4 t -128.18 110.45 12.45 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 106.526 -1.657 . . . . 1.7 106.526 168.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.59 150.91 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.255 1.022 . . . . 2.67 110.72 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.17 122.54 5.59 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.856 -0.528 . . . . 0.79 111.177 174.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.12 -26.36 67.41 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.371 0.668 . . . . 1.6 109.936 161.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.2 -49.19 77.91 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.259 0.481 . . . . 1.17 109.884 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.45 -37.51 36.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.793 0.437 . . . . 1.99 110.349 173.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 m120 68.89 71.75 0.27 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.774 -1.565 . . . . 1.84 106.774 -151.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.33 158.11 43.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.173 -0.329 . . . . 2.46 110.251 173.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.27 129.58 47.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.547 -2.02 . . . . 1.14 105.547 151.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -107.4 116.53 32.11 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 102.85 -3.019 . . . . 1.01 102.85 166.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mm -107.9 149.5 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 104.728 -2.323 . . . . 1.69 104.728 174.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.94 139.8 47.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.2 -1.037 . . . . 2.44 108.2 157.155 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -162.82 160.83 25.65 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 124.092 0.87 . . . . 2.19 109.718 -153.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -93.37 124.61 57.03 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 108.882 -0.785 . . . . 3.57 108.882 168.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.74 -19.08 24.47 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.935 2.424 . . . . 2.04 113.689 -173.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.32 -48.7 10.88 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.003 -1.11 . . . . 4.17 108.003 176.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.4 mt -63.9 -40.13 87.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-O 119.227 -0.416 . . . . 3.11 110.038 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.3 tt -137.34 109.32 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.346 0.594 . . . . 1.39 110.91 173.079 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.88 141.01 47.26 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.411 -1.476 . . . . 1.17 109.411 172.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -55.71 -40.16 86.91 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.741 2.294 . . . . 1.08 111.815 -172.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -56.9 -29.53 63.09 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 118.178 -0.915 . . . . 6.45 112.369 178.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.23 -44.18 92.68 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 120.015 1.279 . . . . 4.12 110.35 -179.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.2 mt -56.56 -52.97 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.308 -0.627 . . . . 0.62 109.308 175.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.1 mm -51.04 -56.87 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.089 0.556 . . . . 1.96 109.833 177.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.33 -34.98 69.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.788 0.835 . . . . 4.69 111.465 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.3 m -65.47 -52.99 48.98 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.881 -1.155 . . . . 0.89 107.881 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.1 mt -50.9 -50.74 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.12 0.568 . . . . 1.22 110.237 176.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -53.54 -50.28 65.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.047 0.451 . . . . 2.25 110.39 175.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.7 t -67.28 -14.66 63.12 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.512 1.125 . . . . 1.26 113.305 -173.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 mp -72.13 -91.01 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.911 1.232 . . . . 2.15 107.709 165.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.44 35.88 0.48 Allowed Glycine 0 CA--C 1.523 0.586 0 O-C-N 121.347 -0.845 . . . . 0.82 111.815 169.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -130.61 177.52 7.32 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.552 0.676 . . . . 1.65 110.927 -156.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -119.73 148.43 43.41 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.593 -1.632 . . . . 3.67 106.593 175.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.58 133.42 32.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.919 0.887 . . . . 1.01 108.736 170.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.3 t -133.77 103.39 5.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.34 1.056 . . . . 1.77 109.002 -177.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.374 0 C-N-CA 124.809 1.244 . . . . 3.11 110.879 178.625 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.74 0 N-CA-C 107.437 -2.265 . . . . 1.33 107.437 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.74 91.57 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.678 1.191 . . . . 2.25 109.65 -177.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -80.71 79.24 7.38 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.277 -1.379 . . . . 2.74 107.277 175.453 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -102.23 116.01 31.75 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.096 -0.956 . . . . 3.85 109.615 174.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.91 166.42 24.52 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.915 1.286 . . . . 1.98 110.421 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.33 143.55 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 106.54 -1.652 . . . . 0.93 106.54 173.187 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.0 t -136.53 130.49 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 126.025 1.73 . . . . 1.89 107.356 175.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -132.03 156.43 46.28 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.262 1.425 . . . . 5.92 108.618 -174.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.34 -24.56 28.51 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.641 -0.533 . . . . 1.1 112.253 177.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.75 76.25 0.85 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.396 1.093 . . . . 2.23 110.201 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -70.21 -12.34 61.52 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 115.399 1.629 . . . . 1.6 115.399 -157.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.6 p -157.14 174.02 16.11 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 120.523 1.511 . . . . 0.73 110.724 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.91 -44.54 14.73 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.814 1.245 . . . . 0.74 111.529 177.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 m -57.67 -37.32 73.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.525 0.73 . . . . 1.5 111.854 178.507 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.6 m -71.43 -50.35 32.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.438 0.563 . . . . 0.78 110.306 171.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.9 t -52.38 -56.6 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 122.737 0.415 . . . . 0.9 111.01 -175.676 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -27.96 64.22 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.613 -0.679 . . . . 0.86 112.065 -177.325 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -57.77 -48.04 80.79 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.776 -0.824 . . . . 3.47 108.776 170.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 81.9 mt -56.67 -66.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 108.743 -0.836 . . . . 0.7 108.743 171.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -46.11 -56.43 5.64 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.176 0.99 . . . . 3.79 110.765 -169.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.4 t -57.63 -51.4 69.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.562 0.745 . . . . 0.88 110.175 -176.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -59.78 -40.66 89.0 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.438 0.637 . . . . 1.44 109.724 -178.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -49.83 75.01 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.547 0.739 . . . . 2.81 110.759 178.069 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.1 p -56.01 -41.48 74.96 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.202 0.91 . . . . 2.13 110.759 175.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -57.53 -9.67 1.21 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.96 1.304 . . . . 4.63 113.154 175.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -56.43 -32.83 65.26 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 119.975 -1.703 . . . . 3.24 111.334 164.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 70.62 -51.05 0.67 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 126.606 1.962 . . . . 7.56 110.927 -168.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.37 53.39 1.89 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.672 0.653 . . . . 1.6 112.775 178.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -136.54 172.02 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.399 -1.334 . . . . 3.17 107.399 172.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.9 mt -117.57 -42.12 2.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.197 0.999 . . . . 2.16 109.346 -178.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -155.8 156.22 34.39 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 108.659 -0.867 . . . . 2.36 108.659 175.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.1 m -132.8 130.4 39.81 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 105.613 -1.995 . . . . 2.76 105.613 176.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.6 p -144.74 98.01 3.12 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.643 -0.873 . . . . 2.67 108.643 173.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 p -116.13 139.81 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.493 1.517 . . . . 2.32 109.342 -172.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.67 123.65 6.28 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.072 0.549 . . . . 0.9 110.294 -172.136 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.48 -32.77 74.56 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 109.56 -0.533 . . . . 1.82 109.56 167.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.9 -34.44 67.9 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.792 0.837 . . . . 1.47 111.825 -176.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.0 m -117.44 21.9 12.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.843 0.857 . . . . 2.16 109.787 175.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.3 m120 25.6 61.4 0.07 Allowed 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 126.834 2.054 . . . . 1.56 113.66 -172.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.57 166.54 26.17 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 120.619 0.247 . . . . 2.47 111.277 -173.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.411 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -139.02 125.9 20.98 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 124.663 1.227 . . . . 0.68 108.395 160.103 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -108.26 102.16 11.31 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.075 -2.194 . . . . 0.85 105.075 171.123 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.411 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -102.38 118.37 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 105.402 -2.073 . . . . 1.74 105.402 171.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -81.14 130.17 34.9 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.267 -1.753 . . . . 2.59 106.267 164.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -139.74 149.18 43.29 Favored 'General case' 0 N--CA 1.46 0.068 0 C-N-CA 124.265 1.026 . . . . 2.04 109.736 -168.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.76 131.48 70.52 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.465 -1.309 . . . . 2.97 107.465 161.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -82.75 0.13 9.82 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.807 2.338 . . . . 1.48 114.268 -172.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -93.09 -50.39 5.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 119.677 1.126 . . . . 4.02 108.148 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.8 tt -70.88 -29.89 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.734 0.642 . . . . 2.64 112.734 -174.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mm -142.69 144.47 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 105.6 -2.0 . . . . 1.38 105.6 -172.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.53 -178.14 15.72 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.187 1.375 . . . . 1.2 110.902 171.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.48 -48.13 22.08 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.208 2.605 . . . . 1.51 110.511 174.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.4 -61.29 1.07 Allowed 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 125.016 1.326 . . . . 6.86 110.895 176.31 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -53.74 -54.38 38.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.644 0.735 . . . . 2.62 110.387 -173.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.2 mt -58.86 -53.75 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.808 -0.633 . . . . 0.72 110.023 -177.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.1 mt -54.11 -53.23 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.416 -0.587 . . . . 1.19 109.416 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 52.3 m170 -55.1 -41.25 71.37 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.332 0.653 . . . . 3.52 110.651 179.03 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.5 m -62.08 -52.11 65.25 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.11 -0.7 . . . . 0.75 109.11 178.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.52 -51.06 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 123.495 0.718 . . . . 1.72 111.086 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -58.31 -58.12 9.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.602 1.161 . . . . 2.13 110.197 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -51.52 -46.94 63.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.317 1.047 . . . . 1.22 110.471 -178.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.32 -53.74 52.88 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.404 -0.331 . . . . 2.25 111.225 177.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.82 -41.48 0.02 OUTLIER Glycine 0 CA--C 1.529 0.919 0 N-CA-C 115.641 1.017 . . . . 1.5 115.641 174.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -122.39 160.83 24.63 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.7 0.63 . . . . 1.78 112.7 -127.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -82.45 150.55 26.99 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.09 -1.078 . . . . 3.68 108.09 -179.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.72 160.04 43.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.81 0.444 . . . . 1.15 111.661 172.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.4 m -155.92 128.0 7.54 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.473 0.709 . . . . 1.71 110.871 177.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.5 mt . . . . . 0 CA--C 1.535 0.375 0 C-N-CA 123.938 0.895 . . . . 3.14 109.546 169.702 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.946 0 CA-C-O 118.587 -1.118 . . . . 2.4 113.447 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.8 t -80.79 129.23 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 120.094 1.947 . . . . 3.87 109.127 174.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -150.94 123.05 8.25 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.845 0.748 . . . . 3.17 110.102 -175.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.39 121.7 45.9 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.945 1.298 . . . . 5.39 110.926 175.042 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 mt -104.06 160.81 14.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.996 -1.112 . . . . 2.83 107.996 164.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -85.08 143.61 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 106.246 -1.761 . . . . 1.23 106.246 147.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.2 144.64 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 106.139 -1.8 . . . . 2.44 106.139 175.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -146.07 164.77 31.1 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.313 0.645 . . . . 5.89 109.958 -178.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.83 -10.14 40.83 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.577 1.084 . . . . 1.09 111.048 -173.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -73.23 79.16 1.3 Allowed 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.045 0.923 . . . . 2.1 110.144 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -64.33 -15.84 61.08 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.479 -1.248 . . . . 1.64 113.358 -177.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.0 p -165.12 175.84 9.02 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 120.511 1.505 . . . . 0.68 110.753 177.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.99 -40.07 43.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.935 0.894 . . . . 0.78 111.499 175.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -57.62 -27.27 62.62 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.83 1.252 . . . . 1.57 111.905 178.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.1 m -73.85 -64.02 1.09 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.414 0.552 . . . . 0.72 110.941 162.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.7 t -44.75 -55.95 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 124.369 1.067 . . . . 0.92 111.646 -168.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -30.71 69.57 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.074 0.464 . . . . 1.67 111.559 -175.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -38.4 71.61 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.594 1.158 . . . . 4.18 109.447 -172.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.0 mt -55.93 -64.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.583 -0.895 . . . . 0.76 108.583 176.491 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -57.51 9.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.407 0.683 . . . . 4.43 109.813 178.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 t -54.75 -43.7 72.93 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.514 -0.741 . . . . 1.02 111.791 -175.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t -71.52 -49.1 44.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.886 -0.508 . . . . 1.46 110.222 -177.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.4 tp -73.35 -52.29 14.37 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 124.813 1.245 . . . . 3.15 112.852 -173.098 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.7 m -59.54 -21.76 60.71 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.288 0.848 . . . . 2.9 113.288 -171.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -22.18 66.92 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.166 -0.959 . . . . 4.52 113.451 172.218 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -66.2 106.03 1.55 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.042 -1.096 . . . . 2.12 108.042 175.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -52.69 100.43 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.274 1.029 . . . . 6.09 109.862 175.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 144.4 -32.06 1.77 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.04 -1.224 . . . . 0.94 110.04 -169.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.1 mm -79.63 151.1 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.26 -1.385 . . . . 4.2 107.26 161.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 50.7 mt -114.21 -47.68 2.93 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.906 1.283 . . . . 2.11 109.42 175.161 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -156.19 150.33 25.37 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 108.117 -1.068 . . . . 2.97 108.117 -175.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.9 m -125.86 80.72 1.93 Allowed 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.149 0.98 . . . . 2.64 110.301 174.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 t -78.26 77.97 4.74 Favored 'General case' 0 C--O 1.237 0.43 0 O-C-N 120.787 -1.196 . . . . 1.49 109.203 178.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -91.13 141.04 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 125.035 1.334 . . . . 2.66 110.456 171.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.77 118.44 6.58 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.218 0.463 . . . . 1.24 110.662 169.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -55.57 -19.61 10.65 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.5 1.12 . . . . 1.33 113.624 177.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.14 -34.63 78.04 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.318 0.647 . . . . 1.34 110.939 175.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.74 -8.22 10.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.904 0.882 . . . . 2.89 111.651 -178.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m120 60.97 26.29 16.24 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 125.023 1.329 . . . . 2.26 110.976 176.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.66 161.98 13.67 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.026 -1.472 . . . . 2.68 107.026 -176.46 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -139.6 90.49 2.41 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 105.533 -2.025 . . . . 1.03 105.533 165.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -78.88 83.81 4.97 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 103.25 -2.87 . . . . 1.63 103.25 167.125 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.0 pt -81.46 165.24 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 106.503 -1.666 . . . . 2.97 106.503 170.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -127.78 133.86 49.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 105.352 -2.092 . . . . 3.44 105.352 160.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.93 176.41 9.3 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 126.13 1.772 . . . . 2.13 108.181 -169.359 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -111.62 132.99 21.62 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 107.568 -1.271 . . . . 3.08 107.568 155.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.26 -17.68 18.8 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.414 2.743 . . . . 1.93 113.489 -172.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -89.6 -50.17 6.23 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 118.878 0.763 . . . . 3.06 109.217 -176.098 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.2 pt -85.96 1.64 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 113.33 0.863 . . . . 3.22 113.33 -176.294 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -152.13 123.55 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 106.624 -1.621 . . . . 1.34 106.624 171.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.63 148.6 42.12 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 109.804 -1.318 . . . . 1.15 109.804 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -56.58 -44.05 49.28 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 CA-C-N 119.402 1.601 . . . . 1.05 108.504 165.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.489 HH11 ' CD2' ' A' ' 60' ' ' HIS . 6.8 tpp180 -51.16 -32.91 24.8 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 117.952 -1.023 . . . . 5.83 112.015 170.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -72.47 -43.39 63.79 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 121.173 1.806 . . . . 2.39 113.112 176.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mt -48.91 -50.99 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.221 -0.592 . . . . 0.72 109.469 165.022 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.7 mm -58.66 -44.88 90.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 118.246 -0.883 . . . . 2.08 111.45 175.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.489 ' CD2' HH11 ' A' ' 56' ' ' ARG . 21.7 m170 -50.44 -45.73 56.07 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.31 1.414 . . . . 3.14 109.348 177.1 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.0 m -65.49 -53.47 42.07 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.291 -0.633 . . . . 0.84 109.291 -177.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.1 mt -50.98 -52.07 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.636 1.174 . . . . 1.45 110.854 178.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -54.12 -55.88 23.4 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.151 1.38 . . . . 2.34 110.182 173.015 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -63.78 -26.23 68.54 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 118.224 -0.893 . . . . 1.39 112.84 -171.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.9 mp -73.55 -95.41 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.251 -1.018 . . . . 2.1 108.251 168.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.97 34.11 0.44 Allowed Glycine 0 C--N 1.336 0.549 0 CA-C-O 119.012 -0.882 . . . . 0.89 112.635 173.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -130.42 163.59 26.59 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.483 1.141 . . . . 2.15 110.408 -163.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -117.03 157.52 25.69 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 108.051 -1.092 . . . . 3.01 108.051 174.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.54 165.53 36.31 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 118.446 0.566 . . . . 1.41 111.735 172.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 p -155.11 147.95 24.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.284 1.433 . . . . 2.44 108.652 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.154 0 N-CA-C 107.79 -1.189 . . . . 2.72 107.79 165.183 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.626 0 N-CA-C 106.372 -2.691 . . . . 1.3 106.372 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.55 96.18 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 125.368 1.467 . . . . 2.21 108.379 -177.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.9 tp -110.16 101.47 10.25 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.427 1.091 . . . . 2.33 108.21 -176.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -99.08 94.82 6.72 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.537 -0.912 . . . . 3.06 108.537 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -85.42 156.69 20.73 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.967 -0.753 . . . . 3.01 108.967 177.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.58 144.36 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.107 -1.442 . . . . 0.7 107.107 149.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.52 133.47 42.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.095 1.358 . . . . 2.31 109.237 177.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -137.37 166.12 24.58 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.04 0.536 . . . . 6.72 110.977 -177.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.55 -11.43 70.09 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.403 1.001 . . . . 1.33 110.726 -165.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 29.0 mtm -74.86 73.39 2.11 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.419 1.088 . . . . 1.71 110.192 -177.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.9 t -60.69 -37.09 80.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.459 1.104 . . . . 1.73 113.029 -170.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.4 p -145.04 167.27 23.09 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 118.81 0.732 . . . . 0.74 110.77 -173.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.5 -47.54 2.67 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.288 1.435 . . . . 1.07 111.965 -178.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 m -43.74 -42.43 5.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.445 1.098 . . . . 1.64 112.387 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.7 m -55.95 -36.0 67.29 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.393 0.677 . . . . 0.94 112.458 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.7 t -55.67 -60.29 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.2 0.524 . . . . 1.57 109.872 -177.139 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -71.25 -30.83 66.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.485 -0.769 . . . . 1.57 111.497 178.027 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -48.88 -45.52 41.2 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.137 0.881 . . . . 3.49 109.495 171.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.2 mt -69.59 -74.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 109.656 -0.498 . . . . 1.33 109.656 168.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -57.25 -48.4 78.96 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.435 0.561 . . . . 3.85 111.764 -161.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 t -63.39 -28.13 69.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.098 -0.477 . . . . 1.25 110.993 -178.137 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.2 t -71.99 -69.26 0.4 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.048 -0.723 . . . . 1.46 109.048 168.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.2 tp -54.62 -32.38 58.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.22 1.808 . . . . 3.2 113.165 -168.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.0 m -58.14 -19.74 35.08 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.151 -0.968 . . . . 2.02 112.656 176.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -57.04 -25.04 57.94 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.896 -1.127 . . . . 4.84 112.272 170.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -89.04 93.79 9.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.965 -1.124 . . . . 2.11 107.965 175.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.63 5.27 0.46 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.105 1.15 . . . . 6.14 114.105 -174.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.73 -26.86 73.95 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.243 -0.911 . . . . 0.96 111.423 164.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.48 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -79.75 146.28 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.438 -1.319 . . . . 2.45 107.438 170.803 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.9 mt -102.32 -42.51 5.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.368 1.467 . . . . 1.95 108.872 175.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -155.46 155.03 32.78 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 118.075 -0.964 . . . . 3.14 109.965 173.209 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -131.07 81.7 2.01 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.969 0.908 . . . . 2.77 109.519 178.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -77.69 78.89 4.19 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.019 -1.051 . . . . 1.47 108.945 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.0 t -79.86 140.01 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 126.311 1.844 . . . . 2.86 109.138 176.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.57 152.14 28.43 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.237 0.542 . . . . 1.15 110.789 169.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -95.84 -36.06 11.26 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.266 1.427 . . . . 1.68 109.938 -178.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.15 -36.99 32.41 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.114 0.966 . . . . 1.24 112.807 179.182 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.2 7.3 15.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.739 0.816 . . . . 1.92 111.445 174.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.3 m120 45.82 51.47 10.42 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.986 0.914 . . . . 2.06 111.744 -175.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -121.39 158.75 27.61 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.578 1.151 . . . . 4.46 110.253 -170.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.76 96.75 2.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.785 -1.098 . . . . 0.67 108.712 168.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -81.24 94.4 6.69 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.352 -1.351 . . . . 1.09 107.352 171.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.09 122.89 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 107.235 -1.394 . . . . 1.63 107.235 171.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -97.18 129.45 44.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.346 -2.094 . . . . 2.36 105.346 161.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -154.6 160.84 41.71 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.004 0.922 . . . . 2.3 109.757 -173.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.22 118.47 69.19 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 108.263 -1.014 . . . . 3.4 108.263 169.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -79.24 61.08 8.06 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.989 3.126 . . . . 2.19 111.877 -167.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -169.35 -45.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.08 1.352 . . . . 3.41 109.519 -174.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.2 mt -66.79 -33.12 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 122.77 0.428 . . . . 3.29 110.007 176.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.8 tt -146.78 134.9 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.241 -1.392 . . . . 1.54 107.241 178.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.17 161.69 37.88 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 111.304 -0.719 . . . . 0.86 111.304 178.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -60.21 -45.03 25.02 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.69 2.26 . . . . 0.93 110.382 177.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.44 HH11 ' CD2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -64.88 -30.59 71.6 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 118.739 -0.648 . . . . 7.01 110.988 177.057 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -66.66 -48.64 68.74 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.814 1.188 . . . . 2.62 109.547 177.378 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.8 mt -49.74 -57.77 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.996 -0.742 . . . . 0.77 108.996 170.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.5 mt -55.69 -47.16 79.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 118.72 -0.657 . . . . 1.03 111.53 -177.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.44 ' CD2' HH11 ' A' ' 56' ' ' ARG . 27.3 m80 -49.12 -45.52 43.62 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.611 0.764 . . . . 3.26 109.821 172.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.5 m -65.16 -48.94 71.75 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.435 -0.95 . . . . 1.01 108.435 -176.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.0 -61.65 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.2 0 N-CA-C 109.584 -0.524 . . . . 1.64 109.584 177.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -60.46 -37.84 82.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.464 -0.334 . . . . 2.15 110.344 -164.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.6 m -54.14 -33.9 59.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.84 0.856 . . . . 1.84 113.184 177.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.66 -60.17 3.43 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.368 0.986 . . . . 2.37 111.409 -176.289 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.95 22.61 0.19 Allowed Glycine 0 CA--C 1.526 0.742 0 O-C-N 120.645 -1.284 . . . . 1.13 112.925 166.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -134.28 176.58 8.47 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.537 1.168 . . . . 2.07 113.093 -143.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -128.89 160.02 33.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.891 -1.522 . . . . 3.83 106.891 167.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.71 163.53 31.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.02 0.528 . . . . 0.92 110.577 171.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -155.18 177.55 11.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.086 1.354 . . . . 1.94 107.773 173.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 C--N 1.332 -0.195 0 C-N-CA 124.213 1.005 . . . . 3.17 109.09 -179.988 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 107.737 -2.145 . . . . 1.99 107.737 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.7 85.57 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 122.662 1.22 . . . . 2.45 108.864 173.241 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 tp -77.76 72.95 4.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.165 -1.05 . . . . 3.29 108.165 167.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.54 125.53 29.48 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.216 -1.356 . . . . 3.22 108.402 153.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -148.39 160.89 42.57 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 125.384 1.678 . . . . 1.9 109.208 178.377 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 42' ' ' ASN . 0.9 OUTLIER -77.88 137.57 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.705 -1.961 . . . . 0.97 105.705 168.732 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.3 t -116.43 135.21 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 105.612 -1.996 . . . . 2.03 105.612 165.123 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -110.01 169.25 8.85 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.838 -1.171 . . . . 7.41 107.838 162.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.39 -119.9 6.34 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 106.373 -2.691 . . . . 2.48 106.373 -152.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 47.0 mtm 36.14 60.84 0.82 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.075 1.75 . . . . 1.7 113.095 178.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.7 t -85.59 -9.81 56.78 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 117.916 -1.04 . . . . 1.51 112.964 -176.306 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.7 p -163.69 171.7 15.26 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.843 1.201 . . . . 0.71 109.708 173.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.97 -43.2 29.27 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.538 1.135 . . . . 0.57 111.538 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.9 m -65.6 -25.91 67.6 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.623 -0.703 . . . . 1.63 112.619 -179.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.1 m -73.36 -57.49 3.97 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 119.093 0.86 . . . . 0.82 110.455 163.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.1 t -43.79 -63.17 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 124.04 0.936 . . . . 1.19 109.971 -175.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.453 ' HA ' ' CG ' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -68.01 -10.55 54.49 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 119.732 -0.787 . . . . 1.24 113.052 -173.372 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -70.23 -41.29 73.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.0 -1.111 . . . . 3.1 108.0 -178.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.6 mt -55.74 -62.97 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.243 -1.021 . . . . 1.1 108.243 177.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 1.6 pt-20 -53.21 -57.65 9.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.993 0.517 . . . . 3.3 110.457 -179.596 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.8 t -51.43 -48.75 62.6 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.058 0.543 . . . . 1.12 111.422 -179.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 t -70.34 -33.22 71.23 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.801 -0.814 . . . . 1.35 108.801 -172.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.2 mt -70.32 -45.71 65.69 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.624 -0.672 . . . . 2.22 111.16 174.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.4 p -57.76 -15.67 8.81 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.513 1.671 . . . . 2.25 115.513 -168.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.94 -36.43 74.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.603 1.092 . . . . 5.49 112.136 168.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -66.85 138.86 57.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.687 -0.857 . . . . 2.06 108.687 177.03 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -92.03 -5.88 52.12 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.274 0.23 . . . . 6.25 110.963 169.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.4 -30.58 58.28 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.585 -0.606 . . . . 0.97 111.585 174.358 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.516 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -78.79 146.19 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.6 -1.63 . . . . 2.46 106.6 168.709 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.0 mt -109.97 -37.79 5.51 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.989 1.716 . . . . 1.91 109.288 -175.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -153.27 150.29 28.8 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.412 -0.958 . . . . 2.09 108.412 176.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.0 m -130.79 142.45 50.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.168 -1.419 . . . . 2.57 107.168 172.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.9 t -152.26 157.23 41.11 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.271 -1.381 . . . . 1.88 107.271 159.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.43 138.83 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 124.573 1.149 . . . . 1.73 109.257 -178.025 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.84 95.95 4.49 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.017 0.927 . . . . 1.52 109.03 177.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -25.59 44.34 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.89 0.33 . . . . 3.02 111.89 167.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.55 -40.48 68.76 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.301 0.64 . . . . 1.3 111.552 178.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.5 t -110.27 -15.34 13.99 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.836 0.855 . . . . 3.21 111.301 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.44 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.3 m-80 65.88 74.31 0.37 Allowed 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 126.493 1.917 . . . . 2.38 110.339 -171.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.46 145.92 21.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.17 -0.678 . . . . 4.17 109.17 171.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 46' ' ' ILE . . . -109.19 132.38 54.17 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 106.818 -1.549 . . . . 0.78 106.818 167.274 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -109.07 99.25 8.59 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 127.496 2.319 . . . . 1.01 104.953 176.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.467 HD11 ' HB1' ' A' ' 44' ' ' ALA . 3.2 mm -108.18 110.93 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 106.077 -1.823 . . . . 2.02 106.077 176.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.2 mmtt -82.45 128.83 34.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.3 -1.741 . . . . 3.14 106.3 165.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -141.88 157.2 45.27 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.84 0.856 . . . . 2.18 108.946 174.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.5 121.89 63.95 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 107.113 -1.44 . . . . 3.48 107.113 173.281 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.56 44.1 1.57 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.196 2.597 . . . . 1.99 112.588 -172.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -132.88 6.47 3.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.946 1.698 . . . . 3.57 110.838 -179.021 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -157.19 -30.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.866 0.866 . . . . 2.7 112.525 -162.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 tt -139.25 145.03 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.765 -1.939 . . . . 1.26 105.765 165.383 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.03 154.53 24.57 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.134 -1.186 . . . . 1.01 110.134 176.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -59.06 -38.5 86.94 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.056 1.838 . . . . 1.04 109.792 173.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -54.35 -39.52 67.19 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.678 0.791 . . . . 5.95 111.864 173.43 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -70.09 -44.83 68.24 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.797 0.726 . . . . 2.44 109.356 -177.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.7 mt -53.95 -52.27 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.394 -0.595 . . . . 0.84 109.394 173.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.4 mt -52.33 -53.93 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.164 0.585 . . . . 1.13 110.34 176.199 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -51.28 -44.24 61.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.858 0.754 . . . . 2.87 110.882 175.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.7 m -66.25 -40.75 90.43 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 110.075 -0.343 . . . . 1.25 110.075 -174.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.8 mt -56.55 -67.58 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.791 -0.818 . . . . 1.36 108.791 168.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -61.82 -43.51 98.71 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.548 -0.296 . . . . 3.8 111.372 -161.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.2 m -63.56 -13.1 38.26 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.249 0.833 . . . . 2.49 113.249 -174.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.7 mt -70.76 -80.16 0.06 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.322 -0.992 . . . . 1.97 108.322 171.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.94 42.41 0.45 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-O 118.759 -1.023 . . . . 1.01 110.828 165.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -131.25 177.16 7.68 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.823 0.812 . . . . 1.87 110.586 -161.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -134.51 145.95 49.26 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.915 -1.513 . . . . 5.0 106.915 176.367 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.44 150.94 48.99 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 120.57 1.532 . . . . 1.01 113.082 -178.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.8 t -155.31 129.18 8.66 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 109.064 -0.717 . . . . 2.69 109.064 166.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 C--O 1.234 0.254 0 N-CA-C 109.314 -0.625 . . . . 2.49 109.314 162.264 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.729 0 N-CA-C 106.872 -2.491 . . . . 1.29 106.872 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -121.87 74.89 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 118.672 1.236 . . . . 2.59 109.058 -176.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 tp -79.99 71.8 6.72 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.766 -0.827 . . . . 2.45 108.766 -177.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -78.03 69.43 4.25 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.645 0.736 . . . . 3.55 109.153 -178.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.81 156.33 26.21 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.437 0.695 . . . . 2.21 111.097 -176.705 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.94 123.51 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.246 -1.39 . . . . 0.85 107.246 172.033 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.2 t -112.06 125.08 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.073 -1.825 . . . . 2.11 106.073 176.287 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.22 176.83 5.4 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.391 1.476 . . . . 6.09 109.231 -173.478 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.46 -69.52 3.24 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 108.767 -1.733 . . . . 2.41 108.767 -177.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.6 mtp 2.31 66.42 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.864 2.866 . . . . 2.06 115.477 -178.468 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.5 t -87.69 -11.43 48.35 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 117.59 -1.195 . . . . 1.44 113.694 -161.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.6 p -164.78 178.9 6.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 120.418 1.463 . . . . 0.71 110.479 175.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.41 -39.64 47.72 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.538 1.135 . . . . 0.64 111.599 175.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -52.4 -43.05 64.53 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.552 -0.536 . . . . 2.63 109.552 175.684 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.7 m -65.33 -57.23 8.91 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 121.504 -0.748 . . . . 0.94 109.153 -178.672 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 83.7 t -40.47 -68.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.567 1.147 . . . . 0.99 111.33 177.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -31.43 68.99 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 119.474 -0.891 . . . . 0.74 111.876 -169.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -65.6 -48.12 73.37 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 121.617 -0.677 . . . . 3.82 109.319 178.169 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.4 mt -53.21 -61.23 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.048 -1.093 . . . . 0.8 108.048 173.33 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -51.3 -49.71 60.77 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.246 0.618 . . . . 3.71 111.793 -176.428 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 t -55.12 -53.42 56.09 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.999 0.519 . . . . 0.97 109.862 176.743 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.4 m -59.86 -40.1 87.44 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.223 0.535 . . . . 1.86 110.08 -176.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -51.52 63.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.922 0.889 . . . . 2.74 110.376 -179.608 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 26.5 m -58.01 -29.47 65.32 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.767 -0.651 . . . . 1.92 110.183 176.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -5.67 8.67 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.412 1.264 . . . . 5.03 114.412 174.446 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -74.02 -122.26 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 120.437 1.471 . . . . 3.44 111.378 -178.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.18 -62.45 0.09 Allowed 'General case' 0 C--N 1.342 0.259 0 O-C-N 120.928 -1.108 . . . . 12.63 110.466 177.707 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.72 47.28 3.62 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.575 -0.61 . . . . 1.13 111.575 -177.817 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -115.06 136.6 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.8 -1.185 . . . . 3.11 107.8 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.9 mt -97.73 -42.22 7.72 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.156 0.983 . . . . 2.06 108.671 175.209 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -156.11 154.04 30.3 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 110.017 -0.364 . . . . 2.16 110.017 -178.278 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 p -132.22 144.34 50.56 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.639 0.775 . . . . 2.69 109.453 162.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 m -154.07 122.58 6.2 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.881 1.272 . . . . 2.75 107.914 161.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -115.18 154.67 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.021 0.529 . . . . 1.58 109.886 -178.12 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.22 123.25 14.53 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.891 0.476 . . . . 0.81 109.918 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.96 -15.0 60.24 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.806 1.242 . . . . 1.46 112.546 177.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.58 -50.4 37.66 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.872 -0.788 . . . . 1.57 108.872 173.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.73 -24.53 41.57 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.586 0.754 . . . . 1.81 110.695 177.392 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.5 m120 62.75 47.9 4.44 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 125.69 1.596 . . . . 1.57 108.881 -170.542 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.48 153.28 51.76 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.796 -0.446 . . . . 2.22 109.796 -172.679 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.74 99.99 6.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 124.523 1.139 . . . . 0.98 108.83 173.182 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -78.45 89.26 4.42 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 105.751 -1.944 . . . . 1.13 105.751 172.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.2 pt -93.27 140.95 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 107.65 -1.241 . . . . 3.12 107.65 165.549 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -112.21 130.33 55.96 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 106.309 -1.737 . . . . 2.49 106.309 160.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -141.07 161.27 38.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.598 0.759 . . . . 1.8 111.361 -166.399 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -93.02 103.8 10.15 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 125.785 1.634 . . . . 4.34 108.105 178.656 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.25 59.6 7.46 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.909 3.073 . . . . 2.45 111.221 -168.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -173.39 -49.01 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.283 1.833 . . . . 3.29 108.04 -172.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.3 mt -74.65 -37.7 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 109.818 -0.438 . . . . 3.14 109.818 173.618 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 tt -128.87 126.42 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 106.593 -1.632 . . . . 1.26 106.593 177.45 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.14 174.86 52.99 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.437 -1.865 . . . . 0.99 108.437 168.145 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.11 -48.51 4.88 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.687 1.592 . . . . 1.12 110.137 175.48 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.25 31.4 ttt85 -70.1 -20.82 63.17 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.271 0.841 . . . . 6.18 113.271 -169.559 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -46.63 -57.18 5.03 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.638 0.654 . . . . 2.84 109.719 167.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.02 -48.21 84.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 109.425 -0.583 . . . . 1.29 109.425 -176.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.5 mt -56.59 -40.89 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.937 -0.574 . . . . 1.23 110.473 -176.34 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -52.52 -40.76 62.8 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 118.938 0.79 . . . . 3.05 111.644 172.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.2 m -66.47 -51.17 59.68 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.741 0.701 . . . . 1.23 109.314 178.296 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.87 -52.56 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.0 0.92 . . . . 2.05 110.735 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.2 -56.2 24.92 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.456 1.102 . . . . 1.88 110.322 174.178 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 t -65.57 -21.19 66.57 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 118.231 -0.89 . . . . 1.56 112.921 -171.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.2 mt -71.23 -96.27 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.008 -1.108 . . . . 2.03 108.008 166.478 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.71 36.93 0.47 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.575 -1.125 . . . . 1.14 112.053 171.053 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -131.86 127.65 37.0 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 118.569 1.184 . . . . 1.84 110.406 -166.106 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -78.73 159.63 27.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.555 -0.905 . . . . 4.16 108.555 178.636 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.34 142.4 50.08 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.883 0.873 . . . . 1.5 110.338 -173.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -155.23 124.24 6.2 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.654 -0.869 . . . . 2.28 108.654 167.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 CA--C 1.529 0.137 0 N-CA-C 109.256 -0.646 . . . . 2.83 109.256 172.589 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.698 0 N-CA-C 106.997 -2.441 . . . . 1.32 106.997 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.69 78.4 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.091 1.356 . . . . 2.6 109.632 -173.076 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.1 82.33 5.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.305 -0.872 . . . . 3.06 109.257 -175.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -85.15 117.21 23.97 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.655 -0.869 . . . . 4.4 108.655 165.113 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.86 169.78 16.86 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.088 0.955 . . . . 1.98 109.995 170.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -90.08 142.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.396 -0.965 . . . . 0.71 108.396 170.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.18 130.46 74.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 125.713 1.605 . . . . 2.47 108.353 174.085 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -121.94 144.55 48.8 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.208 1.803 . . . . 5.62 107.72 -174.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.78 -125.34 7.36 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 106.288 -2.725 . . . . 2.78 106.288 -163.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.8 mtm 49.73 68.61 0.71 Allowed 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.791 1.236 . . . . 1.55 112.288 178.015 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 p -61.39 -28.86 69.54 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.674 0.62 . . . . 3.49 112.674 178.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.56 171.22 16.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.751 0.705 . . . . 1.31 110.259 -171.402 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.45 -37.36 17.04 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.344 1.058 . . . . 1.0 111.45 176.113 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -47.95 -33.84 8.3 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.294 2.238 . . . . 1.59 113.06 174.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.7 m -74.89 -60.99 2.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.305 1.042 . . . . 0.79 111.445 166.554 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.3 t -45.62 -58.4 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.799 1.24 . . . . 0.93 110.947 -171.245 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.47 -30.58 71.36 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.175 0.512 . . . . 1.63 111.363 -176.454 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -71.29 -49.24 44.88 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.192 -1.04 . . . . 3.65 108.192 -176.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 77.0 mt -54.03 -56.15 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 108.572 -0.899 . . . . 0.66 108.572 174.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -64.98 -44.75 88.28 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.59 0.233 . . . . 3.9 111.627 -171.326 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.5 t -63.59 -42.29 98.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.209 0.603 . . . . 0.84 110.617 177.044 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.9 t -62.96 -50.82 69.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.365 -1.346 . . . . 1.5 107.365 -178.255 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.1 mt -47.17 -53.6 12.66 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 122.983 0.513 . . . . 3.09 111.459 174.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.8 p -58.4 -12.22 3.62 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.082 1.142 . . . . 1.98 114.082 -178.392 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -32.48 73.99 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.709 1.141 . . . . 5.05 111.956 172.599 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -88.24 110.26 20.58 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 108.067 -1.086 . . . . 1.99 108.067 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.8 -17.12 33.29 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.309 -0.869 . . . . 6.19 112.005 172.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.47 -33.99 67.74 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.911 -0.938 . . . . 1.01 112.686 169.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.24 128.34 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.783 -1.562 . . . . 2.56 106.783 172.71 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.3 mt -86.58 -35.53 19.41 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.821 1.248 . . . . 2.03 109.35 -176.117 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -154.8 147.36 24.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.295 -1.002 . . . . 2.09 108.295 177.393 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.8 p -124.75 147.18 48.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.02 0.928 . . . . 2.74 109.046 169.221 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.9 t -152.39 101.28 2.66 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.979 -1.119 . . . . 1.55 107.979 169.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.6 m -90.26 161.74 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.048 1.339 . . . . 1.92 110.441 176.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.64 138.39 14.23 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.281 -0.637 . . . . 0.79 109.281 155.19 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 pp -76.13 -32.47 59.15 Favored 'General case' 0 C--O 1.227 -0.099 0 N-CA-C 108.841 -0.8 . . . . 1.65 108.841 159.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.08 -15.45 23.31 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.282 1.033 . . . . 1.87 111.938 179.156 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.9 m -139.3 20.35 2.58 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 121.535 -0.728 . . . . 2.4 110.575 172.557 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.7 m120 33.41 43.72 0.06 Allowed 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 125.757 1.623 . . . . 1.7 114.121 -176.273 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.3 158.49 30.88 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.233 0.613 . . . . 2.64 110.089 -170.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.37 115.32 9.18 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.633 -1.247 . . . . 0.69 107.633 163.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -99.16 105.32 17.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 106.07 -1.826 . . . . 1.0 106.07 170.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.58 110.29 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 105.921 -1.881 . . . . 1.82 105.921 175.371 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -82.91 136.29 34.63 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.717 -1.586 . . . . 3.89 106.717 164.892 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -158.65 155.55 28.38 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 118.956 0.798 . . . . 1.72 112.864 -168.076 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -87.19 120.28 71.3 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.184 0.993 . . . . 3.17 108.432 167.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.07 -14.55 23.49 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.066 2.511 . . . . 1.96 113.695 -174.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -84.67 -47.7 10.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.175 -1.046 . . . . 4.11 108.175 176.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.2 mt -66.47 -36.91 78.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 119.256 -0.402 . . . . 3.14 110.569 -178.388 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.0 tt -144.03 124.2 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.845 -0.798 . . . . 1.31 108.845 176.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.79 154.37 52.17 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.335 -1.106 . . . . 0.87 110.335 179.421 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -57.87 -41.28 70.85 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.923 1.749 . . . . 1.01 109.88 174.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -62.88 -30.09 71.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.922 -0.561 . . . . 5.78 111.911 176.127 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -70.38 -44.94 67.01 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.556 1.071 . . . . 2.26 109.19 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 mt -52.47 -55.94 8.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.15 -0.685 . . . . 0.77 109.15 171.133 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.4 mt -52.2 -53.41 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 119.401 -0.333 . . . . 1.21 110.632 179.411 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -50.65 -43.49 57.21 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.024 0.53 . . . . 3.13 110.938 175.274 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.8 m -62.44 -49.49 75.24 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.561 -0.533 . . . . 0.78 109.561 -177.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.82 -54.47 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.209 0.604 . . . . 1.75 109.96 176.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -58.19 -50.66 72.76 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.428 0.691 . . . . 2.59 110.582 -176.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -54.99 -33.39 62.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.443 1.497 . . . . 1.16 112.217 -172.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.8 mt -63.55 -82.89 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.047 0.385 . . . . 2.07 110.612 178.461 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.98 33.12 0.43 Allowed Glycine 0 CA--C 1.525 0.701 0 O-C-N 121.217 -0.927 . . . . 0.95 112.775 173.355 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -135.08 176.06 9.01 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.26 1.03 . . . . 1.64 110.316 -159.671 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -130.3 136.57 49.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.507 -1.294 . . . . 3.78 107.507 172.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.73 156.97 16.31 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.559 0.744 . . . . 1.11 109.774 177.029 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.2 m -151.33 114.25 4.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.455 -0.942 . . . . 2.29 108.455 170.012 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.365 0 C-N-CA 124.323 1.049 . . . . 3.42 110.849 179.594 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.937 0 CA-C-O 121.805 0.669 . . . . 1.86 114.2 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.98 133.44 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 125.974 1.71 . . . . 2.25 107.066 176.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 tt -139.13 103.56 4.8 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.425 -1.695 . . . . 2.86 106.425 173.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -112.29 117.28 32.06 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.524 0.602 . . . . 3.83 110.667 177.532 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.78 161.32 35.92 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.531 1.132 . . . . 2.8 111.08 -171.068 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.5 t -82.71 111.98 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 125.378 1.471 . . . . 1.08 107.411 176.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -86.85 73.75 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.679 1.192 . . . . 2.58 108.336 172.629 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.11 66.21 3.67 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.445 1.098 . . . . 6.77 109.71 -172.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.36 -44.4 0.02 OUTLIER Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.854 -0.899 . . . . 1.46 110.854 -175.416 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -61.4 120.05 9.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.562 0.681 . . . . 1.7 109.193 177.75 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 t -98.53 -45.65 6.02 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.988 0.515 . . . . 1.42 111.751 -172.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.0 p -130.59 172.75 11.59 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.758 0.708 . . . . 0.76 110.868 -175.125 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.46 -45.47 9.15 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.9 1.28 . . . . 0.86 111.922 179.422 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 m -54.41 -42.12 70.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.217 1.007 . . . . 1.5 111.584 177.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.6 m -71.41 -51.36 24.4 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.031 0.532 . . . . 0.96 110.643 174.736 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.3 t -44.75 -59.02 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.299 1.039 . . . . 1.0 109.988 -179.049 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.43 ' HA ' ' CG ' ' A' ' 23' ' ' GLU 0.306 0.2 OUTLIER -69.14 -14.88 63.24 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 119.257 -0.977 . . . . 1.25 112.028 -175.238 . . . . . . . . 4 4 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.1 tttt -71.34 -46.56 60.24 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 120.766 -1.209 . . . . 2.98 108.269 -175.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.4 mt -52.74 -67.67 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.221 -1.029 . . . . 1.1 108.221 177.378 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.43 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -47.73 -66.09 0.46 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.177 0.806 . . . . 4.25 113.177 178.466 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.2 m -50.69 -39.33 50.92 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 118.433 0.561 . . . . 2.41 112.216 -177.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.3 t -70.57 -60.78 2.06 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.441 -0.948 . . . . 1.24 108.441 179.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -52.58 -34.8 52.22 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.447 1.099 . . . . 2.56 112.296 -174.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.3 m -55.28 -22.59 19.22 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.947 0.721 . . . . 1.91 112.947 179.496 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -66.06 -23.76 66.6 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 120.101 1.319 . . . . 5.17 112.507 174.099 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -81.62 103.7 11.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.09 -1.448 . . . . 2.1 107.09 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 25.3 mtp-105 -57.19 -21.86 36.41 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.498 1.045 . . . . 7.09 112.13 173.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.82 0.97 18.0 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.743 -1.032 . . . . 1.67 113.951 173.191 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 pp -120.06 128.57 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 119.315 1.558 . . . . 2.57 106.933 159.175 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.4 mt -83.71 -30.66 26.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 110.257 -0.275 . . . . 1.78 110.257 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -157.07 151.6 25.42 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.589 -1.263 . . . . 2.26 107.589 178.085 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.5 t -128.65 119.14 24.14 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.882 1.273 . . . . 2.63 108.723 169.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 t -120.91 93.89 4.17 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.019 1.328 . . . . 1.51 109.975 -173.405 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -92.98 149.74 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.973 1.709 . . . . 2.49 111.719 -169.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.9 139.65 18.02 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.237 0.615 . . . . 0.85 111.666 168.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.0 mt -78.89 -54.52 5.96 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 125.541 1.536 . . . . 2.29 108.694 170.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -45.81 -42.61 12.47 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.63 0.772 . . . . 1.47 111.866 -177.28 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.4 ' HB ' ' CG ' ' A' ' 43' ' ' LYS . 3.1 m -101.02 -5.05 26.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.051 0.94 . . . . 2.63 112.247 -178.705 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.02 69.23 0.63 Allowed 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.988 1.315 . . . . 1.89 111.041 -178.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.4 ' CG ' ' HB ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -155.98 163.52 39.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.177 0.513 . . . . 2.17 111.56 -172.501 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -147.01 103.5 3.61 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.959 2.104 . . . . 0.85 107.427 171.097 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -80.37 106.41 12.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.37 -1.715 . . . . 1.04 106.37 172.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.0 mt -105.98 114.41 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 106.66 -1.607 . . . . 1.79 106.66 177.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -78.63 71.93 5.13 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.836 -1.172 . . . . 3.07 107.836 172.719 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.91 153.62 43.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.755 -0.657 . . . . 2.73 111.232 -179.122 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -106.17 117.53 57.19 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 108.869 -0.789 . . . . 3.13 108.869 162.041 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -67.27 -23.16 45.3 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.153 2.568 . . . . 1.63 113.009 -173.539 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -74.52 -43.46 55.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.302 0.955 . . . . 3.8 109.283 -174.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.6 tp -89.16 -34.96 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.339 0.496 . . . . 3.51 112.339 -179.129 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mm -133.47 112.68 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.487 -0.931 . . . . 1.65 108.487 -170.065 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.94 163.28 49.33 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 110.831 -0.908 . . . . 1.27 110.831 177.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -55.97 -43.26 58.5 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.721 2.281 . . . . 1.4 109.957 175.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -32.87 65.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.307 0.643 . . . . 6.89 112.66 176.201 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -70.12 -49.42 50.93 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.879 0.763 . . . . 2.6 109.012 179.139 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.6 mt -53.64 -57.25 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.034 -0.358 . . . . 1.21 110.034 174.936 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.9 mt -49.58 -54.95 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 123.646 0.778 . . . . 1.45 109.139 178.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -55.39 -41.4 72.61 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 111.51 0.189 . . . . 4.26 111.51 178.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 64.5 m -62.94 -49.6 74.11 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.794 -0.817 . . . . 1.16 108.794 -177.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.78 -53.85 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.487 -0.56 . . . . 1.41 109.487 174.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -56.02 -37.63 69.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.146 0.578 . . . . 2.21 111.522 -178.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.1 m -63.67 -15.88 59.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.461 -0.78 . . . . 2.2 113.094 -178.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.31 -96.6 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.593 1.088 . . . . 2.27 108.754 169.936 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.33 44.97 0.47 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.928 -1.269 . . . . 1.02 109.928 174.437 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -134.15 176.62 8.43 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.592 1.157 . . . . 1.86 109.169 -163.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -139.68 167.79 21.31 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.737 -1.208 . . . . 3.51 107.737 164.308 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -135.22 152.41 51.53 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.567 1.147 . . . . 0.9 110.384 -167.076 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.6 m -150.87 124.17 8.88 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.803 -0.56 . . . . 1.98 110.257 168.305 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 CA--C 1.53 0.192 0 N-CA-C 108.929 -0.767 . . . . 3.53 108.929 169.193 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.685 0 N-CA-C 108.23 -1.948 . . . . 1.59 108.23 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.47 158.47 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.517 0.727 . . . . 2.83 109.148 173.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.03 131.74 17.9 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.84 -1.541 . . . . 2.58 106.84 169.732 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -117.34 112.92 21.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.837 -0.801 . . . . 3.31 108.837 175.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.7 mt -109.93 136.16 49.66 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.244 1.417 . . . . 2.27 108.08 -179.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 42' ' ' ASN . 1.0 OUTLIER -78.54 96.45 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.255 -2.498 . . . . 1.66 104.255 156.678 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.5 t -82.69 131.21 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.004 -1.48 . . . . 1.73 107.004 172.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -144.2 136.85 26.93 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.771 0.828 . . . . 5.31 108.877 -169.717 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.4 -25.91 9.46 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.47 1.033 . . . . 1.31 110.775 -169.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -70.57 74.22 0.55 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 122.173 0.987 . . . . 1.61 110.972 179.461 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -50.68 -36.0 33.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.865 1.266 . . . . 1.61 114.303 -168.42 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 p -146.6 170.62 16.54 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.146 0.885 . . . . 0.92 111.978 -168.505 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.79 -41.8 24.36 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.583 1.153 . . . . 0.64 111.457 176.827 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 m -59.98 -33.2 71.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.158 0.583 . . . . 1.73 111.724 178.272 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.5 m -72.62 -46.26 54.95 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 119.007 0.821 . . . . 1.24 112.045 167.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.0 t -51.18 -60.98 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 118.262 0.483 . . . . 0.73 110.8 -178.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -27.65 65.0 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.383 -0.823 . . . . 0.91 111.931 -174.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -55.56 -54.68 41.05 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 108.698 -0.852 . . . . 3.33 108.698 169.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.468 HD11 ' CD2' ' A' ' 67' ' ' PHE . 61.8 mt -54.56 -59.39 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 118.451 -0.785 . . . . 0.74 109.012 176.564 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -50.83 -59.78 3.75 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 123.779 0.674 . . . . 4.24 110.288 -173.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.9 t -58.1 -45.78 86.64 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.653 0.781 . . . . 0.99 110.861 -176.122 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.5 t -64.78 -56.83 11.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.126 -0.694 . . . . 1.18 109.126 -178.038 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.5 tp -52.57 -51.4 59.94 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 125.012 1.325 . . . . 2.43 111.021 -177.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.6 m -62.87 -9.31 9.18 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.954 0.724 . . . . 2.8 112.954 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -31.28 72.44 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.557 -1.339 . . . . 4.82 111.523 168.481 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -79.75 71.87 6.43 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.948 -0.76 . . . . 2.25 108.948 -178.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -42.97 102.23 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.197 1.399 . . . . 6.68 110.137 177.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.24 -39.33 0.81 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.22 -1.552 . . . . 1.26 109.22 -164.167 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.31 140.86 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 104.346 -2.464 . . . . 2.83 104.346 148.579 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.5 mt -104.24 -42.56 5.47 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.576 1.15 . . . . 1.73 109.715 -175.658 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -146.71 153.06 39.82 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.856 -0.424 . . . . 1.99 109.856 176.162 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.3 t -136.93 136.37 38.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.484 1.914 . . . . 2.82 107.986 174.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -131.13 82.17 2.03 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.891 1.277 . . . . 2.02 107.876 172.108 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.407 HG12 ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -78.58 141.71 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.102 0.961 . . . . 1.8 110.268 172.341 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.77 151.07 26.82 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.196 0.598 . . . . 0.92 110.107 169.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.2 -11.97 14.52 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.812 1.245 . . . . 1.36 113.346 -165.935 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.99 -51.01 52.11 Favored 'General case' 0 C--O 1.226 -0.174 0 N-CA-C 108.576 -0.898 . . . . 1.73 108.576 173.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 m -79.81 -29.17 40.17 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.983 -0.553 . . . . 2.22 111.416 174.252 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.526 ' O ' HG22 ' A' ' 9' ' ' VAL . 24.7 m120 67.2 79.71 0.23 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.242 -1.392 . . . . 1.66 107.242 -165.574 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -147.91 158.9 44.28 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.534 -0.543 . . . . 4.98 109.534 -176.186 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.407 ' HB2' HG12 ' A' ' 37' ' ' VAL . . . -146.64 108.86 4.44 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.519 1.928 . . . . 1.03 106.612 163.503 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -86.26 117.16 24.89 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.781 -2.303 . . . . 1.18 104.781 164.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.405 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.8 mp -109.29 148.36 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 105.293 -2.114 . . . . 1.89 105.293 171.358 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.48 141.25 51.05 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.692 -0.855 . . . . 2.36 108.692 156.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -154.46 153.93 32.34 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.315 1.046 . . . . 2.32 109.211 -163.03 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -84.93 114.25 54.62 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 107.665 -1.235 . . . . 3.52 107.665 173.163 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.23 52.51 4.31 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.07 3.18 . . . . 2.09 111.777 -170.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -144.82 -59.7 0.36 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.094 1.758 . . . . 2.82 106.874 -177.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.6 tt -72.63 -25.49 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.203 1.401 . . . . 2.37 111.972 179.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.8 tt -145.93 143.08 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.723 -1.584 . . . . 1.46 106.723 172.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -99.55 161.82 19.66 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.367 -1.093 . . . . 0.92 110.367 174.018 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -56.54 -41.12 79.38 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.501 2.134 . . . . 1.11 110.03 174.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.4 tpt85 -56.28 -36.03 68.14 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.09 -0.957 . . . . 6.11 111.726 179.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -71.26 -48.17 52.65 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.524 0.73 . . . . 2.19 110.026 -177.37 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 mt -49.63 -56.48 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 108.21 -1.033 . . . . 0.81 108.21 171.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.2 mt -56.05 -43.1 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.893 -0.594 . . . . 1.01 109.999 -179.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -56.7 -40.62 75.96 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.397 0.679 . . . . 4.34 111.414 176.308 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.16 -43.92 77.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 119.443 -0.903 . . . . 2.1 109.293 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.9 -52.0 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 124.52 1.128 . . . . 1.76 111.057 174.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -57.92 -55.52 33.8 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.595 1.158 . . . . 1.94 110.019 175.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.2 t -53.48 -43.42 68.18 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.262 1.025 . . . . 1.34 110.851 -175.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.2 mt -62.59 -66.14 0.58 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 110.312 -0.255 . . . . 2.12 110.312 173.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.99 -24.94 0.02 OUTLIER Glycine 0 CA--C 1.53 0.993 0 N-CA-C 117.504 1.762 . . . . 1.31 117.504 -178.223 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.468 ' CD2' HD11 ' A' ' 22' ' ' ILE . 13.5 m-85 -126.6 152.16 47.01 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 119.055 1.427 . . . . 1.74 110.535 -137.779 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -84.41 152.42 24.04 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.521 -1.289 . . . . 4.06 107.521 172.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -122.12 129.51 52.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.78 0.832 . . . . 1.05 109.478 163.514 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -108.36 104.41 13.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.496 -1.298 . . . . 2.75 107.496 169.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 CA--C 1.533 0.312 0 CA-C-N 119.019 0.827 . . . . 3.75 110.633 175.081 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.906 0 N-CA-C 106.239 -2.744 . . . . 1.41 106.239 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.5 82.79 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 124.549 1.14 . . . . 3.25 110.635 -172.267 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 tp -81.55 81.67 7.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.201 -1.037 . . . . 3.38 108.201 175.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -95.0 102.77 14.6 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.155 -0.929 . . . . 2.89 109.029 171.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.6 151.0 40.88 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.755 1.222 . . . . 2.24 109.376 -177.55 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 t -77.6 129.87 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 105.717 -1.957 . . . . 1.01 105.717 166.046 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.4 t -111.35 97.7 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 105.452 -2.055 . . . . 2.3 105.452 174.068 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -81.68 146.43 30.02 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.267 -1.012 . . . . 7.22 108.267 178.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.13 -9.51 56.37 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.06 0.838 . . . . 1.04 112.1 -174.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.7 ttm -65.96 71.95 0.06 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.605 1.562 . . . . 1.95 110.935 176.676 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -71.98 -31.47 66.3 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.697 0.629 . . . . 1.52 112.697 -167.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.9 p -154.18 174.81 14.25 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.255 0.934 . . . . 0.83 112.397 -169.359 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.89 -41.26 45.27 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.503 1.121 . . . . 0.72 111.046 175.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.9 m -63.72 -24.79 67.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.174 0.589 . . . . 1.65 112.235 178.498 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.3 m -72.57 -62.6 1.39 Allowed 'General case' 0 C--N 1.337 0.05 0 CA-C-N 119.478 1.035 . . . . 0.95 110.086 163.207 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.7 t -36.24 -66.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 125.538 1.535 . . . . 0.88 111.072 -177.002 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.33 -27.6 66.41 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.705 -0.398 . . . . 0.83 111.604 -172.555 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -69.43 -55.63 9.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.912 -1.144 . . . . 3.54 107.912 -179.533 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.4 mt -50.02 -59.44 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.293 -1.003 . . . . 0.81 108.293 177.52 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.65 -56.01 25.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.186 -0.915 . . . . 3.88 110.338 -174.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.5 t -66.08 -29.59 69.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.168 -0.92 . . . . 1.56 112.271 -176.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.6 m -70.93 -50.66 32.23 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.957 -1.127 . . . . 2.34 107.957 179.38 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.2 mt -53.54 -46.57 70.24 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.468 -0.333 . . . . 2.4 110.831 175.163 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.2 m -56.4 -9.12 0.63 Allowed 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.964 1.098 . . . . 2.16 113.964 -179.252 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -75.92 -29.81 58.53 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.527 -1.358 . . . . 7.4 112.024 172.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -75.18 161.68 29.16 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.017 0.927 . . . . 2.05 109.509 -173.571 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.45 -42.76 7.57 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-O 119.131 -0.462 . . . . 8.24 111.479 -175.285 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.29 -12.75 69.67 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 119.112 0.869 . . . . 1.08 113.207 -176.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -77.54 159.31 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 107.785 -1.191 . . . . 2.59 107.785 168.18 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.3 mt -129.39 -41.1 1.4 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.223 1.009 . . . . 2.39 110.112 -172.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -149.84 148.22 28.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.646 -1.613 . . . . 2.06 106.646 174.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -128.87 126.25 39.36 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.232 -2.136 . . . . 2.65 105.232 178.473 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.1 t -144.54 104.93 4.11 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.831 -0.803 . . . . 1.49 108.831 178.233 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.95 148.64 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 123.63 0.772 . . . . 1.63 111.428 -175.766 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.74 109.43 3.45 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 122.08 -0.387 . . . . 1.13 111.759 -176.849 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.65 -15.42 19.08 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.919 1.081 . . . . 1.47 113.919 177.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.36 -35.27 76.99 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.874 0.47 . . . . 1.27 110.656 171.589 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -116.49 -6.21 11.7 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.748 1.219 . . . . 3.17 111.467 178.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.9 m120 56.64 29.32 15.48 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.838 1.655 . . . . 1.47 110.764 -179.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.66 144.64 37.73 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.495 -1.668 . . . . 3.19 106.495 -176.89 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.82 114.2 20.73 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.465 -1.68 . . . . 0.99 106.465 165.445 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -91.2 104.7 17.22 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 105.418 -2.067 . . . . 1.75 105.418 172.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 46' ' ' ILE . 2.1 mp -103.99 115.86 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 105.987 -1.857 . . . . 1.66 105.987 170.302 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -78.51 133.9 37.35 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 105.645 -1.983 . . . . 2.98 105.645 162.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -151.53 163.57 38.73 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.548 0.739 . . . . 1.85 109.84 -173.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -100.18 124.92 41.53 Favored Pre-proline 0 N--CA 1.449 -0.513 0 N-CA-C 108.552 -0.907 . . . . 3.48 108.552 163.04 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.79 -17.02 33.2 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.663 2.909 . . . . 2.03 113.663 -174.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.56 -44.47 11.89 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.416 -0.957 . . . . 3.1 108.416 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.6 mt -71.25 -43.09 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 122.244 -0.285 . . . . 3.41 110.82 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.59 118.93 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 105.83 -1.915 . . . . 1.46 105.83 -178.574 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.95 150.38 51.92 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 108.718 -1.753 . . . . 1.13 108.718 171.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -57.64 -40.48 79.63 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 CA-C-N 119.248 1.524 . . . . 1.06 109.736 175.059 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -42.8 -42.23 3.52 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.182 1.393 . . . . 7.44 112.578 168.134 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -71.28 -43.05 67.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.996 0.816 . . . . 2.2 110.121 -172.034 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.5 mt -57.78 -48.3 83.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 109.133 -0.691 . . . . 0.63 109.133 173.503 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.2 mt -54.41 -53.22 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.842 -0.429 . . . . 1.46 109.842 176.09 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -50.63 -45.71 57.82 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.599 0.636 . . . . 3.14 110.422 176.016 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.2 m -60.14 -52.08 66.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.269 -0.641 . . . . 1.06 109.269 -176.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.29 -61.96 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.534 0.734 . . . . 1.23 110.035 175.337 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -66.19 -25.24 66.84 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.308 -0.406 . . . . 3.22 111.438 -167.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.8 t -63.47 -15.73 58.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 117.789 -1.1 . . . . 1.58 112.891 175.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.38 -96.56 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 120.065 1.302 . . . . 2.91 108.664 170.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.72 50.65 0.42 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.739 -1.344 . . . . 0.97 109.739 177.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -135.92 175.03 9.97 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.351 1.06 . . . . 2.18 108.971 -170.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -141.01 140.89 34.38 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.254 -1.387 . . . . 4.87 107.254 173.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.54 159.7 18.55 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.476 0.655 . . . . 1.16 112.611 -173.108 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.4 133.86 10.8 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 125.03 1.332 . . . . 1.91 108.21 172.376 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 CA--C 1.534 0.335 0 CA-C-N 119.646 1.112 . . . . 2.45 110.19 173.419 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 106.465 -1.68 . . . . 9.91 106.465 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.32 154.52 24.46 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 108.945 -1.662 . . . . 6.05 108.945 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -72.67 174.25 7.85 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.075 1.75 . . . . 6.21 111.569 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.72 81.18 0.06 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.917 1.246 . . . . 1.98 111.236 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 p -75.54 123.47 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 108.784 -0.821 . . . . 2.18 108.784 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 tp -146.26 77.37 1.48 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.024 0.44 . . . . 2.82 110.412 -168.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -78.55 76.0 5.06 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.602 0.715 . . . . 4.23 110.101 -178.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -78.91 156.9 28.38 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.922 0.889 . . . . 2.53 110.908 176.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.24 139.07 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.365 -1.717 . . . . 0.92 106.365 172.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.9 t -130.83 122.84 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 C-N-CA 126.844 2.058 . . . . 2.07 105.841 175.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 31.1 mtp-105 -117.75 164.25 15.28 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.828 1.251 . . . . 5.32 109.815 -176.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.55 -6.88 77.79 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.206 0.908 . . . . 1.19 111.625 -171.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 30.3 mtm -72.81 69.64 0.94 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.189 0.996 . . . . 1.6 110.269 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -69.01 -16.77 63.8 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 114.165 1.172 . . . . 1.48 114.165 -166.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.0 p -160.53 173.77 15.05 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 120.205 1.366 . . . . 0.73 110.699 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.13 -40.18 45.41 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.991 0.916 . . . . 0.69 111.341 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 m -61.87 -27.41 68.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.625 0.77 . . . . 1.69 112.291 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 73.4 m -71.15 -61.72 1.66 Allowed 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.913 -0.773 . . . . 0.67 108.913 164.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.6 t -45.42 -59.23 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 123.769 0.828 . . . . 0.72 111.572 -170.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -28.32 68.44 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.58 -0.7 . . . . 0.77 112.01 -175.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -70.55 -47.64 59.32 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.737 -0.838 . . . . 4.05 108.737 179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.9 mt -54.09 -55.58 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 108.273 -1.01 . . . . 0.98 108.273 174.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -48.74 -66.98 0.31 Allowed 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 124.357 1.035 . . . . 3.99 110.174 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.4 t -54.83 -39.4 68.52 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 123.801 0.84 . . . . 0.89 110.88 -175.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.7 t -66.59 -51.12 59.94 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.72 -0.844 . . . . 1.16 108.72 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -60.06 -43.5 95.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 121.383 -0.823 . . . . 2.54 111.301 -178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 68.5 m -59.44 -11.43 4.45 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.87 0.868 . . . . 2.12 112.813 176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -61.79 -35.38 78.0 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 120.905 -1.122 . . . . 5.65 111.426 167.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -59.57 135.03 57.54 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 108.308 -0.997 . . . . 2.98 108.308 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -26.54 61.65 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.143 0.883 . . . . 9.84 108.777 162.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.48 41.41 2.08 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 121.604 -0.685 . . . . 1.96 112.643 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 pp -146.17 150.74 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 105.643 -1.984 . . . . 2.58 105.643 172.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 22.3 mt -104.28 -25.7 12.78 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 123.306 0.379 . . . . 2.05 111.381 167.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -156.34 152.92 28.22 Favored 'General case' 0 C--O 1.231 0.091 0 CA-C-N 118.668 0.667 . . . . 2.38 109.378 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 12.7 t -143.95 128.24 17.79 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.248 1.019 . . . . 2.27 109.25 164.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.1 t -135.5 92.92 2.89 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.191 1.396 . . . . 1.47 108.708 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.35 152.8 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 126.009 1.724 . . . . 1.98 111.563 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.23 129.31 8.81 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 122.705 0.402 . . . . 0.72 110.973 171.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 pp -76.07 -10.25 59.27 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.688 0.795 . . . . 1.32 112.787 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.99 -54.9 17.27 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 109.025 -0.731 . . . . 1.15 109.025 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.74 -27.38 40.58 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.615 0.766 . . . . 2.09 110.812 174.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 21.9 m120 71.13 57.81 0.2 Allowed 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 125.352 1.461 . . . . 1.49 107.964 -169.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.44 170.42 15.74 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 112.484 0.549 . . . . 2.3 112.484 -169.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.72 100.17 3.79 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.631 1.972 . . . . 0.87 109.317 174.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -77.34 82.49 3.8 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 105.307 -2.109 . . . . 1.22 105.307 169.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.9 pt -85.3 147.63 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 CA-C-N 114.486 -1.234 . . . . 3.08 108.322 166.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -113.33 104.7 12.58 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 103.54 -2.763 . . . . 3.17 103.54 157.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -98.46 135.47 39.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 124.168 0.917 . . . . 2.56 109.282 -175.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.92 120.38 81.34 Favored Pre-proline 0 N--CA 1.45 -0.464 0 C-N-CA 123.716 0.806 . . . . 3.22 109.221 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.07 2.68 7.8 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.1 1.867 . . . . 1.87 114.524 -176.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -86.55 -43.01 13.04 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-N 121.414 1.916 . . . . 5.59 109.073 167.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 28.2 mm -88.15 -46.31 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 112.074 0.398 . . . . 3.12 112.074 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mm -120.71 146.32 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 107.921 -1.14 . . . . 1.61 107.921 -162.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.0 160.92 12.86 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 108.999 -1.641 . . . . 1.33 108.999 165.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -53.15 -38.38 80.97 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.828 2.352 . . . . 1.62 111.221 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -47.58 -41.04 20.71 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.565 0.746 . . . . 8.13 111.658 175.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -66.43 -50.61 62.82 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 119.105 0.866 . . . . 2.14 109.481 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.1 mp -54.05 -47.05 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.9 mt -55.87 -51.89 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-O 119.206 -0.426 . . . . 1.38 109.955 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -52.6 -42.75 64.83 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.612 0.642 . . . . 3.4 110.672 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 35.0 m -63.67 -54.84 29.3 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 109.348 -0.612 . . . . 0.82 109.348 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.462 HG23 ' HB2' ' A' ' 67' ' ' PHE . 49.3 mt -48.05 -49.59 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.528 1.531 . . . . 1.47 111.042 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -59.55 -49.77 76.5 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.182 0.993 . . . . 2.05 110.483 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.2 t -62.57 -22.82 66.64 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 118.201 -0.904 . . . . 1.44 112.542 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.26 -102.43 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.195 -1.039 . . . . 2.54 108.195 160.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.46 39.22 0.48 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-O 119.313 -0.715 . . . . 0.79 111.386 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.462 ' HB2' HG23 ' A' ' 62' ' ' ILE . 32.0 m-85 -128.25 171.37 12.03 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 117.937 0.869 . . . . 1.66 110.393 -167.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.12 166.15 21.73 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.523 1.129 . . . . 3.11 108.55 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.43 161.8 40.91 Favored 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.549 0.613 . . . . 1.12 111.998 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.9 m -156.59 131.54 9.04 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.091 1.356 . . . . 1.61 109.787 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.2 mp -69.35 106.34 2.89 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.229 -1.026 . . . . 3.14 108.229 173.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 44.8 t -62.78 -48.12 89.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 108.671 -0.863 . . . . 2.81 108.671 170.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.72 71.39 2.59 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.697 0.799 . . . . 4.71 109.192 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.3 mm -61.43 -79.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.193 -1.04 . . . . 8.6 108.193 171.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 . . . . . 0 C--O 1.248 1.0 0 CA-C-O 117.479 -1.248 . . . . 10.77 109.031 179.245 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.8 mtt . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.075 0.464 . . . . 11.08 110.57 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -179.59 39.53 0.08 OUTLIER Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.055 -1.618 . . . . 4.07 109.055 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -148.81 26.52 0.91 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.489 1.916 . . . . 7.65 109.257 -152.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.31 86.68 1.53 Allowed Glycine 0 N--CA 1.446 -0.647 0 O-C-N 121.918 -0.489 . . . . 2.19 113.14 -162.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.3 p -145.77 137.91 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 117.582 0.691 . . . . 2.23 110.178 170.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.5 tp -148.37 119.3 7.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.543 -0.91 . . . . 2.15 108.543 167.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -108.4 121.51 45.09 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.947 -1.501 . . . . 2.94 106.947 167.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -131.02 146.13 52.28 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.629 -0.878 . . . . 2.34 108.629 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -76.22 135.5 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 104.595 -2.372 . . . . 0.75 104.595 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.4 t -125.21 115.92 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 105.088 -2.19 . . . . 1.98 105.088 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -108.44 153.3 23.51 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.779 0.431 . . . . 6.15 110.115 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 101.24 -5.51 55.62 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 124.651 1.12 . . . . 1.05 111.985 -171.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 38.1 mtm -74.17 66.94 1.3 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.512 1.156 . . . . 1.65 110.677 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -68.88 -15.3 63.46 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 114.267 1.21 . . . . 1.62 114.267 -164.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.9 p -160.1 173.05 16.39 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 120.289 1.404 . . . . 0.72 110.508 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.54 -37.21 38.15 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.864 0.866 . . . . 0.81 111.326 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.7 t -61.08 -29.27 69.64 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 118.867 -0.587 . . . . 1.87 111.523 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.4 m -71.67 -57.08 4.69 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 118.89 0.768 . . . . 0.85 109.551 168.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.9 t -49.6 -60.46 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.472 0.709 . . . . 0.89 111.451 -172.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.86 -29.2 69.05 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.621 -0.674 . . . . 0.84 111.568 -175.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -65.28 -48.35 73.49 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.386 -0.968 . . . . 3.01 108.386 176.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 79.4 mt -55.4 -55.64 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 108.668 -0.864 . . . . 0.65 108.668 174.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -54.99 -49.95 70.19 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.425 0.631 . . . . 3.49 110.87 -175.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -56.55 -48.96 76.18 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.885 0.874 . . . . 0.85 110.682 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 74.3 m -61.65 -42.13 98.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 121.7 -0.625 . . . . 2.09 110.539 -175.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.495 HD11 HG23 ' A' ' 58' ' ' ILE . 1.7 mm? -63.64 -54.19 39.69 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 124.844 1.258 . . . . 2.45 110.671 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.0 p -59.17 -18.59 37.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.151 0.426 . . . . 2.03 112.151 -173.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -50.24 -41.88 50.85 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 118.271 -0.871 . . . . 4.65 113.008 166.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 69.8 m-70 -67.44 163.73 20.28 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.34 0.973 . . . . 2.26 111.661 -170.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.01 -29.13 11.11 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.391 0.677 . . . . 6.42 112.021 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.57 -14.76 77.57 Favored Glycine 0 CA--C 1.526 0.719 0 CA-C-O 119.918 -0.379 . . . . 1.16 112.491 175.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -77.86 149.93 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 117.782 0.791 . . . . 2.91 109.113 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 36.6 tp -109.08 -42.89 4.3 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 126.521 1.928 . . . . 3.55 108.708 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -155.79 163.88 39.27 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 118.22 0.464 . . . . 2.14 110.949 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.7 t -144.19 118.81 9.77 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 127.084 2.154 . . . . 2.14 106.846 174.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.97 96.74 5.14 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.204 -1.406 . . . . 1.63 107.204 175.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 p -107.64 141.32 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 123.23 0.612 . . . . 2.23 111.294 -174.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.47 125.72 9.34 Favored 'General case' 0 C--N 1.343 0.299 0 C-N-CA 123.729 0.811 . . . . 0.76 111.377 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.61 -15.04 60.39 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.522 1.129 . . . . 1.45 112.236 172.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.2 -51.7 68.64 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.012 -0.736 . . . . 1.24 109.012 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.87 -45.28 18.93 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.625 -0.88 . . . . 2.03 108.625 171.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 83.92 52.9 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 127.696 2.398 . . . . 2.48 107.39 -163.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.61 160.24 40.56 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 122.501 0.32 . . . . 2.36 110.705 -178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.12 120.06 30.35 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.61 -1.255 . . . . 0.64 107.61 168.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -93.86 94.44 8.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 105.863 -1.903 . . . . 1.18 105.863 172.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.45 152.22 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.958 0 N-CA-C 107.58 -1.267 . . . . 1.57 107.58 174.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -131.95 134.14 45.3 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.416 -2.439 . . . . 2.23 104.416 159.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -161.65 153.69 19.47 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.066 1.346 . . . . 2.49 107.39 -172.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -80.91 124.2 81.65 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 119.044 0.838 . . . . 3.41 109.732 170.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -63.59 -21.17 70.39 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.995 2.463 . . . . 1.8 115.467 -174.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -79.33 -45.59 19.34 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.991 1.269 . . . . 3.67 108.758 174.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.2 mt -71.71 -38.83 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 120.724 -0.39 . . . . 3.15 111.482 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.48 122.9 45.22 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.221 0 N-CA-C 106.029 -1.841 . . . . 1.56 106.029 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.02 168.29 44.82 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.187 -1.165 . . . . 0.8 110.187 172.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -59.58 -43.08 41.72 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.116 1.878 . . . . 1.08 109.564 170.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.32 -46.0 35.86 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 125.039 1.335 . . . . 5.75 112.455 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -56.06 -55.59 31.05 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 118.864 0.756 . . . . 2.46 110.148 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.495 HG23 HD11 ' A' ' 26' ' ' LEU . 37.6 mt -63.21 -54.37 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.12 -0.491 . . . . 0.78 109.745 -174.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.8 mt -49.52 -50.03 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.219 -0.66 . . . . 1.26 109.219 176.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 59.7 t60 -70.04 -29.21 66.19 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 121.622 -0.674 . . . . 4.41 111.813 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 71.2 m -61.88 -47.27 85.73 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.309 -0.997 . . . . 0.79 108.309 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' A' ' 67' ' ' PHE . 78.7 mt -57.37 -43.0 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.234 1.014 . . . . 1.22 111.006 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -57.21 -57.13 13.97 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 109.181 -0.674 . . . . 2.61 109.181 173.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -55.38 -42.44 73.98 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.168 1.387 . . . . 1.4 111.144 -174.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.9 mt -61.75 -82.11 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.565 0.346 . . . . 2.17 111.241 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.66 17.85 0.17 Allowed Glycine 0 CA--C 1.527 0.804 0 CA-C-O 118.356 -1.247 . . . . 0.74 114.621 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.441 ' HB2' HG23 ' A' ' 62' ' ' ILE . 25.5 m-85 -137.4 175.13 9.88 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 119.352 1.576 . . . . 2.17 110.916 -153.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -126.44 161.28 28.28 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 107.65 -1.241 . . . . 3.34 107.65 172.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.02 160.03 40.94 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 112.325 0.491 . . . . 0.91 112.325 174.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.3 m -155.79 146.59 22.16 Favored 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.845 1.658 . . . . 1.96 107.613 172.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 87.3 mt -59.24 151.83 22.15 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.775 0.716 . . . . 2.5 111.187 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.9 p -140.1 120.59 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 108.272 -1.01 . . . . 3.7 108.272 174.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -167.6 -53.77 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.606 1.562 . . . . 5.3 109.966 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.1 mt -77.33 -71.9 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 N-CA-C 106.2 -1.778 . . . . 5.91 106.2 174.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mp0 . . . . . 0 C--O 1.256 1.411 0 CA-C-O 117.191 -1.385 . . . . 10.13 108.151 156.247 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.472 0.637 0 N-CA-C 108.399 -0.963 . . . . 7.89 108.399 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -54.35 -54.82 29.91 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 108.789 -1.724 . . . . 5.58 108.789 165.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.25 -176.82 4.62 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.691 1.596 . . . . 5.33 107.247 156.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.38 141.62 12.7 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 109.08 -1.608 . . . . 1.64 109.08 175.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 p -86.96 148.82 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 O-C-N 122.162 -0.61 . . . . 2.05 110.152 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 50.2 tp -151.43 159.63 44.12 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.077 -1.083 . . . . 3.13 108.077 162.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 tm-20 -141.65 117.29 10.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 106.43 -1.693 . . . . 4.15 106.43 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.6 mt -118.58 142.43 47.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.33 1.452 . . . . 2.98 107.184 -177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.48 129.69 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.098 -1.816 . . . . 1.14 106.098 163.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.2 t -117.79 102.85 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 126.099 1.76 . . . . 1.96 106.964 -175.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -96.08 134.57 38.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 125.653 1.581 . . . . 6.87 108.134 -172.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 107.43 -9.41 38.47 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.307 0.956 . . . . 1.06 112.455 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 33.4 ttp -70.08 69.76 0.35 Allowed 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.252 1.821 . . . . 1.77 109.831 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 t -79.42 -2.59 42.58 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.281 1.585 . . . . 1.63 115.281 -159.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -159.62 164.48 34.09 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.052 1.296 . . . . 1.22 110.892 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.61 -39.81 51.08 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.326 1.05 . . . . 0.7 110.306 173.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 m -46.59 -43.97 17.74 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.16 1.384 . . . . 1.59 111.676 171.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . 0.258 73.5 m -72.61 -48.19 41.61 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 118.408 -0.806 . . . . 1.08 113.159 173.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.9 t -41.83 -66.31 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.514 0.726 . . . . 0.95 110.65 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.91 -31.07 67.59 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 119.906 -0.717 . . . . 0.79 112.436 -172.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -58.03 -54.4 47.36 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.703 0.683 . . . . 3.4 109.436 173.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.5 mt -50.61 -61.57 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 108.445 -0.946 . . . . 0.69 108.445 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -55.37 -55.88 26.52 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.066 0.46 . . . . 3.24 111.766 -173.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -54.03 -43.77 70.42 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.023 0.929 . . . . 0.79 110.443 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.2 t -68.07 -55.25 13.21 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 108.177 -1.046 . . . . 1.22 108.177 -176.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -57.87 -43.35 85.93 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.052 -0.405 . . . . 2.72 111.884 -175.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 53.9 m -57.24 -16.91 9.45 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.238 0.459 . . . . 1.91 112.238 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.35 -41.66 63.24 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.134 -0.979 . . . . 6.04 111.187 168.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -86.87 109.04 19.04 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.82 -0.807 . . . . 2.21 108.82 -173.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 36.3 mtm105 -52.76 -21.8 4.54 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 113.584 0.957 . . . . 6.89 113.584 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -52.19 -37.07 46.02 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-O 119.385 -0.675 . . . . 0.88 112.081 173.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.5 129.28 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 107.959 -1.126 . . . . 2.52 107.959 170.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.38 -44.85 8.48 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.607 -0.886 . . . . 3.84 108.607 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -142.09 144.18 33.42 Favored 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 109.562 -0.533 . . . . 2.07 109.562 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 25.5 p -131.08 144.43 51.42 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 126.333 1.853 . . . . 2.3 106.767 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.0 t -152.11 83.35 1.26 Allowed 'General case' 0 C--O 1.241 0.641 0 N-CA-C 107.772 -1.195 . . . . 1.55 107.772 -166.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 m -101.85 153.38 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 123.868 0.867 . . . . 1.6 111.077 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.36 136.16 13.58 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.478 -0.564 . . . . 0.93 109.478 173.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -81.42 -11.42 59.26 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.459 1.104 . . . . 1.35 112.697 175.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.07 -49.51 77.07 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.158 -0.682 . . . . 1.14 109.158 173.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -86.01 -40.33 15.92 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.154 0.582 . . . . 2.59 109.597 171.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.9 m-80 80.89 61.79 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 127.25 2.22 . . . . 2.66 107.415 -169.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.32 166.31 25.11 Favored 'General case' 0 CA--C 1.509 -0.605 0 C-N-CA 123.065 0.546 . . . . 2.29 110.187 -175.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -131.24 110.6 11.23 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 127.288 2.235 . . . . 0.63 106.862 163.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -86.3 134.9 33.71 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.301 -2.111 . . . . 0.91 105.301 162.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.8 pt -139.18 151.63 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 C-N-CA 124.682 1.193 . . . . 3.4 107.82 -172.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -139.28 99.84 3.85 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 102.591 -3.115 . . . . 2.95 102.591 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -145.11 142.24 29.5 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.221 1.409 . . . . 2.02 108.801 -162.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -80.3 119.69 77.19 Favored Pre-proline 0 CA--C 1.533 0.298 0 N-CA-C 108.848 -0.797 . . . . 2.82 108.848 175.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.63 -32.8 47.25 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.47 1.447 . . . . 2.03 111.909 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.2 44.67 0.42 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.914 0.779 . . . . 3.72 112.42 -175.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 tp -172.49 -38.34 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.886 1.674 . . . . 3.44 110.25 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 tt -138.05 118.63 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 107.318 -1.364 . . . . 1.6 107.318 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.29 156.28 53.31 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.196 -1.562 . . . . 0.83 109.196 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -53.88 -45.39 41.37 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.527 1.484 . . . . 1.29 109.197 171.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -50.96 -37.73 46.38 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 112.268 0.47 . . . . 6.89 112.268 174.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -70.15 -40.37 74.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.099 0.863 . . . . 2.73 109.522 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.8 mt -57.98 -46.77 87.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 118.841 -0.599 . . . . 0.73 109.933 170.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.7 mm -51.73 -57.73 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.825 0.739 . . . . 1.83 110.081 173.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.1 m170 -50.14 -43.34 51.95 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.285 1.034 . . . . 4.03 110.541 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.9 m -64.48 -49.6 70.75 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.756 -0.461 . . . . 1.12 109.756 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.555 HG21 ' HB2' ' A' ' 69' ' ' ALA . 1.1 mt -53.69 -47.32 61.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.261 0.624 . . . . 1.27 111.324 176.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -58.27 -51.91 67.81 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.169 0.588 . . . . 2.23 109.7 176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.8 t -52.16 -48.25 65.04 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.768 0.827 . . . . 1.18 110.905 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -62.4 -60.01 4.17 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.939 -0.476 . . . . 2.17 111.032 175.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.66 -42.02 0.02 OUTLIER Glycine 0 CA--C 1.529 0.966 0 N-CA-C 116.091 1.196 . . . . 1.7 116.091 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -118.01 164.85 14.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 117.642 0.721 . . . . 1.73 112.769 -136.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -97.81 98.92 10.25 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.983 -1.488 . . . . 4.47 106.983 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.555 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -83.32 139.95 32.74 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.811 -0.44 . . . . 1.27 109.811 169.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.0 t -144.21 128.94 18.27 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.596 -1.631 . . . . 2.06 106.596 -176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -60.97 161.91 7.7 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 119.675 -0.81 . . . . 3.56 109.148 159.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.5 p -159.89 95.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 106.454 -1.684 . . . . 2.78 106.454 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -147.26 -64.58 0.27 Allowed 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 105.397 -2.075 . . . . 4.99 105.397 173.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.6 tp -73.16 150.47 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.688 -1.597 . . . . 7.31 106.688 144.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 C--O 1.256 1.404 0 N-CA-C 103.989 -2.597 . . . . 11.94 103.989 159.18 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.0 mtp . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 107.836 -1.172 . . . . 10.92 107.836 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.12 32.82 77.21 Favored Glycine 0 CA--C 1.533 1.166 0 N-CA-C 109.323 -1.511 . . . . 3.76 109.323 -160.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.99 123.04 18.75 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.18 1.392 . . . . 4.94 109.535 -176.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.64 107.94 2.24 Favored Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 108.269 -1.932 . . . . 1.69 108.269 174.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 p -78.66 120.75 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.432 -1.321 . . . . 2.03 107.432 168.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.16 112.85 12.08 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.019 -1.104 . . . . 3.05 108.019 -172.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -88.01 113.21 23.43 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 107.76 -1.2 . . . . 3.5 107.76 169.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -101.24 150.46 22.94 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.686 -0.857 . . . . 2.5 108.686 166.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 t -81.82 139.82 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 105.107 -2.183 . . . . 0.87 105.107 151.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 p -129.65 133.04 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 106.377 -1.712 . . . . 2.27 106.377 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 mtp85 -129.09 158.68 38.26 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.697 0.799 . . . . 6.0 109.411 -176.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.92 -18.91 55.72 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.727 0.68 . . . . 1.13 112.055 -174.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -74.57 69.48 1.72 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.198 0.999 . . . . 1.4 111.229 -176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.1 t -62.05 -17.23 56.75 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 116.028 1.862 . . . . 1.52 116.028 -162.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.5 p -160.74 -179.92 8.0 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 121.306 1.866 . . . . 0.66 112.502 -172.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.5 -44.19 35.74 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.714 1.206 . . . . 0.62 111.413 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.6 m -63.99 -22.71 67.04 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.814 0.845 . . . . 1.48 112.322 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.3 m -73.64 -64.18 1.05 Allowed 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.524 -0.735 . . . . 0.69 110.733 161.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.7 t -38.08 -64.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 124.945 1.298 . . . . 0.93 112.12 -175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.11 -29.39 70.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.621 -0.431 . . . . 0.99 111.194 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 ttpm? -70.67 -46.55 62.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.682 -0.859 . . . . 3.22 108.682 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.3 mt -54.85 -58.32 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 108.702 -0.851 . . . . 0.82 108.702 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -59.29 -53.71 55.15 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.642 0.258 . . . . 3.51 111.477 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.5 t -53.86 -45.6 71.04 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.975 -0.453 . . . . 0.76 110.629 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.3 t -66.07 -50.85 62.69 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.955 -1.128 . . . . 1.19 107.955 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 21.0 mt -48.57 -51.68 26.59 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.915 0.486 . . . . 2.88 111.376 176.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.4 p -57.81 -14.43 5.92 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.609 0.966 . . . . 2.25 113.609 -178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.83 -28.37 68.3 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.415 1.007 . . . . 4.22 112.39 174.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -90.37 104.97 17.49 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 107.755 -1.202 . . . . 1.73 107.755 178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -26.25 9.43 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.28 -0.888 . . . . 8.91 111.669 172.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -48.89 -40.64 27.24 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 119.103 -0.832 . . . . 0.9 112.811 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.83 123.3 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.513 -1.662 . . . . 2.43 106.513 171.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.3 tp -79.93 -38.05 33.26 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.574 1.15 . . . . 3.27 109.163 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -151.32 154.29 36.45 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 109.651 -0.5 . . . . 1.84 109.651 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.4 p -133.96 147.7 51.07 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 125.184 1.394 . . . . 2.53 108.827 169.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.4 t -155.02 99.64 2.12 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.695 1.598 . . . . 1.51 107.097 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.5 m -91.82 167.87 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 122.627 0.371 . . . . 1.68 110.405 174.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.5 131.68 10.17 Favored 'General case' 0 CA--C 1.516 -0.357 0 O-C-N 121.879 -0.513 . . . . 0.8 110.866 165.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.8 mt -49.8 -50.8 43.58 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 124.488 1.115 . . . . 2.02 108.684 159.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.64 -53.6 17.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.802 0.841 . . . . 1.58 112.113 -170.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.52 -2.42 54.37 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.037 0.935 . . . . 2.02 111.996 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m120 50.02 39.69 19.54 Favored 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 125.047 1.339 . . . . 1.98 110.33 -166.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.61 170.38 8.36 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 120.983 0.42 . . . . 2.53 111.257 -167.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -151.31 97.07 2.37 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 126.64 1.976 . . . . 0.67 108.113 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -79.48 106.09 11.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.708 -2.33 . . . . 1.34 104.708 165.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.77 145.52 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 105.256 -2.127 . . . . 1.58 105.256 163.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.2 mtmt -114.52 129.41 56.66 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.937 -1.875 . . . . 2.87 105.937 158.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -138.03 144.6 41.1 Favored 'General case' 0 C--N 1.338 0.089 0 CA-C-N 118.745 0.702 . . . . 2.53 111.607 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -75.44 117.82 66.17 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 107.36 -1.348 . . . . 3.83 107.36 174.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -80.67 56.36 6.05 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 124.202 3.268 . . . . 2.07 112.014 -165.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -145.61 -53.74 0.28 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.536 1.934 . . . . 3.69 107.55 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.8 mt -74.43 -33.26 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 124.411 1.084 . . . . 2.74 110.738 -172.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.6 tt -147.39 138.37 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.432 -1.322 . . . . 1.71 107.432 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -94.45 168.23 27.97 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 124.359 0.981 . . . . 0.86 111.66 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.08 -43.45 15.24 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.788 2.325 . . . . 1.01 109.534 175.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -54.29 -44.19 71.72 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 122.479 0.312 . . . . 6.13 110.405 173.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -63.98 -47.21 81.29 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.343 -0.614 . . . . 2.65 109.343 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.9 mt -52.79 -52.48 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 O-C-N 122.015 -0.428 . . . . 0.69 110.153 173.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.4 mt -54.25 -53.31 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 O-C-N 122.053 -0.404 . . . . 1.2 110.177 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.4 -32.76 67.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.219 0.608 . . . . 4.48 111.265 177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.5 m -65.2 -49.47 69.61 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.067 -1.021 . . . . 1.07 108.45 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 74.0 mt -54.62 -41.41 55.25 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.703 0.801 . . . . 1.33 110.692 176.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -57.62 -54.98 40.76 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.207 0.458 . . . . 2.3 110.364 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.5 m -57.53 -29.16 64.13 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 124.231 1.012 . . . . 2.22 112.465 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 9.7 mp -65.7 -89.42 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.882 -0.785 . . . . 2.4 108.882 166.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.47 25.0 0.24 Allowed Glycine 0 CA--C 1.525 0.7 0 CA-C-O 118.517 -1.157 . . . . 0.89 113.955 172.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -131.75 175.57 9.07 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-N 119.011 1.406 . . . . 2.19 112.596 -153.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -112.58 149.7 32.39 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 106.299 -1.741 . . . . 3.78 106.299 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.18 161.49 41.19 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.989 0.813 . . . . 1.25 111.68 166.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.0 t -151.75 149.32 28.92 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 106.543 -1.651 . . . . 3.33 106.543 174.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -53.46 144.43 16.95 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.95 -0.759 . . . . 2.77 108.95 162.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.6 p -125.92 130.74 72.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 N-CA-C 109.646 -0.501 . . . . 3.42 109.646 176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.73 -50.32 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.235 1.014 . . . . 4.32 108.838 174.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.4 mt -81.88 104.87 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.063 -1.458 . . . . 6.53 107.063 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 C--O 1.255 1.356 0 N-CA-C 104.84 -2.281 . . . . 11.35 104.84 172.692 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.404 ' H2 ' ' CG ' ' A' ' 3' ' ' ASP . 56.6 mtt . . . . . 0 N--CA 1.473 0.675 0 N-CA-C 106.694 -1.595 . . . . 8.84 106.694 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.98 21.71 73.63 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 123.652 0.595 . . . . 3.57 111.76 -171.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.404 ' CG ' ' H2 ' ' A' ' 1' ' ' MET . 0.0 OUTLIER -85.34 65.72 9.34 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 121.447 -1.031 . . . . 6.07 108.844 -170.012 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.98 113.21 5.66 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 109.567 -1.413 . . . . 1.57 109.567 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.08 141.8 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 107.97 -1.122 . . . . 2.12 107.97 173.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -150.8 148.54 28.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.277 -0.638 . . . . 2.67 109.277 164.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -93.48 127.3 39.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 106.077 -1.823 . . . . 3.16 106.077 152.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.416 HD11 ' HB3' ' A' ' 44' ' ' ALA . 4.1 pp -107.32 151.18 25.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 107.384 -1.339 . . . . 2.54 107.384 164.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.61 143.93 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 104.831 -2.285 . . . . 1.28 104.831 161.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.1 p -141.78 133.51 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 124.007 0.923 . . . . 2.26 108.545 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -134.87 165.53 25.1 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.22 1.408 . . . . 7.1 109.065 -172.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.09 -39.38 2.78 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.12 0.867 . . . . 1.48 111.378 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.407 ' SD ' HD12 ' A' ' 22' ' ' ILE . 13.0 ptt? -67.34 65.27 0.07 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.4 1.48 . . . . 1.92 112.88 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -71.62 19.1 0.07 Allowed 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.117 1.525 . . . . 1.77 115.117 -165.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -166.57 158.57 13.49 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.589 1.086 . . . . 1.14 110.187 177.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.24 -37.41 35.5 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.152 0.981 . . . . 0.91 111.12 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.7 p -58.16 -33.21 68.96 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.727 0.411 . . . . 1.89 111.425 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . 0.259 72.6 m -75.77 -44.71 40.21 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 120.819 -1.176 . . . . 1.61 113.676 168.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.7 t -50.01 -60.03 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.168 0.44 . . . . 0.92 110.738 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.6 -25.44 63.05 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.445 -0.784 . . . . 1.07 112.159 -176.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.16 -51.86 67.26 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 108.562 -0.903 . . . . 3.81 108.562 173.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.407 HD12 ' SD ' ' A' ' 13' ' ' MET . 64.3 mt -52.58 -60.8 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.209 0 N-CA-C 108.447 -0.946 . . . . 0.79 108.447 172.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -53.09 -56.45 16.16 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.336 0.589 . . . . 3.27 110.605 -170.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.1 t -56.09 -48.37 76.25 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.916 1.286 . . . . 0.84 111.103 178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.8 t -64.64 -57.82 8.01 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.04 -0.726 . . . . 1.29 109.04 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 51.3 tp -54.21 -49.12 70.13 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.336 1.454 . . . . 2.46 111.111 -176.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.5 p -59.47 -12.76 6.75 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.601 0.963 . . . . 2.24 113.601 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.11 -24.88 66.77 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.889 1.222 . . . . 4.82 112.322 175.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -80.67 130.77 35.29 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.44 0.564 . . . . 2.33 109.653 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -58.31 151.85 18.72 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.461 -0.94 . . . . 6.39 108.461 169.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.24 -27.82 15.44 Favored Glycine 0 C--O 1.224 -0.495 0 N-CA-C 111.035 -0.826 . . . . 1.02 111.035 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.1 mm -79.22 121.19 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 CA-C-N 119.138 1.469 . . . . 4.08 107.217 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.3 mt -94.99 -44.59 7.63 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.125 -0.695 . . . . 1.87 109.125 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -153.49 153.63 32.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.199 -0.667 . . . . 2.52 109.199 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.5 m -138.75 132.97 31.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 105.481 -2.044 . . . . 2.29 105.481 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 t -134.87 89.67 2.56 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 105.88 -1.896 . . . . 1.93 105.88 166.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 p -97.94 137.61 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.309 1.043 . . . . 2.39 111.156 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 134.07 21.56 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.811 0.845 . . . . 0.87 111.091 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 pp -72.05 -34.38 68.71 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 124.661 1.185 . . . . 2.03 110.672 170.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.64 -32.47 42.11 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.648 0.779 . . . . 1.34 111.674 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -120.55 11.79 11.4 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.801 1.24 . . . . 2.56 111.496 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.0 m120 35.32 52.08 0.65 Allowed 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 125.887 1.675 . . . . 2.12 112.778 -175.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.23 151.97 40.18 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.117 -0.698 . . . . 3.47 109.117 -171.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.416 ' HB3' HD11 ' A' ' 8' ' ' LEU . . . -133.97 118.26 17.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.758 -0.83 . . . . 0.66 108.758 170.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -84.76 106.16 16.09 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.135 -1.802 . . . . 1.02 106.135 170.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.2 mp -106.95 136.3 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.792 -1.558 . . . . 1.73 106.792 173.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -116.09 140.2 49.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.458 -1.682 . . . . 2.93 106.458 163.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -158.69 161.04 37.06 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.724 0.81 . . . . 1.71 110.013 -167.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -87.78 110.94 38.86 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 107.122 -1.436 . . . . 4.04 107.122 173.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -81.23 59.23 7.3 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.088 3.192 . . . . 2.04 110.799 -168.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -167.26 -46.72 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.53 1.532 . . . . 2.9 108.857 -173.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.2 mm -65.96 -39.18 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 109.517 -0.549 . . . . 2.51 109.517 170.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.07 154.73 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 105.835 -1.913 . . . . 1.29 105.835 -175.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -116.77 174.22 15.11 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.875 1.226 . . . . 1.06 112.145 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.15 -39.38 31.31 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.231 2.621 . . . . 1.07 110.413 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -47.57 -56.65 6.69 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 123.804 0.842 . . . . 7.27 110.368 170.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.0 -54.85 29.11 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.716 -0.475 . . . . 2.28 109.716 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.3 mt -52.69 -60.16 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.059 0.544 . . . . 0.79 111.149 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.8 mt -52.11 -51.79 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 C-N-CA 123.715 0.806 . . . . 1.2 110.133 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -68.08 -33.33 74.34 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.215 -0.448 . . . . 4.25 111.07 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.9 m -60.88 -46.62 89.9 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 108.091 -1.077 . . . . 0.77 108.091 176.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.505 HG21 ' HB2' ' A' ' 69' ' ' ALA . 19.2 mt -56.25 -58.15 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.263 -0.643 . . . . 1.31 109.263 173.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -53.99 -43.77 70.3 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.913 0.387 . . . . 2.35 110.356 -168.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.5 m -62.74 -15.62 53.99 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.356 1.462 . . . . 2.53 114.125 -172.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -68.97 -83.27 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.885 -1.154 . . . . 3.02 107.885 170.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.03 42.62 0.48 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 109.476 -1.449 . . . . 1.25 109.476 166.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -126.88 176.65 7.14 Favored 'General case' 0 CA--C 1.524 -0.04 0 CA-C-N 117.311 0.555 . . . . 2.18 111.328 -159.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -121.36 145.52 47.81 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 104.923 -2.251 . . . . 4.82 104.923 170.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.505 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -149.44 146.0 27.21 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 123.688 0.617 . . . . 1.93 111.036 165.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t -155.57 131.0 9.63 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.831 -0.433 . . . . 3.07 109.831 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -53.73 140.38 29.79 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.165 0.986 . . . . 2.36 111.627 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.84 154.36 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 123.363 0.665 . . . . 3.28 110.002 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -167.35 173.04 9.19 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 105.744 -1.947 . . . . 5.98 105.744 175.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.6 pp -137.0 170.04 18.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.851 -1.537 . . . . 6.92 106.851 166.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 . . . . . 0 C--O 1.256 1.438 0 N-CA-C 104.445 -2.428 . . . . 9.31 104.445 170.703 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 107.388 -1.338 . . . . 8.62 107.388 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.4 112.6 1.99 Allowed Glycine 0 CA--C 1.526 0.727 1 N-CA-C 102.66 -4.176 . . . . 4.45 102.66 -135.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 148.07 177.67 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 128.552 2.741 . . . . 5.26 107.609 -145.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.81 175.02 35.18 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.932 -1.267 . . . . 2.1 109.932 175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.31 130.6 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 107.028 -1.471 . . . . 2.34 107.028 170.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.3 tp -124.65 139.62 53.7 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.025 -1.472 . . . . 2.53 107.025 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.41 143.24 48.77 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.64 -1.244 . . . . 4.39 107.64 176.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.47 HD23 ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -156.78 150.09 24.22 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.122 0.969 . . . . 2.8 108.931 176.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.35 112.35 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 N-CA-C 104.186 -2.524 . . . . 0.97 104.186 169.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.82 142.73 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.158 -1.423 . . . . 2.66 107.158 162.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -131.84 166.05 22.47 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.254 -0.647 . . . . 6.1 109.254 167.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.63 -38.72 3.18 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 121.757 -0.59 . . . . 1.13 112.252 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.04 77.36 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.418 1.487 . . . . 2.99 111.93 176.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.4 t -74.52 -16.95 60.82 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 115.069 1.507 . . . . 1.58 115.069 -161.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.2 p -158.36 176.44 12.45 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 120.605 1.548 . . . . 0.65 111.747 -172.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.62 -46.15 9.96 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.288 1.435 . . . . 0.61 111.464 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 m -61.98 -30.67 71.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.679 0.792 . . . . 1.53 112.271 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.3 m -72.88 -56.69 4.83 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.862 0.756 . . . . 0.64 110.333 166.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.4 t -42.8 -61.71 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.593 1.157 . . . . 0.81 111.39 -176.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.99 -28.26 67.28 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 120.046 -0.662 . . . . 0.83 111.692 -174.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -64.86 -48.53 73.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.301 -0.999 . . . . 2.84 108.301 176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.7 mt -53.98 -63.48 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 108.64 -0.874 . . . . 0.69 108.64 173.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -52.95 -50.43 64.06 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.174 0.443 . . . . 3.83 111.729 -173.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.0 t -55.97 -46.79 78.51 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.4 1.08 . . . . 0.76 111.317 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.2 p -69.02 -37.43 78.65 Favored 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.695 -0.628 . . . . 2.31 110.098 -173.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.7 mp -72.2 -48.25 44.48 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.748 1.219 . . . . 2.63 111.631 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.0 t -71.88 65.36 0.53 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 123.325 1.536 . . . . 2.66 112.027 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.61 -23.4 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 128.635 2.774 . . . . 4.75 111.935 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -60.51 -14.38 19.36 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.169 1.174 . . . . 2.95 114.169 176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? 70.83 -54.35 0.66 Allowed 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.402 1.881 . . . . 6.14 110.843 -171.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.94 -32.14 55.84 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 117.953 0.342 . . . . 1.14 112.32 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 38.5 mt -79.37 104.88 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 107.23 -1.396 . . . . 4.15 107.23 167.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 52.2 mt -78.98 -28.12 43.49 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.152 0.581 . . . . 1.71 109.648 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -156.71 157.2 34.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.414 -0.958 . . . . 2.04 108.414 175.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.6 p -138.59 140.28 38.93 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.024 1.73 . . . . 2.6 107.136 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.9 t -146.99 101.3 3.41 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 106.836 -1.542 . . . . 1.54 106.836 169.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.439 HG23 ' HB2' ' A' ' 44' ' ' ALA . 2.2 p -100.72 152.78 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 124.294 1.038 . . . . 2.75 109.848 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.05 127.51 7.89 Favored 'General case' 0 CA--C 1.518 -0.273 0 O-C-N 121.66 -0.65 . . . . 0.76 111.328 170.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.48 -28.69 68.07 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.419 0.687 . . . . 1.7 110.714 162.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.44 -49.77 69.23 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 120.97 0.414 . . . . 1.19 110.001 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.36 -35.11 25.38 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.17 0.588 . . . . 2.08 111.096 173.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.26 76.04 0.36 Allowed 'General case' 0 C--N 1.344 0.339 0 N-CA-C 106.926 -1.509 . . . . 2.03 106.926 -151.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.62 163.13 39.26 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.02 0.528 . . . . 2.63 109.89 177.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.457 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -146.15 94.12 2.42 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.889 1.276 . . . . 0.78 109.916 169.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -77.99 104.19 8.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 105.967 -1.864 . . . . 1.02 105.967 172.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.457 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -106.69 115.61 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 105.923 -1.88 . . . . 1.78 105.923 174.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -82.03 75.46 8.96 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 107.793 -1.188 . . . . 3.63 107.793 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.67 161.44 23.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.055 -0.521 . . . . 2.9 110.794 170.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -104.85 133.49 20.13 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 107.227 -1.397 . . . . 3.22 107.227 142.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -64.57 -31.79 59.65 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 123.138 2.558 . . . . 2.14 114.472 -171.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -81.19 -43.37 19.4 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 120.473 1.488 . . . . 2.97 110.251 -174.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 tp -73.42 -26.19 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 118.85 -0.595 . . . . 2.73 111.459 178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.1 tt -148.09 124.27 2.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 CA-C-N 120.171 1.351 . . . . 1.61 109.96 167.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.08 159.56 49.24 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 109.67 -1.372 . . . . 0.89 109.67 177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -58.85 -39.89 77.21 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.087 1.858 . . . . 1.08 109.247 175.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -41.65 -48.55 4.12 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 125.214 1.406 . . . . 8.98 111.007 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -72.31 -45.11 61.4 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.0 0.92 . . . . 2.31 109.539 -169.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.2 mt -54.04 -50.55 53.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 109.037 -0.727 . . . . 0.62 109.037 172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.4 mt -55.48 -52.42 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 119.582 -0.247 . . . . 1.11 110.467 176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.8 m170 -52.25 -39.67 60.65 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.476 0.71 . . . . 3.44 110.861 177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 31.1 m -64.83 -50.46 66.57 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.238 -0.652 . . . . 0.71 109.238 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 62.4 mt -55.06 -48.26 76.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.21 1.004 . . . . 1.26 110.579 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -56.32 -57.12 13.6 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.59 0.756 . . . . 2.14 110.492 173.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.8 t -51.02 -43.6 60.88 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.813 1.245 . . . . 1.5 110.895 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.63 -73.7 0.08 Allowed 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 122.359 -0.213 . . . . 2.17 110.44 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.41 -5.52 0.05 OUTLIER Glycine 0 CA--C 1.529 0.948 0 N-CA-C 117.41 1.724 . . . . 1.18 117.41 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -131.33 172.21 12.44 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.758 1.779 . . . . 1.74 112.999 -137.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -95.48 150.27 20.49 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.834 -1.543 . . . . 4.8 106.834 177.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.47 ' HB1' HD23 ' A' ' 8' ' ' LEU . . . -149.7 124.88 10.09 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.898 0.38 . . . . 1.54 111.457 162.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.5 p -129.14 122.45 29.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.964 1.305 . . . . 2.12 109.18 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 pp -55.28 -41.86 72.83 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 113.631 0.974 . . . . 3.02 113.631 -172.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.9 t 64.38 -73.52 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 124.866 1.266 . . . . 3.44 111.177 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.1 tptm 45.11 53.25 7.96 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.338 1.855 . . . . 3.76 112.225 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.96 118.31 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.893 -1.892 . . . . 6.36 105.893 165.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 C--O 1.249 1.06 0 N-CA-C 104.289 -2.486 . . . . 8.99 104.289 -164.793 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptp . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 114.595 1.331 . . . . 10.17 114.595 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 124.29 173.78 13.93 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 120.451 1.478 . . . . 4.15 112.671 174.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -17.0 -66.38 0.01 OUTLIER 'General case' 0 C--N 1.339 0.147 0 C-N-CA 129.774 3.23 . . . . 4.97 117.187 -172.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 50.96 71.47 0.64 Allowed Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.733 -0.947 . . . . 1.5 110.733 -167.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -78.26 97.16 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.845 0.858 . . . . 2.09 108.973 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -107.03 155.67 19.57 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.937 0.875 . . . . 4.34 109.071 171.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -146.23 136.75 24.02 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 105.846 -1.909 . . . . 4.32 105.846 -177.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 pp -152.61 148.66 27.59 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.601 1.161 . . . . 2.01 109.217 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -75.89 125.62 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 105.569 -2.012 . . . . 0.77 105.569 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.9 t -104.71 138.03 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 N-CA-C 106.356 -1.72 . . . . 1.74 106.356 168.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -143.16 175.3 9.98 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.777 1.631 . . . . 5.02 108.55 -177.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.43 -50.17 4.3 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.186 -1.166 . . . . 1.64 110.186 -172.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -50.33 126.66 15.48 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.034 0.534 . . . . 1.91 111.556 175.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 p -88.68 -41.37 12.64 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.971 0.73 . . . . 3.09 112.971 -168.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.4 p -152.41 177.06 11.0 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.843 0.747 . . . . 0.69 112.543 -161.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.0 -42.09 17.44 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.876 1.27 . . . . 0.73 111.585 175.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.0 t -60.56 -34.39 74.09 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.507 0.723 . . . . 1.86 110.912 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.2 m -71.53 -54.97 8.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.375 0.534 . . . . 0.67 109.85 169.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 37' ' ' VAL . 49.1 t -45.8 -62.35 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 123.592 0.757 . . . . 0.8 111.45 -175.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.7 -27.0 66.45 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 120.046 -0.661 . . . . 0.96 111.632 -174.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -68.06 -48.89 64.36 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.744 0.818 . . . . 2.85 109.224 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.7 mt -53.8 -58.72 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 N-CA-C 107.899 -1.148 . . . . 0.86 107.899 173.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -51.46 -53.82 33.19 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.369 0.604 . . . . 3.58 110.412 -176.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.2 t -57.76 -37.72 74.13 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.641 1.176 . . . . 0.82 111.754 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.9 t -71.46 -40.78 70.11 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.788 0.835 . . . . 1.17 110.67 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.5 mp -66.86 -51.78 51.42 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.457 1.103 . . . . 2.44 109.26 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.1 t -71.71 60.95 0.37 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 122.258 1.028 . . . . 2.76 110.734 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.05 -48.1 0.32 Allowed 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 128.895 2.878 . . . . 6.83 108.045 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.9 m-70 -69.99 26.2 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 115.281 1.586 . . . . 3.19 115.281 -165.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 66.2 mtp85 66.02 -60.75 0.29 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.651 2.38 . . . . 6.15 114.177 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -65.47 -15.92 62.21 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.715 -0.492 . . . . 1.04 113.23 -177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 28.2 mm -79.43 105.42 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.901 1.28 . . . . 4.3 107.734 176.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -78.73 -38.97 37.57 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.308 -0.627 . . . . 3.1 109.308 178.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -152.41 152.08 31.58 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 108.996 -0.742 . . . . 2.11 108.996 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.0 t -136.26 132.34 35.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.804 1.642 . . . . 2.11 106.586 174.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.1 t -134.85 103.73 5.72 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.927 -1.509 . . . . 1.47 106.927 165.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.444 HG13 HG13 ' A' ' 19' ' ' VAL . 8.8 p -104.23 147.84 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.824 1.25 . . . . 2.68 109.82 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.35 142.32 19.14 Favored 'General case' 0 CA--C 1.521 -0.161 0 O-C-N 121.401 -0.812 . . . . 0.94 110.868 175.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -83.82 -38.09 21.68 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 123.952 0.901 . . . . 2.0 109.753 170.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.24 -35.86 60.43 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 123.458 0.703 . . . . 1.45 110.755 -177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -117.54 16.47 14.61 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.62 1.168 . . . . 2.75 110.35 -178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.4 m120 23.23 70.83 0.03 OUTLIER 'General case' 0 C--N 1.343 0.325 0 C-N-CA 126.646 1.978 . . . . 1.78 112.737 -173.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.35 166.59 26.67 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.576 0.35 . . . . 2.87 110.342 -172.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -152.99 92.91 1.68 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.365 1.466 . . . . 0.91 109.343 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -78.33 108.27 11.55 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.738 -2.319 . . . . 1.51 104.738 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.0 mp -110.92 127.14 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 106.662 -1.607 . . . . 1.58 106.662 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -92.44 104.66 16.96 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 104.869 -2.271 . . . . 2.32 104.869 160.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -122.05 134.6 54.78 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 118.592 0.633 . . . . 1.99 109.344 175.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -72.63 117.68 61.32 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 120.167 -0.613 . . . . 3.01 109.37 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -81.76 64.56 8.55 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.05 2.5 . . . . 2.37 112.471 -163.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -158.38 -52.66 0.07 Allowed 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.526 1.13 . . . . 2.95 109.035 168.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 tp -57.99 -35.16 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.788 1.235 . . . . 2.96 111.659 172.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.0 mm -139.17 139.32 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.748 -1.945 . . . . 1.39 105.748 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.57 167.9 15.01 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.3 1.428 . . . . 0.79 110.374 169.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -61.87 -41.95 34.28 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.534 2.156 . . . . 1.03 110.17 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.9 -35.95 25.54 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-O 118.119 -0.943 . . . . 5.73 112.127 174.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -68.64 -49.81 56.23 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 119.711 1.141 . . . . 2.08 110.147 -176.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.4 mt -53.74 -53.23 27.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.922 -0.77 . . . . 0.68 108.922 172.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.4 mt -53.52 -44.14 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 118.512 -0.756 . . . . 1.15 110.642 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -53.12 -38.42 62.64 Favored 'General case' 0 C--N 1.339 0.14 0 CA-C-N 119.275 0.943 . . . . 3.15 110.776 175.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.1 m -67.01 -53.44 31.32 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.004 0.82 . . . . 1.12 108.875 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mp -50.81 -51.81 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.339 0.656 . . . . 1.32 110.28 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -54.51 -51.58 64.68 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.839 1.256 . . . . 2.35 110.612 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.0 t -65.71 -20.05 66.13 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-O 118.009 -0.996 . . . . 1.43 112.866 -171.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.8 -101.55 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 119.551 1.069 . . . . 2.84 108.388 163.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.46 36.68 0.48 Allowed Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.411 -1.076 . . . . 1.13 110.411 173.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -126.74 154.62 43.94 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.819 -0.808 . . . . 2.37 108.819 -162.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -109.49 152.77 24.99 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.553 -0.906 . . . . 3.6 108.553 -176.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.09 148.45 50.57 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 125.563 1.545 . . . . 1.03 110.246 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.1 m -154.15 99.7 2.26 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.787 0.835 . . . . 1.86 110.402 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mt -54.98 126.31 24.02 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.075 -1.083 . . . . 3.33 108.075 164.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.26 144.5 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 105.13 -2.174 . . . . 3.0 105.13 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -125.86 -48.56 1.63 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.429 1.092 . . . . 4.48 110.166 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.465 HG23 ' H ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -147.76 -54.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 105.574 -2.01 . . . . 6.28 105.574 170.317 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.465 ' H ' HG23 ' A' ' 74' ' ' ILE . 49.3 mt-10 . . . . . 0 C--O 1.248 0.997 0 N-CA-C 106.184 -1.784 . . . . 11.54 106.184 142.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttm . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 119.333 -0.365 . . . . 8.01 110.648 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -145.55 58.24 0.51 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 106.523 -2.631 . . . . 3.36 106.523 174.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -134.26 125.75 28.39 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.501 -1.296 . . . . 5.16 107.501 -159.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.45 136.67 8.53 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 106.984 -2.446 . . . . 1.32 106.984 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.9 t -136.76 134.37 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 106.998 -1.482 . . . . 2.47 106.998 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 45.5 mt -135.19 117.13 15.24 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.324 -1.362 . . . . 2.53 107.324 171.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -79.42 89.38 5.01 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 105.918 -1.882 . . . . 3.52 105.918 155.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 68.2 mt -78.67 134.88 37.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.709 -1.589 . . . . 2.33 106.709 172.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.2 t -82.83 119.2 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 104.977 -2.231 . . . . 1.1 104.977 162.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -124.86 110.41 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 105.708 -1.96 . . . . 2.41 105.708 -175.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.6 mtp-105 -117.63 160.02 21.97 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 124.381 1.073 . . . . 5.97 109.768 -165.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.36 0.59 88.35 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 110.876 -0.889 . . . . 1.16 110.876 -163.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.6 ttm -69.44 68.2 0.22 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.534 1.534 . . . . 2.28 109.805 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -67.36 -31.55 71.89 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.465 0.542 . . . . 1.58 112.465 -166.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.6 p -155.04 174.94 14.47 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.993 0.815 . . . . 0.65 112.117 -170.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.02 -41.97 17.42 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.119 1.368 . . . . 0.92 111.786 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 m -54.2 -43.62 70.9 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 122.953 0.501 . . . . 1.4 110.894 176.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.3 m -66.12 -50.68 63.18 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.291 0.496 . . . . 0.73 109.96 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.2 t -46.19 -64.12 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.377 0.671 . . . . 1.1 110.378 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.17 -31.0 67.13 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 120.233 -0.587 . . . . 0.93 112.218 -174.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -51.85 67.72 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 118.701 0.682 . . . . 5.35 109.467 174.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.3 mt -56.01 -62.67 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 N-CA-C 108.099 -1.074 . . . . 0.89 108.099 177.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -49.33 -56.34 9.83 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 123.744 0.652 . . . . 3.89 110.167 -173.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 38.6 t -57.66 -48.64 78.93 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.959 0.504 . . . . 0.97 111.209 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.5 t -71.81 -22.9 61.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.759 -0.588 . . . . 1.49 110.78 -171.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.8 mp -73.65 -63.79 1.13 Allowed 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 121.349 -0.844 . . . . 2.54 110.569 163.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 84.8 m -54.63 -23.55 17.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.38 1.072 . . . . 2.3 113.1 -170.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -53.0 -34.95 58.68 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.072 1.138 . . . . 5.36 114.072 170.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -70.25 120.45 15.95 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.572 -0.899 . . . . 1.97 108.572 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -74.43 56.61 0.67 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 118.506 0.593 . . . . 7.02 110.66 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.08 42.33 0.44 Allowed Glycine 0 CA--C 1.522 0.474 0 N-CA-C 109.115 -1.594 . . . . 1.97 109.115 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.6 pp -147.51 163.47 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 127.057 2.143 . . . . 2.94 105.243 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -111.36 -43.01 3.77 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.785 0.834 . . . . 2.66 109.833 171.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -156.26 158.05 36.84 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.272 0.942 . . . . 1.88 110.9 -175.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.0 m -143.23 124.87 14.91 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.318 1.847 . . . . 2.43 106.368 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.54 106.3 6.94 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.975 0.91 . . . . 1.95 108.705 173.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.6 m -100.85 147.86 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 125.274 1.43 . . . . 2.6 110.727 -173.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.28 125.5 18.71 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.814 -0.81 . . . . 0.83 108.814 166.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.533 HD12 ' N ' ' A' ' 40' ' ' ALA . 1.4 pp -64.93 -37.34 87.33 Favored 'General case' 0 C--N 1.338 0.098 0 O-C-N 123.395 0.435 . . . . 1.6 110.436 168.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.533 ' N ' HD12 ' A' ' 39' ' ' LEU . . . -50.55 -49.77 55.2 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.458 1.103 . . . . 1.72 111.123 -174.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.5 8.5 33.44 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.256 0.622 . . . . 3.01 110.983 177.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.264 0.0 OUTLIER 47.12 61.22 2.98 Favored 'General case' 0 C--N 1.345 0.41 0 C-N-CA 126.355 1.862 . . . . 1.78 109.907 173.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.24 166.29 31.36 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.303 -0.862 . . . . 2.35 111.944 -173.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.05 110.24 6.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.014 2.526 . . . . 0.91 107.823 -178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -78.74 97.08 5.76 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 105.467 -2.049 . . . . 1.03 105.467 167.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 78.9 mt -104.22 138.91 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 107.001 -1.481 . . . . 1.71 107.001 177.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -127.44 135.99 51.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.904 -1.888 . . . . 3.31 105.904 175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -161.53 158.99 27.28 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.4 1.08 . . . . 2.41 108.149 -167.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -79.63 126.92 79.64 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 107.397 -1.334 . . . . 3.55 107.397 169.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -80.97 46.28 2.23 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.01 2.473 . . . . 2.04 109.801 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -137.45 -62.03 0.62 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.931 1.292 . . . . 4.08 108.181 -165.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 tt -74.13 -26.95 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 O-C-N 121.946 -0.471 . . . . 2.64 111.4 176.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.25 129.96 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 106.269 -1.752 . . . . 1.41 106.269 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.28 -179.53 53.06 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 110.498 -1.041 . . . . 1.22 110.498 169.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -70.66 -54.52 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.211 1.941 . . . . 1.3 111.347 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -67.09 -25.69 66.34 Favored 'General case' 0 C--O 1.221 -0.411 0 O-C-N 121.7 -0.625 . . . . 6.22 111.773 -172.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -42.77 -50.55 5.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.384 1.874 . . . . 2.97 110.744 172.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.9 mt -66.4 -52.16 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.082 -0.71 . . . . 0.66 109.082 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mt -53.68 -45.97 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 122.801 0.44 . . . . 1.17 110.656 -177.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -50.67 -41.3 55.44 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.636 1.174 . . . . 3.69 110.674 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.8 m -65.45 -48.51 72.44 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.169 -0.678 . . . . 0.91 109.169 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 mp -54.07 -55.82 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 123.045 0.538 . . . . 1.35 110.121 175.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -53.3 -53.52 49.67 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.149 0.98 . . . . 2.27 110.081 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 34.9 t -55.01 -40.36 70.07 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.014 1.326 . . . . 1.18 111.452 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 35.6 mt -60.02 -86.22 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 117.946 0.339 . . . . 2.25 111.593 178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.03 32.82 0.38 Allowed Glycine 0 CA--C 1.524 0.623 0 CA-C-O 118.653 -1.082 . . . . 0.96 113.118 176.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -133.06 163.34 29.47 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 118.715 1.257 . . . . 2.1 113.064 -158.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -97.21 144.86 26.61 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.219 2.208 . . . . 3.54 105.157 171.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.95 140.12 40.09 Favored 'General case' 0 CA--C 1.526 0.024 0 CA-C-N 118.772 0.715 . . . . 1.74 111.416 -168.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.6 p -155.76 175.44 13.93 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.235 1.014 . . . . 2.41 108.43 165.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.02 151.68 29.03 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 105.314 -2.106 . . . . 2.45 105.314 158.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.0 t -129.8 136.03 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 107.979 -1.119 . . . . 2.54 107.979 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -170.55 -179.26 2.9 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.236 1.814 . . . . 4.96 106.18 -177.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.0 tp -84.81 -66.04 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.259 0.624 . . . . 6.11 112.557 -173.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.253 1.258 0 C-N-CA 127.907 2.483 . . . . 9.23 113.919 -167.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 107.636 -1.246 . . . . 8.48 107.636 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.18 176.52 28.78 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 107.079 -2.409 . . . . 4.15 107.079 173.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -155.07 164.39 38.94 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.697 -1.594 . . . . 4.31 106.697 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.4 126.45 5.56 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.107 -1.197 . . . . 1.66 110.107 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 m -133.53 66.91 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 124.912 1.285 . . . . 2.8 108.696 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.33 79.63 4.76 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.037 -1.468 . . . . 2.73 107.037 -176.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -99.12 99.74 10.78 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 114.343 -1.299 . . . . 2.98 107.942 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.98 153.32 36.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.487 1.115 . . . . 2.69 109.164 -178.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.9 123.75 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 106.824 -1.547 . . . . 0.81 106.824 174.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.9 t -100.91 109.32 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 105.898 -1.89 . . . . 2.09 105.898 174.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -88.25 137.4 32.36 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.323 -0.991 . . . . 6.71 108.323 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.06 1.68 41.88 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.73 -1.039 . . . . 1.07 113.455 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 48.3 mtm -71.45 71.02 0.65 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 119.44 1.62 . . . . 1.52 110.406 175.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -71.72 -19.17 62.09 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.678 -1.154 . . . . 1.69 113.768 -168.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 p -162.7 173.41 13.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 120.152 1.342 . . . . 0.79 111.022 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.59 -39.41 35.24 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.223 1.009 . . . . 0.59 111.54 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.2 m -59.61 -30.49 68.72 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.406 0.682 . . . . 1.66 112.146 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.1 m -71.07 -55.38 8.35 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 118.834 0.743 . . . . 1.0 109.898 168.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.28 -59.95 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.918 0.887 . . . . 0.67 110.886 -173.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.66 -31.72 71.04 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.236 -0.586 . . . . 1.0 111.707 -174.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -60.41 -51.69 68.4 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 108.75 -0.833 . . . . 3.31 108.75 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.0 mt -53.1 -64.47 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.171 0 N-CA-C 108.63 -0.878 . . . . 0.73 108.63 174.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -49.46 -60.37 2.91 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 123.951 0.782 . . . . 3.8 110.031 -173.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.8 t -52.96 -48.4 67.42 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.87 0.868 . . . . 0.87 110.442 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 51.1 m -59.9 -54.69 43.21 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.125 -0.694 . . . . 2.22 109.125 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.64 -37.19 65.37 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.739 0.815 . . . . 2.42 111.858 -173.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.3 p -54.97 -26.52 37.22 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.592 0.96 . . . . 2.56 113.592 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -4.18 37.55 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.941 1.246 . . . . 4.89 113.457 177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -88.14 69.01 9.22 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 106.843 -1.54 . . . . 2.12 106.843 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -47.59 -16.14 0.06 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 118.017 2.599 . . . . 6.95 118.017 -161.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -77.07 -7.0 86.63 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-N 119.837 1.199 . . . . 1.08 113.114 172.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.16 137.32 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 107.442 -1.318 . . . . 2.41 107.442 168.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.5 mt -85.43 -39.76 17.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.267 1.027 . . . . 2.16 109.683 176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -157.05 153.32 27.72 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.627 -0.879 . . . . 2.34 108.627 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 51.5 t -127.98 146.72 50.57 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.622 -0.881 . . . . 2.26 108.622 166.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 m -148.26 107.89 3.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.873 0.869 . . . . 2.13 109.933 164.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.74 145.3 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 125.951 1.7 . . . . 1.99 110.394 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.14 120.75 10.44 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 124.02 0.928 . . . . 0.91 109.462 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 pp -81.65 -12.34 58.73 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.271 1.029 . . . . 1.5 113.392 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.36 -49.4 34.34 Favored 'General case' 0 C--O 1.224 -0.253 0 N-CA-C 108.134 -1.061 . . . . 1.46 108.134 172.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 m -79.47 -25.56 41.86 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.664 1.186 . . . . 1.69 111.221 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.8 m120 63.82 42.22 6.26 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 126.02 1.728 . . . . 1.48 109.666 -172.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.26 148.88 45.44 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 124.253 1.021 . . . . 2.79 108.319 -170.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.17 109.46 12.37 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.837 -1.171 . . . . 0.8 107.837 165.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -82.84 105.35 13.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.574 -1.639 . . . . 1.36 106.574 167.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.29 123.58 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.545 -1.65 . . . . 1.65 106.545 168.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -93.95 145.92 24.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.712 -1.218 . . . . 2.58 107.712 162.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -163.73 158.45 20.29 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.024 0.529 . . . . 1.74 110.304 -168.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -100.03 121.0 55.43 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 124.441 1.088 . . . . 3.4 108.098 170.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.57 -38.13 19.98 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.845 2.363 . . . . 2.04 112.898 -168.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -58.4 -40.54 82.68 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.978 0.511 . . . . 3.33 111.652 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 tp -81.67 -50.75 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 C-N-CA 123.104 0.562 . . . . 2.9 110.245 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.54 100.71 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 108.63 -0.878 . . . . 1.77 108.63 -173.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -63.9 140.6 44.14 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 108.763 -1.735 . . . . 1.41 108.763 168.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -56.93 -32.43 92.55 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.812 2.341 . . . . 1.26 112.005 -176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.491 HH11 ' CD2' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -58.36 -28.33 65.01 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 117.954 -1.022 . . . . 6.17 112.714 176.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.14 -55.69 23.08 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 120.431 1.469 . . . . 4.94 109.756 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.8 mt -51.74 -52.08 23.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 C-N-CA 123.455 0.702 . . . . 0.79 109.168 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 60.7 mt -57.65 -49.27 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 118.707 -0.663 . . . . 1.58 110.323 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.491 ' CD2' HH11 ' A' ' 56' ' ' ARG . 27.7 m80 -54.09 -41.1 67.85 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 119.225 0.92 . . . . 2.93 111.294 174.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 27.7 m -58.62 -54.85 42.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.449 -0.945 . . . . 0.85 108.449 -178.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -55.85 -55.46 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.598 0.759 . . . . 1.88 110.505 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -51.32 -59.4 4.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.57 0.748 . . . . 2.0 109.718 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.4 t -55.56 -48.4 74.83 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.572 1.149 . . . . 1.45 111.233 -176.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.7 mt -59.04 -51.41 70.15 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 112.835 0.68 . . . . 2.17 112.835 -172.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.69 1.61 0.06 OUTLIER Glycine 0 CA--C 1.529 0.948 0 N-CA-C 117.156 1.623 . . . . 1.13 117.156 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -139.21 177.07 8.17 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.637 1.718 . . . . 1.8 111.712 -139.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -114.94 152.3 32.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.022 -1.473 . . . . 3.15 107.022 165.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.87 146.65 37.33 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.853 0.861 . . . . 1.45 109.251 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.6 m -147.92 107.93 4.04 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.766 0.826 . . . . 2.14 108.835 173.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.81 69.6 0.69 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.755 1.222 . . . . 3.11 111.936 -176.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.36 -46.87 92.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 123.295 0.638 . . . . 2.3 111.662 -178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? 32.5 72.83 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.127 1.771 . . . . 4.74 112.137 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.4 mt -54.06 145.58 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.318 -0.856 . . . . 8.65 109.821 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 C--O 1.249 1.073 0 C-N-CA 127.067 2.147 . . . . 8.63 105.604 171.779 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 113.516 0.932 . . . . 10.2 113.516 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 148.36 -93.43 0.15 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 108.588 -1.805 . . . . 4.27 108.588 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -155.34 159.87 40.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.507 0.723 . . . . 4.2 109.178 165.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.57 123.01 4.57 Favored Glycine 0 N--CA 1.444 -0.819 0 N-CA-C 106.663 -2.575 . . . . 1.46 106.663 165.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.26 109.41 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 123.54 0.736 . . . . 2.33 109.347 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -104.23 87.3 2.72 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.226 -1.398 . . . . 3.24 107.226 166.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -82.06 91.93 6.73 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.586 -1.635 . . . . 4.35 106.586 160.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 pp -105.34 157.71 17.13 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.446 -0.797 . . . . 2.11 109.037 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.2 t -79.05 140.98 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 106.537 -1.653 . . . . 1.26 106.537 171.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.2 t -125.52 123.87 65.67 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 105.951 -1.87 . . . . 1.98 105.951 173.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.6 mtt-85 -112.56 152.72 28.52 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.396 -0.964 . . . . 7.06 108.396 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.49 -6.93 61.34 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 119.271 -0.738 . . . . 1.12 112.886 -171.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 57.0 mtm -69.94 74.46 0.45 Allowed 'General case' 0 C--N 1.343 0.291 0 CA-C-N 118.892 1.346 . . . . 1.53 110.288 173.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -67.36 -34.48 77.38 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 119.255 -0.403 . . . . 1.62 111.757 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.1 p -152.95 172.86 16.17 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.09 0.859 . . . . 0.81 112.678 -173.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.34 -44.02 7.91 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.587 1.555 . . . . 0.94 111.854 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.2 m -58.9 -33.41 70.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.779 0.831 . . . . 1.54 112.387 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.2 m -71.05 -57.16 4.81 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 122.308 1.051 . . . . 0.93 109.252 170.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.498 HG13 HG23 ' A' ' 37' ' ' VAL . 71.5 t -49.26 -60.73 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.75 1.62 . . . . 1.11 110.297 -170.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.68 -28.54 67.77 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.784 -0.573 . . . . 0.92 111.389 -175.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -68.58 -39.26 81.04 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.503 -0.555 . . . . 5.81 109.503 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.2 mt -57.01 -61.29 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.125 -0.694 . . . . 0.75 109.125 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -45.97 -59.76 2.66 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.152 0.581 . . . . 3.36 111.343 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.8 t -56.56 -39.12 72.92 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.825 0.85 . . . . 1.12 111.917 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.8 t -70.46 -55.34 9.23 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.417 -1.327 . . . . 1.17 107.417 -178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -63.0 -35.47 80.33 Favored 'General case' 0 N--CA 1.441 -0.921 0 O-C-N 121.96 -0.462 . . . . 2.74 110.589 -170.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.4 m -69.77 67.49 0.25 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 122.228 1.013 . . . . 2.73 110.238 171.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -158.39 -42.59 0.06 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 128.885 2.874 . . . . 5.39 109.249 175.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -66.69 110.89 3.41 Favored 'General case' 0 C--N 1.345 0.373 0 N-CA-C 108.786 -0.82 . . . . 1.57 108.786 -178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -60.76 -18.83 57.19 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 121.292 -0.88 . . . . 6.6 111.449 173.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -51.86 -39.64 48.23 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 123.717 0.675 . . . . 1.6 112.485 167.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -93.83 157.17 3.02 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 CA-C-N 117.588 0.694 . . . . 2.3 110.794 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.9 mt -105.98 -40.32 5.72 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.933 1.293 . . . . 1.9 109.685 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -153.6 156.95 38.93 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 118.044 0.384 . . . . 2.75 110.775 177.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.8 t -139.64 135.25 33.08 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.029 -1.841 . . . . 2.22 106.029 167.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 t -147.96 144.64 28.14 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 119.027 0.83 . . . . 2.84 110.277 154.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.498 HG23 HG13 ' A' ' 19' ' ' VAL . 20.4 m -113.22 166.57 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 123.939 0.895 . . . . 2.04 111.553 -168.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.93 139.76 29.32 Favored 'General case' 0 CA--C 1.52 -0.198 0 O-C-N 122.061 -0.399 . . . . 1.12 110.985 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 mp -72.0 -63.04 1.22 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.571 1.548 . . . . 3.56 109.845 -174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.76 -45.83 81.82 Favored 'General case' 0 C--N 1.338 0.086 0 C-N-CA 123.808 0.843 . . . . 1.98 111.141 -170.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.25 -16.8 57.46 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.841 0.856 . . . . 1.77 110.857 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 55.12 62.57 2.44 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.125 1.37 . . . . 2.24 107.689 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.3 pttp -134.68 160.78 37.06 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.011 0.374 . . . . 2.14 112.011 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.12 112.9 9.54 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 125.388 1.475 . . . . 0.75 108.491 169.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -79.68 93.72 5.58 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 126.707 2.003 . . . . 1.55 107.006 169.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.0 mm -92.25 134.59 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.323 -1.362 . . . . 1.59 107.323 173.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -118.69 119.97 36.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 105.319 -2.104 . . . . 2.27 105.319 163.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -142.65 156.39 45.05 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 107.918 -1.141 . . . . 1.9 107.918 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -89.33 116.3 65.97 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 118.36 -0.829 . . . . 3.34 109.143 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -72.06 70.12 3.03 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.238 3.292 . . . . 2.89 110.976 -176.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -161.66 -55.65 0.05 OUTLIER 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 127.183 2.193 . . . . 3.05 106.675 -175.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.4 pt -88.88 -11.19 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.906 0.883 . . . . 3.28 112.654 -177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.4 tt -158.35 156.31 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 105.078 -2.193 . . . . 1.68 105.078 171.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.9 -178.71 27.95 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 109.402 -1.479 . . . . 1.11 109.402 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.5 -40.75 9.89 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.866 1.71 . . . . 0.97 109.591 171.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.6 -38.43 69.41 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 117.991 -1.004 . . . . 5.72 111.1 -171.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.57 -50.5 69.24 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 118.772 0.714 . . . . 2.46 110.284 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 58' ' ' ILE . 4.6 mp -60.33 -47.54 91.95 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.204 -1.035 . . . . 1.56 108.204 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 54.4 mt -55.08 -43.44 69.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 116.325 -0.398 . . . . 1.39 110.954 176.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -32.04 73.29 Favored 'General case' 0 C--O 1.224 -0.273 0 O-C-N 120.858 -1.151 . . . . 5.04 111.034 176.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.2 m -63.8 -48.29 77.45 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.356 -0.979 . . . . 0.76 108.356 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.421 HG23 ' HB2' ' A' ' 67' ' ' PHE . 65.2 mt -54.37 -46.18 69.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 124.411 1.084 . . . . 1.44 110.458 175.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -55.57 -54.48 43.57 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.181 0.515 . . . . 2.06 110.362 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 t -56.76 -38.04 71.9 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 126.068 1.747 . . . . 1.2 111.722 -171.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.77 -92.6 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.605 -0.517 . . . . 2.42 109.605 170.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.87 30.13 0.33 Allowed Glycine 0 C--N 1.337 0.602 0 CA-C-O 118.712 -1.049 . . . . 1.06 112.802 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.421 ' HB2' HG23 ' A' ' 62' ' ' ILE . 19.7 m-85 -129.81 160.74 32.53 Favored 'General case' 0 N--CA 1.458 -0.047 0 CA-C-N 118.797 1.299 . . . . 1.68 111.415 -159.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -104.6 154.38 20.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.571 1.549 . . . . 3.27 107.159 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -128.55 151.68 49.17 Favored 'General case' 0 C--O 1.23 0.054 0 C-N-CA 123.315 0.646 . . . . 1.27 110.176 175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.1 m -152.17 104.85 3.0 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.275 -1.009 . . . . 1.72 108.275 174.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -59.3 130.71 48.27 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.279 -0.888 . . . . 2.5 109.964 174.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.9 t -78.35 66.64 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 121.812 0.815 . . . . 3.51 109.785 -171.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -104.54 -49.6 3.51 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.963 -1.495 . . . . 5.32 106.963 165.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 75.1 mt -136.14 134.27 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 106.889 -1.522 . . . . 8.18 106.889 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 . . . . . 0 C--O 1.256 1.437 0 N-CA-C 103.765 -2.679 . . . . 13.66 103.765 149.786 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 106.548 -1.649 . . . . 9.45 106.548 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.91 166.73 33.19 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 107.373 -2.291 . . . . 4.03 107.373 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -168.61 176.63 5.57 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.627 1.571 . . . . 5.57 107.314 -178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.29 66.27 0.52 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.288 -1.925 . . . . 2.01 108.288 164.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.8 t -78.57 126.02 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 107.943 -1.132 . . . . 2.73 107.943 170.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 39.1 tp -155.59 100.63 2.11 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.747 0.419 . . . . 3.0 111.387 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.76 89.39 4.01 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 122.766 1.269 . . . . 3.89 109.276 153.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pp -81.73 154.04 26.22 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 113.967 -1.469 . . . . 2.06 108.52 162.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.79 141.53 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.487 -2.042 . . . . 0.95 105.487 168.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.5 127.81 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 104.942 -2.244 . . . . 1.89 104.942 174.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.6 mtp-105 -120.34 160.82 22.26 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.205 0.911 . . . . 5.43 110.498 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 92.13 6.17 65.16 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.376 0.989 . . . . 1.16 111.691 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 73.4 mtp -74.39 62.79 1.0 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.569 1.148 . . . . 1.91 110.298 -177.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -69.66 -16.4 63.36 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 114.256 1.206 . . . . 1.46 114.256 -162.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.2 p -161.53 175.2 12.38 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 120.202 1.364 . . . . 0.58 110.678 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.96 -39.51 19.57 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.449 1.1 . . . . 0.56 111.718 175.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -59.67 -33.28 71.37 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.112 0.565 . . . . 2.29 111.3 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.8 m -71.65 -54.12 11.41 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 118.643 0.656 . . . . 0.69 109.674 170.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.7 t -47.09 -60.7 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.008 0.923 . . . . 0.79 110.821 -174.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.89 -31.12 68.76 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 120.321 -0.551 . . . . 0.74 111.624 -174.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -60.52 -51.98 67.12 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.902 -0.777 . . . . 2.98 108.902 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.6 mt -51.88 -58.94 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.202 0 C-N-CA 123.302 0.641 . . . . 0.9 109.453 178.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -53.93 -57.01 12.57 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 123.559 0.537 . . . . 3.73 109.845 -177.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.8 t -53.29 -42.7 66.87 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.574 1.15 . . . . 0.85 111.427 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.4 m -70.78 -44.83 65.85 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.999 -0.741 . . . . 1.93 108.999 -175.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.0 mt -64.57 -55.66 18.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.459 -0.337 . . . . 2.71 110.818 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 t -56.68 -19.86 18.63 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.674 -0.641 . . . . 2.64 111.657 -176.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -34.78 75.62 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.122 -0.986 . . . . 4.73 112.757 174.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -80.72 119.56 23.48 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.681 -1.229 . . . . 1.73 107.681 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -49.46 -28.92 5.83 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.883 1.068 . . . . 5.56 113.883 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.16 -22.37 70.73 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 119.017 -0.879 . . . . 0.97 113.227 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.3 mm -84.27 110.3 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.731 -1.211 . . . . 4.39 107.731 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -82.09 -33.28 29.87 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.07 0.548 . . . . 2.78 109.882 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -155.64 158.52 38.47 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.277 -0.638 . . . . 2.32 109.277 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.6 t -145.74 135.52 23.44 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.741 0.817 . . . . 2.84 108.897 168.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.6 t -126.13 94.67 4.16 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 106.858 -1.534 . . . . 2.18 106.858 173.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 m -78.7 148.43 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 125.61 1.564 . . . . 2.46 110.441 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.04 123.58 5.51 Favored 'General case' 0 C--N 1.339 0.13 0 O-C-N 122.088 -0.383 . . . . 0.94 111.097 164.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.02 -8.59 56.95 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.206 1.003 . . . . 1.44 113.001 174.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.56 -64.04 1.16 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.312 -0.996 . . . . 2.19 108.312 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 p -77.0 -5.92 50.6 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.849 -0.532 . . . . 2.03 110.455 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 57.57 57.49 4.29 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.889 1.276 . . . . 2.36 107.742 177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 168.93 18.6 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-O 121.441 0.638 . . . . 2.13 111.68 -170.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -142.3 106.12 4.7 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.38 -1.736 . . . . 0.62 106.518 167.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -77.0 93.29 3.8 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 103.679 -2.711 . . . . 1.03 103.679 168.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 69.1 mt -89.33 143.88 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 106.577 -1.638 . . . . 1.83 106.577 174.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -124.16 119.79 30.44 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 105.181 -2.155 . . . . 3.25 105.181 163.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -139.89 162.37 35.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.324 0.649 . . . . 2.02 110.243 -174.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -93.28 109.87 42.86 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 107.803 -1.184 . . . . 3.47 107.803 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -78.43 60.51 7.56 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 124.331 3.354 . . . . 1.55 111.677 -167.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -171.5 -45.02 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.501 1.92 . . . . 2.94 108.21 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.0 mt -67.13 -38.2 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 108.889 -0.782 . . . . 3.26 108.889 170.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 tt -147.34 136.97 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.655 -1.609 . . . . 1.41 106.655 174.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.22 165.58 30.3 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.009 -0.837 . . . . 0.93 111.009 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -55.24 -47.34 26.67 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.24 1.96 . . . . 1.13 109.737 171.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -51.37 -37.83 50.08 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.314 0.646 . . . . 7.54 112.038 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -70.52 -47.75 58.93 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.284 -0.636 . . . . 2.38 109.284 -178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.4 mt -53.54 -52.09 36.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 122.846 0.458 . . . . 0.91 110.301 174.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.9 mm -51.81 -51.6 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.313 0.645 . . . . 1.86 109.655 173.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -56.22 -40.2 73.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 122.074 -0.391 . . . . 4.98 111.587 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.3 m -60.37 -56.71 18.2 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 109.084 -0.709 . . . . 0.87 109.084 175.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.437 HG21 ' HB2' ' A' ' 69' ' ' ALA . 32.2 mt -47.6 -53.18 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.607 1.163 . . . . 1.56 111.346 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -59.27 -56.23 24.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.466 1.106 . . . . 2.22 110.362 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.3 t -59.12 -30.08 67.86 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.433 0.693 . . . . 1.47 111.841 -176.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.9 mt -71.87 -74.86 0.14 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.349 0.522 . . . . 2.32 110.618 176.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.51 6.83 0.08 OUTLIER Glycine 0 CA--C 1.529 0.965 0 CA-C-O 117.862 -1.521 . . . . 0.84 116.231 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -130.85 158.31 40.52 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 120.2 2.0 . . . . 1.66 112.165 -146.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -92.55 167.53 11.87 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 107.509 -1.293 . . . . 3.08 107.509 170.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.437 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -155.25 169.16 24.83 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.901 0.381 . . . . 0.88 111.192 164.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.4 m -154.6 125.61 7.2 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.831 1.252 . . . . 1.65 108.059 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.37 68.64 1.55 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.516 0.727 . . . . 2.84 111.874 -175.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.6 p -62.53 -52.37 60.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-O 118.688 -0.672 . . . . 2.49 111.385 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.14 61.4 3.18 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.403 -0.962 . . . . 4.67 108.403 -176.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.9 tp -65.33 -47.07 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 114.716 -1.129 . . . . 8.64 113.217 -162.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--O 1.25 1.085 0 C-N-CA 124.403 1.081 . . . . 9.45 110.388 -169.262 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.471 0.593 0 CA-C-O 119.36 -0.352 . . . . 7.3 111.486 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.3 165.26 24.98 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-N 118.124 0.42 . . . . 3.31 112.142 -169.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -70.45 97.7 1.33 Allowed 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.992 -0.744 . . . . 4.99 108.992 171.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.47 90.05 0.37 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 108.155 -1.978 . . . . 1.81 108.155 169.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.96 132.81 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.236 -1.394 . . . . 2.64 107.236 175.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.6 tp -148.48 143.31 26.62 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 107.293 -1.373 . . . . 2.89 107.293 172.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -133.72 113.82 12.75 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.322 -1.362 . . . . 3.98 107.322 172.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.421 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -122.79 153.68 39.21 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.379 0.672 . . . . 2.23 109.493 -179.314 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.48 140.65 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.075 -1.454 . . . . 0.79 107.075 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 89.6 t -131.97 93.0 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 C-N-CA 127.062 2.145 . . . . 2.04 106.052 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.4 mtm105 -79.79 157.74 27.01 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.485 -0.561 . . . . 5.71 109.485 176.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.79 -6.08 56.92 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.403 1.002 . . . . 1.07 112.082 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 71.8 mtp -71.88 74.07 0.86 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.166 0.983 . . . . 1.92 110.958 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 t -70.76 -17.15 62.8 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 117.277 -1.344 . . . . 1.61 114.257 -169.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.2 p -163.78 176.15 9.81 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 120.727 1.603 . . . . 0.61 111.381 -176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.65 -38.41 21.01 Favored 'General case' 0 C--N 1.338 0.096 0 C-N-CA 124.805 1.242 . . . . 0.64 111.892 175.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.2 t -49.07 -48.57 44.05 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 109.425 -0.583 . . . . 2.57 109.425 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.6 m -62.32 -46.03 90.58 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 122.258 0.223 . . . . 0.89 110.773 -178.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 80.2 t -52.49 -65.1 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 109.921 -0.4 . . . . 1.0 109.921 178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -30.58 67.67 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 118.986 -1.085 . . . . 0.86 111.842 -172.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -53.19 -53.43 50.76 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.37 -0.604 . . . . 3.47 109.37 169.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.9 mt -60.65 -58.37 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 118.461 -0.781 . . . . 0.64 110.024 178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -49.51 -55.46 13.25 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 118.994 0.816 . . . . 3.88 110.548 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 26.1 t -56.58 -38.98 72.73 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.326 1.05 . . . . 0.91 111.388 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.3 t -71.13 -36.35 72.07 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.476 -0.765 . . . . 1.51 109.845 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.1 mt -66.99 -62.19 1.56 Allowed 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 118.488 -0.768 . . . . 3.24 110.488 -178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 11.1 p -70.62 65.66 0.32 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.249 1.419 . . . . 1.94 111.697 -172.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.8 tptp -176.48 -48.2 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.55 1.14 . . . . 4.16 108.167 -151.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -73.29 90.59 1.64 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.897 -1.149 . . . . 1.89 107.897 166.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -51.76 105.1 0.1 Allowed 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.526 -0.546 . . . . 6.44 109.526 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.79 -43.9 0.7 Allowed Glycine 0 CA--C 1.522 0.529 0 N-CA-C 108.727 -1.749 . . . . 0.94 108.727 -164.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.45 131.57 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 105.436 -2.061 . . . . 2.5 105.436 161.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.7 mt -94.24 -42.72 8.79 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.909 1.284 . . . . 1.76 108.351 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -149.04 154.24 39.01 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.441 -0.578 . . . . 2.42 109.441 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.3 p -143.93 152.71 41.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.381 1.472 . . . . 2.14 108.306 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.9 m -155.25 82.78 1.06 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 124.673 1.189 . . . . 2.03 108.396 173.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.56 154.24 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 125.086 1.354 . . . . 2.61 108.871 174.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.04 130.06 11.82 Favored 'General case' 0 CA--C 1.519 -0.233 0 O-C-N 120.736 -1.228 . . . . 0.92 110.786 172.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.59 -32.99 72.08 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.316 0.507 . . . . 1.87 110.159 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -47.59 -43.48 25.6 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.621 1.168 . . . . 1.34 112.449 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 t -121.76 1.97 10.0 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.706 0.403 . . . . 2.93 111.975 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 52.17 66.29 1.25 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.481 1.513 . . . . 1.78 108.46 174.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.48 166.02 27.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.427 1.091 . . . . 2.3 108.323 -175.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.48 108.85 12.04 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 126.832 2.053 . . . . 1.07 106.255 166.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -80.54 132.9 35.73 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 103.746 -2.687 . . . . 1.3 103.746 159.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.8 pt -138.84 151.27 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 N-CA-C 106.796 -1.557 . . . . 3.58 106.796 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -139.28 101.01 4.15 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 102.802 -3.036 . . . . 2.46 102.802 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -129.91 149.01 51.83 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.523 0.729 . . . . 1.78 109.205 -169.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -82.96 117.79 69.69 Favored Pre-proline 0 N--CA 1.451 -0.423 0 N-CA-C 107.809 -1.182 . . . . 2.87 107.809 173.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.11 -26.99 78.5 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.443 1.428 . . . . 1.93 111.625 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -80.8 42.04 0.6 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.145 0.884 . . . . 4.27 111.363 -174.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.6 tp -175.5 -43.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.682 1.593 . . . . 2.89 110.277 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.1 tt -132.67 124.03 50.32 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 108.108 -1.071 . . . . 1.19 108.108 176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.4 173.59 51.11 Favored Glycine 0 CA--C 1.533 1.216 0 N-CA-C 110.679 -0.968 . . . . 0.91 110.679 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.63 -54.73 0.53 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.45 2.1 . . . . 0.99 110.263 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -50.46 -42.94 54.97 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 123.297 0.639 . . . . 6.04 110.944 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.51 -49.32 18.68 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.816 2.046 . . . . 2.68 110.154 176.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 54.7 mt -70.32 -47.59 65.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.234 0.614 . . . . 1.34 110.312 176.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.3 mm -50.03 -47.24 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 118.132 0.424 . . . . 1.95 110.858 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -45.17 -44.99 11.25 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 125.316 1.446 . . . . 2.85 111.445 173.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.0 m -58.89 -55.09 39.61 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.565 -0.902 . . . . 1.08 108.565 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -57.5 -53.67 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.197 0.599 . . . . 1.79 109.966 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -61.78 -48.34 81.1 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 120.618 -0.433 . . . . 2.48 110.22 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.6 t -55.65 -48.41 75.04 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.174 0.59 . . . . 1.49 111.549 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.1 mt -54.97 -59.51 4.65 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.903 -0.498 . . . . 2.32 112.316 -175.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.68 -0.01 0.06 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 116.961 1.544 . . . . 1.09 116.961 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -131.94 175.18 9.44 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 119.897 1.849 . . . . 1.85 113.371 -139.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -125.68 103.44 7.83 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.685 1.194 . . . . 4.12 107.977 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.79 157.27 21.03 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.96 0.356 . . . . 1.47 111.96 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.9 t -154.45 133.09 12.12 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.424 1.09 . . . . 2.08 108.315 165.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.6 mt -58.1 155.94 10.33 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.026 -0.731 . . . . 2.32 109.026 163.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.3 t -137.07 -62.17 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 107.396 -1.335 . . . . 2.66 107.396 169.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.7 tttp 67.34 -66.52 0.2 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.934 1.694 . . . . 4.71 111.961 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.275 6.7 tp 44.9 55.27 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.971 1.708 . . . . 6.11 111.618 -172.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 . . . . . 0 C--O 1.248 1.021 0 N-CA-C 103.4 -2.815 . . . . 9.92 103.4 166.77 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 107.925 -1.139 . . . . 8.52 107.925 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 124.52 -55.76 0.7 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 105.567 -3.013 . . . . 5.99 105.567 -165.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -44.5 151.03 0.29 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 114.492 -0.854 . . . . 6.06 109.526 138.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.49 -75.46 0.15 Allowed Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.037 -1.625 . . . . 3.76 109.037 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 p -158.04 166.54 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 106.754 -1.572 . . . . 2.51 106.754 169.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.6 tp -133.27 128.45 35.85 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 107.468 -1.308 . . . . 2.23 107.468 151.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -121.89 133.28 54.86 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 125.385 1.474 . . . . 3.72 108.133 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.98 157.12 41.29 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.378 -0.601 . . . . 2.73 109.378 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.61 145.21 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.263 -1.754 . . . . 0.75 106.263 169.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.8 137.24 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 C-N-CA 125.672 1.589 . . . . 1.72 108.467 173.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -130.36 163.19 27.41 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.093 0.957 . . . . 5.81 108.779 176.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.67 -15.4 63.22 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.455 0.55 . . . . 1.41 112.275 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.458 ' SD ' HD12 ' A' ' 22' ' ' ILE . 64.2 mtm -69.14 78.98 0.34 Allowed 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.208 1.004 . . . . 1.67 110.097 175.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.6 t -71.46 -16.75 62.38 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 117.753 -1.117 . . . . 1.77 113.097 -174.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.5 p -161.72 172.68 15.81 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.94 1.245 . . . . 0.97 110.792 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.16 -41.12 25.98 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.782 1.233 . . . . 0.71 111.536 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.5 m -61.01 -29.29 69.62 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.523 0.729 . . . . 1.62 112.205 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.7 m -72.03 -56.62 5.32 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 119.161 0.892 . . . . 0.81 110.03 166.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.705 HG13 HG23 ' A' ' 37' ' ' VAL . 88.3 t -43.71 -62.35 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.588 1.155 . . . . 0.9 110.781 -173.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.0 -25.31 63.53 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 120.586 -0.446 . . . . 0.82 111.898 -175.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -67.88 -41.17 83.19 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.205 -0.665 . . . . 2.9 109.205 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.458 HD12 ' SD ' ' A' ' 13' ' ' MET . 12.8 mt -54.94 -59.03 2.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 109.494 -0.558 . . . . 0.87 109.494 173.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.443 ' OE2' HG22 ' A' ' 37' ' ' VAL . 93.4 mt-10 -52.97 -51.2 62.31 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.548 0.613 . . . . 3.72 111.388 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.2 t -54.93 -37.38 66.33 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.143 0.977 . . . . 0.95 111.205 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.3 t -71.29 -57.87 4.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.736 -1.209 . . . . 1.45 107.736 177.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.0 mt -51.17 -49.66 60.47 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.014 0.925 . . . . 2.6 112.085 -174.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.3 t -56.77 -17.92 10.85 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.456 -0.777 . . . . 2.67 112.61 -177.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.32 -30.45 71.3 Favored 'General case' 0 C--N 1.343 0.287 0 O-C-N 121.139 -0.976 . . . . 5.76 112.34 175.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -81.18 113.22 19.18 Favored 'General case' 0 C--N 1.34 0.178 0 N-CA-C 106.543 -1.651 . . . . 1.74 106.543 170.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 19.4 tpt180 -55.84 -26.33 46.18 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.524 0.565 . . . . 6.58 112.524 -173.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.82 -22.26 59.62 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.818 0.723 . . . . 1.37 113.437 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.2 mm -79.59 97.88 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.282 -1.377 . . . . 4.13 107.282 174.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.3 mt -77.68 -34.78 52.84 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.024 -0.732 . . . . 1.81 109.024 -175.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -148.75 158.55 44.23 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.591 -0.892 . . . . 2.27 108.591 165.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.6 p -145.26 138.02 26.15 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 125.963 1.705 . . . . 2.35 107.717 173.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 t -142.16 106.93 4.87 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.496 -1.668 . . . . 1.77 106.496 170.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.705 HG23 HG13 ' A' ' 19' ' ' VAL . 35.9 m -84.87 171.78 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 118.159 0.436 . . . . 1.71 109.936 170.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -157.12 141.3 16.36 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 109.063 -0.717 . . . . 0.94 109.063 152.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.98 -38.07 53.92 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 108.521 -0.918 . . . . 2.11 108.521 166.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.36 -38.96 69.49 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.582 0.753 . . . . 1.46 110.609 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 m -112.1 14.52 20.71 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.389 1.076 . . . . 2.41 110.284 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.3 m120 32.29 53.08 0.29 Allowed 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 126.392 1.877 . . . . 1.57 113.512 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.68 168.47 17.69 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 122.864 0.465 . . . . 2.74 111.29 -171.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -140.26 135.59 32.46 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 114.29 -1.323 . . . . 1.13 109.22 150.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -110.4 107.34 17.01 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 104.288 -2.486 . . . . 1.28 104.288 168.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.433 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -106.74 146.56 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 105.889 -1.893 . . . . 1.86 105.889 175.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 50.4 mmtt -113.16 93.21 4.3 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 105.307 -2.108 . . . . 2.61 105.307 170.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.78 150.89 20.87 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.318 1.047 . . . . 3.02 112.755 -174.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -87.22 126.5 62.41 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 107.066 -1.457 . . . . 3.09 107.066 150.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.02 -19.62 20.22 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.877 3.052 . . . . 1.82 113.447 -171.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -93.05 -45.1 8.07 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.874 -0.788 . . . . 3.44 108.874 -177.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 71.1 mt -68.12 -35.76 72.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 109.553 -0.536 . . . . 2.92 109.553 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 mm -130.71 116.18 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 107.041 -1.466 . . . . 1.49 107.041 176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.43 152.64 49.62 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 108.234 -1.946 . . . . 0.88 108.234 169.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -55.66 -38.55 94.12 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.028 1.819 . . . . 1.79 111.013 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.0 ttm180 -67.22 -23.83 65.77 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 118.841 -0.599 . . . . 6.74 112.408 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -65.59 -35.64 81.41 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 120.702 1.592 . . . . 2.44 112.285 -170.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.4 mt -53.47 -48.05 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 N-CA-C 109.176 -0.676 . . . . 1.29 109.176 171.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.0 mt -62.69 -49.02 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 123.705 0.802 . . . . 1.31 109.733 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -48.89 -44.6 40.18 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 119.132 0.878 . . . . 3.91 110.66 175.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 88.6 m -65.0 -56.63 11.99 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.302 -0.629 . . . . 0.82 109.302 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.403 HG23 ' HB2' ' A' ' 67' ' ' PHE . 74.7 mt -46.89 -49.87 6.59 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.454 1.102 . . . . 1.47 110.88 178.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -58.1 -53.76 54.63 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.797 1.239 . . . . 2.15 111.0 174.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 83.2 p -60.06 -29.99 68.91 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 112.316 0.488 . . . . 2.28 112.316 -172.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -68.38 -97.73 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.59 -0.522 . . . . 2.88 109.59 167.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.29 35.94 0.44 Allowed Glycine 0 C--N 1.337 0.607 0 O-C-N 121.167 -0.958 . . . . 0.81 112.403 176.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.403 ' HB2' HG23 ' A' ' 62' ' ' ILE . 26.0 m-85 -131.57 159.37 38.42 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.465 1.132 . . . . 2.22 110.283 -165.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -99.5 155.86 17.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.597 -0.89 . . . . 3.66 108.597 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.72 162.47 35.91 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 122.349 0.26 . . . . 1.15 110.953 162.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.0 m -155.44 116.93 4.0 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.79 0.836 . . . . 1.85 109.847 175.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.42 65.58 0.44 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.029 0.932 . . . . 2.51 110.743 174.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 11.8 p -74.46 65.41 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 124.406 1.082 . . . . 3.32 108.888 174.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -130.07 140.08 50.88 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.52 1.528 . . . . 4.47 107.966 -173.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.6 mt -125.16 132.22 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 103.916 -2.624 . . . . 6.13 103.916 167.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 124.698 1.199 . . . . 11.12 110.114 -170.489 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 106.434 -1.691 . . . . 11.58 106.434 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.01 156.72 27.11 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 106.536 -2.626 . . . . 3.57 106.536 174.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t70 50.75 -139.6 0.91 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.401 -0.963 . . . . 4.04 108.401 -165.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.48 101.43 0.57 Allowed Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 106.626 -2.59 . . . . 1.63 106.626 -172.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.5 p -129.57 134.89 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 107.458 -1.312 . . . . 1.94 107.458 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.4 tp -145.29 113.3 6.47 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.919 -1.141 . . . . 2.09 107.919 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -94.0 133.23 37.67 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 109.681 -0.488 . . . . 3.32 109.681 165.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -131.94 148.73 52.54 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.558 -1.275 . . . . 2.24 107.558 172.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.42 ' HB ' HG22 ' A' ' 72' ' ' VAL . 1.5 t -79.71 142.72 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 106.174 -1.788 . . . . 0.81 106.174 162.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 p -122.73 96.12 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 125.682 1.593 . . . . 2.46 107.678 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -80.87 59.76 3.85 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.388 -0.82 . . . . 6.84 109.768 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.57 0.42 0.21 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 118.988 -0.896 . . . . 1.46 114.419 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.5 mtm -77.13 76.88 3.68 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 119.411 1.605 . . . . 1.64 109.735 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -75.67 -11.63 60.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 117.886 -1.055 . . . . 1.97 112.963 -173.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 16.8 p -160.75 172.51 16.92 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 120.008 1.276 . . . . 1.03 109.2 172.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.23 -44.98 11.52 Favored 'General case' 0 C--O 1.231 0.099 0 C-N-CA 124.459 1.104 . . . . 1.24 111.466 175.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.8 t -50.38 -40.94 51.08 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 122.745 0.418 . . . . 2.48 110.846 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.0 m -58.97 -34.6 71.98 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 112.41 0.522 . . . . 1.14 112.41 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.3 t -59.66 -67.94 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 121.738 0.78 . . . . 0.94 109.19 -175.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.76 -32.25 73.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 118.399 -0.81 . . . . 1.38 111.279 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -53.85 -52.84 59.11 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.767 1.167 . . . . 2.96 109.975 172.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.5 mt -54.93 -64.3 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 109.032 -0.729 . . . . 0.81 109.032 177.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -56.42 -54.73 42.23 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 119.907 -0.717 . . . . 4.22 110.164 -171.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 t -51.64 -43.83 62.75 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.464 1.106 . . . . 0.8 111.98 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.4 t -70.67 -33.28 70.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 121.208 -0.933 . . . . 1.3 109.852 -175.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.1 mp -73.01 -48.15 38.84 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 111.745 0.276 . . . . 2.64 111.745 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.43 ' HA ' HD11 ' A' ' 32' ' ' ILE . 16.2 p -60.29 -18.38 48.91 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 120.737 -1.227 . . . . 2.12 113.671 -165.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -39.3 63.11 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.138 0.792 . . . . 5.35 113.138 168.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -60.92 167.98 2.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.382 0.992 . . . . 2.5 109.13 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.66 -18.53 12.75 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.773 -0.579 . . . . 6.9 111.869 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.27 -22.8 78.49 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 118.63 0.65 . . . . 1.15 112.015 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.43 HD11 ' HA ' ' A' ' 27' ' ' THR . 0.1 OUTLIER -78.7 157.92 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 117.94 0.87 . . . . 3.29 109.785 174.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.5 mt -119.17 -46.43 2.51 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.02 1.328 . . . . 1.98 109.428 175.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -155.44 153.7 30.76 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-O 117.728 -1.13 . . . . 2.17 108.641 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.6 t -131.69 77.06 1.75 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.362 1.065 . . . . 2.77 109.472 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.51 85.05 3.89 Favored 'General case' 0 C--O 1.24 0.586 0 O-C-N 120.75 -1.219 . . . . 3.43 109.82 -168.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -89.89 138.45 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 C-N-CA 128.039 2.536 . . . . 2.67 111.841 -171.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.39 124.3 10.63 Favored 'General case' 0 C--N 1.346 0.441 0 CA-C-N 118.635 0.652 . . . . 1.14 111.629 172.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.4 mt -47.85 -43.79 28.59 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.97 0.908 . . . . 2.16 109.655 158.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.7 -24.71 1.48 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.49 1.116 . . . . 2.38 113.723 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 13.6 t -139.5 25.06 2.43 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.965 0.802 . . . . 3.05 112.438 169.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.2 m120 40.6 45.91 2.08 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 126.821 2.048 . . . . 1.8 112.816 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.99 170.81 14.82 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 118.543 0.611 . . . . 2.29 111.391 -171.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.11 130.19 23.34 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 125.176 1.547 . . . . 0.89 109.614 164.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -97.98 97.7 9.14 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 126.043 1.737 . . . . 0.99 107.618 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.5 mp -86.94 112.78 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 106.285 -1.746 . . . . 1.55 106.285 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt -88.21 135.17 33.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.073 -1.825 . . . . 2.72 106.073 157.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -162.74 175.05 11.71 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.416 1.086 . . . . 1.85 109.253 -171.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -106.34 125.15 33.63 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 107.064 -1.458 . . . . 3.09 107.064 162.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.67 -6.36 18.11 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.696 2.93 . . . . 1.77 113.567 -171.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -108.33 -34.97 6.65 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.643 1.177 . . . . 3.93 109.074 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 69.0 mt -70.32 -33.51 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 O-C-N 121.765 -0.584 . . . . 3.55 110.648 169.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 tt -140.2 129.36 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.97 -1.122 . . . . 1.29 107.97 168.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.53 176.16 42.53 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 123.622 0.63 . . . . 1.57 111.902 -173.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.91 -57.0 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.797 2.332 . . . . 2.62 111.27 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.428 HH21 ' CD ' ' A' ' 63' ' ' GLU . 71.8 ttt180 -65.42 -33.65 76.46 Favored 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 117.958 -1.02 . . . . 6.34 110.695 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -35.6 -57.5 0.63 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.766 1.626 . . . . 2.32 111.486 -178.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.6 mt -52.09 -58.89 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 124.937 1.295 . . . . 0.83 110.868 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.2 mm -50.66 -62.69 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 124.859 1.263 . . . . 1.72 109.409 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -49.68 -34.82 19.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.297 1.839 . . . . 4.89 112.03 176.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.2 m -65.34 -48.4 73.12 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 119.703 1.138 . . . . 0.77 108.82 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 59.3 mt -57.37 -47.07 85.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.584 0.753 . . . . 1.22 111.109 175.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 56' ' ' ARG . 49.7 mt-10 -51.46 -57.73 8.19 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.956 0.902 . . . . 2.28 109.261 172.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.0 t -65.77 -27.31 68.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.394 1.078 . . . . 1.32 112.291 -171.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.0 mt -65.83 -81.32 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 118.859 0.754 . . . . 2.31 110.04 176.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.25 25.94 0.26 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.599 -1.112 . . . . 0.77 113.235 171.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -134.29 176.44 8.6 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 118.825 1.313 . . . . 1.88 112.276 -153.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -127.41 136.34 51.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.357 -2.09 . . . . 3.24 105.357 176.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.19 153.67 35.92 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.27 1.028 . . . . 0.87 110.391 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.1 m -154.67 132.0 11.14 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.757 0.823 . . . . 1.73 109.6 170.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.9 mp -79.58 58.03 2.61 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.251 1.42 . . . . 3.37 109.017 -175.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 9' ' ' VAL . 19.6 m -75.57 77.26 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 122.187 0.994 . . . . 3.81 111.192 -171.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -57.68 -27.88 63.28 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.561 -0.712 . . . . 5.82 111.109 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.7 mm -135.31 149.39 28.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 105.777 -1.935 . . . . 6.66 105.777 169.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 . . . . . 0 C--O 1.25 1.081 0 N-CA-C 104.225 -2.509 . . . . 13.14 104.225 157.701 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 105.515 -2.032 . . . . 11.53 105.515 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.63 160.74 40.48 Favored Glycine 0 CA--C 1.536 1.387 0 N-CA-C 107.765 -2.134 . . . . 4.19 107.765 135.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.401 ' OD1' ' NZ ' ' A' ' 47' ' ' LYS . 21.3 t0 -179.7 174.9 0.91 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 128.058 2.543 . . . . 4.22 105.172 175.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -178.3 -172.7 42.98 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 109.651 -1.38 . . . . 1.88 109.651 173.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 p -145.09 90.42 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 108.389 -0.967 . . . . 2.49 108.389 172.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 6' ' ' LEU . 1.4 tm? -78.51 80.01 4.92 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 105.779 -1.934 . . . . 3.12 105.779 170.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -84.7 123.73 30.71 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 114.071 -1.422 . . . . 3.54 108.802 168.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.36 157.78 39.09 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 123.648 0.592 . . . . 2.56 110.617 178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -79.06 115.77 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 106.476 -1.676 . . . . 0.71 106.476 170.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.2 p -93.04 73.55 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 105.952 -1.87 . . . . 2.22 105.952 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.03 100.98 5.09 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.904 -1.887 . . . . 7.08 105.904 -166.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.92 -43.65 0.24 Allowed Glycine 0 C--N 1.334 0.441 0 O-C-N 120.343 -1.473 . . . . 1.43 113.548 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.31 75.74 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.105 1.15 . . . . 2.61 114.105 -173.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.2 t -69.35 -13.1 62.19 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.723 1.379 . . . . 1.98 114.723 -166.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.7 p -155.12 170.33 22.05 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.078 1.308 . . . . 0.72 109.931 178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.35 -45.73 8.98 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.962 1.305 . . . . 0.67 111.542 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -54.1 -39.53 66.46 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.339 1.456 . . . . 1.79 112.029 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.1 m -71.98 -55.12 8.0 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.994 -0.373 . . . . 0.72 109.994 170.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.449 HG13 HG23 ' A' ' 37' ' ' VAL . 93.7 t -47.56 -60.62 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 123.655 0.782 . . . . 0.85 110.623 -173.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.72 -24.66 65.4 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.657 -0.652 . . . . 0.8 111.863 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -67.14 -48.26 68.58 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.773 -0.825 . . . . 3.56 108.773 174.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.482 HD11 ' CD2' ' A' ' 67' ' ' PHE . 15.8 mt -57.4 -57.12 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 118.507 0.594 . . . . 0.83 109.432 174.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -53.53 -50.92 64.46 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.44 0.638 . . . . 3.53 110.386 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.0 t -56.72 -51.64 68.05 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 118.326 -0.845 . . . . 1.0 109.87 174.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 t -57.33 -44.61 84.4 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 119.494 1.043 . . . . 1.31 108.514 -169.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 40.1 mt -56.44 -53.13 61.06 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.337 -0.847 . . . . 3.07 111.795 175.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.7 p -57.78 -10.41 1.65 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.923 1.083 . . . . 2.25 113.923 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.53 -33.47 69.2 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.427 1.012 . . . . 7.16 110.863 173.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -78.65 148.44 33.18 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.614 -0.884 . . . . 2.27 108.614 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -95.34 -24.41 16.75 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.172 0.589 . . . . 7.07 111.29 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.31 -19.97 76.38 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 122.165 -0.335 . . . . 0.93 112.388 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -84.05 127.71 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 105.932 -1.877 . . . . 2.38 105.932 164.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.91 -38.0 33.48 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 109.442 -0.577 . . . . 2.47 109.442 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -155.48 153.54 30.45 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 107.752 -1.203 . . . . 2.32 107.752 -175.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 13.8 p -139.12 146.76 41.06 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 123.744 0.652 . . . . 2.14 109.359 168.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.3 t -144.5 105.17 4.15 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.154 -1.424 . . . . 1.58 107.154 172.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.449 HG23 HG13 ' A' ' 19' ' ' VAL . 9.1 m -90.45 159.05 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 C-N-CA 123.703 0.801 . . . . 1.8 110.132 174.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.68 130.31 9.09 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 121.745 -0.597 . . . . 0.66 110.757 163.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.6 pp -68.1 -23.61 64.94 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 123.552 0.532 . . . . 1.47 111.957 165.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.43 -47.63 72.62 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.377 0.535 . . . . 1.21 110.084 175.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.99 -17.3 20.15 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.176 0.99 . . . . 1.97 112.144 178.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 58.56 38.26 25.35 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.883 1.273 . . . . 2.59 109.29 -162.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.55 160.83 16.81 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.311 0.645 . . . . 2.59 110.027 -173.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.433 ' HB2' HG12 ' A' ' 37' ' ' VAL . . . -134.4 122.21 22.24 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.147 -1.427 . . . . 0.71 107.147 159.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -96.36 108.89 21.48 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 104.455 -2.424 . . . . 0.93 104.455 166.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 45.8 mt -120.33 104.49 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 107.36 -1.348 . . . . 1.75 107.36 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' NZ ' ' OD1' ' A' ' 3' ' ' ASP . 6.3 mtpm? -79.97 138.68 37.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.367 -1.346 . . . . 2.71 107.367 172.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -159.58 147.78 17.44 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 119.196 -0.43 . . . . 1.99 110.828 -159.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -85.83 103.74 4.2 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 106.356 -1.72 . . . . 3.15 106.356 168.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -60.26 -54.64 2.03 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.573 2.182 . . . . 2.54 111.422 -165.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -53.83 -44.24 70.09 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.007 1.323 . . . . 3.02 111.819 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -73.2 -47.01 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 122.377 0.271 . . . . 2.96 110.624 -173.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -88.44 -48.19 15.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 117.923 0.329 . . . . 3.98 110.87 -171.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.93 116.27 2.42 Favored Glycine 0 CA--C 1.537 1.417 0 N-CA-C 110.41 -1.076 . . . . 1.24 110.41 -170.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -59.95 -39.38 71.63 Favored 'Trans proline' 0 C--N 1.348 0.53 0 CA-C-N 119.955 1.878 . . . . 1.13 109.653 173.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 22.5 ttp180 -37.89 -53.45 1.32 Allowed 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 125.378 1.471 . . . . 8.61 110.815 164.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -73.74 -36.05 65.12 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 123.996 0.918 . . . . 3.01 113.159 -174.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.1 mt -53.48 -48.94 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 O-C-N 121.356 -0.84 . . . . 0.78 109.636 166.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.5 mt -58.71 -47.2 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 109.495 -0.558 . . . . 1.52 109.495 176.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -50.21 -42.49 51.58 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.692 0.678 . . . . 3.04 111.033 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.4 m -60.48 -54.48 45.06 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.279 0.945 . . . . 1.21 109.092 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.1 mt -52.13 -51.64 29.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.382 1.073 . . . . 1.52 111.758 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -60.06 -56.99 14.81 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.257 1.023 . . . . 2.24 110.463 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -52.93 -42.95 65.89 Favored 'General case' 0 CA--C 1.527 0.089 0 C-N-CA 124.629 1.172 . . . . 1.46 110.632 -176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.5 mt -62.56 -70.91 0.18 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.437 -0.316 . . . . 2.32 110.573 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.64 -10.34 0.04 OUTLIER Glycine 0 CA--C 1.531 1.044 0 N-CA-C 117.614 1.805 . . . . 1.17 117.614 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.482 ' CD2' HD11 ' A' ' 22' ' ' ILE . 30.5 m-85 -133.23 156.35 47.69 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 119.845 1.823 . . . . 1.82 111.533 -137.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -80.23 159.04 26.06 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.179 0.992 . . . . 3.63 108.551 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -130.15 141.96 50.63 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.577 1.151 . . . . 1.42 109.432 172.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.7 m -153.37 110.0 3.4 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.543 0.737 . . . . 1.69 109.72 170.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.9 mp -58.77 130.97 49.45 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.768 0.713 . . . . 3.25 109.804 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.34 -94.41 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 108.241 -1.022 . . . . 2.49 108.241 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 60.2 mttp 70.22 -53.87 0.63 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.981 1.712 . . . . 5.37 111.927 -175.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.44 HD13 ' H ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -122.19 165.52 17.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 C-N-CA 124.326 1.051 . . . . 5.48 108.769 168.338 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--O 1.255 1.358 0 N-CA-C 104.48 -2.415 . . . . 11.07 104.48 174.969 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 109.244 -0.65 . . . . 7.19 109.244 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.24 67.06 1.84 Allowed Glycine 0 CA--C 1.527 0.811 0 N-CA-C 109.384 -1.486 . . . . 3.85 109.384 170.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -149.83 156.7 42.25 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.318 1.047 . . . . 4.1 108.996 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.72 163.37 27.63 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.813 -1.315 . . . . 1.42 109.813 178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 m -109.77 101.22 12.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 125.856 1.662 . . . . 2.32 108.975 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.33 106.19 18.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.672 -1.233 . . . . 3.19 107.672 175.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -107.46 103.4 12.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.268 -1.012 . . . . 3.61 108.268 176.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.3 mt -106.09 144.58 32.6 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.081 0.953 . . . . 2.35 108.458 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.49 128.22 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 104.721 -2.326 . . . . 1.09 104.721 151.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 p -101.23 85.31 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 125.014 1.326 . . . . 2.57 107.554 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -83.27 59.25 4.9 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.312 1.045 . . . . 6.21 109.633 -169.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -169.67 -44.01 0.03 OUTLIER Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.849 -0.691 . . . . 1.35 112.959 -174.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.18 131.78 52.04 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.674 -0.861 . . . . 2.73 108.674 177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.2 p -94.08 -57.32 2.56 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.053 0.541 . . . . 3.27 110.317 -175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.1 p -134.44 176.97 8.13 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.477 0.711 . . . . 0.69 112.2 -160.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.43 -42.99 10.95 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.674 1.189 . . . . 0.63 111.9 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -54.4 -48.45 71.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.967 0.507 . . . . 2.44 109.72 177.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.6 m -67.29 -41.43 85.42 Favored 'General case' 0 N--CA 1.448 -0.567 0 O-C-N 122.091 -0.381 . . . . 0.82 111.053 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.45 HG13 HG23 ' A' ' 37' ' ' VAL . 93.1 t -53.5 -63.96 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 122.591 0.357 . . . . 0.73 110.408 176.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.261 0.1 OUTLIER -70.68 -25.89 63.18 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 120.991 -1.068 . . . . 0.89 112.356 -175.639 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -55.01 -52.46 63.09 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.629 0.65 . . . . 3.52 109.703 167.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.1 mt -52.48 -63.83 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.235 0 N-CA-C 108.876 -0.787 . . . . 0.82 108.876 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -56.54 -51.38 68.76 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 120.595 -0.442 . . . . 3.58 111.366 -171.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.6 t -58.19 -43.46 87.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.5 -0.762 . . . . 0.98 110.408 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 t -63.18 -56.19 18.8 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 120.022 1.283 . . . . 1.25 108.1 -175.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.41 -45.08 89.08 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.303 -0.862 . . . . 2.42 112.242 -175.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.418 ' HA ' HD11 ' A' ' 32' ' ' ILE . 32.8 p -58.59 -17.19 19.86 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.943 0.72 . . . . 2.11 112.943 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -65.93 -28.37 68.87 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 119.246 0.93 . . . . 6.85 111.088 173.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -83.88 105.23 14.61 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 108.565 -0.902 . . . . 2.09 108.565 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -57.11 -17.94 12.76 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 113.526 0.936 . . . . 5.96 113.526 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.8 -27.77 70.63 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.185 -0.786 . . . . 0.89 112.122 172.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.4 OUTLIER -84.38 145.31 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 119.186 1.493 . . . . 2.47 108.38 169.24 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.4 mt -109.57 -39.42 5.16 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.678 1.191 . . . . 2.01 109.695 -168.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -155.16 149.54 26.13 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.715 -1.217 . . . . 1.95 107.715 177.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.9 m -124.89 147.39 48.84 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 107.679 -1.23 . . . . 2.01 107.679 173.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.8 m -154.48 85.04 1.12 Allowed 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.982 1.313 . . . . 2.02 108.921 172.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG23 HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -79.11 157.74 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 123.291 0.636 . . . . 1.75 110.678 172.136 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.33 144.94 22.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.063 0.545 . . . . 0.9 110.332 176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mp -85.53 -41.33 15.4 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.956 1.302 . . . . 2.67 108.675 170.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.45 -16.42 3.69 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.071 1.348 . . . . 2.36 112.977 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.6 m -140.79 20.03 2.33 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.432 -0.793 . . . . 2.2 110.392 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.3 m120 36.77 47.27 0.54 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.712 2.005 . . . . 2.24 113.834 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.45 171.7 13.93 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 117.986 0.357 . . . . 2.18 111.386 -165.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.59 108.03 5.56 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.54 2.336 . . . . 0.77 106.211 173.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -87.42 114.48 24.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.722 -2.325 . . . . 0.88 104.722 162.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 67.5 mt -123.16 111.5 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.399 -2.074 . . . . 1.99 105.399 178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.96 134.23 36.24 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.014 -1.476 . . . . 2.65 107.014 170.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -148.32 149.57 32.06 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 117.815 0.279 . . . . 2.69 111.365 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -80.73 115.09 53.17 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 107.42 -1.326 . . . . 3.03 107.42 167.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -73.43 -13.11 25.24 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.124 2.55 . . . . 1.61 113.175 -174.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -88.92 -44.87 10.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.513 -0.921 . . . . 2.82 108.513 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 81.5 mt -72.2 -42.26 66.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 122.848 0.459 . . . . 2.88 110.556 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 mm -125.14 115.47 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 106.18 -1.785 . . . . 1.25 106.18 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.58 148.51 51.24 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 108.178 -1.969 . . . . 0.89 108.178 171.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -57.44 -40.92 77.41 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 CA-C-N 119.493 1.646 . . . . 1.28 110.37 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.418 ' HG3' ' CE1' ' A' ' 60' ' ' HIS . 26.9 tpt180 -56.35 -28.56 59.43 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.553 -0.737 . . . . 6.12 112.153 174.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -71.7 -39.24 70.32 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 120.123 1.329 . . . . 2.5 112.046 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.5 mt -56.48 -47.46 81.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.604 -0.887 . . . . 0.83 108.604 171.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.6 mt -61.26 -45.23 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 118.851 -0.595 . . . . 1.19 110.204 177.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.418 ' CE1' ' HG3' ' A' ' 56' ' ' ARG . 29.4 m170 -50.85 -43.55 59.31 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 119.371 0.987 . . . . 3.72 110.201 173.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 24.6 m -65.54 -54.54 26.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.35 -0.981 . . . . 0.98 108.35 -177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.8 mt -49.02 -53.41 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.026 0.93 . . . . 1.46 110.823 177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -52.48 -53.58 43.78 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.854 0.861 . . . . 2.18 110.145 174.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.1 t -62.73 -26.53 68.73 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 117.788 -1.101 . . . . 1.3 113.091 -174.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -68.16 -91.37 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.854 1.206 . . . . 2.2 109.937 172.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.98 40.89 0.42 Allowed Glycine 0 CA--C 1.524 0.604 0 O-C-N 120.936 -1.103 . . . . 0.97 111.646 174.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -138.82 176.44 8.69 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 117.954 0.877 . . . . 2.71 110.124 -162.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -133.64 164.61 26.82 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.434 -1.321 . . . . 4.22 107.434 167.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.12 166.78 23.27 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.97 0.908 . . . . 1.27 112.118 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.9 m -150.76 155.54 39.47 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 106.708 -1.589 . . . . 1.78 106.708 160.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp -71.63 144.5 49.4 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.557 1.072 . . . . 2.68 109.243 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 69.7 t -69.98 -65.9 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 N-CA-C 108.754 -0.832 . . . . 4.41 108.754 176.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.19 165.83 18.07 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.233 -0.654 . . . . 3.96 109.233 173.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 25.9 pt -67.23 125.09 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 106.784 -1.561 . . . . 6.42 106.784 161.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 C--O 1.253 1.246 0 C-N-CA 124.86 1.264 . . . . 12.32 110.791 -175.291 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ttm . . . . . 0 N--CA 1.472 0.671 0 N-CA-C 107.493 -1.299 . . . . 11.37 107.493 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.37 64.36 2.49 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 109.193 -1.563 . . . . 6.37 109.193 167.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -50.56 -60.63 2.83 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 124.844 1.258 . . . . 9.53 110.835 -168.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 75.76 -64.01 2.67 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.455 -1.058 . . . . 1.86 110.455 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -119.81 136.12 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 126.052 1.741 . . . . 2.14 110.407 -176.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.28 112.71 5.3 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 123.958 0.903 . . . . 3.14 108.822 176.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.62 113.8 27.61 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 122.992 0.517 . . . . 2.95 109.989 173.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.2 mt -86.51 157.07 19.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 124.645 1.215 . . . . 2.51 108.076 171.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.62 142.07 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 105.632 -1.988 . . . . 1.02 105.632 148.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.8 t -135.06 114.25 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 126.314 1.846 . . . . 2.01 106.821 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -110.37 170.97 7.73 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 124.73 1.212 . . . . 6.57 110.466 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.15 -47.78 2.42 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.723 -0.951 . . . . 1.3 110.723 -173.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -51.4 -45.71 62.63 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 121.964 0.888 . . . . 2.92 112.071 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.317 9.3 t 58.71 -63.25 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.986 2.114 . . . . 3.21 115.32 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 p -110.6 162.13 15.03 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 120.271 1.396 . . . . 1.44 112.82 -163.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.7 -48.17 5.5 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 125.58 1.552 . . . . 1.22 111.516 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -51.51 -48.43 62.94 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.098 1.359 . . . . 2.39 111.438 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.6 m -72.71 -42.89 63.69 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 122.147 -0.346 . . . . 0.95 110.858 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.3 t -52.1 -64.1 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 117.928 0.331 . . . . 1.17 110.553 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -28.46 68.2 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.847 -1.158 . . . . 1.57 111.716 -173.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -57.44 -55.23 37.49 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.389 0.675 . . . . 2.67 109.581 169.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.7 mt -55.88 -52.07 53.36 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 108.996 -0.742 . . . . 0.95 108.996 178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -50.83 -60.23 3.28 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.768 0.827 . . . . 3.54 109.785 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.2 t -53.65 -45.95 70.39 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.517 0.727 . . . . 1.17 110.417 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 22.7 t -58.96 -53.37 59.18 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.45 -0.944 . . . . 1.3 108.45 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -49.84 -50.76 44.14 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.911 0.884 . . . . 2.78 110.793 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.0 m -57.49 -24.88 58.43 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.732 0.641 . . . . 2.01 112.732 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -63.5 -33.1 74.82 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.356 -0.84 . . . . 7.89 110.792 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -55.18 143.1 28.67 Favored 'General case' 0 C--N 1.341 0.198 0 N-CA-C 108.558 -0.904 . . . . 2.51 108.558 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.79 159.65 16.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.084 -1.821 . . . . 6.93 106.084 163.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.45 -16.39 45.03 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 122.215 -0.303 . . . . 1.59 113.065 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 pp -78.86 141.14 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 108.191 -1.04 . . . . 3.16 108.191 170.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.6 -47.09 9.5 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.409 1.484 . . . . 3.26 108.318 172.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 92.8 t80 -156.98 158.09 35.93 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.706 -1.22 . . . . 2.27 107.706 -175.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 p -135.08 151.17 50.5 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.717 -1.216 . . . . 2.66 107.717 161.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 t -154.35 146.52 23.74 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.061 -0.718 . . . . 2.42 109.061 152.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.26 152.22 33.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 124.971 1.309 . . . . 1.83 110.207 -176.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.25 155.97 34.75 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-O 121.026 0.441 . . . . 0.8 111.185 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.98 -8.51 14.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.77 1.628 . . . . 1.92 113.046 -165.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.53 -57.62 6.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.034 -1.099 . . . . 1.96 108.034 169.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 m -79.9 -28.99 39.76 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.203 0.601 . . . . 2.52 111.301 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.2 m120 73.91 56.59 0.1 Allowed 'General case' 0 C--N 1.343 0.3 0 C-N-CA 125.542 1.537 . . . . 1.61 108.235 -173.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -124.86 159.22 31.58 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.749 1.22 . . . . 4.07 110.793 -166.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -142.35 96.98 3.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 125.31 1.631 . . . . 1.05 107.894 174.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -81.16 102.42 10.29 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.506 -1.664 . . . . 1.16 106.506 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 46' ' ' ILE . 1.6 mp -101.33 150.11 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 106.027 -1.842 . . . . 1.74 106.027 167.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -120.57 137.64 54.3 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.931 -1.878 . . . . 3.15 105.931 161.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -150.69 154.8 38.09 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 123.579 0.752 . . . . 2.1 111.892 -167.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -74.75 126.02 88.92 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 108.308 -0.997 . . . . 3.67 108.308 159.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.57 -19.2 16.91 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.413 2.742 . . . . 1.71 113.296 -171.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -83.31 -47.34 11.59 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.625 -0.88 . . . . 3.46 108.625 -176.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 tp -71.98 -40.92 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 119.68 -0.2 . . . . 3.7 111.133 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 mm -127.22 110.64 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 107.421 -1.326 . . . . 1.43 107.421 -174.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.48 158.57 39.7 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 108.91 -1.676 . . . . 0.82 108.91 168.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -55.66 -40.47 85.1 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.25 1.967 . . . . 1.23 109.269 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -29.29 -58.23 0.15 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.119 2.168 . . . . 9.53 112.261 163.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -70.58 -43.5 69.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.7 0.762 . . . . 2.41 109.662 -168.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 mt -58.68 -51.54 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-N 115.87 -0.605 . . . . 0.85 109.405 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.2 mt -52.45 -55.48 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.218 -0.66 . . . . 1.18 109.218 176.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 56.0 m170 -51.53 -42.17 61.56 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.957 0.503 . . . . 3.51 111.284 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 31.2 m -62.18 -51.21 68.73 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.718 -0.614 . . . . 1.04 109.79 178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -59.96 -40.85 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 124.465 1.106 . . . . 2.6 111.363 -177.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.04 -53.54 57.15 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.871 0.868 . . . . 2.02 109.955 168.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.6 t -60.96 -27.41 68.24 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.495 0.718 . . . . 1.44 112.174 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.2 mt -66.04 -85.9 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.719 -0.845 . . . . 2.02 108.719 166.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.74 18.54 0.18 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.489 -1.173 . . . . 1.24 114.608 169.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -132.58 151.85 51.8 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 119.441 1.62 . . . . 1.99 111.495 -148.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -78.5 163.96 25.13 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.119 -1.067 . . . . 4.86 108.119 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.12 158.09 42.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 121.395 -0.122 . . . . 0.94 110.902 160.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.5 t -155.18 134.52 12.46 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.543 -0.91 . . . . 2.53 108.543 173.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.14 120.93 24.36 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.6 -0.687 . . . . 2.33 109.283 177.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.6 p -156.74 151.9 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 O-C-N 121.92 -0.487 . . . . 2.94 110.946 -174.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 171.06 122.71 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 129.077 2.951 . . . . 5.21 106.475 169.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.1 pt -149.67 164.46 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 106.692 -1.596 . . . . 6.28 106.692 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 . . . . . 0 C--O 1.255 1.374 0 N-CA-C 104.945 -2.243 . . . . 10.73 104.945 173.58 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.471 0.593 0 N-CA-C 107.275 -1.38 . . . . 12.01 107.275 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.04 -52.76 4.67 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.355 -1.098 . . . . 4.8 110.355 -173.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 3.98 95.99 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 128.537 2.735 . . . . 5.04 114.409 167.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.09 79.71 0.74 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 109.34 -1.504 . . . . 1.89 109.34 173.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.0 t -75.93 133.9 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 107.555 -1.276 . . . . 2.45 107.555 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 tp -136.09 121.06 18.73 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.215 -1.402 . . . . 2.29 107.215 162.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -109.53 70.81 0.74 Allowed 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 125.17 1.388 . . . . 3.58 108.361 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.615 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -78.32 149.96 33.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.13 -0.628 . . . . 2.79 109.439 178.253 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.47 135.26 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 105.52 -2.03 . . . . 0.66 105.52 164.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.08 131.75 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 125.509 1.524 . . . . 2.36 108.003 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -123.67 163.35 21.25 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.886 0.874 . . . . 5.58 109.834 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.56 -15.42 62.79 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.997 0.808 . . . . 1.23 111.856 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.481 ' SD ' HD12 ' A' ' 22' ' ' ILE . 50.8 mtm -70.33 77.61 0.54 Allowed 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 117.891 0.846 . . . . 1.69 110.31 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -70.52 -14.87 62.69 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 117.984 -1.008 . . . . 1.59 113.35 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 p -161.64 169.93 20.68 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 119.652 1.114 . . . . 0.74 109.682 177.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.11 -36.73 30.9 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.331 1.052 . . . . 1.01 111.6 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -47.57 -38.84 15.17 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.334 1.853 . . . . 1.87 112.196 173.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.5 m -71.5 -54.81 9.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 122.039 -0.413 . . . . 0.73 110.117 172.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.4 t -49.05 -60.6 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.189 0.995 . . . . 0.98 110.494 -173.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.21 -27.21 67.06 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.163 -0.615 . . . . 0.8 111.643 -175.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -64.69 -50.95 64.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.952 -0.759 . . . . 2.96 108.952 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.481 HD12 ' SD ' ' A' ' 13' ' ' MET . 19.9 mt -53.09 -58.35 3.07 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.294 0 N-CA-C 108.946 -0.761 . . . . 1.05 108.946 172.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -49.13 -57.71 6.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.417 0.627 . . . . 3.87 110.921 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -62.26 -41.18 98.22 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.268 1.027 . . . . 0.81 111.112 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.8 t -67.0 -45.23 78.2 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.534 -0.913 . . . . 1.16 108.534 -176.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -70.91 -49.31 47.14 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 118.796 -0.621 . . . . 2.85 112.203 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.4 p -54.87 -25.43 28.75 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.883 0.765 . . . . 1.94 112.632 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.4 tpmt? -45.34 -44.28 11.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.894 1.278 . . . . 6.19 112.646 168.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -64.94 117.53 7.74 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.422 1.089 . . . . 1.67 108.869 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 51.4 ttt180 -75.2 36.11 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.523 1.129 . . . . 6.54 113.354 -169.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -132.46 -5.81 3.19 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.397 1.475 . . . . 0.96 111.519 168.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 10.5 mm -83.84 109.46 17.37 Favored 'Isoleucine or valine' 0 C--N 1.344 0.329 0 N-CA-C 107.021 -1.474 . . . . 3.98 107.021 177.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.9 mt -79.72 -38.88 32.42 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.803 0.841 . . . . 1.93 109.489 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -154.38 158.21 39.7 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 108.809 -0.812 . . . . 1.93 108.809 174.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.9 t -139.36 134.84 33.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.244 1.018 . . . . 2.32 108.516 171.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.1 t -134.54 85.38 2.18 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.054 -1.091 . . . . 1.67 108.054 169.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 44' ' ' ALA . 1.1 m -78.9 149.76 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 125.234 1.413 . . . . 1.93 110.081 170.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.15 132.17 10.84 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.014 0.526 . . . . 0.77 109.756 166.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -69.88 -35.36 74.59 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 109.406 -0.591 . . . . 1.75 109.406 167.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.92 -35.82 64.58 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.786 0.835 . . . . 1.33 111.826 -174.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.9 m -119.26 18.04 13.04 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.868 0.867 . . . . 2.12 110.325 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.1 m120 33.95 48.89 0.25 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 126.279 1.831 . . . . 1.86 113.489 -176.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.96 162.84 26.66 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.797 -0.446 . . . . 2.39 109.797 -169.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 37' ' ' VAL . . . -146.43 100.92 3.42 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.713 -0.847 . . . . 0.69 108.713 169.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -80.3 100.41 8.37 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.621 -1.992 . . . . 1.14 105.621 166.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.421 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.8 mp -94.35 135.36 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 N-CA-C 105.797 -1.927 . . . . 1.62 105.797 165.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.0 mmtp -100.45 117.02 33.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 104.831 -2.285 . . . . 2.19 104.831 158.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -117.14 168.81 9.95 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.544 0.738 . . . . 1.95 110.006 172.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.02 133.99 26.71 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 107.238 -1.393 . . . . 3.61 107.238 153.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -72.8 -10.69 25.2 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.558 2.172 . . . . 1.72 113.475 -174.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -83.22 -47.54 11.44 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.39 -0.967 . . . . 3.34 108.39 -173.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.8 mm -81.89 -36.72 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-O 118.723 -0.656 . . . . 2.66 110.927 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 mm -133.72 118.02 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 119.293 0.951 . . . . 1.38 108.534 -174.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.75 176.71 47.9 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 110.16 -1.176 . . . . 0.91 110.16 169.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.52 -42.17 22.52 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.663 2.242 . . . . 1.01 109.985 174.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.85 -54.71 5.04 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.212 1.405 . . . . 7.51 111.214 173.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -53.13 -55.93 20.2 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 118.462 0.574 . . . . 2.46 110.516 -176.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 11.9 mt -59.85 -53.26 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 CA-C-N 116.236 -0.438 . . . . 0.77 110.012 -176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.9 mt -53.59 -54.66 17.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 109.487 -0.56 . . . . 1.08 109.487 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -52.06 -41.27 62.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.267 1.027 . . . . 4.31 111.531 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 44.9 m -69.85 -48.51 58.58 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.721 -0.474 . . . . 1.01 109.721 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 73.8 mt -51.47 -50.64 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 109.527 -0.546 . . . . 1.26 109.527 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.05 -55.58 31.17 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.934 0.893 . . . . 2.46 111.171 176.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 97.7 p -62.68 -32.12 73.14 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.899 -0.572 . . . . 1.78 112.054 -173.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -58.92 -85.44 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.57 0.623 . . . . 2.65 111.17 171.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.59 25.86 0.25 Allowed Glycine 0 CA--C 1.526 0.752 0 O-C-N 121.151 -0.968 . . . . 0.98 113.833 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.409 ' CD2' HD11 ' A' ' 22' ' ' ILE . 29.2 m-85 -137.2 177.35 7.93 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.617 1.209 . . . . 1.64 111.069 -155.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -120.43 157.57 29.04 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 107.856 -1.164 . . . . 3.48 107.856 171.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.41 152.98 40.68 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.75 0.42 . . . . 0.9 111.253 167.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.3 m -156.4 135.44 11.97 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.604 1.162 . . . . 2.2 109.38 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.4 mp -53.28 -67.58 0.24 Allowed 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.271 1.028 . . . . 2.79 110.442 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . 0.316 7.6 p 59.22 -43.82 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 128.967 2.907 . . . . 3.8 116.961 177.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -65.35 88.92 0.09 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.391 1.077 . . . . 4.78 111.764 -175.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.1 pt -57.87 169.56 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.972 1.309 . . . . 5.36 111.303 167.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.254 1.337 0 C-N-CA 127.919 2.488 . . . . 8.72 111.872 -176.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 110.198 -0.297 . . . . 13.01 110.198 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.4 62.09 0.64 Allowed Glycine 0 CA--C 1.52 0.393 0 N-CA-C 105.748 -2.941 . . . . 5.53 105.748 170.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -149.87 168.64 23.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.284 -1.376 . . . . 6.37 107.284 -158.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.32 95.42 0.14 Allowed Glycine 0 CA--C 1.523 0.542 0 N-CA-C 108.417 -1.873 . . . . 1.29 108.417 170.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 m -118.54 131.38 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 106.442 -1.688 . . . . 2.21 106.442 168.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.2 99.19 5.77 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.091 0.956 . . . . 2.72 108.63 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -87.46 106.75 18.19 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 107.194 -1.41 . . . . 3.03 107.194 161.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.91 150.16 30.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.51 -0.922 . . . . 2.4 108.51 168.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.55 142.7 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 104.787 -2.301 . . . . 0.76 104.787 159.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.9 p -139.66 135.54 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 106.796 -1.557 . . . . 2.26 106.796 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.2 mmt180 -134.51 168.78 18.34 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.294 1.438 . . . . 8.18 108.915 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.88 -14.59 61.41 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 123.903 0.764 . . . . 1.29 111.222 -163.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 70.1 mtp -68.51 77.6 0.28 Allowed 'General case' 0 C--N 1.341 0.225 0 CA-C-N 118.194 0.997 . . . . 1.85 110.799 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.5 p -61.09 -41.39 96.57 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 118.72 -0.657 . . . . 3.05 112.516 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.3 p -156.28 -179.37 8.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.171 0.896 . . . . 0.7 112.794 -166.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.09 -40.7 46.54 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.812 1.245 . . . . 0.85 111.577 176.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.0 m -60.81 -29.49 69.5 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.086 0.554 . . . . 1.47 111.898 177.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.7 m -71.85 -58.58 3.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 118.902 0.774 . . . . 0.67 109.927 167.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.0 t -38.7 -64.78 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.937 1.295 . . . . 1.2 111.481 -177.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.58 -28.45 65.98 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.181 -0.608 . . . . 0.96 111.69 -172.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -66.56 -52.49 45.02 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.88 -0.785 . . . . 3.44 108.88 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.1 mt -54.6 -59.37 2.29 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 N-CA-C 108.341 -0.985 . . . . 0.7 108.341 176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -50.15 -62.99 1.25 Allowed 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 124.057 0.848 . . . . 3.8 110.097 -175.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.6 t -56.32 -41.28 75.73 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.484 0.714 . . . . 0.82 111.163 -177.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 t -65.58 -54.13 32.19 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.417 -0.957 . . . . 1.17 108.417 -176.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.9 mp -52.42 -46.58 66.41 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 122.794 0.438 . . . . 2.69 110.911 175.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.1 m -62.8 -9.83 10.87 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.964 0.728 . . . . 2.09 112.964 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -25.1 62.11 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 120.718 -1.239 . . . . 5.57 111.963 169.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -69.54 140.89 53.93 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 107.553 -1.277 . . . . 1.81 107.553 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 57.9 ttm-85 -81.81 -28.02 33.34 Favored 'General case' 0 C--O 1.226 -0.154 0 O-C-N 121.41 -0.807 . . . . 5.52 111.846 -177.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.8 5.47 83.7 Favored Glycine 0 CA--C 1.533 1.16 0 CA-C-O 119.454 -0.636 . . . . 0.91 113.802 -173.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 pp -80.39 159.06 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 118.513 1.157 . . . . 2.99 109.415 164.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.4 mt -113.88 -39.78 3.9 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 125.466 1.506 . . . . 2.25 109.316 176.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -156.15 156.61 34.53 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 109.449 -0.575 . . . . 2.1 109.449 174.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.1 m -138.16 135.21 35.46 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.495 -1.669 . . . . 2.65 106.495 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 40.5 t -147.97 143.77 27.53 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 106.684 -1.598 . . . . 1.96 106.684 163.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 m -137.5 144.03 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.399 1.079 . . . . 1.79 108.741 -175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.29 111.55 6.81 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.638 1.175 . . . . 0.75 110.002 -175.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.94 -22.89 61.4 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.309 1.444 . . . . 1.38 113.152 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.51 -50.28 53.37 Favored 'General case' 0 C--O 1.226 -0.159 0 N-CA-C 108.38 -0.97 . . . . 1.55 108.38 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -78.61 -19.96 51.5 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.192 0.997 . . . . 2.09 110.878 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.4 m120 57.84 46.48 16.84 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 126.118 1.767 . . . . 1.55 109.971 -172.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.47 157.86 45.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.97 -0.381 . . . . 3.32 109.97 -170.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -137.69 127.65 25.71 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.844 -1.169 . . . . 0.98 107.844 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -99.17 98.27 9.28 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 105.332 -2.099 . . . . 0.96 105.332 174.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.0 mm -94.58 147.65 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 106.135 -1.802 . . . . 1.79 106.135 170.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -124.62 135.75 53.37 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.428 -2.434 . . . . 3.73 104.428 159.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -156.34 160.66 39.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.255 0.622 . . . . 2.08 109.902 -162.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -93.44 125.79 52.72 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.752 -0.833 . . . . 3.15 108.752 171.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.0 -14.28 29.15 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.824 2.35 . . . . 1.77 113.875 -172.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -121.19 25.4 9.56 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.866 1.212 . . . . 3.15 112.402 -175.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.7 tp -132.39 -63.56 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-O 118.988 -0.529 . . . . 3.57 110.283 159.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -78.95 -44.28 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 119.669 1.122 . . . . 3.03 108.321 176.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.22 168.51 18.77 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.109 -0.567 . . . . 1.75 111.805 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -71.52 -57.28 0.1 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.043 1.829 . . . . 1.26 111.731 -170.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 ttt-85 -70.64 -20.16 62.75 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 113.064 0.765 . . . . 6.3 113.064 -167.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.31 -35.1 71.14 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 119.438 1.017 . . . . 3.8 112.93 -175.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.3 mt -48.84 -50.22 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 O-C-N 121.432 -0.793 . . . . 0.99 109.236 164.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.1 mt -63.15 -42.6 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 117.715 -1.136 . . . . 1.18 110.727 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 36.8 m170 -49.55 -44.05 46.32 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.39 1.45 . . . . 3.46 110.152 170.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.4 m -66.29 -50.49 63.49 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.32 -0.622 . . . . 0.77 109.32 -175.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.476 HG23 ' HB2' ' A' ' 67' ' ' PHE . 64.0 mt -52.97 -52.81 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 124.537 1.135 . . . . 1.4 110.959 176.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -53.96 -53.92 46.06 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.107 1.363 . . . . 1.9 110.293 175.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t -58.91 -41.77 88.05 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.111 0.964 . . . . 1.24 111.436 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.3 mt -64.13 -84.05 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.584 0.353 . . . . 1.99 110.897 -178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.24 22.51 0.22 Allowed Glycine 0 CA--C 1.527 0.811 0 CA-C-O 118.638 -1.09 . . . . 0.87 113.818 176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.476 ' HB2' HG23 ' A' ' 62' ' ' ILE . 39.0 m-85 -134.92 162.62 31.9 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 118.945 1.372 . . . . 1.66 111.047 -156.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -115.78 152.1 33.93 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.335 1.454 . . . . 3.84 107.412 175.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.85 166.53 33.12 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 119.424 1.011 . . . . 1.34 113.276 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 p -155.33 123.21 5.73 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.193 1.397 . . . . 2.07 109.791 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -54.48 135.34 45.8 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 123.342 0.657 . . . . 2.22 109.942 170.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.9 t -95.4 -74.35 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.044 -1.095 . . . . 2.9 108.044 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? 62.59 -65.14 0.09 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.492 1.917 . . . . 5.59 113.931 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.3 mm 54.65 42.68 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 125.223 1.409 . . . . 5.48 109.381 -165.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 . . . . . 0 C--O 1.259 1.579 0 C-N-CA 130.398 3.479 . . . . 11.56 102.366 -172.89 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mmm . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 106.696 -1.594 . . . . 10.28 106.696 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 58.69 60.08 9.59 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 107.741 -2.144 . . . . 4.46 107.741 -163.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -136.11 176.56 8.58 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.416 0.524 . . . . 4.19 112.416 -145.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.04 66.06 0.32 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 106.955 -2.458 . . . . 2.05 106.955 172.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.33 129.2 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 109.416 -0.587 . . . . 2.15 109.416 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.36 136.8 39.95 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.259 1.024 . . . . 2.79 108.529 176.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.21 144.01 48.83 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.617 -1.994 . . . . 4.87 105.617 167.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.14 147.8 24.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.696 -0.853 . . . . 2.18 108.696 167.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.31 134.58 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 105.665 -1.976 . . . . 0.99 105.665 173.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.3 t -116.44 117.91 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 N-CA-C 106.873 -1.528 . . . . 2.16 106.873 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.1 mtt180 -85.59 143.83 28.23 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 108.09 -1.078 . . . . 6.89 108.09 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 98.14 -1.0 58.98 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-O 119.088 -0.84 . . . . 1.2 113.684 173.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.3 mtp -71.4 72.38 0.69 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 119.138 1.469 . . . . 1.68 110.436 175.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -73.97 -17.0 61.06 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 117.683 -1.151 . . . . 1.55 113.819 -169.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.2 p -159.01 172.75 17.62 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 120.23 1.377 . . . . 0.89 110.724 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.58 -36.7 35.98 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.406 1.082 . . . . 0.88 111.794 177.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.3 t -56.53 -45.4 81.16 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.873 -0.417 . . . . 2.27 109.873 175.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.9 m -63.7 -47.81 79.63 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 121.684 -0.635 . . . . 0.7 110.527 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.2 t -49.66 -66.87 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 109.439 -0.578 . . . . 0.88 109.439 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.288 0.1 OUTLIER -71.19 -23.45 62.04 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 118.954 -1.098 . . . . 1.14 112.804 -173.523 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -52.99 -49.44 66.17 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.718 1.144 . . . . 3.43 109.15 169.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.7 mt -56.95 -59.05 3.52 Favored 'Isoleucine or valine' 0 C--N 1.339 0.145 0 N-CA-C 109.529 -0.545 . . . . 0.79 109.529 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.3 -47.65 84.58 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.125 0.488 . . . . 4.65 111.064 -171.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.5 t -57.07 -33.91 67.74 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.818 1.247 . . . . 1.03 110.826 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 35.7 m -71.72 -60.64 2.13 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 121.705 -0.622 . . . . 1.67 109.409 173.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -54.6 -42.82 71.59 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.433 0.693 . . . . 2.74 112.179 -171.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.2 p -57.39 -18.77 19.33 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.462 0.542 . . . . 2.26 112.462 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -70.79 -27.81 64.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.041 0.937 . . . . 6.34 111.743 175.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -70.74 -12.05 61.32 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 114.039 1.125 . . . . 3.17 114.039 -165.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.6 mmp_? 72.17 -44.54 0.6 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 126.281 1.832 . . . . 6.91 113.567 177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.15 53.21 1.79 Allowed Glycine 0 CA--C 1.525 0.689 0 CA-C-N 119.036 0.835 . . . . 1.65 111.223 169.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.44 133.55 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 106.722 -1.584 . . . . 3.4 106.722 177.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.0 mt -88.66 -45.55 9.74 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.833 -1.173 . . . . 2.28 107.833 167.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -157.15 154.32 29.14 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 122.198 -0.314 . . . . 2.6 111.017 -178.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.3 t -130.2 110.63 11.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.777 1.231 . . . . 2.08 109.932 170.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.1 t -115.71 84.9 2.18 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.224 1.81 . . . . 1.73 107.86 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.76 152.15 3.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.343 1.057 . . . . 2.1 110.341 174.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.08 135.06 12.95 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 119.394 -0.336 . . . . 0.84 110.137 170.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.8 pp -69.55 -32.3 71.02 Favored 'General case' 0 C--O 1.226 -0.182 0 O-C-N 123.409 0.443 . . . . 1.54 110.203 168.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.86 -48.17 60.2 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.386 0.674 . . . . 1.28 111.281 -176.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.1 p -105.52 10.06 33.27 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.327 1.451 . . . . 2.24 111.451 177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.3 m120 41.17 47.66 2.88 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.185 1.794 . . . . 1.61 112.299 -175.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.71 171.2 11.38 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.149 0.58 . . . . 2.45 111.679 -165.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.99 87.41 1.41 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.954 1.302 . . . . 0.92 109.809 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -79.25 96.47 5.93 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 106.797 -1.557 . . . . 1.06 106.797 171.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.32 141.31 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.983 -1.488 . . . . 1.67 106.983 171.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -114.52 116.42 28.79 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 104.207 -2.516 . . . . 2.6 104.207 165.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -125.69 157.3 37.66 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 123.874 0.87 . . . . 1.98 111.65 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.92 114.9 59.51 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.905 1.682 . . . . 5.05 107.879 176.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.79 36.2 0.6 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.481 2.121 . . . . 2.38 113.762 -166.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -140.22 33.23 1.91 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.421 1.088 . . . . 3.3 110.18 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 tp -171.83 -49.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 124.891 1.276 . . . . 4.01 108.671 -170.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mm -122.91 132.73 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 N-CA-C 105.384 -2.08 . . . . 1.33 105.384 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.72 -179.7 19.48 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 125.839 1.685 . . . . 1.09 109.311 167.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.65 -40.59 28.97 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.338 2.025 . . . . 0.99 110.306 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -42.19 69.8 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.187 0.595 . . . . 9.59 111.469 -179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -58.98 -54.14 50.49 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 109.305 -0.628 . . . . 2.2 109.305 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.5 mt -56.9 -50.41 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 123.616 0.766 . . . . 0.69 109.933 -178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 49.6 mt -53.09 -57.42 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.316 0.646 . . . . 1.38 109.957 176.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -52.34 -44.59 65.27 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.236 0.614 . . . . 3.5 110.44 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 60.6 m -64.11 -51.2 65.13 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.308 -0.627 . . . . 0.81 109.308 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.3 mt -51.9 -59.7 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 123.792 0.837 . . . . 1.39 109.157 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -63.14 -47.91 80.71 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 119.676 -0.81 . . . . 1.91 109.979 -169.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.4 t -54.23 -39.95 67.23 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.154 0.582 . . . . 1.49 111.863 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.4 mt -61.23 -59.63 5.0 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.825 0.739 . . . . 2.33 112.431 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.31 16.0 0.14 Allowed Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.409 -1.217 . . . . 1.15 115.432 174.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -143.07 -179.74 6.55 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 119.008 1.404 . . . . 2.15 111.44 -142.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -127.91 154.4 45.57 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 105.765 -1.939 . . . . 3.67 105.765 163.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -113.95 154.52 27.44 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.98 0.809 . . . . 1.16 110.532 174.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 74.3 m -155.26 103.45 2.35 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.102 1.361 . . . . 2.39 109.453 177.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 mt -52.57 135.55 34.1 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.215 0.606 . . . . 2.43 109.453 169.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.8 m -137.13 141.78 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.977 -1.12 . . . . 2.96 107.977 176.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.79 176.32 1.23 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.728 2.011 . . . . 5.6 106.414 176.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.481 HD13 ' H ' ' A' ' 74' ' ' ILE . 0.1 OUTLIER -129.84 -175.94 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 106.227 -1.768 . . . . 6.2 106.227 160.434 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 . . . . . 0 C--O 1.249 1.044 0 C-N-CA 128.208 2.603 . . . . 10.13 104.483 163.42 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpt . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 110.033 -0.358 . . . . 8.65 110.033 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -114.08 44.87 1.4 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 106.301 -2.72 . . . . 4.38 106.301 169.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 167.48 157.05 0.03 OUTLIER 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.736 2.014 . . . . 4.24 106.737 -153.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.38 167.49 24.44 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 108.19 -1.964 . . . . 1.37 108.19 169.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.4 t -98.11 144.79 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 124.753 1.221 . . . . 2.66 108.909 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.8 tp -127.81 123.24 34.71 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 106.418 -1.697 . . . . 2.66 106.418 165.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -120.8 126.52 50.31 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 108.274 -1.01 . . . . 4.09 108.274 179.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.17 155.65 48.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 123.571 0.545 . . . . 3.05 109.994 178.186 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.8 t -78.45 112.24 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 104.435 -2.432 . . . . 1.03 104.435 166.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.9 p -79.6 137.6 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 106.889 -1.523 . . . . 2.81 106.889 166.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -139.28 173.54 11.44 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.194 1.398 . . . . 6.23 108.377 -179.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.39 -46.82 2.28 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 111.478 -0.649 . . . . 1.55 111.478 -176.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.16 136.92 46.62 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.531 -0.914 . . . . 2.45 108.531 -177.128 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -141.56 8.46 1.97 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 115.726 1.75 . . . . 1.93 115.726 -156.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.6 p -159.39 173.19 16.62 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 121.173 1.806 . . . . 0.7 111.782 174.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.59 -42.64 56.01 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.207 1.003 . . . . 0.59 111.135 175.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 m -65.93 -20.95 66.39 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.761 0.824 . . . . 1.7 112.286 178.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.3 m -73.51 -62.1 1.6 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.036 0.835 . . . . 0.82 111.222 158.526 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 47.1 t -39.43 -63.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 C-N-CA 124.588 1.155 . . . . 0.91 111.457 -173.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.87 -29.87 70.38 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.439 -0.505 . . . . 0.77 111.579 -173.603 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -70.45 -44.78 67.12 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.68 0.792 . . . . 3.36 108.976 -178.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.2 mt -55.2 -59.14 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.393 -0.966 . . . . 0.95 108.393 175.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -55.77 -53.92 50.78 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 117.979 0.354 . . . . 3.87 111.014 -178.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -55.37 -36.51 66.42 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.005 0.922 . . . . 0.79 111.973 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.3 t -70.1 -54.72 11.8 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.132 -1.062 . . . . 1.2 108.132 177.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 mp -57.46 -42.72 83.12 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.155 0.582 . . . . 2.48 112.179 -174.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.3 p -60.09 -12.46 8.4 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 121.265 -0.897 . . . . 1.9 113.029 178.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.4 -32.59 74.27 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.093 0.86 . . . . 4.09 110.561 172.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -78.29 106.91 10.53 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.218 -0.66 . . . . 1.93 109.218 178.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -57.66 -20.82 36.18 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.871 -1.143 . . . . 6.07 112.62 171.086 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.3 -32.47 72.29 Favored Glycine 0 CA--C 1.526 0.781 0 CA-C-O 118.902 -0.943 . . . . 0.93 112.323 172.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -88.92 137.36 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 118.671 1.236 . . . . 2.43 108.098 170.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 30.9 mt -95.86 -36.53 11.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.552 0.741 . . . . 1.68 109.471 177.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -150.11 153.69 36.82 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 117.774 0.261 . . . . 1.78 110.483 173.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -137.28 130.46 30.88 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.421 1.888 . . . . 2.56 106.728 171.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 14.4 t -128.18 110.45 12.45 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 106.526 -1.657 . . . . 1.7 106.526 168.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -107.59 150.91 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 C-N-CA 124.255 1.022 . . . . 2.67 110.72 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.17 122.54 5.59 Favored 'General case' 0 N--CA 1.455 -0.199 0 O-C-N 121.856 -0.528 . . . . 0.79 111.177 174.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.12 -26.36 67.41 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 123.371 0.668 . . . . 1.6 109.936 161.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.2 -49.19 77.91 Favored 'General case' 0 C--N 1.339 0.144 0 CA-C-N 118.259 0.481 . . . . 1.17 109.884 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.45 -37.51 36.79 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 122.793 0.437 . . . . 1.99 110.349 173.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 m120 68.89 71.75 0.27 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 106.774 -1.565 . . . . 1.84 106.774 -151.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.33 158.11 43.9 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.173 -0.329 . . . . 2.46 110.251 173.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -127.27 129.58 47.98 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.547 -2.02 . . . . 1.14 105.547 151.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -107.4 116.53 32.11 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 102.85 -3.019 . . . . 1.01 102.85 166.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mm -107.9 149.5 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 104.728 -2.323 . . . . 1.69 104.728 174.2 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.94 139.8 47.51 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.2 -1.037 . . . . 2.44 108.2 157.155 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -162.82 160.83 25.65 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 124.092 0.87 . . . . 2.19 109.718 -153.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -93.37 124.61 57.03 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 108.882 -0.785 . . . . 3.57 108.882 168.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.74 -19.08 24.47 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.935 2.424 . . . . 2.04 113.689 -173.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.32 -48.7 10.88 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 108.003 -1.11 . . . . 4.17 108.003 176.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.4 mt -63.9 -40.13 87.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.093 0 CA-C-O 119.227 -0.416 . . . . 3.11 110.038 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.3 tt -137.34 109.32 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-O 121.346 0.594 . . . . 1.39 110.91 173.079 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.88 141.01 47.26 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 109.411 -1.476 . . . . 1.17 109.411 172.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -55.71 -40.16 86.91 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.741 2.294 . . . . 1.08 111.815 -172.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -56.9 -29.53 63.09 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 118.178 -0.915 . . . . 6.45 112.369 178.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -64.23 -44.18 92.68 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 120.015 1.279 . . . . 4.12 110.35 -179.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.2 mt -56.56 -52.97 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 109.308 -0.627 . . . . 0.62 109.308 175.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 48.1 mm -51.04 -56.87 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.089 0.556 . . . . 1.96 109.833 177.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.33 -34.98 69.32 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.788 0.835 . . . . 4.69 111.465 179.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.3 m -65.47 -52.99 48.98 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.881 -1.155 . . . . 0.89 107.881 179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.1 mt -50.9 -50.74 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 C-N-CA 123.12 0.568 . . . . 1.22 110.237 176.018 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -53.54 -50.28 65.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.047 0.451 . . . . 2.25 110.39 175.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.7 t -67.28 -14.66 63.12 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.512 1.125 . . . . 1.26 113.305 -173.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.5 mp -72.13 -91.01 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.911 1.232 . . . . 2.15 107.709 165.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.44 35.88 0.48 Allowed Glycine 0 CA--C 1.523 0.586 0 O-C-N 121.347 -0.845 . . . . 0.82 111.815 169.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -130.61 177.52 7.32 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.552 0.676 . . . . 1.65 110.927 -156.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -119.73 148.43 43.41 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 106.593 -1.632 . . . . 3.67 106.593 175.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.58 133.42 32.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.919 0.887 . . . . 1.01 108.736 170.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.3 t -133.77 103.39 5.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.34 1.056 . . . . 1.77 109.002 -177.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.08 58.08 0.67 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.809 1.244 . . . . 3.11 110.879 178.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.2 p -64.28 -37.15 79.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 123.848 0.859 . . . . 3.81 110.484 176.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.9 tttm 40.08 79.72 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.726 2.011 . . . . 3.87 113.414 -178.245 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.2 tp -70.49 73.28 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 123.665 0.786 . . . . 7.47 110.068 170.26 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 . . . . . 0 C--O 1.254 1.298 0 C-N-CA 127.551 2.34 . . . . 10.25 109.675 -173.284 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.3 mtm . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 106.46 -1.682 . . . . 9.22 106.46 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -120.63 114.58 2.68 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 108.257 -1.937 . . . . 4.06 108.257 178.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -159.2 165.53 33.43 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.0 -1.482 . . . . 4.24 107.0 177.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 178.35 154.41 12.59 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 107.437 -2.265 . . . . 1.33 107.437 -176.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -117.74 91.57 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.678 1.191 . . . . 2.25 109.65 -177.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -80.71 79.24 7.38 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.277 -1.379 . . . . 2.74 107.277 175.453 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -102.23 116.01 31.75 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.096 -0.956 . . . . 3.85 109.615 174.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -138.91 166.42 24.52 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.915 1.286 . . . . 1.98 110.421 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -77.33 143.55 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 106.54 -1.652 . . . . 0.93 106.54 173.187 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.0 t -136.53 130.49 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 126.025 1.73 . . . . 1.89 107.356 175.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -132.03 156.43 46.28 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.262 1.425 . . . . 5.92 108.618 -174.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.34 -24.56 28.51 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 119.641 -0.533 . . . . 1.1 112.253 177.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.75 76.25 0.85 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 122.396 1.093 . . . . 2.23 110.201 178.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -70.21 -12.34 61.52 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 115.399 1.629 . . . . 1.6 115.399 -157.827 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 18.6 p -157.14 174.02 16.11 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 120.523 1.511 . . . . 0.73 110.724 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.91 -44.54 14.73 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.814 1.245 . . . . 0.74 111.529 177.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 m -57.67 -37.32 73.2 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.525 0.73 . . . . 1.5 111.854 178.507 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.6 m -71.43 -50.35 32.72 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 118.438 0.563 . . . . 0.78 110.306 171.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.9 t -52.38 -56.6 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 122.737 0.415 . . . . 0.9 111.01 -175.676 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.86 -27.96 64.22 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.613 -0.679 . . . . 0.86 112.065 -177.325 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -57.77 -48.04 80.79 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.776 -0.824 . . . . 3.47 108.776 170.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 81.9 mt -56.67 -66.44 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.268 0 N-CA-C 108.743 -0.836 . . . . 0.7 108.743 171.509 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -46.11 -56.43 5.64 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.176 0.99 . . . . 3.79 110.765 -169.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.4 t -57.63 -51.4 69.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 123.562 0.745 . . . . 0.88 110.175 -176.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.1 t -59.78 -40.66 89.0 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.438 0.637 . . . . 1.44 109.724 -178.337 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -49.83 75.01 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.547 0.739 . . . . 2.81 110.759 178.069 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.1 p -56.01 -41.48 74.96 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.202 0.91 . . . . 2.13 110.759 175.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -57.53 -9.67 1.21 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.96 1.304 . . . . 4.63 113.154 175.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 17.7 m170 -56.43 -32.83 65.26 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 119.975 -1.703 . . . . 3.24 111.334 164.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 70.62 -51.05 0.67 Allowed 'General case' 0 C--N 1.339 0.133 0 C-N-CA 126.606 1.962 . . . . 7.56 110.927 -168.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.37 53.39 1.89 Allowed Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.672 0.653 . . . . 1.6 112.775 178.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -136.54 172.02 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 107.399 -1.334 . . . . 3.17 107.399 172.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.9 mt -117.57 -42.12 2.89 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.197 0.999 . . . . 2.16 109.346 -178.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -155.8 156.22 34.39 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 108.659 -0.867 . . . . 2.36 108.659 175.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.1 m -132.8 130.4 39.81 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 105.613 -1.995 . . . . 2.76 105.613 176.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 63.6 p -144.74 98.01 3.12 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.643 -0.873 . . . . 2.67 108.643 173.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.2 p -116.13 139.81 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.493 1.517 . . . . 2.32 109.342 -172.116 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -154.67 123.65 6.28 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 123.072 0.549 . . . . 0.9 110.294 -172.136 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.48 -32.77 74.56 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 109.56 -0.533 . . . . 1.82 109.56 167.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.9 -34.44 67.9 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.792 0.837 . . . . 1.47 111.825 -176.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.0 m -117.44 21.9 12.77 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.843 0.857 . . . . 2.16 109.787 175.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.3 m120 25.6 61.4 0.07 Allowed 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 126.834 2.054 . . . . 1.56 113.66 -172.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.57 166.54 26.17 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 120.619 0.247 . . . . 2.47 111.277 -173.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.411 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -139.02 125.9 20.98 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 124.663 1.227 . . . . 0.68 108.395 160.103 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -108.26 102.16 11.31 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.075 -2.194 . . . . 0.85 105.075 171.123 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.411 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -102.38 118.37 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 105.402 -2.073 . . . . 1.74 105.402 171.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 mmmp? -81.14 130.17 34.9 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.267 -1.753 . . . . 2.59 106.267 164.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -139.74 149.18 43.29 Favored 'General case' 0 N--CA 1.46 0.068 0 C-N-CA 124.265 1.026 . . . . 2.04 109.736 -168.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.76 131.48 70.52 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.465 -1.309 . . . . 2.97 107.465 161.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -82.75 0.13 9.82 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.807 2.338 . . . . 1.48 114.268 -172.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -93.09 -50.39 5.54 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 119.677 1.126 . . . . 4.02 108.148 175.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.8 tt -70.88 -29.89 39.36 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.734 0.642 . . . . 2.64 112.734 -174.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.5 mm -142.69 144.47 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 105.6 -2.0 . . . . 1.38 105.6 -172.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.53 -178.14 15.72 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.187 1.375 . . . . 1.2 110.902 171.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -55.48 -48.13 22.08 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.208 2.605 . . . . 1.51 110.511 174.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -41.4 -61.29 1.07 Allowed 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 125.016 1.326 . . . . 6.86 110.895 176.31 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -53.74 -54.38 38.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.644 0.735 . . . . 2.62 110.387 -173.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 62.2 mt -58.86 -53.75 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 115.808 -0.633 . . . . 0.72 110.023 -177.415 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.1 mt -54.11 -53.23 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.416 -0.587 . . . . 1.19 109.416 179.428 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 52.3 m170 -55.1 -41.25 71.37 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.332 0.653 . . . . 3.52 110.651 179.03 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 45.5 m -62.08 -52.11 65.25 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.11 -0.7 . . . . 0.75 109.11 178.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -53.52 -51.06 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 123.495 0.718 . . . . 1.72 111.086 179.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -58.31 -58.12 9.91 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.602 1.161 . . . . 2.13 110.197 178.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -51.52 -46.94 63.46 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.317 1.047 . . . . 1.22 110.471 -178.841 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.4 mt -61.32 -53.74 52.88 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 119.404 -0.331 . . . . 2.25 111.225 177.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -161.82 -41.48 0.02 OUTLIER Glycine 0 CA--C 1.529 0.919 0 N-CA-C 115.641 1.017 . . . . 1.5 115.641 174.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -122.39 160.83 24.63 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.7 0.63 . . . . 1.78 112.7 -127.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -82.45 150.55 26.99 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.09 -1.078 . . . . 3.68 108.09 -179.233 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.72 160.04 43.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.81 0.444 . . . . 1.15 111.661 172.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.4 m -155.92 128.0 7.54 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.473 0.709 . . . . 1.71 110.871 177.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.5 mt -71.27 66.52 0.44 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.938 0.895 . . . . 3.14 109.546 169.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.9 p -70.54 97.78 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 109.217 -0.66 . . . . 3.21 109.217 178.425 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 38.0 mttp -141.95 122.29 13.98 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.457 -0.942 . . . . 4.64 108.457 173.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.8 mm -145.98 -62.42 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 N-CA-C 104.161 -2.533 . . . . 6.78 104.161 178.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 . . . . . 0 C--O 1.248 1.017 0 N-CA-C 106.698 -1.593 . . . . 10.71 106.698 143.745 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.474 0.762 0 N-CA-C 105.767 -1.938 . . . . 9.41 105.767 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.23 159.19 20.07 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 107.689 -2.164 . . . . 5.21 107.689 134.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -150.82 168.14 25.33 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.464 -1.68 . . . . 5.16 106.464 177.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.04 -2.48 12.48 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.239 1.4 . . . . 2.4 113.447 -178.344 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.8 t -80.79 129.23 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 120.094 1.947 . . . . 3.87 109.127 174.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -150.94 123.05 8.25 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 118.845 0.748 . . . . 3.17 110.102 -175.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.39 121.7 45.9 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.945 1.298 . . . . 5.39 110.926 175.042 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 mt -104.06 160.81 14.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.996 -1.112 . . . . 2.83 107.996 164.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -85.08 143.61 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 N-CA-C 106.246 -1.761 . . . . 1.23 106.246 147.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.2 144.64 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.059 0 N-CA-C 106.139 -1.8 . . . . 2.44 106.139 175.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -146.07 164.77 31.1 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.313 0.645 . . . . 5.89 109.958 -178.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.83 -10.14 40.83 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.577 1.084 . . . . 1.09 111.048 -173.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -73.23 79.16 1.3 Allowed 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.045 0.923 . . . . 2.1 110.144 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -64.33 -15.84 61.08 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.479 -1.248 . . . . 1.64 113.358 -177.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.0 p -165.12 175.84 9.02 Favored 'General case' 0 C--N 1.343 0.314 0 CA-C-N 120.511 1.505 . . . . 0.68 110.753 177.165 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.99 -40.07 43.07 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.935 0.894 . . . . 0.78 111.499 175.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.3 m -57.62 -27.27 62.62 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.83 1.252 . . . . 1.57 111.905 178.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.1 m -73.85 -64.02 1.09 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 118.414 0.552 . . . . 0.72 110.941 162.411 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 64.7 t -44.75 -55.95 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 124.369 1.067 . . . . 0.92 111.646 -168.545 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -30.71 69.57 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.074 0.464 . . . . 1.67 111.559 -175.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.35 -38.4 71.61 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.594 1.158 . . . . 4.18 109.447 -172.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.0 mt -55.93 -64.88 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.583 -0.895 . . . . 0.76 108.583 176.491 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -51.89 -57.51 9.17 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.407 0.683 . . . . 4.43 109.813 178.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.5 t -54.75 -43.7 72.93 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.514 -0.741 . . . . 1.02 111.791 -175.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.0 t -71.52 -49.1 44.23 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.886 -0.508 . . . . 1.46 110.222 -177.835 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 24.4 tp -73.35 -52.29 14.37 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 124.813 1.245 . . . . 3.15 112.852 -173.098 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.7 m -59.54 -21.76 60.71 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.288 0.848 . . . . 2.9 113.288 -171.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -22.18 66.92 Favored 'General case' 0 CA--C 1.543 0.68 0 O-C-N 121.166 -0.959 . . . . 4.52 113.451 172.218 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -66.2 106.03 1.55 Allowed 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 108.042 -1.096 . . . . 2.12 108.042 175.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -52.69 100.43 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.274 1.029 . . . . 6.09 109.862 175.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 144.4 -32.06 1.77 Allowed Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.04 -1.224 . . . . 0.94 110.04 -169.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.1 mm -79.63 151.1 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 107.26 -1.385 . . . . 4.2 107.26 161.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 50.7 mt -114.21 -47.68 2.93 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.906 1.283 . . . . 2.11 109.42 175.161 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -156.19 150.33 25.37 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 108.117 -1.068 . . . . 2.97 108.117 -175.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.9 m -125.86 80.72 1.93 Allowed 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 124.149 0.98 . . . . 2.64 110.301 174.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.4 t -78.26 77.97 4.74 Favored 'General case' 0 C--O 1.237 0.43 0 O-C-N 120.787 -1.196 . . . . 1.49 109.203 178.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 p -91.13 141.04 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 C-N-CA 125.035 1.334 . . . . 2.66 110.456 171.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.77 118.44 6.58 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.218 0.463 . . . . 1.24 110.662 169.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -55.57 -19.61 10.65 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.5 1.12 . . . . 1.33 113.624 177.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.14 -34.63 78.04 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.318 0.647 . . . . 1.34 110.939 175.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.74 -8.22 10.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.904 0.882 . . . . 2.89 111.651 -178.32 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 m120 60.97 26.29 16.24 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 125.023 1.329 . . . . 2.26 110.976 176.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.66 161.98 13.67 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.026 -1.472 . . . . 2.68 107.026 -176.46 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -139.6 90.49 2.41 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 105.533 -2.025 . . . . 1.03 105.533 165.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -78.88 83.81 4.97 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 103.25 -2.87 . . . . 1.63 103.25 167.125 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.0 pt -81.46 165.24 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.18 0 N-CA-C 106.503 -1.666 . . . . 2.97 106.503 170.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -127.78 133.86 49.48 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 105.352 -2.092 . . . . 3.44 105.352 160.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.93 176.41 9.3 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 126.13 1.772 . . . . 2.13 108.181 -169.359 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -111.62 132.99 21.62 Favored Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 107.568 -1.271 . . . . 3.08 107.568 155.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.26 -17.68 18.8 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.414 2.743 . . . . 1.93 113.489 -172.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -89.6 -50.17 6.23 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 118.878 0.763 . . . . 3.06 109.217 -176.098 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 24.2 pt -85.96 1.64 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 113.33 0.863 . . . . 3.22 113.33 -176.294 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -152.13 123.55 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 106.624 -1.621 . . . . 1.34 106.624 171.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -72.63 148.6 42.12 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 109.804 -1.318 . . . . 1.15 109.804 -179.837 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -56.58 -44.05 49.28 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 CA-C-N 119.402 1.601 . . . . 1.05 108.504 165.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.489 HH11 ' CD2' ' A' ' 60' ' ' HIS . 6.8 tpp180 -51.16 -32.91 24.8 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 117.952 -1.023 . . . . 5.83 112.015 170.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -72.47 -43.39 63.79 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 121.173 1.806 . . . . 2.39 113.112 176.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.3 mt -48.91 -50.99 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 120.221 -0.592 . . . . 0.72 109.469 165.022 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.7 mm -58.66 -44.88 90.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 118.246 -0.883 . . . . 2.08 111.45 175.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.489 ' CD2' HH11 ' A' ' 56' ' ' ARG . 21.7 m170 -50.44 -45.73 56.07 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.31 1.414 . . . . 3.14 109.348 177.1 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 17.0 m -65.49 -53.47 42.07 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.291 -0.633 . . . . 0.84 109.291 -177.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.1 mt -50.98 -52.07 18.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 124.636 1.174 . . . . 1.45 110.854 178.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -54.12 -55.88 23.4 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.151 1.38 . . . . 2.34 110.182 173.015 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -63.78 -26.23 68.54 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 118.224 -0.893 . . . . 1.39 112.84 -171.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.9 mp -73.55 -95.41 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.251 -1.018 . . . . 2.1 108.251 168.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.97 34.11 0.44 Allowed Glycine 0 C--N 1.336 0.549 0 CA-C-O 119.012 -0.882 . . . . 0.89 112.635 173.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -130.42 163.59 26.59 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.483 1.141 . . . . 2.15 110.408 -163.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -117.03 157.52 25.69 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 108.051 -1.092 . . . . 3.01 108.051 174.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.54 165.53 36.31 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 118.446 0.566 . . . . 1.41 111.735 172.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.2 p -155.11 147.95 24.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.284 1.433 . . . . 2.44 108.652 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.01 125.09 26.81 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 107.79 -1.189 . . . . 2.72 107.79 165.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.1 p -118.3 138.71 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 106.755 -1.572 . . . . 2.67 106.755 168.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.73 -44.64 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.608 1.563 . . . . 4.1 109.086 176.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 45.1 mm -100.4 -53.46 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.717 -1.216 . . . . 6.33 107.717 167.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 C--O 1.25 1.107 0 C-N-CA 125.318 1.447 . . . . 11.58 107.935 -168.736 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.9 mtt . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 107.079 -1.452 . . . . 11.88 107.079 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.8 -79.65 0.22 Allowed Glycine 0 CA--C 1.52 0.358 0 N-CA-C 107.95 -2.06 . . . . 3.86 107.95 178.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -157.16 170.24 22.95 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.945 -1.502 . . . . 4.67 106.945 163.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.11 108.96 0.38 Allowed Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 106.372 -2.691 . . . . 1.3 106.372 171.495 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.55 96.18 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 125.368 1.467 . . . . 2.21 108.379 -177.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.9 tp -110.16 101.47 10.25 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.427 1.091 . . . . 2.33 108.21 -176.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -99.08 94.82 6.72 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.537 -0.912 . . . . 3.06 108.537 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -85.42 156.69 20.73 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.967 -0.753 . . . . 3.01 108.967 177.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.58 144.36 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.107 -1.442 . . . . 0.7 107.107 149.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -138.52 133.47 42.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 C-N-CA 125.095 1.358 . . . . 2.31 109.237 177.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -137.37 166.12 24.58 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.04 0.536 . . . . 6.72 110.977 -177.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.55 -11.43 70.09 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.403 1.001 . . . . 1.33 110.726 -165.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 29.0 mtm -74.86 73.39 2.11 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.419 1.088 . . . . 1.71 110.192 -177.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.9 t -60.69 -37.09 80.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.459 1.104 . . . . 1.73 113.029 -170.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.4 p -145.04 167.27 23.09 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 118.81 0.732 . . . . 0.74 110.77 -173.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -40.5 -47.54 2.67 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.288 1.435 . . . . 1.07 111.965 -178.901 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.8 m -43.74 -42.43 5.45 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.445 1.098 . . . . 1.64 112.387 -179.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.7 m -55.95 -36.0 67.29 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.393 0.677 . . . . 0.94 112.458 -177.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.7 t -55.67 -60.29 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.2 0.524 . . . . 1.57 109.872 -177.139 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -71.25 -30.83 66.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 118.485 -0.769 . . . . 1.57 111.497 178.027 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -48.88 -45.52 41.2 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.137 0.881 . . . . 3.49 109.495 171.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.2 mt -69.59 -74.3 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.163 0 N-CA-C 109.656 -0.498 . . . . 1.33 109.656 168.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -57.25 -48.4 78.96 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.435 0.561 . . . . 3.85 111.764 -161.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 t -63.39 -28.13 69.78 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 119.098 -0.477 . . . . 1.25 110.993 -178.137 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.2 t -71.99 -69.26 0.4 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.048 -0.723 . . . . 1.46 109.048 168.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.2 tp -54.62 -32.38 58.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.22 1.808 . . . . 3.2 113.165 -168.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.0 m -58.14 -19.74 35.08 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 121.151 -0.968 . . . . 2.02 112.656 176.216 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -57.04 -25.04 57.94 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.896 -1.127 . . . . 4.84 112.272 170.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -89.04 93.79 9.72 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 107.965 -1.124 . . . . 2.11 107.965 175.465 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.63 5.27 0.46 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.105 1.15 . . . . 6.14 114.105 -174.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.73 -26.86 73.95 Favored Glycine 0 CA--C 1.528 0.852 0 O-C-N 121.243 -0.911 . . . . 0.96 111.423 164.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.48 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -79.75 146.28 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 107.438 -1.319 . . . . 2.45 107.438 170.803 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 61.9 mt -102.32 -42.51 5.98 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.368 1.467 . . . . 1.95 108.872 175.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -155.46 155.03 32.78 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 118.075 -0.964 . . . . 3.14 109.965 173.209 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -131.07 81.7 2.01 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.969 0.908 . . . . 2.77 109.519 178.256 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 t -77.69 78.89 4.19 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.019 -1.051 . . . . 1.47 108.945 -179.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.0 t -79.86 140.01 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 126.311 1.844 . . . . 2.86 109.138 176.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.57 152.14 28.43 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.237 0.542 . . . . 1.15 110.789 169.12 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -95.84 -36.06 11.26 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.266 1.427 . . . . 1.68 109.938 -178.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -50.15 -36.99 32.41 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.114 0.966 . . . . 1.24 112.807 179.182 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -115.2 7.3 15.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.739 0.816 . . . . 1.92 111.445 174.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.3 m120 45.82 51.47 10.42 Favored 'General case' 0 CA--C 1.516 -0.355 0 C-N-CA 123.986 0.914 . . . . 2.06 111.744 -175.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.6 pttt -121.39 158.75 27.61 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.578 1.151 . . . . 4.46 110.253 -170.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -146.76 96.75 2.8 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.785 -1.098 . . . . 0.67 108.712 168.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -81.24 94.4 6.69 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.352 -1.351 . . . . 1.09 107.352 171.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.09 122.89 39.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 107.235 -1.394 . . . . 1.63 107.235 171.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 11.6 mmmt -97.18 129.45 44.54 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.346 -2.094 . . . . 2.36 105.346 161.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -154.6 160.84 41.71 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.004 0.922 . . . . 2.3 109.757 -173.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.22 118.47 69.19 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 108.263 -1.014 . . . . 3.4 108.263 169.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -79.24 61.08 8.06 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.989 3.126 . . . . 2.19 111.877 -167.599 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -169.35 -45.27 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 125.08 1.352 . . . . 3.41 109.519 -174.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.2 mt -66.79 -33.12 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 122.77 0.428 . . . . 3.29 110.007 176.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.8 tt -146.78 134.9 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 107.241 -1.392 . . . . 1.54 107.241 178.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -84.17 161.69 37.88 Favored Glycine 0 CA--C 1.532 1.121 0 N-CA-C 111.304 -0.719 . . . . 0.86 111.304 178.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -60.21 -45.03 25.02 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.69 2.26 . . . . 0.93 110.382 177.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.44 HH11 ' CD2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -64.88 -30.59 71.6 Favored 'General case' 0 C--O 1.223 -0.325 0 CA-C-O 118.739 -0.648 . . . . 7.01 110.988 177.057 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -66.66 -48.64 68.74 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.814 1.188 . . . . 2.62 109.547 177.378 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.8 mt -49.74 -57.77 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.996 -0.742 . . . . 0.77 108.996 170.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.5 mt -55.69 -47.16 79.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 118.72 -0.657 . . . . 1.03 111.53 -177.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.44 ' CD2' HH11 ' A' ' 56' ' ' ARG . 27.3 m80 -49.12 -45.52 43.62 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 123.611 0.764 . . . . 3.26 109.821 172.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 18.5 m -65.16 -48.94 71.75 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.435 -0.95 . . . . 1.01 108.435 -176.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 mp -53.0 -61.65 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.2 0 N-CA-C 109.584 -0.524 . . . . 1.64 109.584 177.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -60.46 -37.84 82.27 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.464 -0.334 . . . . 2.15 110.344 -164.39 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 69.6 m -54.14 -33.9 59.02 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.84 0.856 . . . . 1.84 113.184 177.566 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.66 -60.17 3.43 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.368 0.986 . . . . 2.37 111.409 -176.289 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -162.95 22.61 0.19 Allowed Glycine 0 CA--C 1.526 0.742 0 O-C-N 120.645 -1.284 . . . . 1.13 112.925 166.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -134.28 176.58 8.47 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.537 1.168 . . . . 2.07 113.093 -143.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -128.89 160.02 33.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 106.891 -1.522 . . . . 3.83 106.891 167.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.71 163.53 31.09 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.02 0.528 . . . . 0.92 110.577 171.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -155.18 177.55 11.21 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.086 1.354 . . . . 1.94 107.773 173.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -121.4 143.86 48.99 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 124.213 1.005 . . . . 3.17 109.09 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 12.0 p -149.86 26.3 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 123.272 0.629 . . . . 2.97 110.162 -179.559 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.9 ttpt -102.04 103.45 14.05 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.373 -0.973 . . . . 4.45 108.373 179.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.2 mt -68.61 135.14 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.043 -1.465 . . . . 5.76 107.043 166.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 C--O 1.255 1.38 0 N-CA-C 103.964 -2.606 . . . . 10.86 103.964 -176.666 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.409 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 64.4 mtt . . . . . 0 N--CA 1.468 0.435 0 N-CA-C 108.792 -0.818 . . . . 9.3 108.792 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.64 -148.26 17.88 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 106.585 -2.606 . . . . 3.17 106.585 177.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -134.53 166.64 22.42 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.192 -1.781 . . . . 5.12 106.192 155.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.26 72.28 0.25 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 107.737 -2.145 . . . . 1.99 107.737 172.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -78.7 85.57 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 122.662 1.22 . . . . 2.45 108.864 173.241 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.4 tp -77.76 72.95 4.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 108.165 -1.05 . . . . 3.29 108.165 167.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -77.54 125.53 29.48 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.216 -1.356 . . . . 3.22 108.402 153.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -148.39 160.89 42.57 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 125.384 1.678 . . . . 1.9 109.208 178.377 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 42' ' ' ASN . 0.9 OUTLIER -77.88 137.57 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 105.705 -1.961 . . . . 0.97 105.705 168.732 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.3 t -116.43 135.21 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 105.612 -1.996 . . . . 2.03 105.612 165.123 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -110.01 169.25 8.85 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.838 -1.171 . . . . 7.41 107.838 162.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.39 -119.9 6.34 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 106.373 -2.691 . . . . 2.48 106.373 -152.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 47.0 mtm 36.14 60.84 0.82 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 126.075 1.75 . . . . 1.7 113.095 178.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.7 t -85.59 -9.81 56.78 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 117.916 -1.04 . . . . 1.51 112.964 -176.306 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.7 p -163.69 171.7 15.26 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 119.843 1.201 . . . . 0.71 109.708 173.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.97 -43.2 29.27 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.538 1.135 . . . . 0.57 111.538 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.9 m -65.6 -25.91 67.6 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 118.623 -0.703 . . . . 1.63 112.619 -179.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.1 m -73.36 -57.49 3.97 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 119.093 0.86 . . . . 0.82 110.455 163.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.1 t -43.79 -63.17 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 C-N-CA 124.04 0.936 . . . . 1.19 109.971 -175.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.453 ' HA ' ' CG ' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -68.01 -10.55 54.49 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 119.732 -0.787 . . . . 1.24 113.052 -173.372 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -70.23 -41.29 73.76 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.0 -1.111 . . . . 3.1 108.0 -178.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 76.6 mt -55.74 -62.97 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.243 -1.021 . . . . 1.1 108.243 177.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 1.6 pt-20 -53.21 -57.65 9.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.993 0.517 . . . . 3.3 110.457 -179.596 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.8 t -51.43 -48.75 62.6 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.058 0.543 . . . . 1.12 111.422 -179.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.3 t -70.34 -33.22 71.23 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.801 -0.814 . . . . 1.35 108.801 -172.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.2 mt -70.32 -45.71 65.69 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.624 -0.672 . . . . 2.22 111.16 174.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.4 p -57.76 -15.67 8.81 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 115.513 1.671 . . . . 2.25 115.513 -168.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.94 -36.43 74.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.603 1.092 . . . . 5.49 112.136 168.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -66.85 138.86 57.63 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.687 -0.857 . . . . 2.06 108.687 177.03 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -92.03 -5.88 52.12 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.274 0.23 . . . . 6.25 110.963 169.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -75.4 -30.58 58.28 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.585 -0.606 . . . . 0.97 111.585 174.358 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.516 ' C ' HD12 ' A' ' 32' ' ' ILE . 0.6 OUTLIER -78.79 146.19 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.6 -1.63 . . . . 2.46 106.6 168.709 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.0 mt -109.97 -37.79 5.51 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.989 1.716 . . . . 1.91 109.288 -175.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -153.27 150.29 28.8 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.412 -0.958 . . . . 2.09 108.412 176.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.0 m -130.79 142.45 50.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.168 -1.419 . . . . 2.57 107.168 172.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.9 t -152.26 157.23 41.11 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.271 -1.381 . . . . 1.88 107.271 159.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.43 138.83 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 C-N-CA 124.573 1.149 . . . . 1.73 109.257 -178.025 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -126.84 95.95 4.49 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.017 0.927 . . . . 1.52 109.03 177.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.96 -25.59 44.34 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.89 0.33 . . . . 3.02 111.89 167.249 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.55 -40.48 68.76 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.301 0.64 . . . . 1.3 111.552 178.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.5 t -110.27 -15.34 13.99 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.836 0.855 . . . . 3.21 111.301 179.429 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.44 ' O ' HG22 ' A' ' 9' ' ' VAL . 1.3 m-80 65.88 74.31 0.37 Allowed 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 126.493 1.917 . . . . 2.38 110.339 -171.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.46 145.92 21.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.17 -0.678 . . . . 4.17 109.17 171.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 46' ' ' ILE . . . -109.19 132.38 54.17 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 106.818 -1.549 . . . . 0.78 106.818 167.274 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -109.07 99.25 8.59 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 127.496 2.319 . . . . 1.01 104.953 176.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.467 HD11 ' HB1' ' A' ' 44' ' ' ALA . 3.2 mm -108.18 110.93 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 106.077 -1.823 . . . . 2.02 106.077 176.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.2 mmtt -82.45 128.83 34.65 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.3 -1.741 . . . . 3.14 106.3 165.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -141.88 157.2 45.27 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 123.84 0.856 . . . . 2.18 108.946 174.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.5 121.89 63.95 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 107.113 -1.44 . . . . 3.48 107.113 173.281 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.56 44.1 1.57 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.196 2.597 . . . . 1.99 112.588 -172.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' OE1' ' N ' ' A' ' 1' ' ' MET . 80.9 mt-10 -132.88 6.47 3.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.946 1.698 . . . . 3.57 110.838 -179.021 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.8 tp -157.19 -30.78 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.866 0.866 . . . . 2.7 112.525 -162.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 tt -139.25 145.03 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.765 -1.939 . . . . 1.26 105.765 165.383 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.03 154.53 24.57 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.134 -1.186 . . . . 1.01 110.134 176.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -59.06 -38.5 86.94 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.056 1.838 . . . . 1.04 109.792 173.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -54.35 -39.52 67.19 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.678 0.791 . . . . 5.95 111.864 173.43 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -70.09 -44.83 68.24 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.797 0.726 . . . . 2.44 109.356 -177.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.7 mt -53.95 -52.27 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 109.394 -0.595 . . . . 0.84 109.394 173.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 33.4 mt -52.33 -53.93 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 123.164 0.585 . . . . 1.13 110.34 176.199 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -51.28 -44.24 61.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.858 0.754 . . . . 2.87 110.882 175.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 58.7 m -66.25 -40.75 90.43 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 110.075 -0.343 . . . . 1.25 110.075 -174.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 11.8 mt -56.55 -67.58 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 N-CA-C 108.791 -0.818 . . . . 1.36 108.791 168.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -61.82 -43.51 98.71 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.548 -0.296 . . . . 3.8 111.372 -161.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.2 m -63.56 -13.1 38.26 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 113.249 0.833 . . . . 2.49 113.249 -174.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.7 mt -70.76 -80.16 0.06 Allowed 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.322 -0.992 . . . . 1.97 108.322 171.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.94 42.41 0.45 Allowed Glycine 0 CA--C 1.522 0.502 0 CA-C-O 118.759 -1.023 . . . . 1.01 110.828 165.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -131.25 177.16 7.68 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.823 0.812 . . . . 1.87 110.586 -161.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -134.51 145.95 49.26 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.915 -1.513 . . . . 5.0 106.915 176.367 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.44 150.94 48.99 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 120.57 1.532 . . . . 1.01 113.082 -178.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.8 t -155.31 129.18 8.66 Favored 'General case' 0 CA--C 1.521 -0.138 0 N-CA-C 109.064 -0.717 . . . . 2.69 109.064 166.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 pp -56.84 152.56 12.41 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 109.314 -0.625 . . . . 2.49 109.314 162.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.6 t -130.83 -86.58 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 106.157 -1.794 . . . . 2.96 106.157 174.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.4 mttp 61.63 171.05 0.11 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.054 . . . . 5.04 111.654 -173.336 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.7 mp 53.78 63.86 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 N-CA-C 106.482 -1.674 . . . . 5.77 106.482 -157.354 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 . . . . . 0 C--O 1.256 1.442 0 N-CA-C 103.121 -2.918 . . . . 10.64 103.121 -152.258 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 106.896 -1.52 . . . . 10.92 106.896 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 166.89 140.36 2.88 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.07 -2.412 . . . . 3.22 107.07 178.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -76.53 110.63 11.24 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 118.028 0.914 . . . . 4.76 109.024 -179.85 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -70.21 137.55 28.12 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 106.872 -2.491 . . . . 1.29 106.872 165.308 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -121.87 74.89 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 118.672 1.236 . . . . 2.59 109.058 -176.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.0 tp -79.99 71.8 6.72 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.766 -0.827 . . . . 2.45 108.766 -177.787 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -78.03 69.43 4.25 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.645 0.736 . . . . 3.55 109.153 -178.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.81 156.33 26.21 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.437 0.695 . . . . 2.21 111.097 -176.705 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.94 123.51 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.246 -1.39 . . . . 0.85 107.246 172.033 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.2 t -112.06 125.08 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 106.073 -1.825 . . . . 2.11 106.073 176.287 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -99.22 176.83 5.4 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.391 1.476 . . . . 6.09 109.231 -173.478 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.46 -69.52 3.24 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 108.767 -1.733 . . . . 2.41 108.767 -177.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.6 mtp 2.31 66.42 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 128.864 2.866 . . . . 2.06 115.477 -178.468 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.5 t -87.69 -11.43 48.35 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 117.59 -1.195 . . . . 1.44 113.694 -161.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 22.6 p -164.78 178.9 6.89 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 120.418 1.463 . . . . 0.71 110.479 175.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.41 -39.64 47.72 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.538 1.135 . . . . 0.64 111.599 175.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -52.4 -43.05 64.53 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 109.552 -0.536 . . . . 2.63 109.552 175.684 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.7 m -65.33 -57.23 8.91 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 121.504 -0.748 . . . . 0.94 109.153 -178.672 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 83.7 t -40.47 -68.23 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.567 1.147 . . . . 0.99 111.33 177.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -31.43 68.99 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 119.474 -0.891 . . . . 0.74 111.876 -169.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -65.6 -48.12 73.37 Favored 'General case' 0 C--O 1.232 0.162 0 O-C-N 121.617 -0.677 . . . . 3.82 109.319 178.169 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 74.4 mt -53.21 -61.23 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.048 -1.093 . . . . 0.8 108.048 173.33 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -51.3 -49.71 60.77 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.246 0.618 . . . . 3.71 111.793 -176.428 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 t -55.12 -53.42 56.09 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.999 0.519 . . . . 0.97 109.862 176.743 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.4 m -59.86 -40.1 87.44 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 121.223 0.535 . . . . 1.86 110.08 -176.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -51.52 63.77 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 123.922 0.889 . . . . 2.74 110.376 -179.608 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 26.5 m -58.01 -29.47 65.32 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.767 -0.651 . . . . 1.92 110.183 176.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.54 -5.67 8.67 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.412 1.264 . . . . 5.03 114.412 174.446 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -74.02 -122.26 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 120.437 1.471 . . . . 3.44 111.378 -178.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.18 -62.45 0.09 Allowed 'General case' 0 C--N 1.342 0.259 0 O-C-N 120.928 -1.108 . . . . 12.63 110.466 177.707 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.72 47.28 3.62 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 111.575 -0.61 . . . . 1.13 111.575 -177.817 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -115.06 136.6 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.8 -1.185 . . . . 3.11 107.8 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.9 mt -97.73 -42.22 7.72 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.156 0.983 . . . . 2.06 108.671 175.209 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -156.11 154.04 30.3 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 110.017 -0.364 . . . . 2.16 110.017 -178.278 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 p -132.22 144.34 50.56 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.639 0.775 . . . . 2.69 109.453 162.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 22.3 m -154.07 122.58 6.2 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.881 1.272 . . . . 2.75 107.914 161.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -115.18 154.67 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 123.021 0.529 . . . . 1.58 109.886 -178.12 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.22 123.25 14.53 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 122.891 0.476 . . . . 0.81 109.918 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 pp -75.96 -15.0 60.24 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.806 1.242 . . . . 1.46 112.546 177.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.58 -50.4 37.66 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.872 -0.788 . . . . 1.57 108.872 173.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.73 -24.53 41.57 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.586 0.754 . . . . 1.81 110.695 177.392 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.5 m120 62.75 47.9 4.44 Favored 'General case' 0 CA--C 1.516 -0.351 0 C-N-CA 125.69 1.596 . . . . 1.57 108.881 -170.542 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.48 153.28 51.76 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 109.796 -0.446 . . . . 2.22 109.796 -172.679 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.74 99.99 6.76 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 124.523 1.139 . . . . 0.98 108.83 173.182 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -78.45 89.26 4.42 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 105.751 -1.944 . . . . 1.13 105.751 172.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.2 pt -93.27 140.95 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 107.65 -1.241 . . . . 3.12 107.65 165.549 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 46.9 mttt -112.21 130.33 55.96 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 106.309 -1.737 . . . . 2.49 106.309 160.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -141.07 161.27 38.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.598 0.759 . . . . 1.8 111.361 -166.399 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -93.02 103.8 10.15 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 125.785 1.634 . . . . 4.34 108.105 178.656 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.25 59.6 7.46 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.909 3.073 . . . . 2.45 111.221 -168.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -173.39 -49.01 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.283 1.833 . . . . 3.29 108.04 -172.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.3 mt -74.65 -37.7 43.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 N-CA-C 109.818 -0.438 . . . . 3.14 109.818 173.618 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.6 tt -128.87 126.42 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 106.593 -1.632 . . . . 1.26 106.593 177.45 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.14 174.86 52.99 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 108.437 -1.865 . . . . 0.99 108.437 168.145 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.11 -48.51 4.88 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.687 1.592 . . . . 1.12 110.137 175.48 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . 0.25 31.4 ttt85 -70.1 -20.82 63.17 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.271 0.841 . . . . 6.18 113.271 -169.559 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -46.63 -57.18 5.03 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.638 0.654 . . . . 2.84 109.719 167.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 mp -65.02 -48.21 84.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 109.425 -0.583 . . . . 1.29 109.425 -176.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 57.5 mt -56.59 -40.89 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.937 -0.574 . . . . 1.23 110.473 -176.34 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -52.52 -40.76 62.8 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 118.938 0.79 . . . . 3.05 111.644 172.772 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.2 m -66.47 -51.17 59.68 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.741 0.701 . . . . 1.23 109.314 178.296 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -51.87 -52.56 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.0 0.92 . . . . 2.05 110.735 179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -57.2 -56.2 24.92 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.456 1.102 . . . . 1.88 110.322 174.178 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.5 t -65.57 -21.19 66.57 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-O 118.231 -0.89 . . . . 1.56 112.921 -171.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.2 mt -71.23 -96.27 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.008 -1.108 . . . . 2.03 108.008 166.478 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.71 36.93 0.47 Allowed Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.575 -1.125 . . . . 1.14 112.053 171.053 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -131.86 127.65 37.0 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 118.569 1.184 . . . . 1.84 110.406 -166.106 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -78.73 159.63 27.85 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.555 -0.905 . . . . 4.16 108.555 178.636 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.34 142.4 50.08 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 123.883 0.873 . . . . 1.5 110.338 -173.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 t -155.23 124.24 6.2 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.654 -0.869 . . . . 2.28 108.654 167.738 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.0 142.89 49.35 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 109.256 -0.646 . . . . 2.83 109.256 172.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.0 m -139.92 150.05 22.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 106.014 -1.847 . . . . 2.68 106.014 178.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -146.21 -35.95 0.27 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 115.199 1.555 . . . . 4.33 115.199 -179.537 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 99.0 mt -128.23 -63.71 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 104.687 -2.338 . . . . 6.11 104.687 175.03 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 . . . . . 0 C--O 1.258 1.537 0 N-CA-C 105.409 -2.071 . . . . 11.91 105.409 139.569 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtt . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 108.893 -0.78 . . . . 7.45 108.893 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.67 63.93 3.02 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 109.607 -1.397 . . . . 4.3 109.607 175.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -168.59 167.36 11.56 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.228 1.411 . . . . 5.24 108.699 -166.388 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.78 150.49 6.19 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 106.997 -2.441 . . . . 1.32 106.997 -173.374 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.69 78.4 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 125.091 1.356 . . . . 2.6 109.632 -173.076 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.1 82.33 5.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.305 -0.872 . . . . 3.06 109.257 -175.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -85.15 117.21 23.97 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.655 -0.869 . . . . 4.4 108.655 165.113 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 pp -134.86 169.78 16.86 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.088 0.955 . . . . 1.98 109.995 170.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.3 t -90.08 142.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 108.396 -0.965 . . . . 0.71 108.396 170.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.18 130.46 74.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 125.713 1.605 . . . . 2.47 108.353 174.085 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 26.4 mtp180 -121.94 144.55 48.8 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.208 1.803 . . . . 5.62 107.72 -174.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 110.78 -125.34 7.36 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 106.288 -2.725 . . . . 2.78 106.288 -163.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.8 mtm 49.73 68.61 0.71 Allowed 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.791 1.236 . . . . 1.55 112.288 178.015 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 p -61.39 -28.86 69.54 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.674 0.62 . . . . 3.49 112.674 178.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.56 171.22 16.12 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.751 0.705 . . . . 1.31 110.259 -171.402 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.45 -37.36 17.04 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.344 1.058 . . . . 1.0 111.45 176.113 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -47.95 -33.84 8.3 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.294 2.238 . . . . 1.59 113.06 174.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 34.7 m -74.89 -60.99 2.04 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.305 1.042 . . . . 0.79 111.445 166.554 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.3 t -45.62 -58.4 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.799 1.24 . . . . 0.93 110.947 -171.245 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.47 -30.58 71.36 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.175 0.512 . . . . 1.63 111.363 -176.454 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -71.29 -49.24 44.88 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.192 -1.04 . . . . 3.65 108.192 -176.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 77.0 mt -54.03 -56.15 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 108.572 -0.899 . . . . 0.66 108.572 174.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -64.98 -44.75 88.28 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.59 0.233 . . . . 3.9 111.627 -171.326 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.5 t -63.59 -42.29 98.28 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.209 0.603 . . . . 0.84 110.617 177.044 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 36.9 t -62.96 -50.82 69.29 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.365 -1.346 . . . . 1.5 107.365 -178.255 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.1 mt -47.17 -53.6 12.66 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 122.983 0.513 . . . . 3.09 111.459 174.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.8 p -58.4 -12.22 3.62 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 114.082 1.142 . . . . 1.98 114.082 -178.392 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.79 -32.48 73.99 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.709 1.141 . . . . 5.05 111.956 172.599 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -88.24 110.26 20.58 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 108.067 -1.086 . . . . 1.99 108.067 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -59.8 -17.12 33.29 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.309 -0.869 . . . . 6.19 112.005 172.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.47 -33.99 67.74 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.911 -0.938 . . . . 1.01 112.686 169.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -84.24 128.34 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 106.783 -1.562 . . . . 2.56 106.783 172.71 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.3 mt -86.58 -35.53 19.41 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.821 1.248 . . . . 2.03 109.35 -176.117 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -154.8 147.36 24.17 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.295 -1.002 . . . . 2.09 108.295 177.393 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.8 p -124.75 147.18 48.8 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.02 0.928 . . . . 2.74 109.046 169.221 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.9 t -152.39 101.28 2.66 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.979 -1.119 . . . . 1.55 107.979 169.725 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 16.6 m -90.26 161.74 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.048 1.339 . . . . 1.92 110.441 176.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.64 138.39 14.23 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 109.281 -0.637 . . . . 0.79 109.281 155.19 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.3 pp -76.13 -32.47 59.15 Favored 'General case' 0 C--O 1.227 -0.099 0 N-CA-C 108.841 -0.8 . . . . 1.65 108.841 159.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.08 -15.45 23.31 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.282 1.033 . . . . 1.87 111.938 179.156 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.9 m -139.3 20.35 2.58 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 121.535 -0.728 . . . . 2.4 110.575 172.557 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.7 m120 33.41 43.72 0.06 Allowed 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 125.757 1.623 . . . . 1.7 114.121 -176.273 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.3 158.49 30.88 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.233 0.613 . . . . 2.64 110.089 -170.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.37 115.32 9.18 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.633 -1.247 . . . . 0.69 107.633 163.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -99.16 105.32 17.38 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 106.07 -1.826 . . . . 1.0 106.07 170.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -107.58 110.29 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 105.921 -1.881 . . . . 1.82 105.921 175.371 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -82.91 136.29 34.63 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.717 -1.586 . . . . 3.89 106.717 164.892 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -158.65 155.55 28.38 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 118.956 0.798 . . . . 1.72 112.864 -168.076 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -87.19 120.28 71.3 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.184 0.993 . . . . 3.17 108.432 167.03 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.07 -14.55 23.49 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.066 2.511 . . . . 1.96 113.695 -174.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -84.67 -47.7 10.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.175 -1.046 . . . . 4.11 108.175 176.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.2 mt -66.47 -36.91 78.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 119.256 -0.402 . . . . 3.14 110.569 -178.388 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 17.0 tt -144.03 124.2 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 108.845 -0.798 . . . . 1.31 108.845 176.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.79 154.37 52.17 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 110.335 -1.106 . . . . 0.87 110.335 179.421 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -57.87 -41.28 70.85 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.923 1.749 . . . . 1.01 109.88 174.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -62.88 -30.09 71.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 118.922 -0.561 . . . . 5.78 111.911 176.127 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -70.38 -44.94 67.01 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 119.556 1.071 . . . . 2.26 109.19 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 mt -52.47 -55.94 8.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.15 -0.685 . . . . 0.77 109.15 171.133 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.4 mt -52.2 -53.41 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 119.401 -0.333 . . . . 1.21 110.632 179.411 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -50.65 -43.49 57.21 Favored 'General case' 0 CA--C 1.528 0.133 0 C-N-CA 123.024 0.53 . . . . 3.13 110.938 175.274 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 42.8 m -62.44 -49.49 75.24 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.561 -0.533 . . . . 0.78 109.561 -177.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mp -53.82 -54.47 19.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.209 0.604 . . . . 1.75 109.96 176.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -58.19 -50.66 72.76 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.428 0.691 . . . . 2.59 110.582 -176.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -54.99 -33.39 62.49 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.443 1.497 . . . . 1.16 112.217 -172.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.8 mt -63.55 -82.89 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.047 0.385 . . . . 2.07 110.612 178.461 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.98 33.12 0.43 Allowed Glycine 0 CA--C 1.525 0.701 0 O-C-N 121.217 -0.927 . . . . 0.95 112.775 173.355 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -135.08 176.06 9.01 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.26 1.03 . . . . 1.64 110.316 -159.671 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -130.3 136.57 49.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.507 -1.294 . . . . 3.78 107.507 172.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.73 156.97 16.31 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.559 0.744 . . . . 1.11 109.774 177.029 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.2 m -151.33 114.25 4.72 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.455 -0.942 . . . . 2.29 108.455 170.012 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.28 65.42 0.61 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.323 1.049 . . . . 3.42 110.849 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.4 t -55.44 124.41 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.083 -1.08 . . . . 2.9 108.083 169.547 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -167.25 148.08 5.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 104.44 -2.43 . . . . 4.53 104.44 179.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 91.2 mt -131.44 -64.48 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.085 0 N-CA-C 105.78 -1.933 . . . . 6.17 105.78 -178.455 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 . . . . . 0 C--O 1.248 1.002 0 N-CA-C 103.64 -2.726 . . . . 10.46 103.64 136.761 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.4 ttt . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 108.239 -1.023 . . . . 7.63 108.239 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.27 -118.29 0.88 Allowed Glycine 0 CA--C 1.527 0.824 0 N-CA-C 103.314 -3.914 . . . . 3.48 103.314 136.14 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 63.02 28.47 16.23 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 117.662 0.731 . . . . 6.34 111.74 157.16 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.4 -168.97 36.95 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.461 1.029 . . . . 1.86 114.2 -160.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.0 m -130.98 133.44 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 125.974 1.71 . . . . 2.25 107.066 176.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.6 tt -139.13 103.56 4.8 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.425 -1.695 . . . . 2.86 106.425 173.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -112.29 117.28 32.06 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.524 0.602 . . . . 3.83 110.667 177.532 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.78 161.32 35.92 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.531 1.132 . . . . 2.8 111.08 -171.068 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.5 t -82.71 111.98 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 125.378 1.471 . . . . 1.08 107.411 176.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.0 m -86.85 73.75 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.679 1.192 . . . . 2.58 108.336 172.629 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.11 66.21 3.67 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.445 1.098 . . . . 6.77 109.71 -172.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -163.36 -44.4 0.02 OUTLIER Glycine 0 CA--C 1.522 0.484 0 N-CA-C 110.854 -0.899 . . . . 1.46 110.854 -175.416 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.8 ptt? -61.4 120.05 9.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 117.562 0.681 . . . . 1.7 109.193 177.75 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.3 t -98.53 -45.65 6.02 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.988 0.515 . . . . 1.42 111.751 -172.91 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.0 p -130.59 172.75 11.59 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 118.758 0.708 . . . . 0.76 110.868 -175.125 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.46 -45.47 9.15 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.9 1.28 . . . . 0.86 111.922 179.422 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 m -54.41 -42.12 70.09 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.217 1.007 . . . . 1.5 111.584 177.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.6 m -71.41 -51.36 24.4 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.031 0.532 . . . . 0.96 110.643 174.736 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 73.3 t -44.75 -59.02 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 124.299 1.039 . . . . 1.0 109.988 -179.049 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.43 ' HA ' ' CG ' ' A' ' 23' ' ' GLU 0.306 0.2 OUTLIER -69.14 -14.88 63.24 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 119.257 -0.977 . . . . 1.25 112.028 -175.238 . . . . . . . . 4 4 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.1 tttt -71.34 -46.56 60.24 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 120.766 -1.209 . . . . 2.98 108.269 -175.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.4 mt -52.74 -67.67 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 108.221 -1.029 . . . . 1.1 108.221 177.378 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.43 ' CG ' ' HA ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -47.73 -66.09 0.46 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.177 0.806 . . . . 4.25 113.177 178.466 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 58.2 m -50.69 -39.33 50.92 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 118.433 0.561 . . . . 2.41 112.216 -177.965 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 14.3 t -70.57 -60.78 2.06 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.441 -0.948 . . . . 1.24 108.441 179.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.4 mp -52.58 -34.8 52.22 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.447 1.099 . . . . 2.56 112.296 -174.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 86.3 m -55.28 -22.59 19.22 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.947 0.721 . . . . 1.91 112.947 179.496 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -66.06 -23.76 66.6 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 120.101 1.319 . . . . 5.17 112.507 174.099 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -81.62 103.7 11.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.09 -1.448 . . . . 2.1 107.09 179.629 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 25.3 mtp-105 -57.19 -21.86 36.41 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.498 1.045 . . . . 7.09 112.13 173.256 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -69.82 0.97 18.0 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.743 -1.032 . . . . 1.67 113.951 173.191 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.6 pp -120.06 128.57 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 119.315 1.558 . . . . 2.57 106.933 159.175 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.4 mt -83.71 -30.66 26.57 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 110.257 -0.275 . . . . 1.78 110.257 -178.524 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -157.07 151.6 25.42 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.589 -1.263 . . . . 2.26 107.589 178.085 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 47.5 t -128.65 119.14 24.14 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.882 1.273 . . . . 2.63 108.723 169.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 t -120.91 93.89 4.17 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.019 1.328 . . . . 1.51 109.975 -173.405 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.6 m -92.98 149.74 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 125.973 1.709 . . . . 2.49 111.719 -169.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.9 139.65 18.02 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 123.237 0.615 . . . . 0.85 111.666 168.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.0 mt -78.89 -54.52 5.96 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 125.541 1.536 . . . . 2.29 108.694 170.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -45.81 -42.61 12.47 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.63 0.772 . . . . 1.47 111.866 -177.28 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.4 ' HB ' ' CG ' ' A' ' 43' ' ' LYS . 3.1 m -101.02 -5.05 26.33 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.051 0.94 . . . . 2.63 112.247 -178.705 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.02 69.23 0.63 Allowed 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 124.988 1.315 . . . . 1.89 111.041 -178.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.4 ' CG ' ' HB ' ' A' ' 41' ' ' THR . 0.0 OUTLIER -155.98 163.52 39.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.177 0.513 . . . . 2.17 111.56 -172.501 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -147.01 103.5 3.61 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 126.959 2.104 . . . . 0.85 107.427 171.097 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -80.37 106.41 12.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.37 -1.715 . . . . 1.04 106.37 172.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 73.0 mt -105.98 114.41 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 106.66 -1.607 . . . . 1.79 106.66 177.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -78.63 71.93 5.13 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.836 -1.172 . . . . 3.07 107.836 172.719 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.91 153.62 43.07 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.755 -0.657 . . . . 2.73 111.232 -179.122 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -106.17 117.53 57.19 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 108.869 -0.789 . . . . 3.13 108.869 162.041 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -67.27 -23.16 45.3 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.153 2.568 . . . . 1.63 113.009 -173.539 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -74.52 -43.46 55.77 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 119.302 0.955 . . . . 3.8 109.283 -174.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.6 tp -89.16 -34.96 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 112.339 0.496 . . . . 3.51 112.339 -179.129 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.1 mm -133.47 112.68 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.487 -0.931 . . . . 1.65 108.487 -170.065 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.94 163.28 49.33 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 110.831 -0.908 . . . . 1.27 110.831 177.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -55.97 -43.26 58.5 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.721 2.281 . . . . 1.4 109.957 175.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.6 -32.87 65.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.307 0.643 . . . . 6.89 112.66 176.201 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -70.12 -49.42 50.93 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 118.879 0.763 . . . . 2.6 109.012 179.139 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.6 mt -53.64 -57.25 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.034 -0.358 . . . . 1.21 110.034 174.936 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.9 mt -49.58 -54.95 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 123.646 0.778 . . . . 1.45 109.139 178.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -55.39 -41.4 72.61 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 111.51 0.189 . . . . 4.26 111.51 178.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 64.5 m -62.94 -49.6 74.11 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 108.794 -0.817 . . . . 1.16 108.794 -177.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 mp -52.78 -53.85 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.487 -0.56 . . . . 1.41 109.487 174.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -56.02 -37.63 69.44 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.146 0.578 . . . . 2.21 111.522 -178.938 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.1 m -63.67 -15.88 59.54 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 118.461 -0.78 . . . . 2.2 113.094 -178.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.31 -96.6 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.593 1.088 . . . . 2.27 108.754 169.936 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.33 44.97 0.47 Allowed Glycine 0 CA--C 1.524 0.605 0 N-CA-C 109.928 -1.269 . . . . 1.02 109.928 174.437 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -134.15 176.62 8.43 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.592 1.157 . . . . 1.86 109.169 -163.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -139.68 167.79 21.31 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.737 -1.208 . . . . 3.51 107.737 164.308 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -135.22 152.41 51.53 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.567 1.147 . . . . 0.9 110.384 -167.076 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.6 m -150.87 124.17 8.88 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.803 -0.56 . . . . 1.98 110.257 168.305 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mp -65.75 148.9 51.02 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.929 -0.767 . . . . 3.53 108.929 169.193 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 60.0 t -139.64 130.09 31.28 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 N-CA-C 105.069 -2.197 . . . . 2.65 105.069 176.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.267 0.1 OUTLIER 70.04 152.92 0.11 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.616 1.566 . . . . 3.79 111.374 -168.501 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.2 pt -68.95 149.49 11.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 O-C-N 122.12 -0.362 . . . . 8.11 111.23 -176.076 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 . . . . . 0 C--O 1.256 1.397 0 C-N-CA 129.217 3.007 . . . . 12.0 105.265 178.266 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.553 0 N-CA-C 107.421 -1.326 . . . . 8.81 107.421 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -67.39 80.63 0.15 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 108.636 -1.786 . . . . 3.43 108.636 161.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.3 156.43 12.6 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.246 0.618 . . . . 4.45 112.191 -173.02 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.16 142.62 15.53 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.23 -1.948 . . . . 1.59 108.23 170.347 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.1 m -89.47 158.47 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.517 0.727 . . . . 2.83 109.148 173.226 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.03 131.74 17.9 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 106.84 -1.541 . . . . 2.58 106.84 169.732 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -117.34 112.92 21.38 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.837 -0.801 . . . . 3.31 108.837 175.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.7 mt -109.93 136.16 49.66 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.244 1.417 . . . . 2.27 108.08 -179.349 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 42' ' ' ASN . 1.0 OUTLIER -78.54 96.45 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 104.255 -2.498 . . . . 1.66 104.255 156.678 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.5 t -82.69 131.21 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.004 -1.48 . . . . 1.73 107.004 172.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -144.2 136.85 26.93 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.771 0.828 . . . . 5.31 108.877 -169.717 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 115.4 -25.91 9.46 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 124.47 1.033 . . . . 1.31 110.775 -169.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -70.57 74.22 0.55 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 122.173 0.987 . . . . 1.61 110.972 179.461 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -50.68 -36.0 33.73 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.865 1.266 . . . . 1.61 114.303 -168.42 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.5 p -146.6 170.62 16.54 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.146 0.885 . . . . 0.92 111.978 -168.505 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.79 -41.8 24.36 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.583 1.153 . . . . 0.64 111.457 176.827 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.1 m -59.98 -33.2 71.63 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 123.158 0.583 . . . . 1.73 111.724 178.272 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 71.5 m -72.62 -46.26 54.95 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 119.007 0.821 . . . . 1.24 112.045 167.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.0 t -51.18 -60.98 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 118.262 0.483 . . . . 0.73 110.8 -178.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -27.65 65.0 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.383 -0.823 . . . . 0.91 111.931 -174.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -55.56 -54.68 41.05 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 108.698 -0.852 . . . . 3.33 108.698 169.496 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.468 HD11 ' CD2' ' A' ' 67' ' ' PHE . 61.8 mt -54.56 -59.39 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 118.451 -0.785 . . . . 0.74 109.012 176.564 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -50.83 -59.78 3.75 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 123.779 0.674 . . . . 4.24 110.288 -173.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.9 t -58.1 -45.78 86.64 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.653 0.781 . . . . 0.99 110.861 -176.122 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 30.5 t -64.78 -56.83 11.13 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.126 -0.694 . . . . 1.18 109.126 -178.038 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 36.5 tp -52.57 -51.4 59.94 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 125.012 1.325 . . . . 2.43 111.021 -177.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 76.6 m -62.87 -9.31 9.18 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.954 0.724 . . . . 2.8 112.954 179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -31.28 72.44 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.557 -1.339 . . . . 4.82 111.523 168.481 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -79.75 71.87 6.43 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.948 -0.76 . . . . 2.25 108.948 -178.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -42.97 102.23 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.197 1.399 . . . . 6.68 110.137 177.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 151.24 -39.33 0.81 Allowed Glycine 0 CA--C 1.522 0.495 0 N-CA-C 109.22 -1.552 . . . . 1.26 109.22 -164.167 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.31 140.86 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 104.346 -2.464 . . . . 2.83 104.346 148.579 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.5 mt -104.24 -42.56 5.47 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.576 1.15 . . . . 1.73 109.715 -175.658 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -146.71 153.06 39.82 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 109.856 -0.424 . . . . 1.99 109.856 176.162 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.3 t -136.93 136.37 38.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.484 1.914 . . . . 2.82 107.986 174.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.8 t -131.13 82.17 2.03 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.891 1.277 . . . . 2.02 107.876 172.108 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.407 HG12 ' HB2' ' A' ' 44' ' ' ALA . 0.1 OUTLIER -78.58 141.71 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 124.102 0.961 . . . . 1.8 110.268 172.341 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.77 151.07 26.82 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 123.196 0.598 . . . . 0.92 110.107 169.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.2 -11.97 14.52 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.812 1.245 . . . . 1.36 113.346 -165.935 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.99 -51.01 52.11 Favored 'General case' 0 C--O 1.226 -0.174 0 N-CA-C 108.576 -0.898 . . . . 1.73 108.576 173.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.2 m -79.81 -29.17 40.17 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 115.983 -0.553 . . . . 2.22 111.416 174.252 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.526 ' O ' HG22 ' A' ' 9' ' ' VAL . 24.7 m120 67.2 79.71 0.23 Allowed 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 107.242 -1.392 . . . . 1.66 107.242 -165.574 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.8 pttt -147.91 158.9 44.28 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.534 -0.543 . . . . 4.98 109.534 -176.186 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.407 ' HB2' HG12 ' A' ' 37' ' ' VAL . . . -146.64 108.86 4.44 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.519 1.928 . . . . 1.03 106.612 163.503 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -86.26 117.16 24.89 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 104.781 -2.303 . . . . 1.18 104.781 164.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.405 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.8 mp -109.29 148.36 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 105.293 -2.114 . . . . 1.89 105.293 171.358 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.48 141.25 51.05 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.692 -0.855 . . . . 2.36 108.692 156.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -154.46 153.93 32.34 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.315 1.046 . . . . 2.32 109.211 -163.03 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -84.93 114.25 54.62 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 107.665 -1.235 . . . . 3.52 107.665 173.163 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -79.23 52.51 4.31 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.07 3.18 . . . . 2.09 111.777 -170.399 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -144.82 -59.7 0.36 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 126.094 1.758 . . . . 2.82 106.874 -177.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.6 tt -72.63 -25.49 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 125.203 1.401 . . . . 2.37 111.972 179.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.8 tt -145.93 143.08 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 106.723 -1.584 . . . . 1.46 106.723 172.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -99.55 161.82 19.66 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.367 -1.093 . . . . 0.92 110.367 174.018 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -56.54 -41.12 79.38 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.501 2.134 . . . . 1.11 110.03 174.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.4 tpt85 -56.28 -36.03 68.14 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.09 -0.957 . . . . 6.11 111.726 179.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -71.26 -48.17 52.65 Favored 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 123.524 0.73 . . . . 2.19 110.026 -177.37 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 mt -49.63 -56.48 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 N-CA-C 108.21 -1.033 . . . . 0.81 108.21 171.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.2 mt -56.05 -43.1 74.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.893 -0.594 . . . . 1.01 109.999 -179.787 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -56.7 -40.62 75.96 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.397 0.679 . . . . 4.34 111.414 176.308 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.16 -43.92 77.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 119.443 -0.903 . . . . 2.1 109.293 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 mp -51.9 -52.0 25.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 124.52 1.128 . . . . 1.76 111.057 174.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -57.92 -55.52 33.8 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.595 1.158 . . . . 1.94 110.019 175.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.2 t -53.48 -43.42 68.18 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.262 1.025 . . . . 1.34 110.851 -175.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 66.2 mt -62.59 -66.14 0.58 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 110.312 -0.255 . . . . 2.12 110.312 173.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -160.99 -24.94 0.02 OUTLIER Glycine 0 CA--C 1.53 0.993 0 N-CA-C 117.504 1.762 . . . . 1.31 117.504 -178.223 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.468 ' CD2' HD11 ' A' ' 22' ' ' ILE . 13.5 m-85 -126.6 152.16 47.01 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 119.055 1.427 . . . . 1.74 110.535 -137.779 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -84.41 152.42 24.04 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.521 -1.289 . . . . 4.06 107.521 172.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -122.12 129.51 52.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.78 0.832 . . . . 1.05 109.478 163.514 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m -108.36 104.41 13.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.496 -1.298 . . . . 2.75 107.496 169.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -53.69 126.42 21.84 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.019 0.827 . . . . 3.75 110.633 175.081 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.1 m -87.36 -34.45 7.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 117.966 0.348 . . . . 3.57 110.369 176.239 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -165.13 176.07 8.81 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.717 0.807 . . . . 5.59 109.354 172.056 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.5 mm -131.13 147.25 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 C-N-CA 126.896 2.078 . . . . 11.25 105.393 173.501 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.254 1.317 0 N-CA-C 105.026 -2.213 . . . . 12.79 105.026 164.119 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.5 tpt . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 108.022 -1.103 . . . . 8.11 108.022 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.16 52.35 51.95 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 108.392 -1.883 . . . . 4.35 108.392 -161.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . 0.339 2.6 p30 36.64 -108.5 0.05 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.737 1.215 . . . . 4.34 112.251 -153.293 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 140.3 126.43 2.28 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 106.239 -2.744 . . . . 1.41 106.239 -164.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 m -115.5 82.79 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 124.549 1.14 . . . . 3.25 110.635 -172.267 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 tp -81.55 81.67 7.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.201 -1.037 . . . . 3.38 108.201 175.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -95.0 102.77 14.6 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.155 -0.929 . . . . 2.89 109.029 171.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.6 151.0 40.88 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.755 1.222 . . . . 2.24 109.376 -177.55 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.4 t -77.6 129.87 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 105.717 -1.957 . . . . 1.01 105.717 166.046 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.4 t -111.35 97.7 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 N-CA-C 105.452 -2.055 . . . . 2.3 105.452 174.068 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.8 ptp85 -81.68 146.43 30.02 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.267 -1.012 . . . . 7.22 108.267 178.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 102.13 -9.51 56.37 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.06 0.838 . . . . 1.04 112.1 -174.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 31.7 ttm -65.96 71.95 0.06 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.605 1.562 . . . . 1.95 110.935 176.676 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 t -71.98 -31.47 66.3 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.697 0.629 . . . . 1.52 112.697 -167.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.9 p -154.18 174.81 14.25 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 119.255 0.934 . . . . 0.83 112.397 -169.359 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.89 -41.26 45.27 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.503 1.121 . . . . 0.72 111.046 175.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.9 m -63.72 -24.79 67.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.174 0.589 . . . . 1.65 112.235 178.498 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 72.3 m -72.57 -62.6 1.39 Allowed 'General case' 0 C--N 1.337 0.05 0 CA-C-N 119.478 1.035 . . . . 0.95 110.086 163.207 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.7 t -36.24 -66.38 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.315 0 C-N-CA 125.538 1.535 . . . . 0.88 111.072 -177.002 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.33 -27.6 66.41 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 120.705 -0.398 . . . . 0.83 111.604 -172.555 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -69.43 -55.63 9.77 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.912 -1.144 . . . . 3.54 107.912 -179.533 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.4 mt -50.02 -59.44 1.07 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 108.293 -1.003 . . . . 0.81 108.293 177.52 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -55.65 -56.01 25.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.186 -0.915 . . . . 3.88 110.338 -174.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.5 t -66.08 -29.59 69.95 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.168 -0.92 . . . . 1.56 112.271 -176.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.6 m -70.93 -50.66 32.23 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 107.957 -1.127 . . . . 2.34 107.957 179.38 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.2 mt -53.54 -46.57 70.24 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.468 -0.333 . . . . 2.4 110.831 175.163 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.2 m -56.4 -9.12 0.63 Allowed 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.964 1.098 . . . . 2.16 113.964 -179.252 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -75.92 -29.81 58.53 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 120.527 -1.358 . . . . 7.4 112.024 172.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -75.18 161.68 29.16 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.017 0.927 . . . . 2.05 109.509 -173.571 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.45 -42.76 7.57 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-O 119.131 -0.462 . . . . 8.24 111.479 -175.285 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -70.29 -12.75 69.67 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 119.112 0.869 . . . . 1.08 113.207 -176.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.4 pp -77.54 159.31 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 107.785 -1.191 . . . . 2.59 107.785 168.18 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.3 mt -129.39 -41.1 1.4 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.223 1.009 . . . . 2.39 110.112 -172.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -149.84 148.22 28.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.646 -1.613 . . . . 2.06 106.646 174.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.6 m -128.87 126.25 39.36 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 105.232 -2.136 . . . . 2.65 105.232 178.473 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 24.1 t -144.54 104.93 4.11 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 108.831 -0.803 . . . . 1.49 108.831 178.233 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.95 148.64 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 123.63 0.772 . . . . 1.63 111.428 -175.766 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.74 109.43 3.45 Favored 'General case' 0 C--N 1.34 0.166 0 O-C-N 122.08 -0.387 . . . . 1.13 111.759 -176.849 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.65 -15.42 19.08 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.919 1.081 . . . . 1.47 113.919 177.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.36 -35.27 76.99 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.874 0.47 . . . . 1.27 110.656 171.589 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -116.49 -6.21 11.7 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.748 1.219 . . . . 3.17 111.467 178.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.9 m120 56.64 29.32 15.48 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 125.838 1.655 . . . . 1.47 110.764 -179.762 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.66 144.64 37.73 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.495 -1.668 . . . . 3.19 106.495 -176.89 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.82 114.2 20.73 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.465 -1.68 . . . . 0.99 106.465 165.445 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -91.2 104.7 17.22 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 105.418 -2.067 . . . . 1.75 105.418 172.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 46' ' ' ILE . 2.1 mp -103.99 115.86 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 N-CA-C 105.987 -1.857 . . . . 1.66 105.987 170.302 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 36.6 mmtt -78.51 133.9 37.35 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 105.645 -1.983 . . . . 2.98 105.645 162.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -151.53 163.57 38.73 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 123.548 0.739 . . . . 1.85 109.84 -173.559 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -100.18 124.92 41.53 Favored Pre-proline 0 N--CA 1.449 -0.513 0 N-CA-C 108.552 -0.907 . . . . 3.48 108.552 163.04 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.79 -17.02 33.2 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.663 2.909 . . . . 2.03 113.663 -174.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -86.56 -44.47 11.89 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.416 -0.957 . . . . 3.1 108.416 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.6 mt -71.25 -43.09 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 122.244 -0.285 . . . . 3.41 110.82 178.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.59 118.93 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 105.83 -1.915 . . . . 1.46 105.83 -178.574 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.95 150.38 51.92 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 108.718 -1.753 . . . . 1.13 108.718 171.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -57.64 -40.48 79.63 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 CA-C-N 119.248 1.524 . . . . 1.06 109.736 175.059 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -42.8 -42.23 3.52 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.182 1.393 . . . . 7.44 112.578 168.134 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -71.28 -43.05 67.93 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.996 0.816 . . . . 2.2 110.121 -172.034 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.5 mt -57.78 -48.3 83.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 109.133 -0.691 . . . . 0.63 109.133 173.503 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.2 mt -54.41 -53.22 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 109.842 -0.429 . . . . 1.46 109.842 176.09 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -50.63 -45.71 57.82 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.599 0.636 . . . . 3.14 110.422 176.016 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.2 m -60.14 -52.08 66.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.269 -0.641 . . . . 1.06 109.269 -176.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.9 mt -53.29 -61.96 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.534 0.734 . . . . 1.23 110.035 175.337 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -66.19 -25.24 66.84 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.308 -0.406 . . . . 3.22 111.438 -167.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.8 t -63.47 -15.73 58.61 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 117.789 -1.1 . . . . 1.58 112.891 175.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.38 -96.56 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 120.065 1.302 . . . . 2.91 108.664 170.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -157.72 50.65 0.42 Allowed Glycine 0 C--N 1.336 0.566 0 N-CA-C 109.739 -1.344 . . . . 0.97 109.739 177.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -135.92 175.03 9.97 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.351 1.06 . . . . 2.18 108.971 -170.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -141.01 140.89 34.38 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 107.254 -1.387 . . . . 4.87 107.254 173.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -112.54 159.7 18.55 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.476 0.655 . . . . 1.16 112.611 -173.108 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.4 133.86 10.8 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 125.03 1.332 . . . . 1.91 108.21 172.376 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.0 mt -53.57 141.65 24.97 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.646 1.112 . . . . 2.45 110.19 173.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -127.51 -64.11 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-O 118.88 -0.581 . . . . 3.38 110.46 171.186 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.4 ttpp 55.55 98.49 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.635 1.174 . . . . 4.26 112.167 -172.259 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.44 HG23 ' O ' ' A' ' 74' ' ' ILE . 17.0 tt -68.0 74.84 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.667 1.187 . . . . 11.53 111.786 -178.69 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 127.776 2.43 . . . . 11.11 107.98 -165.546 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_